<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="EN" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Rev</journal-id><journal-id journal-id-type="iso-abbrev">Chem Rev</journal-id><journal-id journal-id-type="pmc-domain-id">822</journal-id><journal-id journal-id-type="pmc-domain">acssd</journal-id><journal-id journal-id-type="publisher-id">cr</journal-id><journal-title-group><journal-title>Chemical Reviews</journal-title></journal-title-group><issn pub-type="ppub">0009-2665</issn><issn pub-type="epub">1520-6890</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>ACS AuthorChoice</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9837829</article-id><article-id pub-id-type="pmcid-ver">PMC9837829.1</article-id><article-id pub-id-type="pmcaid">9837829</article-id><article-id pub-id-type="pmcaiid">9837829</article-id><article-id pub-id-type="pmid">36399832</article-id><article-id pub-id-type="doi">10.1021/acs.chemrev.2c00398</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Review</subject></subj-group></article-categories><title-group><article-title>Radiosynthesis,
Preclinical, and Clinical Positron
Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural
Exogenous Compounds</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name name-style="western"><surname>Shegani</surname><given-names initials="A">Antonio</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath2"><name name-style="western"><surname>Kealey</surname><given-names initials="S">Steven</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath3"><name name-style="western"><surname>Luzi</surname><given-names initials="F">Federico</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath4"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0710-4251</contrib-id><name name-style="western"><surname>Basagni</surname><given-names initials="F">Filippo</given-names></name><xref rid="aff2" ref-type="aff">&#8225;</xref></contrib><contrib contrib-type="author" id="ath5"><name name-style="western"><surname>Machado</surname><given-names initials="JDM">Joana do Mar</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath6"><name name-style="western"><surname>Ekici</surname><given-names initials="SD">Sevban Do&#287;an</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath7"><name name-style="western"><surname>Ferocino</surname><given-names initials="A">Alessandra</given-names></name><xref rid="aff3" ref-type="aff">&#167;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath8"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8389-9012</contrib-id><name name-style="western"><surname>Gee</surname><given-names initials="AD">Antony D.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath9"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1309-3045</contrib-id><name name-style="western"><surname>Bongarzone</surname><given-names initials="S">Salvatore</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="notes2" ref-type="notes">&#8741;</xref></contrib><aff id="aff1"><label>&#8224;</label>School
of Biomedical Engineering &amp; Imaging Sciences, <institution>King&#8217;s College London, King&#8217;s Health Partners</institution>, St Thomas&#8217; Hospital, London SE1 7EH, <country>United Kingdom</country></aff><aff id="aff2"><label>&#8225;</label>Department
of Pharmacy and Biotechnology, <institution>Alma Mater
Studiorum&#8722;University of Bologna</institution>, via Belmeloro 6, 40126 Bologna, <country>Italy</country></aff><aff id="aff3"><label>&#167;</label>Institute
of Organic Synthesis and Photoreactivity, <institution>Italian National Research Council</institution>, via Piero Gobetti 101, 40129 Bologna, <country>Italy</country></aff></contrib-group><author-notes><corresp id="cor2"><label>*</label>S.B.:
email, <email>bongarzo@gmail.com</email>.</corresp><corresp id="cor1"><label>*</label>A.G.: email, <email>antony.gee@kcl.ac.uk</email>.</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="collection"><day>11</day><month>01</month><year>2023</year></pub-date><volume>123</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">426344</issue-id><fpage>105</fpage><lpage>229</lpage><history><date date-type="received"><day>09</day><month>06</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>13</day><month>01</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>14</day><month>01</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-09 23:25:18.710"><day>09</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cr2c00398.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" xlink:title="correction" journal-id="Chem Rev" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC10416209"><article-title>Correction to
&#8220;Radiosynthesis, Preclinical
and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled
Endogenous and Natural Exogenous Compounds&#8221;</article-title><volume>123</volume><issue>15</issue><date><day>27</day><month>7</month><year>2023</year></date><fpage>9718</fpage><lpage>9718</lpage><source>Chemical Reviews</source><pub-id pub-id-type="pmcid">PMC10416209</pub-id><pub-id pub-id-type="pmid">37499108</pub-id></related-article><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="ab-tgr1" position="float" orientation="portrait" xlink:href="cr2c00398_0197.jpg"/></p><p>The presence of positron emission tomography (PET) centers
at most
major hospitals worldwide, along with the improvement of PET scanner
sensitivity and the introduction of total body PET systems, has increased
the interest in the PET tracer development using the short-lived radionuclides
carbon-11. In the last few decades, methodological improvements and
fully automated modules have allowed the development of carbon-11
tracers for clinical use. Radiolabeling natural compounds with carbon-11
by substituting one of the backbone carbons with the radionuclide
has provided important information on the biochemistry of the authentic
compounds and increased the understanding of their <italic toggle="yes">in vivo</italic> behavior in healthy and diseased states. The number of endogenous
and natural compounds essential for human life is staggering, ranging
from simple alcohols to vitamins and peptides. This review collates
all the carbon-11 radiolabeled endogenous and natural exogenous compounds
synthesised to date, including essential information on their radiochemistry
methodologies and preclinical and clinical studies in healthy subjects.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>GlaxoSmithKline</institution><institution-id institution-id-type="doi">10.13039/100004330</institution-id></institution-wrap></funding-source><award-id>3000034923</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>EPSRC Centre for Doctoral Training in Medical Imaging</institution><institution-id institution-id-type="doi">10.13039/501100013915</institution-id></institution-wrap></funding-source><award-id>EP/S032789/1</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Bodossaki Foundation</institution><institution-id institution-id-type="doi">10.13039/501100002752</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Kings College London</institution><institution-id institution-id-type="doi">10.13039/501100000764</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Wellcome Trust</institution><institution-id institution-id-type="doi">10.13039/100004440</institution-id></institution-wrap></funding-source><award-id>WT203148/Z/16/Z</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cr2c00398</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cr2c00398</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><sec id="sec1.1"><label>1.1</label><title>Background</title><p>Living biological systems
are composed of myriad molecules providing a physical and functional
scaffold for life to thrive and propagate. The molecules exist in
numerous forms: messenger and transport molecules, sources of fuel,
structural building blocks, or more complex molecular arrangements
such as membranes, proteins, and DNA. In probing the complexity and
function of living systems, the study of the molecules that create
this ecosystem is crucial to enable our understanding of normal function
and disease in humans and other organisms.</p><p>Complex biological
systems are composed of molecules created by the organism itself (endogenous
compounds) and molecules not synthesized <italic toggle="yes">in situ</italic> but
acquired from its environment (exogenous compounds). Exogenous compounds
can be natural products already existing in the natural world but
not synthesized by the organism <italic toggle="yes">per se</italic> (<italic toggle="yes">e.g.</italic>, &#8220;essential&#8221; amino acids) or compounds synthesized
in a laboratory (<italic toggle="yes">e.g.</italic>, therapeutics).</p><p>Many
techniques have been used to study the role of endogenous
and natural exogenous compounds in humans, including the use of radiolabeled
compounds. Over the last 50 years, the <italic toggle="yes">in vivo</italic> imaging
of radiolabeled compounds in humans has been made possible by the
technique called positron emission tomography (PET) using compounds
radiolabeled with biogenic radionuclides such as Carbon-11.</p><p>PET is widely considered the most sensitive technique for noninvasively
studying physiology, metabolism, and molecular pathways in the living
human being. Over the last few decades, tremendous advances have been
made in radiosynthetic/radioanalytical chemistry and instrumentation,
including improved detector sensitivity/responsivity, radiolabeling
techniques, signal processing, and instrumentation. These technological
advances have significantly increased the number of carbon-11 labeled
compounds available for PET studies, providing valuable tools for
understanding human physiology in health and disease. This comprehensive
review aims to compile a library of the most important carbon-11 labeled
endogenous and natural exogenous compounds used to date, including
synthetic methods and <italic toggle="yes">in vivo</italic> distribution and kinetics,
as an essential reference for new and established researchers and
practitioners in the field.</p></sec><sec id="sec1.2"><label>1.2</label><title>Scope of the Review</title><p>This review describes
the synthetic methods and routes developed for radiolabeled endogenous
and natural exogenous compounds, focusing on the synthetic methods
applied to carbon-11 chemistry and their <italic toggle="yes">in vivo</italic> kinetics
in preclinical and clinical studies. The compounds have been divided
into 11 categories: alcohols, alkaloids, amino acids, enzyme cofactors
and vitamins, endogenous gases, fatty acids, hormones and neurotransmitters,
nucleotides, peptides, sugars, and miscellaneous compounds with a
(1) general introduction, (2) radiosynthesis, (3) preclinical, and
(4) clinical studies in healthy subjects described for each radiopharmaceutical
compound. Each section contains a selection of synthetic schemes and
images from <italic toggle="yes">in vivo</italic> PET scanning as appropriate.
This review covers all relevant publications up to May 2022.</p></sec><sec id="sec1.3"><label>1.3</label><title>Carbon-11</title><p>In 1934, Lauritsen <italic toggle="yes">et al</italic>. observed the formation of a radionuclide with a half-life
of 20 min following the deuteron irradiation on boron oxide.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> This radionuclide was subsequently identified
as carbon-11 (<sup>11</sup>C), formed by the <sup>10</sup>B(d,n)<sup>11</sup>C nuclear reaction and isolated in the form of carbon-11
dioxide ([<sup>11</sup>C]CO<sub>2</sub>) and carbon-11 monoxide ([<sup>11</sup>C]CO).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> In 1939, the formation
of carbon-11 by the bombardment of nitrogen-14 gas with high-energy
cyclotron-produced protons was achieved by Barkas.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> To date, the <sup>14</sup>N(p,a)<sup>11</sup>C remains
the most common method of producing <sup>11</sup>C.</p><p>Carbon-11,
with a physical half-life of 20.4 min, decays to stable boron-11.
Decay occurs primarily (99.8%) by positron emission, with the emitted
positron having mean energy of 0.386 MeV and a mean range of 1.2 mm
in water.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The utility of <sup>11</sup>C as a radiolabel for biological applications is evident as the ubiquity
of carbon in biomolecules allows the substitution of a stable carbon-12,
with <sup>11</sup>C producing a corresponding radioactive analogue
(isotopologue) with chemical and physiological properties indistinguishable
from the carbon-12 isotopologue. The first chemical manipulation with <sup>11</sup>C was reported by Long in 1939, in which [<sup>11</sup>C]CO<sub>2</sub> was used to produce the radioactive endogenous compound potassium
[<sup>11</sup>C]oxalate.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> In the same year,
Ruben <italic toggle="yes">et al</italic>. reported the first biological application
of <sup>11</sup>C in their study of [<sup>11</sup>C]CO<sub>2</sub> uptake during photosynthesis.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> The first
human experiments with <sup>11</sup>C were performed in 1945 by Tobias <italic toggle="yes">et al</italic>. studying the [<sup>11</sup>C]CO uptake and bodily
distribution following inhalation of the gas.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p><p>The emergence of medical cyclotrons in the 1960s and PET scanners
in the late 1970s has driven <sup>11</sup>C radiochemistry research
to meet the demands for new or improved tracers for an expanding array
of biological targets.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Short-lived positron-emitting
carbon-11 has thus been widely employed to study the fate of labeled
molecules in biological systems, most notably using the <italic toggle="yes">in
vivo</italic> medical imaging technique PET. As carbon is present
in almost all biologically active molecules, methods developed for
specifically labeling the same molecule in different positions enable
the study of the divergence of metabolic pathways represented by different
radiolabeled metabolites generated. For example, serial studies using
&#946;- and carboxy labeled [<sup>11</sup>C]DOPA in the brains of
the same subjects have enabled the differentiation of [<sup>11</sup>C]dopamine formation from [<sup>11</sup>C]CO<sub>2</sub> formation;
each labeled compound having a distinct kinetic profile corresponding
to the enzymatic cleavage of radiotracers after being acted upon by
DOPA decarboxylase (see <xref rid="sec8.1" ref-type="other">section <xref rid="sec8.1" ref-type="other">8.1</xref></xref>). The following sections summarize the extensive efforts
of generations of radiochemists to label endogenous and natural products
to understand their function in mammalian systems, health, and disease.</p></sec></sec><sec id="sec2"><label>2</label><title>Alcohols</title><p>Simple alcohols are ubiquitous
in nature. Methanol is usually present
in human body fluids in trace amounts derived from dietary sources,
some normal metabolic processes, and by the action of colonic bacteria
on pectin.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Small amounts of ethanol are
endogenously produced by gut microflora through anaerobic fermentation.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> However, most ethanol detected in biofluids
and tissues likely comes from consuming alcoholic beverages.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> Propanol exists as two different isomers, 1-propanol and 2-propanol,
which are also considered byproducts of bacterial fermentation processes.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Butanol is produced in small amounts by gut
microbial fermentation through the butanoate metabolic pathway and
can be detected in blood and urine samples.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Butanol has similar effects as ethanol when ingested and is considered
a central nervous system (CNS) depressant. Carbon-11 alcohols have
been mainly used to study their distribution in the body and measure
the blood-brain barrier (BBB) permeability and cerebral blood flow
(CBF) (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p><table-wrap id="tbl1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Carbon-11 Labeled Alcohols</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compds</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1">molar activity (<italic toggle="yes">A</italic><sub>m</sub>)<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> GBq/&#956;mol</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY<sup><xref ref-type="bibr" rid="ref15">15</xref></sup></th><th style="border:none;" align="center" colspan="1" rowspan="1">total time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">methanol</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">95%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref17">17</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ethanol</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> cats,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> humans<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref21">21</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-propanol</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">6.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref23">23</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-propanol</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">2<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref16">16</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">butanol</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref24">24</xref>&#8722;<xref ref-type="bibr" rid="ref28">28</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> humans<sup><xref ref-type="bibr" rid="ref31">31</xref>&#8722;<xref ref-type="bibr" rid="ref33">33</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">71%</td><td style="border:none;" align="center" colspan="1" rowspan="1">65</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref34">34</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">73%</td><td style="border:none;" align="center" colspan="1" rowspan="1">37</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref35">35</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>nr: not reported.</p></fn><fn id="t1fn2"><label>b</label><p>Reaction time.</p></fn></table-wrap-foot></table-wrap><sec id="sec2.1"><label>2.1</label><title>Methanol</title><sec id="sec2.1.1"><label>2.1.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]methanol was first reported in 1972 by Christman <italic toggle="yes">et al.</italic> as a precursor in the synthesis of [<sup>11</sup>C]formaldehyde for the enzymatic labeling of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> In this process,
[<sup>11</sup>C]CO<sub>2</sub> is cryogenically trapped and then released
into a solution of LiAlH<sub>4</sub> in tetrahydrofuran (THF), where
it is reduced to [<sup>11</sup>C]methoxide. Subsequent hydrolysis
forms [<sup>11</sup>C]methanol, which can be distilled into a second
vessel if required (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). This approach is regularly used in the &#8220;wet method&#8221;
of [<sup>11</sup>C]CH<sub>3</sub>I production, where [<sup>11</sup>C]methanol is subsequently iodinated.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> Roeda and Crouzel,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> however, report
that non-negligible quantities of radioactivity remained in the reduction
vial when distilling out [<sup>11</sup>C]methanol and identified this
as [<sup>11</sup>C]formate arising from incomplete reduction.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> The same group reported that the reducing agent
SmI<sub>2</sub> could improve the yield of [<sup>11</sup>C]methanol
through enhanced reduction of [<sup>11</sup>C]formate.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> This could be performed either by treating the
lithium hydride-reduced [<sup>11</sup>C]CO<sub>2</sub> mixture with
SmI<sub>2</sub> (88% radiochemical yield, RCY) or by making [<sup>11</sup>C]formate intentionally using LiBEt<sub>3</sub>H, followed
by SmI<sub>2</sub> reduction (90&#8211;100% RCY) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). [<sup>11</sup>C]Methanol
production has also been reported using an alumina column impregnated
with ethereal LiAlH<sub>4</sub>.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> This
method allows for direct trapping and reduction of [<sup>11</sup>C]CO<sub>2</sub> from the irradiated target gas, followed by hydrolysis on
the column, with a reported RCY of &gt;95%.</p><fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Radiosynthesis of [<sup>11</sup>C]methanol using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr1" position="float" orientation="portrait" xlink:href="cr2c00398_0001.jpg"/></fig></sec><sec id="sec2.1.2"><label>2.1.2</label><title>Preclinical Studies</title><p>In 1976, Raichle <italic toggle="yes">et al</italic>. performed a scintigraphy study to measure the BBB
permeability of [<sup>11</sup>C]methanol in rhesus monkeys following
intra-arterial injection.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> This allowed
the estimation of the fraction of labeled [<sup>11</sup>C]methanol
extracted by the brain during a single capillary transit and the brain
capillary surface area.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></p></sec></sec><sec id="sec2.2"><label>2.2</label><title>Ethanol</title><sec id="sec2.2.1"><label>2.2.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ethanol was synthesized by DeGraza <italic toggle="yes">et al</italic>. in 1974 by reaction of CH<sub>3</sub>MgBr with [<sup>11</sup>C]CO<sub>2</sub> followed by reduction using LiAlH<sub>4</sub>.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> In total, the researchers produced 37 MBq of
[<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol from 370 MBq of [<sup>11</sup>C]CO<sub>2</sub> trapped in a NaOH solution within 60 min (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).<sup><xref ref-type="bibr" rid="ref21">21</xref></sup></p><fig id="fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr2" position="float" orientation="portrait" xlink:href="cr2c00398_0002.jpg"/></fig></sec><sec id="sec2.2.2"><label>2.2.2</label><title>Preclinical Studies</title><p>In 1973, Robinson <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> studied [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol extraction in the brain of rats, rabbits,
and dogs, and Poe <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> in the heart of dogs; however, quantitative results have not been
reported. A year later, DeGrazia <italic toggle="yes">et al</italic>. reported <italic toggle="yes">in vivo</italic> study of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol
in cats. The results showed a high accumulation of radioactivity in
the liver (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>), with the authors concluding that some aspects of ethanol metabolism
could be assessed in specific tissues such as the liver.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup></p><fig id="fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Images of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol uptake
in
cats&#8217; liver using gamma scan. Reproduced with permission from
ref (<xref ref-type="bibr" rid="ref21">21</xref>). Copyright
1975 Society of Nuclear Medicine. This work is licensed under a Creative
Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr3" position="float" orientation="portrait" xlink:href="cr2c00398_0003.jpg"/></fig><p>In 1976, the extraction of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol
by the brain was studied <italic toggle="yes">in vivo</italic> in six adult rhesus
monkeys (<italic toggle="yes">Macaca mulatta</italic>) by external
detection of the time course of these tracers after their internal
carotid artery injection. The data demonstrated the feasibility of
accurately measuring brain permeability of highly diffusible substances
and showed that [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol could freely
equilibrate within the brain.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Another
study in monkeys was performed in 2002 by Gulyas <italic toggle="yes">et al</italic>. to evaluate the contribution of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol to the regional cerebral radioactivity arising from de-esterification
of [<italic toggle="yes">ethyl</italic>-<sup>11</sup>C]vinpocetine.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Ethanol rapidly
entered the brain, reaching a maximum between 60 and 120 s after iv
injection. After this peak, the radioactivity in the brain rapidly
declined (<italic toggle="yes">t</italic><sub>1/2</sub> = 250 s).<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p><p>In 1980, Kleinanen <italic toggle="yes">et al</italic>. reported
liver perfusion
experiments in male Wistar rats after injection of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol through the portal vein.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> The results showed a maximal extraction of about one, indicating
that [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol distribution is flow-limited
in the liver.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup></p></sec><sec id="sec2.2.3"><label>2.2.3</label><title>Clinical Studies</title><p>The distribution
of ethanol was followed in a healthy human in a fasting state after
the peroral administration of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol.
After 10 min, most of the radioactivity was in the stomach, but smaller
amounts were observed in the proximal part of the small intestine.
After 30 min, intestinal and liver radioactivity concentrations increased.
After 40 min, the uptake in the liver was further increased, and activity
could be detected throughout the body. During this experiment, a considerable
part of the activity was retained in the stomach and liver. The distribution
in all the other tissues was nearly uniform, and there was no distinct
accumulation in the brain.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup></p><p>Pharmacokinetic
imaging following intratumoral injection of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ethanol in eight patients with hepatocellular carcinomas
showed that five out of seven tumors demonstrated high uptake shortly
after injection, followed by a plateau during the remainder of the
45 min study (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>).<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> The PET data demonstrated no significant
elimination of radioactivity from the tumor and no accumulation in
the surrounding liver tissue.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup></p><fig id="fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ethanol intratumoral administration
PET scans after (5a) 5 min and (b) 45 min. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref42">42</xref>). Copyright
2014 Springer Nature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr4" position="float" orientation="portrait" xlink:href="cr2c00398_0004.jpg"/></fig></sec></sec><sec id="sec2.3"><label>2.3</label><title><italic toggle="yes">1</italic>-Propanol and <italic toggle="yes">2</italic>-Propanol</title><sec id="sec2.3.1"><label>2.3.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]1-Propanol was obtained from the reaction of [<sup>11</sup>C]CO<sub>2</sub> with vinyl magnesium bromide, followed by
reduction with different reducing agents, with the best RCY achieved
with AlH<sub>3</sub>. After purification with gas chromatography,
RCY was 4&#8211;6.5% from [<sup>11</sup>C]CO<sub>2</sub> in 40 min
synthesis time from the end of [<sup>11</sup>C]CO<sub>2</sub> production
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Using a slightly different method, CH<sub>3</sub>Li was reacted with [<sup>11</sup>C]CO<sub>2</sub> in ether, followed
by reduction with LiAlH<sub>4</sub>, to obtain 185&#8211;370 MBq
of [<italic toggle="yes">2</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-propanol
from 370&#8211;740 MBq of [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></p><fig id="fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Radiosynthetic schemes of [<italic toggle="yes">1</italic>-<sup>11</sup>C]<italic toggle="yes">1</italic>-propanol and [<italic toggle="yes">2</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-propanol. <sup>11</sup>C radionuclide position
is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr5" position="float" orientation="portrait" xlink:href="cr2c00398_0005.jpg"/></fig></sec><sec id="sec2.3.2"><label>2.3.2</label><title>Preclinical Studies</title><p>In six adult
rhesus monkeys [<italic toggle="yes">2</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-propanol, injected by the internal carotid artery, was evaluated
for its brain permeability by determining the extraction rate of the
brain for a single capillary transit.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> [<italic toggle="yes">2</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-Propanol bolus
freely exchanges with the brain, results that are consistent with
lipophilicity and establish it as one of the best short-chain alcohols
for brain permeability studies.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></p></sec></sec><sec id="sec2.4"><label>2.4</label><title><italic toggle="yes">1</italic>-Butanol</title><sec id="sec2.4.1"><label>2.4.1</label><title>Radiosynthesis</title><p>In 1985, Kothari <italic toggle="yes">et al</italic>. described the synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol <italic toggle="yes">via</italic> two routes: carbonylation
of an organoborane (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A) and carbonation of a Grignard reagent (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B).<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The reaction of [<sup>11</sup>C]CO with <italic toggle="yes">B</italic>-<italic toggle="yes">n</italic>-propyl-<italic toggle="yes">9</italic>-borabicyclo[<italic toggle="yes">4</italic>.<italic toggle="yes">4</italic>.<italic toggle="yes">1</italic>]nonane, followed by oxidation
in an alkaline medium, produced [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol
within 65 min with a RCY of 33&#8211;71% based on the delivered activity
of [<sup>11</sup>C]CO, and radiochemical purity (RCP)<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> &gt;95%.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The reaction of [<sup>11</sup>C]CO<sub>2</sub> with <italic toggle="yes">1</italic>-propylmagnesium
bromide, followed by lithium aluminum hydride (LAH) reduction, produced
[<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol within 27 min with a RCY
of 55&#8211;74% and RCP of 95&#8211;99%.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> A robotic synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol
taking 25 min has also been described with a RCY of 11&#8211;15%.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup></p><fig id="fig6" position="float" orientation="portrait"><label>Figure 6</label><caption><p>Radiosynthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol
using
[<sup>11</sup>C]CO or [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr6" position="float" orientation="portrait" xlink:href="cr2c00398_0006.jpg"/></fig><p>Waterhouse <italic toggle="yes">et al</italic>. described the
automated radiosynthesis
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol consistent with Good
Manufacturing Practice (GMP) guidelines.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Ten batches of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol product
were produced consecutively and fully compliant with United States
Pharmacopeia guidelines within 37 &#177; 5 min, with a RCY of 73 &#177;
13%, and RCP of 97.7 &#177; 1.3% (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>C).<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup></p></sec><sec id="sec2.4.2"><label>2.4.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Butanol has been evaluated in rats,<sup><xref ref-type="bibr" rid="ref24">24</xref>&#8722;<xref ref-type="bibr" rid="ref28">28</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> and monkeys.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> In Sprague-Dawley rats, a measurement of CBF was performed after
a bolus intravenous injection of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol. To improve the preconditions for external hyperthermia
treatment of cancer, Knapp <italic toggle="yes">et al</italic>. measured the effects
of a specific calcium antagonist and 5-hydroxytryptamine (5-HT) on
tumor-to-muscle blood flow in tumor transplants of rats.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Butanol appears
to be an appropriate radiotracer for assessing blood supply to malignant
tumors relative to muscle.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup></p><p>In 1984,
a new method for measuring CBF in rats was described by Takagi <italic toggle="yes">et al.</italic>, which is noninvasive to the brain, skull, or large
cervical vessels, minimizes blood loss and gives stable blood flow
values.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> Three years later, the same group
developed a quantitative method to measure the water extraction fraction
of rat brain after successive intravenous bolus injections of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup></p><p>A study
was performed in dogs to determine whether regional myocardial
perfusion can be assessed quantitatively by administering a freely
diffusible tracer intravenously at an exponentially increasing rate,
with the authors finding that the approach permits accurate measurement
of myocardial perfusion and that it should prove helpful in the noninvasive
measurement of regional myocardial perfusion <italic toggle="yes">in vivo</italic> by PET.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></p><p>Another study by Knapp <italic toggle="yes">et al</italic>. showed that more
than 80% of the activity was cleared from the blood within 1 min following
the administration of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol into
the aorta of two dogs.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Within 25 min,
activity was only observed in the liver, spleen, and kidneys, while
muscle and whole body showed constant levels.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup></p><p>In monkeys, preliminary results with [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol indicate no diffusion limitation, and it is freely
diffusible
in the rhesus monkey brain after an intracarotid injection.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup></p></sec><sec id="sec2.4.3"><label>2.4.3</label><title>Clinical Studies</title><p>Herscovitch <italic toggle="yes">et al</italic>. in 1987 validated the use of [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol in 17 healthy humans as an alternative freely diffusible
tracer for PET to determine the underestimation of CBF that occurs
with [<sup>15</sup>O]H<sub>2</sub>O.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Average
global CBF was significantly greater when measured with [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol than with [<sup>15</sup>O]H<sub>2</sub>O.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Quarles <italic toggle="yes">et al</italic>. in 1993 evaluated
[<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol in three healthy humans
after intravenous administration to further understand the best way
to measure regional CBF with PET.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> In
2012, Pagani <italic toggle="yes">et al</italic>. studied 13 patients with autism
spectrum disorder (ASD) of ordinary intelligence and 10 IQ-, sex-,
and age-matched healthy controls who underwent PET/CT (computerized
tomography) using [<italic toggle="yes">1</italic>-<sup>11</sup>C]butanol.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> Tracer uptake reached a plateau at around one
minute before decreasing with time in all patients. ASD patients showed
increased blood flow in areas such as the limbic, posterior associative,
and cerebellar cortices. Significant CBF differences were found between
highly functioning ASD subjects and healthy controls in part of the
posterior right hemisphere in limbic, posterior associative, visual,
and cerebellar cortices.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup></p></sec></sec></sec><sec id="sec3"><label>3</label><title>Alkaloids</title><p>Of all carbon-11 labeled
natural alkaloids, only <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethyltryptamine
and galantamine are endogenous. <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-Dimethyltryptamine is a hallucinogenic
compound detected in blood, urine, and cerebrospinal fluid in humans.
It interacts with several serotoninergic receptors, mainly 5-HT2A
and glutamate, accounting for its hallucinogenic properties. Due to
little sign of adverse effects, apart from some cardiovascular and
endocrine effects, <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethyltryptamine
represents an exciting model for potential therapies for psychiatric
disorders.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Galantamine is a weak competitive
and reversible cholinesterase inhibitor. Also, it is a potent allosteric
potentiating ligand of human nicotinic acetylcholine receptors (nAChRs)
in some regions of the brain<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> but does
not functionally act as a positive allosteric modulator.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> By binding to the allosteric site of the nAChRs,
a conformational change occurs, increasing the receptor&#8217;s response
to acetylcholine.<sup><xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Approximately 75% of a dose of
galantamine is metabolized in the liver from CYP2D6 and CYP3A4.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>Several natural exogenous alkaloids, important
for humans, have
been labeled with carbon-11 to evaluate their brain uptake, bodily
distribution, and metabolism (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Each of them has unique functions in the brain related
to different receptors, and carbon-11 labeling could potentially be
used for brain imaging:<list list-type="bullet"><list-item><p>Bufotenine, and its methoxy analogue, <italic toggle="yes">O</italic>-methylbufotenine, are potent hallucinogenic compounds that act as
nonselective serotoninergic ligands.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup></p></list-item><list-item><p>Caffeine is the most widely consumed CNS
stimulant of
the methylxanthine class,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> eliminated
in the liver <italic toggle="yes">via</italic> cytochrome P450.<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup></p></list-item><list-item><p>Cocaine is a potent addictive stimulant
having many
short- and long-term effects on users.<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref></sup></p></list-item><list-item><p>Codeine is a selective agonist with a weak affinity
for the &#956;-opioid receptor (MOR).<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Codeine is metabolized to morphine and norcodeine in the liver by
the cytochrome P450 enzyme CYP2D6<sup><xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> and CYP3A4,<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> respectively.</p></list-item><list-item><p>Colchicine
is a potent inhibitor of cellular mitosis.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup></p></list-item><list-item><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-<italic toggle="yes">dimethyl</italic>phenethylamine (<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-DMPEA) is a
trace amine neuromodulator in humans derived from the trace amine
phenethylamine.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref64">64</xref></sup> There is evidence that it is
a potent agonist of human trace amine-associated receptor 1.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref66">66</xref></sup> It is metabolized rapidly by
monoamine oxidases (MAO) and most probably by the isoform MAO-B during
first-pass metabolism.<sup><xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref65">65</xref></sup> Thus, labeling <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-DMPEA could be helpful for <italic toggle="yes">in vivo</italic> measurement of MAO-B activity in the brain.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup></p></list-item><list-item><p>Ephedrine and its derivative <italic toggle="yes">N-methyl-</italic>ephedrine cause the release of norepinephrine from
storage vesicles
in nerve cells and directly stimulates &#945;- and &#946;-adrenergic
receptors.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></p></list-item><list-item><p>Harmine and its derivative, harmaline, belong to the
family of &#946;-carbolines. They are known for their anxiolytic,
sedation, and psychotomimetic effects acting as potent inhibitors
of MAO-A and serotonin antagonists.<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref></sup></p></list-item><list-item><p>Morphine is the most used chronic and acute pain killer
as an opioid receptor ligand.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup></p></list-item><list-item><p>Nicotine elicits the release of neurotransmitters
such
as norepinephrine, dopamine, acetylcholine, serotonin, glutamate,
and GABA.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> It initiates its biological
function by activating the nicotinic acetylcholine receptor through
binding with ligand-gated ion channels.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></p></list-item><list-item><p>Oxycodone is a highly selective full
agonist of the
MOR but has a low affinity for the &#948;-opioid and the &#954;-opioid
receptors.<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> Oxycodone is metabolized in
the liver mainly <italic toggle="yes">via</italic> the cytochrome P450 system by
the enzymes CYP3A4 and CYP2D6.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup></p></list-item><list-item><p>Papaverine was recently identified as a
specific inhibitor
of phosphodiesterase 10A (PDE10A). The latter is a phosphodiesterase
that converts cyclic adenosine monophosphate (cAMP) to AMP and cyclic
guanosine monophosphate (cGMP) to guanosine monophosphate, concentrated
in the brain&#8217;s striatum.<sup><xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref77">77</xref></sup></p></list-item><list-item><p>Physostigmine mimics the binding of acetylcholine to
the enzyme acetylcholinesterase (AChE)<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> as a reversible inhibitor of AChE.<sup><xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref80">80</xref></sup></p></list-item><list-item><p>Psilocin is the brain-penetrant metabolite of psilocybin,
its <italic toggle="yes">O</italic>-phosphorylated derivative, and acts as an agonist
with moderate affinity for serotonin receptors and low affinity for
dopamine receptors.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup></p></list-item><list-item><p>Quinidine interacts with the sodium channels in the
Purkinje fibers of the heart.<sup><xref ref-type="bibr" rid="ref82">82</xref></sup></p></list-item><list-item><p>Scopolamine can antagonize muscarinic acetylcholine
receptors.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref84">84</xref></sup></p></list-item><list-item><p>Theophylline is distributed in the extracellular fluid,
placenta, mother&#8217;s milk, and CNS and is a competitive nonselective
phosphodiesterase inhibitor<sup><xref ref-type="bibr" rid="ref85">85</xref>&#8722;<xref ref-type="bibr" rid="ref88">88</xref></sup> and a nonselective adenosine receptor antagonist
(A1, A2 and A3 receptors).<sup><xref ref-type="bibr" rid="ref89">89</xref></sup></p></list-item></list></p><table-wrap id="tbl2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Carbon-11 Labeled Alkaloids</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub><bold>m</bold></sub> GBq/&#956;mol</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total
time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">bufotenine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref90">90</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr<xref rid="t2fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">9%</td><td style="border:none;" align="center" colspan="1" rowspan="1">20</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref90">90</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-methylbufotenine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref90">90</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">18%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref90">90</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">caffeine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">114.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">27%</td><td style="border:none;" align="center" colspan="1" rowspan="1">5</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref91">91</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">144.3</td><td style="border:none;" align="center" colspan="1" rowspan="1">64%</td><td style="border:none;" align="center" colspan="1" rowspan="1">5</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref91">91</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">7</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> cynomolgus,<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref93">93</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">247.9</td><td style="border:none;" align="center" colspan="1" rowspan="1">68%</td><td style="border:none;" align="center" colspan="1" rowspan="1">5</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref91">91</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">cocaine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref94">94</xref></sup> baboons,<sup><xref ref-type="bibr" rid="ref95">95</xref>&#8722;<xref ref-type="bibr" rid="ref99">99</xref></sup> macaques,<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref102">102</xref></sup> humans<sup><xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref99">99</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">9.25</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref95">95</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">9.25</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref95">95</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">baboons<sup><xref ref-type="bibr" rid="ref103">103</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;3.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref103">103</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">codeine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref104">104</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">25%</td><td style="border:none;" align="center" colspan="1" rowspan="1">10</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref104">104</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">colchicine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref105">105</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.389</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.5%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref106">106</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">10</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref107">107</xref></sup> rats<sup><xref ref-type="bibr" rid="ref107">107</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">8.88</td><td style="border:none;" align="center" colspan="1" rowspan="1">21%</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref108">108</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethylphenethylamine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref109">109</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">3.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref109">109</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenethyl-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> monkey<sup><xref ref-type="bibr" rid="ref109">109</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]C<sub>6</sub>H<sub>5</sub>CH<sub>2</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">3.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref109">109</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethyltryptamine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref90">90</xref></sup> dog<sup><xref ref-type="bibr" rid="ref110">110</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">2.812</td><td style="border:none;" align="center" colspan="1" rowspan="1">90%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref110">110</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ephedrine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice<sup><xref ref-type="bibr" rid="ref92">92</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">11%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref92">92</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-ephedrine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice<sup><xref ref-type="bibr" rid="ref92">92</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">43%</td><td style="border:none;" align="center" colspan="1" rowspan="1">36</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref92">92</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">galanthamine</td><td style="border:none;" align="left" colspan="1" rowspan="1">(+)-<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> rats<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">14.4%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref111">111</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">(&#8722;)-<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> rats<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">13.7%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref111">111</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">harmine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref113">113</xref></sup> baboon,<sup><xref ref-type="bibr" rid="ref114">114</xref></sup> minipigs,<sup><xref ref-type="bibr" rid="ref115">115</xref></sup> humans<sup><xref ref-type="bibr" rid="ref116">116</xref>&#8722;<xref ref-type="bibr" rid="ref120">120</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">101.32</td><td style="border:none;" align="center" colspan="1" rowspan="1">51%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref121">121</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">harmaline</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref112">112</xref></sup> baboons<sup><xref ref-type="bibr" rid="ref114">114</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">87.3</td><td style="border:none;" align="center" colspan="1" rowspan="1">65.9%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref112">112</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">morphine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref122">122</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref123">123</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">962</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref125">125</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref126">126</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">nicotine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref128">128</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref127">127</xref></sup> monkey,<sup><xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup> humans<sup><xref ref-type="bibr" rid="ref131">131</xref>&#8722;<xref ref-type="bibr" rid="ref133">133</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.1</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref127">127</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">648</td><td style="border:none;" align="center" colspan="1" rowspan="1">60.4%</td><td style="border:none;" align="center" colspan="1" rowspan="1">32</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref134">134</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">3.89</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref135">135</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">oxycodone</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref136">136</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">94.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref136">136</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">papaverine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats and monkeys<sup><xref ref-type="bibr" rid="ref137">137</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;740</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref137">137</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">physostigmine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref138">138</xref></sup> baboons,<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> humans<sup><xref ref-type="bibr" rid="ref140">140</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NCO</td><td style="border:none;" align="center" colspan="1" rowspan="1">13</td><td style="border:none;" align="center" colspan="1" rowspan="1">19%</td><td style="border:none;" align="center" colspan="1" rowspan="1">52</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref141">141</xref>&#8722;<xref ref-type="bibr" rid="ref143">143</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]COCl<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">39.6</td><td style="border:none;" align="center" colspan="1" rowspan="1">25%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref144">144</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">psilocin</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">85.1</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref145">145</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">quinidine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref146">146</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">2.22</td><td style="border:none;" align="center" colspan="1" rowspan="1">60%</td><td style="border:none;" align="center" colspan="1" rowspan="1">55</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref147">147</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">259</td><td style="border:none;" align="center" colspan="1" rowspan="1">65%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref146">146</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">scopolamine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref148">148</xref>,<xref ref-type="bibr" rid="ref149">149</xref></sup> humans<sup><xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.037</td><td style="border:none;" align="center" colspan="1" rowspan="1">43%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref152">152</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">theophylline</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">6</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">18%</td><td style="border:none;" align="center" colspan="1" rowspan="1">10</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref153">153</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>nr: not reported.</p></fn></table-wrap-foot></table-wrap><sec id="sec3.1"><label>3.1</label><title>Bufotenine and <italic toggle="yes">o</italic>-Methylbufotenine</title><sec id="sec3.1.1"><label>3.1.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Bufotenine
was obtained by <italic toggle="yes">N</italic>-methylation of <italic toggle="yes">5</italic>-hydroxy-<italic toggle="yes">N</italic>-methyltryptamine with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). The reaction was conducted in methanol at 40 &#176;C for 10 min
and then purified using a solid-phase extraction (SPE) cartridge.
In a process lasting 20 min from the end of [<sup>11</sup>C]CH<sub>3</sub>I trapping, 74 MBq of [<sup>11</sup>C]bufotenine was obtained
starting from 1628 MBq of [<sup>11</sup>C]CH<sub>3</sub>I, in 9% RCY
and 98% RCP. Similarly, <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine was synthesized by the <italic toggle="yes">N</italic>-methylation of <italic toggle="yes">5</italic>-methoxy-<italic toggle="yes">N</italic>-methyltryptamine
with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). The reaction was conducted in acetone
at 40 &#176;C for 10 min, and the purification was achieved using
a reversed-phase SPE cartridge. In a process lasting 30 min from the
end of [<sup>11</sup>C]CH<sub>3</sub>I trapping, 55.5 MBq of <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine was
obtained starting from 1036 MBq of [<sup>11</sup>C]CH<sub>3</sub>I,
with 18% RCY and 92% RCP.<sup><xref ref-type="bibr" rid="ref90">90</xref></sup></p><fig id="fig7" position="float" orientation="portrait"><label>Figure 7</label><caption><p>Radiosynthetic schemes
of [<sup>11</sup>C]bufotenine and <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr7" position="float" orientation="portrait" xlink:href="cr2c00398_0007.jpg"/></fig></sec><sec id="sec3.1.2"><label>3.1.2</label><title>Preclinical Studies</title><p>The tissue
distribution of [<sup>11</sup>C]bufotenine and <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine was evaluated in healthy
Wistar rats. After iv injection of [<sup>11</sup>C]bufotenine and <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine, most
of the radioactivity was accumulated in the liver, kidney, lung, and
small intestine, paired with a fast clearance from the blood for <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine and
slower clearance for [<sup>11</sup>C]bufotenine. The brain-to-blood
ratio of [<sup>11</sup>C]bufotenine was low, but this increased with
time, while <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-[<sup>11</sup>C]bufotenine showed relatively high accumulation in the brain at
5 min post injection (p.i.) and the radioactivity retained over time.
The liver registered a significant accumulation of radioactivity for
both radiotracers.<sup><xref ref-type="bibr" rid="ref90">90</xref></sup></p></sec></sec><sec id="sec3.2"><label>3.2</label><title>Caffeine</title><sec id="sec3.2.1"><label>3.2.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]caffeine was initially prepared
by reaction of theobromine with [<sup>11</sup>C]CH<sub>3</sub>I by
Maziere <italic toggle="yes">et al</italic>. in 1974.<sup><xref ref-type="bibr" rid="ref154">154</xref></sup> Sodium carbonate was added to a solution of theobromine in methanol,
and the mixture was subsequently heated in the presence of [<sup>11</sup>C]CH<sub>3</sub>I for 10 min (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>). The overall time for synthesis, purification, and
sterilization was about 30 min with a RCY of 10-20%.<sup><xref ref-type="bibr" rid="ref154">154</xref>,<xref ref-type="bibr" rid="ref155">155</xref></sup></p><fig id="fig8" position="float" orientation="portrait"><label>Figure 8</label><caption><p>Radiosynthesis
of [<italic toggle="yes">1</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine,
[<italic toggle="yes">3</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine,
and [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine
from theobromine, paraxanthine, and theophylline
with [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr8" position="float" orientation="portrait" xlink:href="cr2c00398_0008.jpg"/></fig><p>[<italic toggle="yes">7</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]caffeine
was initially prepared in 1978 by Saji <italic toggle="yes">et al.</italic>, by
reaction of theophylline with [<sup>11</sup>C]CH<sub>3</sub>I in a
44 min process, with a RCY of 40%.<sup><xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref156">156</xref></sup> A method
using NaH in dimethyl sulfoxide (DMSO) to promote proton abstraction
at N-7 was reported by Denutte <italic toggle="yes">et al</italic>. in 1982 (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>).<sup><xref ref-type="bibr" rid="ref157">157</xref></sup> Following reversed-phase high-pressure liquid chromatography
(HPLC), [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine
was obtained in 90% RCY, with an <italic toggle="yes">A</italic><sub>m</sub> of
2.22 GBq/&#956;mol in a 40 min process.</p><p>In 1992, Funaki <italic toggle="yes">et al</italic>. prepared [<italic toggle="yes">1</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine, [<italic toggle="yes">3</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine, and [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine from theobromine,
paraxanthine, and theophylline with [<sup>11</sup>C]CH<sub>3</sub>I within a solution of NaOH in dimethylformamide (DMF) (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>).<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> The final products were isolated by HPLC with a RCY of
27%, 64%, and 68% and <italic toggle="yes">A</italic><sub>m</sub> of 114.7, 144.3,
and 247.9 GBq/&#956;mol, respectively.<sup><xref ref-type="bibr" rid="ref91">91</xref></sup></p></sec><sec id="sec3.2.2"><label>3.2.2</label><title>Preclinical Studies</title><p>After iv administration
of [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine
in mice, the biodistribution showed high uptake in the liver, kidney,
blood, and brain at 5 min p.i.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> In 2015,
Schou <italic toggle="yes">et al</italic>. examined [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine in cynomolgus and rhesus
monkeys, supporting a preferential distribution to the brain (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>).<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> The metabolism of [<italic toggle="yes">7</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]caffeine was assessed with the PET measurements to
generate an arterial input function corrected for radiometabolites.
The partition coefficients between the brain and plasma obtained in
rhesus monkeys suggested that the passage across the BBB can be characterized
as passive diffusion.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup></p><fig id="fig9" position="float" orientation="portrait"><label>Figure 9</label><caption><p>[<italic toggle="yes">7</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]caffeine
summed retention in rhesus monkey brain (between 3 and 93 min p.i.).
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref93">93</xref>). Copyright 2015 Oxford University Press.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr9" position="float" orientation="portrait" xlink:href="cr2c00398_0009.jpg"/></fig></sec></sec><sec id="sec3.3"><label>3.3</label><title>Cocaine</title><sec id="sec3.3.1"><label>3.3.1</label><title>Radiosynthesis</title><p>Carbon-11 cocaine
has been radiolabeled in two different positions: the <italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-and <italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-positions.<sup><xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref103">103</xref></sup> (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine was synthesized from
norcocaine at the <italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-position
by using [<sup>11</sup>C]CH<sub>3</sub>I (<italic toggle="yes">A</italic><sub>m</sub>: 9.25 GBq/&#956;mol, RCP &gt; 98% in 35 min) (<xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>).<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> In 1990,
(+)-cocaine was synthesized from (<italic toggle="yes">+</italic>)-norcocaine and
[<sup>11</sup>C]CH<sub>3</sub>I with the same method. Radiosynthesis
of (&#8722;)-[<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]Cocaine was achieved in 1994 using [<sup>11</sup>C]CH<sub>3</sub>I and benzoylecgonine with a <italic toggle="yes">A</italic><sub>m</sub> &gt;
3.7
GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref103">103</xref></sup></p><fig id="fig10" position="float" orientation="portrait"><label>Figure 10</label><caption><p>Synthesis of [<sup>11</sup>C]cocaine. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr10" position="float" orientation="portrait" xlink:href="cr2c00398_0010.jpg"/></fig></sec><sec id="sec3.3.2"><label>3.3.2</label><title>Preclinical Studies</title><p>(&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine was studied
in baboons to compare <sup>11</sup>C-labeled cocaine uptake and metabolism
under different conditions.<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> In 1990,
Gatley <italic toggle="yes">et al.</italic> labeled the less biologically active
(<italic toggle="yes">+</italic>)-cocaine and compared its biodistribution and
metabolism to (&#8722;)-cocaine in baboon plasma and brain by <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies.<sup><xref ref-type="bibr" rid="ref96">96</xref></sup> There was no brain uptake of (<italic toggle="yes">+</italic>)-cocaine due to its rapid metabolism in plasma, in which it is primarily
debenzylated to give the (<italic toggle="yes">+</italic>)-ecgonine methyl ester
within 30 s p.i. (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>).</p><fig id="fig11" position="float" orientation="portrait"><label>Figure 11</label><caption><p>(&#8722;)-[<sup>11</sup>C]-Cocaine and (+)-[<sup>11</sup>C]-cocaine
PET images in baboon brain (14 to 24 min p.i.). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref96">96</xref>). Copyright
2006 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr11" position="float" orientation="portrait" xlink:href="cr2c00398_0011.jpg"/></fig><p>Biodistribution and kinetic studies with (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine using PET
in seven
adult female baboon brains after iv injection showed peak uptake in
the thalamus at 2-5 min.<sup><xref ref-type="bibr" rid="ref97">97</xref></sup> The shortest
clearance half-time was 7.9 &#177; 1.9 min in the cerebellum. (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine has also
been studied in the baboon,<sup><xref ref-type="bibr" rid="ref103">103</xref></sup> in male
ddY mice,<sup><xref ref-type="bibr" rid="ref158">158</xref></sup> in the baboon brain,<sup><xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref99">99</xref></sup> and (&#8722;)-[<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine has been studied in the baboon brain to probe the
contribution of radiometabolites to the brain images (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>).<sup><xref ref-type="bibr" rid="ref103">103</xref></sup></p><fig id="fig12" position="float" orientation="portrait"><label>Figure 12</label><caption><p>[<italic toggle="yes">O</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine
pharmacokinetics in baboon heart over time. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref159">159</xref>). Copyright
2004 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr12" position="float" orientation="portrait" xlink:href="cr2c00398_0012.jpg"/></fig><p>In 2005, Benveniste <italic toggle="yes">et al</italic>. performed
biodistribution
studies in six pregnant female bonnet macaques (<italic toggle="yes">Macaca
radiata</italic>) directly after administration of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine <italic toggle="yes">via</italic> the saphenous vein.<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> Significant
accumulation was observed in the fetal liver at 5.5 min p.i., while
fetal brain uptake was slower than maternal brain uptake. [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine uptake
in the maternal heart was 15 times higher than in the fetal heart
at 4.5 min p.i. Peak uptake in maternal kidneys occurred at 1&#8211;2
min, with half activity remaining at 15 min (<xref rid="fig13" ref-type="fig">Figure <xref rid="fig13" ref-type="fig">13</xref></xref>).<sup><xref ref-type="bibr" rid="ref100">100</xref></sup></p><fig id="fig13" position="float" orientation="portrait"><label>Figure 13</label><caption><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine
pharmacokinetics of third-trimester pregnant macaques. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref100">100</xref>). Copyright 2005 Society of Nuclear Medicine. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr13" position="float" orientation="portrait" xlink:href="cr2c00398_0013.jpg"/></fig><p>In 2008, Kimmel <italic toggle="yes">et al</italic>. performed
PET imaging studies
of [<sup>11</sup>C]cocaine (without clarifying the label position)
in awake rhesus monkeys to measure drug uptake in the brain following
iv administration.<sup><xref ref-type="bibr" rid="ref101">101</xref></sup> Results showed that
uptake in putamen was higher than in the cerebellum, with a peak at
9.5 min and dropping markedly by 40&#8211;50 min.</p><p>In 2009,
Du <italic toggle="yes">et al.</italic> performed biodistribution studies
of (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine in six female Sprague-Dawley rat brains to study the effects
of commonly used anesthetics.<sup><xref ref-type="bibr" rid="ref94">94</xref></sup></p><p>In
2014, Howell <italic toggle="yes">et al</italic>. used PET to study effects
of cocaine esterase administration on [<sup>11</sup>C]cocaine uptake
in three rhesus monkeys&#8217; brains, finding that cocaine can be
eliminated rapidly (<xref rid="fig14" ref-type="fig">Figure <xref rid="fig14" ref-type="fig">14</xref></xref>).<sup><xref ref-type="bibr" rid="ref102">102</xref></sup></p><fig id="fig14" position="float" orientation="portrait"><label>Figure 14</label><caption><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine
pharmacokinetics in a rhesus monkey&#8217;s brain. Reproduced with
permission from ref (<xref ref-type="bibr" rid="ref102">102</xref>). Copyright 2014 Springer Nature. This work is licensed under a Creative
Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr14" position="float" orientation="portrait" xlink:href="cr2c00398_0014.jpg"/></fig></sec><sec id="sec3.3.3"><label>3.3.3</label><title>Clinical Studies</title><p>(&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Cocaine was administered
intravenously <italic toggle="yes">via</italic> the saphenous vein to measure cocaine
binding in the brain of six healthy male volunteers in two tracer
doses within 2&#8211;3 h time periods.<sup><xref ref-type="bibr" rid="ref95">95</xref></sup> Highest uptake in the human brain was observed in the corpus striatum
(4&#8211;10 min p.i.) (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>).</p><fig id="fig15" position="float" orientation="portrait"><label>Figure 15</label><caption><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine
regional distribution at 15 min p.i. in healthy human brains. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref95">95</xref>). Copyright 2004 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr15" position="float" orientation="portrait" xlink:href="cr2c00398_0015.jpg"/></fig><p>Kinetic studies were performed on 14 healthy male
volunteers by
iv administration of (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine (<xref rid="fig16" ref-type="fig">Figure <xref rid="fig16" ref-type="fig">16</xref></xref>).<sup><xref ref-type="bibr" rid="ref160">160</xref></sup> The highest accumulation
was observed in the human heart, kidneys, adrenals, and liver. Another
clinical study investigated if cocaine uptake in the human brain and
heart (7 healthy humans) is influenced by the presence of alcohol.<sup><xref ref-type="bibr" rid="ref161">161</xref></sup> A cocaine uptake study showed a difference
in the uptake values of (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine between the brains of healthy volunteers
(20 males) and detoxified cocaine abusers (12 males) but no difference
between dopamine transporter availability.<sup><xref ref-type="bibr" rid="ref162">162</xref></sup> The same group has performed many [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cocaine studies in the human brain,<sup><xref ref-type="bibr" rid="ref163">163</xref>&#8722;<xref ref-type="bibr" rid="ref169">169</xref></sup> published in a review.<sup><xref ref-type="bibr" rid="ref170">170</xref></sup></p><fig id="fig16" position="float" orientation="portrait"><label>Figure 16</label><caption><p>(&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]cocaine thoracic
distribution showed <italic toggle="yes">via</italic> four
contiguous axial planes of the heart (2&#8211;10 min p.i.). The arrow
highlights liver uptake in the bottom-right image. Reproduced with
permission from ref (<xref ref-type="bibr" rid="ref160">160</xref>). Copyright 1992 Society for Nuclear Medicine. This work is licensed
under a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr16" position="float" orientation="portrait" xlink:href="cr2c00398_0016.jpg"/></fig></sec></sec><sec id="sec3.4"><label>3.4</label><title>Codeine</title><sec id="sec3.4.1"><label>3.4.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]codeine was synthesized using
[<sup>11</sup>C]CH<sub>3</sub>I in DMF with a RCY of 15&#8211;25%
within 5&#8211;10 min from [<sup>11</sup>C]CH<sub>3</sub>I addition
(<xref rid="fig17" ref-type="fig">Figure <xref rid="fig17" ref-type="fig">17</xref></xref>).<sup><xref ref-type="bibr" rid="ref104">104</xref></sup></p><fig id="fig17" position="float" orientation="portrait"><label>Figure 17</label><caption><p>Synthesis of [<sup>11</sup>C]codeine using
[<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position
is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr17" position="float" orientation="portrait" xlink:href="cr2c00398_0017.jpg"/></fig></sec><sec id="sec3.4.2"><label>3.4.2</label><title>Preclinical Studies</title><p>Two rhesus
monkeys (<italic toggle="yes">Macaca mulatta</italic>) were imaged
after overnight fasting. The radioactivity uptake in the brain from
[<sup>11</sup>C]codeine peaked within 5 min. The radioactivity was
about 20% higher in gray matter compared to white, probably reflecting
higher blood flow in the gray matter. The uptake of codeine radioactivity
in extracranial soft tissue was slow, and the normalized uptake was
1.5 and 1.6 in two monkeys.<sup><xref ref-type="bibr" rid="ref104">104</xref></sup></p></sec></sec><sec id="sec3.5"><label>3.5</label><title>Colchicine</title><sec id="sec3.5.1"><label>3.5.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">10</italic>-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]colchicine was synthesized
by <italic toggle="yes">O</italic>-[<sup>11</sup>C]methylation of 10-desmethyl-colchicine
with [<sup>11</sup>C]CH<sub>3</sub>I, with a RCY of 21% and <italic toggle="yes">A</italic><sub>m</sub> of 8.88 GBq/&#956;mol in a process lasting
60 min (<xref rid="fig18" ref-type="fig">Figure <xref rid="fig18" ref-type="fig">18</xref></xref>).<sup><xref ref-type="bibr" rid="ref108">108</xref></sup> [3-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]colchicine
was radiolabeled by <italic toggle="yes">O</italic>-[<sup>11</sup>C]methylation
at the 4-position using [<sup>11</sup>C]CH<sub>3</sub>OTf, with a
non-decay correct (ndc) RCY of 0.5%, RCP &gt;99% and <italic toggle="yes">A</italic><sub>m</sub> of 0.389 GBq/&#956;mol (<xref rid="fig18" ref-type="fig">Figure <xref rid="fig18" ref-type="fig">18</xref></xref>).<sup><xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref106">106</xref></sup></p><fig id="fig18" position="float" orientation="portrait"><label>Figure 18</label><caption><p>Synthesis of [<italic toggle="yes">10</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine and
[<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine
using [<sup>11</sup>C]CH<sub>3</sub>I
and [<sup>11</sup>C]CH<sub>3</sub>OTf. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr18" position="float" orientation="portrait" xlink:href="cr2c00398_0018.jpg"/></fig></sec><sec id="sec3.5.2"><label>3.5.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Colchicine was evaluated in mice,<sup><xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref107">107</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref107">107</xref></sup> and rhesus monkey.<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> [<italic toggle="yes">10</italic>-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]colchicine was evaluated
in rodents to quantify P-glycoprotein (P-gp) mediated transport after
retroorbital injection. Relatively high uptake was observed in the
chest area, liver, kidney, and spleen, with low uptake in the brain.
Also, the results suggest that [<italic toggle="yes">10</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine can image P-gp mediated transport in tumors
(BE (2)-C cell line).<sup><xref ref-type="bibr" rid="ref107">107</xref></sup></p><p>In the rhesus
monkey, [<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine was administered intravenously into the hindlimb as
a bolus over 1 min, and the brain was imaged for 90 min (<xref rid="fig19" ref-type="fig">Figure <xref rid="fig19" ref-type="fig">19</xref></xref>).<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> The lack of brain uptake in non-human primates
by [<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine
was expected as colchicine is a known P-gp substrate in rodents.<sup><xref ref-type="bibr" rid="ref107">107</xref></sup> Labeling in different positions (<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>- <italic toggle="yes">vs</italic><italic toggle="yes">10</italic>-<italic toggle="yes">methoxy</italic>-) showed no difference in the compound
distribution.<sup><xref ref-type="bibr" rid="ref105">105</xref></sup></p><fig id="fig19" position="float" orientation="portrait"><label>Figure 19</label><caption><p>Sagittal, coronal, and
transverse planes of [<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]colchicine summed retention
in rhesus monkey brain (between 6 and 60 min p.i.). Reproduced with
permission from ref (<xref ref-type="bibr" rid="ref105">105</xref>). Copyright 2021 Frontiers. This work is licensed under a Creative
Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr19" position="float" orientation="portrait" xlink:href="cr2c00398_0019.jpg"/></fig></sec></sec><sec id="sec3.6"><label>3.6</label><title><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-Dimethylphenethylamine</title><sec id="sec3.6.1"><label>3.6.1</label><title>Radiosynthesis</title><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-DMPEA has been labeled with carbon-11 in the
methyl position<sup><xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref109">109</xref>,<xref ref-type="bibr" rid="ref171">171</xref></sup> and the phenethyl position.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA was first synthesized by Inoue <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> in 1984 and further optimized by Shinoth <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> in 1987 and Halldin <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> in 1989 by reaction
of <italic toggle="yes">N</italic>-methylphenethylamine with [<sup>11</sup>C]CH<sub>3</sub>I, with a total preparation time of 35 min from EOB (<xref rid="fig20" ref-type="fig">Figure <xref rid="fig20" ref-type="fig">20</xref></xref>). <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA
was isolated by semipreparative HPLC within 35 min with a RCY of 30&#8211;35%,
RCP &gt; 99%, and <italic toggle="yes">A</italic><sub>m</sub> of 3.7 GBq/&#956;mol.</p><fig id="fig20" position="float" orientation="portrait"><label>Figure 20</label><caption><p>Synthesis
of <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">methy</italic>l-<sup>11</sup>C]DMPEA and <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA using [<sup>11</sup>C]CH<sub>3</sub>I and [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenethyl iodide, respectively. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr20" position="float" orientation="portrait" xlink:href="cr2c00398_0020.jpg"/></fig><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA was prepared by <italic toggle="yes">N</italic>-alkylation of
dimethylamine with [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenethyl iodide
followed by HPLC purification, with a RCY of 10%, RCP &gt;99%, and <italic toggle="yes">A</italic><sub>m</sub> of 0.37&#8211;3.7 GBq/&#956;mol, in a 50
min process (<xref rid="fig20" ref-type="fig">Figure <xref rid="fig20" ref-type="fig">20</xref></xref>).<sup><xref ref-type="bibr" rid="ref109">109</xref></sup></p></sec><sec id="sec3.6.2"><label>3.6.2</label><title>Preclinical Studies</title><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA
was studied in mice,<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> and rhesus monkeys,<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> while <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA in rats<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> and rhesus
monkeys.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> Male C3H mice were injected <italic toggle="yes">via</italic> the tail vein with <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]DMPEA, which was transported
into most organs with the highest uptake in the kidney and was cleared
rapidly from the blood. A slightly lower uptake was observed in the
brain and the lung. In the brain, the uptake reaches its peak 1 min
after injection, followed by a rapid clearance at 1&#8211;5 min,
and the activity in the blood decreases to lower levels than that
seen in the brain.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> In a biodistribution
study in rats, Halldin <italic toggle="yes">et al</italic>. found that the radioactivity
concentration in the brain was significantly lower for <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA than <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]DMPEA at 45 min post iv injection.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup></p><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA and <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA were studied in the rhesus monkey
using PET.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> Following iv administration,
initial rapid uptake was observed in the brain for both tracers. <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]DMPEA uptake remained constant over 30 min, while <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]DMPEA cleared
from the brain, reflecting the fate of the corresponding radiolabeled
metabolites formed.<sup><xref ref-type="bibr" rid="ref109">109</xref></sup></p></sec><sec id="sec3.6.3"><label>3.6.3</label><title>Clinical Studies</title><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA
has been studied in four male volunteers, varying from 48 to 70 years
old (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>). A
high and rapid accumulation of radioactivity in the brain within 4&#8211;6
min was observed, which gradually increased until the end of the experiment.
High uptake was observed in the thalamus, basal ganglia, cerebral
cortex, and cerebellum, with a moderate uptake in the brain stem.
The radioactivity in the blood was much lower than that in the brain.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup></p><fig id="fig21" position="float" orientation="portrait"><label>Figure 21</label><caption><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]DMPEA summed retention in a healthy volunteer (between
3 and 30 min p.i.). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref67">67</xref>). Copyright 1987 Society
of Nuclear Medicine. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr21" position="float" orientation="portrait" xlink:href="cr2c00398_0021.jpg"/></fig></sec></sec><sec id="sec3.7"><label>3.7</label><title><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-Dimethyltryptamine</title><sec id="sec3.7.1"><label>3.7.1</label><title>Radiosynthesis</title><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]dimethyltryptamine was achieved by the <italic toggle="yes">N</italic>-methylation of <italic toggle="yes">N</italic>-methyltryptamine with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref>). The reaction was conducted in acetone at room temperature
for 5 min, and the purification was achieved by a silica-gel column. <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]dimethyltryptamine was obtained starting from [<sup>11</sup>C]CH<sub>3</sub>I with 50% of RCY in 35 min from the end
of [<sup>11</sup>C]CH<sub>3</sub>I trapping with a RCP of 99%.<sup><xref ref-type="bibr" rid="ref90">90</xref></sup> Subsequently, the same reaction was conducted
at 50&#8211;60 &#176;C, obtaining <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]dimethyltryptamine
with RCY 80&#8211;90% in 50 min. The <italic toggle="yes">A</italic><sub>m</sub> was reported to be 0.37&#8211;2.81 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref110">110</xref></sup></p><fig id="fig22" position="float" orientation="portrait"><label>Figure 22</label><caption><p>Radiosynthetic scheme for the synthesis of <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]dimethyltryptamine. <sup>11</sup>C radionuclide position
is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr22" position="float" orientation="portrait" xlink:href="cr2c00398_0022.jpg"/></fig></sec><sec id="sec3.7.2"><label>3.7.2</label><title>Preclinical Studies</title><p>In healthy
Wistar rats, <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]dimethyltryptamine highly
accumulated in the kidney, liver, spleen, and brain.<sup><xref ref-type="bibr" rid="ref90">90</xref></sup> The brain-to-blood ratio increased over time from 2.7 at
5 min to 6.5 at 60 min.<sup><xref ref-type="bibr" rid="ref90">90</xref></sup><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]dimethyltryptamine accumulated in the cerebral cortex,
caudate-putamen, and amygdaloid nuclei, with traces also in the cerebellum
and medulla oblongata.<sup><xref ref-type="bibr" rid="ref110">110</xref></sup> In dog brain,
a displacement study with <italic toggle="yes">O</italic>-methylbufotenine revealed
a substantial reduction in posterior cerebral cortex uptake, while
a sharp decrease affected basal ganglia and frontal cortex, correlating
well with the distribution and density of serotonin receptors.<sup><xref ref-type="bibr" rid="ref110">110</xref></sup></p></sec></sec><sec id="sec3.8"><label>3.8</label><title>Ephedrine and <italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-ephedrine</title><sec id="sec3.8.1"><label>3.8.1</label><title>Radiosynthesis</title><p>The synthesis of
[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ephedrine
and [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine
were reported by Saji <italic toggle="yes">et al</italic>. in 1978 by the reaction
of [<sup>11</sup>C]CH<sub>3</sub>I with norephedrine and ephedrine,
respectively, in acetone with KOH at 70 &#176;C for 20 min (<xref rid="fig23" ref-type="fig">Figure <xref rid="fig23" ref-type="fig">23</xref></xref>).<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]ephedrine was prepared in 45 min with a RCY of 11% and [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine
in 36 min with a RCY of 43%.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup></p><fig id="fig23" position="float" orientation="portrait"><label>Figure 23</label><caption><p>Radiosynthesis
of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ephedrine
and [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine
using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr23" position="float" orientation="portrait" xlink:href="cr2c00398_0023.jpg"/></fig></sec><sec id="sec3.8.2"><label>3.8.2</label><title>Preclinical Studies</title><p>The biodistribution
of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ephedrine
and [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine
was evaluated <italic toggle="yes">in vivo</italic> after iv injection in mice.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> At 5 min p.i., both tracers showed considerable
uptake in the liver and kidney and relatively high in the brain. Tracer
uptake decreased over time, with the exception of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine in the adrenal
glands, which tended to increase with time. [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methylephedrine had a higher initial
uptake in the brain compared to [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ephedrine, but its washout was quicker. If this difference
is due to demethylation in the brain, [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methylephedrine may be of interest
as a diagnostic agent for healthy brain function; however, further
investigations are needed to confirm these observations.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup></p></sec></sec><sec id="sec3.9"><label>3.9</label><title>Galanthamine</title><sec id="sec3.9.1"><label>3.9.1</label><title>Radiosynthesis</title><p><sup>11</sup>C was
incorporated into [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine by <italic toggle="yes">N</italic>-methylation of norgalanthamines
with [<sup>11</sup>C]CH<sub>3</sub>OTf (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>). The RCYs of (&#8722;)- and (<italic toggle="yes">+</italic>)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine were 13.7 and 14.4%, respectively, with a RCP &gt;99%.<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></p><fig id="fig24" position="float" orientation="portrait"><label>Figure 24</label><caption><p>Radiosynthesis of (&#177;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine from norgalanthamine
and [<sup>11</sup>C]CH<sub>3</sub>OTf. <sup>11</sup>C radionuclide
position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr24" position="float" orientation="portrait" xlink:href="cr2c00398_0024.jpg"/></fig></sec><sec id="sec3.9.2"><label>3.9.2</label><title>Preclinical Studies</title><p>Both (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine and
(<italic toggle="yes">+</italic>)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine were studied in mice and rats.<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> In a biodistribution study in male ddY mice,
both isomers were found to be brain penetrant, reaching maximum uptake
at 10 min p.i. (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]galanthamine showed more significant accumulation
in the striatum than in the cerebellum. Pretreatment with donepezil
led to a significant decrease in the accumulation of (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine but
did not affect the striatal accumulation of (<italic toggle="yes">+</italic>)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine. PET
imaging revealed the localization of (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine in the mouse
striatum, which coincided with the localization of AChE in the brain
as determined by immunostaining and <italic toggle="yes">in vitro</italic> autoradiography
in rat brain tissue (<xref rid="fig25" ref-type="fig">Figure <xref rid="fig25" ref-type="fig">25</xref></xref>). These results indicate that (&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]galanthamine showed specific
binding to AChE and AChR, whereas (<italic toggle="yes">+</italic>)-[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]-galanthamine accumulation
was nonspecific.<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></p><fig id="fig25" position="float" orientation="portrait"><label>Figure 25</label><caption><p>(&#8722;)-[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]galanthamine PET
scan of a ddY mouse (time) with the circle highlighting
the brain position. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref111">111</xref>). Copyright 2014 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr25" position="float" orientation="portrait" xlink:href="cr2c00398_0025.jpg"/></fig></sec></sec><sec id="sec3.10"><label>3.10</label><title>Harmine and Harmaline</title><sec id="sec3.10.1"><label>3.10.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine was synthesized by the <italic toggle="yes">O</italic>-methylation of harmol (normethylharmine) with [<sup>11</sup>C]CH<sub>3</sub>I. The reaction was conducted in DMSO with NaOH at 80 &#176;C
for 5 min (<xref rid="fig26" ref-type="fig">Figure <xref rid="fig26" ref-type="fig">26</xref></xref>). [<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmaline was synthesized
using a similar procedure starting from normethylharmaline. Radiosynthesis,
HPLC purification, and formulation were accomplished in 43 and 40
min with RCY of 72.5 &#177; 3.6% and 65.9 &#177; 9.7%, respectively. <italic toggle="yes">A</italic><sub>m</sub> at the end of synthesis (EOS) was around 18.0&#8211;87.3
GBq/&#956;mol, and RCP &gt; 98%.<sup><xref ref-type="bibr" rid="ref112">112</xref></sup> [<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine was also prepared in a captive
solvent method using an HPLC loop with DMF as the solvent and (C<sub>4</sub>H<sub>9</sub>)<sub>4</sub>NOH in CH<sub>3</sub>OH as a base
(<xref rid="fig26" ref-type="fig">Figure <xref rid="fig26" ref-type="fig">26</xref></xref>).<sup><xref ref-type="bibr" rid="ref172">172</xref></sup> More recently, a fully-automated radiosynthesis
was reported, producing [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine
with a RCY of 51 &#177; 11% and <italic toggle="yes">A</italic><sub>m</sub> of
101.32 &#177; 28.2 GBq/&#956;mol, with a 2 min reaction time and
a total process time of 35 min from EOB.<sup><xref ref-type="bibr" rid="ref121">121</xref></sup></p><fig id="fig26" position="float" orientation="portrait"><label>Figure 26</label><caption><p>Radiosynthetic schemes of [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine and [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmaline. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr26" position="float" orientation="portrait" xlink:href="cr2c00398_0026.jpg"/></fig></sec><sec id="sec3.10.2"><label>3.10.2</label><title>Preclinical Studies</title><p>PET evaluation
in rhesus monkeys revealed a higher brain uptake of [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine than [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmaline at 54 min p.i. Displacement with MAO-A inhibitors strongly
decreased [<sup>11</sup>C]harmine uptake.<sup><xref ref-type="bibr" rid="ref112">112</xref></sup> Generally, [<sup>11</sup>C]harmine showed rapid uptake in all grey
matter regions. After pretreatment with MAO-A inhibitors, its initial
brain uptake doubled, followed by a more rapid washout and less differentiation
between grey and white matter.<sup><xref ref-type="bibr" rid="ref113">113</xref></sup> A PET
biodistribution study in baboons demonstrated very high uptake of
[<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine in the lungs, followed
by kidneys, small intestine, and liver. Dosimetry data indicates the
tracer elimination <italic toggle="yes">via</italic> the hepatobiliary and renal
system, probably due to <italic toggle="yes">O</italic>-demethylation.<sup><xref ref-type="bibr" rid="ref114">114</xref></sup> In minipigs [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine was widely retained in all brain regions, directly
correlating to MAO-A distribution. High uptake was found in the dorsal
striatum, ventral forebrain, and medulla (<xref rid="fig27" ref-type="fig">Figure <xref rid="fig27" ref-type="fig">27</xref></xref>).<sup><xref ref-type="bibr" rid="ref115">115</xref></sup></p><fig id="fig27" position="float" orientation="portrait"><label>Figure 27</label><caption><p>[<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine means distribution
volume (<italic toggle="yes">V</italic><sub>d</sub>, mL/g, A,B) and binding potential
(pB, C,D) in Gottingen minipigs brain with (B,D) and without (A,C)
acute pargyline treatment (90 min p.i.). Regions of interest: (a)
the ventral forebrain, (b) vicinity of the locus coeruleus, (c) the
amygdale and hippocampal formation, and (d) the pituitary gland. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref115">115</xref>). Copyright 2006 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr27" position="float" orientation="portrait" xlink:href="cr2c00398_0027.jpg"/></fig></sec><sec id="sec3.10.3"><label>3.10.3</label><title>Clinical Studies</title><p>In healthy humans,
[<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine was rapidly metabolized,
accounting for &lt;50% of the radioactivity in plasma at 20 min p.i.
The regional distribution of [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine uptake in the brain was consistent with known MAO-A distribution,
revealing high radioactivity in the thalamus followed by striatum
and cortical regions. Treatment with MAO-A inhibitors such as moclobemide
induces enzyme blocking at the peripheral site resulting in increased
radioactivity in the brain.<sup><xref ref-type="bibr" rid="ref172">172</xref></sup> Due to its
promising properties as a CNS MAO-A imaging agent, it was further
evaluated for binding quantification and measuring the effects of
competing substrates in healthy volunteers.<sup><xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref117">117</xref></sup></p><p>[<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine has been
evaluated as a radiotracer to detect MAO-A levels in neuropsychiatric
disorders. In people affected by antisocial personality disorder,
[<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine PET analyses revealed
reduced functional MAO-A levels in all brain regions investigated
(<italic toggle="yes">e.g</italic>., orbitofrontal and prefrontal cortex).<sup><xref ref-type="bibr" rid="ref173">173</xref></sup> In patients with major depressive disorders
following antidepressant therapy, [<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]harmine was used to evaluate MAO-A occupancy and correlated with
treatment efficacies (<xref rid="fig28" ref-type="fig">Figure <xref rid="fig28" ref-type="fig">28</xref></xref>). [<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine was successfully
used to visualize neuroendocrine gastroenteropancreatic tumors and
mood disorders related to perimenopause.<sup><xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref120">120</xref></sup></p><fig id="fig28" position="float" orientation="portrait"><label>Figure 28</label><caption><p>[<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]harmine PET scans of a
depressed patient&#8217;s brain at baseline and 6 weeks post moclobemide
treatment. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref118">118</xref>). Copyright 2011 Canadian
Medical Association.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr28" position="float" orientation="portrait" xlink:href="cr2c00398_0028.jpg"/></fig></sec></sec><sec id="sec3.11"><label>3.11</label><title>Morphine</title><sec id="sec3.11.1"><label>3.11.1</label><title>Radiosynthesis</title><p>In 1979, the radiolabeling
of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine was reported by
two groups using different approaches to achieve <sup>11</sup>C-methylation
at the <italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>- position.<sup><xref ref-type="bibr" rid="ref122">122</xref>,<xref ref-type="bibr" rid="ref174">174</xref></sup> Kloster <italic toggle="yes">et al.</italic> reported the synthesis <italic toggle="yes">via</italic> reaction of normorphine with [<sup>11</sup>C]CH<sub>3</sub>I with
a base in ethanol in 9% RCP in a process lasting 18 min.<sup><xref ref-type="bibr" rid="ref122">122</xref></sup> Allen and Beaumier<sup><xref ref-type="bibr" rid="ref126">126</xref></sup> performed a reductive alkylation of normorphine using [<sup>11</sup>C]CH<sub>2</sub>O and NaBH<sub>4</sub> (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>). In 1982, L&#229;ngstr&#246;m <italic toggle="yes">et al</italic>. reported the synthesis using [<sup>11</sup>C]CH<sub>3</sub>I in DMF solution.<sup><xref ref-type="bibr" rid="ref175">175</xref></sup></p><fig id="fig29" position="float" orientation="portrait"><label>Figure 29</label><caption><p>Radio synthesis
of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine
using normorphine and [<sup>11</sup>C]CH<sub>3</sub>I or [<sup>11</sup>C]CH<sub>2</sub>O. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr29" position="float" orientation="portrait" xlink:href="cr2c00398_0029.jpg"/></fig><p>In 2011, Fan <italic toggle="yes">et al</italic>. published
the first automated
radiosynthesis of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine
for clinical investigations <italic toggle="yes">via</italic> reaction of normorphine
with [<sup>11</sup>C]CH<sub>3</sub>I in DMSO in the presence of NaOH.<sup><xref ref-type="bibr" rid="ref125">125</xref></sup> Total synthesis time was 45 min with a RCY
of 45&#8211;50%, RCP &gt;95%, and <italic toggle="yes">A</italic><sub>m</sub> of
740&#8211;962 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref125">125</xref></sup></p></sec><sec id="sec3.11.2"><label>3.11.2</label><title>Preclinical Studies</title><p>Biodistribution
studies of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine in male
Wistar rats showed accumulation of activity in the small intestine
with very little activity in the brain.<sup><xref ref-type="bibr" rid="ref122">122</xref></sup> A preclinical PET study in five rhesus monkeys was performed to
investigate brain kinetics. No specific localization of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine was observed in the brain, and uptake was
low, reaching a maximum at 30-45 min p.i., followed by slow clearance.<sup><xref ref-type="bibr" rid="ref104">104</xref></sup></p><p>In 1988, Agon <italic toggle="yes">et al</italic>.
performed a PET study in adult mongrel dogs using [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine to probe the effects of BBB disruption on
tracer distribution.<sup><xref ref-type="bibr" rid="ref123">123</xref></sup> The <sup>11</sup>C-labeled morphine was administered at the left femoral vein in two
doses; first, 20 min after the injection of Evans blue as a reference
for the osmotic opening of BBB, and the second 2 min after saline-mannitol
administration.</p><p>PET studies of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine
in pregnant rhesus monkeys (120&#8211;150 days pregnant) were performed
after an iv injection of the tracer. Activity in the placenta reached
a maximum within a few minutes, and rapid fetal liver accumulation
was observed.<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> In 1989, [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine was imaged in the spinal canal of nine rhesus
monkeys. The tracer was administered at different spinal cord levels
at different times, and kinetic measurements were performed up to
120 min post-tracer administration with plasma and cerebrospinal fluid
samples.<sup><xref ref-type="bibr" rid="ref124">124</xref></sup> In 2015, Schou <italic toggle="yes">et al</italic>. studied the brain exposure of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]morphine after intravenous injection to female cynomolgus and rhesus
monkeys.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]morphine was injected at two different dose levels; one
at tracer levels (microdose) and one at pharmacological doses; however,
the brain uptake was very low (<xref rid="fig30" ref-type="fig">Figure <xref rid="fig30" ref-type="fig">30</xref></xref>).<sup><xref ref-type="bibr" rid="ref93">93</xref></sup></p><fig id="fig30" position="float" orientation="portrait"><label>Figure 30</label><caption><p>[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]morphine summed retention
in monkey&#8217;s brain (between 3 and 93 min). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref93">93</xref>). Copyright
2015 Oxford University Press.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr30" position="float" orientation="portrait" xlink:href="cr2c00398_0030.jpg"/></fig></sec></sec><sec id="sec3.12"><label>3.12</label><title>Nicotine</title><sec id="sec3.12.1"><label>3.12.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]nicotine was first reported by Maziere <italic toggle="yes">et
al</italic>. in 1976 by reaction of nor-(&#8722;)-nicotine with [<sup>11</sup>C]CH<sub>2</sub>O in DMF and formic acid at &#8722;19 &#176;C,
obtaining 370&#8211;555 MBq in 30 min and <italic toggle="yes">A</italic><sub>m</sub> of 1.11 GBq/&#956;mol (<xref rid="fig31" ref-type="fig">Figure <xref rid="fig31" ref-type="fig">31</xref></xref>).<sup><xref ref-type="bibr" rid="ref127">127</xref></sup> In 2017,
Garg <italic toggle="yes">et al</italic>. reported the synthesis <italic toggle="yes">via</italic> reaction of <italic toggle="yes">nor</italic>-nicotine biscamsylate with [<sup>11</sup>C]CH<sub>3</sub>OTf and 1,2,2,6,6-pentamethyl piperidine
in acetonitrile, obtaining a RCY of &#8764;30% and <italic toggle="yes">A</italic><sub>m</sub> of 0.26 GBq/&#956;mol at EOS.<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> Xu <italic toggle="yes">et al</italic>. also used [<sup>11</sup>C]CH<sub>3</sub>OTf but with <italic toggle="yes">nor</italic>-nicotine free base in acetone at
45 &#176;C, achieving a RCY of 60.4 &#177; 4.7% and <italic toggle="yes">A</italic><sub>m</sub> of 648 GBq/&#956;mol, with a total synthesis time of
32&#8211;36 min.<sup><xref ref-type="bibr" rid="ref134">134</xref></sup> More recently, Ghosh <italic toggle="yes">et al.</italic> developed an automated loop method to obtain [<sup>11</sup>C]nicotine in a RCY of 19-35% and an <italic toggle="yes">A</italic><sub>m</sub> of 3.89 GBq/&#956;mol, with a total process time of &lt;30
min.<sup><xref ref-type="bibr" rid="ref135">135</xref></sup></p><fig id="fig31" position="float" orientation="portrait"><label>Figure 31</label><caption><p>Synthesis of [<sup>11</sup>C]nicotine
using [<sup>11</sup>C]CH<sub>2</sub>O. <sup>11</sup>C radionuclide
position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr31" position="float" orientation="portrait" xlink:href="cr2c00398_0031.jpg"/></fig></sec><sec id="sec3.12.2"><label>3.12.2</label><title>Preclinical Studies</title><p>An initial
study by Maziere <italic toggle="yes">et al</italic>. investigated the distribution
of [<sup>11</sup>C]nicotine in mice and rabbits.<sup><xref ref-type="bibr" rid="ref127">127</xref></sup> In mice, a radioactivity build-up in all organs (except
liver and spleen) was observed within 5 min p.i. In the brain, maximum
uptake was observed at 5 min, decreasing to almost half at 15 min
p.i. In rabbits, rapid radiotracer accumulation in the brain was also
observed, suggesting that [<sup>11</sup>C]nicotine instantaneously
passes through the BBB. The fast drop in the brain radioactivity was
thought to be due to the rapid oxidation of [<sup>11</sup>C]nicotine
to [<sup>11</sup>C]cotinine, which has a poor affinity to nicotine
targets.<sup><xref ref-type="bibr" rid="ref127">127</xref></sup> These results are also similar
to those of rhesus monkeys obtained by Nordberg <italic toggle="yes">et al.</italic>, where the uptake in the brain peaked within 1&#8211;2 min of radiotracer
administration and then declined very sharply.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> The regional distribution of (<italic toggle="yes">S</italic>)-[<sup>11</sup>C]nicotine in the brain of mice was also studied, showing
that the uptake was higher in the cortex, followed by the hippocampus,
striatum, hypothalamus, and cerebellum at 5 min after injection.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup></p></sec><sec id="sec3.12.3"><label>3.12.3</label><title>Clinical Studies</title><p>Whole-body human
PET scans of healthy nonsmokers showed rapid uptake of [<sup>11</sup>C]nicotine by most significant organs, including the heart, liver,
brain, lungs, and muscle, followed by a drop in radioactivity after
22.6 min (<xref rid="fig32" ref-type="fig">Figure <xref rid="fig32" ref-type="fig">32</xref></xref>).<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> The uptake in the muscle in humans
was significantly higher compared to other organs. This can be due
to the higher mass of muscle in comparison with the liver and spleen,<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> similar to the observations mentioned in the
rhesus monkey study.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup></p><fig id="fig32" position="float" orientation="portrait"><label>Figure 32</label><caption><p>[<sup>11</sup>C]Nicotine
whole-body PET images of (A) male and
(B) female volunteers (top images recorded 2.8 min p.i.; bottom images
recorded 22.6 min p.i.). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref131">131</xref>). Copyright 2017 Society
of Nuclear Medicine and Molecular Imaging. This work is licensed under
a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr32" position="float" orientation="portrait" xlink:href="cr2c00398_0032.jpg"/></fig><p>Rose <italic toggle="yes">et al</italic>. studied the effect
of smoking on the
brain of smokers after single puffs of cigarettes formulated with
[<sup>11</sup>C]nicotine by investigating the rate of nicotine entry
into the brain.<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> This study showed a
rapid uptake of [<sup>11</sup>C]nicotine in the brain at approximately
5 s after inhalation, a possible explanation for the addictiveness
of nicotine.<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> However, another study
compared the kinetics of [<sup>11</sup>C]nicotine in dependent and
nondependent smokers after a single puff of smoke from a cigarette
containing [<sup>11</sup>C]nicotine, showing that dependent smokers
have a lower brain nicotine accumulation rate due to the slower nicotine
washout from the lungs (<xref rid="fig33" ref-type="fig">Figure <xref rid="fig33" ref-type="fig">33</xref></xref>).<sup><xref ref-type="bibr" rid="ref176">176</xref></sup></p><fig id="fig33" position="float" orientation="portrait"><label>Figure 33</label><caption><p>Set-up used for [<sup>11</sup>C]nicotine inhalation through cigarette
smoke. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref176">176</xref>). Copyright 2010 Springer Nature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr33" position="float" orientation="portrait" xlink:href="cr2c00398_0033.jpg"/></fig><p>Recently, Wall <italic toggle="yes">et al</italic>. studied
the distribution
and accumulation of inhaled [<sup>11</sup>C]nicotine in the respiratory
pathways and brain of 15 healthy adult smokers using the <italic toggle="yes">my</italic>blu e-cigarette with two nicotine formulations, freebase, and lactate
salt.<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> Over 30% of the inhaled tracer
accumulated in the lung within 15&#8211;35 seconds. [<sup>11</sup>C]Nicotine<sub>freebase</sub> exhibited higher uptake and deposition
in the upper respiratory pathways than [<sup>11</sup>C]nicotine<sub>lactate</sub>. For [<sup>11</sup>C]nicotine<sub>lactate</sub>, brain
deposition peaked at 4&#8211;5%, with an earlier peak and a steeper
decline (<xref rid="fig34" ref-type="fig">Figure <xref rid="fig34" ref-type="fig">34</xref></xref>). The authors concluded that e-cigarettes with nicotine lactate
formulations might contribute to greater adult smoker acceptance and
satisfaction.<sup><xref ref-type="bibr" rid="ref133">133</xref></sup></p><fig id="fig34" position="float" orientation="portrait"><label>Figure 34</label><caption><p>[<sup>11</sup>C]Nicotine<sub>freebase</sub> (top) and [<sup>11</sup>C]nicotine<sub>lactate</sub> (bottom) distribution in human lungs
and mouth (0.5, 5, and 40 min after inhalation). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref133">133</xref>). Copyright
2022 MDPI. This work is licensed under a Creative Commons Attribution
4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr34" position="float" orientation="portrait" xlink:href="cr2c00398_0034.jpg"/></fig></sec></sec><sec id="sec3.13"><label>3.13</label><title>Oxycodone</title><sec id="sec3.13.1"><label>3.13.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]oxycodone was synthesized
from noroxycodone hydrochloride by alkylation with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig35" ref-type="fig">Figure <xref rid="fig35" ref-type="fig">35</xref></xref>), purified by semipreparative HPLC, and obtained with a RCP of &gt;99%
and <italic toggle="yes">A</italic><sub>m</sub> of 94.7 &#177; 13.2 kBq/&#956;mol
oxycodone (after addition of isotopically unmodified oxycodone) at
the start of <italic toggle="yes">in vivo</italic> studies. The synthesis time
from radionuclide production to the formulated product was approximately
35 min.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup></p><fig id="fig35" position="float" orientation="portrait"><label>Figure 35</label><caption><p>Radiosynthesis of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]oxycodone from <italic toggle="yes">nor</italic>-oxycodone and [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr35" position="float" orientation="portrait" xlink:href="cr2c00398_0035.jpg"/></fig></sec><sec id="sec3.13.2"><label>3.13.2</label><title>Preclinical Studies</title><p>The brain
pharmacokinetics of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]oxycodone have been investigated in Male Sprague-Dawley
rats.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup> Gustafsson <italic toggle="yes">et al</italic>. designed a combined PET and microdialysis analysis, where simultaneous
sampling was performed throughout a 60 min infusion of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]oxycodone with a therapeutic
dose of oxycodone.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup> This design is a
step toward building and verifying a translational concept of brain
drug exposure and BBB transport from rodents to humans. [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]oxycodone was detected in
the harderian glands and brain with increasing concentration during
the infusion, followed by elimination immediately after the infusion
(<xref rid="fig36" ref-type="fig">Figure <xref rid="fig36" ref-type="fig">36</xref></xref>). However,
radioactivity accumulation became more pronounced at later time points,
most likely due to the formation of radioactive metabolites, including
[<sup>11</sup>C]carbonate, crossing into the brain.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup></p><fig id="fig36" position="float" orientation="portrait"><label>Figure 36</label><caption><p>PET/CT scans of rats during a 60 min [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]oxycodone and oxycodone infusion.
parts A and C describe the infusion phase (30-60 min); parts B and
D represent the elimination phase (65&#8211;120 min). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref136">136</xref>). Copyright 2017 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr36" position="float" orientation="portrait" xlink:href="cr2c00398_0036.jpg"/></fig></sec></sec><sec id="sec3.14"><label>3.14</label><title>Papaverine</title><sec id="sec3.14.1"><label>3.14.1</label><title>Radiosynthesis</title><p>The radiosynthesis
of papaverine with <sup>11</sup>C was achieved by <italic toggle="yes">O</italic>-methylation of the <italic toggle="yes">1</italic>-(<italic toggle="yes">4</italic>-(benzyloxy)-<italic toggle="yes">4</italic>-methoxybenzyl)-<italic toggle="yes">6</italic>,<italic toggle="yes">7</italic>-dimethoxyisoquinoline
with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig37" ref-type="fig">Figure <xref rid="fig37" ref-type="fig">37</xref></xref>). The entire synthetic procedure from the
production of [<sup>11</sup>C]CH<sub>3</sub>I to the formulation of
the radiotracer for <italic toggle="yes">in vivo</italic> studies was complete
within 50&#8211;55 min. [<italic toggle="yes">3</italic>-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]papaverine was obtained with RCY of &#8764;70%, <italic toggle="yes">A</italic><sub>m</sub> &gt;740 GBq/&#956;mol to EOB, and RCP of
99%.<sup><xref ref-type="bibr" rid="ref137">137</xref></sup></p><fig id="fig37" position="float" orientation="portrait"><label>Figure 37</label><caption><p>Radiosynthesis of [<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]papaverine from <italic toggle="yes">1</italic>-(<italic toggle="yes">4</italic>-(benzyloxy)-<italic toggle="yes">3</italic>-methoxybenzyl)-<italic toggle="yes">6</italic>,<italic toggle="yes">7</italic>-dimethoxyisoquinoline
and [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr37" position="float" orientation="portrait" xlink:href="cr2c00398_0037.jpg"/></fig></sec><sec id="sec3.14.2"><label>3.14.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">3</italic>-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]papaverine has been evaluated
in adult male Sprague-Dawley rats and two adult male rhesus macaque
monkeys.<sup><xref ref-type="bibr" rid="ref137">137</xref></sup><italic toggle="yes">In vitro</italic> autoradiography
studies of rat and monkey brain sections revealed selective binding
[<italic toggle="yes">3</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]papaverine
to PDE10A enriched regions. The biodistribution in rats at 5 min demonstrated
a high accumulation in the striatum, but the washout was rapid. PET
imaging studies in rhesus macaques displayed similar initial high
uptake in the striatum with very rapid clearance. However, Tu <italic toggle="yes">et al</italic>. suggested that [3-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]papaverine is not an ideal radioligand for clinical imaging of
PDE10A in the CNS, and analogues of papaverine with a higher potency
for inhibiting PDE10A and improved pharmacokinetic properties should
be investigated for PET imaging.<sup><xref ref-type="bibr" rid="ref137">137</xref></sup></p></sec></sec><sec id="sec3.15"><label>3.15</label><title>Physostigmine</title><sec id="sec3.15.1"><label>3.15.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Physostigmine
has been radiolabeled at the carbonyl position <italic toggle="yes">via</italic> reaction of [<sup>11</sup>C]methyl isocyanate and eseroline, with
the purified product obtained within 52 min, with an RCY of 12&#8211;19%
and <italic toggle="yes">A</italic><sub>m</sub> of 11&#8211;13 GBq/&#956;mol
at EOB.<sup><xref ref-type="bibr" rid="ref141">141</xref>&#8722;<xref ref-type="bibr" rid="ref143">143</xref></sup> In this process, [<sup>11</sup>C]methyl
isocyanate was formed by heating [<sup>11</sup>C]CH<sub>3</sub>COCl
with tetrabutylammonium azide in toluene within 10 min, then subsequently
distilled into a solution of eseroline for 10 min at 25 &#176;C (<xref rid="fig38" ref-type="fig">Figure <xref rid="fig38" ref-type="fig">38</xref></xref>), and the final
product isolated by HPLC. [<sup>11</sup>C]Physostigmine has also been
prepared by reaction of [<sup>11</sup>C]COCl<sub>2</sub> on <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-bis(trimethylsilyl)methylamine within
35 min with an RCY of 18&#8211;25% and an <italic toggle="yes">A</italic><sub>m</sub> of 25.9&#8211;39.6 GBq/&#956;mol at EOB.<sup><xref ref-type="bibr" rid="ref144">144</xref></sup></p><fig id="fig38" position="float" orientation="portrait"><label>Figure 38</label><caption><p>Synthesis of [<sup>11</sup>C]physostigmine by the reaction
of [<sup>11</sup>C]methyl isocyanate with eseroline.<sup><xref ref-type="bibr" rid="ref177">177</xref></sup><sup>11</sup>C radionuclide position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr38" position="float" orientation="portrait" xlink:href="cr2c00398_0038.jpg"/></fig></sec><sec id="sec3.15.2"><label>3.15.2</label><title>Preclinical Studies</title><p>The cerebral
distribution of [<sup>11</sup>C]physostigmine has been studied in
rats<sup><xref ref-type="bibr" rid="ref138">138</xref></sup> and baboons.<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> Male Sprague-Dawley rats were injected with [<sup>11</sup>C]physostigmine in the tail vein. In the rat brain, the radioactivity
was significantly correlated to AChE activity, being highest in the
basal ganglia, moderate in the cortex and hippocampus, and low in
the cerebellum (<xref rid="fig39" ref-type="fig">Figure <xref rid="fig39" ref-type="fig">39</xref></xref>).<sup><xref ref-type="bibr" rid="ref138">138</xref></sup></p><fig id="fig39" position="float" orientation="portrait"><label>Figure 39</label><caption><p>AChE stains (A,B) and
corresponding autoradiograms (C,D) of two
coronal slices from rat brain after [<sup>11</sup>C]physostigmine
administration (10 min p.i.). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref138">138</xref>). Copyright 1994 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr39" position="float" orientation="portrait" xlink:href="cr2c00398_0039.jpg"/></fig><p><italic toggle="yes">In vivo</italic> brain distribution and
kinetics of [<sup>11</sup>C]physostigmine were obtained in baboons
(<italic toggle="yes">Papio papio</italic>) after iv bolus injection
of [<sup>11</sup>C]physostigmine (<xref rid="fig40" ref-type="fig">Figure <xref rid="fig40" ref-type="fig">40</xref></xref>).<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> In the
blood, the radioactivity
peaked during the first minute and rapidly declined thereafter. An
excess of unlabeled physostigmine in the brain significantly decreased
the uptake of [<sup>11</sup>C]physostigmine in the striatum, indicating
a high ratio of specific to nonspecific binding. Taking the white
matter as the reference region, the ratio between the total distribution
volumes in the target and reference regions showed a satisfactory
correlation with the AChE concentration measured post-mortem in two
baboon brains.<sup><xref ref-type="bibr" rid="ref139">139</xref></sup></p><fig id="fig40" position="float" orientation="portrait"><label>Figure 40</label><caption><p>[<sup>11</sup>C]Physostigmine
brain distribution in a baboon. (A,C)
Striatal and (B,D) cerebellar imaging at early (A,B, 0-1 min p.i.)
and late (C,D, 15&#8211;20 min p.i.) time points. Reproduced with
permission from ref (<xref ref-type="bibr" rid="ref141">141</xref>). Copyright 1993 Wolters Kluwer Health.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr40" position="float" orientation="portrait" xlink:href="cr2c00398_0040.jpg"/></fig></sec><sec id="sec3.15.3"><label>3.15.3</label><title>Clinical Studies</title><p>The quantification
of regional AChE developed using animal studies was applied to eight
healthy male subjects (24&#8211;76 years old) after a bolus injection
of [<sup>11</sup>C]physostigmine.<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> The
radioactivity rapidly crossed the BBB, reached a maximal level within
a few minutes, and agreed with the known AChE concentrations measured
in post-mortem studies of the human brain (<xref rid="fig41" ref-type="fig">Figure <xref rid="fig41" ref-type="fig">41</xref></xref>).<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> These results
suggest that PET studies with [<sup>11</sup>C]physostigmine can provide <italic toggle="yes">in vivo</italic> brain mapping of human AChE and are promising for
studying changes in AChE levels associated with neurodegenerative
diseases.<sup><xref ref-type="bibr" rid="ref140">140</xref></sup></p><fig id="fig41" position="float" orientation="portrait"><label>Figure 41</label><caption><p>[<sup>11</sup>C]Physostigmine
regional cerebral distribution in
humans (early images = 0&#8211;4 min p.i.; late images = 25&#8211;35
min p.i.; PET-MRI fusion = 25&#8211;35 min p.i.). Reproduced with
permission from ref (<xref ref-type="bibr" rid="ref140">140</xref>). Copyright 2002 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr41" position="float" orientation="portrait" xlink:href="cr2c00398_0041.jpg"/></fig></sec></sec><sec id="sec3.16"><label>3.16</label><title>Psilocin</title><sec id="sec3.16.1"><label>3.16.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]psilocin was achieved by
the <italic toggle="yes">N</italic>-methylation of 4-hydroxy-<italic toggle="yes">N</italic>-methyltryptamine with [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig42" ref-type="fig">Figure <xref rid="fig42" ref-type="fig">42</xref></xref>). The reaction
was conducted in acetonitrile at 80 &#176;C for 10 min, and the purification
was achieved by a semipreparative reversed-phase HPLC. Radiosynthesis,
purification, and formulation were accomplished in 45 min with RCY
of 20 &#177; 5% and <italic toggle="yes">A</italic><sub>m</sub> of 33.3&#8211;85.1
GBq/&#956;mol at EOS. RCP obtained was higher than 97%.<sup><xref ref-type="bibr" rid="ref145">145</xref></sup></p><fig id="fig42" position="float" orientation="portrait"><label>Figure 42</label><caption><p>Radiosynthesis of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]psilocin. <sup>11</sup>C radionuclide
position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr42" position="float" orientation="portrait" xlink:href="cr2c00398_0042.jpg"/></fig></sec></sec><sec id="sec3.17"><label>3.17</label><title>Quinidine</title><sec id="sec3.17.1"><label>3.17.1</label><title>Radiosynthesis</title><p>The radiosynthesis
of [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine was accomplished using the potassium salt of <italic toggle="yes">O</italic>-desmethylquinidine as a precursor and by reacting it with
[<sup>11</sup>C]CH<sub>3</sub>I in dry DMF at 130 &#176;C for 10 min
(<xref rid="fig43" ref-type="fig">Figure <xref rid="fig43" ref-type="fig">43</xref></xref>). The reaction
is then quenched with acetic acid in dichloromethane and injected
into the HPLC for purification. With a total processing time of 55
min from EOB, [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine is obtained with RCY of 50&#8211;60% and <italic toggle="yes">A</italic><sub>m</sub> of 1.48&#8211;2.22 GBq/&#956;mol calculated
at EOS.<sup><xref ref-type="bibr" rid="ref147">147</xref></sup> A similar radiolabeling strategy
was subsequently adopted by Syv&#228;nen <italic toggle="yes">et al</italic>.,<sup><xref ref-type="bibr" rid="ref146">146</xref></sup> with the sodium salt of <italic toggle="yes">O</italic>-desmethyl
quinidine used as a precursor and [<sup>11</sup>C]CH<sub>3</sub>OTf
used as a labeling agent (<xref rid="fig43" ref-type="fig">Figure <xref rid="fig43" ref-type="fig">43</xref></xref>). The reaction, proceeding for 5 min at 80 &#176;C,
was then quenched in water and purified <italic toggle="yes">via</italic> HPLC
to return [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine with an RCY of 55&#8211;65% and <italic toggle="yes">A</italic><sub>m</sub> of 259 &#177; 49 GBq/&#956;mol calculated
at EOS with an overall synthesis time of 45 min from EOB.<sup><xref ref-type="bibr" rid="ref146">146</xref></sup></p><fig id="fig43" position="float" orientation="portrait"><label>Figure 43</label><caption><p>Synthesis of [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine using [<sup>11</sup>C]CH<sub>3</sub>I or
[<sup>11</sup>C]CH<sub>3</sub>OTf. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr43" position="float" orientation="portrait" xlink:href="cr2c00398_0043.jpg"/></fig></sec><sec id="sec3.17.2"><label>3.17.2</label><title>Preclinical Studies</title><p>Preclinical
studies with [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine, a known P-gp substrate, were performed
in rodent models of epilepsy using Sprague-Dawley rats (16 male and
70 female) to assess the interaction with multidrug resistance proteins
at the BBB in pathological states.<sup><xref ref-type="bibr" rid="ref146">146</xref></sup> Epileptic
seizures were induced by implanting electrodes in the right anterior
basolateral nucleus of the amygdala or by phenobarbital administration.<sup><xref ref-type="bibr" rid="ref146">146</xref></sup> PET studies were performed by injection of
[<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-]quinidine
and initial assessment of the biodistribution without pharmacological
alterations. Then rats were infused with Tariquidar, a P-gp inhibitor,
for 10 min, and after 20 min, the second injection of [<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine
and PET scanning was performed to assess any modification in the activity
retained by the brain. Without pharmacological treatment, the activity
in the brain was low, whereas Tariquidar infusion induced a significant
increase in activity retained by the brain (+68%), confirming that
[<italic toggle="yes">7</italic>-<italic toggle="yes">O</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]quinidine is indeed a substrate for P-gp proteins at the
BBB.<sup><xref ref-type="bibr" rid="ref146">146</xref></sup></p></sec></sec><sec id="sec3.18"><label>3.18</label><title>Scopolamine</title><sec id="sec3.18.1"><label>3.18.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]scopolamine was synthesized within 40 min from EOB
by reductive methylation of norscopolamine with [<sup>11</sup>C]CH<sub>2</sub>O and sodium cyanoborohydride and then purified using preparative
HPLC (<xref rid="fig44" ref-type="fig">Figure <xref rid="fig44" ref-type="fig">44</xref></xref>).
The RCY ranged from 30&#8211;40%, with a <italic toggle="yes">A</italic><sub>m</sub> of 0.037&#8211;0.148 GBq/&#956;mol at the EOS.<sup><xref ref-type="bibr" rid="ref148">148</xref></sup></p><fig id="fig44" position="float" orientation="portrait"><label>Figure 44</label><caption><p>Synthesis of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]scopolamine
from norscopolamine and [<sup>11</sup>C]CH<sub>2</sub>O and NaCNBH<sub>3</sub><sup><xref ref-type="bibr" rid="ref148">148</xref></sup> or [<sup>11</sup>C]CH<sub>2</sub>O and KHPO<sub>3</sub><sup>&#8211;</sup>.<sup><xref ref-type="bibr" rid="ref152">152</xref></sup><sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr44" position="float" orientation="portrait" xlink:href="cr2c00398_0044.jpg"/></fig><p>A synthesis of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]scopolamine
in high <italic toggle="yes">A</italic><sub>m</sub> and capable of use in clinical
practice was prepared by Mulholland <italic toggle="yes">et al</italic>. in 1988.<sup><xref ref-type="bibr" rid="ref152">152</xref></sup> [<sup>11</sup>C]CH<sub>2</sub>O, produced by
catalytic oxidation of [<sup>11</sup>C]CH<sub>3</sub>OH over metallic
silver, was used to <italic toggle="yes">N</italic>-<sup>11</sup>C-methylate norscopolamine
(<xref rid="fig44" ref-type="fig">Figure <xref rid="fig44" ref-type="fig">44</xref></xref>). The labeling
reaction was complete after 5 min at 75&#8211;80 &#176;C, and the
[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]scopolamine was isolated by
preparative HPLC with a total synthesis time of 40&#8211;45 min.
The RCY ranged from 20&#8211;43% with a <italic toggle="yes">A</italic><sub>m</sub> of 0.037 GBq/&#956;mol and RCP of 99%.<sup><xref ref-type="bibr" rid="ref152">152</xref></sup></p></sec><sec id="sec3.18.2"><label>3.18.2</label><title>Preclinical Studies</title><p>Seven rats
were given [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]scopolamine <italic toggle="yes">via</italic> the tail vein.<sup><xref ref-type="bibr" rid="ref148">148</xref></sup> Approximately
0.5% reached the brain 20 min p.i. Areas of the brain with the highest
concentration of muscarine receptors, such as the cortex and basal
ganglia, showed the highest radioactivity uptake.<sup><xref ref-type="bibr" rid="ref148">148</xref></sup> Another study in rats showed the whole-body biodistribution
of activity to estimate the radiation dose in humans.<sup><xref ref-type="bibr" rid="ref149">149</xref></sup></p></sec><sec id="sec3.18.3"><label>3.18.3</label><title>Clinical Studies</title><p>The biodistribution
of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]scopolamine in the human
brain was investigated in six normal volunteers 20&#8211;60 years
old.<sup><xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup> Radioactivity in the testes and brain likely
reflects primary sites of metabolism and excretion. Scopolamine is
initially delivered to the brain in a perfusion-directed pattern,
where a significant brain parenchymal tracer uptake was observed.
After 30&#8211;60 min, activity is lost from the cerebellum, thalamus
preferentially, and other cerebral structures with low muscarinic
receptor density. However, activity accumulates in receptor-rich areas,
including the cerebral cortex and the basal ganglia, throughout a
2 h p.i. The total brain uptake averaged 3.2% at 70&#8211;90 min
p.i., resulting in an estimated average brain muscarinic receptor
concentration of 2.6 nM.<sup><xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup></p></sec></sec><sec id="sec3.19"><label>3.19</label><title>Theophylline</title><sec id="sec3.19.1"><label>3.19.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">6</italic>-<sup>11</sup>C]Theophylline was synthesized first by Liger <italic toggle="yes">et al</italic>. in 2019.<sup><xref ref-type="bibr" rid="ref153">153</xref></sup> This is a
one-step reaction, where zinc chloride and <italic toggle="yes">1</italic>,<italic toggle="yes">3</italic>-bis(<italic toggle="yes">2</italic>,<italic toggle="yes">6</italic>-diisopropylphenyl)imidazol-<italic toggle="yes">2</italic>-ylidene (IPr) were added to the vial, followed by a solution
of amine in diglyme (<xref rid="fig45" ref-type="fig">Figure <xref rid="fig45" ref-type="fig">45</xref></xref>). Diphenylsilane was added last, and the vial was sealed.
[<sup>11</sup>C]CO<sub>2</sub> was then released within the vial cooled
at 0 &#176;C, and the reaction vial was heated at 150 &#176;C for
10 min. [<italic toggle="yes">6</italic>-<sup>11</sup>C]Theophylline was obtained
with a RCY of 14&#8211;18% from the end of [<sup>11</sup>C]CO<sub>2</sub> trapping within the vial.<sup><xref ref-type="bibr" rid="ref153">153</xref></sup> Unfortunately,
[<italic toggle="yes">6</italic>-<sup>11</sup>C]theophylline has not been evaluated
to the best of our knowledge.</p><fig id="fig45" position="float" orientation="portrait"><label>Figure 45</label><caption><p>Radiosynthesis of [<italic toggle="yes">6</italic>-<sup>11</sup>C]theophylline
using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr45" position="float" orientation="portrait" xlink:href="cr2c00398_0045.jpg"/></fig></sec></sec></sec><sec id="sec4"><label>4</label><title>Amino Acids</title><p>Natural <sc>l</sc>-amino
acids (AAs) play a crucial role in virtually
all biological processes, from protein synthesis to cell signaling.
In addition, AAs can play a crucial role in metabolic cycles, and
they are precursors for many other biomolecules (<italic toggle="yes">e.g</italic>., adenine, adrenaline, serotonin).<sup><xref ref-type="bibr" rid="ref178">178</xref></sup></p><p>The AAs incorporated biosynthetically into proteins during
translation
are known as proteinogenic AAs. Of the basic set of 20 amino acids,
11 can be synthesized from metabolic pathways, whereas the other nine
must be obtained from dietary sources (essential amino acids).</p><p>Radiolabeled AAs have a broad scope of application as radiopharmaceutical
tracers and have been used as receptor ligands, enzymes, and transporter
substrates for many diseases. Additionally, PET radiolabeled AAs often
results in high-contrast images that are not distorted by tissue inflammation,
known for glucose-based PET tracer <sup>18</sup>F-fluorodeoxyglucose
([<sup>18</sup>F]FDG). Also, in the CNS, [<sup>18</sup>F]FDG has a
high glycolytic signal that often presents an advantage to using labeled
amino acids as radiotracers for CNS tumor imaging.</p><p>Many proteinogenic
amino acids have been radiolabeled, but only
a few have been evaluated in preclinical and clinical studies. These
radiolabeled amino acids differ in ease/route of synthesis, biodistribution,
and formation of radiolabeled metabolites <italic toggle="yes">in vivo</italic> (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>). In humans,
only 12 of them can be synthesized and characterized as nonessential
amino acids, with nine of them to be already labeled with carbon-11:<list list-type="bullet"><list-item><p>Alanine can be synthesized from pyruvate<sup><xref ref-type="bibr" rid="ref179">179</xref></sup> and has a crucial role in the glucose-alanine
cycle catalyzed by alanine transaminase.<sup><xref ref-type="bibr" rid="ref180">180</xref></sup></p></list-item><list-item><p>Asparagine is biosynthesized from aspartic
acid and
ammonia by asparagine synthetase and is required for the development
and function of the brain.<sup><xref ref-type="bibr" rid="ref181">181</xref></sup></p></list-item><list-item><p>Aspartic acid is biosynthesized by the aspartate transferase,
which interconverts aspartate to glutamate<sup><xref ref-type="bibr" rid="ref179">179</xref></sup> and can be transported through the excitatory amino acid transporter
1, expressed in the plasma membrane, cardiac myocytes, astrocytes,
and Bergmann glia in the cerebellum.<sup><xref ref-type="bibr" rid="ref182">182</xref></sup></p></list-item><list-item><p>Glutamic acid, one of the most abundant
amino acids
in the body, is metabolized to a-ketoglutarate by enzymes, including
glutamate dehydrogenase 1 and 2, aspartate aminotransferase 2, and
alanine aminotransferase 1, in the mitochondria. Glutamate is also
converted to &#947;-aminobutyric acid by glutamate decarboxylase
1 and 2, most abundant in the brain and pancreatic &#946;-cells.<sup><xref ref-type="bibr" rid="ref183">183</xref></sup> In the brain, glutamate is converted to glutamine
by glutamine synthetase.<sup><xref ref-type="bibr" rid="ref184">184</xref></sup> Biochemical
receptors for glutamate can be categorized into three major classes:
&#945;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors, <italic toggle="yes">N</italic>-methyl-<sc>d</sc>-aspartate (NMDA) receptors,
and metabotropic glutamate receptors. There is also a fourth class,
much less abundant, known as kainate receptors, similar in many respects
to AMPA receptors.<sup><xref ref-type="bibr" rid="ref185">185</xref></sup></p></list-item><list-item><p>Glutamine, like glucose, has a primary role in the mammalian
body and is an energy source for cellular growth and proliferation.
It has a major role in transporting carbon, nitrogen, and energy between
tissues. Glutamine plays an essential role in the CNS, where it is
converted to the major excitatory amino acid glutamate.<sup><xref ref-type="bibr" rid="ref186">186</xref></sup> Moreover, cancer cells consume more than normal
cells, making glutamine a perfect study target.<sup><xref ref-type="bibr" rid="ref187">187</xref></sup></p></list-item><list-item><p>Glycine can be biosynthesized <italic toggle="yes">via</italic> several
pathways, with the main synthetic route being by enzymatic conversion
of serine to glycine from serine hydroxymethyltransferase. Glycine,
and its <italic toggle="yes">N</italic>-methylated derivative, sarcosine, are part
of the choline degradation pathway, in which sarcosine is metabolized
to glycine by the enzyme sarcosine dehydrogenase.<sup><xref ref-type="bibr" rid="ref188">188</xref></sup> Glycine is a major inhibitory neurotransmitter that binds
to the glycine receptor, a ligand-gated ion channel belonging to the
nicotinic acetylcholine receptor family and acts as co-agonist glutamate
at <italic toggle="yes">N-</italic>methyl-<sc>d</sc>-aspartic acid NMDA receptors.<sup><xref ref-type="bibr" rid="ref189">189</xref></sup> Glycine was first radiolabeled with carbon-11
in 1986 as a precursor to the dipeptides <sc>l</sc><italic toggle="yes">-</italic>phenylalanylglycine and <sc>l</sc>-leueylglycine.<sup><xref ref-type="bibr" rid="ref190">190</xref></sup> In the following year [<sup>11</sup>C]glycine was explored
as a tracer for imaging anaplastic astrocytoma.<sup><xref ref-type="bibr" rid="ref191">191</xref></sup></p></list-item><list-item><p>[<sup>11</sup>C]Sarcosine
has recently been investigated
as a new tracer for PET imaging of the prostate,<sup><xref ref-type="bibr" rid="ref192">192</xref>,<xref ref-type="bibr" rid="ref193">193</xref></sup> because highly elevated sarcosine levels have been observed in localized
prostate cancer.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup></p></list-item><list-item><p>Proline is biosynthetically derived from the amino acid <sc>l</sc>-glutamate and has been found to act as a weak agonist of the
glycine receptor and both NMDA and non-NMDA (AMPA/kainate) ionotropic
glutamate receptors.<sup><xref ref-type="bibr" rid="ref178">178</xref></sup> Therefore, it has
been proposed to be a potential endogenous excitotoxin.<sup><xref ref-type="bibr" rid="ref189">189</xref>,<xref ref-type="bibr" rid="ref195">195</xref>,<xref ref-type="bibr" rid="ref196">196</xref></sup> Proline might mainly be suited
to study collagen synthesis rates. Aberrant collagen production occurs
in a variety of diseased states and tumor growth.</p></list-item><list-item><p>Serine biosynthesis starts with the oxidation of 3-phosphoglycerate
to 3-phosphohydroxypyruvate and nicotinamide adenine dinucleotide
(NADH) by phosphoglycerate dehydrogenase. This ketone&#8217;s reductive
amination by phosphoserine transaminase yields 3-phosphoserine hydrolyzed
to serine by phosphoserine phosphatase.<sup><xref ref-type="bibr" rid="ref197">197</xref>,<xref ref-type="bibr" rid="ref198">198</xref></sup> Serine is the precursor to several amino acids, including glycine
and cysteine, and participates in the biosynthesis of purines and
pyrimidines. Serine plays an important role in the catalytic function
of many enzymes, such as chymotrypsin and trypsin, occurring in their
active sites. <sc>d</sc>-Serine is the second <sc>d</sc>-amino acid
discovered after <sc>d</sc>-aspartate naturally existed in humans.
It is present in the brain and peripheral organs, such as the kidney,
as a signaling molecule.<sup><xref ref-type="bibr" rid="ref199">199</xref>,<xref ref-type="bibr" rid="ref200">200</xref></sup> Endogenous <sc>d</sc>-serine is produced by the epimerization of <sc>l</sc>-serine in
neurons by serine racemase. The resulting <sc>d</sc>-serine is transported
into astrocytes for storage. Na<sup>+</sup>-independent alanine&#8211;serine&#8211;cysteine
transporter-1 (ASCT1) is found exclusively in neurons. Na<sup>+</sup>-dependent ASCT1 and ASCT2 are present in both neurons and astrocytes.
It was demonstrated that <sc>d</sc>-serine plays an important role
in the formation and maturation of synaptic contacts and the earlier
stages of neuronal circuit construction as a regulator of neuroblast
migration in the developing brain.<sup><xref ref-type="bibr" rid="ref201">201</xref></sup></p></list-item><list-item><p>Tyrosine is synthesized by hydroxylation
of phenylalanine
by the enzyme phenylalanine hydroxylase and is mainly incorporated
into all proteins and metabolized to essential substances in the body,
such as thyroxine, melanin, dopamine, and norepinephrine.<sup><xref ref-type="bibr" rid="ref202">202</xref></sup> It is transported across the cell membrane
primarily <italic toggle="yes">via</italic><sc>l</sc>-type amino acid transporter
1 (LAT-1), and it is absorbed from the small intestine and transported
into the liver <italic toggle="yes">via</italic> the portal circulation.<sup><xref ref-type="bibr" rid="ref202">202</xref>,<xref ref-type="bibr" rid="ref203">203</xref></sup></p></list-item></list></p><table-wrap id="tbl3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Carbon-11 Labeled Amino Acids</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">ee</th><th style="border:none;" align="center" colspan="1" rowspan="1">total time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">alanine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref240">240</xref></sup> humans<sup><xref ref-type="bibr" rid="ref240">240</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">99%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref241">241</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">not reported (nr)</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;0.050</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">90%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref242">242</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">asparagine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">18.6</td><td style="border:none;" align="center" colspan="1" rowspan="1">53%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref243">243</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">aspartic acid</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats, rabbits, dogs, pigs, and monkeys,<sup><xref ref-type="bibr" rid="ref244">244</xref>&#8722;<xref ref-type="bibr" rid="ref247">247</xref></sup> humans<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">0.185</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">15</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref244">244</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">97.8%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref249">249</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">glutamic acid</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">8</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref250">250</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats, rabbits,
pigs.,<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref>,<xref ref-type="bibr" rid="ref250">250</xref></sup> humans<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">61%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref250">250</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>CHCO<sub>2</sub>H</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">61%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref251">251</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">glutamine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref252">252</xref>,<xref ref-type="bibr" rid="ref253">253</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref245">245</xref></sup> humans<sup><xref ref-type="bibr" rid="ref254">254</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CsCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">7.0</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;98%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref255">255</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">glycine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref191">191</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">56</td><td style="border:none;" align="center" colspan="1" rowspan="1">49%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">38</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref192">192</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">homocysteine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs<sup><xref ref-type="bibr" rid="ref256">256</xref>,<xref ref-type="bibr" rid="ref257">257</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">15%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref258">258</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">leucine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice&#160;and&#160;rats,<sup><xref ref-type="bibr" rid="ref259">259</xref>&#8722;<xref ref-type="bibr" rid="ref261">261</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref262">262</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref263">263</xref>&#8722;<xref ref-type="bibr" rid="ref266">266</xref></sup> humans<sup><xref ref-type="bibr" rid="ref263">263</xref>,<xref ref-type="bibr" rid="ref264">264</xref>,<xref ref-type="bibr" rid="ref267">267</xref>&#8722;<xref ref-type="bibr" rid="ref270">270</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref271">271</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]alkyl iodide</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">10</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref272">272</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">38%</td><td style="border:none;" align="center" colspan="1" rowspan="1">99%</td><td style="border:none;" align="center" colspan="1" rowspan="1">38</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref260">260</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">lysine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref273">273</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">15%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref274">274</xref>,<xref ref-type="bibr" rid="ref275">275</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">6</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]ICH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref275">275</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">methionine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice, rats, dogs, and pigs,<sup><xref ref-type="bibr" rid="ref214">214</xref>,<xref ref-type="bibr" rid="ref276">276</xref>&#8722;<xref ref-type="bibr" rid="ref278">278</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref279">279</xref></sup> humans<sup><xref ref-type="bibr" rid="ref280">280</xref>,<xref ref-type="bibr" rid="ref281">281</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">75</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;93.7%</td><td style="border:none;" align="center" colspan="1" rowspan="1">15</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref282">282</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-methylglycine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice, rats, and humans<sup><xref ref-type="bibr" rid="ref193">193</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">280</td><td style="border:none;" align="center" colspan="1" rowspan="1">14%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">25</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref192">192</xref>,<xref ref-type="bibr" rid="ref193">193</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice<sup><xref ref-type="bibr" rid="ref192">192</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;56</td><td style="border:none;" align="center" colspan="1" rowspan="1">4%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref192">192</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">S</italic>-methyl-<sc>l</sc>-cysteine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> humans<sup><xref ref-type="bibr" rid="ref284">284</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">12</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref283">283</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">norleucine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref214">214</xref>,<xref ref-type="bibr" rid="ref285">285</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">100</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref286">286</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">norvaline</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">25%</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">20</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref272">272</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ornithine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref273">273</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">14%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref273">273</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]KCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">77.7%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref272">272</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">phenylalanine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref212">212</xref>,<xref ref-type="bibr" rid="ref215">215</xref>,<xref ref-type="bibr" rid="ref287">287</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]C<sub>5</sub>H<sub>5</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">135</td><td style="border:none;" align="center" colspan="1" rowspan="1">27%</td><td style="border:none;" align="center" colspan="1" rowspan="1">99%</td><td style="border:none;" align="center" colspan="1" rowspan="1">24</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref217">217</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">phenylglycine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">n.r</td><td style="border:none;" align="center" colspan="1" rowspan="1">6%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref288">288</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]C<sub>5</sub>H<sub>5</sub>COH</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.037</td><td style="border:none;" align="center" colspan="1" rowspan="1">6%</td><td style="border:none;" align="center" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref289">289</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">proline</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref273">273</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">18%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref273">273</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">serine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.85</td><td style="border:none;" align="center" colspan="1" rowspan="1">2%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref290">290</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">tryptophan</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref291">291</xref></sup> humans<sup><xref ref-type="bibr" rid="ref292">292</xref>,<xref ref-type="bibr" rid="ref293">293</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">2.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">25%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">55</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref220">220</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-hydroxytryptophan</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref218">218</xref>,<xref ref-type="bibr" rid="ref294">294</xref>&#8722;<xref ref-type="bibr" rid="ref296">296</xref></sup> rat,<sup><xref ref-type="bibr" rid="ref297">297</xref>&#8722;<xref ref-type="bibr" rid="ref300">300</xref></sup> mice,<sup><xref ref-type="bibr" rid="ref301">301</xref></sup> humans<sup><xref ref-type="bibr" rid="ref302">302</xref>&#8722;<xref ref-type="bibr" rid="ref307">307</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">44</td><td style="border:none;" align="center" colspan="1" rowspan="1">24%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref220">220</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">tyrosine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref308">308</xref>,<xref ref-type="bibr" rid="ref309">309</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">111</td><td style="border:none;" align="center" colspan="1" rowspan="1">15%</td><td style="border:none;" align="center" colspan="1" rowspan="1">98%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref287">287</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">valine</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats&#160;and&#160;dogs,<sup><xref ref-type="bibr" rid="ref310">310</xref></sup> humans<sup><xref ref-type="bibr" rid="ref292">292</xref>,<xref ref-type="bibr" rid="ref311">311</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]KCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.30</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">racemic</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref312">312</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">2-</italic><sup>11</sup>C](CH<sub>3</sub>)<sub>2</sub>CHI</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">9%</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref286">286</xref>)</td></tr></tbody></table></table-wrap><p>From the nine essential amino acids, only five have
been labeled
with carbon-11:<list list-type="bullet"><list-item><p>Leucine is an essential ketogenic amino acid, metabolized
to acetyl-coenzyme A (acetyl-CoA) and acetoacetate.<sup><xref ref-type="bibr" rid="ref204">204</xref></sup> It has been radiolabeled in positions 1, 3, and 5. Leucine
may be important in the study of regional cerebral protein synthesis
rate and organ function.<sup><xref ref-type="bibr" rid="ref205">205</xref>&#8722;<xref ref-type="bibr" rid="ref208">208</xref></sup></p></list-item><list-item><p>Lysine is used
in the biosynthesis of proteins and the
crosslinking of collagen polypeptides, epigenetic regulation through
histone modification, and fatty acid metabolism <italic toggle="yes">via</italic> the production of carnitine. The &#945;-aminoadipic semialdehyde
synthase protein catalyzes the primary metabolic route for lysine
degradation <italic toggle="yes">via</italic> the saccharopine pathway within the
mitochondria.<sup><xref ref-type="bibr" rid="ref209">209</xref></sup></p></list-item><list-item><p>Methionine is involved in several biological functions
transported into the cell <italic toggle="yes">via</italic> the reversible sodium-independent
transport system LAT-1.<sup><xref ref-type="bibr" rid="ref210">210</xref></sup></p></list-item><list-item><p>Phenylalanine has one of the highest brain uptake indexes
among amino acids.<sup><xref ref-type="bibr" rid="ref211">211</xref></sup> Although it has good
potential for investigating protein synthesis rates <italic toggle="yes">in vivo</italic> by PET, only limited <italic toggle="yes">in vivo</italic> studies have been
performed using this <sup>11</sup>C-labeled amino acid.<sup><xref ref-type="bibr" rid="ref212">212</xref>&#8722;<xref ref-type="bibr" rid="ref215">215</xref></sup> One reason might be its peripheral metabolism to tyrosine and intense
competition with tyrosine and methionine<sup><xref ref-type="bibr" rid="ref216">216</xref></sup> for the same transport system localized in the endothelium of the
brain capillaries with consequent complications for tracer kinetic
modeling. The second reason is that until recently, no automated procedure
has been available for reliable production of [<sup>11</sup>C]phenylalanine
due to complex multistep syntheses or low RCYs after isolation and
purification of <sc>l</sc>-enantiomer.<sup><xref ref-type="bibr" rid="ref217">217</xref></sup></p></list-item><list-item><p>Tryptophan, in addition to its role
as a building block
in protein synthesis, is a crucial biochemical precursor to serotonin,
the hormone melatonin, and the cofactor nicotinamide adenine dinucleotide.
Tryptophan is converted to serotonin in a two-step enzymatic process
involving hydroxylation to 5-hydroxytryptophan (5-HTP), then decarboxylation
by aromatic amino acid decarboxylase. Serotonin is catabolized by
the actions of monoamine oxidase and aldehyde dehydrogenase to 5-hydroxyindoleacetic
acid, which is released into the bloodstream and excreted by the kidneys.
Finally, because serotonin cannot cross the BBB, it is synthesized
within neurons following the transportation of tryptophan across the
BBB by the large amino acid transporter. As endogenous precursors
to serotonin, tryptophan and 5-HTP have been radiolabeled with carbon-11
at either the carboxyl- or &#946;-position and investigated as PET
probes to measure serotonin synthesis in health and disease. [<sup>11</sup>C]Tryptophan is also used for protein and kynurenine synthesis,
so caution should be used as a marker of tryptophan synthesis alone.
5-HTP, on the other hand, is involved solely in serotonin synthesis
through decarboxylation by aromatic <sc>d</sc>-amino acid decarboxylase
(AADC) and can pass the BBB; hence [<sup>11</sup>C]5-HTP is advantageous
as a serotonergic PET probe. The choice of labeling position is important
because decarboxylation will sever the radiolabel from <sup>11</sup>C-carboxyl labeled <italic toggle="yes">5</italic>-HTP, resulting in no specific
signal.<sup><xref ref-type="bibr" rid="ref218">218</xref></sup> When labeled in the &#946;-position, <sup>11</sup>C will be retained within the resultant [<sup>11</sup>C]serotonin
molecule. However, due to specialized enzymes for this radiochemistry,
PET studies using [&#946;-<sup>11</sup>C]HTP have been limited to
a few research institutions.<sup><xref ref-type="bibr" rid="ref219">219</xref>,<xref ref-type="bibr" rid="ref220">220</xref></sup></p></list-item><list-item><p>Valine is used in the biosynthesis of proteins and has
stimulant activity, promoting muscle growth and tissue repair.<sup><xref ref-type="bibr" rid="ref178">178</xref></sup> The amino acid transports across the cell plasma
membrane through the monocarboxylate transporter 10. The latter is
widely expressed across multiple tissues but very low in pancreatic
&#945;- and &#946;-cell membranes. However, valine has the highest
affinity for the pancreas compared to other natural AAs.<sup><xref ref-type="bibr" rid="ref221">221</xref></sup></p></list-item></list></p><p>Nonproteinogenic amino acids occur in nature and are
also crucial
as intermediates in biosynthesis or found in proteins by post-translational
modification:<sup><xref ref-type="bibr" rid="ref222">222</xref></sup><list list-type="bullet"><list-item><p>Homocysteine has two primary metabolic pathways: (a)
through the trans-sulfuration pathway in vitamin B6-dependent reactions<sup><xref ref-type="bibr" rid="ref223">223</xref></sup> and (b) can cyclize to give homocysteine thiolactone
catalyzed by methionyl-tRNA synthetase and vice versa.<sup><xref ref-type="bibr" rid="ref224">224</xref></sup> Intracellular homocysteine can be converted
into <italic toggle="yes">S</italic>-adenosyl-<sc>l</sc>-homocysteine by cytosolic
hydrolase, which is found in sufficient amounts in all organs, including
the heart.<sup><xref ref-type="bibr" rid="ref225">225</xref></sup></p></list-item><list-item><p><italic toggle="yes">S</italic>-Methyl-<sc>l</sc>-cysteine is a natural
amino acid produced by post-transcriptional methylation, mainly in
plants.<sup><xref ref-type="bibr" rid="ref226">226</xref></sup> Several studies reported the
beneficial effects of low doses of S-methyl-<sc>l</sc>-cysteine on
the cardiovascular system due to hypocholesterolemic, antioxidant,
antidiabetic, and hepatoprotective functions.<sup><xref ref-type="bibr" rid="ref205">205</xref>&#8722;<xref ref-type="bibr" rid="ref208">208</xref></sup> The use of <italic toggle="yes">S</italic>-[<sup>11</sup>C]methyl-<sc>l</sc>-cysteine
was proposed as a tumor imaging tool to overcome the low specificity
such as [<sup>18</sup>F]FDG currently presents.<sup><xref ref-type="bibr" rid="ref209">209</xref></sup></p></list-item><list-item><p>Norleucine, biosynthetically,
arises <italic toggle="yes">via</italic> the action of 2-isopropylmalate synthase
on &#945;-ketobutyrate.<sup><xref ref-type="bibr" rid="ref227">227</xref></sup> It penetrates
the brain cells and cell particles
very slowly compared with other amino acids, and its low recovery
rate indicates relatively effective excretion.<sup><xref ref-type="bibr" rid="ref228">228</xref></sup> Although it does not contain sulfur, it is nearly isosteric
with methionine.<sup><xref ref-type="bibr" rid="ref229">229</xref></sup> Thus, norleucine has
been used to probe the role of methionine in amyloid-&#946; peptides
in Alzheimer&#8217;s disease (AD).<sup><xref ref-type="bibr" rid="ref230">230</xref></sup></p></list-item><list-item><p>Norvaline is a natural component of an antifungal
peptide
of <italic toggle="yes">Bacillus subtilis</italic>, a Gram-positive,
catalase-positive bacterium found in the soil and the gastrointestinal
tract of ruminants and humans.<sup><xref ref-type="bibr" rid="ref231">231</xref></sup> Norvaline
promotes tissue regeneration and muscle growth and is commonly used
by bodybuilders.<sup><xref ref-type="bibr" rid="ref226">226</xref>,<xref ref-type="bibr" rid="ref232">232</xref></sup> Norvaline, as a non-competitive
arginase inhibitor, readily crosses the BBB, and reduces arginine
loss in the brain associated with the amyloid-&#946; deposition.<sup><xref ref-type="bibr" rid="ref233">233</xref></sup></p></list-item><list-item><p>Ornithine is produced
in the urea cycle through the
cleavage of urea from arginine and has a central role in the cycle,
allowing the disposal of excess nitrogen. In addition, it is a precursor
of citrulline and arginine found in mitochondria and cytoplasm.<sup><xref ref-type="bibr" rid="ref234">234</xref>,<xref ref-type="bibr" rid="ref235">235</xref></sup></p></list-item><list-item><p>Phenylglycine occurs in natural products,
including
almost all glycopeptide antibiotics and biologically active linear
and cyclic peptides.<sup><xref ref-type="bibr" rid="ref236">236</xref>,<xref ref-type="bibr" rid="ref237">237</xref></sup> Phenylglycine biosynthesis gene
was not identified until 2011. It currently seems to be synthesized
from phenylpyruvate, which is converted into phenylacetyl-CoA by a
pyruvate dehydrogenase-like complex of protein glycosyltransferase
(Pgl) B and C enzymes.<sup><xref ref-type="bibr" rid="ref238">238</xref></sup></p></list-item></list></p><p>In 2018 Pekosak <italic toggle="yes">et al</italic>. published a
comprehensive
review of developed synthesis methods for [<sup>11</sup>C]amino acids,
including <italic toggle="yes">in vivo</italic> studies for some of them.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup> Since then, no other synthetic approaches toward
carbon-11 amino acids production have been reported. Thus, this review
provides for each radiolabeled amino acid, the synthetic methods,
and preclinical and clinical studies on healthy subjects illustrating
the progress up to date.</p><sec id="sec4.1"><label>4.1</label><title>Alanine</title><sec id="sec4.1.1"><label>4.1.1</label><title>Radiosynthesis</title><p>Alanine has been
labeled with <sup>11</sup>C in the 1- and 3- positions. A route to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]alanine
was reported for the first time in 1979 when Langstrom <italic toggle="yes">et
al</italic>. utilized an asymmetric synthesis procedure.<sup><xref ref-type="bibr" rid="ref313">313</xref></sup> Subsequently, several strategies have been
developed to synthesize <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]alanine.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup> The most recent
synthetic strategy was published in 2016 when Filp <italic toggle="yes">et al</italic>. utilized a phase-transfer catalysis enantioselective alkylation
of a commercially available Schiff base glycine precursor with [<sup>11</sup>C]CH<sub>3</sub>I. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]Alanine was synthesized with RCY of 20% and RCP &gt;95%
within 50 min from the EOB. The <italic toggle="yes">A</italic><sub>m</sub> was
&gt;0.050 GBq/&#956;mol at the EOS, and the highest enantiomeric
excess
(ee) achieved was &gt;90%.<sup><xref ref-type="bibr" rid="ref242">242</xref></sup></p><p>The
synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine was first published by Machulla <italic toggle="yes">et al.</italic>, utilizing [<sup>11</sup>C]CO<sub>2</sub> as a precursor
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]propanoic acid, followed by
the synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]<italic toggle="yes">&#945;</italic>-bromopropanoic acid using PBr<sub>3</sub>/Br<sub>2</sub> and subsequent
synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine using NH<sub>3</sub>,
in a RCY of 10% within 70 min.<sup><xref ref-type="bibr" rid="ref314">314</xref></sup> The most
recent synthetic pathway for <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine was published
by Takahashi <italic toggle="yes">et al</italic>. in 1990, where incorporation
of [<sup>11</sup>C]HCN into [<italic toggle="yes">1</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-aminopropanenitrile, followed by hydrolysis, leads to
the final racemic compound with RCY of 75% and RCP &gt;98% within
40
min from EOB. During this preparation, the final solution was sterile
and pyrogen-free.<sup><xref ref-type="bibr" rid="ref315">315</xref></sup></p><p>The preparation
of enantiomerical pure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine has been only reported
by Ropchan <italic toggle="yes">et al</italic>. from the <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine by a modification of the protocol developed by Bjurling <italic toggle="yes">et al</italic>. after passing the racemate through a light-protected <sc><italic toggle="yes">d</italic></sc>-amino acid oxidase and <sc><italic toggle="yes">l</italic></sc>-alanine dehydrogenase column enzyme. The <sc><italic toggle="yes">l</italic></sc> enantiomer was isolated with RCY of 20% and RCP &gt;98% within
40 min (<xref rid="fig46" ref-type="fig">Figure <xref rid="fig46" ref-type="fig">46</xref></xref>).<sup><xref ref-type="bibr" rid="ref241">241</xref></sup></p><fig id="fig46" position="float" orientation="portrait"><label>Figure 46</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]alanine
using [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr46" position="float" orientation="portrait" xlink:href="cr2c00398_0046.jpg"/></fig></sec><sec id="sec4.1.2"><label>4.1.2</label><title>Preclinical Studies</title><p>Preclinical
studies performed by Harper <italic toggle="yes">et al</italic>. in healthy mice
after injecting <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine revealed accumulation
in the pancreas and heart. However, no other details are available
(results presented in the 27<sup>th</sup> Annual Meeting in Detroit).<sup><xref ref-type="bibr" rid="ref240">240</xref></sup></p></sec><sec id="sec4.1.3"><label>4.1.3</label><title>Clinical Studies</title><p>Injecting <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">l</italic>-<sup>11</sup>C]alanine to healthy humans showed virtually no localization
in the heart or pancreas, and the radioactivity was removed as [<sup>11</sup>C]CO<sub>2</sub> by expiration due to decarboxylation. However,
this study showed that <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]alanine has different distribution
by comparing preclinical and clinical studies, and no other studies
have been performed.<sup><xref ref-type="bibr" rid="ref240">240</xref></sup></p></sec></sec><sec id="sec4.2"><label>4.2</label><title>Asparagine</title><sec id="sec4.2.1"><label>4.2.1</label><title>Radiosynthesis</title><p>Labeling asparagine
with carbon-11 has only been performed at the urea position. The method
was published as a conference abstract by Antoni <italic toggle="yes">et al</italic>. in 1995. The group developed an approach based on the enzymatic
synthesis of &#946;-cyanoalanine using cyanide as the labeled precursor.
However, the report describes no purification procedure; thus, no
details about RCY, RCP, or ee were mentioned. A year later, a patent
from the same group was released without further follow-up (EP0733374A3&#183;1999-06-02).</p><p>In 2001, Gillings <italic toggle="yes">et al</italic>. published the first complete
synthetic labeling procedure for the preparation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine, where a novel
and rapid methodology for the synthesis of <sup>11</sup>C radiolabeled
AAs, known as aziridine ring-opening reactions, was described.<sup><xref ref-type="bibr" rid="ref316">316</xref></sup> Aziridines, as alternative electrophiles, can
readily react with [<sup>11</sup>C]cyanide to develop different <sup>11</sup>C-carbonyl AAs. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine has been reported in a RCY of 30-40% and
RCP of 95% within 30 min. Stereospecific synthesis using a highly
enantiomerically enriched aziridine-2-carboxylate precursor was not
achieved, and only racemic amino acid products were obtained with
ee 50%. The <italic toggle="yes">A</italic><sub>m</sub> of the final product was
estimated to be 0.010&#8211;0.050 GBq/&#956;mol at the EOS, based
on the <italic toggle="yes">A</italic><sub>m</sub> of [<sup>11</sup>C]HCN.<sup><xref ref-type="bibr" rid="ref316">316</xref></sup></p><p>In 2018, Xu <italic toggle="yes">et al</italic>. developed
the latest synthetic
pathway to prepare enantiomerically pure <sc>l</sc>-[4-<sup>11</sup>C]asparagine, where a chiral five-membered cyclic sulfamidate was
used as the radiolabeling precursor.<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> Utilizing a [<sup>11</sup>C]CN<sup>&#8211;</sup> nucleophilic ring-opening
reaction followed by selective acidic hydrolysis and deprotection,
enantiomerically pure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine, with a total synthesis time of 45 &#177;
3 min, was isolated with RCY of 53 &#177; 2% and RCP of 96 &#177;
2%. The <italic toggle="yes">A</italic><sub>m</sub> of the <sc>l</sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine was 18.6 &#177; 6.2 GBq/&#956;mol
at EOS (<xref rid="fig47" ref-type="fig">Figure <xref rid="fig47" ref-type="fig">47</xref></xref>).
This semi-automated radiolabeling process should be adaptable to a
commercially available radiosynthesizer and adjustable to a full-scale
automation process, which is beneficial for synthesizing <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine on
a large scale. Additionally, the development of reaction conditions
that retained the stereochemistry during the base-sensitive nucleophilic <sup>11</sup>C-cyanation using the chiral cyclic sulfamidate precursor
will benefit future design and synthesis of radioactive <sc>l</sc>-alanine moiety containing amino acids and analogues.<sup><xref ref-type="bibr" rid="ref243">243</xref></sup></p><fig id="fig47" position="float" orientation="portrait"><label>Figure 47</label><caption><p>Synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]asparagine using [<sup>11</sup>C][N(C<sub>4</sub>H<sub>9</sub>)<sub>4</sub>]CN. <sup>11</sup>C radionuclide
position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr47" position="float" orientation="portrait" xlink:href="cr2c00398_0047.jpg"/></fig></sec></sec><sec id="sec4.3"><label>4.3</label><title>Aspartic Acid</title><sec id="sec4.3.1"><label>4.3.1</label><title>Radiosynthesis</title><p>As with asparagine,
the labeling of aspartic acid has only been performed in one position
(<italic toggle="yes">4</italic>-). The first method was published by Barrio <italic toggle="yes">et al</italic>. and constituted the first example of using enzymatic
synthesis for <sup>11</sup>C-labeled amino acid radiotracer synthesis.
Briefly, phosphoenolpyruvate carboxylase and aspartate transaminase
were immobilized on sepharose activated with cyanogen bromide groups
and applied to synthesize <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid using [<sup>11</sup>C]CO<sub>2</sub> as the <sup>11</sup>C source. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]Aspartate production was completed within
15&#8211;25 min after EOB. The actual RCY was about 10%, with RCP
of 99% and <italic toggle="yes">A</italic><sub>m</sub> of 0.129&#8211;0.185 GBq/&#956;mol
at EOS.<sup><xref ref-type="bibr" rid="ref244">244</xref></sup></p><p>In 2001, Antoni <italic toggle="yes">et al</italic>. published the latest enzymatic procedure for the
preparation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid.<sup><xref ref-type="bibr" rid="ref249">249</xref></sup> The latter
was obtained by enzymatic catalysis from <italic toggle="yes">O</italic>-acetyl-<sc><italic toggle="yes">l</italic></sc>-serine with carrier added [<sup>11</sup>C]HCN,
using <italic toggle="yes">O</italic>-acetyl-<sc><italic toggle="yes">l</italic></sc>-serine
sulfhydrylase (EC 4.2.99.8), followed by alkaline hydrolysis (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>). Enantiomerically
pure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid (ee 97.8%) was prepared with a total synthesis time
of 45 min and isolated with an RCY of 60&#8211;70% and an RCP &gt;95%
from EOB.<sup><xref ref-type="bibr" rid="ref249">249</xref></sup> The immobilization procedures
resulted in a sterile and pyrogen-free product suitable for animal
and human studies.<sup><xref ref-type="bibr" rid="ref244">244</xref>,<xref ref-type="bibr" rid="ref248">248</xref></sup></p><fig id="fig48" position="float" orientation="portrait"><label>Figure 48</label><caption><p>Enzymatic synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid
using [<sup>11</sup>C]CN<sup>&#8211;</sup>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr48" position="float" orientation="portrait" xlink:href="cr2c00398_0048.jpg"/></fig></sec><sec id="sec4.3.2"><label>4.3.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]Aspartic acid
has been evaluated in rats, rabbits, dogs, pigs, and monkeys.<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref246">246</xref></sup> Two different studies have been performed on rats. In the first
one, male Dawley rats were administered with the radiotracer via the
tail vein and sacrificed at 20 min p.i. Co-injection with non-radioactive
aspartate (140 mg/kg) led to a 50% increase in kidney radioactivity,
while the other organs were slightly decreased (<xref rid="fig49" ref-type="fig">Figure <xref rid="fig49" ref-type="fig">49</xref></xref>).<sup><xref ref-type="bibr" rid="ref245">245</xref></sup></p><fig id="fig49" position="float" orientation="portrait"><label>Figure 49</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]Aspartic
acid whole-body imaging (left) and autoradiography (right) in rats.
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref246">246</xref>). Copyright 1984 J-Stage. This work is licensed
under a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr49" position="float" orientation="portrait" xlink:href="cr2c00398_0049.jpg"/></fig><p>In a second study, Wister rats received iv <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic
acid. After 10
min, 90% of the radioactivity was cleared from the blood, while after
60 min, 60% had been exhaled as [<sup>11</sup>C]CO<sub>2</sub>. Whole-body
distribution showed high accumulation in the salivary gland, glandular
stomach, and pancreas after 30 min. In addition, high accumulation
was also noticed in the head and neck, liver, lungs, and kidney at
10 min, with a tendency to gradually wash out from tissue after 60
min (<xref rid="fig49" ref-type="fig">Figure <xref rid="fig49" ref-type="fig">49</xref></xref>).</p><p><sc>l</sc>-[4-<sup>11</sup>C]Aspartic acid has been used to study
pig myocardial uptake and clearance. Preliminary results showed a
low extraction of the order of 8&#8211;12%. According to the authors,
the myocardium&#8217;s clearance rate was rapid, similar to [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetate, measured in the same animal.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> This suggests that aspartate, once extracted,
rapidly enters the tricarboxylic acid (TCA) intermediate pool.<sup><xref ref-type="bibr" rid="ref249">249</xref></sup></p><p>Other studies performed in dogs and monkeys
also showed rapid blood
clearance and high retention in the myocardium. Briefly, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid
(0.74&#8211;1.11 MBq/0.2 mL) was injected into the left anterior
descending coronary artery of open-chest instrumented healthy and
aminooxyacetic acid-treated dogs. The myocardial activity was recorded
for 20 min, where a rapid clearance of the activity from the vascular
and extravascular space was observed, similar to the total body distribution
in rats.<sup><xref ref-type="bibr" rid="ref244">244</xref></sup></p><p>PET imaging 5 min p.i.
of 185 MBq obtained with a positron emission
computed axial tomography showed that the rhesus monkey myocardium
had a higher accumulation than dogs&#8217; hearts. The PET images
in dogs showed a heart/lung activity ratio of 1.2:l, while in monkeys
of 32.8:l, the authors suggested that the <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]aspartic acid could be essential
for assessing local myocardial metabolism.<sup><xref ref-type="bibr" rid="ref244">244</xref></sup></p></sec><sec id="sec4.3.3"><label>4.3.3</label><title>Clinical Studies</title><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]Aspartic acid has not been
evaluated in healthy humans, but it has been used in two clinical
studies with four patients with endocrine pancreatic tumors and three
patients (two with carcinoid and one with the endocrine pancreatic
tumor).<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref></sup> In the first study, the accumulation in
the pancreas was rapid and high, except in one patient with secondary
pancreatic atrophy. An early peak and a rapid decrease in the kidney
were seen. The tracer accumulation in muscle and bone marrow was low.<sup><xref ref-type="bibr" rid="ref249">249</xref></sup> In the second study, after an injection of
790&#8211;980 MBq of the tracer, a region over the liver&#8211;pancreas
was examined with a dynamic imaging sequence consisting of 14 frames
acquired during 45 min. The plasma radioactivity concentration was
low at approximately 1.5 from 10 min p.i. The highest uptake was seen
in the pancreas, followed by the spleen.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup> The uptake was low in all the primary tumors and most hepatic metastases.
These results discourage imaging neuroendocrine tumors and their metastases
because they often reside in those organs.</p></sec></sec><sec id="sec4.4"><label>4.4</label><title>Glutamic Acid</title><sec id="sec4.4.1"><label>4.4.1</label><title>Radiosynthesis</title><p>Glutamate has been
labeled with <sup>11</sup>C in the <italic toggle="yes">1</italic>- and <italic toggle="yes">5</italic>- positions. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]glutamic acid and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid were synthesized for the
first time by Cohen <italic toggle="yes">et al.</italic>, in 1982, as an extension
of their two previously reported biosynthetic methods for the synthesis
of [<sup>11</sup>C]citric acid.<sup><xref ref-type="bibr" rid="ref250">250</xref></sup> For
the synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]glutamic acid
and [<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid, [<sup>11</sup>C]CO<sub>2</sub> is first converted to [<sup>11</sup>C]oxaloacetate
and [<sup>11</sup>C]acetate, respectively. From that point, the label
is incorporated into a series of compounds by the same enzymes; phosphoenolpyruvate
carboxylase, citrate synthase, aconitase, isocitrate dehydrogenase,
and glutamate-pyruvate transaminase. According to the method, labeling
in the 1- and 5-position required 16&#8211;18 and 30&#8211;35 min,
respectively. Both tracers were isolated with RCY of 12&#8211;20%
and high <italic toggle="yes">A</italic><sub>m</sub>. According to the authors&#8217;
report, this method may be suitable for human use after modification
in the final preparation. Specifically, the enzyme should be immobilized
on solid- support to guarantee the absence of enzymes in the final
solution.<sup><xref ref-type="bibr" rid="ref250">250</xref></sup> Subsequently, new synthetic
methods were only published for <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid. The latest method was developed
by Filp <italic toggle="yes">et al</italic>. in 2017, utilizing [<sup>11</sup>C]acrylic
acid in a novel Michael addition reaction, where a Schiff base glycine
derivative was used as a Michael donor. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid was prepared in
ee 61 &#177; 4% with a low RCP of 10&#8211;15%, but this preparation
was only a proof-of-concept study (<xref rid="fig50" ref-type="fig">Figure <xref rid="fig50" ref-type="fig">50</xref></xref>).<sup><xref ref-type="bibr" rid="ref251">251</xref></sup></p><fig id="fig50" position="float" orientation="portrait"><label>Figure 50</label><caption><p>Synthesis
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic
acid using [<sup>11</sup>C]acrylic acid. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr50" position="float" orientation="portrait" xlink:href="cr2c00398_0050.jpg"/></fig></sec><sec id="sec4.4.2"><label>4.4.2</label><title>Preclinical Studies</title><p>Only glutamic
acid labeled in the <italic toggle="yes">5</italic>- position has been preclinically
evaluated. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid has been studied&#8239;in rats, rabbits, and pigs.<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref>,<xref ref-type="bibr" rid="ref250">250</xref></sup> Biodistribution studies in Dawley
rats&#8239;were performed 20 min after administering the tracer <italic toggle="yes">via</italic> the tail vein. The highest uptake was found in the pancreas,
kidney, and lungs. When the organ uptake was normalized to radioactivity
in blood,&#8239;maximum levels were seen in the pancreas, kidney,
liver, and lungs.&#8239;Co-injection&#8239;with non-radioactive
glutamate (70 mg/kg) did not alter the uptake in the organs.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup></p><p>Tissue distribution studies in white
rabbits of different ages, weights, and species were performed after <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]glutamic
or <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic
acid injection into the ear vein. The animals were sacrificed 5 min
p.i., and selected tissues were obtained. The pancreatic uptake ratio
was higher in <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid. The pancreas, heart, blood, lungs, and kidney
to liver ratios for the two <sup>11</sup>C compounds were significantly
different. The blood radioactivity was higher for <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]glutamic acid. The different
distributions suggest they rapidly metabolize <italic toggle="yes">via</italic> transamination and the TCA cycle. The <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]glutamic acid is rapidly decarboxylated
compared to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid. Rabbits and humans appear to have a similar pathway
for glutamic acid metabolism in the pancreas. However, the myocardial
localization in rabbits cannot be reliably extrapolated to humans
because of the differences in the myocardial metabolism of amino acids
between species.<sup><xref ref-type="bibr" rid="ref250">250</xref></sup></p><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamic
acid has been used in a pilot study of pig myocardium, measuring the
myocardial uptake and clearance of the tracer. Preliminary results
suggest a low extraction of about 8&#8211;12%, which was decreased
after a continuous infusion of non-labeled glutamate. According to
the authors, the pigs&#8217; myocardial clearance was rapid, similar
to [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetate.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Thus, they suggested that <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid rapidly enters the TCA intermediate
pool, probably as [<italic toggle="yes">5</italic>-<sup>11</sup>C]<italic toggle="yes">2</italic>-oxoglutaric acid.<sup><xref ref-type="bibr" rid="ref248">248</xref>,<xref ref-type="bibr" rid="ref317">317</xref></sup> However, the low uptake in the
heart discourages <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamic acid for imaging the healthy and diseased heart.</p></sec><sec id="sec4.4.3"><label>4.4.3</label><title>Clinical Studies</title><p>Only the glutamic
acid labeled in the 5- position has been evaluated in&#8239;two&#8239;clinical
studies:&#8239;one patient with an endocrine pancreatic tumor, two&#8239;with
a carcinoid tumor and liver metastases, and one with&#8239;an&#8239;endocrine
tumor pancreatic tumor with liver metastases.<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref248">248</xref></sup> &#8239;In the first study, one patient had high radiotracer accumulation
in normal pancreatic parenchyma. The healthy abdominal organs, liver
and spleen, showed high uptake, while no accumulation was observed
in the stomach. However, accumulation was found in segments of the
intestine.<sup><xref ref-type="bibr" rid="ref317">317</xref></sup> &#8239;In the second study,
after an injection tracer, a region over the liver&#8211;pancreas
was examined with a dynamic imaging sequence of 14&#8239;frames for
45 min.&#8239;The highest uptake was found in the pancreas at 5&#8211;10
min p.i., which decreased at the end of the study (40 min p.i.). The
kidney had a very high uptake within the first 5 min, which rapidly
decreased at 15 min p.i. A study with a co-injection of non-radioactive
glutamic acid showed similar results. All cases showed low uptake
in the primary tumors&#8239;and hepatic metastases.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup> These results&#8239;discourage&#8239;its&#8239;use in
imaging neuroendocrine tumors and their metastases.&#8239;</p></sec></sec><sec id="sec4.5"><label>4.5</label><title>Glutamine</title><sec id="sec4.5.1"><label>4.5.1</label><title>Radiosynthesis</title><p>The first use of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
was reported by Wu <italic toggle="yes">et al.</italic>, but there is no information
about their radiosynthesis method or the purity of the compound.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup> In 2012 Qu <italic toggle="yes">et al</italic>. published
the first detailed radiosynthesis method of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine.<sup><xref ref-type="bibr" rid="ref252">252</xref></sup> For the synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine, [<sup>11</sup>C]CO<sub>2</sub> is first converted to [<sup>11</sup>C]CH<sub>4</sub> and mixed with
ammonia gas to trap [<sup>11</sup>C]HCN in KOH solution of DMF to
have [<sup>11</sup>C]KCN. The DMF solution of (<italic toggle="yes">S</italic>)-<italic toggle="yes">tert</italic>-butyl <italic toggle="yes">2</italic>-((<italic toggle="yes">tert</italic>-butoxycarbonyl)amino)-<italic toggle="yes">4</italic>-iodobutanoate was introduced into the mixture and heated
for 5 min at 120 &#176;C to obtain <italic toggle="yes">5</italic>-<sup>11</sup>C-(<italic toggle="yes">S</italic>)-<italic toggle="yes">tert</italic>-butyl <italic toggle="yes">2</italic>-(<italic toggle="yes">tert</italic>-butoxycarbonyl)amino)-<italic toggle="yes">4</italic>-cyanobutanoate.
Hydrolysis was performed by an acidic workup and after purification, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
was obtained in approximately 60 min in a water solution with a <italic toggle="yes">A</italic><sub>m</sub> of 1.85 &#177; 0.74 GBq/&#956;mol and RCP
&gt;94% (<xref rid="fig51" ref-type="fig">Figure <xref rid="fig51" ref-type="fig">51</xref></xref>).<sup><xref ref-type="bibr" rid="ref239">239</xref>,<xref ref-type="bibr" rid="ref318">318</xref>,<xref ref-type="bibr" rid="ref319">319</xref></sup> Results of
this study were also
published in other papers,<sup><xref ref-type="bibr" rid="ref320">320</xref>,<xref ref-type="bibr" rid="ref321">321</xref></sup> and some adaptations
were made.<sup><xref ref-type="bibr" rid="ref320">320</xref>,<xref ref-type="bibr" rid="ref321">321</xref></sup></p><fig id="fig51" position="float" orientation="portrait"><label>Figure 51</label><caption><p>Synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine using
[<sup>11</sup>C]KCN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr51" position="float" orientation="portrait" xlink:href="cr2c00398_0051.jpg"/></fig><p>In 2015, Gleede <italic toggle="yes">et al.</italic> developed
an improved radiosynthesis
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine.<sup><xref ref-type="bibr" rid="ref255">255</xref></sup> This new method was prepared to better understand
SN<sub>2</sub><sup>11</sup>C-cyanation reactions. In this study,
different reaction conditions were reported. Using CsHCO<sub>3</sub>/18-C-6 as a trapping solution of [<sup>11</sup>C]HCN instead of
KOH has significantly increased the yield of [<sup>11</sup>C]CN<sup>&#8211;</sup> salt (<xref rid="fig52" ref-type="fig">Figure <xref rid="fig52" ref-type="fig">52</xref></xref>). Total synthesis time was decreased to 37&#8211;52 from
60 min with &#8764;80% <sup>11</sup>C-cyanation yield, &#8764;60%
overall RCY, <italic toggle="yes">A</italic><sub>m</sub> of 7.0 &#177; 1.5 GBq/&#956;mol,
and RCP &gt;93%.<sup><xref ref-type="bibr" rid="ref255">255</xref></sup> In the same study,
it
was also reported that <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine was observed as an optical impurity as
a result of introducing the phase transfer catalyst Krypotfix 222
to the reaction.</p><fig id="fig52" position="float" orientation="portrait"><label>Figure 52</label><caption><p>Fully automated synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine using [<sup>11</sup>C]CsCN. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr52" position="float" orientation="portrait" xlink:href="cr2c00398_0052.jpg"/></fig><p>In 2017, Filp <italic toggle="yes">et al</italic>. synthesized <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
by a novel Michael
addition reaction using [<sup>11</sup>C]methyl acrylate and a Schiff
base glycine derivative.<sup><xref ref-type="bibr" rid="ref251">251</xref></sup> In 2019, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
was synthesized by using Synthra HCN plus synthesis module and [<sup>11</sup>C]HCN in 60 min (yield 43-52%, RCP &gt;90%).<sup><xref ref-type="bibr" rid="ref322">322</xref></sup> Similar work was performed with <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
with RCY of 33.5
&#177; 16.0 and 34.9 &#177; 11.3%, respectively.<sup><xref ref-type="bibr" rid="ref253">253</xref></sup></p><p>Rosenberg <italic toggle="yes">et al</italic>. have recently described
a reliable
two-step automated radiosynthesis/production of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine under GMP for
clinical use.<sup><xref ref-type="bibr" rid="ref321">321</xref></sup> The product was prepared
in RCY of 70% (from trapped [<sup>11</sup>C]HCN) within 45 min from
the EOB. The radiosynthesis, optimization, and automation were based
upon the previous reports of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine synthesis.<sup><xref ref-type="bibr" rid="ref252">252</xref>,<xref ref-type="bibr" rid="ref255">255</xref>,<xref ref-type="bibr" rid="ref323">323</xref></sup></p></sec><sec id="sec4.5.2"><label>4.5.2</label><title>Preclinical Studies</title><p>Biodistribution
studies in Dawley rats&#8239;were performed 20 min after administering
the tracer through the tail vein. The highest uptake has been found
in the pancreas, kidney, and liver.&#8239;Co-injection&#8239;with
nonradioactive glutamine did not alter the uptake in the organs.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup></p><p>Biodistribution studies in mice were
performed at 15, 30, and 60 min after administering the tracer through
the lateral tail vein.<sup><xref ref-type="bibr" rid="ref252">252</xref></sup> The highest uptake
was found in the pancreas at 15 min. Uptake in the heart and kidneys
was instant, but the heart uptake decreased rapidly after 15 min,
and the tracer in the kidneys was released into the bladder. Dynamic
small-animal PET studies have been performed with F344 rats and transgenic
mice with mammary tumors. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamine was injected in rats bearing xenografted
9L tumors and transgenic mice bearing spontaneous mammary gland tumors.</p><p>In 2021, Renick <italic toggle="yes">et al</italic>. published <italic toggle="yes">in vitro</italic>, <italic toggle="yes">in vivo</italic>, and <italic toggle="yes">ex vivo</italic> studies
about <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine in bacterial, mammalian cell lines, and mouse
models.<sup><xref ref-type="bibr" rid="ref253">253</xref></sup> This comparative study showed
high uptakes for <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine in all organs except kidneys (<xref rid="fig53" ref-type="fig">Figure <xref rid="fig53" ref-type="fig">53</xref></xref>).</p><fig id="fig53" position="float" orientation="portrait"><label>Figure 53</label><caption><p>(A) <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamine and (B) <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine PET/CT
scans of mice before and after dual
myositis infection. EC, <italic toggle="yes">E. coli</italic>; HK,
Heat-killed. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref253">253</xref>). Copyright 2021 American
Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr53" position="float" orientation="portrait" xlink:href="cr2c00398_0053.jpg"/></fig></sec><sec id="sec4.5.3"><label>4.5.3</label><title>Clinical Studies</title><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamine has been only
evaluated in one&#8239;clinical study&#8239;with&#8239;nine patients
with metastatic colorectal cancer (<xref rid="fig54" ref-type="fig">Figure <xref rid="fig54" ref-type="fig">54</xref></xref>).<sup><xref ref-type="bibr" rid="ref254">254</xref></sup> With this
first and only in-human study, radiologic safety and biodistribution
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]glutamine
were investigated for PET imaging. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamine was given as an iv injection
over 30 seconds. The total scanning time was 58 min for the tumor
region and approximately 18 min for a whole-body PET scan. The highest
activity was observed from the bladder, pancreas, and liver.<sup><xref ref-type="bibr" rid="ref254">254</xref></sup></p><fig id="fig54" position="float" orientation="portrait"><label>Figure 54</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamine
whole-body PET (A) and PET/CT (B) for biodistribution and tumor imaging
in a patient with metastatic colorectal cancer. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref254">254</xref>). Copyright
2022 Society of Nuclear Medicine and Molecular Imaging. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr54" position="float" orientation="portrait" xlink:href="cr2c00398_0054.jpg"/></fig></sec></sec><sec id="sec4.6"><label>4.6</label><title>Glycine and <italic toggle="yes">N</italic>-Methylglycine
(Sarcosine)</title><sec id="sec4.6.1"><label>4.6.1</label><title>Radiosynthesis</title><p>The radiosynthesis
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine was first reported in
1986 by Bolster <italic toggle="yes">et al</italic>. through <sup>11</sup>C-carboxylation
of activated methyl isocyanide (<xref rid="fig55" ref-type="fig">Figure <xref rid="fig55" ref-type="fig">55</xref></xref>A).<sup><xref ref-type="bibr" rid="ref190">190</xref></sup> In this
process, [<sup>11</sup>C]CO<sub>2</sub> was delivered to a solution
of <italic toggle="yes">&#945;</italic>-lithiomethylisocyanide, generated in situ
from methyl isocyanide and <italic toggle="yes">n</italic>-BuLi. Subsequent hydrolysis
of the isocyanide group using hydrochloric acid gave [<sup>11</sup>C]glycine with an RCY of 10&#8211;15% and RCP of 87&#8211;94%,
in a process lasting 30 min. The following year, an alternative preparation
was described by Johnstr&#246;m <italic toggle="yes">et al.</italic>, using [<sup>11</sup>C]cyanide, formaldehyde, and ammonium carbonate in the Bucherer&#8211;Bergs
synthesis (<xref rid="fig55" ref-type="fig">Figure <xref rid="fig55" ref-type="fig">55</xref></xref>B).<sup><xref ref-type="bibr" rid="ref191">191</xref></sup> This reaction uses carrier-added
KCN and proceeds <italic toggle="yes">via</italic> the formation of the intermediate
[<sup>11</sup>C]hydantoin, which is hydrolyzed by a strong base to
produce [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine (synthesis time,
30&#8211;35 min; RCY, 35% based on [<sup>11</sup>C]cyanide, RCP &gt;
98%). In 2017, Xing <italic toggle="yes">et al</italic>. reported the non-carrier-added
synthesis under similar conditions, producing [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine in 49% RCY (based on [<sup>11</sup>C]cyanide) in
a process lasting 38 min (synthesis time, 38 min; activity, 4 GBq;
RCY, 49% based on [<sup>11</sup>C]cyanide; RCP &gt; 95%, <italic toggle="yes">A</italic><sub>m</sub> &gt; 56 GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref192">192</xref></sup></p><fig id="fig55" position="float" orientation="portrait"><label>Figure 55</label><caption><p>Radiosynthetic routes to [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine
using (A) [<sup>11</sup>C]CO<sub>2</sub> and (B) [<sup>11</sup>C]CN<sup>&#8211;</sup>. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr55" position="float" orientation="portrait" xlink:href="cr2c00398_0055.jpg"/></fig><p>Sarcosine has been radiolabeled with carbon-11
at the <italic toggle="yes">N</italic>-methyl position,<sup><xref ref-type="bibr" rid="ref192">192</xref>,<xref ref-type="bibr" rid="ref193">193</xref></sup> and carbonyl.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup> [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine was prepared by methylation
of methyl glycinate using
[<sup>11</sup>C]CH<sub>3</sub>OTf, followed by ester hydrolysis (<xref rid="fig56" ref-type="fig">Figure <xref rid="fig56" ref-type="fig">56</xref></xref>A) within 25 min,
with a RCY of 6&#8211;14%, RCP &gt;95%, and <italic toggle="yes">A</italic><sub>m</sub> &gt;280 GBq/&#956;mol at EOS. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Sarcosine
was prepared by the Strecker synthesis using no-carrier-added [<sup>11</sup>C]cyanide (<xref rid="fig56" ref-type="fig">Figure <xref rid="fig56" ref-type="fig">56</xref></xref>B). This reaction proceeds <italic toggle="yes">via</italic> condensation
of formaldehyde with methylamine and subsequent reaction with [<sup>11</sup>C]NaCN to generate the [<sup>11</sup>C]<italic toggle="yes">&#945;</italic>-aminonitrile. The nitrile group is then hydrolyzed using a strong
base to yield [<italic toggle="yes">1</italic>-<sup>11</sup>C]sarcosine within
40 min, with a RCY of 4% from [<sup>11</sup>C]CO<sub>2</sub>, RCP
&gt;90%, and <italic toggle="yes">A</italic><sub>m</sub> &gt;56 GBq/&#956;mol.</p><fig id="fig56" position="float" orientation="portrait"><label>Figure 56</label><caption><p>Radiosynthetic
routes to [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine using [<sup>11</sup>C]CH<sub>3</sub>OTf
(A) and [<italic toggle="yes">1</italic>-<sup>11</sup>C]sarcosine using [<sup>11</sup>C]NaCN (B). <sup>11</sup>C radionuclide position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr56" position="float" orientation="portrait" xlink:href="cr2c00398_0056.jpg"/></fig></sec><sec id="sec4.6.2"><label>4.6.2</label><title>Preclinical Studies</title><p>PET studies
in mice bearing human prostate cancer xenografts showed significantly
higher tumor-to-background ratios with [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine compared with the established
prostate tracer [<sup>11</sup>C]choline. <italic toggle="yes">In vitro</italic> assays in prostate cancer cell lines found [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine uptake could be blocked
with excess nonradiolabeled sarcosine, confirming a specific transport
mechanism into cells. The palmitoyl acyltransferase (PAT) inhibitor, <italic toggle="yes">5</italic>-hydroxy-<sc><italic toggle="yes">l</italic></sc>-tryptophan competitively
inhibited [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine uptake, confirming PAT-mediated transport.<sup><xref ref-type="bibr" rid="ref193">193</xref></sup></p><p>A biodistribution study of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine in normal rats
showed high activity uptake in the intestine and kidneys, elevated
liver uptake compared with the mediastinum, and negligible brain uptake
(<xref rid="fig57" ref-type="fig">Figure <xref rid="fig57" ref-type="fig">57</xref></xref>). No aqueous
radio-metabolites of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine were detected at any time point from blood and
tissue homogenates of rat prostate and pancreas; however, radioactivity
was observed in the exhaled air, suggesting that the <sup>11</sup>C-methyl group of sarcosine is eliminated <italic toggle="yes">via</italic> sarcosine
dehydrogenase-mediated conversion to glycine and [<sup>11</sup>C]formaldehyde,
with the latter being ultimately degraded to [<sup>11</sup>C]CO<sub>2</sub>. Overall, a substantial majority of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine <italic toggle="yes">vs</italic> [<sup>11</sup>C]CO<sub>2</sub> was observed in the studied tissues at all
time points.<sup><xref ref-type="bibr" rid="ref193">193</xref></sup></p><fig id="fig57" position="float" orientation="portrait"><label>Figure 57</label><caption><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]sarcosine
PET imaging of nu/nu mice highlighting tumor (white arrows) and lower
hepatic (blue arrows) uptake. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref193">193</xref>). Copyright 2017 Society
of Nuclear Medicine and Molecular Imaging. This work is licensed under
a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr57" position="float" orientation="portrait" xlink:href="cr2c00398_0057.jpg"/></fig><p>Nevertheless, to prevent the metabolic loss of
radiolabel from
sarcosine and its exhalation as volatile [<sup>11</sup>C]CO<sub>2</sub>, [<italic toggle="yes">1</italic>-<sup>11</sup>C]sarcosine was investigated.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup> Preliminary PET imaging in human prostate cancer-bearing
mice revealed excellent uptake, better tumor tracer retention, and
a slower metabolism.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup></p></sec><sec id="sec4.6.3"><label>4.6.3</label><title>Clinical Studies</title><p>In 2017, Piert <italic toggle="yes">et al</italic>. performed the first-in-human PET imaging of sarcosine
using [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine
in a subject with localized prostate cancer (<xref rid="fig58" ref-type="fig">Figure <xref rid="fig58" ref-type="fig">58</xref></xref>).<sup><xref ref-type="bibr" rid="ref193">193</xref></sup> High-contrast
images were obtained, and time&#8211;activity curves demonstrated
preferential tracer uptake in the tumor compared with the total prostate
and the arterial blood, with a stable lesion-to-background ratio over
time. Unfortunately, no human studies with [<italic toggle="yes">1</italic>-<sup>11</sup>C]sarcosine have been reported, which would be interesting
for comparing tracer kinetics for the two labeling positions. Nonetheless,
[<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine
as a substrate for the proton-coupled amino acid transporters has
emerged as a promising radiotracer in prostate cancer imaging.</p><fig id="fig58" position="float" orientation="portrait"><label>Figure 58</label><caption><p>PET (A),
CT (B), T2-weighted MR (C), and PET/MRI (D) registration
after [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]sarcosine
administration in human. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref193">193</xref>). Copyright 2017 Society
of Nuclear Medicine and Molecular Imaging. This work is licensed under
a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr58" position="float" orientation="portrait" xlink:href="cr2c00398_0058.jpg"/></fig><p>The only reported human PET study with [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine was performed by Johnstr&#246;m <italic toggle="yes">et al</italic>. in 1987, in which brain imaging was performed in
five patients
with intracerebral tumors, alongside [<sup>68</sup>Ga]EDTA and <sc>l</sc>-[<italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine
(<xref rid="fig59" ref-type="fig">Figure <xref rid="fig59" ref-type="fig">59</xref></xref>).<sup><xref ref-type="bibr" rid="ref191">191</xref></sup> Because glycine lacks a specific transport
system over the intact BBB, [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine
accumulation in tumors was confined to areas with a disrupted BBB.
The latter contrasts with [<italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine, which accumulates in tumors where disruption
of the BBB breakdown is not suspected.</p><fig id="fig59" position="float" orientation="portrait"><label>Figure 59</label><caption><p>Comparison of [<italic toggle="yes">1</italic>-<sup>11</sup>C]glycine (A), [<sup>68</sup>Ga]EDTA (B),
and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine (C) PET scans
in visualizing an anaplastic astrocytoma with disrupted BBB. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref191">191</xref>). Copyright 1987 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr59" position="float" orientation="portrait" xlink:href="cr2c00398_0059.jpg"/></fig></sec></sec><sec id="sec4.7"><label>4.7</label><title>Homocysteine</title><sec id="sec4.7.1"><label>4.7.1</label><title>Radiosynthesis</title><p>Labeling of homocysteine
has only been performed in the <italic toggle="yes">1</italic>-position. Hamacher <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref258">258</xref></sup> have published the
only procedure based on the [<sup>11</sup>C]CO<sub>2</sub> carboxylation
method published by Vaalburg <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref288">288</xref></sup><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Homocysteine thiolactone was
prepared in four steps (<xref rid="fig60" ref-type="fig">Figure <xref rid="fig60" ref-type="fig">60</xref></xref>). Initially, the carboxylation of &#945;-lithiated
3-<italic toggle="yes">S</italic>-(tetrahydropyranyl)thiopropylisonitrile isocyanide
using [<sup>11</sup>C]CO<sub>2</sub> was followed by complete carboxylation
of the residual lithium compound using non-radioactive CO<sub>2</sub>. Finally, by deprotection of the mercapto group and lactonization
in an acid-catalyzed reaction, the tracer was obtained after HPLC
purification with a RCY of 10&#8211;15% and RCP &gt; 98% within 45
min
at EOB. The <italic toggle="yes">K</italic> value of the equilibrium constant of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]homocysteine thiolactone to <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]homocysteine was 0.72.<sup><xref ref-type="bibr" rid="ref258">258</xref></sup></p><fig id="fig60" position="float" orientation="portrait"><label>Figure 60</label><caption><p>Synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]homocysteine thiolactone
using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr60" position="float" orientation="portrait" xlink:href="cr2c00398_0060.jpg"/></fig></sec><sec id="sec4.7.2"><label>4.7.2</label><title>Preclinical Studies</title><p>Animal experiments
were carried out in seven anesthetized, thoracotomized dogs after
iv infusion of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]homocysteine thiolactone over
1 min. Regional radioactivity concentration was measured by PET at
60 min p.i. (<xref rid="fig61" ref-type="fig">Figure <xref rid="fig61" ref-type="fig">61</xref></xref>). The highest radioactivity concentration was found in the bladder
and the kidney, followed by the liver, spine, heart, and skeletal
muscle. The study indicated that the kidneys excreted most of the
activity into the urine. The radioactivity accumulated in the spine
may be due to the hemopoietic cells of the bone marrow, which may
contain high levels of adenosine or SAH-hydrolase, or other metabolic
routes for homocysteine conversion. PET imaging obtained 10&#8211;60
min following infusion of the tracer showed low radioactivity concentrations
in the lung, mediastinum, and thoracic wall, in contrast to the high
concentrations of the heart and spine. Accumulation 3 min after the
end of tracer infusion is dominant in the ischemic area compared to
surrounding tissues, providing a potentially sensitive method to localize
regional myocardial ischemia.<sup><xref ref-type="bibr" rid="ref256">256</xref>,<xref ref-type="bibr" rid="ref257">257</xref></sup></p><fig id="fig61" position="float" orientation="portrait"><label>Figure 61</label><caption><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Homocysteine thiolactone accumulation in
the thorax of infused dogs. (A) Horizontal plane at the myocardial
level with elevated activity in the coronary artery (arrow). (B) Magnification
of the cardiac region from (A). (C,D) left ventricular wall during
perfusion. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref257">257</xref>). Copyright 1992 Society
of Nuclear Medicine. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr61" position="float" orientation="portrait" xlink:href="cr2c00398_0061.jpg"/></fig></sec></sec><sec id="sec4.8"><label>4.8</label><title>Leucine</title><sec id="sec4.8.1"><label>4.8.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Leucine was first mentioned as a possible radiotracer
in 1978 but was not pursued.<sup><xref ref-type="bibr" rid="ref324">324</xref>,<xref ref-type="bibr" rid="ref271">271</xref></sup> Another method to
synthesize pure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine <italic toggle="yes">via</italic> a modified Bucherer&#8211;Strecker
reaction was purified using a column containing <sc><italic toggle="yes">d</italic></sc>-amino acid oxidase.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup> The total
reaction time was 50 min with &gt;99% RCP. In 1983, Barrio <italic toggle="yes">et
al</italic>. developed a new synthetic method using isovaleraldehyde
(<xref rid="fig62" ref-type="fig">Figure <xref rid="fig62" ref-type="fig">62</xref></xref>). The remote-control
synthesis produced the amino acid in a total synthesis time of 30&#8211;40
min with &gt;99% RCP and 1480&#8211;1850 MBq activity.<sup><xref ref-type="bibr" rid="ref262">262</xref></sup></p><fig id="fig62" position="float" orientation="portrait"><label>Figure 62</label><caption><p>Synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine using [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr62" position="float" orientation="portrait" xlink:href="cr2c00398_0062.jpg"/></fig><p>Radiosynthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine has also been achieved from carrier
added<sup><xref ref-type="bibr" rid="ref259">259</xref></sup> or no-carrier added [<sup>11</sup>C]NaCN methods.<sup><xref ref-type="bibr" rid="ref214">214</xref>,<xref ref-type="bibr" rid="ref285">285</xref></sup> In the no-carrier-added method,
[<sup>11</sup>C]HCN was produced
from [<sup>11</sup>C]CH<sub>4</sub> on Pt at 950 &#176;C, bubbled
into the reaction medium with aminosulfite, and subsequently heated
to 60 &#176;C for 10 min, followed by acid hydrolysis and purification.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> In 1985, Washburn and co-workers utilized a
purification method using HPLC to separate <sc><italic toggle="yes">d</italic></sc>- and <sc><italic toggle="yes">l</italic></sc>- enantiomers with good resolution.<sup><xref ref-type="bibr" rid="ref205">205</xref></sup></p><p>Leucine was also radiolabeled in the <italic toggle="yes">3</italic>-position<sup><xref ref-type="bibr" rid="ref272">272</xref></sup> using a phase transfer
alkylation reaction
(in an ultrasonic bath at 45 &#176;C, 10 min) and <sup>11</sup>C-alkyl
iodide (10% RCY and 97% RCP). Labeling in the <italic toggle="yes">5</italic>-
position (<xref rid="fig63" ref-type="fig">Figure <xref rid="fig63" ref-type="fig">63</xref></xref>) has been achieved by Pd<sup>0</sup>-mediated [<sup>11</sup>C]CH<sub>3</sub>I methylation and microfluidic hydrogenation (total synthesis
time 38 min, radioactivity 2.2&#8211;2.7 GBq; RCY 23&#8211;38%;
RCP and chemical purity (CP) more than 95%, 99% ee).<sup><xref ref-type="bibr" rid="ref260">260</xref></sup></p><fig id="fig63" position="float" orientation="portrait"><label>Figure 63</label><caption><p>Synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]leucine using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr63" position="float" orientation="portrait" xlink:href="cr2c00398_0063.jpg"/></fig></sec><sec id="sec4.8.2"><label>4.8.2</label><title>Preclinical Studies</title><p>Carbon-11 labeled <sc><italic toggle="yes">l</italic></sc>-leucine has been used in many preclinical
studies. The first preclinical study was mentioned in an annual meeting
that included monkeys to measure local cerebral protein synthesis.<sup><xref ref-type="bibr" rid="ref263">263</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Leucine was introduced by iv injection and showed
that it could enter the brain. It was also used on dogs to observe
myocardial metabolism,<sup><xref ref-type="bibr" rid="ref262">262</xref></sup> on monkeys to
show a shorter half-life and capability to pass BBB,<sup><xref ref-type="bibr" rid="ref262">262</xref></sup> and on mice as a pancreas imaging agent.<sup><xref ref-type="bibr" rid="ref259">259</xref></sup> In 1984, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine was used in a comparative study on Donryu
rats to show the distribution of amino acids throughout the body.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Leucine mainly accumulated in the pancreas at 20
min p.i. Another biodistribution study was done on pregnant Wistar
rats (16&#8211;19<sup>th</sup> day of pregnancy) to investigate the
distribution of labeled amino acids in maternal organs and their transfer
through the placenta.<sup><xref ref-type="bibr" rid="ref261">261</xref></sup> Radionuclide was
injected through the tail vein to the pregnant rats at 30 min p.i.
maternal liver showed high uptake, with the highest in fetal lungs
and fetal liver. Rhesus monkeys were used to investigate cerebral
protein synthesis rate (CPSR).<sup><xref ref-type="bibr" rid="ref264">264</xref>&#8722;<xref ref-type="bibr" rid="ref266">266</xref></sup> The measurement method produced
regional estimations of protein synthesis from an exogenous source
of amino acids. In the following years, these studies continued to
investigate the sensitivity and stability of the used method.<sup><xref ref-type="bibr" rid="ref325">325</xref></sup> In 2021, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]leucine was used in A431 tumor-bearing
mice to investigate its probe functionality for tumor imaging.<sup><xref ref-type="bibr" rid="ref260">260</xref></sup></p></sec><sec id="sec4.8.3"><label>4.8.3</label><title>Clinical Studies</title><p>The first mention
of clinical <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine studies was in 1982.<sup><xref ref-type="bibr" rid="ref263">263</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Leucine
administered to a patient with glioblastoma showed a high cerebral
protein synthesis rate with the high growth rate of glioblastoma.<sup><xref ref-type="bibr" rid="ref263">263</xref>,<xref ref-type="bibr" rid="ref326">326</xref></sup> In another study, nine healthy human volunteers were used to show
CPSR in humans.<sup><xref ref-type="bibr" rid="ref264">264</xref></sup> Used model parameters
for the kinetic estimations were applied to hemispheres, gray and
white matter.<sup><xref ref-type="bibr" rid="ref327">327</xref></sup> Other research groups
also studied the measurement of regional CPSR using <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine and PET.<sup><xref ref-type="bibr" rid="ref267">267</xref>,<xref ref-type="bibr" rid="ref325">325</xref>,<xref ref-type="bibr" rid="ref328">328</xref></sup> According to their study, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine,<sup><xref ref-type="bibr" rid="ref265">265</xref>,<xref ref-type="bibr" rid="ref266">266</xref>,<xref ref-type="bibr" rid="ref325">325</xref></sup> can also be used in young, healthy
men with low variance and high reproducibility.<sup><xref ref-type="bibr" rid="ref328">328</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine was administered to 10 healthy men volunteers (21&#8211;24
years old, right-handed) <italic toggle="yes">via</italic> intravenous lines on
contralateral antecubital fossa over 1 and 2 mins for a total of 90
min dynamic PET scans and regional CPSR showed differences in most
of the regions.<sup><xref ref-type="bibr" rid="ref328">328</xref></sup></p><p>In 2006, another
study was performed on 27 healthy volunteers (11 men and 16 women
between 20&#8211;50 years old, fast for 8 h before PET scanning)
by introducing <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine <italic toggle="yes">via</italic> a venous catheter as a slow
bolus injection.<sup><xref ref-type="bibr" rid="ref268">268</xref></sup> Blood samples were
collected <italic toggle="yes">via</italic> a radial arterial catheter over 60
min PET scan at different time intervals. According to the results,
the mean plasma concentration of the sum of all large neutral amino
acids was 13% higher in men than in women, and the plasma leucine
concentration was found to be similar in both sexes.<sup><xref ref-type="bibr" rid="ref268">268</xref></sup> Cerebral protein synthesis<sup><xref ref-type="bibr" rid="ref269">269</xref></sup> and amino acid uptake<sup><xref ref-type="bibr" rid="ref270">270</xref></sup> in children
were also studied by the same research group showing similar results.</p></sec></sec><sec id="sec4.9"><label>4.9</label><title>Lysine</title><sec id="sec4.9.1"><label>4.9.1</label><title>Radiosynthesis</title><p>Labeling of lysine
has been performed in positions <italic toggle="yes">1</italic>- or <italic toggle="yes">6</italic>- from two different groups, and no modifications or other methods
have been published (<xref rid="fig64" ref-type="fig">Figure <xref rid="fig64" ref-type="fig">64</xref></xref>).<sup><xref ref-type="bibr" rid="ref274">274</xref>,<xref ref-type="bibr" rid="ref275">275</xref></sup></p><fig id="fig64" position="float" orientation="portrait"><label>Figure 64</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lysine using [<sup>11</sup>C]CO<sub>2</sub> and <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">6</italic>-<sup>11</sup>C]lysine using [<sup>11</sup>C]ICH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr64" position="float" orientation="portrait" xlink:href="cr2c00398_0064.jpg"/></fig><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Lysine was synthesized by
carboxylation
of &#945;-lithioisocyanides, followed by hydrolysis and purification
(RCY 8&#8211;14% and RCP &gt;97%) within 50 min from EOB.<sup><xref ref-type="bibr" rid="ref274">274</xref>,<xref ref-type="bibr" rid="ref275">275</xref></sup> Application of the direct carboxylation method requires the activation
of the <italic toggle="yes">&#945;</italic>-carbon, achieved by the abstraction
of the proton on the <italic toggle="yes">&#945;</italic>-carbon of <italic toggle="yes">1</italic>,<italic toggle="yes">5</italic>-pentylenediisocyanide with <italic toggle="yes">n</italic>-BuLi. The authors attempted to separate the enantiomers by HPLC
using both chiral stationary phases and chiral mobile phases without
success and suggested an enzymatic resolution method using an immobilized <sc><italic toggle="yes">d</italic></sc>-amino acid oxydase/catalase.<sup><xref ref-type="bibr" rid="ref273">273</xref></sup></p><p>To produce [<italic toggle="yes">6</italic>-<sup>11</sup>C]lysine, the anion
of (<italic toggle="yes">S</italic>)-Boc-<italic toggle="yes">2</italic>-<italic toggle="yes">tert</italic>-butyl-3-methyl-<italic toggle="yes">1</italic>,<italic toggle="yes">3</italic>-imidazolidin-<italic toggle="yes">4</italic>-one was treated with lithium <italic toggle="yes">2</italic>,<italic toggle="yes">2</italic>,<italic toggle="yes">6</italic>,<italic toggle="yes">6</italic>-tetramethylpiperidide
to initiate deprotonation of the <italic toggle="yes">&#945;</italic>-carbon,
followed by a <sup>11</sup>C alkylation with <italic toggle="yes">4</italic>-[<sup>11</sup>C]iodobutyronitrile, and subsequent reduction and hydrolysis
to furnish the <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">6</italic>-<sup>11</sup>C]lysine. However, these were only
preliminary findings, and no details about the RCY, RCP, or ee were
provided.<sup><xref ref-type="bibr" rid="ref275">275</xref></sup></p></sec><sec id="sec4.9.2"><label>4.9.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Lysine has been evaluated for tumor imaging in Wistar rats
(<xref rid="fig65" ref-type="fig">Figure <xref rid="fig65" ref-type="fig">65</xref></xref>).<sup><xref ref-type="bibr" rid="ref273">273</xref></sup> Bolster <italic toggle="yes">et al</italic>. injected 1.85
MBq of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lysine in the tail vein and examined radioactivity
distribution at 5 min p.i. Unfortunately, the authors reported only
the tumor/muscle ratio (4.5), and no other results were discussed.
Therefore, a precise interpretation of the whole-body distribution
cannot be given through imaging analysis.</p><fig id="fig65" position="float" orientation="portrait"><label>Figure 65</label><caption><p>Distribution of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lysine 5 min after injection
in rats with a Walker 256 carcinosarcoma transplanted in the hind
leg. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref273">273</xref>). Copyright 1985 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr65" position="float" orientation="portrait" xlink:href="cr2c00398_0065.jpg"/></fig></sec></sec><sec id="sec4.10"><label>4.10</label><title>Methionine</title><sec id="sec4.10.1"><label>4.10.1</label><title>Radiosynthesis</title><p>Methionine is a
sulfur-containing amino acid that can be rapidly synthesized without
complicated purification steps.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup> Numerous
synthetic pathways can be used based on the alkylation of the corresponding
sulfide anion of <sc>l</sc>-homocysteine with either [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig66" ref-type="fig">Figure <xref rid="fig66" ref-type="fig">66</xref></xref>) or [<sup>11</sup>C]CH<sub>3</sub>OTf.<sup><xref ref-type="bibr" rid="ref329">329</xref></sup> Moreover, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine can be efficiently produced by <sup>11</sup>C-methylation of <sc>l</sc>-cysteine thiolactone hydrochloride or <sc>l</sc>-homocysteine in solution using the &#8220;bubbling&#8221;
method,<sup><xref ref-type="bibr" rid="ref330">330</xref></sup> on a solid-phase extraction
cartridge<sup><xref ref-type="bibr" rid="ref282">282</xref></sup> or by using the captive solvent
method (&#8220;in the loop&#8221;) with or without semipreparative
HPLC purification.</p><fig id="fig66" position="float" orientation="portrait"><label>Figure 66</label><caption><p>Synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine using the precursor <sc>l</sc>-homocysteine
thiolactone hydrochloride and [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr66" position="float" orientation="portrait" xlink:href="cr2c00398_0066.jpg"/></fig><p>Langstrom <italic toggle="yes">et al</italic>. produced <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine <italic toggle="yes">via</italic><italic toggle="yes">S-</italic><sup>11</sup>C-methylation of <sc><italic toggle="yes">l</italic></sc>-homocysteine in liquid NH<sub>3</sub> using
[<sup>11</sup>C]CH<sub>3</sub>I, obtaining a RCY of 65&#8211;90%
within 30&#8211;40 min after EOB with a <italic toggle="yes">A</italic><sub>m</sub> of 0.4 GBq/&#956;mol and RCP of 99.5%. This method is time-consuming
and challenging to automate.<sup><xref ref-type="bibr" rid="ref331">331</xref></sup></p><p>Radiosynthesis
and purification on solid supports (C18 Sep Pak
cartridge) have gained more attention due to simplicity (room temperature,
immobilized precursor, easier to automate) and shorter reaction time
due to the elimination of semipreparative HPLC purification. Up to
60% &#924;RCYs (at the EOB) have been reported, which provided enough
activity for multiple patient administration from a single run in
a short total synthesis time (&lt;15 min).<sup><xref ref-type="bibr" rid="ref332">332</xref></sup> More recently, Gomzina <italic toggle="yes">et al</italic>. produced <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine <italic toggle="yes">via</italic><sup>11</sup>C-methylation of <sc><italic toggle="yes">l</italic></sc>-homocysteine thiolactone hydrochloride on C18 solid-phase cartridges,
resulting in the produced activity of 4&#8211;5.7 GBq, RCY of 75
&#177; 3% based on [<sup>11</sup>C]CH<sub>3</sub>I activity, RCP of
99.7 &#177; 0.2%, and enantiomeric purity of 93.7 &#177; 0.5%.<sup><xref ref-type="bibr" rid="ref282">282</xref></sup></p><p>Generally, a conventional method, using
LiAlH<sub>4</sub>/HI, is
used to produce [<sup>11</sup>C]CH<sub>3</sub>I, which gave higher
overall yields but lower <italic toggle="yes">A</italic><sub>m</sub> than the &#8220;gas
phase&#8221; method. However, free methionine concentration in blood
plasma is around 5 mg/L. Therefore, the European Pharmacopeia does
not regulate the <italic toggle="yes">A</italic><sub>m</sub> of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine. Also, the
maximum quantity of other byproducts (homocysteine precursor, homocysteine),
which might be co-injected with methionine, would be negligible compared
to the quantity ordinarily present in the blood plasma ruling out
any metabolic interference with the radiotracer itself and byproducts.<sup><xref ref-type="bibr" rid="ref332">332</xref></sup></p></sec><sec id="sec4.10.2"><label>4.10.2</label><title>Preclinical Studies</title><p>This radiopharmaceutical
was evaluated <italic toggle="yes">in vivo</italic> in mice, rats,<sup><xref ref-type="bibr" rid="ref214">214</xref>,<xref ref-type="bibr" rid="ref276">276</xref></sup> dogs, pigs, and monkeys.<sup><xref ref-type="bibr" rid="ref279">279</xref></sup> Thackeray <italic toggle="yes">et al</italic>. evaluated the whole-body distribution of the radiotracer
in healthy mice. It accumulated in the kidneys and leukocyte-rich
regions such as the spleen, thymus, bone marrow, liver, and metabolic
organ. Lower uptake was also observed in blood, quadriceps, myocardium,
and brain (<xref rid="fig67" ref-type="fig">Figure <xref rid="fig67" ref-type="fig">67</xref></xref>).<sup><xref ref-type="bibr" rid="ref277">277</xref></sup></p><fig id="fig67" position="float" orientation="portrait"><label>Figure 67</label><caption><p>Maximum intensity projection (MIP) PET/CT
images in a healthy mouse
(red squared images) show no <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine uptake in the myocardium.
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref277">277</xref>). Copyright 2016 Ivyspring. This work is licensed
under a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr67" position="float" orientation="portrait" xlink:href="cr2c00398_0067.jpg"/></fig><p>In 2011, &#352;tolc <italic toggle="yes">et al</italic>. published
a study
on the physiological biodistribution of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine in Wistar rats.
Images were acquired 15 min after tracer administration revealing
high uptake in the liver, followed by the spleen and colon. Low uptake
in the brain and heart (<xref rid="fig68" ref-type="fig">Figure <xref rid="fig68" ref-type="fig">68</xref></xref>) was observed.<sup><xref ref-type="bibr" rid="ref276">276</xref></sup></p><fig id="fig68" position="float" orientation="portrait"><label>Figure 68</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine
normal distribution in a rat liver, spleen, and distal
part of the gastrointestinal tract. Reproduced with permission from
ref (<xref ref-type="bibr" rid="ref276">276</xref>). Copyright
2011 Slovak Toxicology Society SETOX. This work is licensed under
a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr68" position="float" orientation="portrait" xlink:href="cr2c00398_0068.jpg"/></fig><p>The accumulation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl-</italic><sup>11</sup>C]methionine in domestic,
juvenile female pigs was also
studied (<xref rid="fig69" ref-type="fig">Figure <xref rid="fig69" ref-type="fig">69</xref></xref>). The highest uptake was found in the small intestines, liver, kidney,
thymus, pyloric antrum/duodenum, and bones. Reduced radiotracer uptake
was also observed in the colon, heart, brain, and bladder.<sup><xref ref-type="bibr" rid="ref333">333</xref></sup></p><fig id="fig69" position="float" orientation="portrait"><label>Figure 69</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine PET scan showing intense uptake in the
liver and small
intestines. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref333">333</xref>). Copyright 2016 AJNMMI.
This work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr69" position="float" orientation="portrait" xlink:href="cr2c00398_0069.jpg"/></fig></sec><sec id="sec4.10.3"><label>4.10.3</label><title>Clinical Studies</title><p>A study by Isohashi <italic toggle="yes">et al</italic>. aimed to standardize the <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine protocol by performing
dynamic images of the radiotracer for 43.7 min after administration
in 11 healthy volunteers (<xref rid="fig70" ref-type="fig">Figure <xref rid="fig70" ref-type="fig">70</xref></xref>)<sup><xref ref-type="bibr" rid="ref280">280</xref></sup> Rapid blood clearance
and high accumulation in the pancreas and liver were observed. High
uptake was also observed in the stomach, kidney, and spleen. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine
accumulation in the parotid glands and myocardium was moderate, and
low uptake in the brain and lung was observed throughout the imaging
period.<sup><xref ref-type="bibr" rid="ref280">280</xref></sup> These biodistribution observations
agree with the above findings in healthy mice and rats<sup><xref ref-type="bibr" rid="ref276">276</xref>,<xref ref-type="bibr" rid="ref277">277</xref></sup> but disagree with pigs.<sup><xref ref-type="bibr" rid="ref333">333</xref></sup></p><fig id="fig70" position="float" orientation="portrait"><label>Figure 70</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine
MIP PET images of a 24-year-old-healthy male showed
increased liver and pancreas uptake for the whole scan duration. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref280">280</xref>). Copyright 2013 Isohashi <italic toggle="yes">et al</italic>., licensee
Springer. This work is licensed under a Creative Commons Attribution
4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/2.0/">https://creativecommons.org/licenses/by/2.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr70" position="float" orientation="portrait" xlink:href="cr2c00398_0070.jpg"/></fig><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine is one of the most commonly used radiotracers
in PET
imaging of brain tumors. Because of its relatively low uptake in brain
tissue, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine incorporates into most brain tumors, including
low-grade gliomas, and its clinical use applies to a wide range of
applications.<sup><xref ref-type="bibr" rid="ref334">334</xref>,<xref ref-type="bibr" rid="ref335">335</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine can also be used to study
non-Hodgkin lymphoma, breast cancer, lung cancer, and melanoma.<sup><xref ref-type="bibr" rid="ref336">336</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Nethyl</italic>-<sup>11</sup>C]methionine has also been used with high sensitivity
in the preoperative localization of primary hyperparathyroidism to
localize the abnormal parathyroid glands.<sup><xref ref-type="bibr" rid="ref337">337</xref></sup></p><p>Metabolite studies have been carried out in the plasma of
eight
patients with cancer. It was found that the total radioactivity remained
constant after a rapid clearance with a rapid increase in protein-bound
radioactivity. Plasma metabolite analysis revealed that the most abundant
metabolites are <italic toggle="yes">4</italic>-methylthio-<italic toggle="yes">2</italic>-oxobutyrate
and serine.<sup><xref ref-type="bibr" rid="ref281">281</xref>,<xref ref-type="bibr" rid="ref338">338</xref></sup></p></sec></sec><sec id="sec4.11"><label>4.11</label><title><italic toggle="yes">S</italic>-<italic toggle="yes">Methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine</title><sec id="sec4.11.1"><label>4.11.1</label><title>Radiosynthesis</title><p>The radiosynthesis
of <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine was accomplished with a fully automated
system by delivering [<sup>11</sup>C]CH<sub>3</sub>I into a cartridge
loaded with a solution of <sc><italic toggle="yes">l</italic></sc>-cysteine and
NaOH in ethanol:water (<xref rid="fig71" ref-type="fig">Figure <xref rid="fig71" ref-type="fig">71</xref></xref>).<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> The product is then
eluted from the cartridge using phosphate buffer, returning the desired <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine within 12 min from EOB with an activity yield of &gt;50%
(based on [<sup>11</sup>C]CH<sub>3</sub>I activity).<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> Quality control was also performed to verify the final
product&#8217;s radiochemical and chemical purity, pH, and sterility
for human use.<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> The same radiochemical
methodology was also employed in the synthesis of the <sc>d</sc> isomer
(<italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">d</italic></sc>-cysteine), which was obtained with the same RCY and
purity.<sup><xref ref-type="bibr" rid="ref339">339</xref></sup></p><fig id="fig71" position="float" orientation="portrait"><label>Figure 71</label><caption><p>Synthesis of <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr71" position="float" orientation="portrait" xlink:href="cr2c00398_0071.jpg"/></fig></sec><sec id="sec4.11.2"><label>4.11.2</label><title>Preclinical Studies</title><p>C57BL/6J mice
(9&#8211;10 weeks old, female and male) were prepared by either inducing
inflammation or inoculating tumor while a group was unmodified and
used as control.<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> The mice were injected
with the radiotracer and the uptake was initially assessed, revealing
a high uptake in the liver, stomach, and heart. A quick washout and
poor <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine protein binding were also identified.<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> Whole-body PET studies were executed to compare
the efficacy of <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc>l</sc>-cysteine against the clinical standards <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine and [<sup>18</sup>F]FDG, highlighting a much higher tumor-to-muscle
ratio and low uptake in inflammation models for <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]cysteine
compared to[<sup>18</sup>F]FDG, suggesting that <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine may be a much more specific radiopharmaceutical for cancer
staging.<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> Subsequent studies by Huang <italic toggle="yes">et al</italic>. explored the efficacy of the <sc><italic toggle="yes">d</italic></sc> isomer, <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">d</italic></sc>-cysteine, in tumor-bearing (S180 fibrosarcoma)
and inflammation model (turpentine-induced) mice. The results suggest
that <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">d</italic></sc>-cysteine has a higher specificity towards
tumors than the <sc>l</sc> isomer.<sup><xref ref-type="bibr" rid="ref339">339</xref></sup> The
specificity of <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine for brain tumor imaging was
then investigated by administering the radiopharmaceutical to glioma-implanted
Male Wistar rats.<sup><xref ref-type="bibr" rid="ref340">340</xref></sup></p></sec><sec id="sec4.11.3"><label>4.11.3</label><title>Clinical Studies</title><p>A 45-year-old
patient with grade iv glioma was scanned with <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine,
showing a specific signal (<xref rid="fig72" ref-type="fig">Figure <xref rid="fig72" ref-type="fig">72</xref></xref>). Further studies focused on depicting the human biodistribution
and radiation dosimetry following <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine administration.<sup><xref ref-type="bibr" rid="ref284">284</xref></sup> For this purpose, six healthy volunteers (six
men and six women aged 41&#8211;56 years) were injected and scanned
for 70&#8211;85 min. All volunteers showed high retention of activity
in the liver, spleen, pancreas, heart, kidneys, and uterus (only in
women), which quickly washed out. The total body radiation dose showed
the most affected organ to be the liver.<sup><xref ref-type="bibr" rid="ref284">284</xref></sup> Given the reported data, the radiation-absorbed dose is considered
within accepted limits and <italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine to be a safe
radiopharmaceutical for cancer staging.<sup><xref ref-type="bibr" rid="ref284">284</xref></sup></p><fig id="fig72" position="float" orientation="portrait"><label>Figure 72</label><caption><p><italic toggle="yes">S</italic>-[<sup>11</sup>C]<italic toggle="yes">Methyl</italic>-<sc><italic toggle="yes">l</italic></sc>-cysteine MRI, PET, and coregistered PET/MRI
images (from top to bottom) show a hypermetabolic lesion (arrow) in
the same area where the tumor was located <italic toggle="yes">via</italic> MRI.
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref283">283</xref>). Copyright 2011 Society of Nuclear Medicine.
This work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr72" position="float" orientation="portrait" xlink:href="cr2c00398_0072.jpg"/></fig></sec></sec><sec id="sec4.12"><label>4.12</label><title>Norleucine</title><sec id="sec4.12.1"><label>4.12.1</label><title>Radiosynthesis</title><p>Labeling of norleucine
has been performed in positions 1 or 3 from two different groups. <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Norleucine was synthesized by a no carrier added
synthesis method. This method was described in detail by Iwata <italic toggle="yes">et al</italic>. in 1987,<sup><xref ref-type="bibr" rid="ref285">285</xref></sup> where [<sup>11</sup>C]HCN was produced by the catalytic reaction of [<sup>11</sup>C]CH<sub>4</sub> on Pt at 950 &#176;C and directly bubbled into a
reaction solution that contained sodium <italic toggle="yes">1</italic>-aminopentane-<italic toggle="yes">1</italic>-sulfonate. The mixture was heated for 10 min, and the
aminonitrile was then extracted with ether. After acid hydrolysis, <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>l1</sup>C]norleucine was purified. The preparation was carried
out with RCY of 35% within 60 min after EOB.<sup><xref ref-type="bibr" rid="ref214">214</xref>,<xref ref-type="bibr" rid="ref285">285</xref></sup></p><p>For the labeling in the <italic toggle="yes">3</italic>-position, Antoni <italic toggle="yes">et al.</italic>, in 1987, performed a phase-transfer alkylation reaction
on <italic toggle="yes">N</italic>-(diphenylmethylene)-glycine <italic toggle="yes">tert</italic>-butyl ester with [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>I followed by acidic hydrolysis
(<xref rid="fig73" ref-type="fig">Figure <xref rid="fig73" ref-type="fig">73</xref></xref>). The labeled
norleucine was obtained in RCY of 10% and RCP of 97% after a total
synthesis time of about 100 min.<sup><xref ref-type="bibr" rid="ref286">286</xref></sup></p><fig id="fig73" position="float" orientation="portrait"><label>Figure 73</label><caption><p>Synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]norleucine using [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>I.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup><sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr73" position="float" orientation="portrait" xlink:href="cr2c00398_0073.jpg"/></fig></sec><sec id="sec4.12.2"><label>4.12.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Norleucine, identical to <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]leucine<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> and <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]methionine,<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> has been evaluated <italic toggle="yes">in vivo</italic> in young male Donryu rats inoculated with transplantable ascitic
hepatoma (AH109A) cells. In the study, five rats were used for each
data point. The animals fasted for 24 h, and <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]norleucine was injected intravenously. The authors reported a low
tumor/blood, tumor/muscle, and tumor/liver ratio at 20 min p.i. Also,
a low pancreas uptake was reported; however, no other outcomes were
mentioned.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></p></sec></sec><sec id="sec4.13"><label>4.13</label><title>Norvaline</title><sec id="sec4.13.1"><label>4.13.1</label><title>Radiosynthesis</title><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]Norvaline was synthesized
by asymmetric alkylation of <italic toggle="yes">N</italic>-(diphenylmethylene)-glycine <italic toggle="yes">tert</italic>-butyl ester using [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>I and, as a final step,
the hydrolysis of the protecting groups (<xref rid="fig74" ref-type="fig">Figure <xref rid="fig74" ref-type="fig">74</xref></xref>). The final product was isolated with RCY
of 25%, RCP of 99%, and ee 80%. After HPLC purification, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]norvaline was
isolated within 20 min.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup></p><fig id="fig74" position="float" orientation="portrait"><label>Figure 74</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]norvaline using [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>I.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup><sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr74" position="float" orientation="portrait" xlink:href="cr2c00398_0074.jpg"/></fig></sec></sec><sec id="sec4.14"><label>4.14</label><title>Ornithine</title><sec id="sec4.14.1"><label>4.14.1</label><title>Radiosynthesis</title><p>Labeling of ornithine
has been performed in positions <italic toggle="yes">1</italic>- or <italic toggle="yes">5</italic>- from two different groups, and no modifications or other method
has been published.<sup><xref ref-type="bibr" rid="ref272">272</xref>,<xref ref-type="bibr" rid="ref273">273</xref></sup> In position <italic toggle="yes">1</italic>-, <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]ornithine was synthesized with the same
procedure as described for <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lysine by carboxylation
of <italic toggle="yes">&#945;</italic>-lithioisocyanides, followed by hydrolysis
and isolation, with RCY of 8&#8211;14% and RCP &gt;97% within 50
min
after EOB (<xref rid="fig75" ref-type="fig">Figure <xref rid="fig75" ref-type="fig">75</xref></xref>).<sup><xref ref-type="bibr" rid="ref273">273</xref></sup> For the labeling in the <italic toggle="yes">5</italic>- position, a displacement reaction of potassium [<sup>11</sup>C]cyanide with the functionally protected <italic toggle="yes">y</italic>-bromohomoserine followed by selective reduction of the [<sup>11</sup>C]nitrile with cobalt chloride-sodium borohydride complex, deprotection
with 6 M HCl, and purification by HPLC gave the <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]ornithine with RCY of 25&#8211;40%
and <italic toggle="yes">A</italic><sub>m</sub> &gt; 77.7 GBq/&#956;mol within
50
min after EOB.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup></p><fig id="fig75" position="float" orientation="portrait"><label>Figure 75</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]ornithine using [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref273">273</xref></sup><sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr75" position="float" orientation="portrait" xlink:href="cr2c00398_0075.jpg"/></fig></sec><sec id="sec4.14.2"><label>4.14.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ornithine, similar to <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lysine, has been
evaluated <italic toggle="yes">in vivo</italic> in both male and female Wistar
rats to detect tumors.<sup><xref ref-type="bibr" rid="ref273">273</xref></sup> The authors reported
a good tumor/muscle ratio without mentioning other outcomes. A high
accumulation in the liver, kidney, and bladder can be observed through
imaging analysis. However, the image lacks a precise interpretation
of the whole-body distribution.</p></sec></sec><sec id="sec4.15"><label>4.15</label><title>Phenylalanine</title><sec id="sec4.15.1"><label>4.15.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Phenylalanine
has been labeled at the <italic toggle="yes">1</italic>- (the <italic toggle="yes">carboxyl</italic>) and <italic toggle="yes">3</italic>-carbon positions.<sup><xref ref-type="bibr" rid="ref211">211</xref>,<xref ref-type="bibr" rid="ref341">341</xref></sup> Racemic carboxyl-labeled <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylalanine
was prepared by a modified B&#252;cherer&#8211;Strecker synthesis
using [<sup>11</sup>C]cyanide<sup><xref ref-type="bibr" rid="ref212">212</xref>,<xref ref-type="bibr" rid="ref215">215</xref>,<xref ref-type="bibr" rid="ref287">287</xref></sup> as a radiolabeling agent and by <sup>11</sup>C-carboxylation of
the activated &#945;-lithioisonitrile precursor with [<sup>11</sup>C]CO<sub>2</sub> followed by acid hydrolysis of the intermediate.<sup><xref ref-type="bibr" rid="ref213">213</xref>,<xref ref-type="bibr" rid="ref288">288</xref></sup> On the other hand, [<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylalanine
was prepared by <sup>11</sup>C-alkylation either <italic toggle="yes">via</italic> condensation reaction of [<sup>11</sup>C]benzaldehyde with <italic toggle="yes">2</italic>-aryl-<italic toggle="yes">5</italic>-oxazolone<sup><xref ref-type="bibr" rid="ref342">342</xref>,<xref ref-type="bibr" rid="ref343">343</xref></sup> and by <sup>11</sup>C-benzylation of commercially available <italic toggle="yes">N</italic>-(<italic toggle="yes">diphenylmethylene</italic>)glycine ester by applying
a phase-transfer reaction/catalysis.<sup><xref ref-type="bibr" rid="ref217">217</xref>,<xref ref-type="bibr" rid="ref344">344</xref>&#8722;<xref ref-type="bibr" rid="ref346">346</xref></sup> Also, the biosynthetic/enzyme approach was used either for the resolution
of racemic <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylalanine<sup><xref ref-type="bibr" rid="ref215">215</xref>,<xref ref-type="bibr" rid="ref272">272</xref>,<xref ref-type="bibr" rid="ref345">345</xref></sup> (which was later replaced by
chiral HPLC) or for the preparation of pure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylalanine<sup><xref ref-type="bibr" rid="ref343">343</xref>,<xref ref-type="bibr" rid="ref347">347</xref></sup> starting from the corresponding <sup>11</sup>C-labeled precursor.
Considerable progress has been made in the enantioselective preparation
of <sc>l</sc>-[<italic toggle="yes">3-</italic><sup>11</sup>C]phenylalanine,<sup><xref ref-type="bibr" rid="ref346">346</xref>,<xref ref-type="bibr" rid="ref347">347</xref></sup> and <sup>11</sup>C-radiolabeled amino acids at the <italic toggle="yes">3</italic>-carbon during the last three decades.<sup><xref ref-type="bibr" rid="ref239">239</xref>,<xref ref-type="bibr" rid="ref348">348</xref>&#8722;<xref ref-type="bibr" rid="ref350">350</xref></sup> In this regard, Peko&#353;ak <italic toggle="yes">et
al</italic>. have recently reported rapid and efficient five-step
radiosynthesis to obtain selectively <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylalanine with ee &gt;90% by utilizing
enantioselective <sup>11</sup>C-alkylation of <italic toggle="yes">tert</italic>-butyl ester protected Schiff base glycine precursor in the presence
of selected chiral quaternary ammonium salt phase-transfer catalyst
without chiral separation as shown in <xref rid="fig76" ref-type="fig">Figure <xref rid="fig76" ref-type="fig">76</xref></xref>.<sup><xref ref-type="bibr" rid="ref217">217</xref></sup> The first
three steps comprised of a one-pot preparation of [<sup>11</sup>C]benzyl
iodide as the <sup>11</sup>C-labeled synthon within 11 min starting
from <sup>11</sup>C-carboxylation of phenylmagnesium bromide (Grignard
reagent) and subsequent reduction, iodination, and K<sub>2</sub>CO<sub>3</sub>/Mg<sub>s</sub>SO<sub>4</sub> column purification.<sup><xref ref-type="bibr" rid="ref351">351</xref></sup> Afterwards, [<sup>11</sup>C]benzyl iodide dissolved
in toluene was slowly transferred in the second reaction vessel to
allow asymmetric [<sup>11</sup>C]benzylation (radiochemical conversion
(RCC) &gt;90%) at the <italic toggle="yes">&#945;</italic>-carbon of the commercially
available <italic toggle="yes">N</italic>-(diphenylmethylene)glycine <italic toggle="yes">tert</italic>-butyl ester in the presence of <sc>l</sc>-selective Maruoka chiral
PTC and the excess of CsOH&#215;H<sub>2</sub>O at 0 &#176;C. In the
last step, the quantitative deprotection under acidic conditions yielded <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylalanine
as the desired product. The radiosynthesis of enantiomerically pure
product was also scaled up and fully automated on the in-house built
platform under optimized conditions with a total synthesis time of
24 min, and RCY of 27 &#177; 7%, calculated from EOB. The <italic toggle="yes">A</italic><sub>m</sub> of the product was 85&#8211;135 GBq/&#956;mol
at EOS. This general radiosynthesis methodology has enabled the preparation
of enantiopure <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylalanine<sup><xref ref-type="bibr" rid="ref217">217</xref></sup> using <sc><italic toggle="yes">d</italic></sc>-selective Maruoka chiral PTC and <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]alanine,<sup><xref ref-type="bibr" rid="ref242">242</xref></sup> which
the same group previously reported. This strategy would allow the
preparation of carbon-11 radiolabeled peptides as well.</p><fig id="fig76" position="float" orientation="portrait"><label>Figure 76</label><caption><p>Synthesis
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylalanine
using [<sup>11</sup>C]CO<sub>2</sub> by applying
a phase-transfer reaction/catalysis.<sup><xref ref-type="bibr" rid="ref217">217</xref></sup><sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr76" position="float" orientation="portrait" xlink:href="cr2c00398_0076.jpg"/></fig></sec><sec id="sec4.15.2"><label>4.15.3</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylalanine has been evaluated in young male Donryu rats
inoculated with transplantable ascitic hepatoma (AH109A) cells. The
animals fasted for 24 h, and <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylalanine
was injected through the vein. The authors reported a low tumor/blood,
tumor/muscle, and tumor/liver ratio at 20 min p.i. Also, a low pancreas
uptake was reported; however, no other outcomes were mentioned.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></p></sec></sec><sec id="sec4.16"><label>4.16</label><title>Phenylglycine</title><sec id="sec4.16.1"><label>4.16.1</label><title>Radiosynthesis</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylglycine was prepared for the first time by a method developed
by Vaalburg <italic toggle="yes">et al</italic>. in 1976.<sup><xref ref-type="bibr" rid="ref288">288</xref></sup> The method is based on the carboxylation of <italic toggle="yes">&#945;</italic>-lithiobenzylisocyanide with [<sup>11</sup>C]CO<sub>2</sub>, followed
by acid hydrolysis. <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylglycine was obtained
with a RCY of 6% and specific activity (<italic toggle="yes">A</italic><sub>s</sub>) of 0.037 GBq/mg (<xref rid="fig77" ref-type="fig">Figure <xref rid="fig77" ref-type="fig">77</xref></xref>).<sup><xref ref-type="bibr" rid="ref288">288</xref></sup> A new method for preparing
the <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">2-</italic><sup>11</sup>C]phenylglycine was published almost 10 years
later. Specifically, they first prepare the [<sup>11</sup>C]benzaldehyde
in a two-step reaction from the corresponding [<sup>11</sup>C]benzoic
acid salt <italic toggle="yes">via</italic> the [<sup>11</sup>C]benzyl alcohol,
starting with a reaction of [<sup>11</sup>C]CO<sub>2</sub> with phenylmagnesium
bromide. Then through a modified B&#252;cherer&#8211;Strecker reaction
with ammonium carbonate and potassium cyanide, followed by hydrolysis, <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">2-</italic><sup>11</sup>C]phenylglycine was isolated with a RCY of 2&#8211;5%
and RCP of 99% within 50 min.<sup><xref ref-type="bibr" rid="ref289">289</xref></sup></p><fig id="fig77" position="float" orientation="portrait"><label>Figure 77</label><caption><p>Synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]phenylglycine using [<sup>11</sup>C]benzaldehyde. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr77" position="float" orientation="portrait" xlink:href="cr2c00398_0077.jpg"/></fig></sec><sec id="sec4.16.2"><label>4.16.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylglycine has been evaluated <italic toggle="yes">in vivo</italic> in young male Donya rats inoculated with transplantable ascitic
hepatoma (AH109A) cells. In the study, five rats were used for each
data point. The animals fasted for 24 h, and <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylglycine was administered. The authors reported a low tumor/blood,
tumor/muscle, and tumor/liver ratio at 20 min p.i. Also, a low pancreas
uptake was reported; however, no other outcomes were mentioned.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup></p></sec></sec><sec id="sec4.17"><label>4.17</label><title>Proline</title><sec id="sec4.17.1"><label>4.17.1</label><title>Radiosynthesis</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Proline has been synthesized only with one method described by
Bolster <italic toggle="yes">et al</italic>. in 1985 (<xref rid="fig78" ref-type="fig">Figure <xref rid="fig78" ref-type="fig">78</xref></xref>). The preparation was achieved by carboxylation
of <italic toggle="yes">&#945;</italic>-lithiopyrrolidyl-<italic toggle="yes">N</italic>-<italic toggle="yes">tert</italic>-butyl-formamidine followed by regeneration of the amine
functionality with a RCY of 12-18% and RCP &gt;95% within 45 min.
However,
no attempts have been made to resolve the <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>Clproline
in its enantiomers.<sup><xref ref-type="bibr" rid="ref273">273</xref></sup></p><fig id="fig78" position="float" orientation="portrait"><label>Figure 78</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]proline using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr78" position="float" orientation="portrait" xlink:href="cr2c00398_0078.jpg"/></fig></sec><sec id="sec4.17.2"><label>4.17.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Proline has been evaluated <italic toggle="yes">in vivo</italic> in
Wistar rats to detect Walker carcinosarcoma tumors.<sup><xref ref-type="bibr" rid="ref273">273</xref></sup> The authors reported a good tumor/non-tumor ratio at 45
min p.i. without mentioning any other results. However, image analysis
shows a high accumulation in the liver, kidney, and bladder (<xref rid="fig79" ref-type="fig">Figure <xref rid="fig79" ref-type="fig">79</xref></xref>).</p><fig id="fig79" position="float" orientation="portrait"><label>Figure 79</label><caption><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Proline distribution in rats with Walker
256 carcinosarcoma transplanted in the hind leg (5 min p.i.). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref273">273</xref>). Copyright 1985 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr79" position="float" orientation="portrait" xlink:href="cr2c00398_0079.jpg"/></fig></sec></sec><sec id="sec4.18"><label>4.18</label><title>Serine</title><sec id="sec4.18.1"><label>4.18.1</label><title>Radiosynthesis</title><p>A multi-enzymatic
synthesis of carbon-11 labeled <sc><italic toggle="yes">l</italic></sc>-serine
was published in 1990. The synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]serine from [<sup>11</sup>C]CO<sub>2</sub> was performed in four steps (<xref rid="fig80" ref-type="fig">Figure <xref rid="fig80" ref-type="fig">80</xref></xref>). The first step was the reduction of [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]CH<sub>3</sub>OH, followed
by selective oxidation by alcoholoxidase to [<sup>11</sup>C]formaldehyde,
which was then condensed nonenzymatically with H<sub>4</sub>-folate.
Finally, the <italic toggle="yes">N</italic>,<sup>5</sup><italic toggle="yes">N</italic><sup>10</sup>-[<sup>11</sup>C]methylenetetrahydrofolate was transferred
to glycine and catalyzed by serine hydroxymethyltransferase and pyridoxalphosphate. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]Serine
(<italic toggle="yes">A</italic><sub>m</sub> 0.30&#8211;1.85 GBq/&#956;mol) was
obtained in a RCY l&#8211;2% within 45&#8211;50 min from the EOB.<sup><xref ref-type="bibr" rid="ref290">290</xref></sup></p><fig id="fig80" position="float" orientation="portrait"><label>Figure 80</label><caption><p>Enzymatic synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]serine using [<sup>11</sup>C]CO<sub>2</sub> in four
steps.<sup><xref ref-type="bibr" rid="ref290">290</xref></sup><sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr80" position="float" orientation="portrait" xlink:href="cr2c00398_0080.jpg"/></fig><p>For the preparation of <sc><italic toggle="yes">d</italic></sc>-[<sup>11</sup>C]serine, a Ni<sup>II</sup>-complex of the Schiff
base of (<italic toggle="yes">S</italic>)-<italic toggle="yes">N</italic>-(2-benzoylphenyl)-<italic toggle="yes">1</italic>-benzylpyrrolidine-<italic toggle="yes">2</italic>-carboxamide with
glycine was
added to [<sup>11</sup>C]CH<sub>2</sub>O prepared by the oxidation
of [<sup>11</sup>C]CH<sub>3</sub>I. This glycine synthon enables the
creation of desired stereochemistry of the chiral center of <sc><italic toggle="yes">d</italic></sc>-serine with a RCY &gt;50% based on [<sup>11</sup>C]CH<sub>3</sub>I and a high diastereomeric excess (80%) in a 1 min
reaction.<sup><xref ref-type="bibr" rid="ref201">201</xref></sup></p></sec></sec><sec id="sec4.19"><label>4.19</label><title>Tryptophan/<italic toggle="yes">5</italic>-Hydroxytryptophan</title><sec id="sec4.19.1"><label>4.19.1</label><title>Radiosynthesis</title><p>Initial efforts
focused on synthesizing racemic [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]tryptophan. This was first reported in 1978 by Hayes <italic toggle="yes">et
al.</italic>,<sup><xref ref-type="bibr" rid="ref324">324</xref></sup> utilizing the Bucherer&#8211;Bergs
reaction (<xref rid="fig81" ref-type="fig">Figure <xref rid="fig81" ref-type="fig">81</xref></xref>A). In this process, the bisulfite adduct derived from 3-indoleacetaldehyde
reacts with carrier-added [<sup>11</sup>C]cyanide and ammonium carbonate
at high temperatures to generate the corresponding hydanton intermediate.
Subsequent hydrolysis using NaOH produces <sc><italic toggle="yes">d</italic></sc>.<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]tryptophan in 30-40% RCY (based on CN<sup>&#8211;</sup>) following
SPE purification, lasting 40 min.<sup><xref ref-type="bibr" rid="ref291">291</xref>,<xref ref-type="bibr" rid="ref324">324</xref></sup> This process
was modified for routine clinical use by Zalutsky <italic toggle="yes">et al</italic>. in 1981, including HPLC purification, achieving a reduced synthesis
time of 28 min, and RCYs of &#8764;50% (based on CN<sup>&#8211;</sup>).<sup><xref ref-type="bibr" rid="ref352">352</xref></sup></p><fig id="fig81" position="float" orientation="portrait"><label>Figure 81</label><caption><p>Radiosynthetic routes to [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]tryptophan/<italic toggle="yes">5</italic>-HTP and [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]tryptophan/<italic toggle="yes">5</italic>-HTP using [<sup>11</sup>C]CH<sub>3</sub>I or [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide
position is highlighted in red and orange.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr81" position="float" orientation="portrait" xlink:href="cr2c00398_0081.jpg"/></fig><p>In 1989, researchers at Uppsala University reported
the synthesis
of enantiomerically pure <sc><italic toggle="yes">l</italic></sc>-tryptophan and <sc><italic toggle="yes">l</italic></sc>-<italic toggle="yes">5</italic>-HTP radiolabeled in the
metabolically stable <italic toggle="yes">&#946;</italic>-position <italic toggle="yes">via</italic> a multienzymatic reaction using racemic [<italic toggle="yes">3</italic>-<sup>11</sup>C]alanine, prepared by <sup>11</sup>C-methylation of a glycine
derivative (<xref rid="fig81" ref-type="fig">Figure <xref rid="fig81" ref-type="fig">81</xref></xref>B).<sup><xref ref-type="bibr" rid="ref353">353</xref></sup> Enzymatic syntheses were carried
out in a one-pot reaction using <sc>d</sc>-amino acid oxidase/catalase
and glutamic-pyruvic transaminase to produce [<sup>11</sup>C]pyruvic
acid, which was converted to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]tryptophan or <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]5-HTP by the action
of the tryptophanase enzyme in the presence of indole or 5-hydroxyindole,
respectively (synthesis time, 50&#8211;55 min; RCY,: 25% (from [<sup>11</sup>C]CO<sub>2</sub>), RCP &gt; 98%; <italic toggle="yes">A</italic><sub>m</sub>, 2.5 GBq/&#956;mol). This procedure has been used for numerous
preclinical and clinical PET investigations with [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP and, in 2006, was implemented
at the University of Groningen (synthesis time: 50 min, RCY: 24% (from
[<sup>11</sup>C]CH<sub>3</sub>I), RCP &gt; 99%; <italic toggle="yes">A</italic><sub>m</sub>, 44 GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref220">220</xref></sup></p><p>Tryptophan and <italic toggle="yes">5</italic>-HTP labeled in the carboxyl position
can also be produced by the multienzymatic reaction utilizing [<italic toggle="yes">1</italic>-<sup>11</sup>C]alanine as the feedstock (<xref rid="fig81" ref-type="fig">Figure <xref rid="fig81" ref-type="fig">81</xref></xref>C).<sup><xref ref-type="bibr" rid="ref354">354</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Alanine is produced by Strecker
reaction of the bisulfite adduct of acetaldehyde with [<sup>11</sup>C]cyanide and ammonia, followed by hydrolysis of the resulting <sup>11</sup>C-aminonitrile (synthesis time, 50 min; RCY, 45-60% (based
on [<sup>11</sup>C]CN<sup>&#8211;</sup>), RCP &gt; 98%; <italic toggle="yes">A</italic><sub>m</sub>,, 0.4&#8211;2.0 GBq/&#956;mol).</p></sec><sec id="sec4.19.2"><label>4.19.2</label><title>Preclinical Studies</title><p>In rhesus
monkeys, [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]tryptophan produced
a homogenous distribution of radioactivity in the brain, with a near-zero
rate constant for striatal uptake, suggesting low conversion to serotonin.<sup><xref ref-type="bibr" rid="ref218">218</xref></sup> Rat biodistribution experiments using [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]tryptophan showed the highest tracer
uptake in the muscle, lung, spleen, and pancreas at 30 min.<sup><xref ref-type="bibr" rid="ref291">291</xref></sup></p><p>Preclinical experiments with [<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP have been performed to study AADC activity/serotonin
synthesis in the rhesus monkey,<sup><xref ref-type="bibr" rid="ref218">218</xref>,<xref ref-type="bibr" rid="ref294">294</xref>&#8722;<xref ref-type="bibr" rid="ref296">296</xref></sup> rat,<sup><xref ref-type="bibr" rid="ref297">297</xref>&#8722;<xref ref-type="bibr" rid="ref300">300</xref></sup> and mice.<sup><xref ref-type="bibr" rid="ref301">301</xref></sup> A study of [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]HTP metabolism in monkeys found that the parent fraction
in plasma gradually decreased to &#8764;50% at 60 min, with [<sup>11</sup>C]hydroxyindoleacetic acid ([<sup>11</sup>C]HIAA) being the
major metabolite (39%).<sup><xref ref-type="bibr" rid="ref296">296</xref></sup> Lundquist <italic toggle="yes">et al</italic>. found that [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]HTP PET was suitable for probing the decarboxylase step in serotonin
synthesis in the monkey brain,<sup><xref ref-type="bibr" rid="ref295">295</xref></sup> although
Visser <italic toggle="yes">et al</italic>. concluded that this was not the case
in rodent brain.<sup><xref ref-type="bibr" rid="ref299">299</xref></sup> Biodistribution studies
of [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]HTP in rat<sup><xref ref-type="bibr" rid="ref298">298</xref>,<xref ref-type="bibr" rid="ref299">299</xref></sup> found the highest radioactivity uptake in the kidneys and pancreas,
with lesser uptake in the duodenum, spleen, stomach, and liver at
60 min.<sup><xref ref-type="bibr" rid="ref298">298</xref></sup> Pancreas uptake may be relevant
because serotonin regulates insulin secretion by <italic toggle="yes">&#946;</italic>-cells in the islets of Langerhans.</p></sec><sec id="sec4.19.3"><label>4.19.3</label><title>Clinical Studies</title><p>AADC, which converts <italic toggle="yes">5</italic>-HTP to serotonin, is widely distributed in the human body,
with the highest peripheral expression in the GI tract, kidney, and
liver<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> while in the brain, it is widely
expressed in monoaminergic neurons.<sup><xref ref-type="bibr" rid="ref295">295</xref></sup> Accordingly,
[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP PET
has been used to probe serotonin biosynthesis in various states of
health and disease. [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]5-HTP
brain PET has been used to measure serotonin synthesis rates in healthy
subjects<sup><xref ref-type="bibr" rid="ref302">302</xref>&#8722;<xref ref-type="bibr" rid="ref307">307</xref></sup> and psychiatric disorders such as depression,<sup><xref ref-type="bibr" rid="ref302">302</xref></sup> social anxiety disorder,<sup><xref ref-type="bibr" rid="ref305">305</xref>,<xref ref-type="bibr" rid="ref306">306</xref>,<xref ref-type="bibr" rid="ref356">356</xref></sup> and premenstrual dysphoria.<sup><xref ref-type="bibr" rid="ref307">307</xref>,<xref ref-type="bibr" rid="ref357">357</xref></sup> Outside of the brain, [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP has been used to detect endocrine tumors,<sup><xref ref-type="bibr" rid="ref358">358</xref>&#8722;<xref ref-type="bibr" rid="ref370">370</xref></sup> based on the amine precursor uptake and decarboxylation concept
in which endocrine tumor cells are known to take up <italic toggle="yes">5</italic>-HTP for conversion to serotonin.<sup><xref ref-type="bibr" rid="ref371">371</xref></sup> [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP has also been
used as an endocrine marker to study diabetes.<sup><xref ref-type="bibr" rid="ref300">300</xref>,<xref ref-type="bibr" rid="ref362">362</xref>,<xref ref-type="bibr" rid="ref372">372</xref>,<xref ref-type="bibr" rid="ref373">373</xref></sup></p><p>[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">5</italic>-HTP is rapidly cleared from the blood (&lt;10% in blood at 20 min)<sup><xref ref-type="bibr" rid="ref374">374</xref></sup> but is metabolically stable (80% unchanged
tracer present in plasma at 60 min, alongside &#8804;16% [<sup>11</sup>C]HIAA and &#8804;4% [<sup>11</sup>C]serotonin).<sup><xref ref-type="bibr" rid="ref304">304</xref></sup> Radioactivity uptake is observed in the kidneys, renal
system, and the bladder, with minimal activity in all soft tissue
structures.<sup><xref ref-type="bibr" rid="ref374">374</xref></sup> In the brain, radioactivity
concentrations in the basal ganglia are about two times higher than
those in cortical areas, reflecting the higher expression of serotonergic
neurons. The highest accumulation rate constants were observed in
the putamen and the caudate.<sup><xref ref-type="bibr" rid="ref304">304</xref></sup></p><p>The
use of [<sup>11</sup>C]tryptophan as a PET probe in humans
is limited to early studies by Hubner <italic toggle="yes">et al</italic>. using <sup>11</sup>C-carboxyl-labeled tryptophan for pancreatic imaging,<sup><xref ref-type="bibr" rid="ref292">292</xref></sup> and to study human brain tumors.<sup><xref ref-type="bibr" rid="ref293">293</xref></sup></p></sec></sec><sec id="sec4.20"><label>4.20</label><title>Tyrosine</title><sec id="sec4.20.1"><label>4.20.1</label><title>Radiosynthesis</title><p>The primary reaction
path of <sc><italic toggle="yes">l</italic></sc>-tyrosine is <italic toggle="yes">via</italic> incorporation into proteins. However, significant decarboxylation
can occur; thus, the labeling of the carboxylic group is essential.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> Studies reported in this section labeled tyrosine
with <sup>11</sup>C at the carbon of carboxylic acid. Production of
[<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine based on isocyanide route
with [<sup>11</sup>C]CO<sub>2</sub> was for the first time reported
for both preclinical and clinical studies in 1986 by Bolster <italic toggle="yes">et al</italic>. [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine was prepared
semiremotely <italic toggle="yes">via</italic> carboxylation of the appropriate
&#945;-lithioisolyanide, followed by hydrolysis of the isocyanide
function and removal of the protecting methoxy group, with the second
butyllithium as the base to lithiated <italic toggle="yes">p</italic>-methoxyphenylethylisocyanide
and tetrahydrofuran. This reaction resulted in low RCY, 2&#8211;4%.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> The microwave-induced Bucherer&#8211;Strecker
synthesis method is the most common [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine synthesis method. Groot <italic toggle="yes">et al</italic>. successfully
synthesized [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine <italic toggle="yes">via</italic> this approach, affording a RCP &gt;95%, an average activity yield
of
800 MBq, and a <italic toggle="yes">A</italic><sub>m</sub> &gt;29.20 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref203">203</xref></sup> An improvement in RCY was possible using the
Studenov <italic toggle="yes">et al</italic>. method (<xref rid="fig82" ref-type="fig">Figure <xref rid="fig82" ref-type="fig">82</xref></xref>): RCY of 15.0 &#177; 4.0%, <italic toggle="yes">A</italic><sub>m</sub> of 74&#8211;111 GBq/&#956;mol, and a synthesis time
of 40&#8211;45 min starting from [<sup>11</sup>C]cyanide.<sup><xref ref-type="bibr" rid="ref287">287</xref></sup> More recently, Hienzsch <italic toggle="yes">et al</italic>. reported the radiolabeling of [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine using a microfluidic platform and an asymmetric version
of the Strecker synthesis, resulting in a RCY of 39.0 &#177; 6%.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup></p><fig id="fig82" position="float" orientation="portrait"><label>Figure 82</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine using
[<sup>11</sup>C]CN<sup>&#8211;</sup>.<sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr82" position="float" orientation="portrait" xlink:href="cr2c00398_0082.jpg"/></fig></sec><sec id="sec4.20.2"><label>4.20.2</label><title>Preclinical Studies</title><p>In the late
1980s, the application of tyrosine was characterized in preclinical
studies, and the first published <italic toggle="yes">in vivo</italic> was also
reported as a first-in-human study.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine has been studied in mice and rats,
but no biodistribution studies in healthy animals have been performed.</p></sec><sec id="sec4.20.3"><label>4.20.3</label><title>Clinical Studies</title><p>To our knowledge,
no studies have assessed the whole-body biodistribution of [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine in healthy humans. However, Halldin <italic toggle="yes">et al</italic>. studied the regional uptake of radioactivity in the
human brain of a 27-year-old healthy male volunteer. After crossing
the BBB, the radiotracer accumulated in cortical and subcortical structures,
especially in the thalamus, occipital, and limbic cortex.<sup><xref ref-type="bibr" rid="ref308">308</xref></sup></p><p>In the last decade, [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine has been subjected to exciting applications.
Kole <italic toggle="yes">et al</italic>. evaluated [<italic toggle="yes">1</italic>-<sup>11</sup>C]tyrosine to measure protein synthesis rate and tumor visualization.<sup><xref ref-type="bibr" rid="ref309">309</xref></sup> Twenty-two patients were injected with the
radiotracer, followed by a 50 min of dynamic study performed immediately
after administration (<xref rid="fig83" ref-type="fig">Figure <xref rid="fig83" ref-type="fig">83</xref></xref>). [<italic toggle="yes">1</italic>-<sup>11</sup>C]Tyrosine accumulation
in various types of malignancy was high, whereas in benign lesions,
the uptake was low, and this uptake was moderately correlated with
the protein synthesis rate quantification.<sup><xref ref-type="bibr" rid="ref309">309</xref></sup></p><fig id="fig83" position="float" orientation="portrait"><label>Figure 83</label><caption><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Tyrosine uptake in a patient
with ductal carcinoma and metastatic lesion in the axilla (left image)
and right inguinal region (right image, indicated by arrows). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref309">309</xref>). Copyright 1997 Society of Nuclear Medicine. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr83" position="float" orientation="portrait" xlink:href="cr2c00398_0083.jpg"/></fig><p>Because tyrosine is an essential AA in patients
with phenylketonuria,
a metabolic disorder caused by elevated blood levels of phenylalanine,
Hoeksma <italic toggle="yes">et al</italic>. used [<sup>11</sup>C]tyrosine to study
the relationship between the <italic toggle="yes">in vivo</italic> plasma phenylalanine
concentrations and protein synthesis rate in 16 patients presented
with this disease. Results revealed a significant association between
the patient&#8217;s age and increased plasma phenylalanine with decreased
protein synthesis rate in the brain.<sup><xref ref-type="bibr" rid="ref376">376</xref></sup></p><p>Although [<sup>11</sup>C]tyrosine was first used to measure
protein
synthesis <italic toggle="yes">in vivo</italic>, nowadays, the AA transport for
imaging tumor metabolism has also been evaluated. Studies performed
in patients with prolactinomas, a benign pituitary gland tumor that
produces an excessive amount of the hormone prolactin, assessed the
effect of bromocriptine treatment, showing the potential use of this
radiotracer for investigating the salivary glands. The incorporation
of tyrosine explains this into secretory proteins synthesized in salivary
glands.<sup><xref ref-type="bibr" rid="ref239">239</xref>,<xref ref-type="bibr" rid="ref377">377</xref>,<xref ref-type="bibr" rid="ref378">378</xref></sup> However,
a later study to detect cervical metastases revealed the unsuitability
of [<sup>11</sup>C]tyrosine due to the increased bilateral uptake
in the salivary glands, which impaired the visualization of metastases
located within this area.<sup><xref ref-type="bibr" rid="ref378">378</xref></sup> Therefore,
[<sup>11</sup>C]tyrosine is probably unsuitable for imaging the liver,
pancreas, or salivary glands due to high accumulation in these organs.</p><p>In humans, the plasma metabolism of [<sup>11</sup>C]tyrosine has
been studied in patients with primary or recurrent brain tumors. It
was found that at 40 min p.i., more than 50% of total plasma radioactivity
was from the plasma metabolites [<sup>11</sup>C]CO<sub>2</sub>, <sup>11</sup>C-proteins, and <sc>l</sc>-[<sup>11</sup>C]dihydroxyphenylalanine
(DOPA). Moreover, the [<sup>11</sup>C]CO<sub>2</sub> level became
significant within 5 min p.i. and reached a plateau of 25% of total
plasma radioactivity at 20 min p.i. <sup>11</sup>C-proteins were negligible
for the first 20 min, and <sc>l</sc>-[<sup>11</sup>C]DOPA was the
only acid-soluble radioactive metabolite detected with levels &#8804;8%
at 40 min p.i.<sup><xref ref-type="bibr" rid="ref379">379</xref></sup></p></sec></sec><sec id="sec4.21"><label>4.21</label><title>Valine</title><sec id="sec4.21.1"><label>4.21.1</label><title>Radiosynthesis</title><p>Valine has been
labeled with carbon-11 in <italic toggle="yes">1</italic>- or <italic toggle="yes">3</italic>- position. A method for labeling <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]valine
was published in 1978.<sup><xref ref-type="bibr" rid="ref311">311</xref></sup> It was synthesized
and purified by procedures analogous to those used for the production
of <italic toggle="yes">1</italic>-[<sup>11</sup>C]aminocyclopentanecarboxylic
acid ([<sup>11</sup>C]ACPC),<sup><xref ref-type="bibr" rid="ref312">312</xref></sup> except
that isobutyraldehyde replaces the cyclopentanone used in the [<sup>11</sup>C]ACPC synthesis. Briefly, the aldehyde is labeled with [<sup>11</sup>C]KCN under high temperature and pressure to give the hydantoin,
which is then hydrolyzed with a base at a high temperature. The RCY
for the two-step synthesis of the racemic <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]valine
was approx 70% with an RCP &gt;95%. The <italic toggle="yes">A</italic><sub>m</sub> was 0.56&#8211;1.30 GBq/mg at the EOS, which required approximately
45 min. The most recent method for labeling valine to position <italic toggle="yes">3</italic>- and high enantiomeric excess was published almost 10
years later.<sup><xref ref-type="bibr" rid="ref286">286</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]valine was synthesized by asymmetric
alkylation of [(+)-<italic toggle="yes">2</italic>-hydroxypinanyl-<italic toggle="yes">3</italic>-idene]glycine <italic toggle="yes">tert</italic>-butyl ester using [<italic toggle="yes">2</italic>-<sup>11</sup>C](CH<sub>3</sub>)<sub>2</sub>CHI and as a final step,
the hydrolysis of the protecting groups (<xref rid="fig84" ref-type="fig">Figure <xref rid="fig84" ref-type="fig">84</xref></xref>). The final product was isolated with RCY
9%, high RCP 99%, and ee 80%.<sup><xref ref-type="bibr" rid="ref286">286</xref></sup></p><fig id="fig84" position="float" orientation="portrait"><label>Figure 84</label><caption><p>Synthesis
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]valine
using [<italic toggle="yes">2</italic>-<sup>11</sup>C](CH<sub>3</sub>)<sub>2</sub>CHI.<sup><xref ref-type="bibr" rid="ref286">286</xref></sup><sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr84" position="float" orientation="portrait" xlink:href="cr2c00398_0084.jpg"/></fig></sec><sec id="sec4.21.2"><label>4.21.2</label><title>Preclinical Studies</title><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Valine was evaluated <italic toggle="yes">in vivo</italic> in 1978.
Washburn <italic toggle="yes">et al</italic>. performed the biodistribution studies
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]valine in healthy male Fischer 344 rats
and sex mongrel dogs. At that time, it was assumed that <sc>d</sc>-AAs were not metabolized as the <sc>l</sc>-AAs and remained in the
blood flow. Thus, injecting a racemic PET tracer has not been considered
trouble. The tracer administration through the tail-vein in rats and
cephalic vein in dogs was followed by a tissue distribution of 30
min p.i. and a whole-body retention and imaging studies 40 min p.i.
The initial results in rats showed a rapid total metabolic loss of
41.3% in 60 min p.i. due to decarboxylative loss of [<sup>11</sup>C]CO<sub>2</sub> through the lungs and urinary excretion. The uptake
in rat pancreas was 50 times lower than in dogs, while the ratios
of pancreas-to-tissue for almost all tissues doubled in rats compared
to dogs. These significant differences may be observed due to a lack
of attention to the feeding protocol, which was later shown to be
very significant. The imaging studies in dogs indicated no sex difference
in tissue distribution, and no evidence of kidney activity was seen
in the dog scans. The most important observation was the effect of
various feeding protocols on the quality of pancreas scans. The typical
arch-shaped dog&#8217;s pancreas was easily visible after fasting,
followed by protein ingestion before administering the tracer. The <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]valine was described as a potential pancreas imaging
agent and highly promoted in clinical studies.<sup><xref ref-type="bibr" rid="ref310">310</xref></sup></p></sec><sec id="sec4.21.3"><label>4.21.3</label><title>Clinical Studies</title><p>Two clinical
trials in patients have been published since 1978. In the first study,
the tracer was administrated in nine patients by iv injections of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]valine, followed by a highly shielded conventional
rectilinear scanning within 5 min p.i. (<xref rid="fig85" ref-type="fig">Figure <xref rid="fig85" ref-type="fig">85</xref></xref>).<sup><xref ref-type="bibr" rid="ref311">311</xref></sup> The second
study was performed on 12 patients with pancreatic disease proven
or clinically suspected. The sum of the whole-body retention and urinary
excretion indicated a slight loss of activity through decarboxylation,
contrasting with results obtained in the preclinical studies. No changes
were observed in any hematological parameters or urinalyses, and no
toxic or other side effects were observed. Blood clearance and whole-body
retention illustrated the rapid plasma clearance of this tracer, where
15 min p.i., the vascular content of the agent had dropped to less
than 20% of the administered dose. Also, 14% was present in urine
40 to 60 min p.i. Rectilinear scans in three patients with healthy
pancreas showed good pancreatic uptake (<xref rid="fig85" ref-type="fig">Figure <xref rid="fig85" ref-type="fig">85</xref></xref>), high kidney concentration, and a high
distinction between pancreas and liver. Therefore, reliable conclusions
could not be made because no sufficient model for quantitative analysis
existed.<sup><xref ref-type="bibr" rid="ref292">292</xref></sup></p><fig id="fig85" position="float" orientation="portrait"><label>Figure 85</label><caption><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Valine PET scans of a patient recovering
from acute pancreatitis (left image) and a patient with mesenteric
lymphoma using (right). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref311">311</xref>). Copyright 1979 Society
of Nuclear Medicine\. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr85" position="float" orientation="portrait" xlink:href="cr2c00398_0085.jpg"/></fig></sec></sec></sec><sec id="sec5"><label>5</label><title>Enzyme Cofactors and Vitamins</title><p>Vitamins
and enzyme cofactors are central in many biological processes
such as body energy production, metabolism, and intracellular signaling
pathways for the normal functioning of the body, and their use has
been claimed to prevent neurodegeneration, cancer, and cardiovascular
disease. By incorporating carbon-11 in their structure, radiolabeled
vitamins could elucidate their absorption, distribution, metabolism,
and excretion in a living organism and provide a qualitative and quantitative
method through PET imaging.</p><p>Enzyme cofactors and vitamins have
a unique role <italic toggle="yes">in vivo</italic>, which could potentially be
explored using PET imaging. Below, we
describe <italic toggle="yes">in vivo</italic> characteristics of compounds that
have been labeled with carbon-11 (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>).<list list-type="bullet"><list-item><p><italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Methylenetetrahydrofolate
(<italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Me-THF) is biologically produced <italic toggle="yes">via</italic> methylation of tetrahydrofolate during serine and glycine
metabolism.<sup><xref ref-type="bibr" rid="ref380">380</xref></sup><italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Me-THF takes part in the folate cycle, acting as a cofactor
of the enzyme thymidylate synthase (TS) that converts deoxyuridine
monophosphate to deoxythymidine monophosphate, serving as both methylene
and hydride donor.<sup><xref ref-type="bibr" rid="ref381">381</xref></sup> Due to the overexpression
of TS in some tumors, [<sup>11</sup>C]<italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Me-THF was considered a tool for cancer diagnosis.<sup><xref ref-type="bibr" rid="ref382">382</xref>,<xref ref-type="bibr" rid="ref383">383</xref></sup> Moreover, 5,10-Me-THF interacts with folate receptors, especially
folate receptor-&#945;, and might be used to trace the expression
of these targets.<sup><xref ref-type="bibr" rid="ref383">383</xref></sup></p></list-item><list-item><p>Coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) is a co-factor
in the respiratory chain of the mitochondrial electron-transfer system
and represents an essential endogenous compound in mammals. Furthermore,
it plays a significant role in cellular antioxidant defense, switching
between the reduced (ubiquinol-10) and oxidized form (ubiquinone-10).<sup><xref ref-type="bibr" rid="ref384">384</xref></sup></p></list-item><list-item><p>Acetyl-coenzyme
A (acetyl-CoA) is a fundamental endogenous
metabolic intermediate that plays a wide variety of biological roles:
energy storage thanks to its thioester bond, acetyl carrier for macromolecule
biosynthesis, and substrate/product of different catabolic/anabolic
pathways. Carnitine has an essential role in the uptake of long-chain
FAs into mitochondria and controls the level between free CoA and
bound CoA, converting it into acyl-carnitine when it becomes excessive.<sup><xref ref-type="bibr" rid="ref385">385</xref></sup> Thus, it could be a powerful radiotracer for
detecting metabolic disorders.</p></list-item><list-item><p><italic toggle="yes">S</italic>-Adenosylmethionine (SAM) is a metabolic
product of methionine that is transported into the liver and converted
to SAM by methionine-adenosyltransferase (MAT).<sup><xref ref-type="bibr" rid="ref386">386</xref>,<xref ref-type="bibr" rid="ref387">387</xref></sup> Therefore, SAM plays a crucial role in diverse cellular processes
such as nucleic acid and protein synthesis,<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> and it serves as the primary donor of methyl groups required in
the synthesis of neuronal messengers and membranes.<sup><xref ref-type="bibr" rid="ref389">389</xref></sup> Found throughout the human body, SAM is highly concentrated
in the liver, adrenal glands, pineal gland, and brain.<sup><xref ref-type="bibr" rid="ref389">389</xref></sup></p></list-item><list-item><p><italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-Dihydroxyvitamin
D<sub>3</sub> is the physiologically active form of vitamin D. It
is obtained in the body after two hydroxylation reactions. The first
occurs in the liver and converts vitamin D<sub>3</sub> to <italic toggle="yes">25</italic>-hydroxyvitamin D<sub>3</sub>, while the second occurs
in the kidneys by the action of <italic toggle="yes">25</italic>-hydroxyvitamin
D<sub>3</sub> 1-&#945;-hydroxylase and forms <italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-dihydroxyvitamin D<sub>3</sub>. <italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-Dihydroxyvitamin D<sub>3</sub> binds to a specific
intracellular receptor<sup><xref ref-type="bibr" rid="ref390">390</xref>,<xref ref-type="bibr" rid="ref391">391</xref></sup> and maintains calcium
homeostasis, inhibits proliferation, stimulates the differentiation,
and induces apoptosis in a wide range of normal and malignant cells.<sup><xref ref-type="bibr" rid="ref392">392</xref>,<xref ref-type="bibr" rid="ref393">393</xref></sup></p></list-item><list-item><p>Biotin is essential for cellular growth,
development,
and well-being.<sup><xref ref-type="bibr" rid="ref394">394</xref></sup> It is involved in fatty
acid biosynthesis, gluconeogenesis, and catabolism of amino and fatty
acids. Biotin is taken up by the cells <italic toggle="yes">via</italic> a sodium-dependent
vitamin transporter (SMVT), expressed in the cytoplasm and the mitochondrial
membranes of the gastrointestinal tract, liver, kidneys, retina, heart,
brain, and skin.<sup><xref ref-type="bibr" rid="ref395">395</xref></sup></p></list-item><list-item><p>Alitretinoin is an active metabolite of Vitamin A produced
in the pancreas,<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> liver, kidneys, small
intestine, and other tissues,<sup><xref ref-type="bibr" rid="ref397">397</xref></sup> with a
high affinity to retinoid X and retinoic acid receptors.<sup><xref ref-type="bibr" rid="ref398">398</xref></sup> So far, very little is known about the <italic toggle="yes">in vivo</italic> synthesis pathway.<sup><xref ref-type="bibr" rid="ref399">399</xref></sup></p></list-item><list-item><p>Vitamin B<sub>3</sub> is a family of
vitamins that includes
niacin, nicotinamide, and nicotinamide riboside found in food and
used as a dietary supplement and medication. Niacin is absorbed in
the intestine <italic toggle="yes">via</italic> proton- and sodium-coupled monocarboxylate
transporters (MCT1 and SMCT, respectively)<sup><xref ref-type="bibr" rid="ref400">400</xref>,<xref ref-type="bibr" rid="ref401">401</xref></sup> and is required for the biosynthesis of nicotinamide adenine dinucleotide
(NAD) and nicotinamide adenine dinucleotide phosphate (NADP), two
coenzymes involved in a variety of redox reactions crucial for cell
survival, apoptosis, differentiation, and metabolism of carbohydrates
and fats.<sup><xref ref-type="bibr" rid="ref402">402</xref></sup> It also acts as a lipid-lowering
agent interacting with a G protein-coupled receptor (GPR109A), found
primarily in the adipose tissue; therefore, it is used to treat hypertriglyceridemia
to reduce the progression of atherosclerosis and the risk for cardiovascular.
Nicotinamide occurrence in the systemic bloodstream, based primarily
on urinary excretion, is higher and more significant than niacin.<sup><xref ref-type="bibr" rid="ref403">403</xref></sup></p></list-item><list-item><p>Thiamine is absorbed
in the upper small intestine and
converted into phosphorylated active forms, which are involved in
many cellular processes, such as the metabolism of glucose and amino
acids. The uptake of thiamine and its derivatives by cells of the
blood and other tissues is mediated by two transporters, hTHTR1 and
hTHTR2.<sup><xref ref-type="bibr" rid="ref404">404</xref></sup></p></list-item><list-item><p>Ascorbic acid is absorbed in the intestine <italic toggle="yes">via</italic> the
sodium-dependent active transporters (SVCT1-2) and in the presence
of reactive oxygen species (ROS), it is converted to its oxidative
state as dehydroascorbic acid, which is a substrate for glucose transport
(GLUT 1, 3, 4). Dysregulation of ROS in several disease states, including
cancer, neurodegeneration, chronic inflammation, and diabetes, provides
a powerful motivation to develop [<italic toggle="yes">1</italic>-<sup>11</sup>C]ascorbic and [<italic toggle="yes">1</italic>-<sup>11</sup>C]dehydroascorbic
acid as noninvasive biomarkers of oxidative stress; indeed, Carrol <italic toggle="yes">et al</italic>. prepared the two tracers and performed PET which
has the potential, as a highly sensitive and nontoxic technique, to
detect ROS in a preclinical setting.<sup><xref ref-type="bibr" rid="ref405">405</xref></sup></p></list-item></list></p><table-wrap id="tbl4" position="float" orientation="portrait"><label>Table 4</label><caption><title>Carbon-11 Labeled Enzyme Cofactors
and Vitamins</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">comp</th><th style="border:none;" align="center" colspan="1" rowspan="1">&#160;</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total time
(min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1&#945;,25</italic>-dihydroxyvitamin D<sub>3</sub></td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">26</italic>,<italic toggle="yes">27</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr<xref rid="t4fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">3</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">48</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref406">406</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-methylenetetrahydrofolate</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.11</td><td style="border:none;" align="center" colspan="1" rowspan="1">95%</td><td style="border:none;" align="center" colspan="1" rowspan="1">2<xref rid="t4fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref407">407</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">acetyl-coenzyme&#160;A</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref408">408</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref409">409</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref408">408</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref408">408</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">carnitine</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-<italic toggle="yes">1</italic>-<italic toggle="yes">acetyl</italic>- and <italic toggle="yes">O</italic>-<italic toggle="yes">2</italic>-<italic toggle="yes">acetyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> humans<sup><xref ref-type="bibr" rid="ref410">410</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref408">408</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref408">408</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref408">408</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">60%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref408">408</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">biotin</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>&#8242;-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice<sup><xref ref-type="bibr" rid="ref411">411</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">7</td><td style="border:none;" align="center" colspan="1" rowspan="1">19%</td><td style="border:none;" align="center" colspan="1" rowspan="1">32</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref411">411</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">coenzyme Q<sub>10</sub></td><td style="border:none;" align="left" colspan="1" rowspan="1">ubiquinone-10</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-<italic toggle="yes">methoxy</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mongolian gerbils,<sup><xref ref-type="bibr" rid="ref412">412</xref>,<xref ref-type="bibr" rid="ref413">413</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref261">261</xref>,<xref ref-type="bibr" rid="ref414">414</xref></sup> dogs<sup><xref ref-type="bibr" rid="ref415">415</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">5.39</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">33</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref416">416</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">ubiquinol</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">39</italic>-<italic toggle="yes">methyl-</italic></td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref417">417</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">76</td><td style="border:none;" align="center" colspan="1" rowspan="1">39%</td><td style="border:none;" align="center" colspan="1" rowspan="1">38</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref418">418</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">vitamin A</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">25%</td><td style="border:none;" align="center" colspan="1" rowspan="1">32</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref419">419</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">vitamin B<sub>3</sub></td><td style="border:none;" align="left" colspan="1" rowspan="1">niacin</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref420">420</xref></sup> humans<sup><xref ref-type="bibr" rid="ref421">421</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO</td><td style="border:none;" align="center" colspan="1" rowspan="1">750</td><td style="border:none;" align="center" colspan="1" rowspan="1">65%</td><td style="border:none;" align="center" colspan="1" rowspan="1">27</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref422">422</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">7</td><td style="border:none;" align="center" colspan="1" rowspan="1">17%</td><td style="border:none;" align="center" colspan="1" rowspan="1">25</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref420">420</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">nicotinamide</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref423">423</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO</td><td style="border:none;" align="center" colspan="1" rowspan="1">1600</td><td style="border:none;" align="center" colspan="1" rowspan="1">54%</td><td style="border:none;" align="center" colspan="1" rowspan="1"><xref rid="t4fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref422">422</xref>,<xref ref-type="bibr" rid="ref424">424</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">74</td><td style="border:none;" align="center" colspan="1" rowspan="1">45%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref423">423</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">S</italic>-adenosylmethionine</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref425">425</xref>,<xref ref-type="bibr" rid="ref426">426</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref426">426</xref>,<xref ref-type="bibr" rid="ref427">427</xref></sup> rabbits<sup><xref ref-type="bibr" rid="ref428">428</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">7.326</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref428">428</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">1363</td><td style="border:none;" align="center" colspan="1" rowspan="1">17%</td><td style="border:none;" align="center" colspan="1" rowspan="1">28</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref387">387</xref>,<xref ref-type="bibr" rid="ref425">425</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">thiamine</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref429">429</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref430">430</xref>)</td></tr><tr><td colspan="9" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">vitamin C</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref431">431</xref></sup> rats<sup><xref ref-type="bibr" rid="ref405">405</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">15.27</td><td style="border:none;" align="center" colspan="1" rowspan="1">18.1%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref431">431</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t4fn1"><label>a</label><p>nr: Not reported.</p></fn><fn id="t4fn2"><label>b</label><p>Time of synthesis.</p></fn></table-wrap-foot></table-wrap><sec id="sec5.1"><label>5.1</label><title><italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-Dihydroxyvitamin D<sub>3</sub></title><sec id="sec5.1.1"><label>5.1.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">26</italic>,<italic toggle="yes">27</italic>-<sup>11</sup>C]<italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-Dihydroxyvitamin D<sub>3</sub> was synthesized <italic toggle="yes">via</italic> a two-step [<sup>11</sup>C]methylation reaction. In
the first step, [<sup>11</sup>C]CH<sub>3</sub>I (obtained from [<sup>11</sup>C]CO<sub>2</sub>, lithium aluminum hydride, and HI) was trapped
at &#8722;70 &#176;C in a reaction vial pre-charged with a methyl
ketone precursor (<italic toggle="yes">1</italic>(<italic toggle="yes">S</italic>),<italic toggle="yes">3</italic>(<italic toggle="yes">R</italic>)-<italic toggle="yes">bis</italic>[(<italic toggle="yes">tert</italic>-butyldimethylsilyl)oxy]-<italic toggle="yes">25</italic>-<italic toggle="yes">keto</italic>-<italic toggle="yes">9</italic>,<italic toggle="yes">10</italic>-<italic toggle="yes">seco</italic>-<italic toggle="yes">27</italic>-norcholesta-<italic toggle="yes">5</italic>(<italic toggle="yes">Z</italic>),<italic toggle="yes">7</italic>(<italic toggle="yes">E</italic>),<italic toggle="yes">10</italic>(<italic toggle="yes">19</italic>)-triene) dissolved in THF; after
the addition of butyllithium, the vial was kept at &#8722;10 &#176;C
for 10 min, providing the <sup>11</sup>C intermediate with the positron-emitting
radionuclide incorporated at the <italic toggle="yes">26</italic>,<italic toggle="yes">27</italic> carbons in about 30&#8211;50% RCY. In the second step, the reaction
was quenched with tetrabutylammonium fluoride, and the vial was heated
at 105 &#176;C for 5 min to allow the cleavage of the two <italic toggle="yes">tert</italic>-butyldimethylsilyl (TBDMS) protecting groups of the <sup>11</sup>C intermediate (<xref rid="fig86" ref-type="fig">Figure <xref rid="fig86" ref-type="fig">86</xref></xref>). At the end of synthesis and semipreparative HPLC
purification, [<italic toggle="yes">26</italic>,<italic toggle="yes">27</italic>-<sup>11</sup>C]<italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-dihydroxyvitamin
D<sub>3</sub> produced with an <italic toggle="yes">A</italic><sub>m</sub> of 2.5&#8211;3
GBq/&#956;mol. Based on the HPLC analysis of the final eluent fraction,
the RCP was &gt;99%, and the chemical purity was about 79%. The entire
process required 48 min from the end of the bombardment, providing
the desired compound in a time frame compatible with the short half-life
of the carbon-11 radionuclide and suitable for developing PET studies
in animals and humans.<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> However, the
compound has not been evaluated to the best of our knowledge.</p><fig id="fig86" position="float" orientation="portrait"><label>Figure 86</label><caption><p>Synthesis
of [<italic toggle="yes">26</italic>,<italic toggle="yes">27</italic>-<sup>11</sup>C]<italic toggle="yes">1&#945;</italic>,<italic toggle="yes">25</italic>-dihydroxyvitamin
D<sub>3</sub> using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr86" position="float" orientation="portrait" xlink:href="cr2c00398_0086.jpg"/></fig></sec></sec><sec id="sec5.2"><label>5.2</label><title><italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Methylenetetrahydrofolate</title><sec id="sec5.2.1"><label>5.2.1</label><title>Radiosynthesis</title><p>Radiolabeling of <italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-Me-THF with <sup>11</sup>C on the
methylene position was accomplished using [<sup>11</sup>C]CH<sub>2</sub>O as a radioactive synthon (<xref rid="fig87" ref-type="fig">Figure <xref rid="fig87" ref-type="fig">87</xref></xref>).<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> [<sup>11</sup>C]CH<sub>3</sub>I was initially treated with trimethylamine oxide for 2 min,
yielding [<sup>11</sup>C]CH<sub>2</sub>O (RCY of 80%), which then
reacted with tetrahydrofolate yielding the desired <italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-[<sup>11</sup>C]Me-THF with a nonisolated RCY
of 95% (calculated from the radio HPLC chromatogram) within 2 min
from [<sup>11</sup>C]CH<sub>2</sub>O delivery and <italic toggle="yes">A</italic><sub>m</sub> of 0.37-1.11 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> Despite the good RCY, the compound has not been evaluated to the
best of our knowledge.</p><fig id="fig87" position="float" orientation="portrait"><label>Figure 87</label><caption><p>Synthesis of <italic toggle="yes">5</italic>,<italic toggle="yes">10</italic>-[<sup>11</sup>C]Me-THF. <sup>11</sup>C radionuclide position is
highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr87" position="float" orientation="portrait" xlink:href="cr2c00398_0087.jpg"/></fig></sec></sec><sec id="sec5.3"><label>5.3</label><title>Acetyl-coenzyme A, Carnitine, and Acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine</title><sec id="sec5.3.1"><label>5.3.1</label><title>Radiosynthesis</title><p><italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetyl CoA (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>) was prepared from incubation
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid, obtained according
to a previously reported procedure,<sup><xref ref-type="bibr" rid="ref409">409</xref></sup> with
a solution of coenzyme A, enzyme acetyl CoA synthetase, adenosine
triphosphate (ATP), and magnesium chloride at pH 8. After 5 min at
37 &#176;C, proteins were denatured with HCl and purified with preparative
HPLC.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup><italic toggle="yes">O</italic>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]Acetyl CoA was prepared from incubation of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid, obtained according to a previously
reported procedure,<sup><xref ref-type="bibr" rid="ref409">409</xref></sup> with a solution
of coenzyme A, enzyme acetyl CoA synthetase, ATP, and magnesium chloride
at pH 8. After 5 min at 37 &#176;C, proteins were denatured with HCl
and purified with preparative HPLC.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup><italic toggle="yes">O</italic>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]Acetyl CoA (<xref rid="fig88" ref-type="fig">Figure <xref rid="fig88" ref-type="fig">88</xref></xref>) was prepared
following the same procedure of <italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl CoA starting from [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid, obtained according to a previously reported
procedure.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> Both acetyl CoA radiotracers
were obtained with 60&#8211;70% RCY with respect to [<sup>11</sup>C]acetate within 45 min from EOB (in a typical run starting with
4.1 GBq of [<sup>11</sup>C]acetate, 1.6 GBq of products were obtained)<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> was prepared following the same procedure of <italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl CoA starting
from [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid, obtained according
to a previously reported procedure.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> Both
acetyl CoA radiotracers were obtained with 60&#8211;70% RCY with
respect to [<sup>11</sup>C]acetate within 45 min from EOB (in a typical
run starting with 4.1 GBq of [<sup>11</sup>C]acetate, and 1.6 GBq
of products were obtained.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup></p><fig id="fig88" position="float" orientation="portrait"><label>Figure 88</label><caption><p>Radiosynthetic
schemes of [<sup>11</sup>C]acetyl CoA, [<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine, and <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]carnitine. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr88" position="float" orientation="portrait" xlink:href="cr2c00398_0088.jpg"/></fig><p><italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetyl-<sc>l</sc>-carnitine and <italic toggle="yes">O</italic>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]acetyl-<sc>l</sc>-carnitine (<xref rid="fig88" ref-type="fig">Figure <xref rid="fig88" ref-type="fig">88</xref></xref>) were obtained following the same procedure
above reported for acetyl CoA radiotracers with the addition of a
solution of <sc><italic toggle="yes">l</italic></sc>-carnitine and enzyme carnitine
acyltransferasein 5 min incubation. Both acetylcarnitine radiotracers
were obtained with 70&#8211;80% RCY with respect to [<sup>11</sup>C]acetate within 45 min from EOB.<sup><xref ref-type="bibr" rid="ref408">408</xref>,<xref ref-type="bibr" rid="ref408">408</xref></sup></p><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]carnitine
(<xref rid="fig88" ref-type="fig">Figure <xref rid="fig88" ref-type="fig">88</xref></xref>) was prepared
from the reaction between [<sup>11</sup>C]CH<sub>3</sub>I and <italic toggle="yes">N</italic>-desmethyl-<sc>l</sc>-carnitine with potassium
carbonate as the base in dimethyl sulfoxide. After 5 min at 90 &#176;C,
the reaction was quenched with water, and the product was purified
through cation exchange resin, obtaining <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine with 60% RCY concerning
[<sup>11</sup>C]CH<sub>3</sub>I within 30 min from EOB. <italic toggle="yes">O</italic>-Acetyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine (<xref rid="fig88" ref-type="fig">Figure <xref rid="fig88" ref-type="fig">88</xref></xref>) was obtained by reacting <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine with acetyl CoA and carnitine
acyltransferase in Tris buffer, obtaining <italic toggle="yes">O</italic>-acetyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine
with 70-80% RCY based on <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine within 40 min from EOB.<sup><xref ref-type="bibr" rid="ref408">408</xref>,<xref ref-type="bibr" rid="ref408">408</xref></sup></p></sec><sec id="sec5.3.2"><label>5.3.2</label><title>Preclinical Studies</title><p>Preliminary
PET studies in monkeys were conducted to evaluate the <italic toggle="yes">in vivo</italic> behavior of <italic toggle="yes">O</italic>-[<sup>11</sup>C]acetyl CoA, <italic toggle="yes">O</italic>-[<sup>11</sup>C]acetyl-<sc>l</sc>-carnitine, and <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]carnitine.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> Plasma clearance in all cases was fast, decreasing immediately after
iv injection. Only <sup>11</sup>C-labeled acetylcarnitine seemed to
have slightly lower clearance rates. <italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl CoA had high initial uptake in the myocardium
(myocardium-plasma ratio around 4&#8211;10 min after injection),
followed by a fast washout. <sup>11</sup>C-Radiolabeled carnitines
showed increased uptake in myocardium over 60 min. Renal uptake was
the highest, with renal/plasma ratio of around 20. Renal excretion
of <italic toggle="yes">1</italic>- and <italic toggle="yes">2</italic>-[<sup>11</sup>C]acetyl
CoA radiotracers were faster than carnitine-labeled radiotracers because
they probably undergo different metabolic pathways. In the liver,
higher uptake was registered for <sup>11</sup>C carnitine-bearing
derivatives, despite being lower than in the kidneys.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> In the brain, an immediate uptake was registered
for all tracers with a fast washout. The uptakes of carnitine-labeled
tracers were different, depending on the position of the <sup>11</sup>C-label, with <italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine showing the highest
uptake after 60 min in the cerebral cortex.<sup><xref ref-type="bibr" rid="ref433">433</xref></sup> The significant differences between acetylcarnitine radiotracers
(<italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine, <italic toggle="yes">O</italic>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine, and <italic toggle="yes">O</italic>-acetyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine) brain uptake suggests that they are rapidly
metabolized into different radiolabeled species, reflecting the different
labeling positions.<sup><xref ref-type="bibr" rid="ref433">433</xref>,<xref ref-type="bibr" rid="ref434">434</xref></sup></p></sec><sec id="sec5.3.3"><label>5.3.3</label><title>Clinical Studies</title><p>After iv injection, <italic toggle="yes">O</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl-<sc>l</sc>-carnitine
registered high brain uptake in healthy volunteers.<sup><xref ref-type="bibr" rid="ref410">410</xref></sup><italic toggle="yes">O</italic>-[<italic toggle="yes">2</italic>-<sup>11</sup>C]Acetyl-<sc>l</sc>-carnitine was used to detect chronic fatigue syndrome (CFS),
a pathological condition where the value of free carnitine remains
normal, while an apparent decrease of acyl-carnitine combined with
fatty acid was displayed.<sup><xref ref-type="bibr" rid="ref410">410</xref></sup> Patients suffering
from CFS registered a lower uptake in the brain, particularly in the
visual cortex, and a lower erythrocyte-to-blood plasma ratio than
healthy volunteers (<xref rid="fig89" ref-type="fig">Figure <xref rid="fig89" ref-type="fig">89</xref></xref>).<sup><xref ref-type="bibr" rid="ref410">410</xref></sup></p><fig id="fig89" position="float" orientation="portrait"><label>Figure 89</label><caption><p>[<italic toggle="yes">2</italic>-<sup>11</sup>C]Acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine (ACM), [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine
(ACN), acetyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine (ACC), and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine
(CRN) distribution in a horizontal section (top) and sagittal section
(bottom) of rhesus monkeys brain (30&#8211;45 min p.i.). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref433">433</xref>). Copyright 1997 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr89" position="float" orientation="portrait" xlink:href="cr2c00398_0089.jpg"/></fig></sec></sec><sec id="sec5.4"><label>5.4</label><title>Biotin</title><sec id="sec5.4.1"><label>5.4.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Biotin
was synthesized by applying a rapid and efficient <sup>11</sup>C-urea
labeling method <italic toggle="yes">via</italic> a simple one-pot reaction in
a fully automated system.<sup><xref ref-type="bibr" rid="ref435">435</xref></sup> In the first
step, cyclotron-produced [<sup>11</sup>C]CO<sub>2</sub> was bubbled
into a reaction vial containing diamino biotin as a precursor and <italic toggle="yes">1</italic>,<italic toggle="yes">8</italic>-diazabicyclo[<italic toggle="yes">5</italic>.<italic toggle="yes">4</italic>.<italic toggle="yes">0</italic>]undec-<italic toggle="yes">7</italic>-ene (DBU)
dissolved in acetonitrile (MeCN) at 0 &#176;C.<sup><xref ref-type="bibr" rid="ref435">435</xref></sup> At the end of the [<sup>11</sup>C]CO<sub>2</sub> delivery,
a solution of Mitsunobu reagents [di-<italic toggle="yes">tert</italic>-butyl azodicarboxylate
(DBAD) and tributylphosphine (PBu<sub>3</sub>)] was added to the reaction
vial, and the reaction mixture was heated at 100 &#176;C for 5 min.
(<xref rid="fig90" ref-type="fig">Figure <xref rid="fig90" ref-type="fig">90</xref></xref>) The reaction
was subsequently cooled to room temperature and quenched with a phosphate-buffered
saline (PBS) solution. [<sup>11</sup>C]Biotin was purified by semipreparative
HPLC, and the formulated solution was used for preclinical studies.
[<sup>11</sup>C]Biotin was obtained after 32 min (total synthesis
time from the end of delivery (EOD) including HPLC purification) with
an isolated RCY of 19 &#177; 2%, a RCP &gt; 99%, and <italic toggle="yes">A</italic><sub>m</sub> of 7 &#177; 1 GBq/&#956;mol. The final amount of [<sup>11</sup>C]biotin was 352 &#177; 38 MBq in 4&#8211;5 mL PBS with
2.5% ethanol.<sup><xref ref-type="bibr" rid="ref411">411</xref></sup></p><fig id="fig90" position="float" orientation="portrait"><label>Figure 90</label><caption><p>Synthesis of [<sup>11</sup>C]biotin using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr90" position="float" orientation="portrait" xlink:href="cr2c00398_0090.jpg"/></fig></sec><sec id="sec5.4.2"><label>5.4.2</label><title>Preclinical Studies</title><p>To examine
the [<sup>11</sup>C]biotin trafficking <italic toggle="yes">in vivo</italic>, [<sup>11</sup>C]biotin was administered iv in healthy anesthetized mice
placed on a high-resolution micro-PET scanner, and the dynamic PET
image data were acquired for 60 min.<sup><xref ref-type="bibr" rid="ref411">411</xref></sup> PET imaging demonstrated the [<sup>11</sup>C]biotin distribution
in the liver, heart, brain, eyes, and kidneys, consistent with the
known expression of the biotin transporter SMVT in these organs. Surprisingly,
accumulation in the interscapular brown adipose tissue (BAT) was also
detected (<xref rid="fig91" ref-type="fig">Figures <xref rid="fig91" ref-type="fig">91</xref></xref> and <xref rid="fig92" ref-type="fig">92</xref>). Furthermore, to investigate the
gastrointestinal uptake of biotin and its body circulation <italic toggle="yes">in vivo</italic>, [<sup>11</sup>C]biotin was orally administered
in isoflurane-anesthetized mice, and PET imaging studies were performed
for 120 min. Once delivered into the intestine, [<sup>11</sup>C]biotin
was rapidly absorbed in the duodenum and, entering the systemic circulation
was distributed throughout the body in the liver, heart, eyes, brain,
and interscapular BAT. The organ distribution of [<sup>11</sup>C]biotin
administered orally is similar to that observed after iv administration.
Preadministration of nonradioactive biotin decreased [<sup>11</sup>C]biotin uptake in all SMVT-expressing organs and increased its elimination
through the kidneys to the urinary bladder, suggesting SMVT saturation
by the administered biotin.<sup><xref ref-type="bibr" rid="ref411">411</xref></sup></p><fig id="fig91" position="float" orientation="portrait"><label>Figure 91</label><caption><p>[<sup>11</sup>C]Biotin PET scans of non-biotin added (A&#8211;C)
and biotin-challenged (D&#8211;F) mice show displacement of the tracer.
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref411">411</xref>). Copyright 2020 American Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr91" position="float" orientation="portrait" xlink:href="cr2c00398_0091.jpg"/></fig><fig id="fig92" position="float" orientation="portrait"><label>Figure 92</label><caption><p>[<sup>11</sup>C]Biotin PET scans after oral administration
in non-biotin
added (A&#8211;C) and biotin-challenged (D&#8211;F) mice. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref411">411</xref>). Copyright 2020 American Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr92" position="float" orientation="portrait" xlink:href="cr2c00398_0092.jpg"/></fig></sec></sec><sec id="sec5.5"><label>5.5</label><title>Coenzyme Q<sub>10</sub> (Ubiquinone-10)</title><sec id="sec5.5.1"><label>5.5.1</label><title>Radiosynthesis</title><p>The first preparation
of [<sup>11</sup>C]CoQ<sub>10</sub> was reported in 1982 by Takahashi <italic toggle="yes">et al</italic>. [<italic toggle="yes">3</italic>-Methyl-<sup>11</sup>C]CoQ<sub>10</sub> was obtained from [<sup>11</sup>C]methylation of <italic toggle="yes">3</italic>-demethylCoQ<sub>10</sub> in acetone at 50&#8211;60 &#176;C
for 10 min, purification through chromatographic separation on the
silica-gel column, and final reformulation (<xref rid="fig93" ref-type="fig">Figure <xref rid="fig93" ref-type="fig">93</xref></xref>). It was prepared in 40&#8211;50 min from
bubbling of [<sup>11</sup>C]CH<sub>3</sub>I with RCY of 15.7% (achieving
880.6 MBq from 5.56 GBq of [<sup>11</sup>C]CH<sub>3</sub>I), RCP &gt;99%,
and <italic toggle="yes">A</italic><sub>m</sub> of 0.148&#8211;0.185 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref412">412</xref>,<xref ref-type="bibr" rid="ref413">413</xref></sup> Final reformulations of [<italic toggle="yes">5</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub> have been reported in two different
ways, depending on the emulsifying agent exploited: in saline with
polyoxyethylene hydrogenated castor oil ([<sup>11</sup>C]CoQ<sub>10</sub>-HCO-60) or ethanol within liposomes ([<sup>11</sup>C]CoQ<sub>10</sub>-liposomes).<sup><xref ref-type="bibr" rid="ref413">413</xref>,<xref ref-type="bibr" rid="ref414">414</xref></sup> Similarly, a CoQ<sub>10</sub> derivative without a side chain, [<sup>11</sup>C]CoQ<sub>10</sub>, has been labeled with [<sup>11</sup>C]CH<sub>3</sub>I, desmethyl
precursor, and potassium carbonate in DMF for 10 min at 80 &#176;C.
It was obtained within 33 min in 38.9 &#177; 10% RCY with 5.39 &#177;
1.73 GBq/&#956;mol as <italic toggle="yes">A</italic><sub>m</sub>.<sup><xref ref-type="bibr" rid="ref416">416</xref></sup> More recently, [<sup>11</sup>C]CoQ<sub>10</sub> has been labeled at the terminal position of the polyprenylated
side chain of ubiquinone. [e9-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub> has obtained from Pd-mediated [<sup>11</sup>C]methylation
of 39-demethyl-39-(pinacolboryl)ubiquinone in DMF at 65 &#176;C for
4 min, purified in reverse-phase semipreparative HPLC and final reformulation
in saline, glycol, and Tween80. It was prepared in 36 min with 53%
RCY, achieving 0.4&#8211;3.5 GBq with <italic toggle="yes">A</italic><sub>m</sub> of 21&#8211;78 GBq/&#956;mol. [39-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub> prepared as above was then used to achieve
[<sup>11</sup>C]ubiquinol through reduction with sodium dithionite
at 75 &#176;C for 6 min. Particularly, [<sup>11</sup>C]ubiquinol was
obtained in 38 min of radiosynthesis with 39% RCY and 95% RCP but
77% chemical purity, achieving 0.16&#8211;1.4 GBq of product with <italic toggle="yes">A</italic><sub>m</sub> of 48&#8211;76 GBq/&#956;mol. Noteworthy,
in this case, the final reformulation included ascorbic acid to partially
avoid [<sup>11</sup>C]ubiquinol degradation.<sup><xref ref-type="bibr" rid="ref418">418</xref></sup></p><fig id="fig93" position="float" orientation="portrait"><label>Figure 93</label><caption><p>Radiosynthetic schemes of [<italic toggle="yes">3</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]CoQ<sub>0</sub>, [<italic toggle="yes">5</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub>, [<italic toggle="yes">39</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub>, and [<italic toggle="yes">39</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ubiquinol. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr93" position="float" orientation="portrait" xlink:href="cr2c00398_0093.jpg"/></fig></sec><sec id="sec5.5.2"><label>5.5.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]CoQ<sub>10</sub>-HCO-60 injected in Mongolian gerbils through a
lateral tail vein revealed high and prolonged retention of activity
in the blood, followed by lung, spleen, gall bladder, and kidney,
accounting for its excretion through urine and feces. The uptake in
the brain was low but increased with time.<sup><xref ref-type="bibr" rid="ref412">412</xref>,<xref ref-type="bibr" rid="ref413">413</xref></sup> In pregnant Wistar rats (16&#8211;19<sup>th</sup> day of gestation)
[<sup>11</sup>C]CoQ<sub>10</sub>-HCO-60 accumulated mainly in maternal
than fetal organs, albeit a fetus-to-placenta ratio increasing with
time, with relatively high uptake in fetal brain than the maternal
brain (fetal/maternal brain uptake ratio at 30 min around 153).<sup><xref ref-type="bibr" rid="ref261">261</xref></sup> Subsequently, [<sup>11</sup>C]CoQ<sub>10</sub>-HCO-60 and [<sup>11</sup>C]CoQ<sub>10</sub>-liposomes biodistributions
were compared in adult and newborn Wistar rats (injected in dorsal
veins and intraperitoneally, respectively).<sup><xref ref-type="bibr" rid="ref414">414</xref></sup> In this case, [<sup>11</sup>C]CoQ<sub>10</sub>-liposomes were rapidly
cleared from the blood and quickly incorporated into the spleen and
liver. The heart-to-blood ratio significantly increased in liposome
formulation in adult and newborn rats. Both [<sup>11</sup>C]CoQ<sub>10</sub>-HCO-60 and [<sup>11</sup>C]CoQ<sub>10</sub>-liposomes demonstrated
very low uptake in the brain.<sup><xref ref-type="bibr" rid="ref414">414</xref></sup> Based
on these premises, [<sup>11</sup>C]CoQ<sub>10</sub>-liposomes were
further evaluated as a myocardial imaging tracer in dogs injected
through the femoral vein.<sup><xref ref-type="bibr" rid="ref415">415</xref></sup> In contrast
to rats, the heart-to-blood ratio was only 0.5 after 30 min (<italic toggle="yes">vs</italic> 10 in rats), preventing acceptable myocardial imaging.
Furthermore, increased heart uptake of [<sup>11</sup>C]CoQ<sub>10</sub>-liposomes, corrected for blood spillover of radioactivity, was registered,
demonstrating incorporation of exogenous [<sup>11</sup>C]CoQ<sub>10</sub> in normal myocardium over a short period (45 min).<sup><xref ref-type="bibr" rid="ref415">415</xref></sup> More recently, biodistributions of the oxidized and reduced
form of [<sup>11</sup>C]CoQ<sub>10</sub> (ubiquinone-10 and ubiquinol-10
labeled at 39 positions) were evaluated in Sprague-Dawley rats.<sup><xref ref-type="bibr" rid="ref417">417</xref></sup> As shown in <xref rid="fig94" ref-type="fig">Figure <xref rid="fig94" ref-type="fig">94</xref></xref>, radiotracers mainly accumulated in the
liver, lung, and spleen combined with an enhanced and persistent uptake
in the heart, aortas, and head region for [<sup>11</sup>C]ubiquinol.
Similar liver uptakes were registered, while cerebellum, cerebrum,
and adipose tissue provided a significant major accumulation of activity
for [<sup>11</sup>C]ubiquinol at 90 min p.i. On the contrary, [<sup>11</sup>C]CoQ<sub>10</sub> showed a more remarkable and significant
uptake in the spleen.<sup><xref ref-type="bibr" rid="ref417">417</xref></sup> In male ddY mice,
[<sup>11</sup>C]CoQ<sub>10</sub> confirmed similar high abdomen accumulation
in the kidney, lung, liver, and heart. [<sup>11</sup>C]CoQ<sub>0</sub> (congener substrate of complex I without isoprenoid side chain)
revealed an increasing uptake in the brain until 5 min p.i., which
slowly decreased over time even if background bloodborne activity
remains too high for brain imaging.<sup><xref ref-type="bibr" rid="ref416">416</xref></sup></p><fig id="fig94" position="float" orientation="portrait"><label>Figure 94</label><caption><p>[<italic toggle="yes">39</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]CoQ<sub>10</sub> and [<italic toggle="yes">39</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]ubiquinol
pharmacokinetics in ddY mice. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref417">417</xref>). Copyright
2019 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr94" position="float" orientation="portrait" xlink:href="cr2c00398_0094.jpg"/></fig></sec></sec><sec id="sec5.6"><label>5.6</label><title>Vitamin A</title><sec id="sec5.6.1"><label>5.6.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]All-<italic toggle="yes">trans</italic>-retinoic acid (ATRA) was reported for the first time
in 2014, using a combination of rapid Pd(0)-mediated C-[<sup>11</sup>C]methylation of an alkenyl boron precursor, which was produced <italic toggle="yes">via</italic> an eight-step method. The Pd(0)-mediated [<sup>11</sup>C]methylation was performed using [<sup>11</sup>C]CH<sub>3</sub>I
in the presence of Pd<sub>2</sub>(dba)<sub>3</sub>, P(<italic toggle="yes">o</italic>-tolyl)<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub> (1:4:9) in DMF at
65 &#176;C for 4 min, followed by basic hydrolysis of the ethyl ester
at 100 &#176;C for 2 min to synthesize [<sup>11</sup>C]ATRA in 14%
yield (HPLC analytical yield). Sodium ascorbate was added to prevent
radiolysis, and rapid [<sup>11</sup>C]methylation in the presence
of sodium ascorbate led to [<sup>11</sup>C]ATRA formation. The RCY
was 25% based on [<sup>11</sup>C]CH<sub>3</sub>I, and RCP &gt;99%
with
a total synthesis time, including HPLC purification and formulation,
of 32 min. <italic toggle="yes">9</italic>-<italic toggle="yes">cis</italic>-[<sup>11</sup>C]Retinoic
acid was also one of the products of this reaction (<xref rid="fig95" ref-type="fig">Figure <xref rid="fig95" ref-type="fig">95</xref></xref>).<sup><xref ref-type="bibr" rid="ref419">419</xref></sup></p><fig id="fig95" position="float" orientation="portrait"><label>Figure 95</label><caption><p>Radiosynthesis of [<sup>11</sup>C]ATRA using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr95" position="float" orientation="portrait" xlink:href="cr2c00398_0095.jpg"/></fig></sec></sec><sec id="sec5.7"><label>5.7</label><title>Vitamin B<sub>3</sub></title><sec id="sec5.7.1"><label>5.7.1</label><title>Niacin</title><sec id="sec5.7.1.1"><label>5.7.1.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin has been synthesized by four different methods.
Machulla <italic toggle="yes">et al</italic>. in 1979 prepared [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin by reaction of [<sup>11</sup>C]CO<sub>2</sub> with <italic toggle="yes">3</italic>-pyridyl-lithium in ether, followed by hydrolysis
and addition of HCl. However, the authors did not mention any details
about the RCY, RCP, or <italic toggle="yes">A</italic><sub>m</sub>.<sup><xref ref-type="bibr" rid="ref436">436</xref>,<xref ref-type="bibr" rid="ref436">436</xref></sup></p><p>Karimi <italic toggle="yes">et al</italic>. introduced another method using
[<sup>11</sup>C]CO.<sup><xref ref-type="bibr" rid="ref422">422</xref></sup> Briefly, in a micro-autoclave
at high pressure, pre-charged with [<sup>11</sup>C]CO, a mixture of
tetrakis(triphenyl-phosphine)palladium(0), <italic toggle="yes">3</italic>-iodopyridine,
and tetra-methylammonium hydroxide in dry THF was added. The micro-autoclave
was heated at 180 &#176;C for 5 min and purified by semipreparative
liquid chromatography. [<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin
was isolated within 27 min, with a RCY of 65 &#177; 3% and <italic toggle="yes">A</italic><sub>m</sub> of 750 &#177; 30 GBq/&#956;mol after EOB.<sup><xref ref-type="bibr" rid="ref422">422</xref></sup></p><p>Ishii <italic toggle="yes">et al.</italic>,<sup><xref ref-type="bibr" rid="ref424">424</xref></sup> in
2015, developed a new method for the Pd(0)-mediated [<sup>11</sup>C]carbonylation of 3-pyridine boronic acid pinacol ester with [<sup>11</sup>C]CO in the presence of <italic toggle="yes">p</italic>-benzoquinone and
triphenylphosphine in a mixture of DMF and MeOH under ambient pressure
at 65 &#176;C. Ishii <italic toggle="yes">et al.</italic>,<sup><xref ref-type="bibr" rid="ref424">424</xref></sup> in 2015, developed a new method for the Pd(0)-mediated
[<sup>11</sup>C]carbonylation of <italic toggle="yes">3</italic>-pyridine boronic
acid pinacol ester with [<sup>11</sup>C]CO in the presence of <italic toggle="yes">p</italic>-benzoquinone and triphenylphosphine in a mixture of DMF
and MeOH under ambient pressure at 65 &#176;C (<xref rid="fig96" ref-type="fig">Figure <xref rid="fig96" ref-type="fig">96</xref></xref>). This method converted the boronate to
the corresponding methyl ester of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin. The addition of NaOH led to the formation of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin with a RCY of 76 &#177; 14%.<sup><xref ref-type="bibr" rid="ref424">424</xref></sup> This method converted the boronate to the corresponding
methyl ester of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin.
The addition of NaOH led to the formation of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin with a RCY of 76 &#177; 14%.<sup><xref ref-type="bibr" rid="ref424">424</xref></sup></p><fig id="fig96" position="float" orientation="portrait"><label>Figure 96</label><caption><p>Synthesis of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin
using
[<sup>11</sup>C]CO. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr96" position="float" orientation="portrait" xlink:href="cr2c00398_0096.jpg"/></fig><p>In 2020, Bongarzone <italic toggle="yes">et al.</italic> synthesized
[<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin <italic toggle="yes">via</italic> a simple,
rapid, one-step Cu-mediated <sup>11</sup>C-carboxylation reaction
in a fully automated system using [<sup>11</sup>C]CO<sub>2</sub>, <italic toggle="yes">3</italic>-pyridine boronic acid pinacol ester precursor (<xref rid="fig97" ref-type="fig">Figure <xref rid="fig97" ref-type="fig">97</xref></xref>).<sup><xref ref-type="bibr" rid="ref420">420</xref></sup> The 10 min reaction at 110 &#176;C used TMEDA
as a base/ligand, CuI as a catalyst, and KF/K2.2.2 as a fluoride ion
source in DMF. The product was obtained with a RCY of 17 &#177; 2%,
RCP &gt;99%, and <italic toggle="yes">A</italic><sub>m</sub> of 7 &#177; 1 GBq/&#956;mol
at EOD. Total synthesis time, including HPLC purification, was 25
&#177; 1 min.</p><fig id="fig97" position="float" orientation="portrait"><label>Figure 97</label><caption><p>Synthesis of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin
using
[<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr97" position="float" orientation="portrait" xlink:href="cr2c00398_0097.jpg"/></fig></sec><sec id="sec5.7.1.2"><label>5.7.1.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin was administered intravenously
in healthy mice, and dynamic PET data were acquired for 60 min (<xref rid="fig98" ref-type="fig">Figures <xref rid="fig98" ref-type="fig">98</xref></xref> and <xref rid="fig99" ref-type="fig">99</xref>).<sup><xref ref-type="bibr" rid="ref420">420</xref></sup> [<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin accumulated in the kidney, liver, retina,
and heart, where SMCTs and MCT1 transporters are primarily expressed.
Pre-administration of nonradioactive niacin or a potent MCT1 inhibitor
(AZD3965) increased urinary excretion and decreased the uptake in
MCT1-expressing organs of [<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin was administered orally in mice, and emission data were
acquired for 120 min (<xref rid="fig98" ref-type="fig">Figures <xref rid="fig98" ref-type="fig">98</xref></xref> and <xref rid="fig99" ref-type="fig">99</xref>). No-carrier added [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin accumulated in the intestine.
In addition, the carrier added [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin resulted in a preferential distribution to the excretory
organs and other tissues expressing niacin transporters.</p><fig id="fig98" position="float" orientation="portrait"><label>Figure 98</label><caption><p>[<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin PET images of
no-niacin added (A,B), niacin-challenged mice (C,D) AZD3965-challenged
(E,F) mice. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref420">420</xref>). Copyright 2020 Elsevier.
This work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr98" position="float" orientation="portrait" xlink:href="cr2c00398_0098.jpg"/></fig><fig id="fig99" position="float" orientation="portrait"><label>Figure 99</label><caption><p>[<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin PET images
after
oral administration in no-niacin added (A&#8211;C) and niacin-challenged
(D&#8211;F) mice. Reproduced with permission from Bongarzone ref (<xref ref-type="bibr" rid="ref420">420</xref>). Copyright 2020 Elsevier.
This work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr99" position="float" orientation="portrait" xlink:href="cr2c00398_0099.jpg"/></fig></sec><sec id="sec5.7.1.3"><label>5.7.1.3</label><title>Clinical Studies</title><p>[<italic toggle="yes">Carboxyl</italic>-<sup>11</sup>C]niacin has been evaluated in one case study of a
67-year-old-male who had no known neurological disorders to study
the permeability of the BBB.<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> Data of
the activity concentration in the blood and tissues were collected
using PET immediately after the iv injection (<italic toggle="yes">A</italic><sub>m</sub> of 0.066 GBq/&#956;mol). PET images showed that the brain
signal was low compared to the signal from CNS blood vessels, leading
to the conclusion that the tracer did not pass the BBB.<sup><xref ref-type="bibr" rid="ref421">421</xref></sup></p></sec></sec><sec id="sec5.7.2"><label>5.7.2</label><title>Nicotinamide</title><sec id="sec5.7.2.1"><label>5.7.2.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]nicotinamide has been synthesized by four different
methods. First, Machulla <italic toggle="yes">et al</italic>. prepared [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide starting with a reaction
of <italic toggle="yes">3</italic>-pyridyl-lithium and [<sup>11</sup>C]CO<sub>2</sub> in ether, followed by the addition of SOCl<sub>2</sub> in DMF and
last by the addition of liquid NH<sub>3</sub> (<xref rid="fig100" ref-type="fig">Figure <xref rid="fig100" ref-type="fig">100</xref></xref>A). The [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide was prepared within 60 min with a RCY
of 20&#8211;45% and RCP &gt;99.9% after chromatographic separation.<sup><xref ref-type="bibr" rid="ref436">436</xref>,<xref ref-type="bibr" rid="ref436">436</xref></sup></p><fig id="fig100" position="float" orientation="portrait"><label>Figure 100</label><caption><p>Synthesis of [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide
using (A) [<sup>11</sup>C]CO<sub>2</sub>, (B) [<sup>11</sup>C]CO,
and (C) [<sup>11</sup>C]CN<sup>&#8211;</sup>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr100" position="float" orientation="portrait" xlink:href="cr2c00398_0100.jpg"/></fig><p>In 1994, Andersson <italic toggle="yes">et al</italic>. prepared
[<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide from the <italic toggle="yes">3</italic>-bromopyridine
and [<sup>11</sup>C]HCN utilizing a Pd(0)-assisted coupling reaction
and subsequent hydrogen peroxide conversion of the cyano group to
the amide with sodium percarbonate. A one-pot procedure for synthesizing
the [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide was developed
(<xref rid="fig100" ref-type="fig">Figure <xref rid="fig100" ref-type="fig">100</xref></xref>B). The
synthesis time for the carbon&#8211;carbon bond-forming reaction
was 5 min. [<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]nicotinamide
was prepared with a total 30&#8211;35 min synthesis time, RCY of
45%, and RCP &gt;99%. The <italic toggle="yes">A</italic><sub>m</sub> was in the
order
of 74 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref423">423</xref></sup></p><p>In 2002,
Karimi <italic toggle="yes">et al</italic>. added NH<sub>3</sub> in
anhydrous dioxane to a reaction mixture of tetrakis(triphenylphosphine)palladium
and <italic toggle="yes">3</italic>-bromopyridine or <italic toggle="yes">3</italic>-iodopyridine,
and the vial was shaken just before injection into the micro-autoclave
precharged with [<sup>11</sup>C]CO.<sup><xref ref-type="bibr" rid="ref422">422</xref></sup> The
mixture was heated at 180 &#176;C for 5 min, and [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide was isolated with the use of a semipreparative
LC with RCY of 11 &#177; 1% (using <italic toggle="yes">3</italic>-bromopyridine)
and 54 &#177; 4% (using 3-iodopyridine) and <italic toggle="yes">A</italic><sub>m</sub> of 1600 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref422">422</xref></sup></p><p>Another method, developed by Ishii <italic toggle="yes">et al</italic>. in 2015,
used [<sup>11</sup>C]CO to prepare the methyl ester of [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]niacin (described above), which was treated with
aqueous ammonium to give the corresponding [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide with RCY of 35 &#177; 2 5% (<xref rid="fig100" ref-type="fig">Figure <xref rid="fig100" ref-type="fig">100</xref></xref>C).<sup><xref ref-type="bibr" rid="ref424">424</xref></sup></p></sec><sec id="sec5.7.2.2"><label>5.7.2.2</label><title>Preclinical Studies</title><p>Initial distribution
and kinetic studies were performed on one rhesus monkey using a dose
of 200 MBq as a rapid bolus injection. Immediately p.i., a dynamic
imaging sequence was started, including I5 scans for 40 min in a whole-body
PET camera (GE 4096). These studies demonstrated that the blood clearance
was fast for [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]nicotinamide.
The brain uptake was low but rapidly accumulated in the liver, kidney,
and lymph nodes without significant washout (<xref rid="fig101" ref-type="fig">Figure <xref rid="fig101" ref-type="fig">101</xref></xref>). The blood radioactivity of [<italic toggle="yes">carbonyl-</italic><sup>11</sup>C]nicotinamide decreased quickly.<sup><xref ref-type="bibr" rid="ref423">423</xref></sup></p><fig id="fig101" position="float" orientation="portrait"><label>Figure 101</label><caption><p>[<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]nicotinamide
PET scans
in a rhesus monkey showing accumulation in lymph nodes (A) and a background
section (B). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref423">423</xref>). Copyright 1994 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr101" position="float" orientation="portrait" xlink:href="cr2c00398_0101.jpg"/></fig></sec></sec></sec><sec id="sec5.8"><label>5.8</label><title><italic toggle="yes">S</italic>-Adenosylmethionine</title><sec id="sec5.8.1"><label>5.8.1</label><title>Radiosynthesis</title><p>The radiosynthesis
of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine
was reported in 1981 by Gueguen <italic toggle="yes">et al</italic>. through enzymatic
synthesis, prepared by condensation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine with ATP. This
is a two-step process: firstly, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine is synthesized using [<sup>11</sup>C]CH<sub>3</sub>I and <sc><italic toggle="yes">l</italic></sc>-homocysteine
thiolactone as the precursor. Secondly, the enzymatic step involves
the incubation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine with ATP, followed by purification. This
method yielded 80% (synthesis time 20 min) and a <italic toggle="yes">A</italic><sub>m</sub> of 7.33 GBq/&#956;mol 45 min after EOB.<sup><xref ref-type="bibr" rid="ref428">428</xref></sup> A few years later, Ishiwata <italic toggle="yes">et al.</italic> reported a very similar method but using rat-liver extract as an
enzyme source in addition to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine and ATP (total synthesis
time of 45&#8211;50 min, RCY of 29&#8211;68%, RCP of 94.2&#8211;99.4%,
and <italic toggle="yes">A</italic><sub>m</sub> of 0.13&#8211;0.83 GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref427">427</xref></sup> Several limitations are associated with the
enzymatic synthesis, such as the preparation of the enzyme source
from the rat liver, the two-step synthesis involving the preparation
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine before the enzymatic process, and several techniques
involved in the product isolation. Therefore, in 2017, Zopollo <italic toggle="yes">et al</italic>. reported the one-pot and automated radiosynthesis
of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine
based on the direct <italic toggle="yes">S</italic>-[<sup>11</sup>C]methylation
of <italic toggle="yes">S</italic>-adenosyl homocysteine, producing <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine with
a RCY of 17 &#177; 4% (based on [<sup>11</sup>C]CH<sub>3</sub>OTf)
within 28 &#177; 1 min from delivery of the [<sup>11</sup>C]CO<sub>2</sub> to the formulated final product, and RCP of 97.7 &#177; 0.3%
(<xref rid="fig102" ref-type="fig">Figure <xref rid="fig102" ref-type="fig">102</xref></xref>).<sup><xref ref-type="bibr" rid="ref387">387</xref></sup><italic toggle="yes">S</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]adenosylmethionine was obtained under GMP conditions
using an automated platform <italic toggle="yes">via</italic> the <italic toggle="yes">S</italic>-methylation reaction of SAH with the <sup>11</sup>C-methylating
agent [<sup>11</sup>C]CH<sub>3</sub>OTf. The RCP &gt;90% and <italic toggle="yes">A</italic><sub>m</sub> of 207&#8211;1363 GBq/&#956;mol taking into
account only the (<italic toggle="yes">S</italic>, <italic toggle="yes">S</italic>) isomer.<sup><xref ref-type="bibr" rid="ref387">387</xref>,<xref ref-type="bibr" rid="ref425">425</xref></sup></p><fig id="fig102" position="float" orientation="portrait"><label>Figure 102</label><caption><p>Synthesis of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine from <italic toggle="yes">S</italic>-adenosyl homocysteine
and [<sup>11</sup>C]CH<sub>3</sub>OTf.<sup><xref ref-type="bibr" rid="ref387">387</xref></sup><sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr102" position="float" orientation="portrait" xlink:href="cr2c00398_0102.jpg"/></fig></sec><sec id="sec5.8.2"><label>5.8.2</label><title>Preclinical Studies</title><p><italic toggle="yes">S</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]adenosylmethionine has been
studied preclinically <italic toggle="yes">in vivo</italic> in mice,<sup><xref ref-type="bibr" rid="ref426">426</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref428">428</xref></sup> and
rats<sup><xref ref-type="bibr" rid="ref426">426</xref>,<xref ref-type="bibr" rid="ref427">427</xref>,<xref ref-type="bibr" rid="ref428">428</xref></sup> in healthy
or disease-model animals. Biodistribution studies in normal mice,
rats, and rabbits have been performed. A biodistribution study of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine
in healthy mice showed a rapid blood clearance with the highest uptake
of activity in the bladder and urine, followed by kidneys which might
reflect not only the excretion of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine due to its high hydrophilicity
but also the transmethylation into macromolecules. Low uptake was
observed in the other organs: heart, liver, spleen, gut, and lungs.
In the same study, mice bearing prostate cancer xenografts showed
significantly higher tumor uptake with <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine compared with the
established prostate radiotracer [<sup>11</sup>C]choline.<sup><xref ref-type="bibr" rid="ref425">425</xref></sup></p><p>Similarly, Ishiwata <italic toggle="yes">et al</italic>. showed that the highest uptake of <italic toggle="yes">S</italic>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]adenosylmethionine was found in the kidneys. Accumulation
was also observed in the small intestine, pancreas, adrenal gland,
liver, and spleen.<sup><xref ref-type="bibr" rid="ref427">427</xref></sup> In 1985, Ishiwata <italic toggle="yes">et al</italic>. performed biodistribution studies of <italic toggle="yes">S</italic>-[<sc>l</sc>-<sup>11</sup>C]adenosylmethionine in pregnant rats (16th&#8211;19th
day of gestation), showing high activity uptake in the blood, placenta,
and lung at 5 min p.i. In addition, a relatively higher uptake in
the fetal brain was observed compared to the maternal brain.<sup><xref ref-type="bibr" rid="ref261">261</xref></sup> Finally, a biodistribution study employing
this radiotracer in rabbits demonstrated high kidney uptake.<sup><xref ref-type="bibr" rid="ref428">428</xref></sup></p></sec></sec><sec id="sec5.9"><label>5.9</label><title>Thiamine</title><sec id="sec5.9.1"><label>5.9.1</label><title>Radiosynthesis</title><p>The rapid and multistep
synthesis involved the (1) incorporation of a [<sup>11</sup>C]methyl
group into a heteroaromatic thiazole ring <italic toggle="yes">via</italic> rapid
Pd<sup>0</sup>-mediated [<sup>11</sup>C]methylation in the presence
of CuBr and CsF at 100 &#176;C for 5 min, and (2) rapid benzylation
using 4-amino-5-(bromomethyl)-2-methylpyrimidine hydrobromide in DMF
at 150 &#176;C for 7 min (<xref rid="fig103" ref-type="fig">Figure <xref rid="fig103" ref-type="fig">103</xref></xref>). The total synthesis was accomplished within 60 min.
The radioactivity of the formulated injectable solution was 400&#8211;700
MBq. The RCP was 99%. To obtain higher-quality PET tracers and meet
the criteria intended for clinical studies, the synthesis of [<sup>11</sup>C]thiamine was then improved by the adoption of dual-port
irradiation in the cyclotron system and further optimization of the
reaction conditions and the purification procedures, as shown in <xref rid="fig103" ref-type="fig">Figure <xref rid="fig103" ref-type="fig">103</xref></xref>.<sup><xref ref-type="bibr" rid="ref430">430</xref></sup></p><fig id="fig103" position="float" orientation="portrait"><label>Figure 103</label><caption><p>Synthesis of [<sup>11</sup>C]thiamine using
[<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position
is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr103" position="float" orientation="portrait" xlink:href="cr2c00398_0103.jpg"/></fig></sec><sec id="sec5.9.2"><label>5.9.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Thiamine was administered in the tail veins of anesthetized rats
and placed in the microPET scanner. Emission PET data were acquired
for 90 min. The organs were dissected, weighed, and their radioactivity
determined. No [<sup>11</sup>C]thiamine accumulation was found in
the heart (<xref rid="fig104" ref-type="fig">Figure <xref rid="fig104" ref-type="fig">104</xref></xref>).<sup><xref ref-type="bibr" rid="ref429">429</xref></sup></p><fig id="fig104" position="float" orientation="portrait"><label>Figure 104</label><caption><p>[<sup>11</sup>C]Thiamine PET scans in
mice show a rapid washout
from the heart. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref429">429</xref>). Copyright 2018 Springer
Nature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr104" position="float" orientation="portrait" xlink:href="cr2c00398_0104.jpg"/></fig></sec></sec><sec id="sec5.10"><label>5.10</label><title>Vitamin C</title><sec id="sec5.10.1"><label>5.10.1</label><title>Radiosynthesis</title><p>Cyclotron-produced
[<sup>11</sup>C]HCN was eluted with water or aqueous KCN (carrier
added) into a vial containing <sc><italic toggle="yes">l</italic></sc>-xylosone
(<xref rid="fig105" ref-type="fig">Figure <xref rid="fig105" ref-type="fig">105</xref></xref>). The
resulting imine intermediate was hydrolyzed with the addition of HCl
and heated for 10 min at 150 &#176;C to yield the desired product.
[<sup>11</sup>C]Ascorbic acid was isolated with RCP &gt;99%, with
different
RCY and <italic toggle="yes">A</italic><sub>m</sub> based on the carrier added.
[<sup>11</sup>C]Ascorbic acid was then oxidized with rapid bubbling
of O<sub>2</sub> for 10 min, and [<sup>11</sup>C]dehydroascorbic acid
was obtained (<xref rid="fig105" ref-type="fig">Figure <xref rid="fig105" ref-type="fig">105</xref></xref>).<sup><xref ref-type="bibr" rid="ref405">405</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Ascorbic acid has also been synthesized, fully automated,
in 35 min from EOB with a RCY of 18.1 &#177; 2.6%, and <italic toggle="yes">A</italic><sub>m</sub> of 15.27 &#177; 3.76 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref431">431</xref></sup></p><fig id="fig105" position="float" orientation="portrait"><label>Figure 105</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ascorbic
and [<italic toggle="yes">1</italic>-<sup>11</sup>C]dehydroascorbic acid using
[<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr105" position="float" orientation="portrait" xlink:href="cr2c00398_0105.jpg"/></fig></sec><sec id="sec5.10.2"><label>5.10.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ascorbic and [<italic toggle="yes">1</italic>-<sup>11</sup>C]dehydroascorbic
acid have been evaluated in mice<sup><xref ref-type="bibr" rid="ref431">431</xref></sup> and
rats.<sup><xref ref-type="bibr" rid="ref405">405</xref></sup> Studies of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ascorbic acid in arthritic mice using PET/CT showed
significant uptake in the liver and kidney due to high toxin/ROS expression
and renal excretion, respectively. The tracer evaluated the effects
of indomethacin treatment, resulting in reduced inflammation based
on a decrease in tracer uptake.<sup><xref ref-type="bibr" rid="ref431">431</xref></sup></p><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ascorbic and [<italic toggle="yes">1</italic>-<sup>11</sup>C]dehydroascorbic acid ([<sup>11</sup>C]DHA) were administered
to normal rats <italic toggle="yes">via</italic> tail vein injection, and a 40
min dynamic scan was obtained using a micro/PET-CT scan in the brain
(<xref rid="fig106" ref-type="fig">Figure <xref rid="fig106" ref-type="fig">106</xref></xref>). Accumulation
of [<sup>11</sup>C]DHA was remarkably higher than that of [<italic toggle="yes">1</italic>-<sup>11</sup>C]ascorbic acid, confirming that only dehydroascorbic
acid crosses the BBB transported by GLUT1.<sup><xref ref-type="bibr" rid="ref405">405</xref></sup> The results also confirm the authors&#8217; hypothesis regarding
the detection of changes in uptake based on oxidized <italic toggle="yes">vs</italic> reduced forms of ascorbic acid using PET. In contrast, the transport
of vitamin C into the brain <italic toggle="yes">via</italic> SVCT2 is a slower
process. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Ascorbic showed lower
accumulation than [<sup>11</sup>C]DHA in the brain, but higher retention
in the lung and liver 1 h after administration, possibly due to high
expression of SVCT in these tissues. [<sup>11</sup>C]DHA reduction
to [<italic toggle="yes">1</italic>-<sup>11</sup>C]ascorbic acid represents a potential
trapping mechanism, with unreduced [<sup>11</sup>C]DHA likely washed
out of the cell. However, there was no difference in the <sup>11</sup>C radiopharmaceutical retention rate in major organs between the
normal and diethyl maleate (DEM) treated groups.<sup><xref ref-type="bibr" rid="ref437">437</xref></sup></p><fig id="fig106" position="float" orientation="portrait"><label>Figure 106</label><caption><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Ascorbic ([<sup>11</sup>C]VitC)
and [<sup>11</sup>C]dehydroascorbic acid ([<sup>11</sup>C]DHA) microPET
images in a rat brain (0&#8211;30 min p.i.). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref405">405</xref>). Copyright
2016 Royal Society of Chemistry.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr106" position="float" orientation="portrait" xlink:href="cr2c00398_0106.jpg"/></fig></sec></sec></sec><sec id="sec6"><label>6</label><title>Endogenous Gases</title><p>Biologically active
gases naturally occurring in the body include
CO<sub>2</sub>, CO, and CH<sub>4</sub>. In the human body, CO<sub>2</sub> is formed as a waste product of cellular respiration from
the metabolism of carbohydrates, fats, and AAs. The body removes the
excess CO<sub>2</sub> by exhalation.<sup><xref ref-type="bibr" rid="ref438">438</xref>,<xref ref-type="bibr" rid="ref439">439</xref></sup> The central
role of CO<sub>2</sub> in the body is to regulate the blood&#8217;s
pH and maintain a physiological acid&#8211;base balance. The latter
is processed by the bicarbonate buffering system in which carbonic
anhydrase catalyzes the reaction that converts CO<sub>2</sub> and
water into H<sub>2</sub>CO<sub>3</sub>. In turn, it rapidly dissociates
into H<sup>+</sup> and HCO<sub>3</sub><sup>&#8211;</sup> as per the
following equation: CO<sub>2</sub> + H<sub>2</sub>O &#8596; H<sub>2</sub>CO<sub>3</sub> &#8596; H<sup>+</sup> + HCO<sub>3</sub><sup>&#8211;</sup>.<sup><xref ref-type="bibr" rid="ref438">438</xref>,<xref ref-type="bibr" rid="ref440">440</xref></sup> CO has shown a broad and remarkable
spectrum of biological activity in several tissues, including: antiproliferative,
anti-inflammatory, antiatherogenic, and antiapoptotic, and vasodilating.
The endogenous CO is produced from the oxidative degradation of heme
proteins (heme catabolism) <italic toggle="yes">via</italic> the enzyme heme oxygenase,
which degrades heme to produce CO and biliverdin.<sup><xref ref-type="bibr" rid="ref441">441</xref></sup> The CO produced is removed from the cell <italic toggle="yes">via</italic> diffusion to the blood, where it avidly binds to hemoglobin (Hb),
and then it is transported as carboxyhemoglobin until it is solely
excreted <italic toggle="yes">via</italic> the lungs.<sup><xref ref-type="bibr" rid="ref442">442</xref></sup> Methane is an alkane involved in critical biological properties
such as anti-inflammatory, antioxidant, and antiapoptotic. It is a
constituent of human breath derived from bacterial fermentation in
the intestinal lumen, in which anaerobic flora converts undigested
carbohydrates into CH<sub>4</sub>.<sup><xref ref-type="bibr" rid="ref443">443</xref></sup> These
have all been radiolabeled with carbon-11, mainly for brain imaging,
to quantify blood volume and perfusion in several organs, in the 1980s.
However, [<sup>11</sup>C]CO<sub>2,</sub> [<sup>11</sup>C]CO and [<sup>11</sup>C]CH<sub>4</sub> are also important labeling precursors for
a variety of functionalized molecules (<xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>).</p><table-wrap id="tbl5" position="float" orientation="portrait"><label>Table 5</label><caption><title>Carbon-11 Labeled Endogenous Gases</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">target gas</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">carbon dioxide</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref444">444</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref445">445</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref445">445</xref></sup> humans<sup><xref ref-type="bibr" rid="ref446">446</xref>&#8722;<xref ref-type="bibr" rid="ref450">450</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">N<sub>2</sub>/O<sub>2</sub> 99.5/0.5</td><td style="border:none;" align="left" colspan="1" rowspan="1">NA<xref rid="t5fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref451">451</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">carbon monoxide</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref452">452</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref452">452</xref>&#8722;<xref ref-type="bibr" rid="ref454">454</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref452">452</xref>&#8722;<xref ref-type="bibr" rid="ref454">454</xref></sup> humans<sup><xref ref-type="bibr" rid="ref455">455</xref>&#8722;<xref ref-type="bibr" rid="ref461">461</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">N<sub>2</sub>/O<sub>2</sub> 99.5/0.5</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref462">462</xref>)</td></tr><tr><td colspan="5" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">methane</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs,<sup><xref ref-type="bibr" rid="ref463">463</xref></sup> humans<sup><xref ref-type="bibr" rid="ref463">463</xref>,<xref ref-type="bibr" rid="ref464">464</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">N<sub>2</sub>/O<sub>2</sub> 99.5/0.5</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref458">458</xref>,<xref ref-type="bibr" rid="ref464">464</xref>,<xref ref-type="bibr" rid="ref465">465</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">N<sub>2</sub>+10%H<sub>2</sub></td><td style="border:none;" align="left" colspan="1" rowspan="1">NA</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref466">466</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t5fn1"><label>a</label><p>NA: not applicable.</p></fn></table-wrap-foot></table-wrap><sec id="sec6.1"><label>6.1</label><title>Carbon Dioxide</title><sec id="sec6.1.1"><label>6.1.1</label><title>Radiosynthesis</title><p><sup>11</sup>C is
produced mainly as [<sup>11</sup>C]CO<sub>2</sub>, one of the most
common and versatile primary labeling precursors used as a starting
point for synthesizing many <sup>11</sup>C-labeled compounds.<sup><xref ref-type="bibr" rid="ref467">467</xref></sup> [<sup>11</sup>C]CO<sub>2</sub> is produced
using a cyclotron in high <italic toggle="yes">A</italic><sub>m</sub> (111&#8211;222
GBq/&#956;mol) by the bombardment of nitrogen gas with high-energy
protons.<sup><xref ref-type="bibr" rid="ref451">451</xref></sup> The preparation of [<sup>11</sup>C]CO<sub>2</sub> in most of the preclinical and clinical studies
has been described by Welch <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref468">468</xref></sup></p><p>Johnson <italic toggle="yes">et al</italic>. absorbed [<sup>11</sup>C]CO<sub>2</sub> as [<sup>11</sup>C]HCO<sup><sub>3</sub>&#8211;</sup> in a NaOH solution, then titrated it with HCl to the desired pH.
In this case, at a pH below 5, over 95% of the <sup>11</sup>C was
in the form of CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref449">449</xref></sup> Shields <italic toggle="yes">et al</italic>. trapped [<sup>11</sup>C]CO<sub>2</sub> using liquid
argon and then bubbled through whole blood with nitrogen gas for less
than 5 min before injecting, resulting in a mixture of labeled CO<sub>2</sub> and HCO<sub>3</sub><sup>&#8211;</sup>. Physiologic saline
was added, and the solution was injected into dogs. The RCP was over
&gt;99% using gas chromatography,<sup><xref ref-type="bibr" rid="ref445">445</xref></sup> obtaining <italic toggle="yes">A</italic><sub>m</sub> of 14.8 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref444">444</xref></sup> Regarding the gas preparation for inhalation studies, no
reagents were required in the system, and the gas was passed through
a copper measuring spiral in a high-pressure ionization chamber. Then,
the gas could be dispensed either continuously or batch-wise.<sup><xref ref-type="bibr" rid="ref469">469</xref></sup></p></sec><sec id="sec6.1.2"><label>6.1.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]CO<sub>2</sub> was studied in rats, dogs, and monkeys, who received
the administration <italic toggle="yes">via</italic> inhalation or iv injection.
However, to our knowledge, no studies have yet assessed the whole-body
biodistribution in healthy animals.</p><p><italic toggle="yes">In vivo</italic> evaluation of brain acid&#8211;base measurements by male Wistar
rats were achieved using a single-breath inhalation of [<sup>11</sup>C]CO<sub>2</sub>. Lockwood <italic toggle="yes">et al</italic>. found that 30%
of the label was metabolically trapped in the brain within 30 min
p.i.al.<sup><xref ref-type="bibr" rid="ref444">444</xref></sup></p><p>Shields <italic toggle="yes">et al</italic>. demonstrated that the injection
of [<sup>11</sup>C]CO<sub>2</sub> in dogs generated 33% of its excretion
by exhalation in the first 20 min and 56% over the first hour.<sup><xref ref-type="bibr" rid="ref445">445</xref></sup> Moreover, approximately 10% of the blood activity
was converted into a nonvolatile form over 60 min p.i. of [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref445">445</xref></sup></p></sec><sec id="sec6.1.3"><label>6.1.3</label><title>Clinical Studies</title><p>Only a few studies
have reported using [<sup>11</sup>C]CO<sub>2</sub> in healthy humans.
Normal biodistribution of [<sup>11</sup>C]CO<sub>2</sub> in the clinical
setting has been determined by Brooks <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref446">446</xref></sup> Four normal subjects were enrolled in the study,
and serial images of the brain were taken during continuous inhalation
of [<sup>11</sup>C]CO<sub>2</sub>. Normal biodistribution is seen
especially in the peripheral cortical grey matter, followed by whole
brain and white matter uptake.<sup><xref ref-type="bibr" rid="ref446">446</xref></sup></p><p>The first study in humans with [<sup>11</sup>C]CO<sub>2</sub> dates
back to 1962, and investigations were conducted until the late 1980s
with the administration of the radiotracer <italic toggle="yes">via</italic> gas
inhalation either by continuous inhalation or rebreathing of [<sup>11</sup>C]CO<sub>2</sub> from a rubber bag diluted with air.<sup><xref ref-type="bibr" rid="ref447">447</xref></sup></p><p>Fowler <italic toggle="yes">et al</italic>. studied
the distribution of [<sup>11</sup>C]CO<sub>2</sub> in relation to
the immediate CO<sub>2</sub> storage capacity. It was found that the
excretion of [<sup>11</sup>C]CO<sub>2</sub><italic toggle="yes">via</italic> inhalation
in two patients
was 49% and 69% of the injected activity over 45 min.<sup><xref ref-type="bibr" rid="ref448">448</xref></sup> Interestingly, these results were consistent
with those of dogs studied by Shields <italic toggle="yes">et al.</italic>, which
also found a similar excretion rate of 56% over the first hour.<sup><xref ref-type="bibr" rid="ref445">445</xref></sup></p><p>[<sup>11</sup>C]CO<sub>2</sub> readily
diffuses across the intact
BBB,<sup><xref ref-type="bibr" rid="ref449">449</xref></sup> so inhalation of the gas has also
been used to measure the brain pH, providing information on the regional
brain tissue acid&#8211;base. Brooks <italic toggle="yes">et al</italic>. also
investigated the brain pH in patients with brain tumors as well as
the effect of BBB disruption after continuous inhalation of [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref450">450</xref></sup> Tumors with
a disrupted BBB had a similar regional brain pH (mean pH 6.98) to
that of equivalent regions of contralateral tissue (mean pH 6.99).
Furthermore, tumors with an intact BBB were found to be more alkaline
(mean pH 7.09) and less aggressive than tumors with a disrupted BBB.<sup><xref ref-type="bibr" rid="ref446">446</xref></sup></p></sec></sec><sec id="sec6.2"><label>6.2</label><title>Carbon Monoxide</title><sec id="sec6.2.1"><label>6.2.1</label><title>Radiosynthesis</title><p>The most common
methods for [<sup>11</sup>C]CO production include the reduction of
[<sup>11</sup>C]CO<sub>2</sub> through a heated column pre-charged
with a reducing agent, which could be metallic zinc at 400 &#176;C
or molybdenum at 850 &#176;C.<sup><xref ref-type="bibr" rid="ref470">470</xref></sup> However,
catalysts and specialist equipment are also required besides the high
temperatures. Zeisler <italic toggle="yes">et al</italic>. produced [<sup>11</sup>C]CO from [<sup>11</sup>C]CO<sub>2</sub> after reaction with molybdenum,
in which the unconverted [<sup>11</sup>C]CO<sub>2</sub> was removed
by passing a gas stream through soda-lime, and [<sup>11</sup>C]CO
was collected in a silica trap cooled with liquid argon, obtaining
a RCY of 54% 15 min at the EOB and <italic toggle="yes">A</italic><sub>m</sub> of
555 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref462">462</xref></sup> A new method developed
by Dahl <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref471">471</xref></sup> used
zinc supported on fused silica particles at 485&#176;C, which is above
the melting point of zinc (420&#176;C), producing [<sup>11</sup>C]CO
with a RCY &gt;96%.<sup><xref ref-type="bibr" rid="ref471">471</xref></sup></p><p>Several other
methods have also been investigated, from chemical conversion of [<sup>11</sup>C]CO<sub>2</sub> by fixation with silyllithium<sup><xref ref-type="bibr" rid="ref472">472</xref></sup> or disilane<sup><xref ref-type="bibr" rid="ref473">473</xref></sup> to
the decomposition of [<sup>11</sup>C]formate<sup><xref ref-type="bibr" rid="ref470">470</xref></sup> and [<sup>11</sup>C]formyl chloride<sup><xref ref-type="bibr" rid="ref470">470</xref></sup> to [<sup>11</sup>C]CO. All of these methods have been recently reviewed
by Eriksson <italic toggle="yes">et al.</italic>.<sup><xref ref-type="bibr" rid="ref474">474</xref></sup></p></sec><sec id="sec6.2.2"><label>6.2.2</label><title>Preclinical Studies</title><p><italic toggle="yes">In
vivo</italic> studies have been conducted in rats, rabbits, and rhesus
monkeys to quantify blood volume in several organs and study the effect
of thermal injury on blood volume.<sup><xref ref-type="bibr" rid="ref452">452</xref>&#8722;<xref ref-type="bibr" rid="ref454">454</xref></sup> A biodistribution study
of [<sup>11</sup>C]CO on four adult male Sprague-Dawley rats was performed
by [<sup>11</sup>C]CO inhalation. Blood volume quantification was
investigated, and whole-body dynamic images were acquired for 30 min. <italic toggle="yes">In vivo</italic> biodistribution showed favorable results, with the
major vessels and cardiac cavities having the highest radiotracer
accumulation, followed by the lungs. Radioactivity in the liver, kidneys,
and brain was low (<xref rid="fig107" ref-type="fig">Figure <xref rid="fig107" ref-type="fig">107</xref></xref>).<sup><xref ref-type="bibr" rid="ref452">452</xref></sup></p><fig id="fig107" position="float" orientation="portrait"><label>Figure 107</label><caption><p>[<sup>11</sup>C]CO
biodistribution studies in adult male Sprague-Dawley
rats showing (<bold>1</bold>) whole-body, (<bold>2</bold>) brain,
and (<bold>3</bold>) heart distribution. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref452">452</xref>). Copyright
2013 John Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr107" position="float" orientation="portrait" xlink:href="cr2c00398_0107.jpg"/></fig></sec><sec id="sec6.2.3"><label>6.2.3</label><title>Clinical Studies</title><p>Shishido <italic toggle="yes">et al</italic>. published the biodistribution of [<sup>11</sup>C]CO
in healthy individuals after a single-breath inhalation of the radiotracer.
Increased uptake has been noted in areas of high blood pooling, such
as venous sinuses, the great vein of Galen, and an insular portion.<sup><xref ref-type="bibr" rid="ref455">455</xref></sup> Also, the uptake in the grey matter concerning
white matter is higher due to the greater blood volume in this structure.</p><p>Weinreich <italic toggle="yes">et al</italic>. also observed that after a single-breath
inhalation, [<sup>11</sup>C]CO was longest retained in the blood,
head, and liver.<sup><xref ref-type="bibr" rid="ref456">456</xref></sup> Despite the blurred
and poor image quality, <xref rid="fig108" ref-type="fig">Figure <xref rid="fig108" ref-type="fig">108</xref></xref> represents the whole-body and upper torso biodistribution
of [<sup>11</sup>C]CO, where increased uptake is seen in the liver,
spleen, lungs, and heart.<sup><xref ref-type="bibr" rid="ref457">457</xref></sup></p><fig id="fig108" position="float" orientation="portrait"><label>Figure 108</label><caption><p>[<sup>11</sup>C]CO inhalation whole-body PET scans in humans. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref457">457</xref>). Copyright 1979 Society of Nuclear Medicine. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr108" position="float" orientation="portrait" xlink:href="cr2c00398_0108.jpg"/></fig><p>No metabolism of [<sup>11</sup>C]CO into [<sup>11</sup>C]CO<sub>2</sub> or other compounds has been observed. Therefore,
part of
the radiotracer migrates from the blood into the intercellular space
while the rest is exhaled intact.<sup><xref ref-type="bibr" rid="ref456">456</xref></sup></p><p>[<sup>11</sup>C]CO was one of the first <sup>11</sup>C-radiopharmaceutical
for imaging the blood volume measurements in humans,<sup><xref ref-type="bibr" rid="ref458">458</xref></sup> one of its main clinical applications, studied under several
conditions, especially in cerebrovascular diseases and cancer (breast,
brain).<sup><xref ref-type="bibr" rid="ref459">459</xref></sup></p><p>Shishido <italic toggle="yes">et al</italic>. evaluated the blood volume in
cerebrovascular diseases. It was found that the quantitative accuracy
of PET in measuring brain blood volume and perfusion with [<sup>11</sup>C]CO might allow the location and assessment of cerebrovascular diseases.<sup><xref ref-type="bibr" rid="ref455">455</xref></sup></p><p>[<sup>11</sup>C]CO has also measured
tumor blood volume in prostate
and breast cancer.<sup><xref ref-type="bibr" rid="ref460">460</xref></sup> Interestingly, some
other applications of [<sup>11</sup>C]CO are placental localization,
which can manage antepartum hemorrhage. The same research group investigated
the use of [<sup>11</sup>C]CO in two studies involving 135 patients.
Overall, it was found that it is possible to localize the placenta
in any of its positions accurately (anterior, posterior, lateral),
as represented in <xref rid="fig109" ref-type="fig">Figure <xref rid="fig109" ref-type="fig">109</xref></xref>.<sup><xref ref-type="bibr" rid="ref461">461</xref></sup></p><fig id="fig109" position="float" orientation="portrait"><label>Figure 109</label><caption><p>[<sup>11</sup>C]CO
gamma camera scans of the abdominal cavity for
placenta localization. (A) Anterior projection and (B) right lateral
projection. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref461">461</xref>). Copyright 1968 Society
of Nuclear Medicine. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr109" position="float" orientation="portrait" xlink:href="cr2c00398_0109.jpg"/></fig></sec></sec><sec id="sec6.3"><label>6.3</label><title>Methane</title><sec id="sec6.3.1"><label>6.3.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]CH<sub>4</sub> is produced in the gas target during proton bombardment of
nitrogen-14 in the presence of 5%<sup><xref ref-type="bibr" rid="ref475">475</xref></sup> or
10% H<sub>2</sub><sup><xref ref-type="bibr" rid="ref466">466</xref></sup> as well as by reduction
of purified [<sup>11</sup>C]CO<sub>2</sub> with over hot nickel (375&#8211;450
&#176;C).<sup><xref ref-type="bibr" rid="ref458">458</xref>,<xref ref-type="bibr" rid="ref464">464</xref>,<xref ref-type="bibr" rid="ref465">465</xref></sup></p></sec><sec id="sec6.3.2"><label>6.3.2</label><title>Preclinical Studies</title><p>The regional
cerebral blood flow has been investigated <italic toggle="yes">via</italic> inhalation
of [<sup>11</sup>C]CH<sub>4</sub> in the myocardium of dogs (<xref rid="fig110" ref-type="fig">Figure <xref rid="fig110" ref-type="fig">110</xref></xref>).<sup><xref ref-type="bibr" rid="ref463">463</xref></sup></p><fig id="fig110" position="float" orientation="portrait"><label>Figure 110</label><caption><p>Distribution of pulmonary gas volume during
transmission (upper
image) and emission images in dogs with [<sup>11</sup>C]CH<sub>4</sub> (lower image). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref463">463</xref>). Copyright 1996 Wolters
Kluwer Health.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr110" position="float" orientation="portrait" xlink:href="cr2c00398_0110.jpg"/></fig></sec><sec id="sec6.3.3"><label>6.3.3</label><title>Clinical Studies</title><p>The regional cerebral
blood flow has been investigated <italic toggle="yes">via</italic> inhalation of
[<sup>11</sup>C]CH<sub>4</sub> in two healthy volunteers.<sup><xref ref-type="bibr" rid="ref464">464</xref></sup> [<sup>11</sup>C]CH<sub>4</sub> has also been
used to assess pulmonary gas distribution, which has proven effective
in human studies and eliminates the need for an additional lung emission
scan.<sup><xref ref-type="bibr" rid="ref463">463</xref></sup></p></sec></sec></sec><sec id="sec7"><label>7</label><title>Fatty Acids</title><p>Fatty acids (FAs) are ubiquitous
molecules shared among the three
domains of life, which represent the building blocks of the lipids&#8217;
family. They constitute the major components of triglycerides, phospholipids,
and other complex lipids.<sup><xref ref-type="bibr" rid="ref476">476</xref></sup> FAs act as
energy sources, thus representing the main contributor to human dietary
fats and essential membrane constituents. Furthermore, they modulate
cell metabolism, function, and signaling by regulating gene expression,
transcription factor activity, and membrane structure.<sup><xref ref-type="bibr" rid="ref477">477</xref></sup> In humans, only two FAs are recognized as essential,
those necessary for the biological function to be introduced from
dietary sources (<italic toggle="yes">e.g</italic>., linoleic and &#945;-linolenic
acid), while the others are physiologically produced or commonly assumed
with the diet.<sup><xref ref-type="bibr" rid="ref478">478</xref></sup></p><p>In addition to
their fundamental impact on human health, FAs, and
their metabolic dysregulation can also influence several diseases,
including cardiovascular and inflammatory disorders.<sup><xref ref-type="bibr" rid="ref477">477</xref></sup> Taken these premises, combined with their distinctive carbon
backbone, which allows several radiolabeling sites, <sup>11</sup>C-labeled
FAs represent essential family radiotracers, allowing us to deepen
the role of FAs at the physiological level (<xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>):<list list-type="bullet"><list-item><p>Acetic acid, obtained from dietary intake and the catabolism
of endogenous compounds, has a pivotal role in cellular function as
an essential building block for lipid biosynthesis and cell metabolism.<sup><xref ref-type="bibr" rid="ref479">479</xref>&#8722;<xref ref-type="bibr" rid="ref483">483</xref></sup> Due to its peculiar cellular involvement, a promising role in PET
investigations has been ascribed, especially for imaging tissues correlated
to high metabolic activity.<sup><xref ref-type="bibr" rid="ref484">484</xref></sup></p></list-item><list-item><p>Acetoacetic acid and &#946;-hydroxybutyrate
are produced
mainly in the liver from the &#946;-oxidation of FAs. During low
carbohydrate intake or fasting, it replaces glucose as fuel for high-metabolic
rate organs and acts as a starting point for lipid biosynthesis. Renewed
interest in ketone bodies and their promiscuous metabolism depending
on different patho/physiological conditions make labeled acetoacetic
acid an interesting PET probe.<sup><xref ref-type="bibr" rid="ref485">485</xref></sup> [<sup>11</sup>C]Acetone is widely used as the building block for the radiosynthesis
of labeled drugs.<sup><xref ref-type="bibr" rid="ref486">486</xref>,<xref ref-type="bibr" rid="ref487">487</xref></sup></p></list-item><list-item><p>Arachidonic acid is a crucial second messenger and regulates
inflammatory processes, ion channel activity, membrane fluidity, and
synaptic plasticity.<sup><xref ref-type="bibr" rid="ref488">488</xref>,<xref ref-type="bibr" rid="ref489">489</xref></sup></p></list-item><list-item><p>Suberic, azelaic, and sebacic acids are endogenous alkyl
dicarboxylic acids produced during the &#946;-oxidation of FAs, found
in trace amounts in human urine,<sup><xref ref-type="bibr" rid="ref490">490</xref>,<xref ref-type="bibr" rid="ref491">491</xref></sup> although
their concentration significantly increases during metabolic disorders.<sup><xref ref-type="bibr" rid="ref491">491</xref>,<xref ref-type="bibr" rid="ref492">492</xref></sup></p></list-item><list-item><p>Butyric acid is produced by several
types of bacteria
that can be found naturally in the human colon. Its isobutyric isomer
can also be found in smaller amounts. Butyric acid dissociated to
its anionic form, butyrate, absorbed and metabolized rapidly in the
mitochondria to produce energy.<sup><xref ref-type="bibr" rid="ref493">493</xref>,<xref ref-type="bibr" rid="ref494">494</xref></sup></p></list-item><list-item><p>Decanoic acid is involved in the biosynthesis of long-chain
fatty acids and has been shown to exert potent antimicrobial and anti-inflammatory
effects.<sup><xref ref-type="bibr" rid="ref495">495</xref></sup></p></list-item><list-item><p>Docosohexaenoic acid is one of the more prevalent fats
in the brain, with up to 40% of FAs in some gray matter regions and
a fundamental role in membrane and synaptic plasticity or neuroreceptor
signaling. It is essential in fetal brain and retina development.<sup><xref ref-type="bibr" rid="ref496">496</xref>&#8722;<xref ref-type="bibr" rid="ref499">499</xref></sup></p></list-item><list-item><p>Dodecanoic acid belongs to the class
of medium-chain
fatty acids recognized as a marker of several metabolic disorders.<sup><xref ref-type="bibr" rid="ref495">495</xref>,<xref ref-type="bibr" rid="ref500">500</xref>,<xref ref-type="bibr" rid="ref501">501</xref></sup></p></list-item><list-item><p>Formic acid is an essential building block in purine
synthesis, thymidylate synthesis, and the provision of methyl groups
for synthetic, regulatory, and epigenetic methylation reactions.<sup><xref ref-type="bibr" rid="ref502">502</xref></sup> Although no direct PET investigations have
been performed with [<sup>11</sup>C]formate, it has been observed
as a radiometabolite following <italic toggle="yes">in vivo</italic> tracer degradation <italic toggle="yes">via</italic> demethylation of <sup>11</sup>C-methylated tracers.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref503">503</xref>&#8722;<xref ref-type="bibr" rid="ref511">511</xref></sup></p></list-item><list-item><p>Hexanoic acid is mainly present in
humans as a metabolite
of FA catabolism.<sup><xref ref-type="bibr" rid="ref512">512</xref></sup> In PET imaging, it
has been evaluated to assess FA metabolism in myocardial and brain
tissue.<sup><xref ref-type="bibr" rid="ref513">513</xref>,<xref ref-type="bibr" rid="ref514">514</xref></sup></p></list-item><list-item><p>Linoleic acid
is an essential FA crucial for the biosynthesis
of arachidonic acid. Due to its biological role, it could be used
for visualizing FAs metabolism in physio-/pathological conditions.<sup><xref ref-type="bibr" rid="ref515">515</xref></sup></p></list-item><list-item><p>Octanoic acid
is a metabolite of FA catabolism in humans
and is used to visualize FA metabolism in CNS as a glutamate/glutamine
metabolism marker.</p></list-item><list-item><p>Stearic acid is one
of the most common saturated FAs
in nature and can be biosynthesized by elongating palmitic acid by
FA elongases.<sup><xref ref-type="bibr" rid="ref516">516</xref></sup> Stearate may also be desaturated
by the enzyme stearoyl-CoA desaturase to form oleic acid. Oleic acid
is the most common fatty acid in nature and is present in fats, phospholipid
membranes,&#8239;cholesterol esters, and&#8239;wax esters.<sup><xref ref-type="bibr" rid="ref517">517</xref></sup><sup>11</sup>C-labeled stearic and oleic acids
have been used to evaluate myocardial metabolism in preclinical studies.<sup><xref ref-type="bibr" rid="ref518">518</xref>,<xref ref-type="bibr" rid="ref519">519</xref></sup> A series of long-chain saturated FAs, including stearic acid, have
been radiolabeled as potential cardiac imaging agents; however, no
human studies have been reported with [<sup>11</sup>C]stearic acid
or [<sup>11</sup>C]oleic acid.</p></list-item><list-item><p>Palmitic
acid is the most abundant saturated FA in the
human body, accounting for 20&#8211;30% of total FAs in membrane
phospholipids. PET studies with radiolabeled palmitic acid can help
to deepen our knowledge of its metabolism in physio-/pathological
conditions.<sup><xref ref-type="bibr" rid="ref520">520</xref></sup></p></list-item><list-item><p>Pentanoic acid, produced by the gut microbiota, is mainly
present in the intestine. Recently, it has been correlated to promising
gut protective effects and histone deacetylase (HDAC) inhibitory potencies,
other than being a potential marker of metabolic disorders.<sup><xref ref-type="bibr" rid="ref521">521</xref>&#8722;<xref ref-type="bibr" rid="ref523">523</xref></sup></p></list-item><list-item><p>Propanoic acid is obtained from dietary
sources but
mainly from fermenting undigested food, such as carbohydrates, peptides,
and FAs, by the anaerobic colonic microbiota. Furthermore, propanoic
acid is considered a major energy source in ruminants. Thus, it is
a major mediator in the link between nutrition, microbiota, and physiology
in the human body, mainly in inflammatory conditions, by lowering
plasma FA levels.</p></list-item><list-item><p>Tetradecanoic acid
is involved in endogenous FA biosynthesis.
It mainly accumulates fat in the body and acts as a cardioprotective
agent and metabolic process regulator.<sup><xref ref-type="bibr" rid="ref524">524</xref></sup></p></list-item></list></p><table-wrap id="tbl6" position="float" orientation="portrait"><label>Table 6</label><caption><title>Carbon-11 Labeled Enzyme Fatty Acids</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total
time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">acetic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref525">525</xref>&#8722;<xref ref-type="bibr" rid="ref527">527</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref525">525</xref>,<xref ref-type="bibr" rid="ref528">528</xref></sup> pigs,<sup><xref ref-type="bibr" rid="ref432">432</xref>,<xref ref-type="bibr" rid="ref529">529</xref>,<xref ref-type="bibr" rid="ref530">530</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref432">432</xref>,<xref ref-type="bibr" rid="ref530">530</xref></sup> humans<sup><xref ref-type="bibr" rid="ref532">532</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">200</td><td style="border:none;" align="center" colspan="1" rowspan="1">43%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref533">533</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">pigs<sup><xref ref-type="bibr" rid="ref432">432</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;0.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">43%</td><td style="border:none;" align="center" colspan="1" rowspan="1">25</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref432">432</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">acetoacetic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref534">534</xref></sup> cats,<sup><xref ref-type="bibr" rid="ref534">534</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref535">535</xref></sup> humans<sup><xref ref-type="bibr" rid="ref536">536</xref>&#8722;<xref ref-type="bibr" rid="ref542">542</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">66.6</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">16</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref535">535</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">acetone</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">baboons<sup><xref ref-type="bibr" rid="ref543">543</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">100</td><td style="border:none;" align="center" colspan="1" rowspan="1">54%</td><td style="border:none;" align="center" colspan="1" rowspan="1">48</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref486">486</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">arachidonic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref544">544</xref></sup> humans<sup><xref ref-type="bibr" rid="ref545">545</xref>&#8722;<xref ref-type="bibr" rid="ref550">550</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">3.7</td><td style="border:none;" align="center" colspan="1" rowspan="1">23%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref551">551</xref>,<xref ref-type="bibr" rid="ref545">545</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">19</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr<xref rid="t6fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.6</td><td style="border:none;" align="center" colspan="1" rowspan="1">23%</td><td style="border:none;" align="center" colspan="1" rowspan="1">52</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref552">552</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">azelaic, sebacic, and suberic acids</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NH<sub>4</sub>CN</td><td style="border:none;" align="center" colspan="1" rowspan="1">15<xref rid="t6fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">40%</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref553">553</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">butyric acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref554">554</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> baboons<xref rid="t6fn3" ref-type="table-fn">c</xref>,<sup><xref ref-type="bibr" rid="ref555">555</xref></sup> humans<xref rid="t6fn3" ref-type="table-fn">c</xref><sup><xref ref-type="bibr" rid="ref556">556</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">37</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref555">555</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">64%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref557">557</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">isobutyric acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">96%</td><td style="border:none;" align="center" colspan="1" rowspan="1">20</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref531">531</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">decanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">10</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">44</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">docosahexaenoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys,<sup><xref ref-type="bibr" rid="ref590">590</xref></sup> humans<sup><xref ref-type="bibr" rid="ref559">559</xref>,<xref ref-type="bibr" rid="ref560">560</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;18.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">18.3%</td><td style="border:none;" align="center" colspan="1" rowspan="1">&lt;43</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref551">551</xref>,<xref ref-type="bibr" rid="ref559">559</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">dodecanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">12</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">pigs<sup><xref ref-type="bibr" rid="ref247">247</xref>,<xref ref-type="bibr" rid="ref561">561</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">28%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">formic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">9</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;98%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref507">507</xref>,<xref ref-type="bibr" rid="ref508">508</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">hexanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref513">513</xref>,<xref ref-type="bibr" rid="ref514">514</xref></sup> cats,<sup><xref ref-type="bibr" rid="ref562">562</xref></sup> dogs<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">71%</td><td style="border:none;" align="center" colspan="1" rowspan="1">15</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref563">563</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">6</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">36%</td><td style="border:none;" align="center" colspan="1" rowspan="1">47</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">linoleic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">18</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">20</td><td style="border:none;" align="center" colspan="1" rowspan="1">48%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref564">564</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">octanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref565">565</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref566">566</xref>,<xref ref-type="bibr" rid="ref567">567</xref></sup> cats,<sup><xref ref-type="bibr" rid="ref566">566</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> pigs,<sup><xref ref-type="bibr" rid="ref561">561</xref></sup> humans<sup><xref ref-type="bibr" rid="ref565">565</xref>,<xref ref-type="bibr" rid="ref568">568</xref>&#8722;<xref ref-type="bibr" rid="ref570">570</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">64%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">7</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">23%</td><td style="border:none;" align="center" colspan="1" rowspan="1">52</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">8</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">32%</td><td style="border:none;" align="center" colspan="1" rowspan="1">44</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">oleic and stearic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs<sup><xref ref-type="bibr" rid="ref518">518</xref>,<xref ref-type="bibr" rid="ref519">519</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref519">519</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">83%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref571">571</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">palmitic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td rowspan="2" style="border:none;" align="left" colspan="1">rats,<sup><xref ref-type="bibr" rid="ref572">572</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref572">572</xref></sup> pigs,<sup><xref ref-type="bibr" rid="ref561">561</xref>,<xref ref-type="bibr" rid="ref573">573</xref>,<xref ref-type="bibr" rid="ref574">574</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref575">575</xref></sup> humans<sup><xref ref-type="bibr" rid="ref574">574</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">12.95</td><td style="border:none;" align="center" colspan="1" rowspan="1">38%</td><td style="border:none;" align="center" colspan="1" rowspan="1">8</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref576">576</xref>&#8722;<xref ref-type="bibr" rid="ref578">578</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">78%</td><td style="border:none;" align="center" colspan="1" rowspan="1">58</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref315">315</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">8</italic>- and <italic toggle="yes">14</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>(CH<sub>2</sub>)<sub>7</sub>CH<sub>2</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">22%</td><td style="border:none;" align="center" colspan="1" rowspan="1">65</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">16</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref572">572</xref></sup> dogs<sup><xref ref-type="bibr" rid="ref572">572</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">73%</td><td style="border:none;" align="center" colspan="1" rowspan="1">46</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref557">557</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">pentanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">59%</td><td style="border:none;" align="center" colspan="1" rowspan="1">47</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref531">531</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">5</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">27%</td><td style="border:none;" align="center" colspan="1" rowspan="1">47</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">propanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">98%</td><td style="border:none;" align="center" colspan="1" rowspan="1">15</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref531">531</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">3</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref579">579</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">tetradecanoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">14</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">pigs<sup><xref ref-type="bibr" rid="ref561">561</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">23%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref558">558</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">&#946;</italic>-hydroxybutyrate</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref580">580</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">36</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref581">581</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><sup>11</sup>C]NH<sub>4</sub>CN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">30%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref582">582</xref>,<xref ref-type="bibr" rid="ref583">583</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t6fn1"><label>a</label><p>nr: not reported.</p></fn><fn id="t6fn2"><label>b</label><p>Azelaic acid.</p></fn><fn id="t6fn3"><label>c</label><p>Radiolabeling position is not clarified.</p></fn></table-wrap-foot></table-wrap><sec id="sec7.1"><label>7.1</label><title>Acetic Acid</title><sec id="sec7.1.1"><label>7.1.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetic acid radiosynthesis was firstly reported in
1943 by Buchanan and coworkers, exploiting the same procedure reported
in detail by Pike <italic toggle="yes">et al</italic>. in 1981.<sup><xref ref-type="bibr" rid="ref554">554</xref>,<xref ref-type="bibr" rid="ref584">584</xref></sup> Methyl magnesium bromide in diethyl ether after [<sup>11</sup>C]carbonation
under inert atmosphere and a final acidification step with HCl 6 M
with further ether extraction, allowed obtaining of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid in 20 min with 73% RCY and <italic toggle="yes">A</italic><sub>m</sub>, at time of preparation, exceeding 18.5 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref409">409</xref>,<xref ref-type="bibr" rid="ref584">584</xref></sup> The same procedure optimized with a remotely-controlled system reduced
the preparation time to 11.5 min.<sup><xref ref-type="bibr" rid="ref585">585</xref></sup> The
final solvent extraction represented a limitation for this automated
radiosynthesis. Therefore, further simplified purification methods, <italic toggle="yes">i.e.</italic>, solid-phase adsorbent, distillation, or ion-exchange
cartridge, were developed, maintaining roughly the same preparation
time and RCY.<sup><xref ref-type="bibr" rid="ref432">432</xref>,<xref ref-type="bibr" rid="ref563">563</xref>,<xref ref-type="bibr" rid="ref586">586</xref>&#8722;<xref ref-type="bibr" rid="ref589">589</xref></sup> In 1995, Kruijer <italic toggle="yes">et al</italic>. selectively separated [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid from byproducts through an
anion-exchange column in 15 min radiosynthesis and a RCY of 60&#8211;65%.<sup><xref ref-type="bibr" rid="ref590">590</xref></sup> Davenport <italic toggle="yes">et al</italic>. overcame
the purification problem using methyl magnesium bromide adsorbed in
a narrow tube, efficiently trapping and releasing radioactivity (95%
and 92%, respectively) during [<sup>11</sup>C]carboxylation, obtaining
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid in 16 min from radionuclide
production with a RCY of 72%.<sup><xref ref-type="bibr" rid="ref591">591</xref></sup> An automated
combination of these two techniques, <italic toggle="yes">i.e.</italic>, loop method
for Grignard reagent carboxylation and SPE purification, was set up
to obtain [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid with a RCY
of 60&#8211;70% in 12 min from EOB.<sup><xref ref-type="bibr" rid="ref592">592</xref></sup> Some of these procedures involved THF as the solvent instead of
ether, as reported by Berridge <italic toggle="yes">et al.</italic>, where solvent
and impurities were removed by evaporation with ethanol obtaining
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid within 15 min from
EOB in RCY of 60%.<sup><xref ref-type="bibr" rid="ref593">593</xref></sup> More recent automated
or fully robotic-controlled procedures generally maintain RCY &#8764;70%
and preparation time 15 min.<sup><xref ref-type="bibr" rid="ref594">594</xref>,<xref ref-type="bibr" rid="ref595">595</xref></sup> An alternative radiosynthetic
approach passed through hydrolysis of radiolabeled acetyl chloride.
The dry salt formed after [<sup>11</sup>C]carboxylation of methyllithium
or methyl magnesium bromide reacted with phthaloyl dichloride and
was finally trapped as sodium [<sup>11</sup>C]acetate by hydrolysis
with isotonic saline, affording [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic
acid within 25&#8211;30 min from EOB, RCY of 43% and <italic toggle="yes">A</italic><sub>m</sub> 90&#8211;200 GBq/&#956;mol at EOS.<sup><xref ref-type="bibr" rid="ref533">533</xref></sup></p><p>The only reported procedure for [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid (<xref rid="fig111" ref-type="fig">Figure <xref rid="fig111" ref-type="fig">111</xref></xref>) was published in 1994 by Kihlberg <italic toggle="yes">et al.</italic>.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> [<sup>11</sup>C]CH<sub>3</sub>I in diethyl ether was firstly converted to [<sup>11</sup>C]CH<sub>3</sub>Li using <italic toggle="yes">n</italic>-butyl lithium, carboxylated
at 60 &#176;C with CO<sub>2</sub> and finally acidified with HCl/NaCl<sub>(aq)</sub>, obtaining [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid
within 25 min, RCY of 43%, and <italic toggle="yes">A</italic><sub>m</sub> &gt;
0.5
GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> was published in 1994
by Kihlberg <italic toggle="yes">et al</italic>. [<sup>11</sup>C]CH<sub>3</sub>I in diethyl ether was firstly converted to [<sup>11</sup>C]CH<sub>3</sub>Li using <italic toggle="yes">n</italic>-butyl lithium, carboxylated at
60 &#176;C with CO<sub>2</sub>, and finally acidified with HCl/NaCl<sub>(aq)</sub>, obtaining [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid
within 25 min, RCY of 43%, and a <italic toggle="yes">A</italic><sub>m</sub> &gt;
0.5 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup></p><fig id="fig111" position="float" orientation="portrait"><label>Figure 111</label><caption><p>Radiosynthetic schemes
of [<sup>11</sup>C]acetic acid. <sup>11</sup>C Radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr111" position="float" orientation="portrait" xlink:href="cr2c00398_0111.jpg"/></fig><p>[<sup>11</sup>C]Acetate can be routinely produced
on a large scale
(for several consecutive PET imaging protocols) on various commercially
available (reconfigured) or in-house built automated modules <italic toggle="yes">via</italic><sup>11</sup>C-carboxylation of methyl magnesium chloride/bromide
(CH<sub>3</sub>MgCl, CH<sub>3</sub>MgBr) in anhydrous ether solvents
(Et<sub>2</sub>O/THF) employing reactor-based (bubbling)<sup><xref ref-type="bibr" rid="ref589">589</xref>,<xref ref-type="bibr" rid="ref595">595</xref>&#8722;<xref ref-type="bibr" rid="ref597">597</xref></sup> or captive-solvent methodology.<sup><xref ref-type="bibr" rid="ref598">598</xref>&#8722;<xref ref-type="bibr" rid="ref600">600</xref></sup> Overall synthesis time is 10&#8211;20 min with 30&#8211;80% RCY
based on [<sup>11</sup>C]CO<sub>2</sub>. However, despite various
improvements and flexibility of synthesis modules throughout these
years, reliable production of [<sup>11</sup>C]acetate and other <sup>11</sup>C-labeled fatty acids is still challenging due to the difficulties
of using Grignard reagents.</p></sec><sec id="sec7.1.2"><label>7.1.2</label><title>Preclinical Studies</title><p>Around 60%
of iv injected [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid in rats
expired as [<sup>11</sup>C]CO<sub>2</sub> in the first 15 min.<sup><xref ref-type="bibr" rid="ref525">525</xref></sup> This was further confirmed by Ng <italic toggle="yes">et
al</italic>. performing the [<sup>11</sup>C]CO<sub>2</sub> metabolite
analysis on simultaneously collected arterial and venous blood samples
of pigs at different time points, following iv administration of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid. It was found that a significant
fraction of the total radioactivity was represented by the [<sup>11</sup>C]CO<sub>2</sub> metabolite over 30 min p.i., where [<sup>11</sup>C]CO<sub>2</sub> rose from 4% to 64%.<sup><xref ref-type="bibr" rid="ref529">529</xref></sup> A study conducted in prostate tumor-bearing mice evaluated that
uptake in the tumor region in the first minute is due to reversibly
labeled tumor pool (tricarboxylic acid cycle metabolites and bicarbonate),
while irreversibly labeled pool (tumor lipid) is dominant at a second
stage. If the latter is confirmed, a higher tumor-to-noise ratio can
be achieved later, suggesting a worthwhile effort for longer acquisition
PET protocols.<sup><xref ref-type="bibr" rid="ref525">525</xref></sup> In pigs, after iv injection, <italic toggle="yes">1</italic>- and [<italic toggle="yes">2</italic>-<sup>11</sup>C]acetic acid was
rapidly cleared from the blood, where <sup>11</sup>C arterial radioactivity
remained only 10% after 60 s.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid concentration in venous blood
rapidly decreased after 5 min in monkeys and pigs.<sup><xref ref-type="bibr" rid="ref432">432</xref></sup> In the monkeys, [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic
acid was mainly uptake in the liver, salivary glands, pancreas, small
bowel, and spleen. At the same time, in pigs, its biodistribution
was like in monkeys, except for pronounced retention in the renal
cortex, gall bladder wall, and bone and less uptake in the salivary
gland. Very low excretion of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic
acid&#8217;s metabolites was found in bile or urine in both species.<sup><xref ref-type="bibr" rid="ref530">530</xref></sup> Biodistribution data in Sprague-Dawley male
rats confirmed fast clearance (30&#8211;60%) from all organs at 1
h, apart from the pancreas.<sup><xref ref-type="bibr" rid="ref528">528</xref></sup> In dogs,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetate showed a very fast progression
to diffuse whole-body biodistribution with time with a marked accumulation
in the liver and abdomen 2 min p.i.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetic acid was also evaluated in mouse
models of multiple myeloma and multidrug resistance gene-2 deficient
hepatocellular carcinoma, confirming its ability to detect the presence
of cancer cells and response to therapy <italic toggle="yes">in vivo</italic>.<sup><xref ref-type="bibr" rid="ref526">526</xref>,<xref ref-type="bibr" rid="ref527">527</xref></sup></p></sec><sec id="sec7.1.3"><label>7.1.3</label><title>Clinical Studies</title><p>A preliminary
dynamic whole-body PET on healthy volunteers was performed by Seltzer <italic toggle="yes">et al</italic>. to evaluate [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic
acid&#8217;s biodistribution (<xref rid="fig112" ref-type="fig">Figure <xref rid="fig112" ref-type="fig">112</xref></xref>).<sup><xref ref-type="bibr" rid="ref532">532</xref></sup> At the
early point (2 min p.i.), intense radiotracer uptake was seen in the
salivary glands, heart, pancreas, kidneys, spleen, and bowel. At the
late time point (28 min p.i.), activity has almost completely cleared
from the heart and kidneys, reflecting the rapid oxidative metabolism
of these organs. At the same time, radioactivity is significantly
retained in the salivary glands, pancreas, liver, spleen, and bowel.
The high tracer concentration within the pancreas is due to a high
rate of lipid synthesis within pancreatic acinar cells. No urinary
excretion of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid was detected,
supporting the potential advantage of acetate PET in evaluating pelvic
tumors.<sup><xref ref-type="bibr" rid="ref532">532</xref></sup></p><fig id="fig112" position="float" orientation="portrait"><label>Figure 112</label><caption><p>[<sup>11</sup>C]Acetate
whole-body PET images at 2 min (A) and
28 min (B) p.i. L = liver, H = heart, K = kidney, P = pancreas, SG
= salivary glands, Sp = spleen. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref532">532</xref>). Copyright 2004 Society
of Nuclear Medicine. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr112" position="float" orientation="portrait" xlink:href="cr2c00398_0112.jpg"/></fig><p>Further clinical PET studies in abdominal parenchymal
organs confirmed
the pancreas as the organ with high uptake, with no statistically
significant differences found between the head and body of the organ.<sup><xref ref-type="bibr" rid="ref601">601</xref>,<xref ref-type="bibr" rid="ref602">602</xref></sup> Other studies highlighted a prolonged clearance of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetic acid from the pancreas (roughly 64% of activity
retained 30 min post-injection) with a pancreas-to-liver ratio 10&#8211;20
min post-injection ranging from 2.1 to 4.5, among the normal subjects
studied, also suggesting its potential to evaluate exocrine pancreas
function and disease-related.<sup><xref ref-type="bibr" rid="ref603">603</xref>,<xref ref-type="bibr" rid="ref604">604</xref></sup></p><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetic acid has been exploited
to assess oxidative and lipid metabolism in various tissues, including
the heart, brown adipose tissue, and pancreas, under physio-/pathological
conditions.<sup><xref ref-type="bibr" rid="ref603">603</xref>,<xref ref-type="bibr" rid="ref605">605</xref>&#8722;<xref ref-type="bibr" rid="ref608">608</xref></sup> Furthermore, it was evaluated for the detection/evaluation of peripheral
tumors (prostate cancer or hepatocellular carcinoma).<sup><xref ref-type="bibr" rid="ref609">609</xref>,<xref ref-type="bibr" rid="ref610">610</xref></sup> More recently, it has been evaluated for PET imaging of neurological
disorders such as cerebral glioma and multiple sclerosis.<sup><xref ref-type="bibr" rid="ref611">611</xref>,<xref ref-type="bibr" rid="ref612">612</xref></sup></p></sec></sec><sec id="sec7.2"><label>7.2</label><title>Acetoacetic Acid</title><sec id="sec7.2.1"><label>7.2.1</label><title>Radiosynthesis</title><p>Radiosynthesis of
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic acid (<xref rid="fig113" ref-type="fig">Figure <xref rid="fig113" ref-type="fig">113</xref></xref>) was firstly reported in
1974 from [<sup>11</sup>C]carboxylation in THF of enolate anion of
acetone, previously achieved from the reaction between methyl lithium
and isoprenyl acetate in ether, and the final acidification which
allows reaching [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic acid
in 55% RCY within 40 min from EOB.<sup><xref ref-type="bibr" rid="ref613">613</xref></sup> Further
optimization using an HPLC purification method furnished [1-<sup>11</sup>C]acetoacetic acid with 24&#8211;58% RCY and <italic toggle="yes">A</italic><sub>m</sub> 0.0222 GBq/&#956;mol 30 min after EOB. In contrast, an automated
one-pot synthesis system with an ion-exchange column purification
step provided the final compound within 18 min with 34% RCY.<sup><xref ref-type="bibr" rid="ref534">534</xref>,<xref ref-type="bibr" rid="ref614">614</xref></sup> The same automated procedure with another synthetic module achieved
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic acid with higher <italic toggle="yes">A</italic><sub>m</sub> (66.6 GBq/&#956;mol) with approximately the
same time and RCY (16 min and 35%).<sup><xref ref-type="bibr" rid="ref535">535</xref></sup> Recently,
following a fluorine-mediated desilylation <sup>11</sup>C-labeling
approach, (isopropenyloxy)trimethylsilane was first converted to a
cesium enolate intermediate using cesium fluoride in THF/DMF solution,
and then [<sup>11</sup>C]carboxylated with the final acidification
step, which obtained [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic
acid in 57% RCY within 29 min from [<sup>11</sup>C]CO<sub>2</sub> collection.<sup><xref ref-type="bibr" rid="ref615">615</xref></sup></p><fig id="fig113" position="float" orientation="portrait"><label>Figure 113</label><caption><p>Radiosynthetic schemes of [<sup>11</sup>C]acetoacetic
acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr113" position="float" orientation="portrait" xlink:href="cr2c00398_0113.jpg"/></fig></sec><sec id="sec7.2.2"><label>7.2.2</label><title>Preclinical Studies</title><p>In a female
vervet monkey, 30 min post iv injection, organ biodistribution of
[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic acid demonstrated high
renal clearance with lower uptake in the heart and liver. In the brain,
there was rapid uptake followed by a fast washout.<sup><xref ref-type="bibr" rid="ref535">535</xref></sup> In rats, after 4 min post iv injection, radioactivity in
the heart, liver, kidney, and brain remain constant.<sup><xref ref-type="bibr" rid="ref534">534</xref></sup></p><p>In the cat, the same pattern, with generally higher
uptakes, was observed, except for the heart, where after the initial
peak, a rapid decrease in the first min until a steady state was reached.
Only a very low amount of [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetoacetic
acid was excreted through blood in cats.<sup><xref ref-type="bibr" rid="ref534">534</xref></sup></p></sec><sec id="sec7.2.3"><label>7.2.3</label><title>Clinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Acetoacetic acid revealed a promising radiotracer
for detecting heart failure and assessing cardiomyopathy in a rat
model.<sup><xref ref-type="bibr" rid="ref536">536</xref></sup> Furthermore, it could be helpful
in imaging tissue with a high metabolic rate (tumors or brain), where
ketone bodies were used instead of glucose and following how ketone
metabolism changed in health and disease.<sup><xref ref-type="bibr" rid="ref537">537</xref>&#8722;<xref ref-type="bibr" rid="ref542">542</xref></sup></p></sec></sec><sec id="sec7.3"><label>7.3</label><title>Acetone</title><sec id="sec7.3.1"><label>7.3.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Acetone
was obtained through the reaction of [<sup>11</sup>C]CO<sub>2</sub> with methyl lithium in ether (<xref rid="fig114" ref-type="fig">Figure <xref rid="fig114" ref-type="fig">114</xref></xref>). The excess methyl lithium was further
quenched to avoid excess formation of byproduct [<sup>11</sup>C]<italic toggle="yes">tert</italic>-butanol. In this way, [<sup>11</sup>C]acetone was obtained
in 30 min with <italic toggle="yes">A</italic><sub>m</sub> of 37 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref616">616</xref></sup> Further optimization, by adding diphenylamine
as a quenching reagent, increased the yield to 100% of [<sup>11</sup>C]acetone, making it suitable for iv administration.<sup><xref ref-type="bibr" rid="ref617">617</xref></sup> In the end, there are two quenching steps:
the first with diphenylamine to neutralize methyl lithium in excess,
while the second with acid water to quench lithium diphenylamide <sup>11</sup>C-labeled lithium olate complex. [<sup>11</sup>C]Acetone
obtained in this way was further achieved with 54% RCY.<sup><xref ref-type="bibr" rid="ref486">486</xref></sup></p><fig id="fig114" position="float" orientation="portrait"><label>Figure 114</label><caption><p>Radiosynthetic scheme of [<sup>11</sup>C]acetone. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr114" position="float" orientation="portrait" xlink:href="cr2c00398_0114.jpg"/></fig></sec><sec id="sec7.3.2"><label>7.3.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Acetone iv injected in baboons revealed a fast uptake in the brain,
followed by a slow clearance after 60 min in the cerebellum and white
matter.<sup><xref ref-type="bibr" rid="ref543">543</xref></sup></p></sec></sec><sec id="sec7.4"><label>7.4</label><title>Arachidonic Acid</title><sec id="sec7.4.1"><label>7.4.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid was synthesized starting from a <italic toggle="yes">1</italic>-bromo precursor, activated by reacting the corresponding
Grignard reagent with magnesium in ether (<xref rid="fig115" ref-type="fig">Figure <xref rid="fig115" ref-type="fig">115</xref></xref>). [<sup>11</sup>C]CO<sub>2</sub> in helium
was delivered <italic toggle="yes">in situ</italic>, and the reaction was quenched
with NH<sub>4</sub>Cl. Magnesium salts were precipitated, and the
crude was purified, obtaining [<italic toggle="yes">1</italic>-<sup>11</sup>C]arachidonic
acid with 23% RCY at EOS within 35 min from the EOB.<sup><xref ref-type="bibr" rid="ref551">551</xref></sup> Further re-radiosynthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]arachidonic acid reached <italic toggle="yes">A</italic><sub>m</sub>, exceeding
3.70 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref545">545</xref></sup></p><fig id="fig115" position="float" orientation="portrait"><label>Figure 115</label><caption><p>Radiosynthetic schemes
of [<sup>11</sup>C]arachidonic acid. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr115" position="float" orientation="portrait" xlink:href="cr2c00398_0115.jpg"/></fig><p>[<italic toggle="yes">19</italic>-<sup>11</sup>C]Arachidonic
acid was synthesized
starting from bisGrignard reagent through a Cu-mediated reaction with
[<sup>11</sup>C]ethyl iodide and final carbonation with 23% RCY and
1.6 GBq/&#956;mol <italic toggle="yes">A</italic><sub>m</sub> within 52 min (<xref rid="fig115" ref-type="fig">Figure <xref rid="fig115" ref-type="fig">115</xref></xref>).<sup><xref ref-type="bibr" rid="ref552">552</xref></sup></p></sec><sec id="sec7.4.2"><label>7.4.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid administered iv to normocapnic and
hypercapnic monkeys were used to evaluate fatty acids incorporation
in the brain, examining brain PL metabolism.<sup><xref ref-type="bibr" rid="ref544">544</xref></sup> Brain uptake reached a maximum of 10 min p.i. with around 0.51%
of the injected dose and remained constant in this steady-state for
45 min. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid showed
a plasmatic half-life of only 1.1 min associated with plasma radioactivity
falling at 5% by 10 min after infusion. The latter is due to its rapid
incorporation in brain lipids with fast peripheric wash-out for oxidative
lipid metabolism. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid
brain incorporation rates are 20&#8211;40% higher in the whole brain
and cortex than in white matter. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid brain incorporation rates (<italic toggle="yes">k</italic>*)
are not dependent on cerebral blood flow, so much so that incorporation
rate (<italic toggle="yes">k*</italic>) is unaffected by 2.6 increment of CBF due
to inhaling 5% CO<sub>2</sub> in the air because of the high amount
of fatty acids bound to plasma protein.<sup><xref ref-type="bibr" rid="ref544">544</xref></sup></p></sec><sec id="sec7.4.3"><label>7.4.3</label><title>Clinical Studies</title><p>Several methods
and strategies were attempted to evaluate radiolabeled arachidonic
acid uptake and metabolism in the brain. Based on the irreversible
uptake model derived from rat studies, the <italic toggle="yes">k</italic>* was
evaluated in healthy adults at rest, equaling 5.6 and 2.6 &#956;L/min&#183;mL
in grey and white matter, respectively, plateauing at 15 min, remaining
constant from 20 to 60 min.<sup><xref ref-type="bibr" rid="ref546">546</xref></sup> Further
PET analysis also revealed that [<italic toggle="yes">1</italic>-<sup>11</sup>C]arachidonic
acid&#8217;s brain incorporation rate is not affected by age.<sup><xref ref-type="bibr" rid="ref547">547</xref></sup> A PET study on [<italic toggle="yes">1</italic>-<sup>11</sup>C]arachidonic acid revealed how proper visual stimulation increases
its <italic toggle="yes">k</italic>* around 2&#8211;8% in visual and related areas
of the human brain, confirming arachidonic acid&#8217;s pivotal role
in cellular signaling processes.<sup><xref ref-type="bibr" rid="ref548">548</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid&#8217;s half-life in
plasma was evaluated around 20 min. More patient-friendly and non-invasive
methods, <italic toggle="yes">i.e</italic>., population-based metabolite correction
and image-derived input function, than common arterial blood-based
ones to evaluate [<italic toggle="yes">1</italic>-<sup>11</sup>C]arachidonic acid&#8217;s <italic toggle="yes">k*</italic> were developed, retaining comparable repeatability and
validity.<sup><xref ref-type="bibr" rid="ref549">549</xref></sup></p><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid uptake was evaluated in eight Alzheimer&#8217;s
disease (AD) patients, showing higher brain uptake compared to healthy
control, particularly in areas with a high density of neuritic plaques
and activated microglia.<sup><xref ref-type="bibr" rid="ref545">545</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Arachidonic acid was also used to visualize perturbation
in dopamine neurotransmission, opening opportunities for further related
disease PET studies.<sup><xref ref-type="bibr" rid="ref550">550</xref></sup></p></sec></sec><sec id="sec7.5"><label>7.5</label><title>Azelaic, Sebacic, and Suberic Acids</title><sec id="sec7.5.1"><label>7.5.1</label><title>Radiosynthesis</title><p>The <sup>11</sup>C-labeling of suberic, azelaic, and sebacic acids was developed using
[<sup>11</sup>C]NH<sub>4</sub>CN as a radioactive synthon. A dibromoalkane
derivative (<xref rid="fig116" ref-type="fig">Figure <xref rid="fig116" ref-type="fig">116</xref></xref>) was initially converted into the corresponding bromonitrile derivative
by reaction with NaCN in refluxing 2-propanol for 24 h (33&#8211;35%).
[<sup>11</sup>C]NH<sub>4</sub>CN was prepared by reduction of [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]CH<sub>4</sub> over nickel
catalysis and subsequent reaction with ammonia gas in a palladium
furnace (<xref rid="fig116" ref-type="fig">Figure <xref rid="fig116" ref-type="fig">116</xref></xref>). [<sup>11</sup>C]NH<sub>4</sub>CN was then added to the bromonitrile
analogue and reacted in DMSO and in the presence of potassium hydroxide
for 5 min at 140 &#176;C to produce the corresponding <sup>11</sup>C-labeled dinitrile species (<xref rid="fig116" ref-type="fig">Figure <xref rid="fig116" ref-type="fig">116</xref></xref>) with non-isolated RCYs of 83&#8211;90%
(calculated by radioTLC). The <sup>11</sup>C-dinitrile intermediate
was then hydrolyzed to the desired <sup>11</sup>C-carboxylic acid
by aqueous NaOH at 140 &#176;C for 5 min. The total synthesis time
was 60 min from EOB, and all three products were obtained with isolated
RCYs ranging between 30 and 40% (relative to trapped [<sup>11</sup>C]NH<sub>4</sub>CN) and <italic toggle="yes">A</italic><sub>m</sub> of 15 GBq/&#956;mol
(calculated only for [<italic toggle="yes">1</italic>-<sup>11</sup>C]azelaic acid).<sup><xref ref-type="bibr" rid="ref553">553</xref></sup></p><fig id="fig116" position="float" orientation="portrait"><label>Figure 116</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]suberic acid (<italic toggle="yes">n</italic> = 4), [<italic toggle="yes">1</italic>-<sup>11</sup>C]azelaic acid
(<italic toggle="yes">n</italic> = 5), and [<italic toggle="yes">1</italic>-<sup>11</sup>C]sebacic
acid (<italic toggle="yes">n</italic> = 6) using [<sup>11</sup>C]NH<sub>4</sub>CN. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr116" position="float" orientation="portrait" xlink:href="cr2c00398_0116.jpg"/></fig></sec></sec><sec id="sec7.6"><label>7.6</label><title>Butyric and Isobutyric Acids</title><sec id="sec7.6.1"><label>7.6.1</label><title>Radiosynthesis</title><p>There are two strategies
to radiolabel butyric acid with carbon-11. The first one was proposed
in 1997 to radiolabel butyric acid in position 4 (<xref rid="fig117" ref-type="fig">Figure <xref rid="fig117" ref-type="fig">117</xref></xref>). [<sup>11</sup>C]CH<sub>3</sub>I reacted with <italic toggle="yes">3</italic>-iodopropionic acid <italic toggle="yes">tert</italic>-butyl ester and copper complex, then heated for 1 min
at 70 &#176;C, cooled rapidly at 0 &#176;C, and deprotection with
trifluoroacetic acid occurred. The mixture was heated for 5 min at
70 &#176;C and purified through solid-phase extraction and semipreparative
HPLC. In this way, [4-<sup>11</sup>C]butyric acid was obtained within
45 min from the end of radionuclide production with 64 &#177; 7% isolated
RCY.<sup><xref ref-type="bibr" rid="ref557">557</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Butyric acid and [<italic toggle="yes">1</italic>-<sup>11</sup>C]isobutyric
acid was obtained using the corresponding Grignard reagent and [<sup>11</sup>C]CO<sub>2</sub> in anhydrous ether (<xref rid="fig117" ref-type="fig">Figure <xref rid="fig117" ref-type="fig">117</xref></xref>). After carbonation, Grignard reagents
were hydrolyzed under acidic conditions, and the [<sup>11</sup>C]carboxylic
acids obtained were ultimately treated with a 6% aqueous solution
of sodium bicarbonate to achieve the corresponding [<sup>11</sup>C]carboxylates.
Total synthesis time from adding HCl to Grignard to the reformulation
was 15&#8211;20 min, achieving 98% and 96% RCY for [<italic toggle="yes">1</italic>-<sup>11</sup>C]butyrate and [<italic toggle="yes">1</italic>-<sup>11</sup>C]isobutyrate,
respectively, with an average yield of 2812 MBq.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> Actually, [<italic toggle="yes">1</italic>-<sup>11</sup>C]butyric acid
radiolabeling was first reported in 1943 by Buchanan <italic toggle="yes">et al</italic>. through [<sup>11</sup>C]CO<sub>2</sub> fixation with Grignard reagent
but without further experimental details.<sup><xref ref-type="bibr" rid="ref554">554</xref></sup> Similarly, [<sup>11</sup>C]CO<sub>2</sub> was passed through a helium
stream into a solution of propyl magnesium chloride in THF at 25&#176;C,
then quenched with water, hydrochloric acid, and NaOH solution subsequentially
to obtain [<italic toggle="yes">1</italic>-<sup>11</sup>C]butyric acid in 40 min
from the EOB to the final formulation. The isolated RCY ranged 31&#8211;50%,
and the <italic toggle="yes">A</italic><sub>m</sub> was 7.4&#8211;37 GBq/&#956;mol
at EOB.<sup><xref ref-type="bibr" rid="ref555">555</xref></sup></p><fig id="fig117" position="float" orientation="portrait"><label>Figure 117</label><caption><p>Synthesis of [<sup>11</sup>C]butyric and [<sup>11</sup>C]isobutyric
acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr117" position="float" orientation="portrait" xlink:href="cr2c00398_0117.jpg"/></fig></sec><sec id="sec7.6.2"><label>7.6.2</label><title>Preclinical Studies</title><p>In dog iv,
injection of [<sup>11</sup>C]butyrate and [<sup>11</sup>C]isobutyrate
showed high uptake in the liver and abdomen within 2&#8211;4 min
p.i., mimicking physiologic lipid storage site distribution. [<sup>11</sup>C]Isobutyrate activity in the heart gradually increased over
time, reaching a homogenous whole-body distribution at 30 min.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> In white rats, [<sup>11</sup>C]butyric acid
was administered along with glucose to evaluate liver glycogen formation.
Radioactivity of expired [<sup>11</sup>C]CO<sub>2</sub> demonstrated
that it is metabolized within 30 min. Furthermore, 55% of the total
radioactivity of liver glycogen was accounted for [<sup>11</sup>C]CO<sub>2</sub> incorporation, indicating that [<sup>11</sup>C]butyrate should
also be metabolized <italic toggle="yes">via</italic> the carbohydrate pathway.<sup><xref ref-type="bibr" rid="ref554">554</xref></sup> More recently, [<sup>11</sup>C]butyric acid
was injected into six female baboons by radial vein, then scanned
over 90 min using PET imaging. The plasma analysis showed rapid metabolism
and fast clearance as the percentage of the unchanged [<sup>11</sup>C]butyric acid in plasma dropped to less than 20% within 5 min p.i.
Biodistribution studies showed high [<sup>11</sup>C]butyric acid uptake
in the pancreas, kidney, spleen, liver, and vertebrae and very low
uptake in the heart (<xref rid="fig118" ref-type="fig">Figure <xref rid="fig118" ref-type="fig">118</xref></xref>). Very low activity was registered in the brain, which
peaked at 10 min.<sup><xref ref-type="bibr" rid="ref555">555</xref></sup></p><fig id="fig118" position="float" orientation="portrait"><label>Figure 118</label><caption><p>Thorax and abdomen
(A) and brain (B) PET images of [<sup>11</sup>C]butyric acid (30&#8211;90
min p.i.). pc = pancreas, k = kidneys,
sp = spleen, liv = liver, vt = vertebrae, and hrt = heart. Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref555">555</xref>). Copyright 2013 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr118" position="float" orientation="portrait" xlink:href="cr2c00398_0118.jpg"/></fig></sec><sec id="sec7.6.3"><label>7.6.3</label><title>Clinical Studies</title><p>[<sup>11</sup>C]Butyrate was evaluated in 32 male patients (mean age 45 &#177;
8 yrs) with coronary artery disease and regional left ventricular
dysfunction to assess the affected tissues&#8217; oxidative metabolism.
[<sup>11</sup>C]Butyrate was iv injected in fasted patients demonstrating
fast elimination in myocardial segments with normal oxidative metabolism,
whereas, in the ischemic region, an increased uptake was registered
after 23&#8211;30 min. Furthermore, it allowed visualizing myocardial
viability in several dysfunctional segments in the presence of oxidative
events.<sup><xref ref-type="bibr" rid="ref556">556</xref></sup> Furthermore, [<sup>11</sup>C]butyrate
iv injected in 24 postoperative patients with brain tumors (15 male
and 9 female, mean age 41 &#177; 12 years) has allowed detection and
differential diagnosis of benign and malignant brain tumors and monitoring
efficacy of therapy.<sup><xref ref-type="bibr" rid="ref556">556</xref></sup> Lastly, a study
in 27 patients (18 male and 9 female, mean age 41 &#177; 14 years)
has resulted in a significant uptake in adenocarcinomas while benign
lesions and chronic pancreatitis demonstrated significantly decreased
uptake.<sup><xref ref-type="bibr" rid="ref556">556</xref></sup></p></sec></sec><sec id="sec7.7"><label>7.7</label><title>Decanoic Acid</title><sec id="sec7.7.1"><label>7.7.1</label><title>Radiosynthesis</title><p>A solution of <italic toggle="yes">1</italic>,<italic toggle="yes">8</italic>-bis-(bromomagnesium)octane in THF was
added to [<sup>11</sup>C]CH<sub>3</sub>I trapped in a reaction vessel
and Li<sub>2</sub>CuCl<sub>4</sub> in THF. A stream of CO<sub>2</sub> was further introduced, obtaining pure [<italic toggle="yes">10</italic>-<sup>11</sup>C]decanoic acid (<xref rid="fig119" ref-type="fig">Figure <xref rid="fig119" ref-type="fig">119</xref></xref>) after chromatography purification in 44 min with
a RCY of 35%.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><fig id="fig119" position="float" orientation="portrait"><label>Figure 119</label><caption><p>Radiosynthetic schemes
of [<italic toggle="yes">10</italic>-<sup>11</sup>C]decanoic
acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr119" position="float" orientation="portrait" xlink:href="cr2c00398_0119.jpg"/></fig></sec></sec><sec id="sec7.8"><label>7.8</label><title>Docosahexaenoic Acid</title><sec id="sec7.8.1"><label>7.8.1</label><title>Radiosynthesis</title><p>To a solution of <italic toggle="yes">1</italic>-bromomagnesium heneicosa-<italic toggle="yes">3</italic>,<italic toggle="yes">6</italic>,<italic toggle="yes">9</italic>,<italic toggle="yes">12</italic>,<italic toggle="yes">15</italic>,<italic toggle="yes">18</italic>-hexaene in diethyl ether was delivered [<sup>11</sup>C]CO<sub>2</sub> in helium. Unreacted gases were trapped on molecular
sieves, and a solution of ammonium chloride was added to quench the
reaction. After purification through the extraction column, pure [<italic toggle="yes">1</italic>-<sup>11</sup>C]docosahexaenoic acid (<xref rid="fig120" ref-type="fig">Figure <xref rid="fig120" ref-type="fig">120</xref></xref>) in less than 43 min with
a RCY of 15.9&#8211;18.3% from EOS.<sup><xref ref-type="bibr" rid="ref551">551</xref></sup> It was further synthesized as described with a <italic toggle="yes">A</italic><sub>m</sub> &gt; 18.5 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref559">559</xref></sup></p><fig id="fig120" position="float" orientation="portrait"><label>Figure 120</label><caption><p>Radiosynthetic schemes of [1-<sup>11</sup>C]docosahexaenoic acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr120" position="float" orientation="portrait" xlink:href="cr2c00398_0120.jpg"/></fig></sec><sec id="sec7.8.2"><label>7.8.2</label><title>Preclinical Studies</title><p>In monkeys
[<italic toggle="yes">1</italic>-<sup>11</sup>C]docosahexaenoic acid was injected
iv, and rapid uptake in the liver without apparent washout over 2
h was observed. No hepatobiliary excretion was registered, while elimination <italic toggle="yes">via</italic> urine was moderate. The highest uptake was observed
in the liver, heart, kidney, gall bladder, spleen, and lungs. A small
amount of activity was seen in the brain, accounting only for 0.5%
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]docosahexaenoic acid injected
(<xref rid="fig121" ref-type="fig">Figure <xref rid="fig121" ref-type="fig">121</xref></xref>).<sup><xref ref-type="bibr" rid="ref559">559</xref></sup></p><fig id="fig121" position="float" orientation="portrait"><label>Figure 121</label><caption><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Docosahexaenoic
acid whole-body
summed retention in monkeys (0-6 min p.i.). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref559">559</xref>). Copyright
2008 American Society for Biochemistry and Molecular Biology. This
work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr121" position="float" orientation="portrait" xlink:href="cr2c00398_0121.jpg"/></fig></sec><sec id="sec7.8.3"><label>7.8.3</label><title>Clinical Studies</title><p>In healthy humans,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]docosahexaenoic acid demonstrated
slow plasma metabolism: from 87% unchanged radiotracer 5 min p.i.
to 35% after 60 min. The net incorporation rate of docosahexaenoic
acid into the whole brain was equivalent to a consumption rate of
3.8 mg/day.<sup><xref ref-type="bibr" rid="ref559">559</xref>,<xref ref-type="bibr" rid="ref560">560</xref></sup></p></sec></sec><sec id="sec7.9"><label>7.9</label><title>Dodecanoic Acid</title><sec id="sec7.9.1"><label>7.9.1</label><title>Radiosynthesis</title><p>Dodecanoic acid
has been labeled with <sup>11</sup>C in the <italic toggle="yes">1</italic>- and <italic toggle="yes">12</italic>- positions. However, the chemistry for the labeling in
position <italic toggle="yes">1</italic>- is not described. Regarding position <italic toggle="yes">12</italic>-, a solution of <italic toggle="yes">1</italic>,<italic toggle="yes">10</italic>-bis-(bromomagnesium)decane in THF was added to [<sup>11</sup>C]CH<sub>3</sub>I trapped in a reaction vessel and Li<sub>2</sub>CuCl<sub>4</sub> in THF. A stream of CO<sub>2</sub> was further introduced,
obtaining pure [<italic toggle="yes">12</italic>-<sup>11</sup>C]dodecanoic acid
(<xref rid="fig122" ref-type="fig">Figure <xref rid="fig122" ref-type="fig">122</xref></xref>) after
chromatography purification in 45 min with a RCY of 28%.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><fig id="fig122" position="float" orientation="portrait"><label>Figure 122</label><caption><p>Synthesis of [<italic toggle="yes">12</italic>-<sup>11</sup>C]dodecanoic acid
using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr122" position="float" orientation="portrait" xlink:href="cr2c00398_0122.jpg"/></fig></sec><sec id="sec7.9.2"><label>7.9.2</label><title>Preclinical Studies</title><p>In pigs, [<italic toggle="yes">12</italic>-<sup>11</sup>C]dodecanoic acid was used to evaluate myocardial
energy metabolism due to its involvement in the TCA cycle and <italic toggle="yes">&#946;</italic>-oxidation processes. It was rapidly cleared from
the blood: at 1 min after iv injection, only 10% of radioactivity
was found in arterial blood. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Dodecanoic
acid shows slower wash-out kinetics compared to [<italic toggle="yes">12</italic>-<sup>11</sup>C]dodecanoic acid due to the different metabolic pathways.
The myocardial concentration was around 10 times the amount of tracer
administered per gram of body weight, irrespective of labeling position.
These tracers&#8217; kinetics are directly related to cardiac workload
and indistinguishable from that of [<sup>11</sup>C]acetate.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Due to the rapid clearance of the tracer, 90%
of the uptake occurs in the first 2 min p.i.<sup><xref ref-type="bibr" rid="ref561">561</xref></sup></p></sec></sec><sec id="sec7.10"><label>7.10</label><title>Formic Acid</title><sec id="sec7.10.1"><label>7.10.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Formic
acid was first synthesized in 1942 as an intermediate in [<sup>11</sup>C]CH<sub>3</sub>I synthesis by enzymatic reduction of [<sup>11</sup>C]CO<sub>2</sub> using formate dehydrogenase present in a suspension
of <italic toggle="yes">Escherichia coli</italic> bacteria.<sup><xref ref-type="bibr" rid="ref618">618</xref></sup> [<sup>11</sup>C]Formic acid synthesis did not
receive further attention until 2001 when Roeda <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref507">507</xref></sup> investigated the product distribution
obtained from the reaction of [<sup>11</sup>C]CO<sub>2</sub> with
lithium aluminum hydride at varying temperatures (<xref rid="fig123" ref-type="fig">Figure <xref rid="fig123" ref-type="fig">123</xref></xref>).<sup><xref ref-type="bibr" rid="ref507">507</xref></sup> This reaction, commonly used to make [<sup>11</sup>C]CH<sub>3</sub>OH as an intermediate in &#8220;wet method&#8221; [<sup>11</sup>C]CH<sub>3</sub>I synthesis,<sup><xref ref-type="bibr" rid="ref619">619</xref></sup> was found
to produce significant amounts of [<sup>11</sup>C]formic acid, especially
at low temperatures. Between &#8722;50&#176;C and &#8722;20&#176;C,
[<sup>11</sup>C]formic acid was formed immediately in a RCY of 80&#8211;90%,
with the remainder of the activity present as [<sup>11</sup>C]formaldehyde
(&lt;20%) and [<sup>11</sup>C]CH<sub>3</sub>OH (&lt;5%).<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref507">507</xref></sup> At &#8722;10 &#176;C and above, the [<sup>11</sup>C]CH<sub>3</sub>OH yields increase with increasing temperature at the expense of
[<sup>11</sup>C]formic acid, while [<sup>11</sup>C]CH<sub>2</sub>O
levels increase to &#8764;20% and remain almost constant. Longer
reaction times did not have a significant effect on the product distribution.</p><fig id="fig123" position="float" orientation="portrait"><label>Figure 123</label><caption><p>Radiosynthesis
of [<sup>11</sup>C]formic acid. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr123" position="float" orientation="portrait" xlink:href="cr2c00398_0123.jpg"/></fig><p>To further improve the yield of [<sup>11</sup>C]formic
acid, Roeda <italic toggle="yes">et al</italic>. found that using the weaker reducing
agent LiEt<sub>3</sub>BH succeeded in converting [<sup>11</sup>C]CO<sub>2</sub> to
[<sup>11</sup>C]formic acid virtually quantitatively at &#8722;10
&#176;C.<sup><xref ref-type="bibr" rid="ref507">507</xref>,<xref ref-type="bibr" rid="ref508">508</xref></sup> This reaction proceeded instantaneously
to produce [<sup>11</sup>C]formate in a RCY &gt;98% and <italic toggle="yes">A</italic><sub>m</sub> of 9 GBq/&#956;mol (corrected to EOB). This reagent
has been utilized as a <sup>11</sup>C-formulating agent,<sup><xref ref-type="bibr" rid="ref509">509</xref>&#8722;<xref ref-type="bibr" rid="ref511">511</xref></sup> and as a precursor to radiolabeling reagents [<sup>11</sup>C]CO
and [<sup>11</sup>C]CH<sub>3</sub>OH.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p></sec></sec><sec id="sec7.11"><label>7.11</label><title>Hexanoic Acid</title><sec id="sec7.11.1"><label>7.11.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Hexanoic acid was prepared from [<sup>11</sup>C]carboxylation
of pentylmagnesium bromide 2M in diethyl ether at &#8722;40 &#176;C,
following later acidification with HCl and a final liquid extraction
with diethyl ether. Subsequent evaporation and dissolution into a
saline solution made [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoic acid
ready for a biological test. In this way, it was obtained with 28%
RCY as a sodium salt.<sup><xref ref-type="bibr" rid="ref514">514</xref></sup> An automated procedure
exploiting final cartridge purification instead of liquid extraction
and using 1M solution of pentylmagnesium bromide in THF at 5&#8211;12
&#176;C achieved a RCY of 71% within 15 min from the end of irradiation.<sup><xref ref-type="bibr" rid="ref563">563</xref></sup> [<italic toggle="yes">6</italic>-<sup>11</sup>C]Hexanoic
acid (<xref rid="fig124" ref-type="fig">Figure <xref rid="fig124" ref-type="fig">124</xref></xref>)
was obtained from the bis-Grignard reagent in a two-step procedure:
[<sup>11</sup>C]methylation in THF using thienyl cuprate at &#8722;72
&#176;C and the following carbonation with CO<sub>2</sub>. After evaporation
and column purification, [<italic toggle="yes">6</italic>-<sup>11</sup>C]hexanoic
acid was obtained with a RCY of 36% in 47 min from EOB.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><fig id="fig124" position="float" orientation="portrait"><label>Figure 124</label><caption><p>Synthesis of [<sup>11</sup>C]hexanoic acid
using [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr124" position="float" orientation="portrait" xlink:href="cr2c00398_0124.jpg"/></fig></sec><sec id="sec7.11.2"><label>7.11.2</label><title>Preclinical Studies</title><p>In mice after
iv injection, [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoic acid was
mainly uptake in kidneys (6.14%ID/g at 5 min), followed by spleen,
pancreas, lungs, liver, brain, and heart. It had a fast washout in
all organs except the pancreas (3.51%ID/g at 90 min). A high percentage
of tracer was excreted into urine (4.0%ID/g at 90 min). In the heart
and plasma, there was a peak immediately after injection and a fast
decrease in radioactivity. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Hexanoic
acid was more retained in the brain with a brain-to-plasma ratio increasing
for the first 5 min, constant until 30 min, and then decreased.<sup><xref ref-type="bibr" rid="ref514">514</xref></sup> At 3 min post iv injection in the brain, there
was almost no traces of unmetabolized [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoic acid, with 9% of [<sup>11</sup>C]CO<sub>2</sub>/HCO<sub>3</sub><sup>&#8211;</sup> and a high percentage of glutamate/glutamine
metabolites.<sup><xref ref-type="bibr" rid="ref513">513</xref></sup> In starvation/fasting conditions,
a higher uptake in both brain and heart was registered.<sup><xref ref-type="bibr" rid="ref513">513</xref>,<xref ref-type="bibr" rid="ref514">514</xref></sup> In cat brain, an increasing uptake in the brain of [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoic acid was registered in the first 2 min,
followed by a fast decrease and a second peak at 7&#8211;10 min after
iv injection with a final gradual washout (<xref rid="fig125" ref-type="fig">Figure <xref rid="fig125" ref-type="fig">125</xref></xref>). At the same time, in blood at 5 min,
there was almost no parent radiotracer present, but only [<sup>11</sup>C]CO<sub>2</sub>/HCO<sub>3</sub><sup>&#8211;</sup>. These findings
suggest that the second phase of brain activity uptake could be due
to the [<sup>11</sup>C]CO<sub>2</sub>/HCO<sub>3</sub><sup>&#8211;</sup> from the periphery.<sup><xref ref-type="bibr" rid="ref562">562</xref></sup> In dogs, [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoate showed significant uptake in
the liver, kidney, and abdomen within 3 min p.i., followed by a homogenous
whole-body distribution after 1 h.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p><fig id="fig125" position="float" orientation="portrait"><label>Figure 125</label><caption><p>PET
images of cat brain acquired with [<sup>15</sup>O]labeled water,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoate (within 2 and 5 min),
and [<italic toggle="yes">1</italic>-<sup>11</sup>C]hexanoate (within 5 and 10
min). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref562">562</xref>). Copyright 1996 Springer Nature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr125" position="float" orientation="portrait" xlink:href="cr2c00398_0125.jpg"/></fig></sec></sec><sec id="sec7.12"><label>7.12</label><title>Linoleic Acid</title><sec id="sec7.12.1"><label>7.12.1</label><title>Radiosynthesis</title><p>Radiosynthesis
of [<italic toggle="yes">18</italic>-<sup>11</sup>C]linoleic acid was performed <italic toggle="yes">via</italic> a coupling reaction between unsaturated <italic toggle="yes">17</italic>-iodo heptadecanoic acid with carboxylic function protected as a <italic toggle="yes">tert</italic>-butyl ester (<xref rid="fig126" ref-type="fig">Figure <xref rid="fig126" ref-type="fig">126</xref></xref>). It was treated with copper complex as the coupling
agent and [<sup>11</sup>C]CH<sub>3</sub>I, with final cleavage of
acid function using trifluoroacetate. [<italic toggle="yes">18</italic>-<sup>11</sup>C]Linoleic acid was obtained with 36&#8211;48% isolated RCY, <italic toggle="yes">A</italic><sub>m</sub> &#8764;20 GBq/&#956;mol within 45 min from
EOB.<sup><xref ref-type="bibr" rid="ref564">564</xref></sup></p><fig id="fig126" position="float" orientation="portrait"><label>Figure 126</label><caption><p>Radiosynthetic scheme of [<italic toggle="yes">18</italic>-<sup>11</sup>C]linoleic
acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr126" position="float" orientation="portrait" xlink:href="cr2c00398_0126.jpg"/></fig></sec></sec><sec id="sec7.13"><label>7.13</label><title>Octanoic Acid</title><sec id="sec7.13.1"><label>7.13.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Octanoic acid (<xref rid="fig127" ref-type="fig">Figure <xref rid="fig127" ref-type="fig">127</xref></xref>) was obtained from carboxylation of a
Grignard reagent (heptyl magnesium bromide) in THF and the following
acidification with HCl. Final purification through liquid extraction
with ether and reformulation with saline made it feasible for further
biological evaluation.<sup><xref ref-type="bibr" rid="ref620">620</xref></sup> Automated procedures
with an HPLC purification instead of liquid extraction were developed,
achieving pure [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid within
40 min from EOB.<sup><xref ref-type="bibr" rid="ref621">621</xref>,<xref ref-type="bibr" rid="ref622">622</xref></sup> Purification with cation-exchange
resin allows achieving a RCY of 68% within 15 min.<sup><xref ref-type="bibr" rid="ref563">563</xref></sup> Modifications, such as using ether as solvent at 35&#176;C
or exploiting a tube-based method produced [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid with a RCY of 64% within 35 min and 37% in
30 min, respectively.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><fig id="fig127" position="float" orientation="portrait"><label>Figure 127</label><caption><p>Radiosynthetic schemes
of [<sup>11</sup>C]octanoic acid using [<sup>11</sup>C]CO<sub>2</sub>, [<sup>11</sup>C]CH<sub>3</sub>I, or [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>CH<sub>2</sub>I. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr127" position="float" orientation="portrait" xlink:href="cr2c00398_0127.jpg"/></fig><p>[<italic toggle="yes">8</italic>-<sup>11</sup>C]Octanoic acid
and [<italic toggle="yes">7</italic>-<sup>11</sup>C]octanoic acid were achieved
after [<sup>11</sup>C]alkylation
of the appropriate bis-Grignard reagent (<xref rid="fig127" ref-type="fig">Figure <xref rid="fig127" ref-type="fig">127</xref></xref>) in THF using dilithium tetrachlorocuprate
as the catalyst and final carbonation using CO<sub>2</sub>. [<italic toggle="yes">8</italic>-<sup>11</sup>C]Octanoic acid and [<italic toggle="yes">7</italic>-<sup>11</sup>C]octanoic acid were obtained within 44 and 52 min from EOB
with 32% and 23% RCY, respectively.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p></sec><sec id="sec7.13.2"><label>7.13.2</label><title>Preclinical Studies</title><p>In rats, 60
min after [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid iv injection,
high radioactivity was detected in the liver, kidneys, harderian glands,
and submaxillary glands. Lower activity was detected in the brain.<sup><xref ref-type="bibr" rid="ref566">566</xref></sup> In cats, activity was rapidly cleared from
the blood, while in the brain, there was a transient peak immediately
after injection and a second peak 5&#8211;10 min later with a gradual
decline. In cats, the highest radioactivity was registered in submaxillary
glands.<sup><xref ref-type="bibr" rid="ref566">566</xref></sup> In healthy mice, [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid was highly retained in kidneys with
a fast washout, followed by heart, lung, blood, and liver. In the
liver, it was mainly taken up in parenchymal cells (98% of total liver
activity 5 min p.i.), and most of the radioactivity was extracted
in an aqueous layer, suggesting metabolization through &#946;-oxidation
instead of more lipophilic esterification.<sup><xref ref-type="bibr" rid="ref565">565</xref></sup> In rats, [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid rapidly
entered the brain, followed by a slow washout, with a brain-to-blood
ratio increasing over time. In the brain, it is metabolically trapped,
possibly as glutamine or glutamate. At 0.5 min p.i., only 8% parent
compound remained in the blood (<xref rid="fig128" ref-type="fig">Figure <xref rid="fig128" ref-type="fig">128</xref></xref>).<sup><xref ref-type="bibr" rid="ref567">567</xref></sup> In pigs,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoic acid was used to evaluate
its fractional oxidation and metabolic rate compared to longer fatty
acids, showing a comparatively low concentration in the blood.<sup><xref ref-type="bibr" rid="ref561">561</xref></sup> In dogs, [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoate
showed marked activity in the liver and abdomen within 4 min, with
initial and prolonged retention in the lungs, probably due to trapping
in lipoprotein membranes of the alveolar capillary.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p><fig id="fig128" position="float" orientation="portrait"><label>Figure 128</label><caption><p>Radioactivity retention and reactive oxygen intermediates
of [<sup>15</sup>O]H<sub>2</sub>O (0&#8211;2 min) and [<italic toggle="yes">1</italic>-<sup>11</sup>C]octanoate (5&#8211;15 min) in rats brain with (B)
or without (A) focal cerebral ischemia recorded 1&#8211;2 h (a),
3&#8211;4 h (b), and 5&#8211;6 h (c) after middle cerebral artery
occlusion. Arrows show reduced radioactivity in the lesioned (right)
hemisphere. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref570">570</xref>). Copyright 2000 Springer
Nature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr128" position="float" orientation="portrait" xlink:href="cr2c00398_0128.jpg"/></fig></sec><sec id="sec7.13.3"><label>7.13.3</label><title>Clinical Studies</title><p>Only one preliminary
PET study in a healthy volunteer was performed, revealing a clear
image of the liver with a rapid hepatic clearance in two phases.<sup><xref ref-type="bibr" rid="ref565">565</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Octanoic
acid was a potential imaging agent for cerebral ischemia in rat and
canine models and to evaluate the pathophysiology of thromboembolic
stroke in a canine model. At the same time, it was determined not
to be useful for imaging myocardial ischemia in dogs.<sup><xref ref-type="bibr" rid="ref568">568</xref>&#8722;<xref ref-type="bibr" rid="ref570">570</xref></sup></p></sec></sec><sec id="sec7.14"><label>7.14</label><title>Oleic and Stearic Acid</title><sec id="sec7.14.1"><label>7.14.1</label><title>Radiosynthesis</title><p>In 1975, Poe <italic toggle="yes">et al</italic>. radiolabeled stearic acid and oleic acid at the <sup>11</sup>C-carboxyl position by reacting the appropriate long-chain
Grignard reagent with [<sup>11</sup>C]CO<sub>2</sub> (<xref rid="fig129" ref-type="fig">Figure <xref rid="fig129" ref-type="fig">129</xref></xref>A).<sup><xref ref-type="bibr" rid="ref519">519</xref></sup> In this process, [<sup>11</sup>C]CO<sub>2</sub> was bubbled through
the Grignard reagent for 20 min until radioactive equilibrium was
reached, producing between 70&#8211;260 MBq of the <sup>11</sup>C-fatty
acid. Purification techniques and product purities were not discussed.</p><fig id="fig129" position="float" orientation="portrait"><label>Figure 129</label><caption><p>Synthesis
of [<sup>11</sup>C]oleic acid and [<sup>11</sup>C]stearic
acid using [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]NaCN. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr129" position="float" orientation="portrait" xlink:href="cr2c00398_0129.jpg"/></fig><p>An alternative radiosynthetic route to <sup>11</sup>C-fatty acids
that does not require Grignard reagents was described by Takahashi <italic toggle="yes">et al</italic>. in 1990.<sup><xref ref-type="bibr" rid="ref571">571</xref></sup> Utilizing
[<sup>11</sup>C]NaCN as the radiolabeling reagent, alkyl bromides
were converted to the corresponding <sup>11</sup>C-alkyl nitrile,
which was then hydrolyzed using acid or base to produce the <sup>11</sup>C-fatty acid (<xref rid="fig129" ref-type="fig">Figure <xref rid="fig129" ref-type="fig">129</xref></xref>B). Purification was performed using a C18 Sep-Pak cartridge.
In a process lasting about 50 min, [<sup>11</sup>C]oleic acid and
[<sup>11</sup>C]stearic acid were obtained with a RCY of 70&#8211;83%
(based on [<sup>11</sup>C]HCN) and RCP of 93&#8211;98%.</p></sec><sec id="sec7.14.2"><label>7.14.2</label><title>Preclinical Studies</title><p>To evaluate
the potential of radiolabeled fatty acids to measure myocardial blood
flow <italic toggle="yes">in vivo</italic>, Poe <italic toggle="yes">et al</italic>. performed
studies in anesthetized dogs comparing the behavior of <sup>11</sup>C-labelled stearic acid and oleic acid with their <sup>131</sup>I-iodinated
analogues.<sup><xref ref-type="bibr" rid="ref518">518</xref>,<xref ref-type="bibr" rid="ref519">519</xref></sup></p><p>Following direct tracer
injection into the coronary artery, the radioactivity of the heart
was measured using a scintillation detector, enabling the myocardial
retention of each fatty acid to be estimated. Similar myocardial retentions
were observed for [<sup>11</sup>C]stearic acid, [<sup>11</sup>C]oleic
acid, and the terminally iodinated hexadecenoic acid. The radiotracers
were found to clear quickly from the blood, with &lt;20% remaining
at 10 min p.i.<sup><xref ref-type="bibr" rid="ref518">518</xref></sup></p></sec></sec><sec id="sec7.15"><label>7.15</label><title>Palmitic Acid</title><sec id="sec7.15.1"><label>7.15.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid was produced from <italic toggle="yes">n</italic>-pentadecyl magnesium bromide and [<sup>11</sup>C]CO<sub>2</sub> in
diethyl ether. Adding acid to the solution, the Grignard reagent in
excess was quenched, and [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic
acid obtained was solubilized with serum albumin (solution 4% in saline),
providing [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid in injectable
form for the biological test. The entire procedure took 30 min from
the carbonation and produced 400&#8211;700 MBq of [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid starting from 7.4 GBq of [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref584">584</xref>,<xref ref-type="bibr" rid="ref623">623</xref></sup> Further optimizations of this
radiosynthetic procedure allowed increased isolated RCY, Am, and reaction
time.<sup><xref ref-type="bibr" rid="ref576">576</xref>,<xref ref-type="bibr" rid="ref577">577</xref>,<xref ref-type="bibr" rid="ref624">624</xref>&#8722;<xref ref-type="bibr" rid="ref626">626</xref></sup> A remote semiautomated chemical process system developed by Padgett <italic toggle="yes">et al</italic>. with a more accessible product purification, through
column chromatography on acetic acid-treated neutral alumina oxide,
in 30 min synthesis time obtained [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid with <italic toggle="yes">A</italic><sub>m</sub> higher than 0.259
GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref625">625</xref></sup> A captive solvent method
has been exploited using microporous propylene powder or alumina cartridges
to obtain [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid until 74%
isolated RCY.<sup><xref ref-type="bibr" rid="ref624">624</xref></sup> Furthermore, an automated
SPE-based radiosynthesis achieved [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid in 33% isolated RCY within 10 min from [<sup>11</sup>C]CO<sub>2</sub> trapping, which increased in a solid-based method
obtaining [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid in 8 min
from EOB, 38% isolated RCY, and <italic toggle="yes">A</italic><sub>m</sub> of
9.25&#8211;12.95 GBq/&#956;mol and 50% isolated RCY in 15 min using
column extraction method.<sup><xref ref-type="bibr" rid="ref576">576</xref>&#8722;<xref ref-type="bibr" rid="ref578">578</xref></sup> Recently, Amor-Coarasa <italic toggle="yes">et al</italic>. developed a 3D-printed automated synthesis unit able
to produce [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid with 57%
isolated RCY within 6.5 min.<sup><xref ref-type="bibr" rid="ref626">626</xref></sup></p><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid was also synthesized through
[<sup>11</sup>C]HCN addition to precursor <italic toggle="yes">n</italic>-pentadecyl
magnesium bromide with potassium hydroxide in DMSO and final acidic
hydrolysis, achieving [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic
acid in 78% isolated RCY within 58 min from EOB.<sup><xref ref-type="bibr" rid="ref315">315</xref></sup></p><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid,
[<italic toggle="yes">14</italic>-<sup>11</sup>C]palmitic acid, and [<italic toggle="yes">16</italic>-<sup>11</sup>C]palmitic acid were synthesized through a cross-coupling
reaction
between Bu<sup>t</sup>-protected &#969;-iodo fatty acid precursors,
properly converted in a copper&#8211;zinc reagent as labeling precursor
(<xref rid="fig130" ref-type="fig">Figure <xref rid="fig130" ref-type="fig">130</xref></xref>). The
final deprotection with TFA gives radiolabeled derivatives with free
carboxylic functions. RCY of 6% within 30 min from EOB and RCP 88%
were achieved.<sup><xref ref-type="bibr" rid="ref627">627</xref></sup></p><fig id="fig130" position="float" orientation="portrait"><label>Figure 130</label><caption><p>Radiosynthetic schemes
of [<sup>11</sup>C]palmitic acid. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr130" position="float" orientation="portrait" xlink:href="cr2c00398_0130.jpg"/></fig><p>[<italic toggle="yes">16</italic>-<sup>11</sup>C]Palmitic acid
was also radiosynthesized
starting from Bu<sup>t</sup>-protected &#969;-iodopentanoic acid
with copper complex and [<sup>11</sup>C]CH<sub>3</sub>I in THF with
73% isolated RCY within 46 min from the end of radionuclide production.<sup><xref ref-type="bibr" rid="ref557">557</xref></sup> Similar strategy but with starting alkylfuran
Grignard precursor and final oxidative cleavage with ruthenium tetraoxide
lead to 5 in 75 min of total synthesis time, purified through a resin-packed
column, and incubated with human serum albumin to obtain an injectable
solution.<sup><xref ref-type="bibr" rid="ref572">572</xref></sup></p><p>[<italic toggle="yes">8</italic>-<sup>11</sup>C]Palmitic acid, [<italic toggle="yes">14</italic>-<sup>11</sup>C]palmitic
acid, and [16-<sup>11</sup>C]palmitic acid
were also synthesized from the proper bis-Grignard precursors reacting
with [<sup>11</sup>C]alkyl iodide with copper catalyst and final-stage
carboxylation in THF with RCY of 12&#8211;22% in 45&#8211;65 min.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><p>Because the [<sup>11</sup>C]palmitic
acid has very poor water solubility,
the preparation for injection requires the radiopharmaceutical to
be water-solubilized by binding to human serum albumin. Consequently,
the purification and formulation of [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitate compared to [<sup>11</sup>C]acetate is more time-consuming
and challenging, producing lower yields. Despite technological advances
and optimizations, developing a reliable, fully automated [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid procedure is challenging.
Alejandro Amor-Corasa <italic toggle="yes">et al</italic>. recently developed and
reported the lightweight (4 kg) and fully automated 3D-printed cassette-based
synthesis unit for <sup>11</sup>C-labeled fatty acid production,<sup><xref ref-type="bibr" rid="ref626">626</xref></sup> giving [<sup>11</sup>C]palmitic acid with a
RCYs 57.2 &#177; 12.4% to the EOS within 10 min.<sup><xref ref-type="bibr" rid="ref576">576</xref>,<xref ref-type="bibr" rid="ref626">626</xref></sup></p></sec><sec id="sec7.15.2"><label>7.15.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid and [<italic toggle="yes">16</italic>-<sup>11</sup>C]palmitic acid showed different biodistribution in rats iv administered:
[<italic toggle="yes">16</italic>-<sup>11</sup>C]Palmitic acid exerted around 50%
higher uptake in the heart, probably due to the egress of [<sup>11</sup>C]CO<sub>2</sub> from the heart after [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid metabolic oxidation. They exerted high uptake in
the liver and low absorption in blood, lung, kidney, and muscle. At
the same time, they showed similar biodistribution and uptake in dogs&#8217;
hearts.<sup><xref ref-type="bibr" rid="ref572">572</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid was further evaluated as a PET radiotracer for myocardial
fatty acid metabolism in normal and increased metabolic demand and
acute myocardial ischemia in dogs (<xref rid="fig131" ref-type="fig">Figure <xref rid="fig131" ref-type="fig">131</xref></xref>),<sup><xref ref-type="bibr" rid="ref573">573</xref></sup> in liver
fatty oxidation in pigs.<sup><xref ref-type="bibr" rid="ref573">573</xref></sup> In monkeys,
its incorporation rate was almost double in the temporal and parietal
cortex compared to white matter.<sup><xref ref-type="bibr" rid="ref575">575</xref></sup> The
primary metabolite of [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic
acid was considered [<sup>11</sup>C]CO<sub>2</sub> due to peripheral
oxidation of fatty acids, as confirmed by the integrated plasma [<sup>11</sup>C]CO<sub>2</sub> increasing after [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid administration. The latter was confirmed
in a methyl palmoxirate-treated group (mitochondrial fatty acid &#946;-oxidation
blocker), where integrated plasma [<sup>11</sup>C]CO<sub>2</sub> was
around 50% less than control.<sup><xref ref-type="bibr" rid="ref575">575</xref></sup> In pigs,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid caused increased
radioactivity in the heart, liver, spleen, and kidneys, with almost
no urine excretion.<sup><xref ref-type="bibr" rid="ref574">574</xref></sup> Furthermore, in
pigs, [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid was used to
assess oxidative fatty acids consumption. It showed a low clearance
rate from blood paired with a low transfer rate constant, with its
oxidative utilization strongly decreased by inhibiting fatty acid
oxidation.<sup><xref ref-type="bibr" rid="ref561">561</xref></sup></p><fig id="fig131" position="float" orientation="portrait"><label>Figure 131</label><caption><p>[<italic toggle="yes">16</italic>-<sup>11</sup>C]Palmitic acid (top) and [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid (bottom) midventricular PET
images of a dog heart. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref572">572</xref>). Copyright 1994 American
Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr131" position="float" orientation="portrait" xlink:href="cr2c00398_0131.jpg"/></fig></sec><sec id="sec7.15.3"><label>7.15.3</label><title>Clinical Studies</title><p>In healthy patients,
[<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid showed a biological
half-life of around 20 min and mainly accumulated in the liver and
heart, as seen in preclinical studies. No radiotracer was detected
in urine, suggesting that all [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic
acid bound to albumin and was metabolized as esterified fatty acid
(<italic toggle="yes">e.g</italic>., triglycerides) or oxidized: this was confirmed
by the increased radioactivity registered in CO<sub>2</sub> and triglycerides
fraction with a reduction of <sup>11</sup>C radioactivity in free
fatty acid fraction after bolus injection, confirming that [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid also underwent to a liver
re-esterification and not only metabolic oxidation.<sup><xref ref-type="bibr" rid="ref574">574</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Palmitic acid uptake
and biodistribution were evaluated in patients with heart-related
diseases due to impairment of fatty acid oxidation and the resulting
ROS overexpression in these pathologies. Particularly, PET studies
with [<italic toggle="yes">1</italic>-<sup>11</sup>C]palmitic acid in cardiomyopathy,
ischemic heart disease, and myocardial infarction patients could help
to assess the pathological mechanisms involved and evaluate the efficacy
of proper therapeutic interventions.<sup><xref ref-type="bibr" rid="ref574">574</xref></sup></p></sec></sec><sec id="sec7.16"><label>7.16</label><title>Pentanoic Acid</title><sec id="sec7.16.1"><label>7.16.1</label><title>Radiosynthesis</title><p>A solution of thienyl
cuprate and <italic toggle="yes">1</italic>,<italic toggle="yes">3</italic>-bis(bromomagnesium)propane
in THF was added to [<sup>11</sup>C]CH<sub>3</sub>I trapped in a reaction
vessel. A stream of CO<sub>2</sub> was further introduced, obtaining
pure [<italic toggle="yes">5</italic>-<sup>11</sup>C]pentanoic acid (<xref rid="fig132" ref-type="fig">Figure <xref rid="fig132" ref-type="fig">132</xref></xref>) after chromatography
purification in 47 min with a RCY of 27%.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Pentanoic acid was obtained from
[<sup>11</sup>C]CO<sub>2</sub> fixation to the respective Grignard
reagent with the following acidic workup in 15&#8211;20 min overall
preparation, albeit it was further tested as [<italic toggle="yes">1</italic>-<sup>11</sup>C]pentanoate sodium salt. It was achieved with a RCY of 59%,
with an average of 2.812 GBq.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p><fig id="fig132" position="float" orientation="portrait"><label>Figure 132</label><caption><p>Radiosynthetic
schemes of [<sup>11</sup>C]pentanoic acids. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr132" position="float" orientation="portrait" xlink:href="cr2c00398_0132.jpg"/></fig></sec><sec id="sec7.16.2"><label>7.16.2</label><title>Preclinical Studies</title><p>In dogs, [<italic toggle="yes">1</italic>-<sup>11</sup>C] pentanoate activity was concentrated in
the kidney and liver, mainly excreted in bile and concentrated in
the gallbladder.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p></sec></sec><sec id="sec7.17"><label>7.17</label><title>Propanoic Acid</title><sec id="sec7.17.1"><label>7.17.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Propanoic acid was firstly synthesized by Fang <italic toggle="yes">et al</italic>. with a RCY of 99% within 30 min. However, [<italic toggle="yes">1</italic>-<sup>11</sup>C]propanoic acid was obtained through reaction
with the proper Grignard reagent (<italic toggle="yes">i.e</italic>., ethyl magnesium
chloride) and [<sup>11</sup>C]CO<sub>2</sub> followed by an acidic
workup to achieve it in neutral form (<xref rid="fig133" ref-type="fig">Figure <xref rid="fig133" ref-type="fig">133</xref></xref>). The total preparation time was 15&#8211;20
min with a RCY of 98%.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Propanoic acid has also been synthesized during the
development of a method for the preparation of [<italic toggle="yes">1</italic>-<sup>11</sup>C]propyl iodide from [<sup>11</sup>C]CO and its use
in alkylation reactions. In this case, [<italic toggle="yes">1</italic>-<sup>11</sup>C]propanoic acid was prepared by a palladium-mediated formylation
of ethene with [<sup>11</sup>C]CO within 3 min.<sup><xref ref-type="bibr" rid="ref579">579</xref></sup> The total preparation time was 15&#8211;20 min with a
RCY of 98% and an average of 2812 MBq obtained.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p><fig id="fig133" position="float" orientation="portrait"><label>Figure 133</label><caption><p>Radiosynthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]propanoic
acid from CH<sub>3</sub>CH<sub>2</sub>MgBr and [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr133" position="float" orientation="portrait" xlink:href="cr2c00398_0133.jpg"/></fig></sec><sec id="sec7.17.2"><label>7.17.2</label><title>Preclinical Studies</title><p>In dogs, [<italic toggle="yes">1</italic>-<sup>11</sup>C]propanoate revealed high uptake in the
cardiovascular system and abdomen within 3--6 min, followed by a homogenous
whole-body biodistribution after 30 min. Particularly, the accumulation
in the liver and diffusely in the abdomen suggested that it equilibrates
with lipid storage sites with high perfusion rates.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p></sec></sec><sec id="sec7.18"><label>7.18</label><title>Tetradecanoic Acid</title><sec id="sec7.18.1"><label>7.18.1</label><title>Radiosynthesis</title><p>A solution of <italic toggle="yes">1</italic>,<italic toggle="yes">12</italic>-bis-(bromomagnesium)dodecane in THF
was added to [<sup>11</sup>C]CH<sub>3</sub>I trapped in a reaction
vessel and Li<sub>2</sub>CuCl<sub>4</sub> in THF. A CO<sub>2</sub> stream was introduced, obtaining pure [<italic toggle="yes">14</italic>-<sup>11</sup>C]tetradecanoic acid (<xref rid="fig134" ref-type="fig">Figure <xref rid="fig134" ref-type="fig">134</xref></xref>) after chromatography purification in
45 min with RCY of 23%.<sup><xref ref-type="bibr" rid="ref558">558</xref></sup></p><fig id="fig134" position="float" orientation="portrait"><label>Figure 134</label><caption><p>Radiosynthetic
schemes of [<italic toggle="yes">14</italic>-<sup>11</sup>C]tetradecanoic
acid. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr134" position="float" orientation="portrait" xlink:href="cr2c00398_0134.jpg"/></fig></sec><sec id="sec7.18.2"><label>7.18.2</label><title>Preclinical Studies</title><p>In pigs, [<italic toggle="yes">14</italic>-<sup>11</sup>C]tetradecanoic acid has been used to investigate
the oxidative utilization of fatty acids. The study showed a relatively
fast blood clearance, rational oxidative utilization of around 82%,
and a distribution volume of 25%. Furthermore, the transfer rate constants
of tracer from blood to myocardium and the myocardial uptake were
reduced by oxfenicine, an inhibitor of long-chain fatty acid oxidation.<sup><xref ref-type="bibr" rid="ref561">561</xref></sup></p></sec></sec><sec id="sec7.19"><label>7.19</label><title><italic toggle="yes">&#946;</italic>-Hydroxybutyrate</title><sec id="sec7.19.1"><label>7.19.1</label><title>Radiosynthesis</title><p>Propylene oxide
was reacted with [<sup>11</sup>C]ammonium cyanide for 10 min at 40
&#176;C, followed by acid hydrolysis for 5 min at room temperature
(<xref rid="fig135" ref-type="fig">Figure <xref rid="fig135" ref-type="fig">135</xref></xref>). After
HPLC purification, [<italic toggle="yes">1</italic>-<sup>11</sup>C]-<italic toggle="yes">&#946;</italic>-hydroxybutyric acid was obtained in 45&#8211;50 min from the end
of trapping with a RCY of 20&#8211;30%.<sup><xref ref-type="bibr" rid="ref582">582</xref>,<xref ref-type="bibr" rid="ref583">583</xref></sup> A stereospecific synthesis was also developed, obtaining the final
product with &gt;87% enantiomeric excess, using only HCl in the hydrolysis
step.<sup><xref ref-type="bibr" rid="ref583">583</xref></sup></p><fig id="fig135" position="float" orientation="portrait"><label>Figure 135</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]-<italic toggle="yes">&#946;</italic>-hydroxybutyric acid using [<sup>11</sup>C]NH<sub>4</sub>CN or [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr135" position="float" orientation="portrait" xlink:href="cr2c00398_0135.jpg"/></fig><p>Another reported synthesis procedure started from
radiolabeled
acetoacetate, obtained with the same procedure previously reported,
and final enzymatic conversion to [<italic toggle="yes">1</italic>-<sup>11</sup>C]-<italic toggle="yes">&#946;</italic>-hydroxybutyric acid using (<sc><italic toggle="yes">d</italic></sc>)-<italic toggle="yes">&#946;</italic>-hydroxybutyrate dehydrogenase
(<sc><italic toggle="yes">d</italic></sc>-<italic toggle="yes">3</italic>-HBD). The optimized
procedure was performed at pH 6.7 with phosphoric acid in the presence
of nicotinamide adenine dinucleotide with purification by ion exchange
column produced [<italic toggle="yes">1</italic>-<sup>11</sup>C]-<italic toggle="yes">&#946;</italic>-hydroxybutyric acid in 36 min with 10% RCY.<sup><xref ref-type="bibr" rid="ref581">581</xref></sup></p></sec><sec id="sec7.19.2"><label>7.19.2</label><title>Clinical Studies</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]-<italic toggle="yes">&#946;</italic>-Hydroxybutyric acid was
assessed in healthy volunteers to determine the regional cerebral
uptake of ketone bodies.<sup><xref ref-type="bibr" rid="ref580">580</xref></sup> The concentration
of unmetabolized tracer in the brain was very low, indicating that
the BBB passage was the rate-limiting step in ketone body utilization.
The utilization rate increased linearly with plasma concentration,
and it was higher in grey than white matter.<sup><xref ref-type="bibr" rid="ref580">580</xref></sup></p></sec></sec></sec><sec id="sec8"><label>8</label><title>Hormones and Neurotransmitters</title><p>Hormones
and neurotransmitters are fundamental chemical messengers
in maintaining homeostasis in the human body. Their function enables
the communication between cells, which selectively respond to a signal
by interaction with surface receptors. Whilst neurotransmitters act
between neighboring neurons, hormones are released in the bloodstream
and interact with cells distant from the hormone release site. The
radiolabeling of hormones and neurotransmitters with carbon-11 allows
for studying these signaling molecules&#8217; physiological and pathological
functions and sometimes monitoring the activity and expression of
the dedicated receptors (<xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>).</p><table-wrap id="tbl7" position="float" orientation="portrait"><label>Table 7</label><caption><title>Carbon-11 Labeled hormones and neurotransmitters</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">&#160;</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total
time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" colspan="1" rowspan="1">dopamine</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">dogs,<sup><xref ref-type="bibr" rid="ref663">663</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref664">664</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">30%</td><td style="border:none;" colspan="1" rowspan="1">65</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref663">663</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" colspan="1" rowspan="1">37</td><td style="border:none;" colspan="1" rowspan="1">20%</td><td style="border:none;" colspan="1" rowspan="1">45</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref664">664</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">epinephrine</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" colspan="1" rowspan="1">rabbit,<sup><xref ref-type="bibr" rid="ref665">665</xref></sup><italic toggle="yes">pigs,<sup><xref ref-type="bibr" rid="ref666">666</xref></sup></italic> humans<sup><xref ref-type="bibr" rid="ref637">637</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" colspan="1" rowspan="1">nr<xref rid="t7fn1" ref-type="table-fn">a</xref></td><td style="border:none;" colspan="1" rowspan="1">10%</td><td style="border:none;" colspan="1" rowspan="1">35</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref667">667</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">25%</td><td style="border:none;" colspan="1" rowspan="1">35</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref667">667</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine</td><td style="border:none;" colspan="1" rowspan="1">7.4</td><td style="border:none;" colspan="1" rowspan="1">20%</td><td style="border:none;" colspan="1" rowspan="1">30</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref665">665</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">GABA</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" colspan="1" rowspan="1">4</td><td style="border:none;" colspan="1" rowspan="1">65%</td><td style="border:none;" colspan="1" rowspan="1">40</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref638">638</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1"><sc>l</sc>-DOPA</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref668">668</xref>,<xref ref-type="bibr" rid="ref669">669</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref635">635</xref>,<xref ref-type="bibr" rid="ref670">670</xref>&#8722;<xref ref-type="bibr" rid="ref672">672</xref></sup> humans<sup><xref ref-type="bibr" rid="ref673">673</xref>&#8722;<xref ref-type="bibr" rid="ref677">677</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<italic toggle="yes">3</italic>-<sup>11</sup>C]alanine</td><td style="border:none;" colspan="1" rowspan="1">0.4</td><td style="border:none;" colspan="1" rowspan="1">30%</td><td style="border:none;" colspan="1" rowspan="1">50</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref678">678</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref679">679</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[1-<sup>11</sup>C]alanine</td><td style="border:none;" colspan="1" rowspan="1">2.5</td><td style="border:none;" colspan="1" rowspan="1">60%</td><td style="border:none;" colspan="1" rowspan="1">50</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref678">678</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">melatonin</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref679">679</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>COCl</td><td style="border:none;" colspan="1" rowspan="1">3.49</td><td style="border:none;" colspan="1" rowspan="1">13%</td><td style="border:none;" colspan="1" rowspan="1">35</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref650">650</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>COOH</td><td style="border:none;" colspan="1" rowspan="1">155</td><td style="border:none;" colspan="1" rowspan="1">12%</td><td style="border:none;" colspan="1" rowspan="1">45</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref680">680</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" colspan="1" rowspan="1">100</td><td style="border:none;" colspan="1" rowspan="1">36%</td><td style="border:none;" colspan="1" rowspan="1">2<sup>**</sup></td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref681">681</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">norepinephrine</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">1-</td><td style="border:none;" colspan="1" rowspan="1">dogs,<sup><xref ref-type="bibr" rid="ref682">682</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref642">642</xref>,<xref ref-type="bibr" rid="ref683">683</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">25%</td><td style="border:none;" colspan="1" rowspan="1">40</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref684">684</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" colspan="1" rowspan="1">56</td><td style="border:none;" colspan="1" rowspan="1">25%</td><td style="border:none;" colspan="1" rowspan="1">70</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref685">685</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">octopamine</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">m</italic>-</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">2.3%</td><td style="border:none;" colspan="1" rowspan="1">60</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref686">686</xref>,<xref ref-type="bibr" rid="ref687">687</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">2.3%</td><td style="border:none;" colspan="1" rowspan="1">60</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref686">686</xref>,<xref ref-type="bibr" rid="ref687">687</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" colspan="1" rowspan="1">56</td><td style="border:none;" colspan="1" rowspan="1">25%</td><td style="border:none;" colspan="1" rowspan="1">60</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref685">685</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">progesterone</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">21</italic>-</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" colspan="1" rowspan="1">0.74</td><td style="border:none;" colspan="1" rowspan="1">13%</td><td style="border:none;" colspan="1" rowspan="1">60</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref688">688</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>(<italic toggle="yes">2</italic>-thienyl)Cu</td><td style="border:none;" colspan="1" rowspan="1">14</td><td style="border:none;" colspan="1" rowspan="1">35%</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref689">689</xref>)</td></tr><tr><td colspan="9" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">serotonin</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">rabbits,<sup><xref ref-type="bibr" rid="ref690">690</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref690">690</xref></sup> humans<sup><xref ref-type="bibr" rid="ref691">691</xref></sup></td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]KCN</td><td style="border:none;" colspan="1" rowspan="1">5.1</td><td style="border:none;" colspan="1" rowspan="1">13%</td><td style="border:none;" colspan="1" rowspan="1">78</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref692">692</xref>)</td></tr><tr><td style="border:none;" colspan="1" rowspan="1">tyramine</td><td style="border:none;" colspan="1" rowspan="1">&#160;</td><td style="border:none;" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" colspan="1" rowspan="1">nr</td><td style="border:none;" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" colspan="1" rowspan="1">37</td><td style="border:none;" colspan="1" rowspan="1">20%</td><td style="border:none;" colspan="1" rowspan="1">45</td><td style="border:none;" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref664">664</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t7fn1"><label>a</label><p>nr: not reported</p></fn></table-wrap-foot></table-wrap><p>Dopamine is a fundamental neurotransmitter for the
healthy functioning
of the human brain. It involves several key functions, such as reward
mechanisms, motor control, learning, and emotions.<sup><xref ref-type="bibr" rid="ref628">628</xref></sup> Dopamine also fulfills other vital functions outside of
the brain.<sup><xref ref-type="bibr" rid="ref629">629</xref>,<xref ref-type="bibr" rid="ref630">630</xref></sup><sc><italic toggle="yes">l</italic></sc>-<italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-Dihydroxyphenylalanine (<sc>l</sc>-DOPA)
is the precursor of the neurotransmitter dopamine <italic toggle="yes">via</italic> interaction with the enzyme <sc>l</sc>-amino acid decarboxylase.<sup><xref ref-type="bibr" rid="ref631">631</xref></sup> Growing evidence suggests that the role of <sc><italic toggle="yes">l</italic></sc>-DOPA is not only as a metabolic precursor
but also as a neurotransmitter and neuromodulator.<sup><xref ref-type="bibr" rid="ref631">631</xref>,<xref ref-type="bibr" rid="ref632">632</xref></sup><sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA has also been used
to investigate dopaminergic metabolism<sup><xref ref-type="bibr" rid="ref632">632</xref>,<xref ref-type="bibr" rid="ref633">633</xref></sup> and study
the behavior of <italic toggle="yes">6</italic>-[<sup>18</sup>F]fluoro-<sc><italic toggle="yes">l</italic></sc>-DOPA, which proved to be quite different in crucial
aspects.<sup><xref ref-type="bibr" rid="ref634">634</xref>,<xref ref-type="bibr" rid="ref635">635</xref></sup></p><p>The use of carbon-11 labeled
epinephrine was suggested as a tool
to evaluate the functional integrity of the cardiac sympathetic nervous
system and detect cardiac diseases. Epinephrine is the main signaling
agent of the sympathetic nervous system alongside its demethylated
analogue norepinephrine. The biosynthesis of epinephrine mainly occurs
in the adrenal medulla and the medulla oblongata from norepinephrine
by the enzyme phenylethanolamine <italic toggle="yes">N</italic>-methyltransferase.<sup><xref ref-type="bibr" rid="ref630">630</xref></sup> Its action mainly activates the fight-or-flight
response by binding to the &#945; and &#946; adrenergic receptors.<sup><xref ref-type="bibr" rid="ref630">630</xref>,<xref ref-type="bibr" rid="ref636">636</xref>,<xref ref-type="bibr" rid="ref637">637</xref></sup></p><p>It was suggested that
PET studies using <sup>11</sup>C-labeled <italic toggle="yes">&#947;</italic>-aminobutyric
acid (GABA) would give a deeper insight
into the pathophysiology of associated diseases and clarify the CNS
trafficking of GABA.<sup><xref ref-type="bibr" rid="ref638">638</xref></sup> The neurotransmitter
GABA plays a pivotal role in the CNS in the early stages of embryonic
life,<sup><xref ref-type="bibr" rid="ref639">639</xref></sup> while in the mature CNS, it acts
as the primary inhibitory signaling agent by binding to ligand-gated
ion channels (GABA<sub>A</sub> and GABA<sub>B</sub> receptors)<sup><xref ref-type="bibr" rid="ref640">640</xref></sup> that favor the movement of chloride anions
through the neuronal membrane.<sup><xref ref-type="bibr" rid="ref639">639</xref></sup> GABA
activity is further regulated by transmembrane sodium symporters known
as GABA transporters.<sup><xref ref-type="bibr" rid="ref638">638</xref>,<xref ref-type="bibr" rid="ref641">641</xref></sup></p><p>Norepinephrine is the
predominant transmitter of sympathetic innervation
and regulates the body&#8217;s fight-or-flight response by binding
to the &#945; and &#946; adrenergic receptors, and its uptake is
regulated by norepinephrine transporters.<sup><xref ref-type="bibr" rid="ref642">642</xref></sup> The use of a carbon-11 variant of norepinephrine allowed sympathetic
innervation imaging in the myocardium and diagnosis of cardiac diseases.<sup><xref ref-type="bibr" rid="ref643">643</xref></sup></p><p>The neurotransmitter serotonin is most
active in the brain, regulating
many behavioral and psychological aspects such as anxiety, aggression,
learning, and depression.<sup><xref ref-type="bibr" rid="ref644">644</xref></sup> Serotonin
can also be found outside the CNS, particularly in the lungs, with
regulatory functions on respiration and vasoconstriction.<sup><xref ref-type="bibr" rid="ref645">645</xref>,<xref ref-type="bibr" rid="ref646">646</xref></sup> A viable way to assess serotonin concentration in the lungs would
be to determine the amount of neurotransmitters released by the lung
endothelium, a physiological phenomenon that occurs while breathing.<sup><xref ref-type="bibr" rid="ref647">647</xref></sup> Serotonin release can be easily assessed by
administration of [<sup>11</sup>C]serotonin and subsequent quantification
of its release by serotonin lung extraction.</p><p>Even though melatonin,
dihydroxyphenylalanine, progesterone, and
tyramine have been labeled with carbon-11, they have not been evaluated.
Melatonin its physiological function is to adapt body activity in
relation to circadian rhythms.<sup><xref ref-type="bibr" rid="ref648">648</xref></sup> Within
its functions, the most renowned is the sleep-inducing action after
interaction with the suprachiasmatic nucleus in the hypothalamus.<sup><xref ref-type="bibr" rid="ref649">649</xref>,<xref ref-type="bibr" rid="ref650">650</xref></sup> Octopamine is an endogenous agonist of human trace amine-associated
receptor 1<sup><xref ref-type="bibr" rid="ref651">651</xref>&#8722;<xref ref-type="bibr" rid="ref653">653</xref></sup> and initiates cell signal transduction pathways
through binding to G-protein coupled receptors.<sup><xref ref-type="bibr" rid="ref654">654</xref></sup> It is related structurally and functionally to noradrenaline
and acts as a &#8220;stress hormone&#8221; in fight-or-flight responses.<sup><xref ref-type="bibr" rid="ref655">655</xref></sup> Progesterone is a steroid hormone that regulates
physiological female reproductive functions.<sup><xref ref-type="bibr" rid="ref656">656</xref></sup> However, it also plays a vital role in the mammary gland, cardiovascular,
CNS, and bones.<sup><xref ref-type="bibr" rid="ref656">656</xref>&#8722;<xref ref-type="bibr" rid="ref658">658</xref></sup> Tyramine is a decarboxylation product of
tyrosine and a dehydroxylated analogue of dopamine.<sup><xref ref-type="bibr" rid="ref659">659</xref></sup> The presence of tyramine was initially confirmed in the
human brain by post-mortem analysis<sup><xref ref-type="bibr" rid="ref660">660</xref></sup> and
subsequently confirmed by discovering the G-coupled receptor, trace
amine-associated receptor 1.<sup><xref ref-type="bibr" rid="ref661">661</xref>,<xref ref-type="bibr" rid="ref662">662</xref></sup></p><sec id="sec8.1"><label>8.1</label><title>Dopamine</title><sec id="sec8.1.1"><label>8.1.1</label><title>Radiosynthesis</title><p>The synthesis of
the radiopharmaceutical was achieved in its hydrochloride form ([<sup>11</sup>C]dopamine&#183;HCl, <xref rid="fig136" ref-type="fig">Figure <xref rid="fig136" ref-type="fig">136</xref></xref>) using either the synthon [<sup>11</sup>C]HCN or [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>. In the former
case, [<sup>11</sup>C]HCN was reacted with <italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-hydroxybenzyl chloride to yield a [<sup>11</sup>C]<italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-hydroxybenzylcyanide, which was subsequently
reduced with hydrogen over palladium (<xref rid="fig136" ref-type="fig">Figure <xref rid="fig136" ref-type="fig">136</xref></xref>). The hydrochloride form was obtained
by adding HCl. The entire procedure requires 65 min, and the radiotracer
was obtained with an isolated RCY of 25&#8211;30% based on the activity
of [<sup>11</sup>C]HCN.<sup><xref ref-type="bibr" rid="ref663">663</xref></sup> In the latter
strategy, instead, [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> was
reacted with 3,4-benzylidenedioxybenzaldehyde to form a [<sup>11</sup>C]nitrovinylbenzene that was reduced to [<sup>11</sup>C]dopamine
by the use of BH<sub>3</sub> and LiAlH<sub>4</sub> and deprotected
by the addition of HCl with a total processing time of 45&#8211;50
min, isolated RCY of 8&#8211;20% to the initial production of [<sup>11</sup>C]CO<sub>2</sub> and <italic toggle="yes">A</italic><sub>m</sub> of 15&#8211;37
GBq/&#956;mol at time of injection. (<xref rid="fig136" ref-type="fig">Figure <xref rid="fig136" ref-type="fig">136</xref></xref>).<sup><xref ref-type="bibr" rid="ref664">664</xref></sup></p><fig id="fig136" position="float" orientation="portrait"><label>Figure 136</label><caption><p>Synthesis
of [<sup>11</sup>C]dopamine&#183;HCl using [<sup>11</sup>C]HCN or
[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr136" position="float" orientation="portrait" xlink:href="cr2c00398_0136.jpg"/></fig></sec><sec id="sec8.1.2"><label>8.1.2</label><title>Preclinical Studies</title><p>A biodistribution
study on five Mongrel dogs highlighted a high uptake of [<sup>11</sup>C]dopamine in the adrenal medulla compared to other analyzed organs
(kidney, liver, heart, adrenal cortex, blood). Injecting the radiotracer
in the presence of nonradioactive dopamine (0.01 mg/kg) also showed
binding displacement of [<sup>11</sup>C]dopamine&#183;HCl and a four-fold
lower signal in the adrenal medulla.<sup><xref ref-type="bibr" rid="ref663">663</xref></sup></p><p>These results were further explored by testing the distribution
of [<sup>11</sup>C]dopamine in cynomolgus monkeys. This experiment
used three animals, a different target organ was examined in each
monkey. The first animal was scanned for brain distribution 21 min
post [<sup>11</sup>C]dopamine injection, showing low brain activity
compared to other organs (<italic toggle="yes">e.g.</italic>, heart, kidney, adrenal
medulla). These findings suggest that dopamine does not cross the
BBB and that the recorded low activity was related to [<sup>11</sup>C]dopamine in the cerebral blood volume.<sup><xref ref-type="bibr" rid="ref664">664</xref></sup> On the other hand, high amounts of activity were found in the pituitary
gland, suggesting the potential use of [<sup>11</sup>C]dopamine for
clinical evaluation of the pituitary. The second monkey was tested
for heart and liver retention, with the heart having higher activity
retention than the liver. The activity decreased in both organs to <sup>1</sup>/<sub>3</sub> peak concentrations within 63 min of scanning.<sup><xref ref-type="bibr" rid="ref664">664</xref></sup> The third animal, scanned for 38 min, showed
that [<sup>11</sup>C]dopamine was quickly washed out from the kidneys
with partial retention in the adrenal cortex (<xref rid="fig137" ref-type="fig">Figure <xref rid="fig137" ref-type="fig">137</xref></xref>).<sup><xref ref-type="bibr" rid="ref664">664</xref></sup></p><fig id="fig137" position="float" orientation="portrait"><label>Figure 137</label><caption><p>[<sup>11</sup>C]Dopamine PET biodistribution in cynomolgus monkeys
at renal (left) and cardiac (right) levels (21 min p.i.). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref664">664</xref>). Copyright 1993 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr137" position="float" orientation="portrait" xlink:href="cr2c00398_0137.jpg"/></fig></sec></sec><sec id="sec8.2"><label>8.2</label><title>Epinephrine</title><sec id="sec8.2.1"><label>8.2.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Epinephrine
can be synthesized by either direct methylation of <italic toggle="yes">R</italic>-(&#8722;)-norepinephrine or by enzymatic transmethylation of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine
(<xref rid="fig138" ref-type="fig">Figure <xref rid="fig138" ref-type="fig">138</xref></xref>). The
former synthetic route proceeds with the aid of tetrabutylammonium
hydroxide (TBAH) as a base and [<sup>11</sup>C]CH<sub>3</sub>I or
[<sup>11</sup>C]CH<sub>3</sub>OTf as methylating agents (<xref rid="fig138" ref-type="fig">Figure <xref rid="fig138" ref-type="fig">138</xref></xref>A). The isolated
RCY resulted slightly higher when the more reactive [<sup>11</sup>C]CH<sub>3</sub>OTf was employed as a synthon (15&#8211;25% with
[<sup>11</sup>C]CH<sub>3</sub>OTf <italic toggle="yes">vs</italic> 5&#8211;10%
with [<sup>11</sup>C]CH<sub>3</sub>I). The total processing time was
35&#8211;40 min for both methods.<sup><xref ref-type="bibr" rid="ref667">667</xref></sup> The <italic toggle="yes">A</italic><sub>m</sub> with [<sup>11</sup>C]CH<sub>3</sub>I and [<sup>11</sup>C]CH<sub>3</sub>OTf were comparable and ranged between 33
and 81 GBq/&#956;mol at EOS. The second method requires the initial
synthesis of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine <italic toggle="yes">via</italic><sup>11</sup>C-methylation,
which was then used as a substrate for the enzymatic reaction with <sc>l</sc>-methionine-<italic toggle="yes">S</italic>-adenosine transferase in the
presence of ATP to yield <italic toggle="yes">S</italic>-adenosyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine. Then, this
intermediate undergoes another enzymatic transformation carried by
phenylethanolamine <italic toggle="yes">N</italic>-methyltransferase (PNMT) that
moves the [<sup>11</sup>C]methyl group onto <italic toggle="yes">R</italic>(&#8722;)-norepinephrine
(<xref rid="fig138" ref-type="fig">Figure <xref rid="fig138" ref-type="fig">138</xref></xref>B). [<sup>11</sup>C]Epinephrine was obtained in 30&#8211;35 min with an isolated
RCY of 20% from <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine and <italic toggle="yes">A</italic><sub>m</sub> of
7.4 GBq/&#956;mol at 35 min from <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine synthesis.<sup><xref ref-type="bibr" rid="ref665">665</xref></sup></p><fig id="fig138" position="float" orientation="portrait"><label>Figure 138</label><caption><p>Synthesis of [<sup>11</sup>C]epinephrine. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr138" position="float" orientation="portrait" xlink:href="cr2c00398_0138.jpg"/></fig></sec><sec id="sec8.2.2"><label>8.2.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Epinephrine was evaluated <italic toggle="yes">in vivo</italic> by injection
in one rabbit (28 min scanning). The radiopharmaceutical was mainly
biodistributed in the heart, liver-pancreas, kidneys, and adrenal
glands. The activity in the heart, liver, and pancreas was constant
during the scan. Surprisingly, the expected signal in the lungs was
neglectable despite the high expression of adrenergic receptors in
this tissue. An increase in activity in the kidneys (&#8764;40%)
and bladder (3.5-fold higher) was also observed during the time of
the scan, indicating a fast excretion of [<sup>11</sup>C]epinephrine.
Given this data, the biological half-life of [<sup>11</sup>C]epinephrine
was estimated to be 3 min.<sup><xref ref-type="bibr" rid="ref665">665</xref></sup><italic toggle="yes">In
vivo</italic> studies also aimed to understand the effects of myocardial
infarction on sympathetic innervation in the heart.<sup><xref ref-type="bibr" rid="ref666">666</xref></sup> [<sup>11</sup>C]Epinephrine (dynamic image acquisition
for 40 min) was administered to 11 pigs with induced myocardial infarction,
revealing a decrease of 44% in radioactivity retention compared with
healthy animal control.<sup><xref ref-type="bibr" rid="ref666">666</xref></sup></p></sec><sec id="sec8.2.3"><label>8.2.3</label><title>Clinical Studies</title><p>Modifications
on the heart sympathetic innervation with [<sup>11</sup>C]epinephrine
were also studied in the case of heart transplantation. Ten patients
who underwent heart transplantation 3.5&#8211;48.0 months before
the study were injected with [<sup>11</sup>C]epinephrine and scanned
for 60 min. The results highlighted a considerable decrease in activity
in the myocardium compared to seven healthy volunteers (&#8722;75%
of activity detected, <xref rid="fig139" ref-type="fig">Figure <xref rid="fig139" ref-type="fig">139</xref></xref>). Metabolite analysis was also carried out by collecting
blood samples at different time points after the injection. As early
as 5 min after tracer injection, the amount of unmetabolized [<sup>11</sup>C]epinephrine was only 65% of total blood radioactivity,
which decreased to 14% after 60 min, thus highlighting a quick metabolism
and washout of the tracer. The metabolite identification was not performed.
No significant differences were observed between the healthy volunteers
and the transplant recipients.<sup><xref ref-type="bibr" rid="ref637">637</xref></sup></p><fig id="fig139" position="float" orientation="portrait"><label>Figure 139</label><caption><p>[<sup>11</sup>C]Epinephrine (EPI) and [<sup>11</sup>C]hydroxyephedrine
(HED) PET images and corresponding polar maps in (A) a healthy volunteer
and (B) a patient who underwent heart transplantation 37 months before
PET studies. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref637">637</xref>). Copyright 2000 Wolters
Kluwer Health.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr139" position="float" orientation="portrait" xlink:href="cr2c00398_0139.jpg"/></fig></sec></sec><sec id="sec8.3"><label>8.3</label><title>Gamma-Aminobutyric Acid (GABA)</title><sec id="sec8.3.1"><label>8.3.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]GABA was accomplished <italic toggle="yes">via</italic> Michael&#8217;s
addition of [<sup>11</sup>C]KCN (previously obtained by dissolving
[<sup>11</sup>C]HCN in a KOH/K222 solution) on an ethyl acrylate precursor
followed by a selective reduction and hydrolysis of the resulting
amino ester (<xref rid="fig140" ref-type="fig">Figure <xref rid="fig140" ref-type="fig">140</xref></xref>). With this methodology, the radiolabeled [<italic toggle="yes">4</italic>-<sup>11</sup>C]GABA was obtained with a RCY of 60&#8211;65% based on
the activity of [<sup>11</sup>C]HCN within 40 min from [<sup>11</sup>C]HCN addition.<sup><xref ref-type="bibr" rid="ref638">638</xref></sup> The final product had
a <italic toggle="yes">A</italic><sub>m</sub> of 4 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref638">638</xref></sup></p><fig id="fig140" position="float" orientation="portrait"><label>Figure 140</label><caption><p>Synthesis of [<italic toggle="yes">4</italic>-<sup>11</sup>C]GABA using [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide position
is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr140" position="float" orientation="portrait" xlink:href="cr2c00398_0140.jpg"/></fig></sec></sec><sec id="sec8.4"><label>8.4</label><title><sc><italic toggle="yes">l</italic></sc>-DOPA</title><sec id="sec8.4.1"><label>8.4.1</label><title>Radiosynthesis</title><p>The synthesis of
the radiopharmaceutical was achieved in both <italic toggle="yes">&#946;</italic> (<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA) and terminal carboxylic position (<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]DOPA) by a combination
of organic synthesis methods and a multienzymatic procedure.<sup><xref ref-type="bibr" rid="ref693">693</xref>,<xref ref-type="bibr" rid="ref694">694</xref></sup> A <sup>11</sup>C-labeled alanine was used as a substrate for the
enzymes <sc>d</sc>-amino acid oxydase, catalase, glutamic-pyruvic
transaminase, and <italic toggle="yes">&#946;</italic>-tyrosinase, which in turn
oxidizes the [<sup>11</sup>C]alanine and then attach it to a catechol
precursor (<xref rid="fig141" ref-type="fig">Figure <xref rid="fig141" ref-type="fig">141</xref></xref>). Both <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]DOPA were obtained within 50 min and with an isolated
RCY of 25&#8211;30% and 45&#8211;60%, respectively, and <italic toggle="yes">A</italic><sub>m</sub> ranging between 0.4 and 2.5 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref678">678</xref></sup> The <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA synthesis was also fully automated using an
immobilized enzyme column.<sup><xref ref-type="bibr" rid="ref694">694</xref></sup></p><fig id="fig141" position="float" orientation="portrait"><label>Figure 141</label><caption><p>Synthesis
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]DOPA <italic toggle="yes">via</italic> a multienzymatic procedure. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr141" position="float" orientation="portrait" xlink:href="cr2c00398_0141.jpg"/></fig></sec><sec id="sec8.4.2"><label>8.4.2</label><title>Preclinical Studies</title><p>Both variants
of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA were tested <italic toggle="yes">in vivo</italic> to disentangle <sc>l</sc>-DOPA&#8217;s metabolic pathways and assess its distribution in
the brain, the rate of decarboxylation to dopamine and the effect
of pharmacological treatments. Studies in rhesus monkeys highlighted
a prominent accumulation of radioactivity in the striatal region.<sup><xref ref-type="bibr" rid="ref635">635</xref>,<xref ref-type="bibr" rid="ref670">670</xref></sup> The maximum accumulation of activity in the striatum was reached
after 10 min,<sup><xref ref-type="bibr" rid="ref671">671</xref></sup> and the binding specificity
was confirmed <italic toggle="yes">via</italic> levodopa blocking studies.<sup><xref ref-type="bibr" rid="ref672">672</xref></sup> The use of pharmacological treatments such
as <italic toggle="yes">6R</italic>-BH<sub>4</sub> (a cofactor of AADC, catalyzing
dopamine synthesis) significantly increased the influx of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA in the striatum. In contrast,
the administration of tolcapone or catechol-<italic toggle="yes">O</italic>-methyltransferase
inhibitors did not give significant variations.<sup><xref ref-type="bibr" rid="ref635">635</xref>,<xref ref-type="bibr" rid="ref670">670</xref>,<xref ref-type="bibr" rid="ref672">672</xref></sup> High doses of 6R-BH4 also increased
the rate of decarboxylation of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA to [<sup>11</sup>C]dopamine. This effect was further amplified
by the simultaneous administration of <italic toggle="yes">6R</italic>-BH<sub>4</sub> and <sc><italic toggle="yes">l</italic></sc>-tyrosine.<sup><xref ref-type="bibr" rid="ref635">635</xref>,<xref ref-type="bibr" rid="ref670">670</xref>&#8722;<xref ref-type="bibr" rid="ref672">672</xref>,<xref ref-type="bibr" rid="ref695">695</xref></sup></p><p>The
infusion of scopolamine, a muscarinic cholinergic antagonist, or nicotine
also resulted in a dose-dependent increase in uptake and decarboxylation
rate of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA in the striatum
(0.017 MBq/mL with scopolamine <italic toggle="yes">versus</italic> 0.012 MBq/mL
without scopolamine; 33% increase in <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA decarboxylation rate when nicotine was administered),
confirming the presence of a connection between cholinergic and dopaminergic
systems in the striatal region.<sup><xref ref-type="bibr" rid="ref671">671</xref>,<xref ref-type="bibr" rid="ref696">696</xref></sup> AADC inhibition
resulted in increased retention of activity in the brain of 43&#8211;50%,
whereas infusion of reserpine or <sc><italic toggle="yes">l</italic></sc>-deprenyl
(to reduce the accumulation in presynaptic vesicles) did not significantly
alter <sc>l</sc>-[<sup>11</sup>C]DOPA uptake.<sup><xref ref-type="bibr" rid="ref672">672</xref></sup></p><p>Microdialysis studies on male Sprague-Dawley rats
made a deeper
understanding of dopaminergic metabolism. <sc>l</sc>-[<sup>11</sup>C]DOPA was metabolized in [<sup>11</sup>C]<italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-dihydroxyphenylacetic acid ([<sup>11</sup>C]DOPAC) for
44% and [<sup>11</sup>C]homovanillic acid ([<sup>11</sup>C]HVA) for
42% within 10 min. Pharmacological treatments, however, can modify
the metabolic pathway of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA. The use of the monoamine oxidase inhibitor pargyline 30 min
before <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA administration
lowered the production of the two species mentioned above in favor
of [<sup>11</sup>C]3-methoxytyramine ([<sup>11</sup>C]<italic toggle="yes">3</italic>-MT). In contrast, the infusion of COMT inhibitors or benserazide
significantly favored the formation of [<sup>11</sup>C]DOPAC (<xref rid="fig142" ref-type="fig">Figure <xref rid="fig142" ref-type="fig">142</xref></xref>).<sup><xref ref-type="bibr" rid="ref668">668</xref></sup> Furthermore, the administration of 6<italic toggle="yes">R</italic>-<sc>l</sc>-erythro-5,6,7,8-tetrahydrobiopterin (<italic toggle="yes">6R</italic>-BH<sub>4</sub>, 50 mg/kg 40 min after <sc>l</sc>-[<sup>11</sup>C]DOPA injection) showed to enhance the uptake and turnover
of <sc>l</sc>-[<sup>11</sup>C]DOPA in the striatum. The simultaneous
infusion of <sc>l</sc>-tyrosine further enhanced the effect of 6<italic toggle="yes">R</italic>-BH<sub>4,</sub> whereas only <sc><italic toggle="yes">l</italic></sc>-tyrosine did not have any effect.<sup><xref ref-type="bibr" rid="ref669">669</xref></sup></p><fig id="fig142" position="float" orientation="portrait"><label>Figure 142</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA metabolism analyzed
by microdialysis studies on male Sprague-Dawley rats (&#8220;Other&#8221;
indicates an unidentified <sup>11</sup>C-labeled metabolite). Graph
was prepared with data from Okada et al.<sup><xref ref-type="bibr" rid="ref668">668</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr142" position="float" orientation="portrait" xlink:href="cr2c00398_0142.jpg"/></fig><p>Alterations in the dopaminergic synthesis were
subsequently studied
by concomitant administration of <sc><italic toggle="yes">d</italic></sc>-amphetamine
and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA to eight anesthetized rhesus monkeys to study the variation
in the decarboxylation rate of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA.<sup><xref ref-type="bibr" rid="ref697">697</xref></sup><sc>d</sc>-Amphetamine was administered as a bolus dose of 0.1&#8211;0.4
mg/kg 30 min prior to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA, and the scan proceeded for 60 min. Results
showed an increased decarboxylation rate of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA of 5% when 0.1
mg/kg of <sc>d</sc>-amphetamine was administered and 12% with a bolus
dose of 0.4 mg/kg, confirming the positive effect of amphetamines
on dopamine production. The constant intravenous infusion showed no
prominent increase in <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA decarboxylation as bolus administration.<sup><xref ref-type="bibr" rid="ref697">697</xref></sup></p></sec><sec id="sec8.4.3"><label>8.4.3</label><title>Clinical Studies</title><p>Clinical studies
in humans confirmed what preclinical experiments suggested. The scanning
of eight healthy volunteers showed high retention of activity in the
striatal region and mesial frontal cortex (in line with dopaminergic
neuron presence) and a steep washout from the cerebellum 15 min p.i.
of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA.<sup><xref ref-type="bibr" rid="ref673">673</xref>,<xref ref-type="bibr" rid="ref674">674</xref></sup> In contrast to preclinical studies,<sup><xref ref-type="bibr" rid="ref672">672</xref></sup> pretreatments with unlabeled <sc><italic toggle="yes">l</italic></sc>-DOPA increased
brain activity.<sup><xref ref-type="bibr" rid="ref673">673</xref></sup> Due to the rapid decarboxylation
in the body, <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]DOPA was quickly metabolized into [<sup>11</sup>C]carboxylates
which nonspecifically bind in all brain regions, lowering the specificity
of the carboxy-labeled analogue. <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA, instead, does not generate
any nonspecific metabolites.<sup><xref ref-type="bibr" rid="ref673">673</xref></sup></p><p>Another
clinical study on 10 healthy male volunteers focused on the relationship
between the concentration of neutral amino acids in the blood and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA
influx in the brain by injection of <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]DOPA.<sup><xref ref-type="bibr" rid="ref674">674</xref></sup> A strong negative correlation was found between the amount of <italic toggle="yes">N</italic>-acetylaspartate in the blood pool and the influx rate
constant, with a decrease of 25% in the influx rate constant in the
putamen region when the NAA concentration increases by 40%. Thus,
this data suggests that <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA is transported inside the CNS by the <italic toggle="yes">N</italic>-acetylaspartate
transporter system at the BBB and competes with <italic toggle="yes">N</italic>-acetylaspartates for the transporter.<sup><xref ref-type="bibr" rid="ref674">674</xref></sup></p><p>Alterations in the dopaminergic system are frequently seen
in brain
disorders, particularly Parkinson&#8217;s disease and schizophrenia.<sup><xref ref-type="bibr" rid="ref675">675</xref>&#8722;<xref ref-type="bibr" rid="ref677">677</xref></sup> The use of <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA would
help to depict these modifications. A study on eight idiopathic Parkinson&#8217;s
disease patients highlighted a 35% decrease in <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]DOPA accumulation in the brain compared to
healthy references.<sup><xref ref-type="bibr" rid="ref673">673</xref>,<xref ref-type="bibr" rid="ref676">676</xref></sup> On the other hand, a comparative
study between 113 patients with schizophrenia and 131 healthy controls
showed a 14% increase in dopamine synthetic capacity in schizophrenic
subjects.<sup><xref ref-type="bibr" rid="ref677">677</xref></sup></p></sec></sec><sec id="sec8.5"><label>8.5</label><title>Melatonin</title><sec id="sec8.5.1"><label>8.5.1</label><title>Radiosynthesis</title><p>Three strategies
for the synthesis of a <sup>11</sup>C-labeled analogue of melatonin
were proposed in the past years to better understand its activity
in the brain.<sup><xref ref-type="bibr" rid="ref650">650</xref>,<xref ref-type="bibr" rid="ref680">680</xref>,<xref ref-type="bibr" rid="ref681">681</xref></sup> All these methodologies proceed with radiolabeling the terminal
acetyl group of melatonin (<xref rid="fig143" ref-type="fig">Figure <xref rid="fig143" ref-type="fig">143</xref></xref>). The first requires the production of the synthon
[<sup>11</sup>C]CH<sub>3</sub>COCl by reacting CH<sub>3</sub>MgBr
with the cyclotron-produced [<sup>11</sup>C]CO<sub>2</sub>, obtaining
[<sup>11</sup>C]acetate, which was subsequently functionalized by
reaction with phthaloyl chloride.<sup><xref ref-type="bibr" rid="ref650">650</xref></sup> The
synthon [<sup>11</sup>C]CH<sub>3</sub>COCl then reacts with the precursor
5-methoxytryptamine producing [<sup>11</sup>C]melatonin with a RCY
of 13% and <italic toggle="yes">A</italic><sub>m</sub> of 3.49 GBq/&#956;mol within
35 min from the EOB (<xref rid="fig143" ref-type="fig">Figure <xref rid="fig143" ref-type="fig">143</xref></xref>A).<sup><xref ref-type="bibr" rid="ref650">650</xref></sup></p><fig id="fig143" position="float" orientation="portrait"><label>Figure 143</label><caption><p>Synthesis of [<sup>11</sup>C]melatonin using [<sup>11</sup>C]CH<sub>3</sub>COCl, [<sup>11</sup>C]CO<sub>2</sub> and [<sup>11</sup>C]CH<sub>3</sub>CO<sub>2</sub>H. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr143" position="float" orientation="portrait" xlink:href="cr2c00398_0143.jpg"/></fig><p>The second, instead, exploits [<sup>11</sup>C]acetate
as the radiolabeling
agent, obtained by the reaction of CH<sub>3</sub>MgBr with [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref680">680</xref></sup> The newly synthesized
labeling agent was then reacted with the precursor <italic toggle="yes">5</italic>-methoxytryptamine with the aid of <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>&#8242;-dicyclohexylcarbodiimide (DCC) (<xref rid="fig143" ref-type="fig">Figure <xref rid="fig143" ref-type="fig">143</xref></xref>B).<sup><xref ref-type="bibr" rid="ref680">680</xref></sup> [<sup>11</sup>C]Melatonin was obtained with RCY of 12% and <italic toggle="yes">A</italic><sub>m</sub> of 155 GBq/&#956;mol in 45 min from EOB.<sup><xref ref-type="bibr" rid="ref680">680</xref></sup></p><p>Improvements in [<sup>11</sup>C]CO<sub>2</sub> chemistry allowed
the development of the third method for radiolabeling [<sup>11</sup>C]melatonin.<sup><xref ref-type="bibr" rid="ref681">681</xref></sup> Using a CO<sub>2</sub>-fixating agent (<italic toggle="yes">1</italic>,<italic toggle="yes">8</italic>-diazabicyclo[<italic toggle="yes">5</italic>.<italic toggle="yes">4</italic>.<italic toggle="yes">0</italic>]undec-<italic toggle="yes">7</italic>-ene (DBU)), Mitsunobu reagents (tri-<italic toggle="yes">n</italic>-butyl phosphine
(Bu<sub>3</sub>P) and di-<italic toggle="yes">tert</italic>-butyl azodicarboxylate
(DBAD)), and CH<sub>3</sub>MgBr, the radiopharmaceutical was obtained
with RCY of 36% (non-isolated, calculated from the radio HPLC chromatogram)
and <italic toggle="yes">A</italic><sub>m</sub> of 70&#8211;100 GBq/&#956;mol
in only 2 min from EOB.<sup><xref ref-type="bibr" rid="ref681">681</xref></sup> Neither preclinical
nor clinical studies have been reported (<xref rid="fig143" ref-type="fig">Figure <xref rid="fig143" ref-type="fig">143</xref></xref>C).</p></sec><sec id="sec8.5.2"><label>8.5.2</label><title>Clinical Studies</title><p>Biodistribution
studies with [<sup>11</sup>C]melatonin were performed on a 38-year-old
volunteer. After injection of the tracer, PET images and 23 blood
samples were regularly taken over a 75 min period to monitor the accumulation
of radioactivity in the body and the formation of radiometabolites.
[<sup>11</sup>C]Melatonin quickly crossed the BBB, and activity in
the brain peaked within 8.5 min, whereas plasma concentration apexed
in 3.5 min. The main metabolite was 6-sulfatoxymelatonin, and its
concentration plateaued after 20 min. However, it was impossible to
locate the specific binding sites of [<sup>11</sup>C]melatonin in
the human brain, potentially due to the low affinity or low molar
activity of the produced tracer.<sup><xref ref-type="bibr" rid="ref679">679</xref></sup></p></sec></sec><sec id="sec8.6"><label>8.6</label><title>Norepinephrine</title><sec id="sec8.6.1"><label>8.6.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]norepinephrine was achieved with two strategies involving
the synthons [<sup>11</sup>C]HCN or [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>. The radiolabeling with [<sup>11</sup>C]HCN proceeds
with the initial trapping of the synthon as [<sup>11</sup>C]NaCN and
the subsequent reaction with 3,4-hydroxybenzaldehyde in the presence
of NaHSO<sub>3</sub> as a reducing agent (<xref rid="fig144" ref-type="fig">Figure <xref rid="fig144" ref-type="fig">144</xref></xref>A). The use of HCl then allows the purification <italic toggle="yes">via</italic> ion-exchange chromatography and gives [<sup>11</sup>C]norepinephrine&#183;HCl with an isolated RCY of 20&#8211;25% (at
the end of [<sup>11</sup>C]HCN synthesis) within 40 min.<sup><xref ref-type="bibr" rid="ref684">684</xref></sup> The second strategy involving [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>, instead, requires the two hydroxyl
groups to be protected as dioxole. [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> reacts with a <italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-methylenedioxybenzaldehyde
in the presence of TBAF, forming a [<italic toggle="yes">&#946;</italic>-<sup>11</sup>C]<italic toggle="yes">3</italic>,<italic toggle="yes">4</italic>-(methylenedioxy)-<italic toggle="yes">&#946;</italic>-nitrophenetyl alcohol, which was subsequently reduced
using Raney nickel and formic acid and deprotected with BH<sub>3</sub> (<xref rid="fig144" ref-type="fig">Figure <xref rid="fig144" ref-type="fig">144</xref></xref>B).<sup><xref ref-type="bibr" rid="ref685">685</xref></sup> [<sup>11</sup>C]Norepinephrine was synthesized
with an isolated RCY of 20&#8211;25% at the end of [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> synthesis and <italic toggle="yes">A</italic><sub>m</sub> of 26&#8211;56 GBq/&#956;mol with a total processing time
of 65&#8211;70 min.<sup><xref ref-type="bibr" rid="ref685">685</xref></sup></p><fig id="fig144" position="float" orientation="portrait"><label>Figure 144</label><caption><p>Synthesis of [<sup>11</sup>C]norepinephrine. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr144" position="float" orientation="portrait" xlink:href="cr2c00398_0144.jpg"/></fig></sec><sec id="sec8.6.2"><label>8.6.2</label><title>Preclinical Studies</title><p>The biodistribution
of [<sup>11</sup>C]norepinephrine was tested with <italic toggle="yes">in vivo</italic> studies on four dogs. The radiopharmaceutical showed a quick blood
clearance with an estimated biological half-life of 2 min.<sup><xref ref-type="bibr" rid="ref682">682</xref></sup> The highest retention was detected in the adrenal
medulla, heart, and kidneys, whereas very little activity was detected
in the lungs. The activity in each organ was stable for the whole
scanning time (90 min), thus showing a slow washout from the target
organs.<sup><xref ref-type="bibr" rid="ref682">682</xref></sup></p><p>Other <italic toggle="yes">in vivo</italic> studies focused on how pharmacological agents affect the pharmacokinetics
of [<sup>11</sup>C]norepinephrine. In particular, the effect of desipramine
(inhibitor of the norepinephrine reuptake transporter) and cocaine
on [<sup>11</sup>C]norepinephrine biodistribution was investigated
in cynomolgus monkeys.<sup><xref ref-type="bibr" rid="ref642">642</xref>,<xref ref-type="bibr" rid="ref683">683</xref></sup> Both desipramine and
cocaine had a negative effect on [<sup>11</sup>C]norepinephrine retention
in the heart (&#8722;80% with desipramine and &#8722;33% with cocaine).<sup><xref ref-type="bibr" rid="ref642">642</xref>,<xref ref-type="bibr" rid="ref683">683</xref></sup></p><p>Metabolite studies were also performed in cynomolgus monkeys.
[<sup>11</sup>C]Norepinephrine showed a high metabolic resistance
in the
plasma, with 90% of the parent molecule remaining intact at 30 min
after the tracer injection.<sup><xref ref-type="bibr" rid="ref642">642</xref>,<xref ref-type="bibr" rid="ref643">643</xref></sup></p></sec></sec><sec id="sec8.7"><label>8.7</label><title>Octopamine</title><sec id="sec8.7.1"><label>8.7.1</label><title>Radiosynthesis</title><p><italic toggle="yes">p</italic>- and <italic toggle="yes">m</italic>-[<sup>11</sup>C]Octopamine have been first
synthesized from [<sup>11</sup>C]HCN in a two-step sequence by Maeda <italic toggle="yes">et al</italic>. (<xref rid="fig145" ref-type="fig">Figure <xref rid="fig145" ref-type="fig">145</xref></xref>).<sup><xref ref-type="bibr" rid="ref686">686</xref>,<xref ref-type="bibr" rid="ref687">687</xref></sup> Chemical and enzymatic approaches
have produced [<sup>11</sup>C]cyanohydrin intermediates as the critical
step. [<sup>11</sup>C]octopamine was prepared within 40&#8211;60
min, with a RCY of 0.7&#8211;2.3% at EOS, and ee of 92% in the (<italic toggle="yes">S</italic>)-enantiomer for <italic toggle="yes">p</italic>- and 42% in the (<italic toggle="yes">R</italic>)-enantiomer for <italic toggle="yes">m</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]octopamine, through the enzymatic process, as determined
by HPLC without any derivatization.<sup><xref ref-type="bibr" rid="ref686">686</xref>,<xref ref-type="bibr" rid="ref687">687</xref></sup></p><fig id="fig145" position="float" orientation="portrait"><label>Figure 145</label><caption><p>Synthesis
of <italic toggle="yes">p</italic>- and <italic toggle="yes">m</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]octopamine from [<sup>11</sup>C]HCN in
a two-step sequence.<sup><xref ref-type="bibr" rid="ref686">686</xref>,<xref ref-type="bibr" rid="ref687">687</xref></sup><sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr145" position="float" orientation="portrait" xlink:href="cr2c00398_0145.jpg"/></fig><p><sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-<italic toggle="yes">p</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Octopamine
has also
been prepared by reaction of 4-methoxy-benzaldehyde and the formed
[<italic toggle="yes">2-</italic><sup>11</sup>C]<italic toggle="yes">4</italic>-methoxy-nitrophenethyl
alcohol, followed by Raney nickel reduction and boron tribromide deprotection
as described in <xref rid="fig146" ref-type="fig">Figure <xref rid="fig146" ref-type="fig">146</xref></xref>. <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-<italic toggle="yes">p</italic>-[1-<sup>11</sup>C]Octopamine was prepared within 60&#8211;65
min, with a RCY of 20&#8211;25% (from [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>), RCP of &gt;98%, and <italic toggle="yes">A</italic><sub>m</sub> of
26&#8211;56 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref685">685</xref></sup></p><fig id="fig146" position="float" orientation="portrait"><label>Figure 146</label><caption><p>Synthesis
of <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-<italic toggle="yes">p</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]octopamine
from [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref685">685</xref></sup><sup>11</sup>C radionuclide position is highlighted in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr146" position="float" orientation="portrait" xlink:href="cr2c00398_0146.jpg"/></fig></sec></sec><sec id="sec8.8"><label>8.8</label><title>Progesterone</title><sec id="sec8.8.1"><label>8.8.1</label><title>Radiosynthesis</title><p>Following these
hypotheses, the labeling of a carbon-11 analogue of progesterone was
proposed as a viable alternative for cancer imaging. Two pathways
were developed for the synthesis of [<italic toggle="yes">21</italic>-<sup>11</sup>C]progesterone.<sup><xref ref-type="bibr" rid="ref688">688</xref>,<xref ref-type="bibr" rid="ref689">689</xref></sup> The first method employed [<sup>11</sup>C]CH<sub>3</sub>I as a radiolabeling agent and a <italic toggle="yes">p</italic>-toluenesulfonylmethyl isocyanide derivative of progesterone
(<xref rid="fig147" ref-type="fig">Figure <xref rid="fig147" ref-type="fig">147</xref></xref>) as the
precursor. The precursor was initially dissolved in aqueous NaOH,
followed by [<sup>11</sup>C]CH<sub>3</sub>I delivery and the radiolabeling
at 100 &#176;C for 15 min. The isocyanide intermediate was hydrolyzed
to yield the desired product by adding concentrated HCl and stirring
for 5 min at 70 &#176;C. [<italic toggle="yes">21</italic>-<sup>11</sup>C]Progesterone
was obtained within 60 min from [<sup>11</sup>C]CH<sub>3</sub>I delivery
with an isolated RCY of 13% and <italic toggle="yes">A</italic><sub>m</sub> of
0.74 GBq/&#956;mol at 60 min from [<sup>11</sup>C]CH<sub>3</sub>I
delivery.<sup><xref ref-type="bibr" rid="ref688">688</xref></sup></p><fig id="fig147" position="float" orientation="portrait"><label>Figure 147</label><caption><p>Synthesis of [<italic toggle="yes">21</italic>-<sup>11</sup>C]progesterone. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr147" position="float" orientation="portrait" xlink:href="cr2c00398_0147.jpg"/></fig><p>The second radiolabeling pathway proceeded with
the aid of [<sup>11</sup>C]methyl(<italic toggle="yes">2</italic>-thienyl)cuprate
as a synthon
which was synthesized from [<sup>11</sup>C]CH<sub>3</sub>I by initial
conversion to [<sup>11</sup>C]CH<sub>3</sub>Li with an excess of <italic toggle="yes">n</italic>-BuLi and subsequent reaction with lithium(<italic toggle="yes">2</italic>-thienyl)cyanocuprate (<xref rid="fig147" ref-type="fig">Figure <xref rid="fig147" ref-type="fig">147</xref></xref>). The precursor <italic toggle="yes">4</italic>-androsten-<italic toggle="yes">3</italic>-one-<italic toggle="yes">5</italic>-ene-<italic toggle="yes">17</italic>-carboxylic
acid chloride was synthesized starting from desoxycortisone by oxidation
to <italic toggle="yes">4</italic>-androsten-<italic toggle="yes">3</italic>-one-<italic toggle="yes">5</italic>-ene-<italic toggle="yes">17</italic>-carboxylic acid and functionalization to
its acyl chloride analogue with oxalyl chloride (<xref rid="fig147" ref-type="fig">Figure <xref rid="fig147" ref-type="fig">147</xref></xref>).<sup><xref ref-type="bibr" rid="ref689">689</xref></sup> The <sup>11</sup>C-labeling was then performed <italic toggle="yes">via</italic> cross-coupling of LiCN and <italic toggle="yes">4</italic>-androsten-<italic toggle="yes">3</italic>-one-<italic toggle="yes">5</italic>-ene-<italic toggle="yes">17</italic>-carboxylic
acid chloride in THF at 50 &#176;C in the presence of trimethylsilyl
chloride (TMSCl) (<xref rid="fig147" ref-type="fig">Figure <xref rid="fig147" ref-type="fig">147</xref></xref>). [<italic toggle="yes">21</italic>-<sup>11</sup>C]Progesterone was obtained
with an isolated RCY of 30&#8211;35% (based on [<sup>11</sup>C]CH<sub>3</sub>I initial activity) within 35 min from EOB and <italic toggle="yes">A</italic><sub>m</sub> of 14 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref689">689</xref></sup></p></sec></sec><sec id="sec8.9"><label>8.9</label><title>Serotonin</title><sec id="sec8.9.1"><title>8.9.1. Radiosynthesis</title><p>The synthesis of [<sup>11</sup>C]serotonin was achieved by the aid of the synthon [<sup>11</sup>C]HCN, which was initially trapped in solution as a potassium salt
([<sup>11</sup>C]KCN) using Kryptofix K222 and K<sub>2</sub>CO<sub>3</sub>. A 5-methoxygramine methyl sulfate precursor was introduced
into the reaction mixture and reacts with [<sup>11</sup>C]KCN to yield
a [<sup>11</sup>C]<italic toggle="yes">5</italic>-methoxy-<italic toggle="yes">3</italic>-acetonitrile
indole. By deprotection with BBr<sub>3</sub> and reduction with LiAlH<sub>4</sub>, the product [<sup>11</sup>C]serotonin was obtained (<xref rid="fig148" ref-type="fig">Figure <xref rid="fig148" ref-type="fig">148</xref></xref>) with an isolated
RCY of 13% and <italic toggle="yes">A</italic><sub>m</sub> of 5.1 GBq/&#956;mol
within 78 min.<sup><xref ref-type="bibr" rid="ref692">692</xref></sup></p><fig id="fig148" position="float" orientation="portrait"><label>Figure 148</label><caption><p>Synthesis of [<sup>11</sup>C]serotonin using [<sup>11</sup>C]KCN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr148" position="float" orientation="portrait" xlink:href="cr2c00398_0148.jpg"/></fig></sec><sec id="sec8.9.2"><label>8.9.2</label><title>Preclinical Studies</title><p>Determination
of single-pass extraction was initially tested on anesthetized dogs
and rabbits, highlighting a radioactivity uptake in the lung &gt;50%
of the total bolus of [<sup>11</sup>C]serotonin injected. The study,
however, does not report any data on pulmonary extraction.<sup><xref ref-type="bibr" rid="ref690">690</xref></sup></p></sec><sec id="sec8.9.3"><label>8.9.3</label><title>Clinical Studies</title><p>Determination
of single-pass extraction was tested on three healthy volunteers,
and pathological modifications were mimicked by infusing imipramine
(a serotonin transporter inhibitor, 0.4&#8211;0.5 mg/kg iv, 10 min
before [<sup>11</sup>C]serotonin administration).<sup><xref ref-type="bibr" rid="ref691">691</xref></sup> After imipramine infusion, the amount of [<sup>11</sup>C]serotonin extracted by the lungs was significantly lower (&#8722;16%
at 5 min p.i. of [<sup>11</sup>C]serotonin), confirming the feasibility
of using this technique to assess the integrity of the lung endothelium.<sup><xref ref-type="bibr" rid="ref691">691</xref></sup></p></sec></sec><sec id="sec8.10"><label>8.10</label><title>Tyramine</title><sec id="sec8.10.1"><label>8.10.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]tyramine was achieved by using [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> as a radioactive synthon that reacts with 4-hydroxybenzaldehyde
in the presence of ammonium acetate and acetic acid for 10 min at
140 &#176;C.<sup><xref ref-type="bibr" rid="ref664">664</xref></sup> The resulting [<sup>11</sup>C]nitropropene (<xref rid="fig149" ref-type="fig">Figure <xref rid="fig149" ref-type="fig">149</xref></xref>) was reduced over borane and lithium aluminum hydride at
120 &#176;C for 6 min, returning [<sup>11</sup>C]tyramine with RCY
of 8&#8211;20% based on the activity of [<sup>11</sup>C]CO<sub>2</sub>, within 45&#8211;50 min from EOB and <italic toggle="yes">A</italic><sub>m</sub> of 15&#8211;37 GBq/&#956;mol at EOS.<sup><xref ref-type="bibr" rid="ref664">664</xref></sup></p><fig id="fig149" position="float" orientation="portrait"><label>Figure 149</label><caption><p>Graphical representation of the radiolabeling strategy for [<sup>11</sup>C]tyramine. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr149" position="float" orientation="portrait" xlink:href="cr2c00398_0149.jpg"/></fig></sec></sec></sec><sec id="sec9"><label>9</label><title>Nucleotides, Nucleosides, and Nucleobases</title><p>Nucleotides are the monomeric units of DNA and ribonucleic acid
(RNA), consisting of a nucleoside and a phosphate. Nucleosides are
glucosamines consisting of a nucleobase and a five-carbon sugar. Nucleobases
are simple bases constituting the basic building blocks of nucleic
acids, with the five (adenine, cytosine, guanine, thymine, and uracil)
being the fundamental units of the genetic code. Adenine forms the
nucleoside adenosine when coupled with ribose <italic toggle="yes">via</italic> a <italic toggle="yes">&#946;</italic>-<italic toggle="yes">N</italic><sup>9</sup>-glycosidic
bond, as found in RNA. In DNA, adenine is attached to deoxyribose
to form deoxyadenosine. Its phosphorylated analogues AMP, adenosine
diphosphate (ADP), and adenosine triphosphate (ATP) act as cellular
energy sources, while cAMP is an important second messenger involved
in intracellular signal transduction.</p><p>Adenosine, ADP, and AMP
are endogenous ligands that mediate many
physiological processes through binding to the purinergic receptors
(P1, P2X, and P2Y).<sup><xref ref-type="bibr" rid="ref698">698</xref></sup> Thymidine consists
of the pyrimidine nucleobase thymine attached to deoxyribose <italic toggle="yes">via</italic> an <italic toggle="yes">N</italic>-glycosidic bond. Thymidine is
transported across the cell membrane from the bloodstream by equilibrative
nucleoside and concentrative transporters, found in most cell types.
Inside the cell, it can either be phosphorylated by thymidine kinase
and incorporated into DNA or degraded to thymine by thymidine phosphorylase.
Thymine is ultimately catabolized to CO<sub>2</sub>, NH<sub>3</sub>, and <italic toggle="yes">&#946;</italic>-aminoisobutyric acid (<italic toggle="yes">&#946;</italic>-AIB), by reduction, ring-opening, and decarboxylation.<sup><xref ref-type="bibr" rid="ref699">699</xref></sup> The pyrimidine derivative uracil, initially
discovered by Alberto Ascoli in 1900,<sup><xref ref-type="bibr" rid="ref700">700</xref></sup> is one of the four nucleobases in RNA, while in DNA, it is replaced
by its demethylated form, thymine.<sup><xref ref-type="bibr" rid="ref701">701</xref></sup> Unlike
adenine, cytosine, and guanine, thymine is not incorporated into RNA,
making thymidine a unique precursor to DNA.</p><p>Thymidine was one
of the earliest endogenous compounds radiolabeled
with carbon-11 due to its potential to measure DNA synthesis and tumor
proliferation.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref702">702</xref></sup> To evaluate metabolite kinetics
in [<sup>11</sup>C]thymidine PET imaging studies, the initial degradation
product, [<sup>11</sup>C]thymine, has also been radiolabeled and studied <italic toggle="yes">in vivo</italic>.<sup><xref ref-type="bibr" rid="ref703">703</xref></sup> Adenine has been
radiolabeled with carbon-11 to evaluate the placental transfer of
metabolic substrates.<sup><xref ref-type="bibr" rid="ref261">261</xref>,<xref ref-type="bibr" rid="ref704">704</xref></sup> AMP has been radiolabeled and
evaluated for its potential as an imaging agent of tumor metabolism.<sup><xref ref-type="bibr" rid="ref261">261</xref>,<xref ref-type="bibr" rid="ref704">704</xref>&#8722;<xref ref-type="bibr" rid="ref707">707</xref></sup> Uracil has also been labeled but not evaluated yet (<xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref>).</p><table-wrap id="tbl8" position="float" orientation="portrait"><label>Table 8</label><caption><title>Carbon-11 Labeled Nucleotides, Nucleosides,
and Nucleobases</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total time
(min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">adenine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-, <italic toggle="yes">5</italic>-, and <italic toggle="yes">6</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref261">261</xref>,<xref ref-type="bibr" rid="ref704">704</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr<xref rid="t8fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">8%</td><td style="border:none;" align="center" colspan="1" rowspan="1">60</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref708">708</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">adenosine monophosphate</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref705">705</xref></sup> rats<sup><xref ref-type="bibr" rid="ref706">706</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">90</td><td style="border:none;" align="center" colspan="1" rowspan="1">2.4%</td><td style="border:none;" align="center" colspan="1" rowspan="1">34</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref705">705</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">thymidine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref709">709</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref702">702</xref></sup> rat,<sup><xref ref-type="bibr" rid="ref710">710</xref>&#8722;<xref ref-type="bibr" rid="ref713">713</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref445">445</xref>,<xref ref-type="bibr" rid="ref709">709</xref>,<xref ref-type="bibr" rid="ref714">714</xref></sup> humans<sup><xref ref-type="bibr" rid="ref699">699</xref>,<xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref715">715</xref>&#8722;<xref ref-type="bibr" rid="ref721">721</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">3</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref702">702</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">147</td><td style="border:none;" align="center" colspan="1" rowspan="1">75%</td><td style="border:none;" align="center" colspan="1" rowspan="1">39</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref722">722</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>ZnI</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;50</td><td style="border:none;" align="center" colspan="1" rowspan="1">6%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref723">723</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO(NH<sub>2</sub>)<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">52</td><td style="border:none;" align="center" colspan="1" rowspan="1">14%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref724">724</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">thymine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref715">715</xref>&#8722;<xref ref-type="bibr" rid="ref717">717</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO(NH<sub>2</sub>)<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">52</td><td style="border:none;" align="center" colspan="1" rowspan="1">14%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref724">724</xref>&#8722;<xref ref-type="bibr" rid="ref726">726</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]COCl<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">38%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref727">727</xref>,<xref ref-type="bibr" rid="ref728">728</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">uracil</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO(NH<sub>2</sub>)<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">75%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref729">729</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t8fn1"><label>a</label><p>nr: not reported.</p></fn></table-wrap-foot></table-wrap><sec id="sec9.1"><label>9.1</label><title>Adenine and Adenosine Monophosphate</title><sec id="sec9.1.1"><label>9.1.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]adenine was reported in 1983 by Ido <italic toggle="yes">et al.</italic>,<sup><xref ref-type="bibr" rid="ref704">704</xref></sup><italic toggle="yes">via</italic> reaction of
carrier-added [<sup>11</sup>C]HCN with formamide (<xref rid="fig150" ref-type="fig">Figure <xref rid="fig150" ref-type="fig">150</xref></xref>). This procedure is based
on a process performed five years ago with [<sup>13</sup>C/<sup>15</sup>N]HCN.<sup><xref ref-type="bibr" rid="ref708">708</xref></sup> The <sup>11</sup>C-labeling
reaction was conducted in a sealed reaction vessel at 160 &#176;C
over 30 min, producing [<sup>11</sup>C]adenine in 6&#8211;8% isolated
RCY, with an overall synthesis time of 60&#8211;70 min, including
HPLC purification. As elucidated from the <sup>13</sup>C/<sup>15</sup>N experiments, the C-4, C-5, and C-6 adenine carbons are derived
from HCN. Hence the <sup>11</sup>C radiolabel is expected to reside
in any of these positions, although not in multiple positions within
the same molecule due to the high isotopic dilution of <sup>11</sup>C under standard radiolabeling conditions.</p><fig id="fig150" position="float" orientation="portrait"><label>Figure 150</label><caption><p>Synthesis of [<sup>11</sup>C]adenine using [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide
positions are highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr150" position="float" orientation="portrait" xlink:href="cr2c00398_0150.jpg"/></fig><p>The nucleotide AMP has been radiolabeled with <sup>11</sup>C in
the C-2 position through cyclization reaction of an acyclic carboxamidine
precursor with [<sup>11</sup>C]formaldehyde in the presence of Pd/C
(<xref rid="fig151" ref-type="fig">Figure <xref rid="fig151" ref-type="fig">151</xref></xref>).<sup><xref ref-type="bibr" rid="ref705">705</xref></sup></p><fig id="fig151" position="float" orientation="portrait"><label>Figure 151</label><caption><p>Synthesis of [<sup>11</sup>C]AMP using [<sup>11</sup>C]CH<sub>2</sub>O. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr151" position="float" orientation="portrait" xlink:href="cr2c00398_0151.jpg"/></fig><p>This one-step reaction proceeded at 80 &#176;C
over 10 min, and
after HPLC purification and formulation, provided [<sup>11</sup>C]AMP
for use in preclinical experiments (synthesis time, 34 min; RCY, 2.4%
from [<sup>11</sup>C]CH<sub>2</sub>O; <italic toggle="yes">A</italic><sub>m</sub>, 90 GBq/&#956;mol).</p></sec><sec id="sec9.1.2"><label>9.1.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Adenine has been administered to male and pregnant rats to evaluate
the biodistribution, and placental transfer of metabolic substrates
following iv injection.<sup><xref ref-type="bibr" rid="ref261">261</xref>,<xref ref-type="bibr" rid="ref704">704</xref></sup> High incorporations
were observed in the lung, with moderate uptake in the heart, liver,
small intestine, and pancreas.<sup><xref ref-type="bibr" rid="ref704">704</xref></sup> In pregnant
rats, the [<sup>11</sup>C]adenosine concentration was much smaller
in the fetal organs than in the maternal organs. A fetus-to-placenta
ratio of 31% <italic toggle="yes">vs</italic> a placenta-to-blood ratio of 52%
(at 30 min) also indicated limited transfer through the placenta.
Less than 0.1%ID/g was observed in the maternal brain because of the
effect of the BBB. However, a fetal brain-to-maternal brain uptake
ratio of 5 was observed, suggesting an immature BBB in the fetal brain.<sup><xref ref-type="bibr" rid="ref261">261</xref></sup></p><p>[<sup>11</sup>C]AMP has been evaluated
in mice<sup><xref ref-type="bibr" rid="ref705">705</xref></sup> and tumor-bearing rats,<sup><xref ref-type="bibr" rid="ref706">706</xref></sup> for biodistribution and PET studies, respectively. <italic toggle="yes">In vivo</italic>, extracellular adenylates such as AMP are known
to undergo rapid dephosphorylation to adenosine, which is then available
for cellular uptake <italic toggle="yes">via</italic> nucleoside transporters and
subsequent intracellular rephosphorylation to ATP. As such, [<sup>11</sup>C]AMP was investigated for its potential to study normal
adenylate metabolism and in pathological conditions such as cancer,
where accelerated import/export of adenylates associated with tumor
metabolism is expected.</p><p>The biodistribution study of [<sup>11</sup>C]AMP in mice showed
the highest accumulation of activity in the lungs (30%ID/g), blood
(27%ID/g), and heart (18%ID/g), with the lowest in the brain (1%ID/g)
(all values 30 min p.i.). The high uptake in blood and perfused organs
indicates that [<sup>11</sup>C]AMP participates in the normal adenylate
metabolism and delivery cycle. The low brain uptake suggests that
the tracer does not cross the intact BBB. The effect of the nucleoside
transporter inhibitor dipyridamole (30 mg/kg) on [<sup>11</sup>C]AMP
uptake in mice was also investigated. This showed no significant effect
on blood activity levels; however, at 60 min p.i., lung uptake was
reduced to about 40%.<sup><xref ref-type="bibr" rid="ref705">705</xref></sup></p><p>A baseline <italic toggle="yes">in vitro</italic> experiment was performed to
study radiotracer metabolism in human blood. Three adenylate radiometabolites
were observed, ATP, ADP, and adenosine. In whole blood, [<sup>11</sup>C]AMP was found to convert to ATP <italic toggle="yes">via</italic> ADP rapidly;
at 5 min p.i., the parent was almost undetectable (&lt;1%), with most
of the activity as ADP (42%) and AMP (44%). AMP levels increased to
&#8764;60% at 10 min and stabilized afterward. Conversely, in plasma,
where red blood cells are absent, [<sup>11</sup>C]AMP was dephosphorylated
to adenosine after 5 min. A similar effect was observed in dipyridamole-treated
whole blood, where cellular uptake of adenosine was blocked; at 5
min, the major metabolite was adenosine (&gt;70%), with minimal ADP
and
ATP formation.</p><p>In 2006, the potential of [<sup>11</sup>C]AMP
as a PET radiotracer
for imaging nucleoside transporters in a rat tumor model was explored
by Cho <italic toggle="yes">et al.</italic>,<sup><xref ref-type="bibr" rid="ref706">706</xref></sup> having
previously demonstrated that various tumor cell lines had marked uptake
of [<sup>3</sup>H]AMP through equilibrative or concentrative nucleoside
transporters.<sup><xref ref-type="bibr" rid="ref707">707</xref></sup> Whole-body images showed
intense [<sup>11</sup>C]AMP distribution and uptake to lungs, myocardium,
kidney, and brown adipose tissue in both tumor model systems. The
authors concluded that there was sufficient tumor uptake <italic toggle="yes">in
vivo</italic> to warrant further evaluation of [<sup>11</sup>C]AMP
as a radiotracer for tumor nucleoside transporter activity and possibly
to assess resistance to nucleoside analogue chemotherapy agents; however,
no further studies with this tracer have been reported to date.<sup><xref ref-type="bibr" rid="ref706">706</xref></sup></p></sec></sec><sec id="sec9.2"><label>9.2</label><title>Thymidine and Thymine</title><sec id="sec9.2.1"><label>9.2.1</label><title>Radiosynthesis</title><p>Thymidine has been
labeled with <sup>11</sup>C, either at the 5-methyl position ([<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine) or in the 2-carbonyl position
of the pyrimidine ring ([2-<sup>11</sup>C]thymidine).</p><p>[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]thymidine was first synthesized in
1972 <italic toggle="yes">via</italic> a two-step enzymatic process, beginning
with the transfer of [<sup>11</sup>C]CH<sub>2</sub>O to deoxyuridine
monophosphate to give [<sup>11</sup>C]thymidine-monophosphate, followed
by dephosphorylation<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref702">702</xref></sup> (<xref rid="fig152" ref-type="fig">Figure <xref rid="fig152" ref-type="fig">152</xref></xref>A. Time: 70 min, Product activity: 0.15
GBq. <italic toggle="yes">A</italic><sub>m</sub>: 3 GBq/&#956;mol for [<sup>11</sup>C]CH<sub>2</sub>O at EOB).<sup><xref ref-type="bibr" rid="ref702">702</xref></sup> To increase
yields and <italic toggle="yes">A</italic><sub>m</sub> and allow for automation,
alternative preparations utilizing [<sup>11</sup>C]CH<sub>3</sub>I
were developed and used in clinical tracer productions.<sup><xref ref-type="bibr" rid="ref702">702</xref>,<xref ref-type="bibr" rid="ref730">730</xref>&#8722;<xref ref-type="bibr" rid="ref733">733</xref></sup> To increase yields and <italic toggle="yes">A</italic><sub>m</sub> and allow
for automation, alternative preparations utilizing [<sup>11</sup>C]CH<sub>3</sub>I were developed and used in clinical tracer productions.<sup><xref ref-type="bibr" rid="ref731">731</xref>,<xref ref-type="bibr" rid="ref732">732</xref>,<xref ref-type="bibr" rid="ref734">734</xref>,<xref ref-type="bibr" rid="ref735">735</xref></sup> In this approach, 5-bromo-2&#8242;-deoxyuridine derivatives bearing
trimethylsilyl<sup><xref ref-type="bibr" rid="ref730">730</xref>,<xref ref-type="bibr" rid="ref733">733</xref>,<xref ref-type="bibr" rid="ref736">736</xref></sup> or tetrahydropyranyl<sup><xref ref-type="bibr" rid="ref730">730</xref>,<xref ref-type="bibr" rid="ref733">733</xref>,<xref ref-type="bibr" rid="ref736">736</xref></sup> hydroxyl protecting groups are lithiated, then <sup>11</sup>C-methylated
to produce [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine after
protecting group removal (<xref rid="fig152" ref-type="fig">Figure <xref rid="fig152" ref-type="fig">152</xref></xref>B). Time: 30&#8211;35 min. Product activity: 0.7&#8211;1.1
GBq. RCY: 19%, <italic toggle="yes">A</italic><sub>m</sub>: 45 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref733">733</xref></sup> More recently, Pd(0)-mediated reactions that
do not require protecting groups have been reported to produce [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine in one step <italic toggle="yes">via</italic> Stille coupling of [<sup>11</sup>C]CH<sub>3</sub>I with <italic toggle="yes">5</italic>-tributylstannyl-<italic toggle="yes">2&#8242;</italic>-deoxyuridine<sup><xref ref-type="bibr" rid="ref722">722</xref>,<xref ref-type="bibr" rid="ref737">737</xref></sup> (<xref rid="fig152" ref-type="fig">Figure <xref rid="fig152" ref-type="fig">152</xref></xref>C; time,
39 min; product activity of 7.9 GBq, RCY of 75%, <italic toggle="yes">A</italic><sub>m</sub> of 86&#8211;147 GBq/&#956;mol)<sup><xref ref-type="bibr" rid="ref722">722</xref></sup> and <italic toggle="yes">via</italic> Negishi coupling of <italic toggle="yes">5</italic>-iodo-<italic toggle="yes">2</italic>-deoxyuridine with the <sup>11</sup>C-nucleophile
[<sup>11</sup>C]ZnCH<sub>3</sub>I (<xref rid="fig152" ref-type="fig">Figure <xref rid="fig152" ref-type="fig">152</xref></xref>D. RCY of 6%, <italic toggle="yes">A</italic><sub>m</sub> &gt;50 GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref723">723</xref></sup></p><fig id="fig152" position="float" orientation="portrait"><label>Figure 152</label><caption><p>Synthesis
of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine
from different synthons [<sup>11</sup>C]CO<sub>2</sub>, [<sup>11</sup>C]CH<sub>3</sub>I, and [<sup>11</sup>C]CH<sub>3</sub>ZnI. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr152" position="float" orientation="portrait" xlink:href="cr2c00398_0152.jpg"/></fig><p>The preparation of [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine
was first described in 1991 <italic toggle="yes">via</italic> a two-step process,
beginning with the cyclo-condensation reaction of (derived from [<sup>11</sup>C]cyanide) and diethyl &#946;-methylmalate is fuming sulfuric
acid to produce [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymine, which
was subsequently converted to [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine <italic toggle="yes">via</italic> enzymatic glycosylation (<xref rid="fig153" ref-type="fig">Figure <xref rid="fig153" ref-type="fig">153</xref></xref>A).<sup><xref ref-type="bibr" rid="ref725">725</xref></sup> This
process has been automated,<sup><xref ref-type="bibr" rid="ref726">726</xref></sup> modified
using alternative cyclization reagents,<sup><xref ref-type="bibr" rid="ref738">738</xref></sup> and using [<sup>11</sup>C]urea derived from [<sup>11</sup>C]phosgene
(production time of 40&#8211;50 min, product activity of 1.5&#8211;3.3
GBq, RCY of 14%, <italic toggle="yes">A</italic><sub>m</sub> of 30&#8211;52 GBq/&#956;mol)<sup><xref ref-type="bibr" rid="ref724">724</xref>,<xref ref-type="bibr" rid="ref726">726</xref></sup> for applications in clinical tracer production.<sup><xref ref-type="bibr" rid="ref724">724</xref>&#8722;<xref ref-type="bibr" rid="ref726">726</xref>,<xref ref-type="bibr" rid="ref738">738</xref></sup></p><fig id="fig153" position="float" orientation="portrait"><label>Figure 153</label><caption><p>Synthesis of [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine from
different synthons [<sup>11</sup>C]COCl<sub>2</sub> and [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr153" position="float" orientation="portrait" xlink:href="cr2c00398_0153.jpg"/></fig><p>Ohkura, Seki <italic toggle="yes">et al</italic>. reported an
alternative approach
to the cyclocondensation reaction involving a direct reaction of [<sup>11</sup>C]phosgene with a dinucleophilic thymine precursor.<sup><xref ref-type="bibr" rid="ref727">727</xref>,<xref ref-type="bibr" rid="ref728">728</xref></sup> In this process, the potassium salt of <italic toggle="yes">&#946;</italic>-(<italic toggle="yes">N</italic>-benzoylamino)methacrylamide undergoes reaction with [<sup>11</sup>C]phosgene to produce [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymine
after amide hydrolysis (<xref rid="fig153" ref-type="fig">Figure <xref rid="fig153" ref-type="fig">153</xref></xref>B). Although the RCY for [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymine formation was lower than that reported <italic toggle="yes">via</italic> [<sup>11</sup>C]urea (24% <italic toggle="yes">vs</italic> 38.5%, from [<sup>11</sup>C]COCl<sub>2</sub>),<sup><xref ref-type="bibr" rid="ref724">724</xref></sup> it was
operationally simple (one-pot process).</p></sec><sec id="sec9.2.2"><label>9.2.2</label><title>Preclinical Studies</title><p>[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]thymidine<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref702">702</xref>,<xref ref-type="bibr" rid="ref709">709</xref>&#8722;<xref ref-type="bibr" rid="ref712">712</xref>,<xref ref-type="bibr" rid="ref714">714</xref></sup> and [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine<sup><xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref716">716</xref>,<xref ref-type="bibr" rid="ref725">725</xref></sup> have been studied preclinically <italic toggle="yes">in vivo</italic> in mice,<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref709">709</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref702">702</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref710">710</xref>&#8722;<xref ref-type="bibr" rid="ref713">713</xref></sup> and dogs<sup><xref ref-type="bibr" rid="ref445">445</xref>,<xref ref-type="bibr" rid="ref709">709</xref>,<xref ref-type="bibr" rid="ref714">714</xref></sup> to probe metabolism, DNA incorporation, and biodistribution in healthy
and disease-model animals. Regardless of radiolabeling position, the
tracer was rapidly catabolized <italic toggle="yes">in vivo</italic>. In dog<sup><xref ref-type="bibr" rid="ref714">714</xref></sup> and rat<sup><xref ref-type="bibr" rid="ref711">711</xref></sup> studies,
less than 30% [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine was
found to remain in plasma at 5 min p.i. Despite this, the majority
of activity was found to arise from [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine incorporated in DNA or as DNA precursors.<sup><xref ref-type="bibr" rid="ref712">712</xref></sup></p><p>A biodistribution study of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine in healthy mice observed that primary direct
uptake in the liver and organs are known to have high cell proliferation
rates, such as the spleen and intestine.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Similar uptake was observed in healthy rats; liver, spleen, and
large intestines.<sup><xref ref-type="bibr" rid="ref710">710</xref></sup> A PET study of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine in rats found activity accumulation
in the liver and kidneys.<sup><xref ref-type="bibr" rid="ref712">712</xref></sup></p></sec><sec id="sec9.2.3"><label>9.2.3</label><title>Clinical Studies</title><p>In a study of
the biokinetics and dosimetry of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine, preferential uptake of activity was observed in the
liver and kidneys, with less pronounced uptake in the skeletal muscle
tissue, heart wall, lungs, and salivary glands.<sup><xref ref-type="bibr" rid="ref716">716</xref></sup> PET studies using [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymine
and [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine in healthy volunteers
have been performed to validate the kinetic models used to estimate
tumor proliferation<sup><xref ref-type="bibr" rid="ref703">703</xref>,<xref ref-type="bibr" rid="ref717">717</xref></sup> and to develop and evaluate
a system for the measurement of expired [<sup>11</sup>C]CO<sub>2</sub> during <sup>11</sup>C PET scans.<sup><xref ref-type="bibr" rid="ref715">715</xref>,<xref ref-type="bibr" rid="ref716">716</xref></sup></p><p>Numerous
PET studies using [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine,<sup><xref ref-type="bibr" rid="ref710">710</xref>,<xref ref-type="bibr" rid="ref714">714</xref>,<xref ref-type="bibr" rid="ref718">718</xref>,<xref ref-type="bibr" rid="ref730">730</xref>,<xref ref-type="bibr" rid="ref739">739</xref>&#8722;<xref ref-type="bibr" rid="ref743">743</xref></sup> and [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine,<sup><xref ref-type="bibr" rid="ref717">717</xref>,<xref ref-type="bibr" rid="ref719">719</xref>,<xref ref-type="bibr" rid="ref744">744</xref>&#8722;<xref ref-type="bibr" rid="ref752">752</xref></sup> have been performed to evaluate cell proliferation in human tissue
tumors, including lymphoma, head and neck tumors, brain tumors, renal
cell carcinoma, lung cancer, and gastrointestinal cancers.</p><p>For
both labeling positions, radiometabolites account for most
plasma radioactivity at just three min post-injection.<sup><xref ref-type="bibr" rid="ref718">718</xref>,<xref ref-type="bibr" rid="ref719">719</xref></sup> The radiometabolic profile is influenced by the position of the
radiolabel, whereas metabolism of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]thymidine ultimately generates radiolabeled [<sup>11</sup>C]<italic toggle="yes">&#946;</italic>-AIB, the principal radiometabolite of [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine is [<sup>11</sup>C]CO<sub>2</sub>. Because
[<sup>11</sup>C]CO<sub>2</sub> may be rapidly eliminated, the accumulation
of labeled metabolites in tissue is minimized, thus favoring [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine for cell proliferation studies.
However, irrespective of the choice of <sup>11</sup>C labeling position,
the <italic toggle="yes">in vivo</italic> decomposition limits its utility for
PET studies.<sup><xref ref-type="bibr" rid="ref699">699</xref>,<xref ref-type="bibr" rid="ref720">720</xref>,<xref ref-type="bibr" rid="ref721">721</xref></sup> To overcome this, radiolabeled thymidine analogues that are resistant
to <italic toggle="yes">in vivo</italic> degradation have been developed, notably <italic toggle="yes">3&#8242;&#8217;</italic>-deoxy-<italic toggle="yes">3&#8242;</italic>-[<sup>18</sup>F]fluorothymidine.<sup><xref ref-type="bibr" rid="ref753">753</xref></sup></p></sec></sec><sec id="sec9.3"><label>9.3</label><title>Uracil</title><sec id="sec9.3.1"><label>9.3.1</label><title>Radiosynthesis</title><p>In 1997, Chakraborty <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref729">729</xref></sup> reported the synthesis
of [<sup>11</sup>C]uracil from [<sup>11</sup>C]urea, based on the
cyclocondensation reaction used to radiolabel the 5-methylated uracil
derivative, [<italic toggle="yes">2</italic>-<sup>11</sup>C]thymidine.<sup><xref ref-type="bibr" rid="ref725">725</xref></sup> Here, a simplified means of accessing [<sup>11</sup>C]urea from cyclotron-produced [<sup>11</sup>C]CO<sub>2</sub> was described, avoiding the previously reported multistep preparations
involving the secondary <sup>11</sup>C-labeling reagents [<sup>11</sup>C]cyanide,<sup><xref ref-type="bibr" rid="ref724">724</xref>,<xref ref-type="bibr" rid="ref754">754</xref></sup> or [<sup>11</sup>C]phosgene.<sup><xref ref-type="bibr" rid="ref755">755</xref></sup> The subsequent conversion of [<sup>11</sup>C]urea to [<sup>11</sup>C]uracil was investigated as a model reaction
(<xref rid="fig154" ref-type="fig">Figure <xref rid="fig154" ref-type="fig">154</xref></xref>).</p><fig id="fig154" position="float" orientation="portrait"><label>Figure 154</label><caption><p>Synthesis
of [<sup>11</sup>C]uracil using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr154" position="float" orientation="portrait" xlink:href="cr2c00398_0154.jpg"/></fig><p>In this process, [<sup>11</sup>C]CO<sub>2</sub> was bubbled through
a solution of lithium bis(trimethylsilyl)amide to produce the intermediate
[<sup>11</sup>C]bis(trimethylsilyl)carbodiimide, which was then hydrolyzed
with aqueous ammonium chloride.<sup><xref ref-type="bibr" rid="ref729">729</xref></sup> Following
azeotropic drying, anhydrous [<sup>11</sup>C]urea was obtained in
55&#8211;70% RCY in 16 min. Condensation of [<sup>11</sup>C]urea
and unlabeled urea with diethyl malate in the presence of fuming sulfuric
acid produced [<sup>11</sup>C]uracil (carrier-added) with a nonisolated
RCY of 40&#8211;75%. To date, no biological evaluation of [<sup>11</sup>C]uracil or its nucleoside analogue [<sup>11</sup>C]uridine has been
reported.<sup><xref ref-type="bibr" rid="ref729">729</xref></sup></p></sec></sec></sec><sec id="sec10"><label>10</label><title>Peptides</title><p>The use of <sup>11</sup>C
for labeling peptides is, up to date,
far more challenging even though peptides and AAs are alike in many
ways. Their translation into PET imaging agents has been supported
with specialized radiolabeling reactions in very recent years.<sup><xref ref-type="bibr" rid="ref756">756</xref></sup> However, the application of <sup>11</sup>C-labeled
peptides remains largely unexplored. A challenge for the application
might be associated with slow distribution for <italic toggle="yes">in vivo</italic> studies due to rapid metabolism. The only examples of <sup>11</sup>C-labeled natural peptides were methionine enkephalin (Met-enkephalin)<sup><xref ref-type="bibr" rid="ref757">757</xref>,<xref ref-type="bibr" rid="ref758">758</xref></sup> and substance P<sup><xref ref-type="bibr" rid="ref759">759</xref>,<xref ref-type="bibr" rid="ref760">760</xref></sup> (<xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>).</p><table-wrap id="tbl9" position="float" orientation="portrait"><label>Table 9</label><caption><title>Important Carbon-11 Labeled Peptides</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total synthesis
t (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Met5-enkephalin</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">monkeys<sup><xref ref-type="bibr" rid="ref757">757</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref757">757</xref>,<xref ref-type="bibr" rid="ref759">759</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">substance&#160;P</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">S</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr<xref rid="t9fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">7.4</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref759">759</xref>,<xref ref-type="bibr" rid="ref760">760</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t9fn1"><label>a</label><p>nr: not reported</p></fn></table-wrap-foot></table-wrap><p>Met-enkephalin was initially discovered by Hughes
in 1975.<sup><xref ref-type="bibr" rid="ref761">761</xref></sup> Met-enkephalin is a naturally
occurring pentapeptide
with the amino acid sequence of Tyr-Gly-Gly-Phe-Met, found in the
blood at low concentrations and is present in all parts of the nervous
system,<sup><xref ref-type="bibr" rid="ref762">762</xref></sup> mainly in the adrenal medulla
and throughout the CNS.<sup><xref ref-type="bibr" rid="ref763">763</xref></sup> As Met-enkephalin
has low bioavailability, is rapidly metabolized, and has a short half-life,
Met-enkephalin, also called opioid growth factor, has an important
role in pain regulation by inhibiting the release of neurotransmitters
when specific opioid receptors are activated. Met-enkephalin is a
potent agonist of the &#948;-opioid receptor and to a lesser extent,
the &#956;-opioid receptor, with little to no effect on the &#954;-opioid
receptor.<sup><xref ref-type="bibr" rid="ref764">764</xref></sup></p><p>Substance P was initially
discovered in 1931 by Ulf von Euler and
Gaddum.<sup><xref ref-type="bibr" rid="ref765">765</xref></sup> It is an undecapeptide member
of the tachykinin neuropeptide family with the amino acid sequence
of Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met.<sup><xref ref-type="bibr" rid="ref766">766</xref></sup> It is found in the brain and spinal cord and is associated
with inflammatory processes and pain, acting as a neurotransmitter
and neuromodulator.<sup><xref ref-type="bibr" rid="ref767">767</xref></sup> Substance P is widely
distributed in the peripheral and CNS of vertebrates.<sup><xref ref-type="bibr" rid="ref768">768</xref></sup> The endogenous receptor for substance P is
the neurokinin 1 receptor.<sup><xref ref-type="bibr" rid="ref768">768</xref>,<xref ref-type="bibr" rid="ref769">769</xref></sup></p><sec id="sec10.1"><label>10.1</label><title>Met5-enkephalin</title><sec id="sec10.1.1"><label>10.1.1</label><title>Radiosynthesis</title><p>The peptide was
radiolabeled with <sup>11</sup>C by cooling a mixture of protected
peptide precursor (<xref rid="fig155" ref-type="fig">Figure <xref rid="fig155" ref-type="fig">155</xref></xref>) and sodium in condensed ammonia to &#8722;78 &#176;C. [<sup>11</sup>C]CH<sub>3</sub>I was added to the mixture. The reaction
mixture was gently heated, and ammonia was removed using nitrogen
gas flow. The resulting solid residue was dissolved in a physiological
buffer and purified by HPLC. The isolated RCY, including purification,
was between 50&#8211;80% and the total synthesis time was between
35&#8211;50 min.<sup><xref ref-type="bibr" rid="ref757">757</xref>,<xref ref-type="bibr" rid="ref759">759</xref></sup></p><fig id="fig155" position="float" orientation="portrait"><label>Figure 155</label><caption><p>Synthesis of [<sup>11</sup>C]Met-enkephalin using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr155" position="float" orientation="portrait" xlink:href="cr2c00398_0155.jpg"/></fig></sec><sec id="sec10.1.2"><label>10.1.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Met-enkephalin was studied by Hartvig <italic toggle="yes">et al</italic>. in
1986 in two rhesus monkeys (<italic toggle="yes">Macaca mulatta</italic>) after an overnight fast.<sup><xref ref-type="bibr" rid="ref757">757</xref></sup> An intravenous
catheter was inserted in each hind leg of the monkey, one for injection
of radioactive dose and the other for blood sampling. After iv administration,
the radioactivity, as measured with PET, rapidly reached the head
of the monkeys, where it peaked within 1 min p.i. The radioactivity
then rapidly declined with half-lives in the range of 2&#8211;3.5
min. The authors could not distinguish any localization of the radioactivity
within the brain. High activity was observed in the liver and lower
in muscle. However, no activity was observed in other tissues. Plasma
and urine analysis showed that a significant fraction of the radioactivity
was from [<sup>11</sup>C]methionine, whereas the intact [<sup>11</sup>C]Met-enkephalin only constituted a minor proportion of about 1&#8211;2%.
[<sup>11</sup>C]Methionine was present in significant amounts in the
plasma only a few min after administration of the radioactive dose,
indicating that [<sup>11</sup>C]Met-enkephalin was hydrolyzed <italic toggle="yes">in vivo</italic>. Increased incorporation of radioactivity (47%,
1 h p.i.) into the plasma protein fraction, probably <italic toggle="yes">via</italic> [<sup>11</sup>C]methionine, was also observed. After the initial
blood distribution phase, the radioactivity derived from [<sup>11</sup>C]Met-enkephalin remained at a high level in the pituitary for the
whole period of observation, up to 60 min (<xref rid="fig156" ref-type="fig">Figure <xref rid="fig156" ref-type="fig">156</xref></xref>). Therefore, the authors concluded that
[<sup>11</sup>C]methionine was probably taken up in the brain, mainly
responsible for the high brain uptake.<sup><xref ref-type="bibr" rid="ref757">757</xref></sup></p><fig id="fig156" position="float" orientation="portrait"><label>Figure 156</label><caption><p>[<sup>11</sup>C]Met-enkephalin PET scan of a rhesus monkey&#8217;s
head at the pituitary level. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref757">757</xref>). Copyright 1986 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr156" position="float" orientation="portrait" xlink:href="cr2c00398_0156.jpg"/></fig></sec></sec><sec id="sec10.2"><label>10.2</label><title>Substance P</title><sec id="sec10.2.1"><label>10.2.1</label><title>Radiosynthesis</title><p>Substance P was
radiolabeled with <sup>11</sup>C, similar to the preparation of [<sup>11</sup>C]Met-enkephalin described above from the same group (<xref rid="fig157" ref-type="fig">Figure <xref rid="fig157" ref-type="fig">157</xref></xref>).<sup><xref ref-type="bibr" rid="ref759">759</xref>,<xref ref-type="bibr" rid="ref760">760</xref></sup> The isolated RCY, including purification, was 35% with at least
98% RPP, and the total synthesis time was between 45&#8211;60 min.
The <italic toggle="yes">A</italic><sub>m</sub> of the labeled peptide was 0.37&#8211;7.4
GBq/&#956;mol at the end of the peptide labeling.<sup><xref ref-type="bibr" rid="ref760">760</xref></sup></p><fig id="fig157" position="float" orientation="portrait"><label>Figure 157</label><caption><p>Synthesis of [<sup>11</sup>C]substance P using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted
in
red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr157" position="float" orientation="portrait" xlink:href="cr2c00398_0157.jpg"/></fig></sec></sec></sec><sec id="sec11"><label>11</label><title>Sugars</title><p>The human body uses sugars
mainly as an energy source. Glucose,
in the human body, acts as the primary form of energy for the cells
after being metabolized in the cytoplasm<sup><xref ref-type="bibr" rid="ref770">770</xref></sup> and is stored as glycogen.<sup><xref ref-type="bibr" rid="ref771">771</xref></sup> Fructose
is mainly found in plants; however, recent reports showed that fructose
is produced by the human body, following the polyol metabolic pathway,
which consists of two enzymes and allows the isomerization of glucose
into fructose.<sup><xref ref-type="bibr" rid="ref555">555</xref></sup> Galactose is an endogenous
sugar and takes part in glucose metabolism. However, its metabolism
is independent of glucose in the blood.<sup><xref ref-type="bibr" rid="ref772">772</xref></sup> Mannose is an endogenous sugar monomer and epimer of glucose. Therefore,
it can be produced from glucose and converted to glucose in the human
body.<sup><xref ref-type="bibr" rid="ref773">773</xref></sup> For these reasons, using <sup>11</sup>C-labeled sugars and their amide derivatives would allow
imaging of their metabolism and transport in potentially each part
of the body. Furthermore, glucose itself would accurately determine
metabolic rates compared to its analogues.<sup><xref ref-type="bibr" rid="ref774">774</xref></sup> In this chapter, the radiolabeling and application of [<sup>11</sup>C]glucose, [<sup>11</sup>C]fructose, [<sup>11</sup>C]galactose, and
[<sup>11</sup>C]mannose are reviewed (<xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref>).</p><table-wrap id="tbl10" position="float" orientation="portrait"><label>Table 10</label><caption><title>Important Carbon-11 Labeled Sugars</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub>(GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total time
(min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">glucose</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref775">775</xref></sup> dogs,<sup><xref ref-type="bibr" rid="ref776">776</xref>&#8722;<xref ref-type="bibr" rid="ref779">779</xref></sup> macaques,<sup><xref ref-type="bibr" rid="ref780">780</xref>,<xref ref-type="bibr" rid="ref781">781</xref></sup> humans<sup><xref ref-type="bibr" rid="ref779">779</xref>,<xref ref-type="bibr" rid="ref782">782</xref>&#8722;<xref ref-type="bibr" rid="ref794">794</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr<xref rid="t10fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">15%</td><td style="border:none;" align="center" colspan="1" rowspan="1">38</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref795">795</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NH<sub>4</sub>CN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">30%</td><td style="border:none;" align="center" colspan="1" rowspan="1">70</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref780">780</xref>,<xref ref-type="bibr" rid="ref782">782</xref>,<xref ref-type="bibr" rid="ref796">796</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">17%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref797">797</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">fructose</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>/<italic toggle="yes">6</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref261">261</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">15%</td><td style="border:none;" align="center" colspan="1" rowspan="1">70</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref560">560</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">galactose</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref798">798</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">26%</td><td style="border:none;" align="center" colspan="1" rowspan="1">70</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref796">796</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">mannose</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">46</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref796">796</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>NO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">30%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref799">799</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t10fn1"><label>a</label><p>nr: not reported.</p></fn></table-wrap-foot></table-wrap><sec id="sec11.1"><label>11.1</label><title>Glucose</title><sec id="sec11.1.1"><label>11.1.1</label><title>Radiochemistry</title><p>Several radiochemical
or photosynthetic pathways achieved the radiosynthesis of [<sup>11</sup>C]glucose. Radiochemical preparation was achieved using <sc>d</sc>-arabinose as starting material, which was reacted with [<sup>11</sup>C]NaCN (rt, 10 min)<sup><xref ref-type="bibr" rid="ref796">796</xref></sup> or [<sup>11</sup>C]NH<sub>4</sub>CN (rt, 5 min),<sup><xref ref-type="bibr" rid="ref780">780</xref>,<xref ref-type="bibr" rid="ref782">782</xref>,<xref ref-type="bibr" rid="ref795">795</xref></sup> forming an [<italic toggle="yes">1</italic>-<sup>11</sup>C]aldonitrile
intermediate, which was subsequently reduced by Raney nickel in formic
acid for 6&#8211;10 min at 110 &#176;C. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Glucose was obtained with a total synthesis time of 50&#8211;70
min and RCYs reaching 30%.<sup><xref ref-type="bibr" rid="ref780">780</xref>,<xref ref-type="bibr" rid="ref782">782</xref>,<xref ref-type="bibr" rid="ref796">796</xref></sup> A shorter reaction time (38 min) was achieved <italic toggle="yes">via</italic> a solid phase-supported reaction while keeping the RCY similar (&#8764;15%).<sup><xref ref-type="bibr" rid="ref795">795</xref></sup> An alternative radiochemical route used [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> as a labeling agent: <sc>d</sc>-arabinose reacted with [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> at 40 &#176;C for 3 min in the presence of NaOH to form a [<italic toggle="yes">1</italic>-<sup>11</sup>C]nitro alcohol (<xref rid="fig158" ref-type="fig">Figure <xref rid="fig158" ref-type="fig">158</xref></xref>). The addition of sulfuric acid returned
[<italic toggle="yes">1</italic>-<sup>11</sup>C]glucose with an overall RCY of
14&#8211;17% within 50 min.<sup><xref ref-type="bibr" rid="ref797">797</xref></sup></p><fig id="fig158" position="float" orientation="portrait"><label>Figure 158</label><caption><p>Synthesis
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]glucose using [<sup>11</sup>C]NaCN, [<sup>11</sup>C]NH<sub>4</sub>CN, or [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr158" position="float" orientation="portrait" xlink:href="cr2c00398_0158.jpg"/></fig><p>The photosynthetic procedure was accomplished with
either Swiss
chard plants,<sup><xref ref-type="bibr" rid="ref774">774</xref>,<xref ref-type="bibr" rid="ref795">795</xref></sup> spinach,<sup><xref ref-type="bibr" rid="ref800">800</xref></sup> or algae.<sup><xref ref-type="bibr" rid="ref779">779</xref></sup> The plant was exposed
to light, and [<sup>11</sup>C]CO<sub>2</sub> from the target was recirculated
into the chamber containing the plant for 6&#8211;20 min while maintaining
a temperature between rt and 40 &#176;C to allow photosynthesis. This
process yielded [<italic toggle="yes">U</italic>-<sup>11</sup>C]glucose (where
all carbons have the same probability of being radiolabeled) with
a minimum <italic toggle="yes">A</italic><sub>m</sub> of 19 GBq/&#956;mol, RCY
of 9%, with an overall processing time of 75 min.<sup><xref ref-type="bibr" rid="ref775">775</xref></sup> Alongside [<italic toggle="yes">U</italic>-<sup>11</sup>C]glucose, photosynthetic
methods also produced [<sup>11</sup>C]fructose which, however, was
easily removed from the final product by HCl hydroysis<sup><xref ref-type="bibr" rid="ref774">774</xref></sup> or by HPLC purification.<sup><xref ref-type="bibr" rid="ref775">775</xref></sup></p></sec><sec id="sec11.1.3"><label>11.1.2</label><title>Preclinical Studies</title><p>The ubiquitous
consumption of glucose makes [<sup>11</sup>C]glucose a viable probe
for imaging the metabolism of a variety of organs. Studies with [<italic toggle="yes">1</italic>-<sup>11</sup>C]glucose and [<italic toggle="yes">U</italic>-<sup>11</sup>C]glucose were also performed to highlight differences in the radiolabeling
position.</p><p>Initial assessment of the cerebral metabolic rate
(CMR<sub>glc</sub>) and BBB glucose flux was done by 48 min scans
of macaques after [<sup>11</sup>C]glucose injection.<sup><xref ref-type="bibr" rid="ref780">780</xref></sup> Analysis of the results returned a net utilization fraction
of 0.12.<sup><xref ref-type="bibr" rid="ref780">780</xref></sup> A more accurate description
of [<sup>11</sup>C]glucose biodistribution was then reported after <italic toggle="yes">ex vivo</italic> analysis of male mice.<sup><xref ref-type="bibr" rid="ref775">775</xref></sup> The highest activity was detected in the brain, where the radiopharmaceutical
quickly peaked, plateaued, and stayed constant for 20 min. These studies
also highlighted increasing activity as a function of time by the
pancreas, while all other organs cleared it.<sup><xref ref-type="bibr" rid="ref775">775</xref></sup></p><p>The ability to differentiate metabolic states with [<sup>11</sup>C]glucose was also studied.<sup><xref ref-type="bibr" rid="ref776">776</xref>,<xref ref-type="bibr" rid="ref777">777</xref></sup> Twenty-two mongrel
dogs with diverse metabolic states (fasting, hyperinsulinemic, enhanced
glycolysis, increased glycogen production) were injected and scanned
for 1 h while collecting coronary blood for metabolite analysis.<sup><xref ref-type="bibr" rid="ref776">776</xref>,<xref ref-type="bibr" rid="ref777">777</xref></sup> The information retrieved allowed the accuracy of the various metabolic
states at the myocardium level.<sup><xref ref-type="bibr" rid="ref776">776</xref>,<xref ref-type="bibr" rid="ref777">777</xref></sup> Following
studies also revealed a higher accuracy of [<sup>11</sup>C]glucose
in myocardial assessment compared to [<sup>18</sup>F]FDG.<sup><xref ref-type="bibr" rid="ref778">778</xref></sup> No significant difference was detected after
comparing [<sup>11</sup>C]glucose with [<italic toggle="yes">U</italic>-<sup>14</sup>C]glucose to determine brain influx and metabolism.<sup><xref ref-type="bibr" rid="ref779">779</xref></sup></p><p>Preclinical studies also focused on determining the
most reliable
compartmental model to describe glucose influx and metabolism in the
brain. While the studies mentioned above related to a three-compartmental
model,<sup><xref ref-type="bibr" rid="ref801">801</xref></sup> the use of a four-compartmental
model (where the fourth rate constant considers the <sup>11</sup>C-metabolite
egress) showed to be a more accurate estimation, as confirmed by PET
scanning and blood metabolite analysis on four adult male macaques
in hypo- and normoglycemic conditions.<sup><xref ref-type="bibr" rid="ref781">781</xref></sup></p></sec><sec id="sec11.1.4"><label>11.1.3</label><title>Clinical Studies</title><p>Clinical studies
focused on assessing brain glucose metabolism in different metabolic
states. Initial assessment of [<sup>11</sup>C]glucose distribution
was done on seven healthy volunteers injected with [<sup>11</sup>C]glucose
and scanned for 24 min while simultaneously collecting blood samples
for metabolite analysis.<sup><xref ref-type="bibr" rid="ref783">783</xref></sup> The data analysis
returned a rCMR<sub>glc</sub> consistent with known brain metabolic
rates.<sup><xref ref-type="bibr" rid="ref783">783</xref></sup> Moreover, the images acquired
during scanning a patient who suffered brain infarction clearly show
the differences in metabolic rate between the infarcted and noninfarcted
areas (<xref rid="fig159" ref-type="fig">Figure <xref rid="fig159" ref-type="fig">159</xref></xref>).<sup><xref ref-type="bibr" rid="ref779">779</xref></sup> Radiation dosimetry studies after
[<sup>11</sup>C]glucose administration was confirmed to be small and
comparable to other clinically-available radiopharmaceuticals, limiting
the radiation risks associated with its use.<sup><xref ref-type="bibr" rid="ref784">784</xref></sup></p><fig id="fig159" position="float" orientation="portrait"><label>Figure 159</label><caption><p>[<sup>11</sup>C]Glucose PET images of a patient suffering brain
infarction. Darker areas (right frontal and temporal lobes) indicate
a lower [<sup>11</sup>C]glucose metabolism. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref779">779</xref>). Copyright
1983 Society of Nuclear Medicine. This work is licensed under a Creative
Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr159" position="float" orientation="portrait" xlink:href="cr2c00398_0159.jpg"/></fig><p>The effect of insulin-dependent diabetes mellitus
was investigated
by scanning six and eight nondiabetic patients while being infused
with insulin (to maintain the same insulin level as healthy controls).<sup><xref ref-type="bibr" rid="ref785">785</xref></sup> The results potentially indicate a higher rate
of nonoxidative glucose metabolism in diabetic patients.<sup><xref ref-type="bibr" rid="ref785">785</xref></sup> PET scanning of five healthy male individuals
aged 22&#8211;40 in hyperglycemic conditions instead highlighted
a slight increase in brain glucose metabolism compared to normoglycemia,
with the white matter being the most affected part.<sup><xref ref-type="bibr" rid="ref786">786</xref></sup> A nonlinear relationship between glucose blood levels and
brain glucose metabolism was also found.<sup><xref ref-type="bibr" rid="ref786">786</xref></sup></p><p>The ability of [<sup>11</sup>C]glucose to image neuronal activity
within different brain regions was then employed to identify aberrant
patterns associated with schizophrenia. The hypothesis of a hypofrontality
pattern, in which the blood flow in the frontal cortex is decreased,
was disproven by Widen <italic toggle="yes">et al</italic>. after studying a cohort
of six young schizophrenic patients.<sup><xref ref-type="bibr" rid="ref787">787</xref></sup> The scanning of a larger cohort (20 patients) could not identify
a typical aberrant pattern.<sup><xref ref-type="bibr" rid="ref788">788</xref></sup> Following
studies, however, identified three subtypes of schizophrenia based
on glucose metabolism patterns: (i) hypofrontal, with lower activity
retention in the frontal cortex (&#8722;38% compared to control);
(ii) hypoparietal, with a 26% decrease in glucose metabolism in the
parietal cortex; and (iii) normal, which did not have any significant
changes from control.<sup><xref ref-type="bibr" rid="ref789">789</xref></sup> To each subtype,
a behavioral pattern was associated, with hypofrontal being more blunted
and flat, hypoparietal being hallucinating and delusional, and the
normal subtype having a mix of both.<sup><xref ref-type="bibr" rid="ref789">789</xref></sup> Differences in glucose metabolism were also highlighted in depressed
patients, with a 35% decrease in overall brain activity retention
compared to control subjects.<sup><xref ref-type="bibr" rid="ref790">790</xref></sup></p><p>The detection of other neurological diseases, such as temporal
lobe epilepsy, encephalitis, and brain tumors, was also possible with
[<sup>11</sup>C]glucose.<sup><xref ref-type="bibr" rid="ref791">791</xref></sup> The scanning
of a 10-year-old encephalitis patient with [<italic toggle="yes">U</italic>-<sup>11</sup>C]glucose, instead, showed a significant white matter low
attenuation, indicating a regression in the cortical tissue, which,
however, completely disappeared after recovery from the disease.<sup><xref ref-type="bibr" rid="ref792">792</xref></sup> Regarding the detection of glioma brain tumors,
clinical studies were carried out on 40 patients.<sup><xref ref-type="bibr" rid="ref793">793</xref></sup> The detection of other brain tumors such as astrocytoma
(grade II and anaplastic), oligoastrocytoma, or meningiomas, instead,
was shown to be limited compared to other clinically-available radiopharmaceuticals
(<italic toggle="yes">e.g</italic>., [<sup>11</sup>C]methionine), especially for
low-grade tumors.<sup><xref ref-type="bibr" rid="ref794">794</xref></sup></p><p>Besides evaluating
different metabolic states and diseases, clinical
studies with [<sup>11</sup>C]glucose also focused on disclosing the
radiopharmaceutical stability and the formation of metabolites.<sup><xref ref-type="bibr" rid="ref782">782</xref>,<xref ref-type="bibr" rid="ref783">783</xref></sup> In particular, [<sup>11</sup>C]CO<sub>2</sub> egress was determined
by blood metabolite analysis on healthy male volunteers.<sup><xref ref-type="bibr" rid="ref782">782</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Glucose
showed to be metabolically more stable than [<italic toggle="yes">U</italic>-<sup>11</sup>C]glucose, having a slower and delayed [<sup>11</sup>C]CO<sub>2</sub> release.<sup><xref ref-type="bibr" rid="ref782">782</xref></sup> The slower egress
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]glucose also positively impacts
distinguishing between white and grey matter in the brain.<sup><xref ref-type="bibr" rid="ref783">783</xref></sup></p></sec></sec><sec id="sec11.2"><label>11.2</label><title>Fructose</title><sec id="sec11.2.1"><label>11.2.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Fructose
production was mainly achieved as a byproduct in the radiolabeling
of [<sup>11</sup>C]glucose and proceeded <italic toggle="yes">via</italic> photosynthesis.
Light-deprived leaves of Swiss chards were exposed to [<sup>11</sup>C]CO<sub>2</sub> and subsequently to light to trigger the photosynthetic
production of [<sup>11</sup>C]glucose, [<sup>11</sup>C]fructose, and
[<sup>11</sup>C]sucrose for 20 min, which were then alcohol extracted
from the leaf. The resulting radioactive mixture of saccharides contained
30&#8211;32% of [<sup>11</sup>C]fructose. The various products were
then separated using ion-exchange resins and specific carriers.<sup><xref ref-type="bibr" rid="ref557">557</xref>,<xref ref-type="bibr" rid="ref558">558</xref></sup> This synthetic method was subsequently fully automated.<sup><xref ref-type="bibr" rid="ref559">559</xref></sup></p><p>An alternative radiolabeling pathway
was developed to directly produce [<sup>11</sup>C]fructose (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>.4). This pathway
required the reaction of [<sup>11</sup>C]CH<sub>3</sub>I with <italic toggle="yes">2</italic>,<italic toggle="yes">4</italic>:<italic toggle="yes">4</italic>,<italic toggle="yes">5</italic> di-<italic toggle="yes">O</italic>-isopropylidene-<sc><italic toggle="yes">d</italic></sc>-arabinose in the presence of triphenylphosphine in <italic toggle="yes">o</italic>-dichlorobenzene, yielding <italic toggle="yes">4</italic>,<italic toggle="yes">4</italic>:5,<italic toggle="yes">6</italic>di-<italic toggle="yes">O</italic>-isopropylidene-<sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]arabino-hex-<italic toggle="yes">1</italic>-enitol within 6 min and subsequent conversion into <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]mannitol by addition of
osmium tetroxide and deprotection by 6 M HCl (<xref rid="fig160" ref-type="fig">Figure <xref rid="fig160" ref-type="fig">160</xref></xref>). <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Mannitol was then converted into [<sup>11</sup>C]fructose by enzymatic reaction with <sc>d</sc>-mannitol
dehydrogenase in the presence of NAD<sup>+</sup> and KOH for 7 min
(<xref rid="fig160" ref-type="fig">Figure <xref rid="fig160" ref-type="fig">160</xref></xref>). [<sup>11</sup>C]Fructose was produced with a total processing time of 70
min and with a RCY of 15%.<sup><xref ref-type="bibr" rid="ref560">560</xref></sup></p><fig id="fig160" position="float" orientation="portrait"><label>Figure 160</label><caption><p>Enzymatic
synthesis of <sc><italic toggle="yes">d</italic></sc>-[<sup>11</sup>C]fructose
using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C
radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr160" position="float" orientation="portrait" xlink:href="cr2c00398_0160.jpg"/></fig></sec><sec id="sec11.2.2"><label>11.2.2</label><title>Preclinical Studies</title><p>Clinical studies
were carried out using pregnant Wistar rats on their 16&#8211;19<sup>th</sup> day of gestation. The study aimed to disclose the crossing
of the placenta of several endogenous compounds, including [<sup>11</sup>C]fructose. A mixture of [<sup>11</sup>C]fructose and [<sup>11</sup>C]glucose (1.85&#8211;7.40 MBq) was injected, followed by culling
at regular time intervals (1, 5, 10, and 30 min) and tissue analysis.
The concentration of <sup>11</sup>C-sugars in fetal and maternal tissues
was comparable and increasing over time, reaching values higher than
1 within 30 min.<sup><xref ref-type="bibr" rid="ref261">261</xref></sup></p></sec></sec><sec id="sec11.3"><label>11.3</label><title>Galactose</title><sec id="sec11.3.1"><label>11.3.1</label><title>Radiosynthesis</title><p>Galactose was only
labeled from position 1 and synthesized using natural plants.<sup><xref ref-type="bibr" rid="ref798">798</xref></sup> The first radiolabeling of galactose with carbon-11
was done as biosynthesis from marine algae (<italic toggle="yes">Girgartina
stellata</italic>). Synthesis was started with [<sup>11</sup>C]CO<sub>2</sub> and completed in 40 min.<sup><xref ref-type="bibr" rid="ref798">798</xref></sup> Labeled galactose was separated by using LC. Another method which
includes the synthesis of <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]galactose, starts from [<sup>11</sup>C]HCN and <sc><italic toggle="yes">d</italic></sc>-lyxose, and then continues with the reduction
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]aldonitriles by Raney alloy
in formic acid (<xref rid="fig161" ref-type="fig">Figure <xref rid="fig161" ref-type="fig">161</xref></xref>).<sup><xref ref-type="bibr" rid="ref796">796</xref></sup> Total synthesis time was
70 min with a RCY of 26%.</p><fig id="fig161" position="float" orientation="portrait"><label>Figure 161</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]galactose using [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr161" position="float" orientation="portrait" xlink:href="cr2c00398_0161.jpg"/></fig></sec></sec><sec id="sec11.4"><label>11.4</label><title>Mannose</title><sec id="sec11.4.1"><label>11.4.1</label><title>Radiosynthesis</title><p>The first synthesis
was reported in 1985 for the <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]mannose by starting from [<sup>11</sup>C]HCN in NaCN solution and then reducing <sc>d</sc>-arabinose with
Raney alloy in formic acid made in the same solution.<sup><xref ref-type="bibr" rid="ref796">796</xref></sup> Final product was purified using HPLC and the
total synthesis time without purification was 46 min with a RCY of
40&#8211;50%. It was also shown that the yield depends on pH, and
in time glucose and mannose interchange affects the yield ratio. <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]Mannose
was also prepared from [<sup>11</sup>C]nitromethane in 50 min with
a RCY of 25&#8211;30% (based on [<sup>11</sup>C]nitromethane) (<xref rid="fig162" ref-type="fig">Figure <xref rid="fig162" ref-type="fig">162</xref></xref>).<sup><xref ref-type="bibr" rid="ref799">799</xref></sup></p><fig id="fig162" position="float" orientation="portrait"><label>Figure 162</label><caption><p>Synthesis of <sc><italic toggle="yes">d</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]mannose using [<sup>11</sup>C]CH<sub>2</sub>NO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr162" position="float" orientation="portrait" xlink:href="cr2c00398_0162.jpg"/></fig></sec></sec></sec><sec id="sec12"><label>12</label><title>Other Compounds</title><p>Besides the compounds
described below (<xref rid="tbl11" ref-type="other">Table <xref rid="tbl11" ref-type="other">11</xref></xref>), other natural exogenous compounds, less
common, have been labeled with carbon-11. Among these, [<sup>11</sup>C]cinnamic acid<sup><xref ref-type="bibr" rid="ref802">802</xref></sup> (oil of cinnamon),
[<sup>11</sup>C]1,3-diphenylurea<sup><xref ref-type="bibr" rid="ref803">803</xref>,<xref ref-type="bibr" rid="ref804">804</xref></sup> (a cytokinin
found in coconut milk), [<sup>11</sup>C]benzothiazole<sup><xref ref-type="bibr" rid="ref153">153</xref></sup> (food additive), [<sup>11</sup>C]benzaldehyde<sup><xref ref-type="bibr" rid="ref805">805</xref></sup> (food additive), [<sup>11</sup>C]octanal<sup><xref ref-type="bibr" rid="ref805">805</xref></sup> (citrus oil), and [<sup>11</sup>C]heptanoic
acid<sup><xref ref-type="bibr" rid="ref531">531</xref></sup> (additive in cigarettes). However,
these compounds have been described only in one or two studies and
not evaluated <italic toggle="yes">in vivo</italic>. Thus, they are not discussed
in this review.</p><table-wrap id="tbl11" position="float" orientation="portrait"><label>Table 11</label><caption><title>Other Carbon-11 Labeled Compounds</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">compd</th><th style="border:none;" align="center" colspan="1" rowspan="1">radiolabeling position</th><th style="border:none;" align="center" colspan="1" rowspan="1">preclinical and clinical studies</th><th style="border:none;" align="center" colspan="1" rowspan="1">synthon</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">A</italic><sub>M</sub> (GBq/&#956;mol)</th><th style="border:none;" align="center" colspan="1" rowspan="1">RCY</th><th style="border:none;" align="center" colspan="1" rowspan="1">total
time (min)</th><th style="border:none;" align="center" colspan="1" rowspan="1">ref</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1">4-aminobenzoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref850">850</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref851">851</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref851">851</xref></sup> humans<sup><xref ref-type="bibr" rid="ref851">851</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">407</td><td style="border:none;" align="center" colspan="1" rowspan="1">14%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr<xref rid="t11fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref852">852</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">benzoic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rabbits,<sup><xref ref-type="bibr" rid="ref810">810</xref>,<xref ref-type="bibr" rid="ref853">853</xref></sup> dogs<sup><xref ref-type="bibr" rid="ref854">854</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">10</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref810">810</xref>,<xref ref-type="bibr" rid="ref853">853</xref>,<xref ref-type="bibr" rid="ref855">855</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">cadaverine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref815">815</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">77%</td><td style="border:none;" align="center" colspan="1" rowspan="1">63</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref815">815</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">putrescine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref856">856</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref857">857</xref></sup> humans<sup><xref ref-type="bibr" rid="ref858">858</xref>&#8722;<xref ref-type="bibr" rid="ref860">860</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;52</td><td style="border:none;" align="center" colspan="1" rowspan="1">20%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref858">858</xref>&#8722;<xref ref-type="bibr" rid="ref860">860</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">choline</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref817">817</xref>,<xref ref-type="bibr" rid="ref861">861</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref862">862</xref>,<xref ref-type="bibr" rid="ref863">863</xref></sup> monkeys,<sup><xref ref-type="bibr" rid="ref864">864</xref></sup> humans<sup><xref ref-type="bibr" rid="ref817">817</xref>,<xref ref-type="bibr" rid="ref862">862</xref>,<xref ref-type="bibr" rid="ref865">865</xref>&#8722;<xref ref-type="bibr" rid="ref870">870</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;133</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;98%</td><td style="border:none;" align="center" colspan="1" rowspan="1">25</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref862">862</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>OTf</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;29.6</td><td style="border:none;" align="center" colspan="1" rowspan="1">85%</td><td style="border:none;" align="center" colspan="1" rowspan="1">15</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref871">871</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239;
&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">daunorubicin</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-<italic toggle="yes">acetyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref820">820</xref>,<xref ref-type="bibr" rid="ref821">821</xref>,<xref ref-type="bibr" rid="ref872">872</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>N<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">1.111</td><td style="border:none;" align="center" colspan="1" rowspan="1">3%</td><td style="border:none;" align="center" colspan="1" rowspan="1">53</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref820">820</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">4</italic>-<italic toggle="yes">methoxy</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1"><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">1%</td><td style="border:none;" align="center" colspan="1" rowspan="1">75</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref821">821</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">erythromycin lactobionate</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl-</italic></td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref873">873</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>2</sub>O</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">12%</td><td style="border:none;" align="center" colspan="1" rowspan="1">42</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref822">822</xref>,<xref ref-type="bibr" rid="ref823">823</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">glycerol</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">1.08&#160;&#215;&#160;10<sup>&#8211;4</sup></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref798">798</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">hippuric acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref874">874</xref></sup> rabbits<sup><xref ref-type="bibr" rid="ref855">855</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">8%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref874">874</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">lactic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">dogs,<sup><xref ref-type="bibr" rid="ref875">875</xref></sup> rabbits<sup><xref ref-type="bibr" rid="ref876">876</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]KCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">40%</td><td style="border:none;" align="center" colspan="1" rowspan="1">90</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref877">877</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]NaCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">&gt;80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">45</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref878">878</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref241">241</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">2</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO(CH<sub>3</sub>)<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">150</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref877">877</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">rats,<sup><xref ref-type="bibr" rid="ref879">879</xref></sup></italic> dogs<sup><xref ref-type="bibr" rid="ref880">880</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO(CH<sub>3</sub>)<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">150</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref877">877</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.02</td><td style="border:none;" align="center" colspan="1" rowspan="1">26.5%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref881">881</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-acetyl-leukotriene E4</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">acetyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref832">832</xref>,<xref ref-type="bibr" rid="ref882">882</xref>,<xref ref-type="bibr" rid="ref883">883</xref></sup> pigs,<sup><xref ref-type="bibr" rid="ref883">883</xref></sup> monkeys<sup><xref ref-type="bibr" rid="ref883">883</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>COCl</td><td style="border:none;" align="center" colspan="1" rowspan="1">2</td><td style="border:none;" align="center" colspan="1" rowspan="1">1.3%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref883">883</xref>,<xref ref-type="bibr" rid="ref884">884</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-methyltaurine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">3</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref885">885</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">oxalic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CN<sup>&#8211;</sup></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70.8%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref886">886</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">paclitaxel</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<italic toggle="yes">1</italic>-<sup>11</sup>C]C<sub>6</sub>H<sub>5</sub>COCl</td><td style="border:none;" align="center" colspan="1" rowspan="1">0.0499</td><td style="border:none;" align="center" colspan="1" rowspan="1">7%</td><td style="border:none;" align="center" colspan="1" rowspan="1">38</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref887">887</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">phenylethanolamine</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]HCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">130.1</td><td style="border:none;" align="center" colspan="1" rowspan="1">4%</td><td style="border:none;" align="center" colspan="1" rowspan="1">50</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref888">888</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">56</td><td style="border:none;" align="center" colspan="1" rowspan="1">50%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref685">685</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">phenylpyruvic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">40%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref428">428</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">pyruvic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats,<sup><xref ref-type="bibr" rid="ref889">889</xref>,<xref ref-type="bibr" rid="ref890">890</xref></sup> rabbits,<sup><xref ref-type="bibr" rid="ref891">891</xref></sup> humans<sup><xref ref-type="bibr" rid="ref891">891</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">80%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref891">891</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">3</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref892">892</xref></sup> pigs<sup><xref ref-type="bibr" rid="ref893">893</xref>&#8722;<xref ref-type="bibr" rid="ref897">897</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">73%</td><td style="border:none;" align="center" colspan="1" rowspan="1">35</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref898">898</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">salicylic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">1</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">mice,<sup><xref ref-type="bibr" rid="ref899">899</xref></sup> dogs<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">23.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">7.3%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref899">899</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">salvinorin A</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">acetoxy-</italic></td><td style="border:none;" align="left" colspan="1" rowspan="1">baboons<sup><xref ref-type="bibr" rid="ref813">813</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>COCl</td><td style="border:none;" align="center" colspan="1" rowspan="1">27.8</td><td style="border:none;" align="center" colspan="1" rowspan="1">10%</td><td style="border:none;" align="center" colspan="1" rowspan="1">40</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref813">813</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">O</italic>-<italic toggle="yes">methyl-</italic></td><td style="border:none;" align="left" colspan="1" rowspan="1">nr</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CH<sub>3</sub>I</td><td style="border:none;" align="center" colspan="1" rowspan="1">159.1</td><td style="border:none;" align="center" colspan="1" rowspan="1">72%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref900">900</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">urea</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">carbonyl</italic>-</td><td style="border:none;" align="left" colspan="1" rowspan="1">humans<sup><xref ref-type="bibr" rid="ref901">901</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]COCl<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">6.475</td><td style="border:none;" align="center" colspan="1" rowspan="1">35%</td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref902">902</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]KOCN</td><td style="border:none;" align="center" colspan="1" rowspan="1">129.5</td><td style="border:none;" align="center" colspan="1" rowspan="1">95%</td><td style="border:none;" align="center" colspan="1" rowspan="1">20</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref903">903</xref>)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]CO<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">nr</td><td style="border:none;" align="center" colspan="1" rowspan="1">70%</td><td style="border:none;" align="center" colspan="1" rowspan="1">16</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref729">729</xref>)</td></tr><tr><td colspan="8" align="left" rowspan="1">&#8239; &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">uric acid</td><td style="border:none;" align="left" colspan="1" rowspan="1"><italic toggle="yes">6</italic>-/(<italic toggle="yes">carbonyl</italic>)-</td><td style="border:none;" align="left" colspan="1" rowspan="1">rats<sup><xref ref-type="bibr" rid="ref904">904</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[<sup>11</sup>C]COCl<sub>2</sub></td><td style="border:none;" align="center" colspan="1" rowspan="1">142</td><td style="border:none;" align="center" colspan="1" rowspan="1">36%</td><td style="border:none;" align="center" colspan="1" rowspan="1">30</td><td style="border:none;" align="center" colspan="1" rowspan="1">(<xref ref-type="bibr" rid="ref904">904</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="t11fn1"><label>a</label><p>nr: not reported.</p></fn></table-wrap-foot></table-wrap><p>Although the compounds below could not fit in any
of the other
categories described in sections 1&#8211;11, they are crucial for
humans, and their labeling with carbon-11 has led to relevant outcomes:<list list-type="bullet"><list-item><p>4-Aminobenzoic acid (PABA) is an intermediate in folate
synthesis by fungi, plants, and bacteria, including those found in
the human intestinal tract.<sup><xref ref-type="bibr" rid="ref806">806</xref></sup> In humans,
although PABA was considered a &#8220;vitamin Bx&#8221;, it is no
longer recognized as a vitamin because it is generated through the
microbiome.<sup><xref ref-type="bibr" rid="ref807">807</xref></sup> PABA is metabolized in the
liver by phase II conjugation <italic toggle="yes">via</italic><italic toggle="yes">N</italic>-acetyltransferase 1 and glycine conjugation. PABA and all its metabolites
are characterized by fast renal excretion. Thus, carbon-11 PABA could
be used for PET renal imaging and is an excellent candidate for imaging
bacterial infections.<sup><xref ref-type="bibr" rid="ref808">808</xref>,<xref ref-type="bibr" rid="ref809">809</xref></sup></p></list-item><list-item><p>Benzoic acid, a natural exogenous compound, is produced
as an intermediate in synthesizing secondary metabolites by esterifying
with various alcohols. The sodium salt of benzoic acid, sodium benzoate,
is a food preservative widely used in food manufacturing.<sup><xref ref-type="bibr" rid="ref810">810</xref></sup> Benzoate salts and esters are quickly detoxified
in the liver by conjugating various biomolecules in the human body.
The conjugation of benzoate with glycine generates hippuric acid,
quickly excreted by the kidneys. Considering benzoates&#8217; quick
metabolism and excretion, using carbon-11 labeled analogues, is hypothesized
to quantify hepatic and renal functions.<sup><xref ref-type="bibr" rid="ref810">810</xref></sup></p></list-item><list-item><p>Putrescine and cadaverine, natural
exogenous compounds,
are foul-smelling diamines produced by breaking down amino acids in
living and dead organisms. Putrescine is produced by the enzymatic
decarboxylation of ornithine-by-ornithine decarboxylase (ODC). It
is found in healthy living cells, serving as a precursor to polyamines,
spermidine, and spermine. Because these polyamines are protonated
under physiological conditions, they can interact with nucleic acids
and are involved in cell growth and viability.<sup><xref ref-type="bibr" rid="ref811">811</xref></sup> While ODC activity and putrescine levels are low in the
normal brain; they are elevated in a wide variety of rapidly growing
tissues, including primary and metastatic brain tumors. Hence, [<sup>11</sup>C]putrescine was investigated as a potential biomarker of
cell division and growth.<sup><xref ref-type="bibr" rid="ref812">812</xref>,<xref ref-type="bibr" rid="ref813">813</xref></sup> Ultimately, the diagnostic
utility of [<sup>11</sup>C]putrescine was limited by a lack of specificity,
with uptake resulting primarily from BBB breakdown. Cadaverine is
formed during the putrefaction of animal tissue by bacterial lysine
decarboxylase. Although mammalian cells do not possess this enzyme,
cadaverine is produced in small quantities by the action of ornithine
decarboxylase on intracellular lysine.<sup><xref ref-type="bibr" rid="ref814">814</xref></sup> [<sup>11</sup>C]Cadaverine has been radiolabeled and studied, along
with other aliphatic diamines, to examine the relationship between
their molecular structure and <italic toggle="yes">in vivo</italic> biodistribution.<sup><xref ref-type="bibr" rid="ref815">815</xref></sup></p></list-item><list-item><p>Choline is a nutrient
obtained through dietary intake
and endogenous synthesis <italic toggle="yes">via</italic> the hepatic phosphatidylethanolamine <italic toggle="yes">N</italic>-methyltransferase pathway.<sup><xref ref-type="bibr" rid="ref816">816</xref></sup> Choline plays an essential role as a precursor for synthesizing
the neurotransmitter acetylcholine and the two most abundant phospholipids
in the brain, phosphatidylcholine and sphingomyelin. It is also implicated
in other diverse functions such as lipid transport (lipoproteins),
cell-membrane integrity and signaling, and methyl-group metabolism
as a significant source of methyl groups in the diet.<sup><xref ref-type="bibr" rid="ref816">816</xref></sup> Moreover, choline is oxidized to betaine aldehyde,<sup><xref ref-type="bibr" rid="ref817">817</xref></sup> which is then converted into betaine, a direct
methyl group donor in the methionine cycle for the formation of S-adenosylmethionine.<sup><xref ref-type="bibr" rid="ref818">818</xref>,<xref ref-type="bibr" rid="ref819">819</xref></sup> The expression of choline kinases is upregulated during carcinogenesis
to keep up with the demands of the synthesis of phospholipids in their
cellular membranes. Therefore, choline transport is closely associated
with cell growth. Hence, [<sup>11</sup>C]choline has been used to
detect various cancers.</p></list-item><list-item><p>Carbon-11 antibiotics
could be used as a tracer for
a site of infection and as a measure of the tissue distribution of
the antibiotic in humans. So far, only one natural antibiotic has
been labeled and evaluated <italic toggle="yes">in vivo</italic> for both the above
reasons, Erythromycin lactobionate, a macrolide that inhibits protein
synthesis. Another compound, daunorubicin, which is classified as
an antibiotic but used as a chemotherapeutic compound, has also been
labeled.<sup><xref ref-type="bibr" rid="ref820">820</xref>&#8722;<xref ref-type="bibr" rid="ref823">823</xref></sup> Daunorubicin, an exogenous compound, is an anthracycline antibiotic
initially isolated in the 1950s from a new strain of<italic toggle="yes">Streptomyces peucetius</italic>bacteria.<sup><xref ref-type="bibr" rid="ref824">824</xref>,<xref ref-type="bibr" rid="ref825">825</xref></sup> However, it is mainly used to treat various types of cancers, especially
leukemias, through various mechanisms that include anti-mitotic and
anti-cytotoxic activities.<sup><xref ref-type="bibr" rid="ref826">826</xref></sup></p></list-item><list-item><p>Glycerol, an endogenous compound, is trivalent alcohol
produced by the human white adipose tissue (WAT) when an excess of
glucose is present.<sup><xref ref-type="bibr" rid="ref827">827</xref></sup> Glycerol is usually
stored in the body in the adipose tissue in the form of triglycerides
and phospholipids, which are metabolized by the liver as a source
of energy. Glycerol is also the substrate of hepatic gluconeogenesis.<sup><xref ref-type="bibr" rid="ref827">827</xref></sup></p></list-item><list-item><p>Hippuric acid,
an endogenous compound, has been a major
human metabolite for years, found in urine and formed from benzoic
acid and glycine. Hippuric acid can appear in humans as an excretory
product from natural or unnatural sources.<sup><xref ref-type="bibr" rid="ref828">828</xref></sup> Levels of hippuric acid rise with fruit juice, tea, and wine, rich
in phenolic compounds.<sup><xref ref-type="bibr" rid="ref829">829</xref></sup> The phenols are
first converted to benzoic acid and then to hippuric acid and excreted
in the urine. Hippuric acid is also associated with inborn errors
of metabolism such as phenylketonuria, propionic acidemia, and tyrosinemia
I.<sup><xref ref-type="bibr" rid="ref830">830</xref></sup></p></list-item><list-item><p>Lactic
acid, an endogenous compound, is produced by
reducing pyruvate in a reversible process catalyzed by <sc>l</sc>-lactate
dehydrogenase, which is predominantly located in the cytosol of human
cells. Lactate removal occurs <italic toggle="yes">via</italic> oxidation back
to pyruvate, followed by oxidation to CO<sub>2</sub> to produce energy
or gluconeogenesis to produce glucose.<sup><xref ref-type="bibr" rid="ref831">831</xref></sup> The role of lactic acid as an energy source has prompted preclinical
studies using [<sup>11</sup>C]lactic acid to probe <italic toggle="yes">in vivo</italic> lactate metabolism.</p></list-item><list-item><p><italic toggle="yes">N</italic>-Acetyl-leukotriene E<sub>4</sub> is
an endogenous metabolite biologically less active than cysteinyl leukotrienes
but follows the same elimination pathway.<sup><xref ref-type="bibr" rid="ref832">832</xref></sup></p></list-item><list-item><p><italic toggle="yes">N</italic>-Methyltaurine, a
natural exogenous
compound mainly found in red algae, is a derivative of endogenous
neuroprotector taurine.<sup><xref ref-type="bibr" rid="ref833">833</xref></sup></p></list-item><list-item><p>Oxalic acid, an endogenous compound, is synthesized
in erythrocytes and the liver through the metabolism of glycine, glyoxylate,
and ascorbic acid.<sup><xref ref-type="bibr" rid="ref834">834</xref></sup> Oxalic acid is a
metabolic end-product that is eliminated unchanged and primarily through
the kidneys by glomerular filtration and tubular secretion.<sup><xref ref-type="bibr" rid="ref835">835</xref></sup></p></list-item><list-item><p>Paclitaxel, a
natural exogenous compound, works by interference
with the normal function of microtubules during cell division and
is a chemotherapy medication used to treat several types of cancer,
including ovarian cancer, esophageal cancer, breast cancer, lung cancer,
Kaposi&#8217;s sarcoma,<sup><xref ref-type="bibr" rid="ref836">836</xref></sup> cervical cancer,
and pancreatic cancer.<sup><xref ref-type="bibr" rid="ref837">837</xref>,<xref ref-type="bibr" rid="ref838">838</xref></sup></p></list-item><list-item><p>Phenylethanolamine, an endogenous compound, acts as
a trace amine-associated receptor 1 agonist and a monoaminergic modulator.
It is distributed at very low concentrations throughout the central
and peripheral nervous systems and has a crucial role in neurotransmission
and neuromodulation.<sup><xref ref-type="bibr" rid="ref839">839</xref></sup></p></list-item><list-item><p>Phenylpyruvic acid is the &#945;-keto acid of phenylalanine,<sup><xref ref-type="bibr" rid="ref840">840</xref></sup> present in high levels in the urine of individuals
with phenylketonuria due to the lack of phenylalanine hydroxylase.<sup><xref ref-type="bibr" rid="ref841">841</xref></sup></p></list-item><list-item><p>Pyruvic acid,
an endogenous compound, is essential in
most biological pathways and can be converted from alanine to lactic
acid by enzymes.<sup><xref ref-type="bibr" rid="ref842">842</xref></sup></p></list-item><list-item><p>Salicylic acid is a major metabolite of aspirin, with
a mechanism of action still poorly understood.<sup><xref ref-type="bibr" rid="ref843">843</xref></sup> Aspirin is readily hydrolyzed to salicylic acid in the
blood and liver,<sup><xref ref-type="bibr" rid="ref844">844</xref></sup> which can either be
directly excreted (1&#8211;31%) or undergo conjugation reactions
generating the major metabolite salicyluric acid (20&#8211;65%)<sup><xref ref-type="bibr" rid="ref845">845</xref></sup> and ether and ester glucuronides of salicylic
acid (1&#8211;42%). Salicylic acid can also be metabolized to <italic toggle="yes">2</italic>,<italic toggle="yes">5</italic>-dihydroxybenzoic acid (<italic toggle="yes">2</italic>,<italic toggle="yes">5</italic>-DHBA; gentisic acid) and <italic toggle="yes">2</italic>,<italic toggle="yes">3</italic>-dihydroxybenzoic acid (<italic toggle="yes">2</italic>,<italic toggle="yes">3</italic>-DHBA; pyrocatechuic acid) <italic toggle="yes">via</italic> the CYP450 enzymes.<sup><xref ref-type="bibr" rid="ref844">844</xref></sup> Although salicylic acid is a poor inhibitor
of cyclooxygenases COX1 and COX2, it suppresses prostaglandin synthesis.<sup><xref ref-type="bibr" rid="ref846">846</xref></sup></p></list-item><list-item><p>Salvinorin A is
the main active principle of<italic toggle="yes">Salvia divinorum</italic>from the mint family and possesses
a chemical structure of a neoclerodane diterpene. It acts as a potent
hallucinogen in the body by agonistically binding &#954; opioid receptors,
although its effects only last for a few minutes.<sup><xref ref-type="bibr" rid="ref812">812</xref>,<xref ref-type="bibr" rid="ref813">813</xref></sup> Due to the strong perceptive distortion provoked, salvinorin A and
dried <italic toggle="yes">Salvia divinorum</italic> leaves quickly
became recreational drugs.<sup><xref ref-type="bibr" rid="ref812">812</xref>,<xref ref-type="bibr" rid="ref813">813</xref></sup> Biodistribution studies
of an <sup>11</sup>C-labeled analogue of salvinorin A would help understand
its exact action mechanism and map &#954;-opioid receptors in the
brain.</p></list-item><list-item><p>Urea is considered the main nitrogenous
waste product
of metabolism and is mainly derived from protein catalysis. In the
human body, it is excreted through the kidney in urine, and its plasma
concentration is considered a marker of renal function.<sup><xref ref-type="bibr" rid="ref847">847</xref></sup></p></list-item><list-item><p>Uric acid is a
normal component of urine, discovered
by Carl Wilhelm Scheele in 1776 in kidney stones. It is the final
oxidation product of purine nucleotides metabolism,<sup><xref ref-type="bibr" rid="ref848">848</xref></sup> and a high blood concentration could lead to gout, formation
of ammonium acid urate kidney stones, and diabetes.<sup><xref ref-type="bibr" rid="ref849">849</xref></sup></p></list-item></list></p><sec id="sec12.1"><label>12.1</label><title><italic toggle="yes">4</italic>-Aminobenzoic Acid</title><sec id="sec12.1.1"><label>12.1.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]PABA
has been prepared by reacting the commercially available Grignard
precursor with [<sup>11</sup>C]CO<sub>2</sub>. [<sup>11</sup>C]PABA
was isolated with a RCY of 35%, RCP &gt;99%, and <italic toggle="yes">A</italic><sub>m</sub> of 30.34 &#177; 9.55 GBq/&#956;mol at EOS (<xref rid="fig163" ref-type="fig">Figure <xref rid="fig163" ref-type="fig">163</xref></xref>).<sup><xref ref-type="bibr" rid="ref850">850</xref></sup> Holt <italic toggle="yes">et al</italic>.,<sup><xref ref-type="bibr" rid="ref852">852</xref></sup> following
the method above, developed by Mutch <italic toggle="yes">et al</italic>.,<sup><xref ref-type="bibr" rid="ref850">850</xref></sup> produced [<sup>11</sup>C]PABA by conforming
to cGMP requirements. [<sup>11</sup>C]PABA was produced with a RCY
of 14%, high RCP, and <italic toggle="yes">A</italic><sub>m</sub> of 407 GBq/&#956;mol
as a sterile, pyrogen-free solution suitable for injection.<sup><xref ref-type="bibr" rid="ref852">852</xref></sup></p><fig id="fig163" position="float" orientation="portrait"><label>Figure 163</label><caption><p>Synthesis of [<sup>11</sup>C]PABA using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr163" position="float" orientation="portrait" xlink:href="cr2c00398_0163.jpg"/></fig></sec><sec id="sec12.1.2"><label>12.1.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]PABA has been evaluated in mice,<sup><xref ref-type="bibr" rid="ref850">850</xref></sup> rats,<sup><xref ref-type="bibr" rid="ref850">850</xref></sup> and rabbits.<sup><xref ref-type="bibr" rid="ref851">851</xref></sup> In
mice, [<sup>11</sup>C]PABA was evaluated in CBA/J female mice after
iv injection to distinguish between infection and sterile inflammation
in a murine model of acute bacterial infection. [<sup>11</sup>C]PABA
showed high accumulation in the infected left shoulder, with low accumulation,
slightly above background, in the heat-killed inoculated right deltoid
(<xref rid="fig164" ref-type="fig">Figure <xref rid="fig164" ref-type="fig">164</xref></xref>).<sup><xref ref-type="bibr" rid="ref850">850</xref></sup></p><fig id="fig164" position="float" orientation="portrait"><label>Figure 164</label><caption><p>[<sup>11</sup>C]PABA microPET/CT image in
a murine myositis model.
Live = area inoculated with live <italic toggle="yes">E. coli</italic>; Heat-killed = area inoculated with 10-fold greater (10&#215;) heat-killed
bacteria. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref850">850</xref>). Copyright 2018 American
Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr164" position="float" orientation="portrait" xlink:href="cr2c00398_0164.jpg"/></fig><p>[<sup>11</sup>C]PABA in healthy Wistar rats (3
females, 1 male)
(<xref rid="fig165" ref-type="fig">Figure <xref rid="fig165" ref-type="fig">165</xref></xref>) and
healthy New Zealand white rabbits (2 females) (<xref rid="fig166" ref-type="fig">Figure <xref rid="fig166" ref-type="fig">166</xref></xref>) was evaluated by a dynamic
PET demonstrating a fast renal excretion with a very low background
signal, rapid and high accumulation in the renal cortex, followed
by fast clearance through the pelvicalyceal system.<sup><xref ref-type="bibr" rid="ref851">851</xref></sup></p><fig id="fig165" position="float" orientation="portrait"><label>Figure 165</label><caption><p>[<sup>11</sup>C]PABA PET/CT maximum-intensity-projection
images
in healthy Wistar rats. BI = bladder. Reproduced with permission from
ref (<xref ref-type="bibr" rid="ref851">851</xref>). Copyright
2020 Society of Nuclear Medicine and Molecular Imaging. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr165" position="float" orientation="portrait" xlink:href="cr2c00398_0165.jpg"/></fig><fig id="fig166" position="float" orientation="portrait"><label>Figure 166</label><caption><p>[<sup>11</sup>C]PABA PET/CT renal imaging in healthy rabbits
(20
min p.i.). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref851">851</xref>). Copyright 2020 Society
of Nuclear Medicine and Molecular Imaging. This work is licensed under
a Creative Commons Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr166" position="float" orientation="portrait" xlink:href="cr2c00398_0166.jpg"/></fig></sec><sec id="sec12.1.3"><label>12.1.3</label><title>Clinical Studies</title><p>[<sup>11</sup>C]PABA has been evaluated in three healthy volunteers (2 male, 1
female) at least 18 y old (age range, 23&#8211;30 y).<sup><xref ref-type="bibr" rid="ref851">851</xref></sup> [<sup>11</sup>C]PABA PET was safe and well-tolerated,
without any adverse or clinically detectable pharmacologic effects.
The cortex was delineated on PET, and the activity gradually transited
to the medulla and then pelvis with a high spatiotemporal resolution
with low radiation exposure (<xref rid="fig167" ref-type="fig">Figure <xref rid="fig167" ref-type="fig">167</xref></xref>).<sup><xref ref-type="bibr" rid="ref851">851</xref></sup></p><fig id="fig167" position="float" orientation="portrait"><label>Figure 167</label><caption><p>[<sup>11</sup>C]PABA PET/CT renal imaging in a healthy human subject.
Reproduced with permission from ref (<xref ref-type="bibr" rid="ref851">851</xref>). Copyright 2020 Society of Nuclear Medicine
and Molecular Imaging. This work is licensed under a Creative Commons
Attribution 4.0 International License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr167" position="float" orientation="portrait" xlink:href="cr2c00398_0167.jpg"/></fig></sec></sec><sec id="sec12.2"><label>12.2</label><title>Benzoic Acid</title><sec id="sec12.2.1"><label>12.2.1</label><title>Radiochemistry</title><p>[<sup>11</sup>C]Sodium
benzoate was synthesized by carbonation of phenylmagnesium bromide
with [<sup>11</sup>C]CO<sub>2</sub>, followed by acidic hydrolysis
with HCl and extraction with sodium bicarbonate (<xref rid="fig168" ref-type="fig">Figure <xref rid="fig168" ref-type="fig">168</xref></xref>).<sup><xref ref-type="bibr" rid="ref810">810</xref>,<xref ref-type="bibr" rid="ref853">853</xref>,<xref ref-type="bibr" rid="ref855">855</xref></sup> The product was obtained within
10&#8211;20 min with a RCY of 60&#8211;80% at EOB.<sup><xref ref-type="bibr" rid="ref810">810</xref>,<xref ref-type="bibr" rid="ref853">853</xref>,<xref ref-type="bibr" rid="ref855">855</xref></sup> The simplicity made [<sup>11</sup>C]benzoic acid the substrate of choice for carboxylation and carbonylation
studies. Several methods have been developed in the past year using
[<sup>11</sup>C]benzoic acid and [<sup>11</sup>C]benzoate as pilot
compounds, such as fluoride-mediated desilylative methods,<sup><xref ref-type="bibr" rid="ref615">615</xref>,<xref ref-type="bibr" rid="ref905">905</xref></sup> copper-catalyzed labeling of arylstannanes,<sup><xref ref-type="bibr" rid="ref906">906</xref></sup> palladium-catalyzed <sup>11</sup>C-carbonylation with [<sup>11</sup>C]CO,<sup><xref ref-type="bibr" rid="ref907">907</xref></sup> and <sup>11</sup>C-carboxylation
of arylboronic esters <italic toggle="yes">via</italic> copper catalysis.<sup><xref ref-type="bibr" rid="ref908">908</xref></sup></p><fig id="fig168" position="float" orientation="portrait"><label>Figure 168</label><caption><p>Synthesis of sodium [<sup>11</sup>C]benzoate
using [<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide
position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr168" position="float" orientation="portrait" xlink:href="cr2c00398_0168.jpg"/></fig></sec><sec id="sec12.2.2"><label>12.2.2</label><title>Preclinical</title><p>[<sup>11</sup>C]Sodium
benzoate was used to evaluate renal function in dogs,<sup><xref ref-type="bibr" rid="ref810">810</xref>,<xref ref-type="bibr" rid="ref853">853</xref></sup> and rabbits,<sup><xref ref-type="bibr" rid="ref854">854</xref></sup> showing a rapid accumulation
(within 10 min) and extended retention of the radiopharmaceutical
in the kidneys, suggesting the potential use of the tracer to visualize
the renal parenchyma.<sup><xref ref-type="bibr" rid="ref853">853</xref>&#8722;<xref ref-type="bibr" rid="ref855">855</xref></sup> Sodium [<sup>11</sup>C]benzoate was also
successfully employed to image a dog&#8217;s osteogenic sarcoma.<sup><xref ref-type="bibr" rid="ref853">853</xref></sup></p></sec></sec><sec id="sec12.3"><label>12.3</label><title>Cadaverine and Putrescine</title><sec id="sec12.3.1"><label>12.3.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]Putrescine was first synthesized by Winstead <italic toggle="yes">et al</italic>. in 1980 in a two-step process involving the reaction
of <italic toggle="yes">3</italic>-bromopropionitrile with carrier-added [<sup>11</sup>C]NaCN to form [<sup>11</sup>C]succinonitrile, followed by
reduction using borane-THF (<xref rid="fig169" ref-type="fig">Figure <xref rid="fig169" ref-type="fig">169</xref></xref>A).<sup><xref ref-type="bibr" rid="ref815">815</xref></sup> The product was precipitated
as the hydrochloride salt and used without further purification (reaction
time, 70 min; RCY, 57% based on [<sup>11</sup>C]NaCN).<sup><xref ref-type="bibr" rid="ref815">815</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Cadaverine
was produced under the same conditions, starting from 3-bromobutyronitrile
(reaction time, 63 min; RCY, 77% based on [<sup>11</sup>C]NaCN).</p><fig id="fig169" position="float" orientation="portrait"><label>Figure 169</label><caption><p>Synthesis
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine and
[<italic toggle="yes">1</italic>-<sup>11</sup>C]cadaverine using [<sup>11</sup>C]CN<sup>&#8211;</sup>.<sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr169" position="float" orientation="portrait" xlink:href="cr2c00398_0169.jpg"/></fig><p>A similar approach was used by Jerabek <italic toggle="yes">et al</italic>.
in 1985 to synthesize [<sup>11</sup>C]putrescine under no-carrier-added
conditions.<sup><xref ref-type="bibr" rid="ref857">857</xref></sup> Despite reaction optimization
through DMSO as solvent and borane-THF as a more efficient reductant,
low RCYs were observed (reaction time of 50&#8211;60 min, RCY of
7&#8211;13% based on [<sup>11</sup>C]NaCN, <italic toggle="yes">A</italic><sub>m</sub> of 2.3 GBq/&#956;mol at EOS).<sup><xref ref-type="bibr" rid="ref857">857</xref></sup> It was postulated that the reaction proceeds <italic toggle="yes">via</italic> elimination of HBr from the alkyl bromide starting material to form
acrylonitrile, which undergoes Michael addition with cyanide to form
succinonitrile. Thus, under noncarrier added conditions, [<sup>11</sup>C]cyanide was consumed through reaction with HBr. This led McPherson <italic toggle="yes">et al</italic>. to explore the direct Michael addition of [<sup>11</sup>C]KCN with acrylonitrile (<xref rid="fig169" ref-type="fig">Figure <xref rid="fig169" ref-type="fig">169</xref></xref>B).<sup><xref ref-type="bibr" rid="ref856">856</xref></sup> This proved successful,
with [<sup>11</sup>C]succinonitrile obtained in &#8764;70% RCY within
5 min.<sup><xref ref-type="bibr" rid="ref856">856</xref></sup> Subsequent azeotropic drying,
reduction using borane-dimethylsulfide, and HPLC purification produced
[<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine, suitable for use in
clinical PET studies (reaction time, 50 min; RCY, 20% based on [<sup>11</sup>C]HCN; RCP &gt; 97%, <italic toggle="yes">A</italic><sub>m</sub> &gt;52
GBq/&#956;mol
at EOS).<sup><xref ref-type="bibr" rid="ref858">858</xref>&#8722;<xref ref-type="bibr" rid="ref860">860</xref></sup> In 1991, Lambrecht <italic toggle="yes">et al</italic>. reported the use of solid-state support, which enabled the Michael
addition to be performed under anhydrous conditions.<sup><xref ref-type="bibr" rid="ref909">909</xref></sup></p></sec><sec id="sec12.3.2"><label>12.3.2</label><title>Preclinical Studies</title><p>The biodistribution
of carrier-added carbon-11 labeled diamines of the formula NH<sub>2</sub>(CH<sub>2</sub>)<sub><italic toggle="yes">n</italic></sub>NH<sub>2</sub> (<italic toggle="yes">n</italic> = 4&#8211;9) was studied in rats by Winstead <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref815">815</xref></sup> For all diamines, activity
was found to accumulate in the prostate between 5 and 30 min.<sup><xref ref-type="bibr" rid="ref815">815</xref></sup> For all diamines, activity accumulated in the
prostate between 5 and 30 min. The highest uptake was observed for
[<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine in the prostrate while
increasing the chain length by one carbon atom to [<italic toggle="yes">1</italic>-<sup>11</sup>C]cadaverine gave a significant reduction. Significant
uptake at 5 min p.i. was observed in the lungs and kidneys, while
brain uptake was negligible for [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine
and [<italic toggle="yes">1</italic>-<sup>11</sup>C]cadaverine. With [<italic toggle="yes">1</italic>-<sup>11</sup>C]cadaverine, the adrenal glands showed a progressive
increase in activity until 60 min p.i. Most other tissues showed a
progressive decrease over time for all the diamines.</p><p>The biodistribution
of [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine in mice was similar,
with most uptake being observed in the liver, kidneys, and small intestine,
while little activity was observed in the brain.<sup><xref ref-type="bibr" rid="ref856">856</xref></sup></p><p>Rat biodistribution studies using [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine in varying levels of nonradioactive putrescine
were
performed by Jerabek <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref857">857</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Putrescine binding was found
to be saturable, with a progressive reduction of uptake being observed
in the prostate at 1 h.<sup><xref ref-type="bibr" rid="ref857">857</xref></sup> In addition,
a prostate to nontarget tissue (muscle) ratio of 10.5/1 was observed
under baseline conditions, which the administration of unlabeled putrescine
reduced.</p></sec><sec id="sec12.3.3"><label>12.3.3</label><title>Clinical Studies</title><p>Human PET imaging
studies with [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine have been
performed by researchers at Brookhaven to examine the utility of the
tracer for metabolic imaging of brain tumours,<sup><xref ref-type="bibr" rid="ref858">858</xref>,<xref ref-type="bibr" rid="ref859">859</xref></sup> and prostatic adenocarcinoma.<sup><xref ref-type="bibr" rid="ref860">860</xref></sup> In a
study on primary and metastatic brain tumors, [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine was taken up and retained in tumors, and higher
contrast between tumor/normal brain was observed compared with [<sup>11</sup>C]<italic toggle="yes">2</italic>-deoxyglucose.<sup><xref ref-type="bibr" rid="ref858">858</xref></sup> This was ascribed to putrescine&#8217;s inability to cross the
normal BBB and its low metabolism in the normal brain compared to
glucose but did not ascertain whether or not [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine uptake reflects the rate of tumor polyamine
biosynthesis and prostatic adenocarcinoma.<sup><xref ref-type="bibr" rid="ref860">860</xref></sup></p><p>In a follow-up publication to address this question, [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine was studied in 33 patients with
various malignant brain tumors and benign or non-neoplastic lesions
(<xref rid="fig170" ref-type="fig">Figure <xref rid="fig170" ref-type="fig">170</xref></xref>).<sup><xref ref-type="bibr" rid="ref859">859</xref></sup> These studies found that [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine uptake was not specific for malignant
tumors, with uptake relying on disruption of the BBB.</p><fig id="fig170" position="float" orientation="portrait"><label>Figure 170</label><caption><p>[<sup>11</sup>C]Putrescine PET scan of a patient with cerebellar
metastases from lung carcinoma (45 min post-injection). Reproduced
with permission from ref (<xref ref-type="bibr" rid="ref858">858</xref>). Copyright 1987 Society of Nuclear Medicine. This work
is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr170" position="float" orientation="portrait" xlink:href="cr2c00398_0170.jpg"/></fig><p>Similarly, in a study of human prostatic adenocarcinoma,
Wang <italic toggle="yes">et al</italic>. observed a significant accumulation of
activity in
the prostate, bone, and rectum.<sup><xref ref-type="bibr" rid="ref860">860</xref></sup> However,
despite rapid prostate uptake and retention and low uptake in the
bladder, the tracer lacked specificity for prostatic adenocarcinoma,
with significantly higher prostate uptake in normal controls <italic toggle="yes">versus</italic> cancer patients.</p><p>Analysis of the metabolic
profile of [<italic toggle="yes">1</italic>-<sup>11</sup>C]putrescine in human
plasma has only been reported for one subject,
where it was found that by 20 min p.i., only 9% of intact tracer remained,
with [<sup>11</sup>C]CO<sub>2</sub> and nonvolatile metabolites accounting
for the remainder of activity.<sup><xref ref-type="bibr" rid="ref858">858</xref></sup></p></sec></sec><sec id="sec12.4"><label>12.4</label><title>Choline</title><sec id="sec12.4.1"><label>12.4.1</label><title>Radiosynthesis</title><p>In 1985, Rosen <italic toggle="yes">et al</italic>. synthesized [<sup>11</sup>C]choline by reacting [<sup>11</sup>C]CH<sub>3</sub>I with <italic toggle="yes">2</italic>-dimethylaminoethanol,
producing [<sup>11</sup>C]choline, a synthesis time of 35 mins, RCY
of &#8764;50%, and <italic toggle="yes">A</italic><sub>m</sub> of &gt;11.1 GBq/&#956;mol
(<xref rid="fig171" ref-type="fig">Figure <xref rid="fig171" ref-type="fig">171</xref></xref>).<sup><xref ref-type="bibr" rid="ref910">910</xref></sup> A few years later, this method was improved
by Hara <italic toggle="yes">et al</italic>., where [<sup>11</sup>C]choline was
reacted with [<sup>11</sup>C]methyl iodide with dimethylaminoethanol
at 120 &#176;C for 5 min, producing 11 GBq of [<sup>11</sup>C]choline,
a synthesis time of 25 mins and RCY &gt; 98% and <italic toggle="yes">A</italic><sub>m</sub> &gt; 133 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref862">862</xref></sup> The same
group developed an automated synthesis of [<sup>11</sup>C]choline
by reacting [<sup>11</sup>C]CH<sub>3</sub>I with <italic toggle="yes">2</italic>-dimethylaminoethanol at 130 &#176;C for 5 mins, producing 11 GBq
of [<sup>11</sup>C]choline, a synthesis time of 20 mins, RCY of 86%,
and <italic toggle="yes">A</italic><sub>m</sub> of 150 GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref911">911</xref></sup> An alternative synthetic route to [<sup>11</sup>C]choline production is the reaction of [<sup>11</sup>C]methyl triflate
with <italic toggle="yes">2</italic>-dimethylaminoethanol, obtaining 60&#8211;85%
RCY (based on [<sup>11</sup>C]CO<sub>2</sub> with a reaction time
of 15&#8211;20 min) and <italic toggle="yes">A</italic><sub>m</sub> &gt;29.6 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref871">871</xref></sup></p><fig id="fig171" position="float" orientation="portrait"><label>Figure 171</label><caption><p>Synthesis of [<sup>11</sup>C]choline using
[<sup>11</sup>C]CH<sub>3</sub>I.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr171" position="float" orientation="portrait" xlink:href="cr2c00398_0171.jpg"/></fig><p>[<sup>11</sup>C]Choline was approved in 2012 by
the U.S. Food and
Drug Administration and the European Medicines Agency in 2018 for
clinical use. There was no <italic toggle="yes">A</italic><sub>m</sub> release
limit for [<sup>11</sup>C]choline. Several synthetic approaches have
been described in the literature,<sup><xref ref-type="bibr" rid="ref656">656</xref></sup> and
different automated production methods and modules for clinical production.<sup><xref ref-type="bibr" rid="ref911">911</xref>&#8722;<xref ref-type="bibr" rid="ref918">918</xref></sup> Excellent yields (RCY &gt; 80% at EOB) are always obtained in a
short
synthesis time, allowing reliable production of multiple doses and
several batches per day.<sup><xref ref-type="bibr" rid="ref919">919</xref></sup> In addition,
Trasis offers commercially available cassette kits and ready-to-use
consumables for fully automated preparation of [<sup>11</sup>C]choline
on the Trasis <italic toggle="yes">AllinOne</italic> synthesizer, further facilitating
GMP implementation. The most simple, efficient, and reliable automated
method for [<sup>11</sup>C]choline routine clinical production was
described in detail, and the quality control procedures by Hockley,
Shao, <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref848">848</xref>,<xref ref-type="bibr" rid="ref851">851</xref></sup> Typical RCYs &gt;60%
at EOB in a total synthesis time of 20 min.</p></sec><sec id="sec12.4.2"><label>12.4.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Choline has shown potential for assessing the degree of inflammation
in atherosclerotic plaques<sup><xref ref-type="bibr" rid="ref920">920</xref></sup> to detect
cancer (breast,<sup><xref ref-type="bibr" rid="ref921">921</xref></sup> colorectal,<sup><xref ref-type="bibr" rid="ref922">922</xref></sup> papillomavirus,<sup><xref ref-type="bibr" rid="ref863">863</xref></sup> prostate,<sup><xref ref-type="bibr" rid="ref922">922</xref></sup> and brain cancer<sup><xref ref-type="bibr" rid="ref862">862</xref></sup>) and pulmonary arterial hypertension.<sup><xref ref-type="bibr" rid="ref923">923</xref></sup> A biodistribution study of [<sup>11</sup>C]choline
in normal rats showed high uptake in the kidneys, lungs, liver, and
adrenal glands with a gradual decline in the uptake of these organs
after 10 min p.i.<sup><xref ref-type="bibr" rid="ref861">861</xref></sup> A metabolite study
was carried out in the plasma and urine of rats, showing that [<sup>11</sup>C]choline represented &lt;50% in plasma after 5 min p.i.
Similar results were found in urine, where unmetabolized [<sup>11</sup>C]choline represented about 70% after 10 min p.i. The major metabolite
was identified as [<sup>11</sup>C]betaine.<sup><xref ref-type="bibr" rid="ref817">817</xref></sup> A biodistribution study of [<sup>11</sup>C]choline in normal rabbits
showed the highest uptake in the liver, followed by the kidneys and
spleen. Other organs such as the brain, lungs, and heart had no visible
uptake.<sup><xref ref-type="bibr" rid="ref862">862</xref></sup> Similar pattern uptake was also
observed in rabbits to detect papillomavirus-induced tumors (<xref rid="fig172" ref-type="fig">Figure <xref rid="fig172" ref-type="fig">172</xref></xref>).<sup><xref ref-type="bibr" rid="ref863">863</xref></sup></p><fig id="fig172" position="float" orientation="portrait"><label>Figure 172</label><caption><p>[<sup>11</sup>C]Choline whole-body PET (left),
CT (middle), and
fused image (right) of a NZW rabbit at 10 months post-infection with
papillomavirus (scans made 50 min p.i.). Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref863">863</xref>). Copyright
2014 Decker. This work is licensed under a Creative Commons Attribution
3.0 License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.creativecommons.org/licenses/by/3.0/">http://www.creativecommons.org/licenses/by/3.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr172" position="float" orientation="portrait" xlink:href="cr2c00398_0172.jpg"/></fig><p>The only reported monkey study with [<sup>11</sup>C]choline was
performed by Friedland <italic toggle="yes">et al</italic>. in 1983, in which brain
imaging and organ biodistribution were studied.<sup><xref ref-type="bibr" rid="ref864">864</xref></sup> [<sup>11</sup>C]Choline had a rapid brain uptake followed
by a rapid decline compared with other organs such as the heart, lung,
liver, and kidney. This can be explained by a washout from the intravascular
and interstitial fluid spaces as well as the re-entering of [<sup>11</sup>C]choline into circulation after clearance from the blood
during the first pass, and distribution to other organs.<sup><xref ref-type="bibr" rid="ref864">864</xref></sup></p></sec><sec id="sec12.4.3"><label>12.4.3</label><title>Clinical Studies</title><p>Several reported
PET studies with [<sup>11</sup>C]choline have been performed over
the last few years. Uptake of [<sup>11</sup>C]choline was investigated
in a normal 60-year-old man, showing the highest uptake in the kidney,
liver, pancreas, small intestine, and spleen.<sup><xref ref-type="bibr" rid="ref865">865</xref></sup> Similar to the rabbit studies, the uptake in the brain
of healthy patients was deficient compared to extracerebral tissue.
The pituitary body represented the brain area with the highest uptake
of [<sup>11</sup>C]choline.<sup><xref ref-type="bibr" rid="ref862">862</xref></sup> Choline
is highly concentrated in prostate cancer cells;<sup><xref ref-type="bibr" rid="ref866">866</xref></sup> therefore, [<sup>11</sup>C]choline has been used to evaluate
prostate cancer, showing promising results in defining local tumor
stage and nodal involvement.<sup><xref ref-type="bibr" rid="ref867">867</xref></sup> An example
is represented in <xref rid="fig173" ref-type="fig">Figure <xref rid="fig173" ref-type="fig">173</xref></xref>, where it is possible to observe several bone metastases
using [<sup>11</sup>C]choline. The sensitivity of [<sup>11</sup>C]choline
to detect bone metastases was 96.9% compared to 90.3% detected by
conventional imaging.<sup><xref ref-type="bibr" rid="ref868">868</xref></sup></p><fig id="fig173" position="float" orientation="portrait"><label>Figure 173</label><caption><p>[<sup>11</sup>C]Choline
MIP PET image showing several spots of
uptake. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref868">868</xref>). Copyright 2018 Cureus.
This work is licensed under a Creative Commons Attribution 3.0 License
(<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.creativecommons.org/licenses/by/3.0/">http://www.creativecommons.org/licenses/by/3.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr173" position="float" orientation="portrait" xlink:href="cr2c00398_0173.jpg"/></fig><p>In recent years, PET/CT imaging with [<sup>11</sup>C]choline has
gained interest in detecting and localizing parathyroid adenomas.
Noltes <italic toggle="yes">et al</italic>. evaluated the diagnostic performance
of [<sup>11</sup>C]choline in patients with primary hyperparathyroidism
after negative or discordant first-line imaging (<xref rid="fig174" ref-type="fig">Figure <xref rid="fig174" ref-type="fig">174</xref></xref>).<sup><xref ref-type="bibr" rid="ref869">869</xref></sup> The sensitivity of [<sup>11</sup>C]choline to localize lesions was
97%, where 37 of the 40 suspected lesions were histologically confirmed
as parathyroid adenoma or parathyroid hyperplasia.<sup><xref ref-type="bibr" rid="ref869">869</xref></sup> Moreover, Parvinian <italic toggle="yes">et al</italic>. evaluated the
efficacy of [<sup>11</sup>C]choline in detecting parathyroid adenomas
in patients with abnormally high serum calcium and parathyroid hormone
levels. All suspected adenomas were [<sup>11</sup>C]choline avid,
and a low frequency of incidental thyroid lesions as possible parathyroid
adenomas was observed.<sup><xref ref-type="bibr" rid="ref870">870</xref></sup> The promising
results of these studies might lead to more minimally invasive parathyroid
procedures.</p><fig id="fig174" position="float" orientation="portrait"><label>Figure 174</label><caption><p>[<sup>11</sup>C]Choline axial PET (d), CT (e), PET/CT
(f), axial
PET (g), and coronal PET (h) images of a suspected parathyroid adenoma
(red arrow). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref869">869</xref>). Copyright 2021 Springer-Verlag.
This work is licensed under a Creative Commons Attribution 4.0 International
License (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr174" position="float" orientation="portrait" xlink:href="cr2c00398_0174.jpg"/></fig><p>Metabolite studies were carried out in patients
with brain tumors,
prostate cancer, and prostate hyperplasia. [<sup>11</sup>C]Choline
rapidly declined in arterial plasma within 25 min. This analysis also
revealed that the most abundant metabolism was [<sup>11</sup>C]betaine.
Another metabolite was also identified but not analyzed.<sup><xref ref-type="bibr" rid="ref817">817</xref></sup></p></sec></sec><sec id="sec12.5"><label>12.5</label><title>Daunorubicin</title><sec id="sec12.5.1"><label>12.5.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Daunorubicin
has been labeled in two positions, 2-<italic toggle="yes">acetyl</italic>-<sup><xref ref-type="bibr" rid="ref820">820</xref></sup> and 4-<italic toggle="yes">methoxy</italic>-.<sup><xref ref-type="bibr" rid="ref821">821</xref></sup> [<italic toggle="yes">2</italic>-<italic toggle="yes">acetyl</italic>-<sup>11</sup>C]Daunorubicin was prepared by reaction of [<sup>11</sup>C]CH<sub>2</sub>N<sub>2</sub> with 9-formyl-trifluoroacetyl-daunorubicin
in KOH/hydrazine/ethanol solution for 5 min at 60 &#176;C followed
by NaOH hydrolysis (<xref rid="fig175" ref-type="fig">Figure <xref rid="fig175" ref-type="fig">175</xref></xref>). The overall RCY was 3 &#177; 1%, with a RCP of 99% and <italic toggle="yes">A</italic><sub>m</sub> of 0.740&#8211;1.111 GBq/&#956;mol with
a total synthesis time of 53 min.</p><fig id="fig175" position="float" orientation="portrait"><label>Figure 175</label><caption><p>Synthesis of [<italic toggle="yes">2</italic>-<italic toggle="yes">acetyl</italic>-<sup>11</sup>C]daunorubicin using [<sup>11</sup>C]CH<sub>2</sub>N<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr175" position="float" orientation="portrait" xlink:href="cr2c00398_0175.jpg"/></fig><p>[<italic toggle="yes">4</italic>-<italic toggle="yes">Methoxy</italic>-<sup>11</sup>C]daunorubicin
has been synthesized using an enzymatic route by the methylation of
carminomycin, catalyzed by carminomycin-<italic toggle="yes">4</italic>-<italic toggle="yes">O</italic>-methyltransferase (CMT), to [<italic toggle="yes">4</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]daunorubicin by <italic toggle="yes">S</italic>-adenosyl-<sc>l</sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine.
The latter was initially synthesized from <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine catalyzed by <sc><italic toggle="yes">l</italic></sc>-methionine-<italic toggle="yes">S</italic>-adenosine transferase
(MAT). The final product was isolated within 75 min and with a RCY
of 1% (EOB) (<xref rid="fig176" ref-type="fig">Figure <xref rid="fig176" ref-type="fig">176</xref></xref>).<sup><xref ref-type="bibr" rid="ref821">821</xref></sup></p><fig id="fig176" position="float" orientation="portrait"><label>Figure 176</label><caption><p>Synthesis of [<italic toggle="yes">4</italic>-<italic toggle="yes">methoxy</italic>-<sup>11</sup>C]daunorubicin using <italic toggle="yes">S</italic>-adenosyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]methionine. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr176" position="float" orientation="portrait" xlink:href="cr2c00398_0176.jpg"/></fig></sec><sec id="sec12.5.2"><label>12.5.2</label><title>Preclinical Studies</title><p>[2-<italic toggle="yes">Acetyl</italic>-<sup>11</sup>C]daunorubicin has been evaluated <italic toggle="yes">in vivo</italic> in healthy<sup><xref ref-type="bibr" rid="ref820">820</xref></sup> and tumor-bearing
rats.<sup><xref ref-type="bibr" rid="ref872">872</xref></sup> In healthy male Wistar rats, biodistribution
studies were performed 60 min after iv injection of the tracer (tracer
or pharmacological dosage: 10 mg/kg body weight for [2-<italic toggle="yes">acetyl</italic>-<sup>11</sup>C]daunorubicin) to determine the pharmacokinetics.
Differences in uptake are observed in the radioactivity level, between
the noncarrier-added and a pharmacological dose of 10 mg/kg body weight,
in plasma, liver and urine.<sup><xref ref-type="bibr" rid="ref820">820</xref></sup></p><p><italic toggle="yes">In vivo</italic> studies in male nude rats bearing tumors bilaterally,
a P-gp-negative small cell lung carcinoma (GLC4) and its P-gp-overexpressing
subline (GLC4/P-gp) showed a 159% higher level of [2-<italic toggle="yes">acetyl</italic>-<sup>11</sup>C]daunorubicin in GLC4 than in GLC4/P-gp tumors. According
to the authors, [<italic toggle="yes">2</italic>-<italic toggle="yes">acetyl</italic>-<sup>11</sup>C]daunorubicin levels showed rapid plasma clearance after the injection,
and activity levels showed no significant increase in any other tissue
than the GLC4/P-gp tumor; however, no specific data are available.<sup><xref ref-type="bibr" rid="ref872">872</xref></sup></p></sec></sec><sec id="sec12.6"><label>12.6</label><title>Erythromycin Lactobionate</title><sec id="sec12.6.1"><label>12.6.1</label><title>Radiosynthesis</title><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]erythromycin lactobionate
has been prepared by reductive alkylation of an <italic toggle="yes">N</italic>-desmethyl-erythromycin using [<sup>11</sup>C]CH<sub>2</sub>O in
the presence of H<sub>2</sub> and Pd on charcoal at 18 &#176;C for
20 min (<xref rid="fig177" ref-type="fig">Figure <xref rid="fig177" ref-type="fig">177</xref></xref>).<sup><xref ref-type="bibr" rid="ref822">822</xref>,<xref ref-type="bibr" rid="ref823">823</xref></sup> The purified fraction from the silica column,
dissolved in dextrose solution for injection (5% wt/v; 5 cm<sup>3</sup>) containing lactobionic acid and the mixture added to unlabeled
erythromycin A (12.8 mg), shaken thoroughly and passed through a sterile
filter (0.22 &#956;m). The final product required 42 min from the
end of [<sup>11</sup>C]CO<sub>2</sub> production, with a RCY of 4&#8211;12%
(based on the [<sup>11</sup>C]CO<sub>2</sub> activity used at the
end of proton irradiation).<sup><xref ref-type="bibr" rid="ref822">822</xref>,<xref ref-type="bibr" rid="ref823">823</xref></sup></p><fig id="fig177" position="float" orientation="portrait"><label>Figure 177</label><caption><p>Synthesis of [<sup>11</sup>C]erythromycin lactobionate using [<sup>11</sup>C]CH<sub>2</sub>O. <sup>11</sup>C radionuclide position is
highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr177" position="float" orientation="portrait" xlink:href="cr2c00398_0177.jpg"/></fig></sec><sec id="sec12.6.2"><label>12.6.2</label><title>Clinical Studies</title><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]erythromycin lactobionate
has been used to determine the pulmonary concentration of the drug
in five patients with acute lobar pneumonia in the first few days
of their illness. Only one lobe of the lung was infected during lobar
pneumonia; thus, the uninfected lung was used as a control. [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]erythromycin A
lactobionate was administered intravenously in a typical clinical
dose of 270 mg. Blood samples and tomographic data were collected
every 10 min for 60 min (<xref rid="fig178" ref-type="fig">Figure <xref rid="fig178" ref-type="fig">178</xref></xref>). Lung images were corrected for tracer present in
the blood content of this tissue using [<sup>11</sup>C]CO to measure
the pulmonary blood volume throughout the experiment with [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]erythromycin A
lactobionate.<sup><xref ref-type="bibr" rid="ref873">873</xref></sup> [<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]erythromycin A lactobionate uptake
at the pulmonary reached a peak at 10 min after injection and remained
at a pharmacologically effective dose throughout the study. Although
the infected lung showed an increase in uptake compared to the uninvolved
lung, the corrected data proved no statistical difference in the extravascular
concentration.<sup><xref ref-type="bibr" rid="ref873">873</xref></sup></p><fig id="fig178" position="float" orientation="portrait"><label>Figure 178</label><caption><p>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]erythromycin
A lactobionate chest radiograph (left) and tomograms showing regional
distribution of extravascular lung density (middle) and extravascular
(right) in a patient with upper-lobe pneumonia. Reproduced with permission
from ref (<xref ref-type="bibr" rid="ref873">873</xref>). Copyright
1982 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr178" position="float" orientation="portrait" xlink:href="cr2c00398_0178.jpg"/></fig></sec></sec><sec id="sec12.7"><label>12.7</label><title>Glycerol</title><sec id="sec12.7.1"><label>12.7.1</label><title>Radiosynthesis</title><p>The synthesis of
[<sup>11</sup>C]glycerol was achieved by biosynthesis using the alga<italic toggle="yes">Girgartina stellata</italic>.<sup><xref ref-type="bibr" rid="ref798">798</xref></sup> After being exposed to light, the chamber containing the alga was
recirculated with a flow of [<sup>11</sup>C]CO<sub>2</sub> in N<sub>2</sub> for 20 min, allowing the synthesis of [<sup>11</sup>C]glycerol
(35%) and [<sup>11</sup>C]galactose (65%). The mixture of products
was extracted with alcohol and separated by liquid chromatography,
returning 2.5 MBq of [<sup>11</sup>C]glycerol with a total processing
time of 80&#8211;90 min and <italic toggle="yes">A</italic><sub>m</sub> of 1.08
&#215; 10<sup>&#8211;4</sup> GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref798">798</xref></sup></p></sec></sec><sec id="sec12.8"><label>12.8</label><title>Hippuric Acid</title><sec id="sec12.8.1"><label>12.8.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Hippuric
acid was first prepared from carboxylation of phenylmagnesium bromide
with [<sup>11</sup>C]CO<sub>2</sub> to make [<sup>11</sup>C]benzoic
acid,and then to attach glycine to this biosynthetically using rat
liver mitochondria with a RCY of 1.5&#8211;10% and a total synthetic
time of 70 min (<xref rid="fig179" ref-type="fig">Figure <xref rid="fig179" ref-type="fig">179</xref></xref>).<sup><xref ref-type="bibr" rid="ref855">855</xref></sup> [<sup>11</sup>C]Hippuric
acid was also prepared by adding an aqueous alkaline solution of glycine
to neat [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]benzoyl chloride
with a RCY of 8 &#177; 2%, based on [<sup>11</sup>C]CO<sub>2</sub> (<xref rid="fig179" ref-type="fig">Figure <xref rid="fig179" ref-type="fig">179</xref></xref>).<sup><xref ref-type="bibr" rid="ref874">874</xref></sup></p><fig id="fig179" position="float" orientation="portrait"><label>Figure 179</label><caption><p>Synthesis of [<sup>11</sup>C]hippuric acid:
(a) biosynthetically
using rat liver mitochondrial; (b) reaction of glycine with [<italic toggle="yes">carbonyl</italic>-<sup>11</sup>C]benzoyl chloride. <sup>11</sup>C
radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr179" position="float" orientation="portrait" xlink:href="cr2c00398_0179.jpg"/></fig></sec><sec id="sec12.8.2"><label>12.8.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Hippuric acid has been studied in mice and rabbits after iv injection.<sup><xref ref-type="bibr" rid="ref855">855</xref>,<xref ref-type="bibr" rid="ref874">874</xref></sup> In healthy, Mrp<sub>4</sub><sup>+</sup> and Oat<sub>3</sub><sup>+</sup> mice using PET, Kikuchi <italic toggle="yes">et al</italic>. evaluated
the uptake of [<sup>11</sup>C]hippuric acid in the brain and heart
after injection of the ester forms using the so-called metabolite
extrusion method.<sup><xref ref-type="bibr" rid="ref874">874</xref></sup> The esters were rapidly
hydrolyzed, leading to the corresponding [<sup>11</sup>C]hippuric
acid, with no other detected metabolites. The low level of radioactivity
observed in the brain at 0.5 min post-injection considerably decreased
at 15 min p.i., even in the organic anion transporter knockout mice.
Comparable low uptake of [<sup>11</sup>C]hippuric acid into the heart
was observed.<sup><xref ref-type="bibr" rid="ref874">874</xref></sup> In rabbits, [<sup>11</sup>C]hippuric acid was rapidly excreted through the kidneys, and the
renograms were comparable to those made with &#8220;hippuran&#8221;.<sup><xref ref-type="bibr" rid="ref855">855</xref></sup></p></sec></sec><sec id="sec12.9"><label>12.9</label><title>Lactic Acid</title><sec id="sec12.9.1"><label>12.9.1</label><title>Radiosynthesis</title><p>The synthesis of
racemic, carrier-added [<sup>11</sup>C]lactic acid was first reported
by Cramer and Kistiakowsky in 1941 <italic toggle="yes">via</italic> reaction of
KCN with acetaldehyde and subsequent hydrolysis of the intermediate
[<sup>11</sup>C]lactonitrile (<xref rid="fig180" ref-type="fig">Figure <xref rid="fig180" ref-type="fig">180</xref></xref>A).<sup><xref ref-type="bibr" rid="ref877">877</xref></sup> Using
[<sup>11</sup>C]KCN gave [<sup>11</sup>C]lactic acid labeled in the
1-position (RCY of 30&#8211;40%, synthesis time of 90&#8211;120
min), while an isotopomeric mixture of [<sup>11</sup>C]acetaldehyde
yielded [<sup>11</sup>C]lactic acid labeled at the <italic toggle="yes">2</italic>-/<italic toggle="yes">3</italic>-position (RCY of 40&#8211;50%, synthesis time
of 150 min). In 1978 Winstead <italic toggle="yes">et al</italic>. used an <italic toggle="yes">in situ</italic> generated acetaldehyde&#8211;bisulfite adduct in
reaction with [<sup>11</sup>C]NaCN to generate [<italic toggle="yes">1</italic>-<sup>11</sup>C]lactonitrile, which following hydrolysis, gave [<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid (<xref rid="fig180" ref-type="fig">Figure <xref rid="fig180" ref-type="fig">180</xref></xref>B; yield of 280 MBq, RCY of 53.5%, synthesis
time of 119 min).<sup><xref ref-type="bibr" rid="ref875">875</xref></sup> Based on this approach,
Drandarov <italic toggle="yes">et al</italic>. developed an automated, no-carrier-added
synthesis of enantiopure <sc><italic toggle="yes">d</italic></sc>- and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid using
chiral ligand exchange chromatography (yield of 2.5 GBq at EOS, RCY
&gt;80%, synthesis time of 45 min, RCP &gt;99%, ee &gt;99%).<sup><xref ref-type="bibr" rid="ref878">878</xref></sup></p><fig id="fig180" position="float" orientation="portrait"><label>Figure 180</label><caption><p>Chemical preparations of [<sup>11</sup>C]lactic
acid. <sup>11</sup>C radionuclide positions are highlighted in red,
orange, and blue.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr180" position="float" orientation="portrait" xlink:href="cr2c00398_0180.jpg"/></fig><p>Several enzymatic approaches have been used to
prepare enantiopure <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic
acid,<sup><xref ref-type="bibr" rid="ref241">241</xref>,<xref ref-type="bibr" rid="ref924">924</xref>,<xref ref-type="bibr" rid="ref925">925</xref></sup> and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]lactic acid (<xref rid="fig181" ref-type="fig">Figure <xref rid="fig181" ref-type="fig">181</xref></xref>).<sup><xref ref-type="bibr" rid="ref879">879</xref>,<xref ref-type="bibr" rid="ref881">881</xref>,<xref ref-type="bibr" rid="ref925">925</xref></sup> Each preparation proceeds <italic toggle="yes">via</italic> the synthesis of intermediate [<sup>11</sup>C]pyruvic
acid and its reduction to <sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]lactic acid using <sc>l</sc>-lactate dehydrogenase, while the method
of forming pyruvic acid varies. In 1980, Cohen <italic toggle="yes">et al.</italic>,<sup><xref ref-type="bibr" rid="ref924">924</xref></sup> used [<sup>11</sup>C]CO<sub>2</sub> and acetyl coenzyme A in the presence of pyruvate synthase to access <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvic
acid, which was then converted to <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid (<xref rid="fig181" ref-type="fig">Figure <xref rid="fig181" ref-type="fig">181</xref></xref>A; RCY of 3&#8211;5%, synthesis time of
20 min). Alternatively, [<sup>11</sup>C]pyruvic acid can be formed
from <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]alanine using multicomponent enzyme reactions. <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]alanine
has been radiolabeled in the <italic toggle="yes">3</italic>-position by <sup>11</sup>C-methylation of glycine derivatives to ultimately form <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]lactic acid (<xref rid="fig181" ref-type="fig">Figure <xref rid="fig181" ref-type="fig">181</xref></xref>B; yield of 220
MBq, RCY of 26.5%, synthesis time of 40 min, <italic toggle="yes">A</italic><sub>m</sub> of 0.02 GBq/&#956;mol;<sup><xref ref-type="bibr" rid="ref881">881</xref></sup><xref rid="fig181" ref-type="fig">Figure <xref rid="fig181" ref-type="fig">181</xref></xref>C; yield of 400
MBq, RCY of 60%, synthesis time of 40 min, RCP &gt;99%;<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> yield of 1.4 GBq, RCY of 13.4%, activity yield
of 2.5%,
synthesis time of 49 min, RCP of 97%, ee &gt;99%<sup><xref ref-type="bibr" rid="ref879">879</xref></sup>). Meanwhile, <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<sup>11</sup>C]alanine can be radiolabeled in the <italic toggle="yes">1</italic>-position <italic toggle="yes">via</italic> a reaction of [<sup>11</sup>C]cyanide with the acetaldehyde-bisulfite adduct to ultimately form <sc><italic toggle="yes">l</italic></sc><italic toggle="yes">-</italic>[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid (<xref rid="fig181" ref-type="fig">Figure <xref rid="fig181" ref-type="fig">181</xref></xref>D; yield of 925 MBq, RCY of 25% (from HCN), synthesis
time of 40 min from HCN, RCP &gt;97%, <italic toggle="yes">A</italic><sub>m</sub> of
2&#8211;3 GBq/&#956;mol;<sup><xref ref-type="bibr" rid="ref241">241</xref></sup> yield of
320 MBq, RCY of 80% (from HCN), synthesis time of 40 min (from CO<sub>2</sub>), RCP &gt;99%<sup><xref ref-type="bibr" rid="ref925">925</xref></sup>).</p><fig id="fig181" position="float" orientation="portrait"><label>Figure 181</label><caption><p>Enzymatic
preparations of <italic toggle="yes">L</italic>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid using [<sup>11</sup>C]CH<sub>3</sub>I
or [<sup>11</sup>C]HCN. <sup>11</sup>C radionuclide positions are
highlighted in red and orange.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr181" position="float" orientation="portrait" xlink:href="cr2c00398_0181.jpg"/></fig></sec><sec id="sec12.9.2"><label>12.9.2</label><title>Preclinical Studies</title><p>In an early
scintigraphic study in 1978, Winstead <italic toggle="yes">et al</italic>. studied
the distribution of [<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid
in a dog, observing the accumulation of activity principally in the
pancreas, liver, lungs, heart-blood pool, and kidneys with significant
excretion in urine and bile.<sup><xref ref-type="bibr" rid="ref875">875</xref></sup> In 1979
Cohen <italic toggle="yes">et al</italic>. reported a biodistribution study in
rabbits using <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]lactic acid and found a seven-fold increase in activity
myocardium compared to the lung.<sup><xref ref-type="bibr" rid="ref876">876</xref></sup> The
next <italic toggle="yes">in vivo</italic> study, and first lactate PET study,
was performed nearly 30 years later by Herrero <italic toggle="yes">et al</italic>. using <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]lactic acid as a tracer for myocardial lactate metabolism in dogs.<sup><xref ref-type="bibr" rid="ref880">880</xref></sup> Arterial blood metabolism studies found the
most abundant <sup>11</sup>C fraction to be lactate + pyruvate (43%),
followed by neutral metabolites (glucose, 31%) and CO<sub>2</sub> (15%),
with basic metabolites (primary alanine) contributing 10% to total
arterial <sup>11</sup>C activity. In 2018, Temma <italic toggle="yes">et al.</italic>, used <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]lactic acid for the pharmacokinetic analysis of lactate metabolism
in rat brains, and their finding suggests active lactate brain usage <italic toggle="yes">in vivo</italic> (<xref rid="fig182" ref-type="fig">Figure <xref rid="fig182" ref-type="fig">182</xref></xref>).<sup><xref ref-type="bibr" rid="ref879">879</xref></sup> Rapid metabolic conversion
to [<sup>11</sup>C]glucose was observed in arterial blood (79% [<sup>11</sup>C]glucose; 12% <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]lactate at 10 min p.i.).</p><fig id="fig182" position="float" orientation="portrait"><label>Figure 182</label><caption><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">3</italic>-<sup>11</sup>C]Lactate
PET images of a rat head in (A) transverse, (B) coronal, and (C) sagittal
planes. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref879">879</xref>). Copyright 2018 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr182" position="float" orientation="portrait" xlink:href="cr2c00398_0182.jpg"/></fig></sec></sec><sec id="sec12.10"><label>12.10</label><title><italic toggle="yes">N</italic>-Acetyl-leukotriene <sub>4</sub></title><sec id="sec12.10.1"><label>12.10.1</label><title>Radiosynthesis</title><p><sup>11</sup>C-Labeled <italic toggle="yes">N</italic>-acetyl-LTE<sub>4</sub> was first labeled from the <italic toggle="yes">N</italic>-acetyl group using [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>COCl (<xref rid="fig183" ref-type="fig">Figure <xref rid="fig183" ref-type="fig">183</xref></xref>).<sup><xref ref-type="bibr" rid="ref882">882</xref></sup> RCP was &gt;95%, and <italic toggle="yes">A</italic><sub>m</sub> was about 2 GBq/&#956;mol. However, there
was no mention of total synthesis time or other reaction conditions.
In the following years, <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub> was produced from LTE<sub>4</sub> and [<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl chloride in THF in 50 min (yield 1.3%, CP
and RCP was 95%, the average <italic toggle="yes">A</italic><sub>m</sub> was 2
GBq/&#956;mol).<sup><xref ref-type="bibr" rid="ref883">883</xref>,<xref ref-type="bibr" rid="ref884">884</xref></sup></p><fig id="fig183" position="float" orientation="portrait"><label>Figure 183</label><caption><p>Synthesis of <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub> using [<italic toggle="yes">1</italic>-<sup>11</sup>C]CH<sub>3</sub>COCl. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr183" position="float" orientation="portrait" xlink:href="cr2c00398_0183.jpg"/></fig></sec><sec id="sec12.10.2"><label>12.10.2.1</label><title>Preclinical Studies</title><p>The first
preclinical study was done in 1991 to investigate leukotriene elimination
in rats using <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub> from the jugular vein.<sup><xref ref-type="bibr" rid="ref882">882</xref></sup><italic toggle="yes">N</italic>-[<sup>11</sup>C]Acetyl-LTE<sub>4</sub> cleared rapidly from the
blood, reached its maximum in the liver 4 min after the iv injection
and then metabolized through the intestines. In the following year,
the same study was repeated to observe <italic toggle="yes">in vivo</italic> elimination
of cysteinyl leukotrienes in rats.<sup><xref ref-type="bibr" rid="ref832">832</xref></sup> Results
were consistent with the previous study (iv injection, the dose was
27 MBq/kg). Keppler and his co-workers continued expanding their studies
and used <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub> in female Wistar rats, male Hartley guinea pigs (no data was shown),
female homozygous transport mutant Wistar rats, and female Cynomolgus
monkey.<sup><xref ref-type="bibr" rid="ref883">883</xref></sup><italic toggle="yes">N</italic>-[<sup>11</sup>C]Acetyl-LTE<sub>4</sub> was given intravenously and rapid elimination
was observed from the blood to the liver, and then excretion into
the bile was observed.<sup><xref ref-type="bibr" rid="ref883">883</xref></sup> As in previous
studies, in monkeys, renal excretion into urine was observed, and
transit time through the liver was 34 min with 16 min hepatic excretion
half-time. These times for normal rats were 17 and 8.5 min, respectively.
In mutant and healthy rats with cholestasis due to bile duct obstruction
(induced with surgery before injection of <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub>), these periods were much more extended
than monkeys&#8217; and showed longer organ storage and metabolism.
Accumulation of the <italic toggle="yes">N</italic>-[<sup>11</sup>C]acetyl-LTE<sub>4</sub> was seen in the bladder of mutant rats and rats with cholestasis
due to bile duct obstruction instead of the intestines (<xref rid="fig184" ref-type="fig">Figure <xref rid="fig184" ref-type="fig">184</xref></xref>).<sup><xref ref-type="bibr" rid="ref883">883</xref></sup></p><fig id="fig184" position="float" orientation="portrait"><label>Figure 184</label><caption><p><italic toggle="yes">N</italic>-[<sup>11</sup>C]Acetyl-LTE<sub>4</sub> pharmacokinetics
in a normal rat (left) and a rat with bile duct obstruction-induced
cholestasis (right). Reproduced with permission from ref (<xref ref-type="bibr" rid="ref883">883</xref>). Copyright 2005 John
Wiley and Sons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr184" position="float" orientation="portrait" xlink:href="cr2c00398_0184.jpg"/></fig></sec></sec><sec id="sec12.11"><label>12.11</label><title><italic toggle="yes">N</italic>-Methyltaurine</title><sec id="sec12.11.1"><label>12.11.1</label><title>Radiosynthesis</title><p>Labeling of <italic toggle="yes">N</italic>-methyltaurine has only been performed from the methylamino
group to synthesis of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]taurine by using [<sup>11</sup>C]CH<sub>3</sub>I (<xref rid="fig185" ref-type="fig">Figure <xref rid="fig185" ref-type="fig">185</xref></xref>).<sup><xref ref-type="bibr" rid="ref885">885</xref>,<xref ref-type="bibr" rid="ref926">926</xref>,<xref ref-type="bibr" rid="ref927">927</xref></sup> The first synthesis was done
from the sodium salt of taurine and [<sup>11</sup>C]CH<sub>3</sub>I at 80 &#176;C in 3 min. This synthesis was done to see the biodistribution
of conjugated bile acids (cholic acid, chenodeoxycholic acid, deoxycholic
acid, ursodeoxycholic acid, lithocholic acid) in pigs, so there is
no data available for the activity of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]taurine.<sup><xref ref-type="bibr" rid="ref885">885</xref></sup></p><fig id="fig185" position="float" orientation="portrait"><label>Figure 185</label><caption><p>Synthesis of [<italic toggle="yes">N</italic>-<italic toggle="yes">methyl</italic>-<sup>11</sup>C]taurine using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr185" position="float" orientation="portrait" xlink:href="cr2c00398_0185.jpg"/></fig></sec></sec><sec id="sec12.12"><label>12.12</label><title>Oxalic Acid</title><sec id="sec12.12.1"><label>12.12.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Oxalic acid was first synthesized in 1942 by Nahisky <italic toggle="yes">et
al</italic>. from the oxidation of [<italic toggle="yes">1</italic>-<sup>11</sup>C]propionic acid and <italic toggle="yes">&#945;</italic>- and <italic toggle="yes">&#946;</italic>-hydroxypropionic acid.<sup><xref ref-type="bibr" rid="ref928">928</xref></sup> A few years
later, Thorell <italic toggle="yes">et al</italic>. prepared [<sup>11</sup>C]oxalic
acid in a three-step procedure. In this process, [<sup>11</sup>C]CN<sup>&#8211;</sup> was reacted with methyl chloroformate to generate
the intermediate [<sup>11</sup>C]cyanoformate, and after evaporation
of HCl, the [<sup>11</sup>C]oxalic acid was obtained (<xref rid="fig186" ref-type="fig">Figure <xref rid="fig186" ref-type="fig">186</xref></xref>). This reaction produced
[<sup>11</sup>C]oxalic acid in a RCY of 70.8%.<sup><xref ref-type="bibr" rid="ref886">886</xref></sup></p><fig id="fig186" position="float" orientation="portrait"><label>Figure 186</label><caption><p>Synthesis of [<sup>11</sup>C]oxalic acid using [<sup>11</sup>C]CN<sup>&#8211;</sup>. <sup>11</sup>C radionuclide position is
highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr186" position="float" orientation="portrait" xlink:href="cr2c00398_0186.jpg"/></fig></sec></sec><sec id="sec12.13"><label>12.13</label><title>Paclitaxel</title><sec id="sec12.13.1"><label>12.13.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Paclitaxel was synthesized by reacting the primary amine precursor
of paclitaxel with [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]benzoyl
chloride (<xref rid="fig187" ref-type="fig">Figure <xref rid="fig187" ref-type="fig">187</xref></xref>). The synthesis, purification, and formulation time was 38 min from
EOB with an average <italic toggle="yes">A</italic><sub>m</sub> of 0.0499 GBq/&#956;mol
at EOS. The average RCY was 7%, with a RCP &gt; 99%.<sup><xref ref-type="bibr" rid="ref887">887</xref></sup></p><fig id="fig187" position="float" orientation="portrait"><label>Figure 187</label><caption><p>Radiosynthesis of [<sup>11</sup>C]paclitaxel using [<italic toggle="yes">carboxyl</italic>-<sup>11</sup>C]benzoyl chloride. <sup>11</sup>C
radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr187" position="float" orientation="portrait" xlink:href="cr2c00398_0187.jpg"/></fig></sec></sec><sec id="sec12.14"><label>12.14</label><title>Phenylethanolamine</title><sec id="sec12.14.1"><label>12.14.1</label><title>Radiosynthesis</title><p>No-carrier-added
[<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine was prepared
in two steps <italic toggle="yes">via</italic> a combined enzymatic and radiochemical
synthesis. Free of ammonia hydrogen [<sup>11</sup>C]cyanide was prepared
following an established protocol and collected by bubbling through
a solution of 0.05 M 50% methanolic acetate buffer (pH 5.4) held at
&#8722;20 &#176;C.<sup><xref ref-type="bibr" rid="ref929">929</xref></sup> A mixture of benzaldehyde
and salt-free mandelonitrile lyase in CH<sub>2</sub>Cl<sub>2</sub> was added to this trapping solution and stirred for 10 min at room
temperature (20&#8211;25&#176;C). The solvent was evaporated, and
the [<sup>11</sup>C]mandelonitrile intermediate was used for the next
step without further purification. The [<sup>11</sup>C]cyanohydrin
intermediate was reduced by applying two different approaches (<xref rid="fig188" ref-type="fig">Figure <xref rid="fig188" ref-type="fig">188</xref></xref>). In the first
one, the reduction was carried out using sodium borohydride&#8211;cobaltous
chloride in methanol at room temperature for 10 min. The final product
was purified by a small cation-exchange column (H<sup>+</sup> form)
and then analyzed by analytical HPLC, indicating the presence of two
radioactive peaks, one corresponding to [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine and the other corresponding to a [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenethylamine byproduct. When the purification was
performed with a preparative HPLC using a reversed-phase column and
eluting with a 4:1 mixture of 0.01 N HCl and methanol, no chemical
and radiochemical impurities were detected. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylethanolamine hydrochloride was isolated with a RCP
of &gt;98%. In the second approach, the [<sup>11</sup>C]cyanohydrin
intermediate
was reduced to the required amino alcohol functionality with the boran&#8211;THF
complex at 50 &#176;C for 8 min, and only the [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine hydrochloride was isolated with a RCP
of better than 98% (<xref rid="fig188" ref-type="fig">Figure <xref rid="fig188" ref-type="fig">188</xref></xref>A). The two synthetic approaches to [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine gave almost the same overall RCYs of
2&#8211;4% at EOS in a total synthesis time of 50&#8211;60 min.
The <italic toggle="yes">A</italic><sub>m</sub> of the product obtained was 130.1
GBq/&#956;mol as determined by UV spectroscopy.<sup><xref ref-type="bibr" rid="ref888">888</xref></sup></p><fig id="fig188" position="float" orientation="portrait"><label>Figure 188</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine
using [<sup>11</sup>C]HCN or [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr188" position="float" orientation="portrait" xlink:href="cr2c00398_0188.jpg"/></fig><p>Another method was developed by Nagren <italic toggle="yes">et al</italic>.
in 1993. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Phenylethanolamine was
prepared by reaction of [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub> with a mixture of benzaldehyde and TBAF in THF at 0 &#176;C for
2 min, followed by reduction with Raney nickel in formic acid (<xref rid="fig188" ref-type="fig">Figure <xref rid="fig188" ref-type="fig">188</xref></xref>). After semipreparative
HPLC purification, [<italic toggle="yes">1</italic>-<sup>11</sup>C]phenylethanolamine
was isolated with a RCY of 37&#8211;50% (based on [<sup>11</sup>C]CH<sub>3</sub>NO<sub>2</sub>), RCP &gt;98%, and <italic toggle="yes">A</italic><sub>m</sub> of 26&#8211;56 GBq/&#956;mol within 40&#8211;45 min.<sup><xref ref-type="bibr" rid="ref685">685</xref></sup></p></sec></sec><sec id="sec12.15"><label>12.15</label><title>Phenylpyruvic Acid</title><sec id="sec12.15.1"><label>12.15.1</label><title>Radiosynthesis</title><p>The preparation
of [<italic toggle="yes">4</italic>-<sup>11</sup>C]phenylpyruvic acid in the 4-
position of the side chain was first described in 1986, starting from
[<sup>11</sup>C]CO<sub>2</sub> (<xref rid="fig189" ref-type="fig">Figure <xref rid="fig189" ref-type="fig">189</xref></xref>). In this process, a mixture of 2-phenyl-5-oxazolone
in absolute ethanol and <italic toggle="yes">1</italic>,<italic toggle="yes">4</italic>-diazabicyclo[<italic toggle="yes">2</italic>.<italic toggle="yes">2</italic>.<italic toggle="yes">2</italic>]octane (DABCO) in
absolute ethanol was added to a solution containing [<sup>11</sup>C]benzaldehyde. NaOH was added to the mixture to convert the condensation
product [&#945;-<sup>11</sup>C]<italic toggle="yes">4</italic>-benzylidene-<italic toggle="yes">2</italic>-phenyl-<italic toggle="yes">5</italic>-oxazolone into [<italic toggle="yes">4</italic>-<sup>11</sup>C]phenylpyruvic, in a process lasting 40 min with RCY
of 40%.<sup><xref ref-type="bibr" rid="ref428">428</xref></sup></p><fig id="fig189" position="float" orientation="portrait"><label>Figure 189</label><caption><p>Synthesis of [<italic toggle="yes">3</italic>-<sup>11</sup>C]phenylpyruvate
from [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref428">428</xref></sup><sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr189" position="float" orientation="portrait" xlink:href="cr2c00398_0189.jpg"/></fig></sec></sec><sec id="sec12.16"><label>12.16</label><title>Pyruvic Acid</title><sec id="sec12.16.1"><label>12.16.1</label><title>Radiosynthesis</title><p>The first synthesis
of [<sup>11</sup>C]pyruvic acid was done in 1979 from [<sup>11</sup>C]CO<sub>2</sub>, pyruvate-ferredoxin oxidoreductase, and coenzymes.<sup><xref ref-type="bibr" rid="ref924">924</xref></sup> In 1985, Hara <italic toggle="yes">et al</italic>. synthesized
[<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate by using a similar method
and purified it using sublimation.<sup><xref ref-type="bibr" rid="ref891">891</xref></sup> Total
synthesis was completed in 35 min with a RCY of 80% from [<sup>11</sup>C]CO<sub>2</sub>. [<italic toggle="yes">1</italic>-<sup>11</sup>C]Pyruvic acid
was also synthesized by hydrolyzation of carbon-11 labeled <italic toggle="yes">&#945;</italic>-imino acid in 35&#8211;40 min (550&#8211;9960
MBq)<sup><xref ref-type="bibr" rid="ref930">930</xref></sup> (<xref rid="fig190" ref-type="fig">Figure <xref rid="fig190" ref-type="fig">190</xref></xref>), and also purification with SEP-PAK C<sub>18</sub> cartridges, were explicitly studied.<sup><xref ref-type="bibr" rid="ref931">931</xref></sup> Another enzymatic radiosynthesis was also done by using
two different purification methods.<sup><xref ref-type="bibr" rid="ref241">241</xref></sup> Both
methods had the same radiolabeled starter, [<sup>11</sup>C]HCN, and <sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]alanine
was synthesized with [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvic acid
and purified both <italic toggle="yes">via</italic><sc>d</sc>-amino acid oxidase
and <sc>l</sc>-alanine dehydrogenase and <italic toggle="yes">via</italic><sc><italic toggle="yes">d</italic></sc>- and <sc><italic toggle="yes">l</italic></sc>- amino acid
oxidases. A similar method from <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">1</italic>-<sup>11</sup>C]alanine was also
investigated, and synthesis was completed in 47 min with 703 MBq activity.<sup><xref ref-type="bibr" rid="ref932">932</xref></sup></p><fig id="fig190" position="float" orientation="portrait"><label>Figure 190</label><caption><p>Synthesis of [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvic acid using
[<sup>11</sup>C]CO<sub>2</sub>. <sup>11</sup>C radionuclide position
is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr190" position="float" orientation="portrait" xlink:href="cr2c00398_0190.jpg"/></fig><p>Pyruvic acid was also labeled from position <italic toggle="yes">3</italic>-
in different studies. The known first reaction started from [<sup>11</sup>C]CH<sub>3</sub>I to form racemic <sc>d</sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]alanine and then
enzymatically synthesis [4-<sup>11</sup>C]pyruvic acid in 35 min with
a RCY of 73% and RCP &gt;99%.<sup><xref ref-type="bibr" rid="ref898">898</xref></sup> In addition
to these methods, [<italic toggle="yes">4</italic>-<sup>11</sup>C]pyruvic acid
synthesis was also done with immobilized enzymes in one single column.<sup><xref ref-type="bibr" rid="ref933">933</xref></sup> For radiolabeling, <sc><italic toggle="yes">d</italic></sc>,<sc>l</sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]alanine was synthesized
from [<sup>11</sup>C]CH<sub>3</sub>I, and different enzymes were used
for each method. Similar synthesis from <sc><italic toggle="yes">d</italic></sc>,<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">4</italic>-<sup>11</sup>C]alanine, <sc><italic toggle="yes">d</italic></sc>-amino acid oxidase, alanine racemase, and
catalase resulted in approximately 52 min with a RCY &#8764; 18%
and RCP &gt; 99%.<sup><xref ref-type="bibr" rid="ref892">892</xref></sup> It was also used to
synthesize
carbon-11 labeled lactic acid as a reactive intermediate.<sup><xref ref-type="bibr" rid="ref879">879</xref>,<xref ref-type="bibr" rid="ref925">925</xref></sup></p></sec><sec id="sec12.16.2"><label>12.16.2</label><title>Preclinical Studies</title><p>The first
body distribution study of [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate
was tried on female rabbits with a brain tumor and injected through
the ear vein.<sup><xref ref-type="bibr" rid="ref891">891</xref></sup> According to the results,
radioactivity in the tumor had increased in time, and in the liver,
it had decreased. Radioactivity accumulation was seen in the urine
in the urinary bladder. [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate
has been used for the estimation of hemic hypoxia in rats and compared
with healthy ones.<sup><xref ref-type="bibr" rid="ref889">889</xref>,<xref ref-type="bibr" rid="ref890">890</xref></sup></p><p><italic toggle="yes">In vivo</italic> biodistribution of [<italic toggle="yes">4</italic>-<sup>11</sup>C]pyruvate was
studied in two previously healthy mini-pigs that had diabetic hearts
in the study.<sup><xref ref-type="bibr" rid="ref893">893</xref></sup> Another <italic toggle="yes">in vivo</italic> study that used [<italic toggle="yes">4</italic>-<sup>11</sup>C]pyruvate was
the characterization of prostate cancer metabolic phenotype in two
different prostate cancers.<sup><xref ref-type="bibr" rid="ref892">892</xref></sup> For this
study, male tumor-bearing mice were used, and after 10 min of injection,
30 min PET scans were done.</p></sec><sec id="sec12.16.3"><label>12.16.3</label><title>Clinical Studies</title><p>The first clinical
study with [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate purified by
sublimation was performed on a 51-year-old man with a brain tumor.<sup><xref ref-type="bibr" rid="ref891">891</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Pyruvate
was intravenously injected, and images were collected at 0&#8211;5
and 10&#8211;15 min p.i. Tumor accumulation was observed in this
study. The same research group then tried [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate on 8<sup><xref ref-type="bibr" rid="ref894">894</xref></sup> and 12 patients.<sup><xref ref-type="bibr" rid="ref895">895</xref></sup> In the first study, patients were females and
males with different brain problems between 38 and 78 years old, and
the study aimed to visualize ischemia and infarction in the brain.<sup><xref ref-type="bibr" rid="ref894">894</xref></sup> [<italic toggle="yes">1</italic>-<sup>11</sup>C]Pyruvate
was given intravenously, and a PET scan was started immediately after
the injection. In the second study, female and male patients between
40 and 50 years old with different brain tumors.<sup><xref ref-type="bibr" rid="ref895">895</xref></sup> According to this study, [1-<sup>11</sup>C]pyruvate can
be used on local brain tumors using a PET scan. <italic toggle="yes">In vivo</italic> metabolism of [1-<sup>11</sup>C]pyruvate was also investigated for
brain tissue distribution in patients with epilepsy and Leigh&#8217;s
disease and brain and epicranial muscle distribution in mitochondrial
encephalomyopathy.<sup><xref ref-type="bibr" rid="ref896">896</xref></sup> Pyruvate metabolism
was also investigated by using [<italic toggle="yes">1</italic>-<sup>11</sup>C]pyruvate.<sup><xref ref-type="bibr" rid="ref897">897</xref></sup></p></sec></sec><sec id="sec12.17"><label>12.17</label><title>Salicylic Acid</title><sec id="sec12.17.1"><label>12.17.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Salicylic acid was reported by Sasaki <italic toggle="yes">et al</italic>. through
carboxylation of <italic toggle="yes">2</italic>-bromomagnesiumanisole using [<sup>11</sup>C]CO<sub>2</sub> (<xref rid="fig191" ref-type="fig">Figure <xref rid="fig191" ref-type="fig">191</xref></xref>) and gave [<sup>11</sup>C]salicylic acid with a RCY
of 7.3 &#177; 1.6% and <italic toggle="yes">A</italic><sub>m</sub> of 23.5 &#177;
9.6 GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref899">899</xref></sup> An alternative preparation
was described by Winstead <italic toggle="yes">et al</italic>., where salicylic
acid (cold compound) was produced by carbonating the aryl lithium
intermediate obtained from the reaction of <italic toggle="yes">o</italic>-bromophenol
with <italic toggle="yes">n</italic>-butyl lithium. Although details were not provided
on the radiosynthesis procedure, a RCY of 50% was obtained.</p><fig id="fig191" position="float" orientation="portrait"><label>Figure 191</label><caption><p>Synthesis
of [<sup>11</sup>C]salicylic acid using [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref899">899</xref></sup><sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr191" position="float" orientation="portrait" xlink:href="cr2c00398_0191.jpg"/></fig></sec><sec id="sec12.17.2"><label>12.17.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Salicylic acid was studied in mice by Sasaki <italic toggle="yes">et al</italic>. in 1999 to evaluate the production of <italic toggle="yes">2</italic>,<italic toggle="yes">3</italic>-dihydroxybenzoic acid and <italic toggle="yes">2</italic>,<italic toggle="yes">5</italic>-dihydroxybenzoic acid as a result of the reaction of reactive oxygen
species with salicylic acid.<sup><xref ref-type="bibr" rid="ref899">899</xref></sup> Biodistribution
studies at 1 min p.i. found the highest uptake in the kidneys and
blood, with lower uptake in the liver, lung, and heart.<sup><xref ref-type="bibr" rid="ref899">899</xref></sup> Studies on dogs showed activity uptake in the
heart-blood pool, liver, and upper abdomen at 2&#8211;3 min p.i.<sup><xref ref-type="bibr" rid="ref531">531</xref></sup></p></sec></sec><sec id="sec12.18"><label>12.18</label><title>Salvinorin A</title><sec id="sec12.18.1"><label>12.18.1</label><title>Radiosynthesis</title><p>The production
of [<sup>11</sup>C]salvinorin A used [<sup>11</sup>C]CH<sub>3</sub>COCl as a radiolabeling agent, which was prepared by reaction of
cyclotron produced [<sup>11</sup>C]CO<sub>2</sub> with methyl magnesium
bromide in diethyl ether. [<sup>11</sup>C]CH<sub>3</sub>COCl was then
transferred into a second vial containing a solution of salvinorin
B (a deacetylated analogue of salvinorin A, <xref rid="fig192" ref-type="fig">Figure <xref rid="fig192" ref-type="fig">192</xref></xref>) and <italic toggle="yes">4</italic>-dimethylaminopyridine
(DMAP) in DMF and reacted for 7&#8211;10 min.<sup><xref ref-type="bibr" rid="ref813">813</xref></sup> [<italic toggle="yes">Acetoxy</italic>-<sup>11</sup>C]salvinorin A was
obtained within 40 min with RCY of 3.5&#8211;10% (based on the initial
activity of [<sup>11</sup>C]CO<sub>2</sub>) and <italic toggle="yes">A</italic><sub>m</sub> of 7.4&#8211;27.8 GBq/&#956;mol (corrected to EOB).<sup><xref ref-type="bibr" rid="ref813">813</xref></sup></p><fig id="fig192" position="float" orientation="portrait"><label>Figure 192</label><caption><p>Synthesis of [<italic toggle="yes">acetoxy</italic>-<sup>11</sup>C]salvinorin
A using [<sup>11</sup>C]CH<sub>3</sub>COCl and [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]salvinorin A using [<sup>11</sup>C]CH<sub>3</sub>I. <sup>11</sup>C radionuclide position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr192" position="float" orientation="portrait" xlink:href="cr2c00398_0192.jpg"/></fig><p>Alternatively, [<sup>11</sup>C]salvinorin A was
radiolabeled using
[<sup>11</sup>C]CH<sub>3</sub>I starting from <italic toggle="yes">O</italic>-demethylsalvinorin
A (<xref rid="fig192" ref-type="fig">Figure <xref rid="fig192" ref-type="fig">192</xref></xref>).<sup><xref ref-type="bibr" rid="ref900">900</xref></sup> The reaction was carried out for 5 min at 80
&#176;C in DMSO with the aid of Cs<sub>2</sub>CO<sub>3</sub>. This
alternative route yielded [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]salvinorin
A with RCY of 72 &#177; 6% and <italic toggle="yes">A</italic><sub>m</sub> of 159.1
&#177; 44.4 GBq/&#956;mol.</p></sec><sec id="sec12.18.2"><label>12.18.2</label><title>Preclinical Studies</title><p>Pharmacokinetics
of [<sup>11</sup>C]salvinorin A was initially assessed on six female<italic toggle="yes">Papio Anubis</italic> baboons on either the brain or the chest.
[<sup>11</sup>C]Salvinorin A was injected and scans proceeded for
60 min with and without prior administration of naloxone (15 min before
[<sup>11</sup>C]salvinorin A administration, 1.0 mg/kg) for binding
specificity assessment.<sup><xref ref-type="bibr" rid="ref813">813</xref></sup> PET scanning
showed that the concentration of [<sup>11</sup>C]salvinorin A rapidly
peaks in the brain (3.3% of the administered dose within 40 s) and
washes out with a half-life of 8 min, with the most affected areas
being in salivary and nasal tracts and the cerebellum, which is in
contrast with known &#954; opioid receptor expression. Moreover,
the binding was constant even with naloxone pretreatment (<xref rid="fig193" ref-type="fig">Figure <xref rid="fig193" ref-type="fig">193</xref></xref>), suggesting
a high degree of nondisplaceable binding.<sup><xref ref-type="bibr" rid="ref813">813</xref></sup> Metabolite studies also highlighted the quick metabolism of [<sup>11</sup>C]salvinorin A to [<sup>11</sup>C]salvinorin B.<sup><xref ref-type="bibr" rid="ref813">813</xref>,<xref ref-type="bibr" rid="ref900">900</xref></sup></p><fig id="fig193" position="float" orientation="portrait"><label>Figure 193</label><caption><p>[<sup>11</sup>C]Salvinorin A PET images of<italic toggle="yes">Papio
Anubis</italic>baboons with (bottom) and without (top) naloxone
pretreatment. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref813">813</xref>). Copyright 2008 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr193" position="float" orientation="portrait" xlink:href="cr2c00398_0193.jpg"/></fig></sec></sec><sec id="sec12.19"><label>12.19</label><title>Urea</title><sec id="sec12.19.1"><label>12.19.1</label><title>Radiosynthesis</title><p>In 1980, it was
first reported [<sup>11</sup>C]urea&#8217;s automated radiosynthesis
from [<sup>11</sup>C]COCl<sub>2</sub> and ammonia aqueous solution
reacting at 100 &#176;C for 15 min (<xref rid="fig194" ref-type="fig">Figure <xref rid="fig194" ref-type="fig">194</xref></xref>). The total synthesis takes 30 min, achieving
RCY of 15% with respect to [<sup>11</sup>C]CO<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref754">754</xref></sup> This procedure was further optimized by Bera <italic toggle="yes">et al</italic>. using a continuous conversion of [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]urea and by maintaining moisture-free
conditions with a frequent catalyst replacement.<sup><xref ref-type="bibr" rid="ref902">902</xref></sup> In this case, 296&#8211;370 MBq of [<sup>11</sup>C]urea
were produced on-line from 925&#8211;1110 MBq of [<sup>11</sup>C]CO<sub>2</sub>, with RCY of 35% and <italic toggle="yes">A</italic><sub>m</sub> of 6.475
GBq/&#956;mol.<sup><xref ref-type="bibr" rid="ref902">902</xref></sup></p><fig id="fig194" position="float" orientation="portrait"><label>Figure 194</label><caption><p>Synthesis of [<sup>11</sup>C]urea from [<sup>11</sup>C]CO<sub>2</sub>, [<sup>11</sup>C]COCl<sub>2</sub>, and [<sup>11</sup>C]KCN. <sup>11</sup>C radionuclide
position is highlighted in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr194" position="float" orientation="portrait" xlink:href="cr2c00398_0194.jpg"/></fig><p>More recently, [<sup>11</sup>C]urea was prepared
as an intermediate
in the synthesis of [2-<sup>11</sup>C]thimidine from [<sup>11</sup>C]COCl<sub>2</sub> by reacting with aqueous ammonia and achieving
a RCC of 55% in 20 min.<sup><xref ref-type="bibr" rid="ref724">724</xref></sup> Furthermore,
[<sup>11</sup>C]urea&#8217;s radiosynthesis was investigated starting
from [<sup>11</sup>C]cyanide to increase RCY and A<sub>m</sub>. Firstly,
[<sup>11</sup>C]KCN was converted to [<sup>11</sup>C]KOCN by catalytic
oxidation with Cu(OH)<sub>2</sub> and successively converted to its
ammonium salt with ammonium hydroxide to achieve final [<sup>11</sup>C]urea (<xref rid="fig194" ref-type="fig">Figure <xref rid="fig194" ref-type="fig">194</xref></xref>). After HPLC purification, RCY was higher than 85% from no-carrier-added
[<sup>11</sup>C]KCN in 20&#8211;25 min with <italic toggle="yes">A</italic><sub>m</sub> of 129.5 &#177; 29.6 GBq/&#956;mol at EOB.<sup><xref ref-type="bibr" rid="ref903">903</xref>,<xref ref-type="bibr" rid="ref934">934</xref></sup> Further optimizations by increasing the pH and temperature and using
an appropriate vessel to reduce urea decomposition provided RCY of
95.0 &#177; 2.5%, decreasing the total synthesis time to approximately
16 min from EOB.<sup><xref ref-type="bibr" rid="ref755">755</xref></sup> Lastly, [<sup>11</sup>C]urea was also obtained directly from [<sup>11</sup>C]CO<sub>2</sub> by reaction with lithium bis(trimethylsilyl)amide (LBTMSA) in THF,
followed by a process with aqueous NH<sub>4</sub>Cl solution. In this
case, no-carrier-added [<sup>11</sup>C]urea was achieved with a RCY
of 55&#8211;70% in 16 min from EOB (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>.32).<sup><xref ref-type="bibr" rid="ref729">729</xref></sup></p></sec><sec id="sec12.19.2"><label>12.19.2</label><title>Clinical Studies</title><p>[<sup>11</sup>C]Urea was evaluated as a potential external imaging radiotracer
to detect <italic toggle="yes">Helicobacter pylori</italic> colonization
in the stomach by locating its specific urease activity. Notably,
a 200 mL aqueous solution containing [<sup>11</sup>C]urea with [<sup>99m</sup>Tc]diethylenetriamine pentaacetate ([<sup>99m</sup>Tc]DTPA)
(a nonabsorbable marker used as a control for loss of radioactivity
from the stomach due to gastric emptying) was orally administered
to a patient suffering from esophageal and gastric erosions due to <italic toggle="yes">Helicobacter pylori</italic>&#8217;s presence and to healthy
negative control. From 5&#8211;10 min after administration, radioactivity
in the stomach decreases due to gastric emptying and urea metabolism
until 20 min, after which it remains constant. Simultaneously, in
the breath test in the same time frame, increasing <sup>11</sup>C
activity was registered in the patient due to [<sup>11</sup>C]urea
hydrolysis in [<sup>11</sup>C]CO<sub>2</sub> by <italic toggle="yes">H.
pylori</italic>, while <sup>11</sup>C activity in control subject
breath remains at background level.<sup><xref ref-type="bibr" rid="ref901">901</xref></sup></p></sec></sec><sec id="sec12.20"><label>12.20</label><title>Uric Acid</title><sec id="sec12.20.1"><label>12.20.1</label><title>Radiosynthesis</title><p>[<sup>11</sup>C]Uric acid was obtained in an efficient and automated synthesis
method from the reaction of [<sup>11</sup>C]COCl<sub>2</sub> and 5,6-diaminouracil
in <italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethylpropyleneurea (DMPU)
solution at 100 &#176;C for 2 min (<xref rid="fig195" ref-type="fig">Figure <xref rid="fig195" ref-type="fig">195</xref></xref>). After cooling, the reaction mixture
was diluted with phosphate buffer, and the final product was purified
using a preparative HPLC system. [<sup>11</sup>C]Uric acid was prepared
within 30 min after the EOB with a RCY of 36 &#177; 6%, <italic toggle="yes">A</italic><sub>m</sub> of 89&#8211;142 GBq/&#956;mol, and RCP of 98%.<sup><xref ref-type="bibr" rid="ref904">904</xref></sup></p><fig id="fig195" position="float" orientation="portrait"><label>Figure 195</label><caption><p>Synthesis of [<sup>11</sup>C]uric acid from
[<sup>11</sup>C]COCl<sub>2</sub> and <italic toggle="yes">5</italic>,<italic toggle="yes">6</italic>-diaminouracil. <sup>11</sup>C radionuclide position is highlighted
in red.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr195" position="float" orientation="portrait" xlink:href="cr2c00398_0195.jpg"/></fig></sec><sec id="sec12.20.2"><label>12.20.2</label><title>Preclinical Studies</title><p>[<sup>11</sup>C]Uric acid has been evaluated in two rats after intravenous bolus
injection <italic toggle="yes">via</italic> the tail vein under normal or hyperuricemic
conditions (<xref rid="fig196" ref-type="fig">Figure <xref rid="fig196" ref-type="fig">196</xref></xref>). The scans were performed at 65&#8211;70 min p.i., in addition
to blood sampling <italic toggle="yes">via</italic> the femoral vein. The radiometabolite
analysis of blood specimens under normal conditions showed that most
of the radioactivity was derived from the metabolite [<sup>11</sup>C]allantoin, whereas, under hyperuricemic conditions, almost all
radioactivity was present as [<sup>11</sup>C]uric acid. In addition,
the limbs showed a high accumulation of radioactivity under hyperuricemic
conditions. Thus, according to Yashio <italic toggle="yes">et al</italic>. [<sup>11</sup>C]uric acid could be a potential tool for diagnosing hyperuricemia,
gout, and other urate-related lifestyle diseases.<sup><xref ref-type="bibr" rid="ref904">904</xref></sup></p><fig id="fig196" position="float" orientation="portrait"><label>Figure 196</label><caption><p>[<sup>11</sup>C]Uric acid whole-body MIP PET image in
normal (A)
and hyperuremic (B) rats (65&#8211;70 min p.i.). Arrows indicate
the region of limbs in which a higher accumulation of radioactivity
was observed. Reproduced with permission from ref (<xref ref-type="bibr" rid="ref904">904</xref>). Copyright 2012 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr196" position="float" orientation="portrait" xlink:href="cr2c00398_0196.jpg"/></fig></sec></sec></sec><sec id="sec13"><label>13</label><title>Future Perspectives and Conclusions</title><p>Since the discovery of carbon-11, many synthetic methods have been
developed and applied to incorporate carbon-11 into organic molecules.
This manuscript reviews these methods and their subsequent application
to the synthesis of carbon-11 labeled endogenous compounds: alcohols,
alkaloids, amino acids, enzyme cofactors, and vitamins, endogenous
gases, fatty acids, hormones and neurotransmitters, nucleotides, peptides,
sugars, and miscellaneous compounds (up until May 2022). A brief description
of clinical and preclinical <italic toggle="yes">in vivo</italic> studies is provided,
along with a selection of synthetic schemes and images/data from <italic toggle="yes">in vivo</italic> PET imaging studies.</p><p>In the review, we show
PET imaging can provide pivotal information
on how endogenous compounds are trafficked, interact with molecular
recognition sites, accumulate in organs, and metabolize in living
animals/humans. As discussed herein, the choice of the route of radiotracer
administration affects the tracer&#8217;s pharmacokinetics and temporal/regional
biodistribution (see oral <italic toggle="yes">versus</italic> iv, for [<sup>11</sup>C]biotin and [<sup>11</sup>C]niacin; inhalation <italic toggle="yes">versus</italic> iv, [<sup>11</sup>C]nicotine). In particular, the choice of the
iv route, the most common route of PET radiotracer administration,
allows the elucidation of the trafficking of endogenous compounds <italic toggle="yes">via</italic> the bloodstream. This does not, however, account for
the transport from their site of synthesis (<italic toggle="yes">e.g</italic>.,
in the brain or gut) into the bloodstream.</p><p>Based on the aim
to radiolabel autologously endogenous compounds
with carbon-11, PET radionuclides such as <sup>13</sup>N and <sup>15</sup>O can be employed. However, <sup>15</sup>O and <sup>13</sup>N have very short half-lives (2.1 and 10 min, respectively), requiring
an unwieldy amount of starting radioactivity for performing the steps
from the start of the radiolabelling process to the end of PET imaging.
Moreover, their use is also hampered by the limited rapid synthetic
approaches available to incorporate <sup>15</sup>O and <sup>13</sup>N into endogenous compounds despite some valuable progress being
made.<sup><xref ref-type="bibr" rid="ref935">935</xref>,<xref ref-type="bibr" rid="ref936">936</xref></sup> Therefore, the most convenient choice for
the autologous radiolabelling of endogenous compounds often leads
to the use of carbon-11. This also allows the incorporation of the
radionuclide in different positions of the organic scaffold, enabling
the study of diverging metabolic pathways.</p><p>The favorable half-life
of carbon-11 also allows the administration
of multiple radiotracers to the same subject on the same day, enabling
a systems biology approach to multiplex PET imaging. This will become
increasingly important with the recent implementation of extremely
sensitive &#8220;total body PET&#8221; scanners, enhancing the feasibility
of multitracer studies in individuals at significantly lower radiation
doses (also making possible studies in pregnant women and pediatrics).</p><p>Over the years, we have seen the evolution of novel, simplified
radiosynthetic approaches employing rapid and fully automated methods
to increase synthetic robustness and reliability of processing, improve
radiochemical yields, minimize synthesis times and losses of radioactivity
due to technical handling.</p><p>Nowadays, comprehensive regulatory
practices (initially intended
for regulating commercial drug development at scale) have been applied
to the bespoke synthesis of short-lived radiotracers, including stricter
regulations for evaluating the toxicology of subpharmacological doses
(usually subnanomolar doses) of novel radiotracers applied in PET
studies. However, the toxicological profile of endogenous compounds
is almost exclusively well documented, removing this costly and time-consuming
step in the translational process.</p><p>Finally, the variety and
flexibility of synthetic approaches using
carbon-11 discussed here are matched by the biological complexity
of carbon-based life forms. As such, the future of carbon-11 labeled
compounds for <italic toggle="yes">in vivo</italic> imaging of biological systems
will expand in step with our burgeoning knowledge of in vivo physiology,
biochemistry, and pharmacology in health and disease.</p></sec></body><back><notes notes-type="" id="notes2"><title>Author Present Address</title><p><sup>&#8741;</sup> S.B.: Technical Research and Development, Advanced Accelerator
Applications, a Novartis Company, Via Ribes 5, Colleretto Giacosa
10010, Italy</p></notes><notes notes-type="COI-statement" id="notes3"><p>The authors
declare no competing financial interest.</p></notes><bio id="bio1" rid="ath1"><p>Antonio Shegani holds a position as a Research Associate in the
School of Biomedical Engineering and Imaging Sciences at King&#8217;s
College London, funded by GlaxoSmithKline. Currently, his research
is focused on carbon-11 and fluorine-18 chemistry for developing PET
imaging probes. He obtained a Degree in Pharmacy and a M.Sc. (2015)
and Ph.D. (2019) in radiopharmaceutical chemistry at the Department
of Pharmacy of the National and Kapodistrian University of Athens,
Greece, developing SPECT and PET imaging probes with <sup>99m</sup>Tc, <sup>186</sup>Re, <sup>68</sup>Ga, and <sup>64</sup>Cu.</p></bio><bio id="bio2" rid="ath2"><p>Steven Kealey is a Research Fellow in
PET Radiochemistry within
the School of Biomedical Engineering and Imaging Sciences at King&#8217;s
College London. He completed his Chemistry M.Sc. degree (2004) and
Ph.D. (2008) at Imperial College London. Since then, Steven has worked
as a researcher in PET radiochemistry at the University of Bath, Imperial
College, King&#8217;s College, and, most recently, at the Wolfson
Brain Imaging Centre at the University of Cambridge. In addition,
he has worked closely with researchers at the Imanova Centre for Imaging
Sciences (now known as Invicro, formerly the GSK Clinical Imaging
Centre) at Hammersmith Hospital. His research interests include novel
radiolabeling methodologies and the development of new PET probes
for CNS imaging.</p></bio><bio id="bio3" rid="ath3"><p>Federico Luzi
is currently pursuing a Ph.D. degree in Medical Imaging
at King&#8217;s College London under the supervision of Prof. Antony
Gee. His research focuses on developing novel methodologies for carbon-11
labeling and its application to neurodegeneration. Federico previously
obtained a Master&#8217;s degree in Pharmaceutical Chemistry and
Technology from Alma Mater Studiorum&#8211;University of Bologna
(Italy) and a MRes degree in Medical Imaging from King&#8217;s College,
London.</p></bio><bio id="bio4" rid="ath4"><p>Filippo Basagni is currently
a Postdoctoral Researcher at University
of Bologna. He obtained a Master&#8217;s degree in Pharmaceutical
Chemistry and Technology (2017) and Ph.D. in Medicinal Chemistry (2021)
at the Department of Pharmacy and Biotechnology of Alma Mater Studiorum&#8212;University
of Bologna, developing chemical probes to investigate neurodegenerative
disorders. In addition, he was visiting researcher at University of
W&#252;rzburg (2020) and King&#8217;s College London (2017), where
he was involved in the development of [<sup>18</sup>F]FAMTO.</p></bio><bio id="bio5" rid="ath5"><p>Joana do Mar Machado is currently a Ph.D.
candidate at King&#8217;s
College London under the supervision of Prof. Phil Blower, Dr. Michelle
Ma, and Dr. Levente Meszaros. Her research focuses on the direct attachment
of <sup>99m</sup>Tc and <sup>188</sup>Re to his-tagged proteins for
diagnostic imaging and therapeutics. She obtained her BSc in Nuclear
Medicine from ESTeSL (Lisbon) in 2014. She then worked as a Nuclear
Medicine and PET/CT Technologist in several hospitals in the UK until
she returned to university to carry out an M.Sc. in Radiopharmaceutics
and PET at KCL (2020).</p></bio><bio id="bio6" rid="ath6"><p>Sevban
Do&#287;an Ekici is currently a Ph.D. candidate at King&#8217;s
College London under the supervision of Prof. Antony D. Gee, Dr. Rafael
T. M. de Rosales, and Dr. Antonio Shegani. Her research is focused
on the Synthesis and Biodistribution of Boron-Containing Radiotracers.
She obtained her B.Sc. (2016) and M.Sc. (2019) in Chemistry from Middle
East Technical University (METU), T&#252;rkiye. She worked as a
part-time graduate student assistant at METU Central Laboratory (Solid
NMR, 2017) and at METU Chemistry Department (Liquid NMR, 2018) and
worked as a chemist at the National Boron Research Institute in Ankara,
T&#252;rkiye (2018&#8211;2021).</p></bio><bio id="bio7" rid="ath7"><p>Alessandra Ferocino is currently working as a Research Fellow at
the Italian National Research Council of Bologna. Alessandra previously
obtained a Master&#8217;s degree in Pharmaceutical Chemistry and
Technology at Alma Mater Studiorum&#8212;University of Bologna (2020).
As a visiting student, she collaborated with the School of Biomedical
Engineering and Imaging Sciences at King&#8217;s College London (2019)
under the supervision of Prof. Antony Gee and Dr. Salvatore Bongarzone,
developing new carbon-11 radiotracers for preclinical and clinical
studies using PET imaging.</p></bio><bio id="bio8" rid="ath8"><p>Antony
D. Gee is a Professor of PET and Radiochemistry in the School
of Biomedical Engineering and Imaging Sciences at King&#8217;s College
London. He obtained a B.Sc. (Hons) in Chemistry at the University
of Sussex (1985) and his Ph.D. in Radiopharmaceutical Organic Chemistry
at Uppsala University, Sweden (1991). Since then, he has worked as
the Director of PET Chemistry at the Guy&#8217;s and St. Thomas&#8217;
Hospitals Clinical PET Center, UMDS, London, the Aarhus University
Hospital PET Centre in Aarhus, Denmark, and SmithKlineBeecham/GlaxoSmithKline
before returning to academia and current position at King&#8217;s
College in 2010.</p></bio><bio id="bio9" rid="ath9"><p>Salvatore Bongarzone
attained his Ph.D. in Physics and Chemistry
of Biological Systems at the International School for Advanced Studies
(SISSA, Trieste, Italy, 2011), under the supervision of Prof. Paolo
Carloni and Prof. Maria Laura Bolognesi. Subsequent postdoctoral positions
were held at the Institute for Research in Biomedicine (IRB, Barcelona,
Spain) co-founded by Marie Curie Action fellowship in the groups of
Prof. Fernando Albericio and Prof. Miquel Coll and later at the School
of Biomedical Engineering and Imaging Sciences at King&#8217;s College
London (KCL, St. Thomas&#8217; Hospital, UK) supported by Medical
Research Council (MRC) capacity building fellowship in the group of
Prof. Antony Gee. In April 2018, he was appointed Translational Radiochemist
at the Wellcome/EPSRC Centre for Medical Engineering (KCL, UK). At
KCL, Dr. Bongarzone conceived novel radiochemical reactions for developing
PET imaging probes ([<sup>11</sup>C]niacin, [<sup>11</sup>C]biotin,
[<sup>18</sup>F]FAMTO, and [<sup>11</sup>C]FPSZM1) and their preclinical
characterization. Since 2021, he works as Senior Scientist in radiochemistry
at Advanced Accelerator Applications, a Novartis company. In February
2022, Dr. Bongarzone has been qualified as Associate Professor in
Organic Chemistry as well as Associate Professor in Medicinal, toxicological
and nutritional chemistry and applied technologies from the Italian
Minister of University and Research.</p></bio><ack><title>Acknowledgments</title><p>This work was supported by core funding from the
Wellcome/EPSRC Centre for Medical Engineering [WT203148/Z/16/Z], EPSRC
programme for Next Generation Molecular Imaging and Therapy with Radionuclides
(EP/S032789/1, &#8220;MITHRAS&#8221;), Antonio Shegani gratefully
acknowledges the Bodossaki Foundation, Stamatis G. Mantzavinos&#8217;s
Memorial Postdoctoral Scholarship and GlaxoSmithKline (GSK) [3000034923] for the financial support. We thank Dr. Abdul
Karim Haji Dheere, Dr. Mitja Kovac, Layla Alsulaimani and Dr. Thomas
Bonasera for their expertise and assistance throughout all aspects
of our review.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term><italic toggle="yes">2</italic>,<italic toggle="yes">5</italic>-DHBA</term><def><p><italic toggle="yes">2</italic>,<italic toggle="yes">5</italic>-dihydroxybenzoic</p></def></def-item><def-item><term><italic toggle="yes">5</italic>-HT</term><def><p><italic toggle="yes">5</italic>-hydroxytryptamine</p></def></def-item><def-item><term><italic toggle="yes">5</italic>-HTP</term><def><p><italic toggle="yes">5</italic>-hydroxytryptophan</p></def></def-item><def-item><term>AA</term><def><p>amino acid</p></def></def-item><def-item><term>AADC</term><def><p>aromatic <sc>l</sc>-amino acid
decarboxylase</p></def></def-item><def-item><term>ACC</term><def><p>acetyl-<sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine</p></def></def-item><def-item><term>AChE</term><def><p>acetylcholinesterase</p></def></def-item><def-item><term>AChR</term><def><p>acetylcholine receptor</p></def></def-item><def-item><term>ACM</term><def><p>[<italic toggle="yes">2</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine</p></def></def-item><def-item><term>ACPC</term><def><p>aminocyclopentanecarboxylic acid</p></def></def-item><def-item><term>AD</term><def><p>Alzheimer&#8217;s disease</p></def></def-item><def-item><term>ADP</term><def><p>adenosine diphosphate</p></def></def-item><def-item><term><italic toggle="yes">A</italic><sub>m</sub></term><def><p>molar
activity</p></def></def-item><def-item><term>AMP</term><def><p>Adenosine
monophosphate</p></def></def-item><def-item><term>AMPA</term><def><p>a-amino-<italic toggle="yes">3</italic>-hydroxy-<italic toggle="yes">5</italic>-methyl-<italic toggle="yes">4</italic>-isoxazolepropionic acid</p></def></def-item><def-item><term>ASD</term><def><p>autism spectrum disorder</p></def></def-item><def-item><term>ATP</term><def><p>adenosine triphosphate</p></def></def-item><def-item><term>ATRA</term><def><p>[<sup>11</sup>C]all-<italic toggle="yes">trans</italic>-retinoic acid</p></def></def-item><def-item><term>BAT</term><def><p>brown adipose tissue</p></def></def-item><def-item><term>BBB</term><def><p>blood&#8211;brain barrier</p></def></def-item><def-item><term>CAI</term><def><p>carbonic anhydrase</p></def></def-item><def-item><term>cAMP</term><def><p>cyclic adenosine monophosphate</p></def></def-item><def-item><term>CAN</term><def><p>[<italic toggle="yes">1</italic>-<sup>11</sup>C]acetyl-<sc><italic toggle="yes">l</italic></sc>-carnitine</p></def></def-item><def-item><term>CBF</term><def><p>cerebral blood flow</p></def></def-item><def-item><term>CFS</term><def><p>chronic fatigue
syndrome</p></def></def-item><def-item><term>cGMP</term><def><p>cyclic
guanosine monophosphate</p></def></def-item><def-item><term>COMPDS</term><def><p>compounds</p></def></def-item><def-item><term>CMR</term><def><p>cerebral metabolic rate</p></def></def-item><def-item><term>CMT</term><def><p>carminomycin-<italic toggle="yes">4</italic>-<italic toggle="yes">O</italic>-methyltransferase</p></def></def-item><def-item><term>CNS</term><def><p>central nervous
system</p></def></def-item><def-item><term>CoA</term><def><p>coenzyme
A</p></def></def-item><def-item><term>CPSR</term><def><p>cerebral
protein synthesis rate</p></def></def-item><def-item><term>CRN</term><def><p><sc><italic toggle="yes">l</italic></sc>-[<italic toggle="yes">methyl</italic>-<sup>11</sup>C]carnitine</p></def></def-item><def-item><term>CT</term><def><p>computerized tomography</p></def></def-item><def-item><term>D-<italic toggle="yes">3</italic>-HBD</term><def><p>(<sc><italic toggle="yes">d</italic></sc>)-<italic toggle="yes">&#946;</italic>-hydroxybutyrate dehydrogenase</p></def></def-item><def-item><term>DABCO</term><def><p><italic toggle="yes">1</italic>,<italic toggle="yes">4</italic>-diazabicyclo[<italic toggle="yes">2</italic>.<italic toggle="yes">2</italic>.<italic toggle="yes">2</italic>]octane</p></def></def-item><def-item><term>DBAD</term><def><p>di-<italic toggle="yes">tert</italic>-butyl
azodicarboxylate</p></def></def-item><def-item><term>DBU</term><def><p><italic toggle="yes">1</italic>,<italic toggle="yes">8</italic>-diazabicyclo[<italic toggle="yes">5</italic>.<italic toggle="yes">4</italic>.<italic toggle="yes">0</italic>]undec-<italic toggle="yes">7</italic>-ene</p></def></def-item><def-item><term>DCC</term><def><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>&#8242;-dicyclohexylcarbodiimide</p></def></def-item><def-item><term>DEM</term><def><p>diethyl maleate</p></def></def-item><def-item><term>DHA</term><def><p>dehydroascorbic acid</p></def></def-item><def-item><term>DMAP</term><def><p><italic toggle="yes">4</italic>-dimethylaminopyridine</p></def></def-item><def-item><term>DMF</term><def><p>dimethylformamide</p></def></def-item><def-item><term>DMPU</term><def><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethylpropyleneurea</p></def></def-item><def-item><term>DMSO</term><def><p>dimethyl sulfoxide</p></def></def-item><def-item><term>DNA</term><def><p>deoxyribonucleic
acid</p></def></def-item><def-item><term>DOPA</term><def><p>dihydroxyphenylalanine</p></def></def-item><def-item><term>DTPA</term><def><p>diethylenetriamine
pentaacetate</p></def></def-item><def-item><term>ee</term><def><p>enantiomeric excess</p></def></def-item><def-item><term>EOB</term><def><p>end of bombardment</p></def></def-item><def-item><term>EOD</term><def><p>end of delivery</p></def></def-item><def-item><term>EOS</term><def><p>end of synthesis</p></def></def-item><def-item><term>EPI</term><def><p>[<sup>11</sup>C]epinephrine</p></def></def-item><def-item><term>FA</term><def><p>fatty acid</p></def></def-item><def-item><term>FDG</term><def><p>fluorodeoxyglucose</p></def></def-item><def-item><term>GABA</term><def><p><italic toggle="yes">&#947;</italic>-aminobutyric
acid</p></def></def-item><def-item><term>Gln</term><def><p>glutamine</p></def></def-item><def-item><term>GLUT</term><def><p>glucose transport</p></def></def-item><def-item><term>GMP</term><def><p>Good Manufacturing
Practice</p></def></def-item><def-item><term>Hb</term><def><p>hemoglobin</p></def></def-item><def-item><term>HDAC</term><def><p>histone deacetylase</p></def></def-item><def-item><term>HED</term><def><p>[<sup>11</sup>C]hydroxyephedrine</p></def></def-item><def-item><term>HIAA</term><def><p>hydroxyindoleacetic
acid</p></def></def-item><def-item><term>HPLC</term><def><p>high-pressure
liquid chromatography</p></def></def-item><def-item><term>HTP</term><def><p>hydroxytryptophan</p></def></def-item><def-item><term>IPr</term><def><p><italic toggle="yes">1</italic>,<italic toggle="yes">3</italic>-bis(<italic toggle="yes">2</italic>,<italic toggle="yes">6</italic>-diisopropylphenyl)imidazol-<italic toggle="yes">2</italic>-ylidene</p></def></def-item><def-item><term>iv</term><def><p>intravenously</p></def></def-item><def-item><term>LAT-1</term><def><p><italic toggle="yes">L</italic>-type amino
acid transporter 1</p></def></def-item><def-item><term>LBTMSA</term><def><p>lithium bis(trimethylsilyl)amide</p></def></def-item><def-item><term>LC</term><def><p>liquid chromatography</p></def></def-item><def-item><term>LTE</term><def><p>leukotriene</p></def></def-item><def-item><term>MAO</term><def><p>monoamine oxidases</p></def></def-item><def-item><term>MAT</term><def><p><sc><italic toggle="yes">l</italic></sc>-methionine-<italic toggle="yes">S</italic>-adenosine transferase</p></def></def-item><def-item><term>MCT1</term><def><p>monocarboxylate transporter
1</p></def></def-item><def-item><term>MeCN</term><def><p>acetonitrile</p></def></def-item><def-item><term>MIP</term><def><p>maximum intensity
projection</p></def></def-item><def-item><term>MOR</term><def><p>&#956;-opioid
receptor</p></def></def-item><def-item><term>MRI</term><def><p>magnetic
resonance imaging</p></def></def-item><def-item><term>MT</term><def><p>methoxytyramine</p></def></def-item><def-item><term><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-DMPEA</term><def><p><italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>-dimethylphenethylamine</p></def></def-item><def-item><term>ndc</term><def><p>not decay corrected</p></def></def-item><def-item><term>nr</term><def><p>not reported</p></def></def-item><def-item><term>nAChRs</term><def><p>nicotinic acetylcholine receptors</p></def></def-item><def-item><term>NAD</term><def><p>nicotinamide adenine
dinucleotide</p></def></def-item><def-item><term>NADH</term><def><p>nicotinamide adenine dinucleotide</p></def></def-item><def-item><term>NADP</term><def><p>nicotinamide adenine dinucleotide
phosphate</p></def></def-item><def-item><term>NMDA</term><def><p><italic toggle="yes">N</italic>-methyl-<sc><italic toggle="yes">d</italic></sc>-aspartate</p></def></def-item><def-item><term>ODC</term><def><p>ornithine decarboxylase</p></def></def-item><def-item><term>p.i.</term><def><p>post-injection</p></def></def-item><def-item><term>P.N.M.T.</term><def><p>phenylethanolamine <italic toggle="yes">N</italic>-methyltransferase</p></def></def-item><def-item><term>PABA</term><def><p><italic toggle="yes">4</italic>-aminobenzoic
acid</p></def></def-item><def-item><term>PAT</term><def><p>palmitoyl
acyltransferase</p></def></def-item><def-item><term>pB</term><def><p>binding potential</p></def></def-item><def-item><term>PBS</term><def><p>phosphate-buffered saline</p></def></def-item><def-item><term>PBu<sub>3</sub></term><def><p>tributylphosphine</p></def></def-item><def-item><term>PDE10A</term><def><p>phosphodiesterase 10A</p></def></def-item><def-item><term>PET</term><def><p>positron emission tomography</p></def></def-item><def-item><term>Pgl</term><def><p>protein glycosyltransferase</p></def></def-item><def-item><term>P-gp</term><def><p>P-glycoprotein</p></def></def-item><def-item><term>RCC</term><def><p>radiochemical conversion</p></def></def-item><def-item><term>RCP</term><def><p>radiochemical purity</p></def></def-item><def-item><term>RCY</term><def><p>radiochemical yield</p></def></def-item><def-item><term>RNA</term><def><p>ribonucleic acid</p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen
species</p></def></def-item><def-item><term>SAM</term><def><p><italic toggle="yes">S</italic>-adenosylmethionine</p></def></def-item><def-item><term>SMCT</term><def><p>sodium-coupled monocarboxylate
transporters</p></def></def-item><def-item><term>SMVT</term><def><p>sodium-dependent vitamin transporter</p></def></def-item><def-item><term>SPE</term><def><p>solid-phase extraction</p></def></def-item><def-item><term>SVCT1-2</term><def><p>sodium-dependent active transporters</p></def></def-item><def-item><term>TBAH</term><def><p>tetrabutylammonium
hydroxide</p></def></def-item><def-item><term>TBDMS</term><def><p><italic toggle="yes">tert</italic>-butyldimethylsilyl</p></def></def-item><def-item><term>TCA</term><def><p>tricarboxylic acid</p></def></def-item><def-item><term>THF</term><def><p>tetrahydrofuran</p></def></def-item><def-item><term>TMSCl</term><def><p>trimethylsilyl chloride</p></def></def-item><def-item><term>TS</term><def><p>thymidylate synthase</p></def></def-item><def-item><term><italic toggle="yes">V</italic><sub>d</sub></term><def><p>distribution
volume</p></def></def-item><def-item><term>WAT</term><def><p>white
adipose tissue</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name name-style="western"><surname>Lauritsen</surname><given-names>C. C.</given-names></name>; <name name-style="western"><surname>Crane</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Harper</surname><given-names>W. W.</given-names></name><article-title>Artificial Production of Radioactive
Substances</article-title>. <source>Science</source><year>1934</year>, <volume>79</volume>, <fpage>234</fpage>&#8211;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1126/science.79.2045.234</pub-id>.<pub-id pub-id-type="pmid">17788543</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name name-style="western"><surname>Crane</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Lauritsen</surname><given-names>C. C.</given-names></name><article-title>Radioactivity
from Carbon and Boron Oxide Bombarded
with Deutons and the Conversion of Positrons into Radiation</article-title>. <source>Phys. Rev.</source><year>1934</year>, <volume>45</volume>, <fpage>430</fpage>&#8211;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1103/PhysRev.45.430.2</pub-id>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name name-style="western"><surname>Barkas</surname><given-names>W. H.</given-names></name><article-title>Some New
Reactions in Light Nuclei with High Energy Protons</article-title>. <source>Phys. Rev.</source><year>1939</year>, <volume>56</volume>, <fpage>287</fpage>&#8211;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1103/PhysRev.56.287</pub-id>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name name-style="western"><surname>Conti</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>L.</given-names></name><article-title>Physics of Pure and Non-Pure Positron Emitters for
PET: A Review and a Discussion</article-title>. <source>EJNMMI Phys.</source><year>2016</year>, <volume>3</volume>, <fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s40658-016-0144-5</pub-id>.<pub-id pub-id-type="pmid">27271304</pub-id><pub-id pub-id-type="pmcid">PMC4894854</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name name-style="western"><surname>Long</surname><given-names>F.</given-names></name><article-title>A Study of
the Interchange between Chromioxalate Ion and Oxalate Ion, Using Radio-carbon</article-title>. <source>J. Am. Chem. Soc.</source><year>1939</year>, <volume>61</volume>, <fpage>570</fpage>&#8211;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1021/ja01872a008</pub-id>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name name-style="western"><surname>Ruben</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hassid</surname><given-names>W. Z.</given-names></name>; <name name-style="western"><surname>Kamen</surname><given-names>M. D.</given-names></name><article-title>Radioactive Carbon in the Study of
Photosynthesis</article-title>. <source>J. Am. Chem. Soc.</source><year>1939</year>, <volume>61</volume>, <fpage>661</fpage>&#8211;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1021/ja01872a034</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name name-style="western"><surname>Tobias</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Lawrence</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Roughton</surname><given-names>F. J. W.</given-names></name>; <name name-style="western"><surname>Root</surname><given-names>W. S.</given-names></name>; <name name-style="western"><surname>Gregersen</surname><given-names>M. I.</given-names></name><article-title>The Elimination
of Carbon Monoxide From the Human Body With Reference to the Possible
Conversion of CO to CO<sub>2</sub></article-title>. <source>Am. J. Physiol.</source><year>1945</year>, <volume>145</volume>, <fpage>253</fpage>&#8211;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1152/ajplegacy.1945.145.2.253</pub-id>.<pub-id pub-id-type="pmid">21009266</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name name-style="western"><surname>Dahl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Schou</surname><given-names>M.</given-names></name><article-title>New Methodologies
for the Preparation
of Carbon-11 Labeled Radiopharmaceuticals</article-title>. <source>Clin.
Transl. Imaging</source><year>2017</year>, <volume>5</volume>, <fpage>275</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/s40336-017-0223-1</pub-id>.<pub-id pub-id-type="pmid">28596949</pub-id><pub-id pub-id-type="pmcid">PMC5437136</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="book" id="cit9"><person-group person-group-type="allauthors"><name name-style="western"><surname>Kroke</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dierkes</surname><given-names>J.</given-names></name></person-group><article-title>107 - Urinary
Markers of Alcohol Consumption</article-title>. In <source>Comprehensive
Handbook of Alcohol Related Pathology</source>, <person-group person-group-type="editor"><name name-style="western"><surname>Preedy</surname><given-names>V. R.</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>R. R.</given-names></name></person-group>, Eds.; <publisher-name>Academic
Press</publisher-name>, <year>2005</year>; pp <fpage>1445</fpage>&#8211;<lpage>1458</lpage>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="book" id="cit10"><person-group person-group-type="allauthors"><name name-style="western"><surname>Tillonen</surname><given-names>J.</given-names></name></person-group><source>Ethanol, Acetaldehyde,
and Gastrointestinal Flora: Regulatory Factors and Pathophysiological
Consequences of Microbial Ethanol Oxidation and Acetaldehyde Production
in the Digestive Tract</source>; <publisher-name>J. Tillonen</publisher-name>, <year>2000</year>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name name-style="western"><surname>Wunder</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Weber</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Paulke</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Koelzer</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Holz</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Toennes</surname><given-names>S. W.</given-names></name><article-title>Endogenous Formation
of 1-Propanol and Methanol After
Consumption of Alcoholic Beverages</article-title>. <source>Forensic
Sci. Int.</source><year>2021</year>, <volume>325</volume>, <fpage>110905</fpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2021.110905</pub-id>.<pub-id pub-id-type="pmid">34280599</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="book" id="cit12"><person-group person-group-type="allauthors"><name name-style="western"><surname>Drummer</surname><given-names>O. H.</given-names></name></person-group><article-title>Alcohol Congeners
and the Source of Ethanol</article-title>. In <source>Encyclopedia
of Forensic Sciences</source>, <edition>2nd</edition> ed.; <person-group person-group-type="editor"><name name-style="western"><surname>Siegel</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Saukko</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>M. M.</given-names></name></person-group>, Eds.; <publisher-name>Academic
Press</publisher-name>, <year>2013</year>; pp <fpage>318</fpage>&#8211;<lpage>322</lpage>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name name-style="western"><surname>Cho</surname><given-names>E.-S.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>Y.-H.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>J.-H.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>S.-j.</given-names></name>; <name name-style="western"><surname>Park</surname><given-names>K.-y.</given-names></name>; <name name-style="western"><surname>Jo</surname><given-names>J.-m.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>S.-B.</given-names></name><article-title>Evaluation
of 1-Propanol Toxicity
in B6C3F1Mice <italic toggle="yes">via</italic> Repeated Inhalation Over 28 and
90 Days</article-title>. <source>J. Toxicol.</source><year>2020</year>, <volume>2020</volume>, <fpage>9172569</fpage><pub-id pub-id-type="doi">10.1155/2020/9172569</pub-id>.<pub-id pub-id-type="pmid">33029140</pub-id><pub-id pub-id-type="pmcid">PMC7532428</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name name-style="western"><surname>Liebich</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Buelow</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Kallmayer</surname><given-names>R.</given-names></name><article-title>Quantification of Endogenous Aliphatic
Alcohols in Serum and Urine</article-title>. <source>J. Chromatogr.
A</source><year>1982</year>, <volume>239</volume>, <fpage>343</fpage>&#8211;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9673(00)81993-7</pub-id>.<pub-id pub-id-type="pmid">7096503</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Adam</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Cutler</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Fujibayashi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Jeong</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Mach</surname><given-names>R. H.</given-names></name>; <name name-style="western"><surname>Mindt</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; et al. <article-title>Consensus Nomenclature Rules for Radiopharmaceutical
Chemistry &#8212; Setting the Record Straight</article-title>. <source>Nucl. Med. Biol.</source><year>2017</year>, <volume>55</volume>, <fpage>v</fpage>&#8211;<lpage>xi</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2017.09.004</pub-id>.<pub-id pub-id-type="pmid">29074076</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name name-style="western"><surname>Raichle</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Eichling</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Straatmann</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>K. B.</given-names></name>; <name name-style="western"><surname>Ter-Pogossian</surname><given-names>M. M.</given-names></name><article-title>Blood-Brain
Barrier Permeability of <sup>11</sup>C-Labeled
Alcohols and <sup>15</sup>O-Labeled Water</article-title>. <source>Am.
J. Physiol.</source><year>1976</year>, <volume>230</volume>, <fpage>543</fpage>&#8211;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1152/ajplegacy.1976.230.2.543</pub-id>.<pub-id pub-id-type="pmid">816209</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name name-style="western"><surname>Sarkadi</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Kov&#225;cs</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Horv&#225;th</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Lehikoinen</surname><given-names>P.</given-names></name><article-title>Synthesis
of [<sup>11</sup>C]Methanol on Alumina Column for Production of [<sup>11</sup>C]Methyl Iodide</article-title>. <source>Radiochim. Acta</source><year>1998</year>, <volume>83</volume>, <fpage>49</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1998.83.1.49</pub-id>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="book" id="cit18"><person-group person-group-type="allauthors"><name name-style="western"><surname>Robinson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>NS</surname><given-names>M.</given-names></name></person-group><source>Biological Dynamics of F-18 and C-11
Labeled Carboxylates and Alcohols</source>; <publisher-name>Society
for Nuclear Medicine</publisher-name>: <publisher-loc>1850 Samuel
Morse Drive, Reston, VA 20190-5316, USA</publisher-loc>, <year>1973</year>; Vol. <volume>14</volume>, pp <fpage>446</fpage>&#8211;<lpage>447</lpage>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name name-style="western"><surname>Kein&#228;nen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kuikka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Heselius</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>St Jolinna</surname><given-names>E. M.</given-names></name>; <name name-style="western"><surname>Solin</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>N&#228;nt&#246;</surname><given-names>V.</given-names></name><article-title>Transcapillary
Exchange and Distribution of Carbon-11 Labelled Ethanol in the Isolated
Perfused Rat Liver</article-title>. <source>Acta Physiol. Scand.</source><year>1980</year>, <volume>110</volume>, <fpage>39</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.1980.tb06627.x</pub-id>.<pub-id pub-id-type="pmid">7468269</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="book" id="cit20"><person-group person-group-type="allauthors"><name name-style="western"><surname>Poe</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Robinson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>NS</surname><given-names>M.</given-names></name></person-group><source>Myocardial Extraction
of Variously
Labeled Fatty-Acids and Carboxylates</source>; <publisher-name>Society
for Nuclear Medicine</publisher-name>, <publisher-loc>1850 Samuel
Morse Drive, Reston, VA 20190-5316, USA</publisher-loc>, <year>1973</year>; Vol. <volume>14</volume>, pp <fpage>440</fpage>&#8211;<lpage>440</lpage>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name name-style="western"><surname>DeGrazia</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Rodden</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Teresi</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Busick</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Walz</surname><given-names>D. R.</given-names></name><article-title>Radioscintigraphic
Studies of <sup>11</sup>C Distribution in Cats Given 1-<sup>11</sup>C-Ethanol</article-title>. <source>J. Nucl. Med.</source><year>1975</year>, <volume>16</volume>, <fpage>73</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">1110408</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name name-style="western"><surname>Guly&#225;s</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Vas</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>S&#243;v&#225;g&#243;</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sandell</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Olsson</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Fredriksson</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name><article-title>Cerebral Uptake of [<italic toggle="yes">Ethyl</italic>-<sup>11</sup>C]Vinpocetine and 1-[<sup>11</sup>C]Ethanol in Cynomolgous
Monkeys: A Comparative Preclinical PET Study</article-title>. <source>Nucl. Med. Biol.</source><year>2002</year>, <volume>29</volume>, <fpage>753</fpage>&#8211;<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(02)00319-0</pub-id>.<pub-id pub-id-type="pmid">12381455</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name name-style="western"><surname>Lasne</surname><given-names>M.-C.</given-names></name>; <name name-style="western"><surname>Moreau</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Cairon</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Barr&#233;</surname><given-names>L.</given-names></name><article-title>The Radiosynthesis
of No-Carrier Added [1-<sup>11</sup>C]allyl Alcohol Evidence for the
Formation of a New Reducing Species: Lithium Aluminium Hydride &#8212;
Vinylmagnesium Bromide</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1994</year>, <volume>34</volume>, <fpage>1165</fpage>&#8211;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580341206</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name name-style="western"><surname>Knapp</surname><given-names>W. H.</given-names></name>; <name name-style="western"><surname>Debatin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Layer</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Helus</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Altmann</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sinn</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Ostertag</surname><given-names>H.</given-names></name><article-title>Selective
Drug-Induced Reduction
of Blood Flow in Tumor Transplants</article-title>. <source>Int. J.
Radiat. Oncol. Biol. Phys.</source><year>1985</year>, <volume>11</volume>, <fpage>1357</fpage>&#8211;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1016/0360-3016(85)90252-4</pub-id>.<pub-id pub-id-type="pmid">4008292</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name name-style="western"><surname>Knapp</surname><given-names>W. H.</given-names></name>; <name name-style="western"><surname>Helus</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Layer</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sinn</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ostertag</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Matzku</surname><given-names>S.</given-names></name><article-title><sup>11</sup>C-Butanol for Imaging
of the Blood-Flow Distribution in Tumor-Bearing Animals</article-title>. <source>Eur. J. Nucl. Med.</source><year>1985</year>, <volume>10</volume>, <fpage>540</fpage>&#8211;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1007/BF00252749</pub-id>.<pub-id pub-id-type="pmid">3928384</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name name-style="western"><surname>Knapp</surname><given-names>W. H.</given-names></name>; <name name-style="western"><surname>Panzer</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Helus</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Layer</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sinn</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Ostertag</surname><given-names>H.</given-names></name><article-title>Effect of Methotrexate on Perfusion and Nitrogen-13
Glutamate Uptake in the Walker-256 Carcinosarcoma</article-title>. <source>J. Nucl. Med.</source><year>1988</year>, <volume>29</volume>, <fpage>208</fpage>&#8211;<lpage>216</lpage>.<pub-id pub-id-type="pmid">2894416</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name name-style="western"><surname>Takagi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ehara</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kenny</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Gilson</surname><given-names>A. J.</given-names></name><article-title>Measurement of Cerebral Blood Flow in the Rat With
Intravenous Injection of [<sup>11</sup>C]Butanol by External Coincidence
Counting: A Repeatable and Noninvasive Method in the Brain</article-title>. <source>J. Cereb. Blood. Flow. Metab.</source><year>1984</year>, <volume>4</volume>, <fpage>275</fpage>&#8211;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1984.38</pub-id>.<pub-id pub-id-type="pmid">6427238</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name name-style="western"><surname>Takagi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ehara</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name><article-title>Water Extraction
Fraction and Permeability-Surface
Product After Intravenous Injection in Rats</article-title>. <source>Stroke</source><year>1987</year>, <volume>18</volume>, <fpage>177</fpage>&#8211;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.18.1.177</pub-id>.<pub-id pub-id-type="pmid">3810751</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name name-style="western"><surname>Hack</surname><given-names>S. N.</given-names></name>; <name name-style="western"><surname>Eichling</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Bergmann</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Sobel</surname><given-names>B. E.</given-names></name><article-title>External
Quantification of Myocardial Perfusion by Exponential Infusion of
Positron-Emitting Radionuclides</article-title>. <source>J. Clin. Invest.</source><year>1980</year>, <volume>66</volume>, <fpage>918</fpage>&#8211;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1172/JCI109959</pub-id>.<pub-id pub-id-type="pmid">6968756</pub-id><pub-id pub-id-type="pmcid">PMC371526</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name name-style="western"><surname>Hack</surname><given-names>S. N.</given-names></name>; <name name-style="western"><surname>Bergmann</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Eichling</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Sobel</surname><given-names>B. E.</given-names></name><article-title>Quantification of
Regional Myocardial Perfusion by Exponential Infusion of <sup>11</sup>C-Butanol</article-title>. <source>IEEE Trans. Biomed. Eng.</source><year>1983</year>, <volume>BME-30</volume>, <fpage>716</fpage>&#8211;<lpage>722</lpage>. <pub-id pub-id-type="doi">10.1109/TBME.1983.325185</pub-id>.<pub-id pub-id-type="pmid">6607206</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Raichle</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Positron Emission
Tomographic Measurement of Cerebral Blood Flow and Permeability-Surface
Area Product of Water Using [<sup>15</sup>O]Water and [<sup>11</sup>C]Butanol</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1987</year>, <volume>7</volume>, <fpage>527</fpage>&#8211;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1987.102</pub-id>.<pub-id pub-id-type="pmid">3498732</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name name-style="western"><surname>Quarles</surname><given-names>R. P.</given-names></name>; <name name-style="western"><surname>Mintun</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>K. B.</given-names></name>; <name name-style="western"><surname>Markham</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>MacLeod</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Raichle</surname><given-names>M. E.</given-names></name><article-title>Measurement of Regional
Cerebral Blood Flow With Positron
Emission Tomography: A Comparison of [<sup>15</sup>O]Water to [<sup>11</sup>C]Butanol With Distributed-Parameter and Compartmental Models</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1993</year>, <volume>13</volume>, <fpage>733</fpage>&#8211;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1993.94</pub-id>.<pub-id pub-id-type="pmid">8360280</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name name-style="western"><surname>Pagani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Manouilenko</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Odh</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Salmaso</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Hatherly</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Brolin</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Jacobsson</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Larsson</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Bejerot</surname><given-names>S.</given-names></name><article-title>Brief Report:
Alterations in Cerebral
Blood Flow As Assessed by PET/CT in Adults With Autism Spectrum Disorder
With Normal IQ</article-title>. <source>J. Autism Dev. Disord.</source><year>2012</year>, <volume>42</volume>, <fpage>313</fpage>&#8211;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-011-1240-y</pub-id>.<pub-id pub-id-type="pmid">21487836</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Vora</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Boothe</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Emran</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Kabalka</surname><given-names>G. W.</given-names></name><article-title>1-[<sup>11</sup>C]Butanol: Synthesis and Development
as a Radiopharmaceutical for Blood Flow Measurements</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>412</fpage>&#8211;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90285-6</pub-id>.<pub-id pub-id-type="pmid">4018902</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name name-style="western"><surname>Waterhouse</surname><given-names>N. N.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Dooley</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>de Leon</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Babich</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Qu</surname><given-names>W.</given-names></name><article-title>Synthesis of [1-<sup>11</sup>C]Butanol
via a Facile Solid Phase Extraction Protocol</article-title>. <source>Appl. Radiat. Isot.</source><year>2020</year>, <volume>159</volume>, <fpage>109078</fpage><pub-id pub-id-type="doi">10.1016/j.apradiso.2020.109078</pub-id>.<pub-id pub-id-type="pmid">32068145</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name name-style="western"><surname>Christman</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Crawford</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Friedkin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Detection of DNA
Synthesis in Intact Organisms with Positron-Emitting [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine</article-title>. <source>Proc. Natl. Acad.
Sci. U. S. A.</source><year>1972</year>, <volume>69</volume>, <fpage>988</fpage><pub-id pub-id-type="doi">10.1073/pnas.69.4.988</pub-id>.<pub-id pub-id-type="pmid">4554538</pub-id><pub-id pub-id-type="pmcid">PMC426610</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name name-style="western"><surname>Thompson</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kealey</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sephton</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Aigbirhio</surname><given-names>F. I.</given-names></name><article-title>Radiochemistry
with Carbon-11</article-title>. <source>Handbook of Radiopharmaceuticals</source><year>2020</year>, <fpage>143</fpage>&#8211;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1002/9781119500575.ch7</pub-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Doll&#233;</surname><given-names>F.</given-names></name><article-title>[<sup>11</sup>C]Methanol Production by a Fast and Mild
Aqueous-Phase Reduction of [<sup>11</sup>C]Formic Acid With Samarium
Diiodide</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2006</year>, <volume>49</volume>, <fpage>295</fpage>&#8211;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1041</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>[<sup>11</sup>C]Formaldehyde
Revisited: Considerable
Concurrent [<sup>11</sup>C]Formic Acid Formation in the Low-Temperature
Conversion of [<sup>11</sup>C]Carbon Dioxide Into [<sup>11</sup>C]Formaldehyde</article-title>. <source>Appl. Radiat. Isot.</source><year>2001</year>, <volume>54</volume>, <fpage>935</fpage>&#8211;<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(00)00352-3</pub-id>.<pub-id pub-id-type="pmid">11300407</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name name-style="western"><surname>Kulmala</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kein&#228;nen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Markkula</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Heselius</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Solin</surname><given-names>O.</given-names></name><article-title>Preliminary
Biodistribution Studies With a Hybrid Positron Scanner</article-title>. <source>Eur. J. Nucl. Med.</source><year>1981</year>, <volume>6</volume>, <fpage>561</fpage>&#8211;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1007/BF00252670</pub-id>.<pub-id pub-id-type="pmid">7333318</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name name-style="western"><surname>Dimitrakopoulou-Strauss</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Strauss</surname><given-names>L. G.</given-names></name>; <name name-style="western"><surname>Gutzler</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Irngartinger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Kontaxakis</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>D. K.</given-names></name>; <name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>van Kaick</surname><given-names>G.</given-names></name><article-title>Pharmacokinetic Imaging of <sup>11</sup>C Ethanol With
PET in Eight Patients With Hepatocellular Carcinomas Who Were Scheduled
for Treatment With Percutaneous Ethanol Injection</article-title>. <source>Radiology</source><year>1999</year>, <volume>211</volume>, <fpage>681</fpage>&#8211;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1148/radiology.211.3.r99jn12681</pub-id>.<pub-id pub-id-type="pmid">10352591</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name name-style="western"><surname>Dimitrakopoulou-Strauss</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Gutzler</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Strauss</surname><given-names>L. G.</given-names></name>; <name name-style="western"><surname>Irngartinger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Doll</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Stremmel</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>van Kaick</surname><given-names>G.</given-names></name><article-title>PET Studies
With C-11 Ethanol in Intratumoral Therapy of Hepatocellular Carcinomas</article-title>. <source>Radiologe</source><year>1996</year>, <volume>36</volume>, <fpage>744</fpage>&#8211;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1007/s001170050137</pub-id>.<pub-id pub-id-type="pmid">8999452</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name name-style="western"><surname>Brodack</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Automated Production of Several Positron-Emitting
Radiopharmaceuticals Using a Single Laboratory Robot</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1988</year>, <volume>39</volume>, <fpage>689</fpage>&#8211;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(88)90059-7</pub-id>.<pub-id pub-id-type="pmid">2844701</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name name-style="western"><surname>Del
Fiore</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Peters</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Quaglia</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Boudjelida</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Pardon</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Piette</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Cantineau</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>De Landsheere</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Rigo</surname><given-names>P.</given-names></name><article-title>Automated Preparation of Carbon-11
Ethanol and Carbon-11 Butanol for Human Studies Using Positron Emission
Tomography</article-title>. <source>J. Radioanal. Nucl. Chem.</source><year>1986</year>, <volume>104</volume>, <fpage>301</fpage>&#8211;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1007/BF02163212</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Helus</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Maier-Borst</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Silvester</surname><given-names>D. J.</given-names></name><article-title>The Synthesis
of [1-<sup>11</sup>C]-Butanol</article-title>. <source>Radiochem. Radioanal.
Lett.</source><year>1982</year>, <volume>53</volume>, <fpage>237</fpage>&#8211;<lpage>252</lpage>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name name-style="western"><surname>Carbonaro</surname><given-names>T. M.</given-names></name>; <name name-style="western"><surname>Gatch</surname><given-names>M. B.</given-names></name><article-title>Neuropharmacology
of <italic toggle="yes">N</italic>, <italic toggle="yes">N</italic>-Dimethyltryptamine</article-title>. <source>Brain Res. Bull.</source><year>2016</year>, <volume>126</volume>, <fpage>74</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2016.04.016</pub-id>.<pub-id pub-id-type="pmid">27126737</pub-id><pub-id pub-id-type="pmcid">PMC5048497</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name name-style="western"><surname>Woodruff-Pak</surname><given-names>D. S.</given-names></name>; <name name-style="western"><surname>Vogel</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Wenk</surname><given-names>G. L.</given-names></name><article-title>Galantamine:
Effect on Nicotinic
Receptor Binding, Acetylcholinesterase Inhibition, and Learning</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2001</year>, <volume>98</volume>, <fpage>2089</fpage><pub-id pub-id-type="doi">10.1073/pnas.98.4.2089</pub-id>.<pub-id pub-id-type="pmid">11172080</pub-id><pub-id pub-id-type="pmcid">PMC29386</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name name-style="western"><surname>Kowal</surname><given-names>N. M.</given-names></name>; <name name-style="western"><surname>Ahring</surname><given-names>P. K.</given-names></name>; <name name-style="western"><surname>Liao</surname><given-names>V. W. Y.</given-names></name>; <name name-style="western"><surname>Indurti</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>Harvey</surname><given-names>B. S.</given-names></name>; <name name-style="western"><surname>O&#8217;Connor</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Chebib</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Olafsdottir</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Balle</surname><given-names>T.</given-names></name><article-title>Galantamine Is Not a Positive Allosteric Modulator of Human &#945;<sub>4</sub>&#946;<sub>2</sub> or &#945;<sub>7</sub> Nicotinic Acetylcholine
Receptors</article-title>. <source>Br. J. Pharmacol.</source><year>2018</year>, <volume>175</volume>, <fpage>2911</fpage>&#8211;<lpage>2925</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14329</pub-id>.<pub-id pub-id-type="pmid">29669164</pub-id><pub-id pub-id-type="pmcid">PMC6016680</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name name-style="western"><surname>Raskind</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Peskind</surname><given-names>E. R.</given-names></name>; <name name-style="western"><surname>Wessel</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yuan</surname><given-names>W.</given-names></name><article-title>Galantamine in AD:
A 6-Month Randomized, Placebo-Controlled Trial With a 6-Month Extension.
The Galantamine USA-1 Study Group</article-title>. <source>Neurology</source><year>2000</year>, <volume>54</volume>, <fpage>2261</fpage>&#8211;<lpage>2268</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.54.12.2261</pub-id>.<pub-id pub-id-type="pmid">10881250</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name name-style="western"><surname>Mannens</surname><given-names>G. S. J.</given-names></name>; <name name-style="western"><surname>Snel</surname><given-names>C. A. W.</given-names></name>; <name name-style="western"><surname>Hendrickx</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Verhaeghe</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Le Jeune</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Bode</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>van Beijsterveldt</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lavrijsen</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Leempoels</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Van Osselaer</surname><given-names>N.</given-names></name>; et al. <article-title>The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans</article-title>. <source>Drug Metab. Dispos.</source><year>2002</year>, <volume>30</volume>, <fpage>553</fpage><pub-id pub-id-type="doi">10.1124/dmd.30.5.553</pub-id>.<pub-id pub-id-type="pmid">11950787</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name name-style="western"><surname>Farlow</surname><given-names>M. R.</given-names></name><article-title>Clinical
Pharmacokinetics of Galantamine</article-title>. <source>Clin. Pharmacokinet.</source><year>2003</year>, <volume>42</volume>, <fpage>1383</fpage>&#8211;<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.2165/00003088-200342150-00005</pub-id>.<pub-id pub-id-type="pmid">14674789</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name name-style="western"><surname>Emanuele</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Colombo</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Martinelli</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Brondino</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Marini</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Boso</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Barale</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Politi</surname><given-names>P.</given-names></name><article-title>Elevated Urine Levels
of Bufotenine in Patients With Autistic Spectrum Disorders and Schizophrenia</article-title>. <source>Neurolog. Endocrinol. Lett.</source><year>2010</year>, <volume>31</volume>, <fpage>117</fpage>&#8211;<lpage>121</lpage>.<pub-id pub-id-type="pmid">20150873</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name name-style="western"><surname>Nehlig</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Daval</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Debry</surname><given-names>G.</given-names></name><article-title>Caffeine and the Central Nervous
System: Mechanisms of Action, Biochemical, Metabolic and Psychostimulant
Effects</article-title>. <source>Brain Res. Rev.</source><year>1992</year>, <volume>17</volume>, <fpage>139</fpage>&#8211;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0165-0173(92)90012-B</pub-id>.<pub-id pub-id-type="pmid">1356551</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name name-style="western"><surname>Arnaud</surname><given-names>M. J.</given-names></name><article-title>Pharmacokinetics
and Metabolism of Natural Methylxanthines in Animal and Man</article-title>. <source>Handb. Exp. Pharmacol.</source><year>2011</year>, <volume>200</volume>, <fpage>33</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-13443-2_3</pub-id>.<pub-id pub-id-type="pmid">20859793</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name name-style="western"><surname>Newton</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Broughton</surname><given-names>L. J.</given-names></name>; <name name-style="western"><surname>Lind</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Morrison</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Rogers</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Bradbrook</surname><given-names>I. D.</given-names></name><article-title>Plasma and Salivary Pharmacokinetics
of Caffeine in
Man</article-title>. <source>Eur. J. Clin. Pharmacol.</source><year>1981</year>, <volume>21</volume>, <fpage>45</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/BF00609587</pub-id>.<pub-id pub-id-type="pmid">7333346</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name name-style="western"><surname>Calatayud</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gonz&#225;lez</surname><given-names>&#193;.</given-names></name><article-title>History
of the Development and Evolution
of Local Anesthesia Since the Coca Leaf</article-title>. <source>Anesthesiology</source><year>2003</year>, <volume>98</volume>, <fpage>1503</fpage>&#8211;<lpage>1508</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200306000-00031</pub-id>.<pub-id pub-id-type="pmid">12766665</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name name-style="western"><surname>Redman</surname><given-names>M.</given-names></name><article-title>Cocaine: What
is the Crack? A Brief History of the Use of Cocaine as an Anesthetic</article-title>. <source>Anesth. Pain Med.</source><year>2011</year>, <volume>1</volume>, <fpage>95</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.5812/aapm.1890</pub-id>.<pub-id pub-id-type="pmid">25729664</pub-id><pub-id pub-id-type="pmcid">PMC4335732</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="book" id="cit58"><person-group person-group-type="allauthors"><name name-style="western"><surname>Corbett</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Paterson</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kosterlitz</surname><given-names>H.</given-names></name></person-group><article-title>Selectivity of
Ligands for Opioid Receptors</article-title>. In <source>Opioids</source>; <publisher-name>Springer</publisher-name>, <year>1993</year>; pp <fpage>645</fpage>&#8211;<lpage>679</lpage>.</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name name-style="western"><surname>Neri</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Guarna</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bianchi</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Sonetti</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Matteucci</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Stefano</surname><given-names>G. B.</given-names></name><article-title>Endogenous Morphine and Codeine in the Brain of Non
Human Primate</article-title>. <source>Med. Sci. Monit.</source><year>2004</year>, <volume>10</volume>, <fpage>MS1</fpage>&#8211;<lpage>MS5</lpage>.<pub-id pub-id-type="pmid">15173678</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name name-style="western"><surname>Stefano</surname><given-names>G. B.</given-names></name>; <name name-style="western"><surname>Pt&#225;&#269;ek</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ku&#382;elov&#225;</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kream</surname><given-names>R. M.</given-names></name><article-title>Endogenous
Morphine: Up-to-Date Review 2011</article-title>. <source>Folia. Biol.
(Praha)</source><year>2012</year>, <volume>58</volume>, <fpage>49</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="pmid">22578954</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name name-style="western"><surname>Srinivasan</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Wielbo</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Tebbett</surname><given-names>I. R.</given-names></name><article-title>Analgesic Effects of Codeine-6-Glucuronide
After Intravenous Administration</article-title>. <source>Eur. J. Pain.</source><year>1997</year>, <volume>1</volume>, <fpage>185</fpage>&#8211;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/S1090-3801(97)90103-8</pub-id>.<pub-id pub-id-type="pmid">15102399</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name name-style="western"><surname>Audi</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Belson</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Patel</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Schier</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Osterloh</surname><given-names>J.</given-names></name><article-title>Ricin PoisoningA
Comprehensive Review</article-title>. <source>JAMA</source><year>2005</year>, <volume>294</volume>, <fpage>2342</fpage>&#8211;<lpage>2351</lpage>. <pub-id pub-id-type="doi">10.1001/jama.294.18.2342</pub-id>.<pub-id pub-id-type="pmid">16278363</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name name-style="western"><surname>Broadley</surname><given-names>K. J.</given-names></name><article-title>The Vascular
Effects of Trace Amines and Amphetamines</article-title>. <source>Pharmacology
&amp; Therapeutics</source><year>2010</year>, <volume>125</volume>, <fpage>363</fpage>&#8211;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2009.11.005</pub-id>.<pub-id pub-id-type="pmid">19948186</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name name-style="western"><surname>Pendleton</surname><given-names>R. G.</given-names></name>; <name name-style="western"><surname>Gessner</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Sawyer</surname><given-names>J.</given-names></name><article-title>Studies on
Lung N-Methyltransferases,
a Pharmacological Approach</article-title>. <source>Naunyn-Schmiedeb.
Arch. Pharmacol.</source><year>1980</year>, <volume>313</volume>, <fpage>263</fpage>&#8211;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1007/BF00505743</pub-id>.<pub-id pub-id-type="pmid">7432557</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name name-style="western"><surname>Lindemann</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hoener</surname><given-names>M. C.</given-names></name><article-title>A Renaissance in Trace Amines Inspired by a Novel GPCR
Family</article-title>. <source>Trends Pharmacol. Sci.</source><year>2005</year>, <volume>26</volume>, <fpage>274</fpage>&#8211;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2005.03.007</pub-id>.<pub-id pub-id-type="pmid">15860375</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name name-style="western"><surname>Wainscott</surname><given-names>D. B.</given-names></name>; <name name-style="western"><surname>Little</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Rocco</surname><given-names>V. P.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>J. X.</given-names></name>; <name name-style="western"><surname>Nelson</surname><given-names>D. L.</given-names></name><article-title>Pharmacologic Characterization
of
the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence
for Species Differences with the Rat TAAR1</article-title>. <source>J. Pharmacol. Exp. Ther.</source><year>2007</year>, <volume>320</volume>, <fpage>475</fpage><pub-id pub-id-type="doi">10.1124/jpet.106.112532</pub-id>.<pub-id pub-id-type="pmid">17038507</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name name-style="western"><surname>Shinotoh</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Inoue</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iyo</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tominaga</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Itoh</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tateno</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ikehira</surname><given-names>H.</given-names></name><article-title>Kinetics of [<sup>11</sup>C]<italic toggle="yes">N</italic>, <italic toggle="yes">N</italic>-Dimethylphenylethylamine in Mice and Humans: Potential
for Measurement of Brain MAO-B Activity</article-title>. <source>J.
Nucl. Med.</source><year>1987</year>, <volume>28</volume>, <fpage>1006</fpage>&#8211;<lpage>1011</lpage>.<pub-id pub-id-type="pmid">3495646</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="book" id="cit68"><person-group person-group-type="allauthors"><name name-style="western"><surname>Rorabaugh</surname><given-names>B.</given-names></name></person-group><article-title>Ephedrine</article-title>. In <source>xPharm: The Comprehensive Pharmacology Reference</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Enna</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Bylund</surname><given-names>D. B.</given-names></name></person-group>, Eds.; <publisher-name>Elsevier</publisher-name>, <year>2007</year>; pp <fpage>1</fpage>&#8211;<lpage>6</lpage>.</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name name-style="western"><surname>Li</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y. W.</given-names></name>; <name name-style="western"><surname>Qi</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y. P.</given-names></name>; <name name-style="western"><surname>Deng</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>W. Z.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>Q. Y.</given-names></name>; <name name-style="western"><surname>Guan</surname><given-names>H. D.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>; et al. <article-title>Analogous
&#946;-Carboline Alkaloids Harmaline and
Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating
Acetylcholinesterase Activity, Oxidative Stress, and Inflammation
in Mice</article-title>. <source>Front. Pharmacol.</source><year>2018</year>, <volume>9</volume>, <fpage>346</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00346</pub-id>.<pub-id pub-id-type="pmid">29755345</pub-id><pub-id pub-id-type="pmcid">PMC5932362</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name name-style="western"><surname>Wu</surname><given-names>L. W.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>J. K.</given-names></name>; <name name-style="western"><surname>Rao</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Z. Y.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><article-title>Harmine Suppresses the Proliferation
of Pancreatic Cancer Cells and
Sensitizes Pancreatic Cancer to Gemcitabine Treatment</article-title>. <source>OncoTargets Ther.</source><year>2019</year>, <volume>12</volume>, <fpage>4585</fpage>&#8211;<lpage>4593</lpage>. <pub-id pub-id-type="doi">10.2147/OTT.S205097</pub-id>.<pub-id pub-id-type="pmcid">PMC6580126</pub-id><pub-id pub-id-type="pmid">31354292</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name name-style="western"><surname>Cumming</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Marton</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lilius</surname><given-names>T. O.</given-names></name>; <name name-style="western"><surname>Olberg</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Rominger</surname><given-names>A.</given-names></name><article-title>A Survey of
Molecular Imaging of Opioid Receptors</article-title>. <source>Molecules</source><year>2019</year>, <volume>24</volume>, <fpage>4190</fpage><pub-id pub-id-type="doi">10.3390/molecules24224190</pub-id>.<pub-id pub-id-type="pmid">31752279</pub-id><pub-id pub-id-type="pmcid">PMC6891617</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name name-style="western"><surname>Kishioka</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kiguchi</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kobayashi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Saika</surname><given-names>F.</given-names></name><article-title>Nicotine Effects and
the Endogenous Opioid System</article-title>. <source>J. Pharmacol.
Sci.</source><year>2014</year>, <volume>125</volume>, <fpage>117</fpage>&#8211;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.14R03CP</pub-id>.<pub-id pub-id-type="pmid">24882143</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name name-style="western"><surname>Jia</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Kawahata</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Cheng</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fukunaga</surname><given-names>K.</given-names></name><article-title>The Role of CaMKII
and ERK Signaling in Addiction</article-title>. <source>Int. J. Mol.
Sci.</source><year>2021</year>, <volume>22</volume>, <fpage>3189</fpage><pub-id pub-id-type="doi">10.3390/ijms22063189</pub-id>.<pub-id pub-id-type="pmid">33804804</pub-id><pub-id pub-id-type="pmcid">PMC8004038</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="book" id="cit74"><person-group person-group-type="allauthors"><name name-style="western"><surname>Davis</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Glare</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Hardy</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Quigley</surname><given-names>C.</given-names></name></person-group><source>Opioids in
Cancer Pain</source>; <publisher-name>Oxford University Press</publisher-name>, <year>2009</year>.</mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name name-style="western"><surname>Moore</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Ramcharitar</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Levine</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>D.</given-names></name><article-title>Tentative Identification
of Novel Oxycodone Metabolites in Human Urine</article-title>. <source>J. Anal. Toxicol.</source><year>2003</year>, <volume>27</volume>, <fpage>346</fpage>&#8211;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1093/jat/27.6.346</pub-id>.<pub-id pub-id-type="pmid">14516487</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name name-style="western"><surname>Weber</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Breier</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ko</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Thangaraj</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Marzan</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Swerdlow</surname><given-names>N. R.</given-names></name><article-title>Evaluating the Antipsychotic Profile
of the Preferential PDE10A Inhibitor, Papaverine</article-title>. <source>Psychopharmacology (Berl)</source><year>2009</year>, <volume>203</volume>, <fpage>723</fpage>&#8211;<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-008-1419-x</pub-id>.<pub-id pub-id-type="pmid">19066855</pub-id><pub-id pub-id-type="pmcid">PMC2748940</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name name-style="western"><surname>Siuciak</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Chapin</surname><given-names>D. S.</given-names></name>; <name name-style="western"><surname>Harms</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Lebel</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>McCarthy</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Chambers</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Shrikhande</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Menniti</surname><given-names>F. S.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>C. J.</given-names></name><article-title>Inhibition of the
Striatum-Enriched Phosphodiesterase
PDE10A: A Novel Approach to the Treatment of Psychosis</article-title>. <source>Neuropharmacol.</source><year>2006</year>, <volume>51</volume>, <fpage>386</fpage>&#8211;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.04.013</pub-id>.<pub-id pub-id-type="pmid">16780899</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name name-style="western"><surname>Shinotoh</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Fukushi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nagatsuka</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Irie</surname><given-names>T.</given-names></name><article-title>Acetylcholinesterase
Imaging: Its Use in Therapy Evaluation and Drug Design</article-title>. <source>Curr. Pharm. Des.</source><year>2004</year>, <volume>10</volume>, <fpage>1505</fpage>&#8211;<lpage>1517</lpage>. <pub-id pub-id-type="doi">10.2174/1381612043384763</pub-id>.<pub-id pub-id-type="pmid">15134572</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="book" id="cit79"><person-group person-group-type="allauthors"><name name-style="western"><surname>Katzung</surname><given-names>B. G.</given-names></name>; <name name-style="western"><surname>Masters</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Trevor</surname><given-names>A. J.</given-names></name></person-group><source>Basic and Clinical
Pharmacology</source>, <edition>12th</edition> ed.; <publisher-name>McGraw-Hill</publisher-name>, <year>2004</year>.</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name name-style="western"><surname>Moore</surname><given-names>P. W.</given-names></name>; <name name-style="western"><surname>Rasimas</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Donovan</surname><given-names>J. W.</given-names></name><article-title>Physostigmine is the Antidote for
Anticholinergic Syndrome</article-title>. <source>J. Med. Toxicol.</source><year>2015</year>, <volume>11</volume>, <fpage>159</fpage>&#8211;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1007/s13181-014-0442-z</pub-id>.<pub-id pub-id-type="pmid">25339374</pub-id><pub-id pub-id-type="pmcid">PMC4371033</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name name-style="western"><surname>Cumming</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Scheidegger</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Dornbierer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Palner</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Quednow</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Martin-Soelch</surname><given-names>C.</given-names></name><article-title>Molecular
and Functional Imaging Studies of Psychedelic
Drug Action in Animals and Humans</article-title>. <source>Molecules</source><year>2021</year>, <volume>26</volume>, <fpage>2451</fpage><pub-id pub-id-type="doi">10.3390/molecules26092451</pub-id>.<pub-id pub-id-type="pmid">33922330</pub-id><pub-id pub-id-type="pmcid">PMC8122807</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name name-style="western"><surname>Grace</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Camm</surname><given-names>A. J.</given-names></name><article-title>Quinidine</article-title>. <source>N. Engl. J. Med.</source><year>1998</year>, <volume>338</volume>, <fpage>35</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199801013380107</pub-id>.<pub-id pub-id-type="pmid">9414330</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name name-style="western"><surname>Renner</surname><given-names>U. D.</given-names></name>; <name name-style="western"><surname>Oertel</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kirch</surname><given-names>W.</given-names></name><article-title>Pharmacokinetics and
Pharmacodynamics
in Clinical Use of Scopolamine</article-title>. <source>Ther. Drug Monit.</source><year>2005</year>, <volume>27</volume>, <fpage>655</fpage>&#8211;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1097/01.ftd.0000168293.48226.57</pub-id>.<pub-id pub-id-type="pmid">16175141</pub-id></mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name name-style="western"><surname>Lakstygal</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Kolesnikova</surname><given-names>T. O.</given-names></name>; <name name-style="western"><surname>Khatsko</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Zabegalov</surname><given-names>K. N.</given-names></name>; <name name-style="western"><surname>Volgin</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Demin</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Shevyrin</surname><given-names>V. A.</given-names></name>; <name name-style="western"><surname>Wappler-Guzzetta</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Kalueff</surname><given-names>A. V.</given-names></name><article-title>DARK Classics in
Chemical Neuroscience: Atropine, Scopolamine,
and Other Anticholinergic Deliriant Hallucinogens</article-title>. <source>ACS Chem. Neurosci.</source><year>2019</year>, <volume>10</volume>, <fpage>2144</fpage>&#8211;<lpage>2159</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.8b00615</pub-id>.<pub-id pub-id-type="pmid">30566832</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name name-style="western"><surname>Essayan</surname><given-names>D. M.</given-names></name><article-title>Cyclic
Nucleotide Phosphodiesterases</article-title>. <source>J. Allergy Clin.
Immunol.</source><year>2001</year>, <volume>108</volume>, <fpage>671</fpage>&#8211;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1067/mai.2001.119555</pub-id>.<pub-id pub-id-type="pmid">11692087</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name name-style="western"><surname>Deree</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Martins</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Melbostad</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Loomis</surname><given-names>W. H.</given-names></name>; <name name-style="western"><surname>Coimbra</surname><given-names>R.</given-names></name><article-title>Insights Into
the Regulation of TNF-Alpha Production in Human Mononuclear Cells:
The Effects of Non-Specific Phosphodiesterase Inhibition</article-title>. <source>Clinics</source><year>2008</year>, <volume>63</volume>, <fpage>321</fpage>&#8211;<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1590/S1807-59322008000300006</pub-id>.<pub-id pub-id-type="pmid">18568240</pub-id><pub-id pub-id-type="pmcid">PMC2664230</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name name-style="western"><surname>Marques</surname><given-names>L. J.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Poulakis</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Guzman</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Costabel</surname><given-names>U.</given-names></name><article-title>Pentoxifylline
Inhibits TNF-Alpha Production From Human Alveolar Macrophages</article-title>. <source>Am. J. Respir. Crit. Care Med.</source><year>1999</year>, <volume>159</volume>, <fpage>508</fpage>&#8211;<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.159.2.9804085</pub-id>.<pub-id pub-id-type="pmid">9927365</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name name-style="western"><surname>Peters-Golden</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Canetti</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Mancuso</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Coffey</surname><given-names>M. J.</given-names></name><article-title>Leukotrienes: Underappreciated
Mediators of Innate Immune Responses</article-title>. <source>J. Immunol.</source><year>2005</year>, <volume>174</volume>, <fpage>589</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.174.2.589</pub-id>.<pub-id pub-id-type="pmid">15634873</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name name-style="western"><surname>Daly</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Jacobson</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Ukena</surname><given-names>D.</given-names></name><article-title>Adenosine
Receptors: Development
of Selective Agonists and Antagonists</article-title>. <source>Prog.
Clin. Biol. Res.</source><year>1987</year>, <volume>230</volume>, <fpage>41</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">3588607</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yanai</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nozoe</surname><given-names>S.</given-names></name><article-title><sup>11</sup>C-Labeling of Indolealkylamine
Alkaloids and the Comparative Study of Their Tissue Distributions</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>965</fpage>&#8211;<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90257-1</pub-id>.<pub-id pub-id-type="pmid">3866749</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="report" id="cit91"><person-group><name name-style="western"><surname>Funaki</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name></person-group><article-title>Preparation of [<sup>11</sup>C]Caffeines
from [<sup>11</sup>C]Methyl
Iodide</article-title><source>CYRIC Annual Report</source>; <publisher-name>Tohoku University Repository</publisher-name>, <year>1992</year>,
Vol. <volume>1992</volume>, pp <fpage>103</fpage>&#8211;<lpage>105</lpage>.</mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name name-style="western"><surname>Saji</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tamate</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yoshikawa</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kasida</surname><given-names>Y.</given-names></name><article-title>Caffeine-<sup>11</sup>C, Ephedrine-<sup>11</sup>C and
Methylephedrine-<sup>11</sup>C: Synthesis and Distribution in Mice
(Author&#8217;s Transl)</article-title>. <source>Radioisotopes</source><year>1978</year>, <volume>27</volume>, <fpage>451</fpage>&#8211;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.3769/radioisotopes.27.8_451</pub-id>.<pub-id pub-id-type="pmid">734163</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name name-style="western"><surname>Schou</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Varn&#228;s</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lundquist</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nakao</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Amini</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Takano</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Finnema</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name><article-title>Large Variation
in Brain Exposure of Reference CNS Drugs: A PET Study in Nonhuman
Primates</article-title>. <source>Int. J. Neuropsychopharmacol.</source><year>2015</year>, <volume>18</volume>, <fpage>pyv036</fpage><pub-id pub-id-type="doi">10.1093/ijnp/pyv036</pub-id>.<pub-id pub-id-type="pmid">25813017</pub-id><pub-id pub-id-type="pmcid">PMC4648157</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name name-style="western"><surname>Du</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Tully</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Schiffer</surname><given-names>W. K.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Luo</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Koretsky</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Benveniste</surname><given-names>H.</given-names></name><article-title>Differential Effects of Anesthetics
on Cocaine&#8217;s Pharmacokinetic and Pharmacodynamic Effects in
Brain</article-title>. <source>Eur. J. Neurosci.</source><year>2009</year>, <volume>30</volume>, <fpage>1565</fpage>&#8211;<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.06931.x</pub-id>.<pub-id pub-id-type="pmid">19821842</pub-id><pub-id pub-id-type="pmcid">PMC2775450</pub-id></mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Hitzemann</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bendriem</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; et al. <article-title>Mapping Cocaine Binding Sites in Human and
Baboon Brain <italic toggle="yes">In Vivo</italic></article-title>. <source>Synapse</source><year>1989</year>, <volume>4</volume>, <fpage>371</fpage>&#8211;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890040412</pub-id>.<pub-id pub-id-type="pmid">2557686</pub-id></mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D. J.</given-names></name><article-title>Rapid Stereoselective
Hydrolysis of (<italic toggle="yes">+</italic>)-Cocaine in Baboon Plasma Prevents
Its Uptake in the Brain: Implications
for Behavioral Studies</article-title>. <source>J. Neurochem.</source><year>1990</year>, <volume>54</volume>, <fpage>720</fpage>&#8211;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1990.tb01933.x</pub-id>.<pub-id pub-id-type="pmid">2299363</pub-id></mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Comparative
PET Studies of the Kinetics
and Distribution of Cocaine and Cocaethylene in Baboon Brain</article-title>. <source>Synapse</source><year>1992</year>, <volume>12</volume>, <fpage>220</fpage>&#8211;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890120307</pub-id>.<pub-id pub-id-type="pmid">1481141</pub-id></mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Pappas</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>King</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name><article-title>Carbon-11-Cocaine Binding Compared at Subpharmacological
and Pharmacological Doses: A PET Study</article-title>. <source>J. Nucl.
Med.</source><year>1995</year>, <volume>36</volume>, <fpage>1289</fpage>&#8211;<lpage>1297</lpage>.<pub-id pub-id-type="pmid">7790958</pub-id></mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name name-style="western"><surname>Gatley</surname><given-names>S.
J.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name><article-title>Sensitivity
of Striatal [<sup>11</sup>C]Cocaine Binding to Decreases in Synaptic
Dopamine</article-title>. <source>Synapse</source><year>1995</year>, <volume>20</volume>, <fpage>137</fpage>&#8211;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890200207</pub-id>.<pub-id pub-id-type="pmid">7570343</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal" id="cit100"><name name-style="western"><surname>Benveniste</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Rooney</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>Y.-S.</given-names></name>; <name name-style="western"><surname>Baumann</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Moller</surname><given-names>D. H.</given-names></name>; <name name-style="western"><surname>Du</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Backus</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Carter</surname><given-names>P.</given-names></name>; et al. <article-title>Maternal
and Fetal <sup>11</sup>C-Cocaine Uptake and Kinetics Measured <italic toggle="yes">In Vivo</italic> by Combined PET and MRI in Pregnant Nonhuman Primates</article-title>. <source>J. Nucl. Med.</source><year>2005</year>, <volume>46</volume>, <fpage>312</fpage>&#8211;<lpage>320</lpage>.<pub-id pub-id-type="pmid">15695792</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal" id="cit101"><name name-style="western"><surname>Kimmel</surname><given-names>H. L.</given-names></name>; <name name-style="western"><surname>Negus</surname><given-names>S. S.</given-names></name>; <name name-style="western"><surname>Wilcox</surname><given-names>K. M.</given-names></name>; <name name-style="western"><surname>Ewing</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Stehouwer</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Goodman</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Votaw</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Mello</surname><given-names>N. K.</given-names></name>; <name name-style="western"><surname>Carroll</surname><given-names>F. I.</given-names></name>; <name name-style="western"><surname>Howell</surname><given-names>L. L.</given-names></name><article-title>Relationship Between Rate of Drug
Uptake in Brain and Behavioral Pharmacology of Monoamine Transporter
Inhibitors in Rhesus Monkeys</article-title>. <source>Pharmacol. Biochem.
Behav.</source><year>2008</year>, <volume>90</volume>, <fpage>453</fpage>&#8211;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2008.03.032</pub-id>.<pub-id pub-id-type="pmid">18468667</pub-id><pub-id pub-id-type="pmcid">PMC2453312</pub-id></mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal" id="cit102"><name name-style="western"><surname>Howell</surname><given-names>L. L.</given-names></name>; <name name-style="western"><surname>Nye</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Stehouwer</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Voll</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Mun</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Narasimhan</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Nichols</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sunahara</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Goodman</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Carroll</surname><given-names>F. I.</given-names></name>; et al. <article-title>A Thermostable Bacterial Cocaine Esterase Rapidly
Eliminates Cocaine
From Brain in Nonhuman Primates</article-title>. <source>Transl. Psychiatry</source><year>2014</year>, <volume>4</volume>, <elocation-id>e407</elocation-id><pub-id pub-id-type="doi">10.1038/tp.2014.48</pub-id>.<pub-id pub-id-type="pmid">24984194</pub-id><pub-id pub-id-type="pmcid">PMC4119218</pub-id></mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal" id="cit103"><name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>D.-W.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Martin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name><article-title>Studies with Differentially
Labeled
[<sup>11</sup>C]Cocaine, [<sup>11</sup>C]Norcocaine, [<sup>11</sup>C]Benzoylecgonine, and [<sup>11</sup>C]-and <italic toggle="yes">4&#8242;</italic>-[<sup>18</sup>F]Fluorococaine to Probe the Extent to Which [<sup>11</sup>C]Cocaine Metabolites Contribute to PET Images of the Baboon
Brain</article-title>. <source>J. Neurochem.</source><year>1994</year>, <volume>62</volume>, <fpage>1154</fpage>&#8211;<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1994.62031154.x</pub-id>.<pub-id pub-id-type="pmid">8113802</pub-id></mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal" id="cit104"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lindberg</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lundberg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Sv&#228;rd</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rane</surname><given-names>A.</given-names></name><article-title>Kinetics of <sup>11</sup>C-Labeled Opiates in the Brain of Rhesus
Monkeys</article-title>. <source>J. Pharmacol. Exp. Ther.</source><year>1984</year>, <volume>230</volume>, <fpage>250</fpage>&#8211;<lpage>255</lpage>.<pub-id pub-id-type="pmid">6611397</pub-id></mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal" id="cit105"><name name-style="western"><surname>Lindberg</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mossine</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Aliaga</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hopewell</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Massarweh</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Rosa-Neto</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Bernard-Gauthier</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name>; <name name-style="western"><surname>Vasdev</surname><given-names>N.</given-names></name><article-title>Preliminary
Evaluations of [<sup>11</sup>C]Verubulin: Implications for Microtubule
Imaging With PET</article-title>. <source>Front. Neurosci.</source><year>2021</year>, <volume>15</volume>, <fpage>725873</fpage><pub-id pub-id-type="doi">10.3389/fnins.2021.725873</pub-id>.<pub-id pub-id-type="pmid">34566568</pub-id><pub-id pub-id-type="pmcid">PMC8456034</pub-id></mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal" id="cit106"><name name-style="western"><surname>Dileep Kumar</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Prabhakaran</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Damuka</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Hines</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Norman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dodda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>John Mann</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Mintz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sai</surname><given-names>K. K. S.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Comparison
of N-<sup>11</sup>CH<sub>3</sub> vs O-<sup>11</sup>CH<sub>3</sub> Radiolabeled
Microtubule Targeted PET Ligands</article-title>. <source>Bioorg. Med.
Chem. Lett.</source><year>2020</year>, <volume>30</volume>, <fpage>126785</fpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2019.126785</pub-id>.<pub-id pub-id-type="pmid">31753695</pub-id><pub-id pub-id-type="pmcid">PMC11659960</pub-id></mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal" id="cit107"><name name-style="western"><surname>Levchenko</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mehta</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Humm</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Augensen</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Squire</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Leonard</surname><given-names>E. F.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>S. M.</given-names></name><article-title>Evaluation of <sup>11</sup>C-Colchicine
for PET Imaging of Multiple Drug Resistance</article-title>. <source>J. Nucl. Med.</source><year>2000</year>, <volume>41</volume>, <fpage>493</fpage>&#8211;<lpage>501</lpage>.<pub-id pub-id-type="pmid">10716325</pub-id></mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="journal" id="cit108"><name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>S. M.</given-names></name><article-title>Synthesis of Colchicine
and Isocolchicine Labelled With Carbon-11 or Carbon-13</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1995</year>, <volume>36</volume>, <fpage>521</fpage>&#8211;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580360603</pub-id>.</mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal" id="cit109"><name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>St&#229;lnacke</surname><given-names>C.-G.</given-names></name>; <name name-style="western"><surname>Jossan</surname><given-names>S. S.</given-names></name>; <name name-style="western"><surname>Oreland</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title><sup>11</sup>C-Labelling of Dimethylphenethylamine in Two Different Positions
and Biodistribution Studies</article-title>. <source>Int. J. Rad. Appl.
Instrum. A. Appl. Radiat. Isot.</source><year>1989</year>, <volume>40</volume>, <fpage>557</fpage>&#8211;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(89)90108-1</pub-id>.<pub-id pub-id-type="pmid">2551855</pub-id></mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal" id="cit110"><name name-style="western"><surname>Yanai</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hatazawa</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Matsuzawa</surname><given-names>T.</given-names></name><article-title>In Vivo Kinetics
and Displacement Study of a Carbon-11-Labeled Hallucinogen, <italic toggle="yes">N</italic>, <italic toggle="yes">N</italic>-[<sup>11</sup>C]Dimethyltryptamine</article-title>. <source>Eur. J. Nucl. Med.</source><year>1986</year>, <volume>12</volume>, <fpage>141</fpage>&#8211;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1007/BF00276707</pub-id>.<pub-id pub-id-type="pmid">3489620</pub-id></mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal" id="cit111"><name name-style="western"><surname>Kimura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kawai</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hamashima</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Miura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nakaya</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hirasawa</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Arimitsu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kajimoto</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ohmomo</surname><given-names>Y.</given-names></name>; et al. <article-title>Synthesis
and Evaluation of (&#8722;)- and (<italic toggle="yes">+</italic>)-[<sup>11</sup>C]Galanthamine as PET Tracers for Cerebral Acetylcholinesterase Imaging</article-title>. <source>Bioorg. Med. Chem.</source><year>2014</year>, <volume>22</volume>, <fpage>285</fpage>&#8211;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2013.11.026</pub-id>.<pub-id pub-id-type="pmid">24315193</pub-id></mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal" id="cit112"><name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Westerberg</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of Some <sup>11</sup>C-Labelled MAO-A Inhibitors and Their <italic toggle="yes">In Vivo</italic> Uptake Kinetics in Rhesus Monkey Brain</article-title>. <source>Nucl. Med. Biol.</source><year>1997</year>, <volume>24</volume>, <fpage>381</fpage>&#8211;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(97)80003-0</pub-id>.<pub-id pub-id-type="pmid">9290071</pub-id></mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal" id="cit113"><name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Westerberg</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title><sup>11</sup>C-Harmine as a Tracer
for Monoamine Oxidase a (MAO-a): <italic toggle="yes">In
Vitro</italic> and <italic toggle="yes">In Vivo</italic> Studies</article-title>. <source>Nucl. Med. Biol.</source><year>1997</year>, <volume>24</volume>, <fpage>287</fpage>&#8211;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(97)00013-9</pub-id>.<pub-id pub-id-type="pmid">9257326</pub-id></mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal" id="cit114"><name name-style="western"><surname>Murthy</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Erlandsson</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Van Heertum</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Mann</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Parsey</surname><given-names>R.</given-names></name><article-title>Biodistribution and Radiation Dosimetry
of 11C-Harmine in Baboons</article-title>. <source>Nucl. Med. Commun.</source><year>2007</year>, <volume>28</volume>, <fpage>748</fpage>&#8211;<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1097/MNM.0b013e32827420b5</pub-id>.<pub-id pub-id-type="pmid">17667755</pub-id></mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="journal" id="cit115"><name name-style="western"><surname>Jensen</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Olsen</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Pedersen</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Cumming</surname><given-names>P.</given-names></name><article-title>Effect of
Monoamine Oxidase Inhibition on Amphetamine-Evoked Changes in Dopamine
Receptor Availability in the Living Pig: A Dual Tracer PET Study With
[<sup>11</sup>C]Harmine and [<sup>11</sup>C]Raclopride</article-title>. <source>Synapse</source><year>2006</year>, <volume>59</volume>, <fpage>427</fpage>&#8211;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20258</pub-id>.<pub-id pub-id-type="pmid">16485265</pub-id></mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal" id="cit116"><name name-style="western"><surname>Zanderigo</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>D&#8217;Agostino</surname><given-names>A.
E.</given-names></name>; <name name-style="western"><surname>Joshi</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Schain</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Parsey</surname><given-names>R. V.</given-names></name>; <name name-style="western"><surname>DeLorenzo</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Mann</surname><given-names>J. J.</given-names></name><article-title>[<sup>11</sup>C]Harmine Binding to Brain Monoamine
Oxidase A: Test-Retest Properties and Noninvasive Quantification</article-title>. <source>Mol. Imaging Biol.</source><year>2018</year>, <volume>20</volume>, <fpage>667</fpage>&#8211;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-018-1165-3</pub-id>.<pub-id pub-id-type="pmid">29423903</pub-id></mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal" id="cit117"><name name-style="western"><surname>Sacher</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rabiner</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Clark</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rusjan</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Soliman</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Boskovic</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kish</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Houle</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>J. H.</given-names></name><article-title>Dynamic, Adaptive Changes in MAO-A
Binding After Alterations in Substrate Availability: An <italic toggle="yes">In
Vivo</italic> [<sup>11</sup>C]-Harmine Positron Emission Tomography
Study</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2012</year>, <volume>32</volume>, <fpage>443</fpage>&#8211;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2011.184</pub-id>.<pub-id pub-id-type="pmid">22186668</pub-id><pub-id pub-id-type="pmcid">PMC3293124</pub-id></mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal" id="cit118"><name name-style="western"><surname>Sacher</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Houle</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Parkes</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rusjan</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sagrati</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>J. H.</given-names></name><article-title>Monoamine
Oxidase
a Inhibitor Occupancy During Treatment of Major Depressive Episodes
With Moclobemide or St. John&#8217;s Wort: An [<sup>11</sup>C]-Harmine
PET Study</article-title>. <source>J. Psychiatry Neurosci.</source><year>2011</year>, <volume>36</volume>, <fpage>375</fpage>&#8211;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.100117</pub-id>.<pub-id pub-id-type="pmid">21463543</pub-id><pub-id pub-id-type="pmcid">PMC3201991</pub-id></mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="journal" id="cit119"><name name-style="western"><surname>Orlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fasth</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Oberg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name><article-title>Demonstration
of High Monoaminoxidase-A Levels in Neuroendocrine Gastroenteropancreatic
Tumors <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">In Vivo</italic>-Tumor
Visualization Using Positron Emission Tomography With <sup>11</sup>C-Harmine</article-title>. <source>Nucl. Med. Biol.</source><year>2003</year>, <volume>30</volume>, <fpage>669</fpage>&#8211;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(03)00034-9</pub-id>.<pub-id pub-id-type="pmid">12900293</pub-id></mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="journal" id="cit120"><name name-style="western"><surname>Rekkas</surname><given-names>P. V.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Yogalingam</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sacher</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rusjan</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Houle</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Stewart</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Kolla</surname><given-names>N. J.</given-names></name>; <name name-style="western"><surname>Kish</surname><given-names>S.</given-names></name>; et al. <article-title>Greater
Monoamine Oxidase
a Binding in Perimenopausal Age As Measured With Carbon 11-Labeled
Harmine Positron Emission Tomography</article-title>. <source>JAMA Psychiatry</source><year>2014</year>, <volume>71</volume>, <fpage>873</fpage>&#8211;<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.250</pub-id>.<pub-id pub-id-type="pmid">24898155</pub-id><pub-id pub-id-type="pmcid">PMC4942269</pub-id></mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal" id="cit121"><name name-style="western"><surname>Philippe</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Zeilinger</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mitterhauser</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Dumanic</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lanzenberger</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Hacker</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wadsak</surname><given-names>W.</given-names></name><article-title>Parameter
Evaluation and Fully-Automated Radiosynthesis of [<sup>11</sup>C]Harmine
for Imaging of MAO-A for Clinical Trials</article-title>. <source>Appl.
Radiat. Isot.</source><year>2015</year>, <volume>97</volume>, <fpage>182</fpage>&#8211;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2015.01.002</pub-id>.<pub-id pub-id-type="pmid">25594603</pub-id><pub-id pub-id-type="pmcid">PMC4337850</pub-id></mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal" id="cit122"><name name-style="western"><surname>Kloster</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Machulla</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>R&#246;der</surname><given-names>E.</given-names></name><article-title>Synthesis,
Chromatography and Tissue Distribution of <italic toggle="yes">Methyl</italic>-<sup>11</sup>C-Morphine and <italic toggle="yes">Methyl</italic>-<sup>11</sup>C-Heroin</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>441</fpage>&#8211;<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580160310</pub-id>.</mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal" id="cit123"><name name-style="western"><surname>Agon</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kaufman</surname><given-names>J.-M.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>van Haver</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Bogaert</surname><given-names>M. G.</given-names></name><article-title>Study with Positron Emission Tomography
of the Osmotic
Opening of the Dog Blood-Brain Barrier for Quinidine and Morphine</article-title>. <source>J. Pharm. Pharmacol.</source><year>2011</year>, <volume>40</volume>, <fpage>539</fpage>&#8211;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1111/j.2042-7158.1988.tb05298.x</pub-id>.<pub-id pub-id-type="pmid">2907006</pub-id></mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal" id="cit124"><name name-style="western"><surname>Gustafsson</surname><given-names>L. L.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bergstr&#214;M</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lindberg</surname><given-names>B. S.</given-names></name>; <name name-style="western"><surname>L&#197;Ngstr&#214;M</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Sv&#196;Rd</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rane</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tamsen</surname><given-names>A.</given-names></name><article-title>Distribution of <sup>11</sup>C-Labelled Morphine and Pethidine After Spinal Administration
to Rhesus Monkey</article-title>. <source>Acta Anaesthesiol. Scand.</source><year>1989</year>, <volume>33</volume>, <fpage>105</fpage>&#8211;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-6576.1989.tb02870.x</pub-id>.<pub-id pub-id-type="pmid">2784246</pub-id></mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal" id="cit125"><name name-style="western"><surname>Fan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Meissner</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Gaehle</surname><given-names>G. G.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kharasch</surname><given-names>E. D.</given-names></name>; <name name-style="western"><surname>Mach</surname><given-names>R. H.</given-names></name>; <name name-style="western"><surname>Tu</surname><given-names>Z.</given-names></name><article-title>Automated Radiosynthesis
of [<sup>11</sup>C]Morphine for Clinical Investigation</article-title>. <source>Appl. Radiat. Isot.</source><year>2011</year>, <volume>69</volume>, <fpage>431</fpage>&#8211;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2010.11.003</pub-id>.<pub-id pub-id-type="pmid">21112214</pub-id><pub-id pub-id-type="pmcid">PMC3026438</pub-id></mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal" id="cit126"><name name-style="western"><surname>Allen</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Beaumier</surname><given-names>P. L.</given-names></name><article-title>[<italic toggle="yes">N</italic>-<sup>11</sup>CH<sub>3</sub>]-Morphine</article-title>. <source>J.
Label. Compd.
Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>61</fpage>&#8211;<lpage>62</lpage>.</mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal" id="cit127"><name name-style="western"><surname>Mazi&#232;re</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Marazano</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>G.</given-names></name><article-title>Nicotine-<sup>11</sup>C: Synthesis
and Distribution Kinetics in Animals</article-title>. <source>Eur. J.
Nucl. Med.</source><year>1976</year>, <volume>1</volume>, <fpage>255</fpage>&#8211;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/BF00252173</pub-id>.<pub-id pub-id-type="pmid">1031371</pub-id></mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal" id="cit128"><name name-style="western"><surname>Saji</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yamada</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tajima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yokoyama</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Magata</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yonekura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Konishi</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ohmomo</surname><given-names>Y.</given-names></name><article-title>Synthesis
of (5)-N-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Nicotine and Its
Regional Distribution in the Mouse Brain: A Potential Tracer for Visualization
of Brain Nicotinic Receptors by Positron Emission Tomography</article-title>. <source>Chem. Pharm. Bull.</source><year>1992</year>, <volume>40</volume>, <fpage>734</fpage>&#8211;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.40.734</pub-id>.<pub-id pub-id-type="pmid">1611685</pub-id></mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal" id="cit129"><name name-style="western"><surname>Nordberg</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ulin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Uptake and
Regional Distribution of (+)-(<italic toggle="yes">R</italic>)- and (&#8722;)-(<italic toggle="yes">S</italic>)-<italic toggle="yes">N</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]-Nicotine in the Brains of Rhesus Monkey an Attempt To Study Nicotinic
Receptors <italic toggle="yes">In Vivo</italic></article-title>. <source>J. Neural
Transm., Parkinson&#8217;s Dis. Dement.</source><year>1989</year>, <volume>1</volume>, <fpage>195</fpage>&#8211;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/BF02248669</pub-id>.<pub-id pub-id-type="pmid">2789067</pub-id></mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="book" id="cit130"><person-group person-group-type="allauthors"><name name-style="western"><surname>Maziere</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Plummer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Masse</surname><given-names>R.</given-names></name></person-group><source>The &#8220;In
Vivo&#8221; Distribution
of Carbon 11 Labeled-Nicotine in Animals a Method Suitable for Use
in Man</source>; <publisher-name>CEA-CONF-4478</publisher-name>; <publisher-loc>France</publisher-loc>, <year>1978</year>.</mixed-citation></ref><ref id="ref131"><mixed-citation publication-type="journal" id="cit131"><name name-style="western"><surname>Garg</surname><given-names>P. K.</given-names></name>; <name name-style="western"><surname>Lokitz</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Nazih</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Garg</surname><given-names>S.</given-names></name><article-title>Biodistribution
and Radiation Dosimetry of <sup>11</sup>C-Nicotine From Whole-Body
PET Imaging in Humans</article-title>. <source>J. Nucl. Med.</source><year>2017</year>, <volume>58</volume>, <fpage>473</fpage>&#8211;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.116.180059</pub-id>.<pub-id pub-id-type="pmid">27660145</pub-id></mixed-citation></ref><ref id="ref132"><mixed-citation publication-type="journal" id="cit132"><name name-style="western"><surname>Rose</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Mukhin</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Lokitz</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Turkington</surname><given-names>T. G.</given-names></name>; <name name-style="western"><surname>Herskovic</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Behm</surname><given-names>F. M.</given-names></name>; <name name-style="western"><surname>Garg</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Garg</surname><given-names>P. K.</given-names></name><article-title>Kinetics
of Brain Nicotine Accumulation in Dependent and Nondependent Smokers
Assessed With PET and Cigarettes Containing <sup>11</sup>C-Nicotine</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2010</year>, <volume>107</volume>, <fpage>5190</fpage>&#8211;<lpage>5195</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909184107</pub-id>.<pub-id pub-id-type="pmid">20212132</pub-id><pub-id pub-id-type="pmcid">PMC2841893</pub-id></mixed-citation></ref><ref id="ref133"><mixed-citation publication-type="journal" id="cit133"><name name-style="western"><surname>Wall</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Roslin</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Borg</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>McDermott</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Walele</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Nahde</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>O&#8217;connell</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Thompson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lubberink</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name><article-title>E-Cigarette Aerosol
Deposition and Disposition of [<sup>11</sup>C]Nicotine Using Positron
Emission Tomography: A Comparison of Nicotine Uptake in Lungs and
Brain Using Two Different Nicotine Formulations</article-title>. <source>Pharmaceuticals</source><year>2022</year>, <volume>15</volume>, <fpage>367</fpage><pub-id pub-id-type="doi">10.3390/ph15030367</pub-id>.<pub-id pub-id-type="pmid">35337164</pub-id><pub-id pub-id-type="pmcid">PMC8950566</pub-id></mixed-citation></ref><ref id="ref134"><mixed-citation publication-type="journal" id="cit134"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Schueller</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name><article-title>A Mild, Rapid Synthesis
of Freebase [<sup>11</sup>C]Nicotine
From [<sup>11</sup>C]Methyl Triflate</article-title>. <source>Appl.
Radiat. Isot.</source><year>2016</year>, <volume>118</volume>, <fpage>62</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2016.08.020</pub-id>.<pub-id pub-id-type="pmid">27611082</pub-id></mixed-citation></ref><ref id="ref135"><mixed-citation publication-type="journal" id="cit135"><name name-style="western"><surname>Ghosh</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Woolum</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Knopp</surname><given-names>M. V.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>K.</given-names></name><article-title>Development
and Optimization of a Novel Automated Loop Method for Production of
[<sup>11</sup>C]Nicotine</article-title>. <source>Appl. Radiat. Isot.</source><year>2018</year>, <volume>140</volume>, <fpage>76</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2018.05.030</pub-id>.<pub-id pub-id-type="pmid">29957537</pub-id><pub-id pub-id-type="pmcid">PMC6119483</pub-id></mixed-citation></ref><ref id="ref136"><mixed-citation publication-type="journal" id="cit136"><name name-style="western"><surname>Gustafsson</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Syv&#228;nen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Hammarlund-Udenaes</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name><article-title>Combined PET and Microdialysis
for <italic toggle="yes">In Vivo</italic> Estimation of Drug Blood-Brain Barrier
Transport and Brain Unbound Concentrations</article-title>. <source>NeuroImage</source><year>2017</year>, <volume>155</volume>, <fpage>177</fpage>&#8211;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.04.068</pub-id>.<pub-id pub-id-type="pmid">28467891</pub-id></mixed-citation></ref><ref id="ref137"><mixed-citation publication-type="journal" id="cit137"><name name-style="western"><surname>Tu</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Mach</surname><given-names>R. H.</given-names></name><article-title>Carbon-11
Labeled Papaverine as a PET Tracer for Imaging PDE10A: Radiosynthesis, <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">In Vivo</italic> Evaluation</article-title>. <source>Nucl. Med. Biol.</source><year>2010</year>, <volume>37</volume>, <fpage>509</fpage>&#8211;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2009.12.012</pub-id>.<pub-id pub-id-type="pmid">20447563</pub-id><pub-id pub-id-type="pmcid">PMC2866165</pub-id></mixed-citation></ref><ref id="ref138"><mixed-citation publication-type="journal" id="cit138"><name name-style="western"><surname>Planas</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Hinnen</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Jobert</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>N&#233;</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>DiGiamberardino</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Tavitian</surname><given-names>B.</given-names></name><article-title>Rat Brain Acetylcholinesterase
Visualized With [<sup>11</sup>C]Physostigmine</article-title>. <source>NeuroImage</source><year>1994</year>, <volume>1</volume>, <fpage>173</fpage>&#8211;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.1994.1002</pub-id>.<pub-id pub-id-type="pmid">9343568</pub-id></mixed-citation></ref><ref id="ref139"><mixed-citation publication-type="journal" id="cit139"><name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Tavitian</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Pappata</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Jobert</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Doignon</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Di Giamberardino</surname><given-names>L.</given-names></name><article-title>Quantitative
measurement of cerebral acetylcholinesterase using [<sup>11</sup>C]physostigmine
and positron emission tomography</article-title>. <source>J. Cereb.
Blood Flow Metab.</source><year>2001</year>, <volume>21</volume>, <fpage>114</fpage>&#8211;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-200102000-00003</pub-id>.<pub-id pub-id-type="pmid">11176277</pub-id></mixed-citation></ref><ref id="ref140"><mixed-citation publication-type="journal" id="cit140"><name name-style="western"><surname>Pappata</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Tavitian</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Traykov</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Jobert</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dalger</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mangin</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Di Giamberardino</surname><given-names>L.</given-names></name><article-title><italic toggle="yes">In
Vivo</italic> Imaging of Human Cerebral Acetylcholinesterase</article-title>. <source>J. Neurochem.</source><year>1996</year>, <volume>67</volume>, <fpage>876</fpage>&#8211;<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.67020876.x</pub-id>.<pub-id pub-id-type="pmid">8764619</pub-id></mixed-citation></ref><ref id="ref141"><mixed-citation publication-type="journal" id="cit141"><name name-style="western"><surname>Tavitian</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Pappata</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Planas</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Jobert</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bonnot-Lours</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>DiGiamberardino</surname><given-names>L.</given-names></name><article-title><italic toggle="yes">In
Vivo</italic> Visualization of Acetylcholinesterase With Positron
Emission Tomography</article-title>. <source>Neuroreport.</source><year>1993</year>, <volume>4</volume>, <fpage>535</fpage>&#8211;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199305000-00018</pub-id>.<pub-id pub-id-type="pmid">8513134</pub-id></mixed-citation></ref><ref id="ref142"><mixed-citation publication-type="journal" id="cit142"><name name-style="western"><surname>Bonnot-Lours</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Prenant</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Hinnen</surname><given-names>F.</given-names></name><article-title>Carbon-11
Labelling of an Inhibitor of Acetylcholinesterase: [<sup>11</sup>C]Physostigmine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1993</year>, <volume>33</volume>, <fpage>277</fpage>&#8211;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580330405</pub-id>.</mixed-citation></ref><ref id="ref143"><mixed-citation publication-type="journal" id="cit143"><name name-style="western"><surname>Bonnot Lours</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Prenant</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>Synthesis
of [<sup>11</sup>C]Methyl Isocyanate. Application to the Labelling
of a Potent
Acetylcholinesterase Inhibitor: [11C]Physostigmine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1993</year>, <volume>32</volume>, <fpage>152</fpage>&#8211;<lpage>153</lpage>.</mixed-citation></ref><ref id="ref144"><mixed-citation publication-type="journal" id="cit144"><name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Hinnen</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Maitre</surname><given-names>E.</given-names></name><article-title>Radiosynthesis of Methyl
and Heptyl [<sup>11</sup>C]Isocyanates From [<sup>11</sup>C]Phosgene,
Application to the Synthesis of Carbamates: [<sup>11</sup>C]Physostygmine
and [<sup>11</sup>C]Heptylphysostigmine</article-title>. <source>Appl.
Radiat. Isot.</source><year>1995</year>, <volume>46</volume>, <fpage>167</fpage>&#8211;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)00126-K</pub-id>.</mixed-citation></ref><ref id="ref145"><mixed-citation publication-type="journal" id="cit145"><name name-style="western"><surname>Ametamey</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Vollenweider</surname><given-names>F. X.</given-names></name>; <name name-style="western"><surname>Patt</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bourquin</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Hasler</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Beer</surname><given-names>H. F.</given-names></name>; <name name-style="western"><surname>Schubiger</surname><given-names>P. A.</given-names></name><article-title><sup>11</sup>C-Radiolabeling of Hallucinogenic
Psilocin, a Potential Radioligand
for Studying the Role of Serotonin Receptors in Psychotic Symptom
Formation</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1998</year>, <volume>41</volume>, <fpage>585</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1344(199807)41:7&amp;#x0003c;585::AID-JLCR115&amp;#x0003e;3.0.CO;2-U</pub-id>.</mixed-citation></ref><ref id="ref146"><mixed-citation publication-type="journal" id="cit146"><name name-style="western"><surname>Syv&#228;nen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Russmann</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Verbeek</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Labots</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Zellinger</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Seeger</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Schuit</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Rongen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>van Kooij</surname><given-names>R.</given-names></name>; et al. <article-title>[<sup>11</sup>C]Quinidine
and [<sup>11</sup>C]Laniquidar PET Imaging in a Chronic Rodent Epilepsy
Model: Impact of Epilepsy and Drug-Responsiveness</article-title>. <source>Nucl. Med. Biol.</source><year>2013</year>, <volume>40</volume>, <fpage>764</fpage>&#8211;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2013.05.008</pub-id>.<pub-id pub-id-type="pmid">23827307</pub-id></mixed-citation></ref><ref id="ref147"><mixed-citation publication-type="journal" id="cit147"><name name-style="western"><surname>Van Haver</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Vandewalle</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Slegers</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Vandecasteele</surname><given-names>C.</given-names></name><article-title>Production
of <sup>11</sup>C-Labeled Quinidine and Tamoxifen</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1985</year>, <volume>22</volume>, <fpage>535</fpage>&#8211;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580220603</pub-id>.</mixed-citation></ref><ref id="ref148"><mixed-citation publication-type="journal" id="cit148"><name name-style="western"><surname>Vora</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Boothe</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Liskwosky</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Potter</surname><given-names>L. T.</given-names></name><article-title>[<italic toggle="yes">N</italic>-<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]-Scopolamine: Synthesis and Distribution in Rat Brain</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1983</year>, <volume>20</volume>, <fpage>1229</fpage>&#8211;<lpage>1236</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580201103</pub-id>.</mixed-citation></ref><ref id="ref149"><mixed-citation publication-type="journal" id="cit149"><name name-style="western"><surname>Mulholland</surname><given-names>G. K.</given-names></name>; <name name-style="western"><surname>Otto</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Jewett</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Koeppe</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Sherman</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Petry</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Carey</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Atkinson</surname><given-names>E. R.</given-names></name>; <name name-style="western"><surname>Archer</surname><given-names>S.</given-names></name>; et al. <article-title>Synthesis,
Rodent Biodistribution,
Dosimetry, Metabolism, and Monkey Images of Carbon-11-Labeled (+)-2&#945;-Tropanyl
Benzilate: A Central Muscarinic Receptor Imaging Agent</article-title>. <source>J. Nucl. Med.</source><year>1992</year>, <volume>33</volume>, <fpage>423</fpage>&#8211;<lpage>430</lpage>.<pub-id pub-id-type="pmid">1740713</pub-id></mixed-citation></ref><ref id="ref150"><mixed-citation publication-type="journal" id="cit150"><name name-style="western"><surname>Frey</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Koeppe</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Mulholland</surname><given-names>G. K.</given-names></name>; <name name-style="western"><surname>Jewett</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Hichwa</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ehrenkaufer</surname><given-names>R. L. E.</given-names></name>; <name name-style="western"><surname>Carey</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Kuhl</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Agranoff</surname><given-names>B. W.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Muscarinic Cholingeric Receptor
Imaging in Human
Brain With [<sup>11</sup>C]scopolamine and Positron Emission Tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1992</year>, <volume>12</volume>, <fpage>147</fpage>&#8211;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1992.18</pub-id>.<pub-id pub-id-type="pmid">1727135</pub-id></mixed-citation></ref><ref id="ref151"><mixed-citation publication-type="conf-proc" id="cit151"><person-group person-group-type="allauthors"><name name-style="western"><surname>Frey</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Koeppe</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Jewett</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Mulholland</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Hichwa</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kuhl</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Agranoff</surname><given-names>B.</given-names></name></person-group><article-title>The <italic toggle="yes">In
Vivo</italic> Distribution of [<sup>11</sup>C]scopolamine in Human
Brain Determined
by Positron Emission Tomography</article-title>. In <source>Society
of Neuroscience 17th Annual Meeting</source>, <year>1987</year>; Vol. <volume>13</volume>.</mixed-citation></ref><ref id="ref152"><mixed-citation publication-type="journal" id="cit152"><name name-style="western"><surname>Mulholland</surname><given-names>G. K.</given-names></name>; <name name-style="western"><surname>Jewett</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Toorongian</surname><given-names>S. A.</given-names></name><article-title>Routine
Synthesis of <italic toggle="yes">N</italic>-[<sup>11</sup>C-<italic toggle="yes">Methyl</italic>]Scopolamine by Phosphite Mediated Reductive Methylation with [<sup>11</sup>C]Formaldehyde</article-title>. <source>Int. J. Radiat. Appl.
Instrum. A. Appl. Radiat. Isot.</source><year>1988</year>, <volume>39</volume>, <fpage>373</fpage>&#8211;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(88)90065-2</pub-id>.<pub-id pub-id-type="pmid">2840412</pub-id></mixed-citation></ref><ref id="ref153"><mixed-citation publication-type="journal" id="cit153"><name name-style="western"><surname>Liger</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Cadarossanesaib</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Iecker</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tourvieille</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Le Bars</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Billard</surname><given-names>T.</given-names></name><article-title><sup>11</sup>C-Labeling: Intracyclic
Incorporation of Carbon-11 into Heterocycles</article-title>. <source>Eur. J. Org. Chem.</source><year>2019</year>, <volume>2019</volume>, <fpage>6968</fpage>&#8211;<lpage>6972</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201901386</pub-id>.</mixed-citation></ref><ref id="ref154"><mixed-citation publication-type="conf-proc" id="cit154"><person-group person-group-type="allauthors"><name name-style="western"><surname>Maziere</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Marazano</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name></person-group><source>Colloque De M&#233;decine Nucl&#233;aire
De Langue Fran&#231;aise (I)-58</source>; <publisher-name>Clermont-Ferrand</publisher-name>, <year>1974</year>.</mixed-citation></ref><ref id="ref155"><mixed-citation publication-type="journal" id="cit155"><name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Maziere</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Marazano</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Raynaud</surname><given-names>C.</given-names></name><article-title>Carbon 11
Labelled Psychoactive Drugs</article-title>. <source>J. Nucl. Med.</source><year>1975</year>, <volume>16</volume>, <fpage>521</fpage>.</mixed-citation></ref><ref id="ref156"><mixed-citation publication-type="journal" id="cit156"><name name-style="western"><surname>Saji</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name><article-title>The Preparation of <sup>11</sup>C-Methyl Iodide and Its Use in the Synthesis of <sup>11</sup>C-Caffeine</article-title>. <source>Kakuigaku</source><year>1978</year>, <volume>15</volume>, <fpage>406</fpage>&#8211;<lpage>407</lpage>.</mixed-citation></ref><ref id="ref157"><mixed-citation publication-type="journal" id="cit157"><name name-style="western"><surname>Denutte</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Vandewalle</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Cattoir</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Vandecasteele</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Jonckheere</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Slegers</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Gelijkens</surname><given-names>C. F.</given-names></name>; <name name-style="western"><surname>De Leenheer</surname><given-names>A. P.</given-names></name><article-title>The Preparation of <sup>11</sup>C-Labeled Caffeine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1982</year>, <volume>19</volume>, <fpage>735</fpage>&#8211;<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580190605</pub-id>.</mixed-citation></ref><ref id="ref158"><mixed-citation publication-type="journal" id="cit158"><name name-style="western"><surname>Mizugaki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hishinuma</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kimura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nakamura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Aso</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Nishikawa</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Itoh</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tomioka</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>S.</given-names></name>; et al. <article-title>The Distribution of [<sup>11</sup>C]Cocaine
in Normal and Cocaine-Sensitization Mice</article-title>. <source>Nucl.
Med. Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>793</fpage>&#8211;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90158-9</pub-id>.<pub-id pub-id-type="pmid">9234328</pub-id></mixed-citation></ref><ref id="ref159"><mixed-citation publication-type="journal" id="cit159"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>Y.-S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Martin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>King</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Pappas</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; et al. <article-title>PET Studies of Cocaine
Inhibition of Myocardial Norepinephrine Uptake</article-title>. <source>Synapse</source><year>1994</year>, <volume>16</volume>, <fpage>312</fpage>&#8211;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890160407</pub-id>.<pub-id pub-id-type="pmid">8059340</pub-id></mixed-citation></ref><ref id="ref160"><mixed-citation publication-type="journal" id="cit160"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Dewey</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>HItzemann</surname><given-names>R.</given-names></name><article-title>Distribution
and Kinetics of Carbon-11-Cocaine in the
Human Body Measured With PET</article-title>. <source>J. Nucl. Med.</source><year>1992</year>, <volume>33</volume>, <fpage>521</fpage>&#8211;<lpage>525</lpage>.<pub-id pub-id-type="pmid">1552335</pub-id></mixed-citation></ref><ref id="ref161"><mixed-citation publication-type="journal" id="cit161"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Alcohol Inoxication
Does Not Change
[<sup>11</sup>C]cocaine Pharmacokinetics in Human Brain and Heart</article-title>. <source>Synapse</source><year>1992</year>, <volume>12</volume>, <fpage>228</fpage>&#8211;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890120308</pub-id>.<pub-id pub-id-type="pmid">1481142</pub-id></mixed-citation></ref><ref id="ref162"><mixed-citation publication-type="journal" id="cit162"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Hitzemann</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Cocaine Uptake Is Decreased in the Brain of Detoxified
Cocaine Abusers</article-title>. <source>Neuropsychopharmacol.</source><year>1996</year>, <volume>14</volume>, <fpage>159</fpage>&#8211;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/0893-133X(95)00073-M</pub-id>.<pub-id pub-id-type="pmid">8866699</pub-id></mixed-citation></ref><ref id="ref163"><mixed-citation publication-type="journal" id="cit163"><name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Fischman</surname><given-names>M. W.</given-names></name>; <name name-style="western"><surname>Foltin</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Abumrad</surname><given-names>N. N.</given-names></name>; <name name-style="western"><surname>Vitkun</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Pappas</surname><given-names>N.</given-names></name>; et al. <article-title>Concentration
and Occupancy
of Dopamine Transporters in Cocaine Abusers With [<sup>11</sup>C]Cocaine
and PET</article-title>. <source>Synapse</source><year>1997</year>, <volume>27</volume>, <fpage>347</fpage>&#8211;<lpage>356</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-2396(199712)27:4&amp;#x0003c;347::AID-SYN8&amp;#x0003e;3.0.CO;2-C</pub-id>.<pub-id pub-id-type="pmid">9372557</pub-id></mixed-citation></ref><ref id="ref164"><mixed-citation publication-type="journal" id="cit164"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Pappas</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>King</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>Y.-S.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name><article-title>Measuring
Dopamine Transporter Occupancy by Cocaine <italic toggle="yes">In Vivo</italic>: Radiotracer Considerations</article-title>. <source>Synapse</source><year>1998</year>, <volume>28</volume>, <fpage>111</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-2396(199802)28:2&amp;#x0003c;111::AID-SYN1&amp;#x0003e;3.0.CO;2-E</pub-id>.<pub-id pub-id-type="pmid">9450511</pub-id></mixed-citation></ref><ref id="ref165"><mixed-citation publication-type="journal" id="cit165"><name name-style="western"><surname>Telang</surname><given-names>F. W.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Levy</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Felder</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name><article-title>Distribution
of Tracer Levels of Cocaine in the Human Brain As Assessed With Averaged
[<sup>11</sup>C]cocaine images</article-title>. <source>Synapse</source><year>1999</year>, <volume>31</volume>, <fpage>290</fpage>&#8211;<lpage>296</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-2396(19990315)31:4&amp;#x0003c;290::AID-SYN7&amp;#x0003e;3.0.CO;2-G</pub-id>.<pub-id pub-id-type="pmid">10051110</pub-id></mixed-citation></ref><ref id="ref166"><mixed-citation publication-type="journal" id="cit166"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Fischman</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Foltin</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Abumrad</surname><given-names>N. N.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gifford</surname><given-names>A.</given-names></name>; et al. <article-title>Methylphenidate
and
Cocaine Have a Similar <italic toggle="yes">In Vivo</italic> Potency To Block Dopamine
Transporters in the Human Brain</article-title>. <source>Life Sci.</source><year>1999</year>, <volume>65</volume>, <fpage>PL7</fpage>&#8211;<lpage>PL12</lpage>. <pub-id pub-id-type="doi">10.1016/S0024-3205(99)00225-8</pub-id>.<pub-id pub-id-type="pmid">10403500</pub-id></mixed-citation></ref><ref id="ref167"><mixed-citation publication-type="journal" id="cit167"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Fischman</surname><given-names>M. W.</given-names></name>; <name name-style="western"><surname>Foltin</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Franceschi</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Franceschi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>C.</given-names></name>; et al. <article-title>Effects
of Route of Administration on Cocaine Induced Dopamine Transporter
Blockade in the Human Brain</article-title>. <source>Life Sci.</source><year>2000</year>, <volume>67</volume>, <fpage>1507</fpage>&#8211;<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1016/S0024-3205(00)00731-1</pub-id>.<pub-id pub-id-type="pmid">10983846</pub-id></mixed-citation></ref><ref id="ref168"><mixed-citation publication-type="journal" id="cit168"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Telang</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Jayne</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hooker</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>C.</given-names></name>; et al. <article-title>Effects
of Modafinil on Dopamine and Dopamine Transporters
in the Male Human Brain: Clinical Implications</article-title>. <source>JAMA</source><year>2009</year>, <volume>301</volume>, <fpage>1148</fpage>&#8211;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2009.351</pub-id>.<pub-id pub-id-type="pmid">19293415</pub-id><pub-id pub-id-type="pmcid">PMC2696807</pub-id></mixed-citation></ref><ref id="ref169"><mixed-citation publication-type="journal" id="cit169"><name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Kollins</surname><given-names>S. H.</given-names></name>; <name name-style="western"><surname>Wigal</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Newcorn</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Telang</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name>; et al. <article-title>Evaluating Dopamine
Reward Pathway in ADHD: Clinical Implications</article-title>. <source>JAMA</source><year>2009</year>, <volume>302</volume>, <fpage>1084</fpage>&#8211;<lpage>1091</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2009.1308</pub-id>.<pub-id pub-id-type="pmid">19738093</pub-id><pub-id pub-id-type="pmcid">PMC2958516</pub-id></mixed-citation></ref><ref id="ref170"><mixed-citation publication-type="journal" id="cit170"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name><article-title>[<sup>11</sup>C]Cocaine: PET Studies of Cocaine Pharmacokinetics,
Dopamine Transporter Availability and Dopamine Transporter Occupancy</article-title>. <source>Nucl. Med. Biol.</source><year>2001</year>, <volume>28</volume>, <fpage>561</fpage>&#8211;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(01)00211-6</pub-id>.<pub-id pub-id-type="pmid">11516700</pub-id></mixed-citation></ref><ref id="ref171"><mixed-citation publication-type="journal" id="cit171"><person-group person-group-type="allauthors"><name name-style="western"><surname>Inoue</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Tominaga</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Fukuda</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamasaki</surname><given-names>T.</given-names></name></person-group><article-title>Development
of
Positron Tracer for <italic toggle="yes">In Vivo</italic> Estimation of Brain MAO-B
Activity. Theoretical Consideration of Metabolic-Trapping Tracers
and Evaluation of <sup>11</sup>C-<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic> Dimethylphenylethylamine</article-title>. <source>Kakuigaku</source><year>1984</year><volume>21</volume> (<issue>6</issue>), <fpage>671</fpage><lpage>678</lpage>.<pub-id pub-id-type="pmid">6492473</pub-id></mixed-citation></ref><ref id="ref172"><mixed-citation publication-type="journal" id="cit172"><name name-style="western"><surname>Ginovart</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Boovariwala</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hussey</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Rabiner</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Houle</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name><article-title>Positron
Emission Tomography Quantification of [11C]-Harmine Binding to Monoamine
Oxidase-A in the Human Brain</article-title>. <source>J. Cereb. Blood
Flow Metab.</source><year>2006</year>, <volume>26</volume>, <fpage>330</fpage>&#8211;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600197</pub-id>.<pub-id pub-id-type="pmid">16079787</pub-id></mixed-citation></ref><ref id="ref173"><mixed-citation publication-type="journal" id="cit173"><name name-style="western"><surname>Kolla</surname><given-names>N. J.</given-names></name>; <name name-style="western"><surname>Matthews</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Houle</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bagby</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Links</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Simpson</surname><given-names>A. I.</given-names></name>; <name name-style="western"><surname>Hussain</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>J. H.</given-names></name><article-title>Lower Monoamine
Oxidase-A Total Distribution Volume
in Impulsive and Violent Male Offenders with Antisocial Personality
Disorder and High Psychopathic Traits: An [<sup>11</sup>C] Harmine
Positron Emission Tomography Study</article-title>. <source>Neuropsychopharmacology</source><year>2015</year>, <volume>40</volume>, <fpage>2596</fpage>&#8211;<lpage>2603</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.106</pub-id>.<pub-id pub-id-type="pmid">26081301</pub-id><pub-id pub-id-type="pmcid">PMC4569949</pub-id></mixed-citation></ref><ref id="ref174"><mixed-citation publication-type="journal" id="cit174"><name name-style="western"><surname>Allen</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Beaumier</surname><given-names>P. L.</given-names></name><article-title>[<italic toggle="yes">N</italic>-<sup>11</sup>CH<sub>3</sub>]-morphine</article-title>. <source>J.
Labelled Compds.
Radiopharmaceuticals</source><year>1979</year>, <volume>16</volume>, <fpage>61</fpage>&#8211;<lpage>62</lpage>.</mixed-citation></ref><ref id="ref175"><mixed-citation publication-type="journal" id="cit175"><name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sv&#228;rd</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bergson</surname><given-names>G.</given-names></name><article-title>Synthesis of Some <sup>11</sup>C-Labelled
Alkaloids</article-title>. <source>Chem. Scr.</source><year>1982</year>, <volume>20</volume>, <fpage>46</fpage>&#8211;<lpage>48</lpage>.</mixed-citation></ref><ref id="ref176"><mixed-citation publication-type="journal" id="cit176"><name name-style="western"><surname>Berridge</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Apana</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Nagano</surname><given-names>K. K.</given-names></name>; <name name-style="western"><surname>Berridge</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Leisure</surname><given-names>G. P.</given-names></name>; <name name-style="western"><surname>Boswell</surname><given-names>M. V.</given-names></name><article-title>Smoking Produces Rapid Rise of [<sup>11</sup>C]Nicotine in Human Brain</article-title>. <source>Psychopharmacology</source><year>2010</year>, <volume>209</volume>, <fpage>383</fpage>&#8211;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-1809-8</pub-id>.<pub-id pub-id-type="pmid">20232056</pub-id></mixed-citation></ref><ref id="ref177"><mixed-citation publication-type="journal" id="cit177"><name name-style="western"><surname>Bonnot Lours</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Prenant</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>Synthesis
of [<sup>11</sup>C]methyl isocyanate. Application to the labelling
of a potent
acetylcholinesterase inhibitor: [<sup>11</sup>C]physostigmine</article-title>. <source>J. Labelled Comp. Radiopharm.</source><year>1993</year>, <volume>32</volume>, <fpage>152</fpage>&#8211;<lpage>153</lpage>.</mixed-citation></ref><ref id="ref178"><mixed-citation publication-type="book" id="cit178"><person-group person-group-type="allauthors"><name name-style="western"><surname>Litwack</surname><given-names>G.</given-names></name></person-group><article-title>Metabolism of
Amino Acids</article-title>. In <source>Human Biochemistry</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Litwack</surname><given-names>G.</given-names></name></person-group>, Ed.; <publisher-name>Academic Press</publisher-name>, <year>2018</year>; Chapter 13, pp <fpage>359</fpage>&#8211;<lpage>394</lpage>.</mixed-citation></ref><ref id="ref179"><mixed-citation publication-type="journal" id="cit179"><name name-style="western"><surname>Karmen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wroblewski</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ladue</surname><given-names>J. S.</given-names></name><article-title>Transaminase Activity
in Human Blood</article-title>. <source>J. Clin. Invest.</source><year>1955</year>, <volume>34</volume>, <fpage>126</fpage>&#8211;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1172/JCI103055</pub-id>.<pub-id pub-id-type="pmid">13221663</pub-id><pub-id pub-id-type="pmcid">PMC438594</pub-id></mixed-citation></ref><ref id="ref180"><mixed-citation publication-type="book" id="cit180"><person-group person-group-type="allauthors"><name name-style="western"><surname>Kohlmeier</surname><given-names>M.</given-names></name></person-group><article-title>Amino Acids and
Nitrogen Compounds</article-title>. In <source>Nutrient Metabolism</source>, <edition>2nd</edition> ed.; <person-group person-group-type="editor"><name name-style="western"><surname>Kohlmeier</surname><given-names>M.</given-names></name></person-group>, Ed.; <publisher-name>Academic Press</publisher-name>, <year>2015</year>; Chapter 8, pp <fpage>265</fpage>&#8211;<lpage>477</lpage>.</mixed-citation></ref><ref id="ref181"><mixed-citation publication-type="journal" id="cit181"><name name-style="western"><surname>Pant</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Cao</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><article-title>Asparagine
Is a Critical
Limiting Metabolite for Vaccinia Virus Protein Synthesis during Glutamine
Deprivation</article-title>. <source>J. Virol.</source><year>2019</year>, <volume>93</volume>, <fpage>e01834-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.01834-18</pub-id>.<pub-id pub-id-type="pmid">30996100</pub-id><pub-id pub-id-type="pmcid">PMC6580962</pub-id></mixed-citation></ref><ref id="ref182"><mixed-citation publication-type="book" id="cit182"><person-group person-group-type="allauthors"><name name-style="western"><surname>Underhill</surname><given-names>S.</given-names></name></person-group><article-title>Excitatory Amino
Acid Transporters in Neurons and Glia&#9734;</article-title>. In <source>Reference Module in Biomedical Sciences</source>; <publisher-name>Elsevier</publisher-name>, <year>2014</year>.</mixed-citation></ref><ref id="ref183"><mixed-citation publication-type="journal" id="cit183"><name name-style="western"><surname>Ereci&#324;ska</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Silver</surname><given-names>I. A.</given-names></name><article-title>Metabolism and Role of Glutamate
in Mammalian Brain</article-title>. <source>Prog. Neurobiol.</source><year>1990</year>, <volume>35</volume>, <fpage>245</fpage>&#8211;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(90)90013-7</pub-id>.<pub-id pub-id-type="pmid">1980745</pub-id></mixed-citation></ref><ref id="ref184"><mixed-citation publication-type="journal" id="cit184"><name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Seino</surname><given-names>S.</given-names></name><article-title>Glutamate
As Intracellular
and Extracellular Signals in Pancreatic Islet Functions</article-title>. <source>Proc. Jpn. Acad. B: Phys. Biol. Sci.</source><year>2019</year>, <volume>95</volume>, <fpage>246</fpage>&#8211;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.2183/pjab.95.017</pub-id>.<pub-id pub-id-type="pmcid">PMC6751295</pub-id><pub-id pub-id-type="pmid">31189778</pub-id></mixed-citation></ref><ref id="ref185"><mixed-citation publication-type="journal" id="cit185"><name name-style="western"><surname>Meldrum</surname><given-names>B. S.</given-names></name><article-title>Glutamate as a Neurotransmitter in
the Brain: Review
of Physiology and Pathology</article-title>. <source>J. Nutr.</source><year>2000</year>, <volume>130</volume>, <fpage>1007s</fpage>&#8211;<lpage>1015s</lpage>. <pub-id pub-id-type="doi">10.1093/jn/130.4.1007S</pub-id>.<pub-id pub-id-type="pmid">10736372</pub-id></mixed-citation></ref><ref id="ref186"><mixed-citation publication-type="journal" id="cit186"><name name-style="western"><surname>Cruzat</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Macedo Rogero</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Noel Keane</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Curi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Newsholme</surname><given-names>P.</given-names></name><article-title>Glutamine:
Metabolism and Immune
Function, Supplementation and Clinical Translation</article-title>. <source>Nutrients</source><year>2018</year>, <volume>10</volume>, <fpage>1564</fpage><pub-id pub-id-type="doi">10.3390/nu10111564</pub-id>.<pub-id pub-id-type="pmid">30360490</pub-id><pub-id pub-id-type="pmcid">PMC6266414</pub-id></mixed-citation></ref><ref id="ref187"><mixed-citation publication-type="journal" id="cit187"><name name-style="western"><surname>Wise</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Thompson</surname><given-names>C. B.</given-names></name><article-title>Glutamine Addiction:
A New Therapeutic
Target in Cancer</article-title>. <source>Trends Biochem. Sci.</source><year>2010</year>, <volume>35</volume>, <fpage>427</fpage>&#8211;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2010.05.003</pub-id>.<pub-id pub-id-type="pmid">20570523</pub-id><pub-id pub-id-type="pmcid">PMC2917518</pub-id></mixed-citation></ref><ref id="ref188"><mixed-citation publication-type="journal" id="cit188"><name name-style="western"><surname>Caspi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Billington</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Fulcher</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Keseler</surname><given-names>I. M.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Krummenacker</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Latendresse</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Midford</surname><given-names>P. E.</given-names></name>; <name name-style="western"><surname>Ong</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Ong</surname><given-names>W. K.</given-names></name>; et al. <article-title>The
MetaCyc Database of Metabolic Pathways and Enzymes</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>D633</fpage>&#8211;<lpage>D639</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx935</pub-id>.<pub-id pub-id-type="pmid">29059334</pub-id><pub-id pub-id-type="pmcid">PMC5753197</pub-id></mixed-citation></ref><ref id="ref189"><mixed-citation publication-type="journal" id="cit189"><name name-style="western"><surname>Harvey</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Yee</surname><given-names>B. K.</given-names></name><article-title>Glycine Transporters As Novel Therapeutic
Targets in Schizophrenia, Alcohol Dependence and Pain</article-title>. <source>Nat. Rev. Drug Discovery</source><year>2013</year>, <volume>12</volume>, <fpage>866</fpage>&#8211;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3893</pub-id>.<pub-id pub-id-type="pmid">24172334</pub-id></mixed-citation></ref><ref id="ref190"><mixed-citation publication-type="journal" id="cit190"><name name-style="western"><surname>Bolster</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Wynberg</surname><given-names>H.</given-names></name><article-title>Synthesis of Carbon-11 Labelled Glycine
and the Dipeptides
L-Phenylalanylglycine and L-Leucylglycine</article-title>. <source>Int.
J. Rad. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1986</year>, <volume>37</volume>, <fpage>985</fpage>&#8211;<lpage>987</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(86)90251-0</pub-id>.<pub-id pub-id-type="pmid">3021684</pub-id></mixed-citation></ref><ref id="ref191"><mixed-citation publication-type="journal" id="cit191"><name name-style="western"><surname>Johnstr&#246;m</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ericson</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Mosskin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name><article-title><sup>11</sup>C-Labelled Glycine: Synthesis and Preliminary
Report on Its Use in the Investigation of Intracranial Tumours Using
Positron Emission Tomography</article-title>. <source>Int. J. Radiat.
Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1987</year>, <volume>38</volume>, <fpage>729</fpage>&#8211;<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90254-1</pub-id>.<pub-id pub-id-type="pmid">2822628</pub-id></mixed-citation></ref><ref id="ref192"><mixed-citation publication-type="journal" id="cit192"><name name-style="western"><surname>Xing</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Brooks</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Fink</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Piert</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name><article-title>High-Yielding
Automated
Convergent Synthesis of No-Carrier-Added [<sup>11</sup>C-Carbonyl]-Labeled
Amino Acids Using the Strecker Reaction</article-title>. <source>Synlett</source><year>2017</year>, <volume>28</volume>, <fpage>371</fpage>&#8211;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1588638</pub-id>.<pub-id pub-id-type="pmid">29430080</pub-id><pub-id pub-id-type="pmcid">PMC5804752</pub-id></mixed-citation></ref><ref id="ref193"><mixed-citation publication-type="journal" id="cit193"><name name-style="western"><surname>Piert</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Raffel</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Davenport</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Montgomery</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kunju</surname><given-names>L. P.</given-names></name>; <name name-style="western"><surname>Hockley</surname><given-names>B. G.</given-names></name>; <name name-style="western"><surname>Siddiqui</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name>; <name name-style="western"><surname>Chinnaiyan</surname><given-names>A. M.</given-names></name>; et al. <article-title>Preclinical Evaluation
of <sup>11</sup>C-Sarcosine as a Substrate of Proton-Coupled Amino
Acid Transporters and First Human Application in Prostate Cancer</article-title>. <source>J. Nucl. Med.</source><year>2017</year>, <volume>58</volume>, <fpage>1216</fpage><pub-id pub-id-type="doi">10.2967/jnumed.116.173179</pub-id>.<pub-id pub-id-type="pmid">28302759</pub-id><pub-id pub-id-type="pmcid">PMC5537613</pub-id></mixed-citation></ref><ref id="ref194"><mixed-citation publication-type="journal" id="cit194"><name name-style="western"><surname>Sreekumar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Poisson</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Rajendiran</surname><given-names>T. M.</given-names></name>; <name name-style="western"><surname>Khan</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Cao</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Laxman</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Mehra</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Lonigro</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; et al. <article-title>Metabolomic
Profiles Delineate Potential Role for Sarcosine in Prostate Cancer
Progression</article-title>. <source>Nature</source><year>2009</year>, <volume>457</volume>, <fpage>910</fpage>&#8211;<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1038/nature07762</pub-id>.<pub-id pub-id-type="pmid">19212411</pub-id><pub-id pub-id-type="pmcid">PMC2724746</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="statement-of-misconduct" ext-link-type="pmc" xlink:href="PMC5019565"/></mixed-citation></ref><ref id="ref195"><mixed-citation publication-type="journal" id="cit195"><name name-style="western"><surname>Thwaites</surname><given-names>D. T.</given-names></name>; <name name-style="western"><surname>Anderson</surname><given-names>C. M.</given-names></name><article-title>The SLC36 Family
of Proton-Coupled
Amino Acid Transporters and Their Potential Role in Drug Transport</article-title>. <source>Br. J. Pharmacol.</source><year>2011</year>, <volume>164</volume>, <fpage>1802</fpage>&#8211;<lpage>1816</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01438.x</pub-id>.<pub-id pub-id-type="pmid">21501141</pub-id><pub-id pub-id-type="pmcid">PMC3246705</pub-id></mixed-citation></ref><ref id="ref196"><mixed-citation publication-type="journal" id="cit196"><name name-style="western"><surname>Stevens</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Verrill</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bryant</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>McKee</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Turley</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Fan</surname><given-names>S.-J.</given-names></name>; <name name-style="western"><surname>Perera</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Harris Adrian</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hamdy Freddie</surname><given-names>C.</given-names></name>; et al. <article-title>MP55-12 the Proton-Assisted
Amino Acid Transporter 4 (PAT4/SLC36A4) Is Up-Regulated in Prostate
Cancer</article-title>. <source>J. Urol.</source><year>2015</year>, <volume>193</volume>, <elocation-id>e677</elocation-id><pub-id pub-id-type="doi">10.1016/j.juro.2015.02.2055</pub-id>.</mixed-citation></ref><ref id="ref197"><mixed-citation publication-type="journal" id="cit197"><name name-style="western"><surname>Stryer</surname><given-names>L.</given-names></name><article-title>Glycolysis</article-title>. <source>Biochemistry</source><year>1987</year>, <fpage>349</fpage>&#8211;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-322-83526-0_20</pub-id>.</mixed-citation></ref><ref id="ref198"><mixed-citation publication-type="journal" id="cit198"><name name-style="western"><surname>Borkenhagen</surname><given-names>L. F.</given-names></name>; <name name-style="western"><surname>Kennedy</surname><given-names>E. P.</given-names></name><article-title>The Enzymatic Exchange
of <italic toggle="yes">L</italic>-Serine With <italic toggle="yes">O</italic>-Phospho-<italic toggle="yes">L</italic>-Serine Catalyzed by a Specific Phosphatase</article-title>. <source>J. Biol. Chem.</source><year>1959</year>, <volume>234</volume>, <fpage>849</fpage>&#8211;<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(18)70188-9</pub-id>.<pub-id pub-id-type="pmid">13654276</pub-id></mixed-citation></ref><ref id="ref199"><mixed-citation publication-type="journal" id="cit199"><name name-style="western"><surname>Mothet</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Parent</surname><given-names>A. T.</given-names></name>; <name name-style="western"><surname>Wolosker</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Brady</surname><given-names>R. O.</given-names><suffix>Jr.</suffix></name>; <name name-style="western"><surname>Linden</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Ferris</surname><given-names>C. D.</given-names></name>; <name name-style="western"><surname>Rogawski</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Snyder</surname><given-names>S. H.</given-names></name><article-title><italic toggle="yes">D</italic>-Serine Is an Endogenous Ligand for
the Glycine Site of the <italic toggle="yes">N-Methyl-D</italic>-Aspartate Receptor</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2000</year>, <volume>97</volume>, <fpage>4926</fpage>&#8211;<lpage>4931</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.9.4926</pub-id>.<pub-id pub-id-type="pmid">10781100</pub-id><pub-id pub-id-type="pmcid">PMC18334</pub-id></mixed-citation></ref><ref id="ref200"><mixed-citation publication-type="journal" id="cit200"><name name-style="western"><surname>Ma</surname><given-names>M.-C.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>H.-S.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.-S.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>S.-H.</given-names></name><article-title>Mechanosensitive
N-Methyl-d-Aspartate Receptors Contribute to Sensory Activation in
the Rat Renal Pelvis</article-title>. <source>Hypertension</source><year>2008</year>, <volume>52</volume>, <fpage>938</fpage>&#8211;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.114116</pub-id>.<pub-id pub-id-type="pmid">18809793</pub-id></mixed-citation></ref><ref id="ref201"><mixed-citation publication-type="journal" id="cit201"><name name-style="western"><surname>Popkov</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Itsenko</surname><given-names>O.</given-names></name><article-title>An Asymmetric Approach
to the Synthesis
of a Carbon-11 Labelled Gliotransmitter D-Serine</article-title>. <source>J. Radioanal. Nucl. Chem.</source><year>2015</year>, <volume>304</volume>, <fpage>455</fpage>&#8211;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-014-3670-4</pub-id>.</mixed-citation></ref><ref id="ref202"><mixed-citation publication-type="journal" id="cit202"><article-title><sc>l</sc>-Tyrosine. Monograph</article-title>. <source>Altern. Med.
Rev.</source><year>2007</year>, <volume>12</volume>, <fpage>364</fpage>&#8211;<lpage>368</lpage>.<pub-id pub-id-type="pmid">18069906</pub-id></mixed-citation></ref><ref id="ref203"><mixed-citation publication-type="journal" id="cit203"><name name-style="western"><surname>de Groot</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Hoeksma</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Reijngoud</surname><given-names>D.-J.</given-names></name>; <name name-style="western"><surname>de Valk</surname><given-names>H. W.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M. J.</given-names></name>; <name name-style="western"><surname>Sauer</surname><given-names>P. J. J.</given-names></name>; <name name-style="western"><surname>van
Spronsen</surname><given-names>F. J.</given-names></name><article-title>Phenylketonuria: Reduced Tyrosine Brain Influx Relates
to Reduced Cerebral Protein Synthesis</article-title>. <source>Orphanet.
J. Rare Dis.</source><year>2013</year>, <volume>8</volume>, <fpage>133</fpage><pub-id pub-id-type="doi">10.1186/1750-1172-8-133</pub-id>.<pub-id pub-id-type="pmid">24007597</pub-id><pub-id pub-id-type="pmcid">PMC3847152</pub-id></mixed-citation></ref><ref id="ref204"><mixed-citation publication-type="journal" id="cit204"><name name-style="western"><surname>Wilkinson</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Hossain</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hill</surname><given-names>D. S.</given-names></name>; <name name-style="western"><surname>Phillips</surname><given-names>B. E.</given-names></name>; <name name-style="western"><surname>Crossland</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Williams</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Loughna</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Churchward-Venne</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Breen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Phillips</surname><given-names>S. M.</given-names></name>; et al. <article-title>Effects
of Leucine and
Its Metabolite &#946;-Hydroxy-&#946;-Methylbutyrate on Human Skeletal
Muscle Protein Metabolism</article-title>. <source>J. Physiol.</source><year>2013</year>, <volume>591</volume>, <fpage>2911</fpage>&#8211;<lpage>2923</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2013.253203</pub-id>.<pub-id pub-id-type="pmid">23551944</pub-id><pub-id pub-id-type="pmcid">PMC3690694</pub-id></mixed-citation></ref><ref id="ref205"><mixed-citation publication-type="journal" id="cit205"><name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T. T.</given-names></name>; <name name-style="western"><surname>Byrd</surname><given-names>B. L.</given-names></name>; <name name-style="western"><surname>Callahan</surname><given-names>A. P.</given-names></name><article-title>Resolution
of [<sup>11</sup>C]<italic toggle="yes">DL</italic>-Leucine and [<sup>11</sup>C]<italic toggle="yes">DL</italic>-Tryptophan by High-Performance Liouid Chromatography</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1985</year>, <volume>22</volume>, <fpage>135</fpage>&#8211;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580220206</pub-id>.</mixed-citation></ref><ref id="ref206"><mixed-citation publication-type="journal" id="cit206"><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Kong</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>G.</given-names></name><article-title>Leucine Nutrition
in Animals and Humans: mTOR Signaling and Beyond</article-title>. <source>Amino Acids</source><year>2011</year>, <volume>41</volume>, <fpage>1185</fpage>&#8211;<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-011-0983-2</pub-id>.<pub-id pub-id-type="pmid">21773813</pub-id></mixed-citation></ref><ref id="ref207"><mixed-citation publication-type="journal" id="cit207"><name name-style="western"><surname>Nair</surname><given-names>K. S.</given-names></name>; <name name-style="western"><surname>Matthews</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Welle</surname><given-names>S. L.</given-names></name>; <name name-style="western"><surname>Braiman</surname><given-names>T.</given-names></name><article-title>Effect of
Leucine on Amino Acid and Glucose Metabolism in Humans</article-title>. <source>Metab. Clin. Exp.</source><year>1992</year>, <volume>41</volume>, <fpage>643</fpage>&#8211;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(92)90057-H</pub-id>.<pub-id pub-id-type="pmid">1640850</pub-id></mixed-citation></ref><ref id="ref208"><mixed-citation publication-type="journal" id="cit208"><name name-style="western"><surname>Nie</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name><article-title>Branched Chain
Amino Acids: Beyond Nutrition Metabolism</article-title>. <source>Int.
J. Mol. Sci.</source><year>2018</year>, <volume>19</volume>, <fpage>954</fpage><pub-id pub-id-type="doi">10.3390/ijms19040954</pub-id>.<pub-id pub-id-type="pmid">29570613</pub-id><pub-id pub-id-type="pmcid">PMC5979320</pub-id></mixed-citation></ref><ref id="ref209"><mixed-citation publication-type="journal" id="cit209"><name name-style="western"><surname>Papes</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Kemper</surname><given-names>E. L.</given-names></name>; <name name-style="western"><surname>Cord-Neto</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Langone</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Arruda</surname><given-names>P.</given-names></name><article-title>Lysine Degradation Through the Saccharopine
Pathway in Mammals: Involvement of Both Bifunctional and Monofunctional
Lysine-Degrading Enzymes in Mouse</article-title>. <source>Biochem J.</source><year>1999</year>, <volume>344</volume>, <fpage>555</fpage>&#8211;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1042/bj3440555</pub-id>.<pub-id pub-id-type="pmid">10567240</pub-id><pub-id pub-id-type="pmcid">PMC1220675</pub-id></mixed-citation></ref><ref id="ref210"><mixed-citation publication-type="journal" id="cit210"><name name-style="western"><surname>Harris</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Davis</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Snyder</surname><given-names>S. E.</given-names></name>; <name name-style="western"><surname>Butch</surname><given-names>E. R.</given-names></name>; <name name-style="western"><surname>Vavere</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Kocak</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shulkin</surname><given-names>B. L.</given-names></name><article-title>Evaluation
of the
Biodistribution of <sup>11</sup>C-Methionine in Children and Young
Adults</article-title>. <source>J. Nucl. Med.</source><year>2013</year>, <volume>54</volume>, <fpage>1902</fpage>&#8211;<lpage>1908</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.112.118125</pub-id>.<pub-id pub-id-type="pmid">24050936</pub-id><pub-id pub-id-type="pmcid">PMC3924715</pub-id></mixed-citation></ref><ref id="ref211"><mixed-citation publication-type="journal" id="cit211"><name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lemaire</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>G. J.</given-names></name><article-title>Amino Acids
for the Measurement of Protein Synthesis In Vivo by PET</article-title>. <source>Int. J. Rad. Appl. Instrum. B. Nucl. Med. Biol.</source><year>1992</year>, <volume>19</volume>, <fpage>227</fpage>&#8211;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2897(92)90011-M</pub-id>.<pub-id pub-id-type="pmid">1601675</pub-id></mixed-citation></ref><ref id="ref212"><mixed-citation publication-type="journal" id="cit212"><person-group person-group-type="allauthors"><name name-style="western"><surname>Barrio</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Keen</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ackerman</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M.</given-names></name></person-group><article-title><sc>l</sc>-[1-C-11]Phenylalanine
for the Determination of Cerebral Protein-Synthesis Rates in Man With
Positron Emission Tomography</article-title>. In <source>J. Nucl.
Med.</source>, <year>1983</year>, <volume>24</volume>, <fpage>P70</fpage>&#8211;<lpage>P70</lpage>.</mixed-citation></ref><ref id="ref213"><mixed-citation publication-type="journal" id="cit213"><name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Beerling-van der Molen</surname><given-names>H. D.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name><article-title>Evaluation
of Carbon-11 Labelled Phenylglycine and Phenylalanine for Pancreas
Scintigraphy</article-title>. <source>Nucl. Med. (Stuttg)</source><year>1975</year>, <volume>14</volume>, <fpage>60</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1055/s-0038-1624886</pub-id>.<pub-id pub-id-type="pmid">1144056</pub-id></mixed-citation></ref><ref id="ref214"><mixed-citation publication-type="journal" id="cit214"><name name-style="western"><surname>Kubota</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamada</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Fukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Endo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Fujiwara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ito</surname><given-names>K.</given-names></name>; et al. <article-title>Tumor
Detection With Carbon-11-Labelled Amino Acids</article-title>. <source>Eur. J. Nucl. Med.</source><year>1984</year>, <volume>9</volume>, <fpage>136</fpage>&#8211;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1007/BF00253516</pub-id>.<pub-id pub-id-type="pmid">6609075</pub-id></mixed-citation></ref><ref id="ref215"><mixed-citation publication-type="journal" id="cit215"><name name-style="western"><surname>Casey</surname><given-names>D. L.</given-names></name>; <name name-style="western"><surname>Digenis</surname><given-names>G. A.</given-names></name>; <name name-style="western"><surname>Wesner</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Chaney</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Hayes</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Callahan</surname><given-names>A. P.</given-names></name><article-title>Preparation and
Preliminary Tissue Studies of Optically Active <sup>11</sup>C-<italic toggle="yes">D</italic>- and <italic toggle="yes">L</italic>-Phenylalanine</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1981</year>, <volume>32</volume>, <fpage>325</fpage>&#8211;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(81)90093-4</pub-id>.<pub-id pub-id-type="pmid">7251209</pub-id></mixed-citation></ref><ref id="ref216"><mixed-citation publication-type="journal" id="cit216"><name name-style="western"><surname>O&#8217;Tuama</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Guilarte</surname><given-names>T. R.</given-names></name>; <name name-style="western"><surname>Douglass</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Wagner</surname><given-names>H. N.</given-names><suffix>Jr.</suffix></name>; <name name-style="western"><surname>Wong</surname><given-names>D. F.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>Ravert</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>LaFrance</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Bice</surname><given-names>A. N.</given-names></name>; et al. <article-title>Assessment
of [<sup>11</sup>C]-<italic toggle="yes">L</italic>-Methionine Transport Into the
Human Brain</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1988</year>, <volume>8</volume>, <fpage>341</fpage>&#8211;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1988.69</pub-id>.<pub-id pub-id-type="pmid">3259240</pub-id></mixed-citation></ref><ref id="ref217"><mixed-citation publication-type="journal" id="cit217"><name name-style="western"><surname>Peko&#353;ak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Filp</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>&#352;krinjar</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Poot</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name><article-title>A Rapid and Highly Enantioselective
C-<sup>11</sup>C Bond Formation of <italic toggle="yes">L</italic>-[<sup>11</sup>C]Phenylalanine <italic toggle="yes">via</italic> Chiral Phase-Transfer Catalysis</article-title>. <source>Org. Biomol. Chem.</source><year>2017</year>, <volume>15</volume>, <fpage>570</fpage>&#8211;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1039/C6OB02633H</pub-id>.<pub-id pub-id-type="pmid">27991625</pub-id></mixed-citation></ref><ref id="ref218"><mixed-citation publication-type="journal" id="cit218"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Andersson</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Brain Kinetics of <sup>11</sup>C-Labelled <italic toggle="yes">L</italic>-Tryptophan and <italic toggle="yes">5-Hydroxy-L</italic>-Tryptophan in the Rhesus Monkey</article-title>. <source>J. Neural
Transm.</source><year>1992</year>, <volume>88</volume>, <fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/BF01245032</pub-id>.<pub-id pub-id-type="pmid">1575951</pub-id></mixed-citation></ref><ref id="ref219"><mixed-citation publication-type="journal" id="cit219"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tokushige</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Oda</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Syntheses
of &#946;-<sup>11</sup>C-Labelled <italic toggle="yes">L</italic>-Tryptophan and <italic toggle="yes">5</italic>-Hydroxy-<italic toggle="yes">L</italic>-Tryptophan Using a Multi-Enzymatic
Reaction Route</article-title>. <source>J. Chem. Soc., Perkin Trans.
1</source><year>1989</year>, <fpage>1331</fpage>&#8211;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1039/P19890001331</pub-id>.</mixed-citation></ref><ref id="ref220"><mixed-citation publication-type="journal" id="cit220"><name name-style="western"><surname>Neels</surname><given-names>O. C.</given-names></name>; <name name-style="western"><surname>Jager</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Koopmans</surname><given-names>K. P.</given-names></name>; <name name-style="western"><surname>Eriks</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. G. E.</given-names></name>; <name name-style="western"><surname>Kema</surname><given-names>I. P.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name><article-title>Development
of a
Reliable Remote-Controlled Synthesis of &#946;-[<sup>11</sup>C]-<italic toggle="yes">5</italic>-Hydroxy-<italic toggle="yes">L</italic>-Tryptophan on a Zymark Robotic
System</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2006</year>, <volume>49</volume>, <fpage>889</fpage>&#8211;<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1110</pub-id>.</mixed-citation></ref><ref id="ref221"><mixed-citation publication-type="journal" id="cit221"><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Schuit</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Halestrap</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Rutter</surname><given-names>G. A.</given-names></name><article-title>Expression and Distribution of Lactate/Monocarboxylate
Transporter Isoforms in Pancreatic Islets and the Exocrine Pancreas</article-title>. <source>Diabetes</source><year>2001</year>, <volume>50</volume>, <fpage>361</fpage>&#8211;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.50.2.361</pub-id>.<pub-id pub-id-type="pmid">11272148</pub-id></mixed-citation></ref><ref id="ref222"><mixed-citation publication-type="journal" id="cit222"><name name-style="western"><surname>Blenis</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Resh</surname><given-names>M. D.</given-names></name><article-title>Subcellular Localization Specified
by Protein Acylation and Phosphorylation</article-title>. <source>Curr.
Opin. Cell Biol.</source><year>1993</year>, <volume>5</volume>, <fpage>984</fpage>&#8211;<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/0955-0674(93)90081-Z</pub-id>.<pub-id pub-id-type="pmid">8129952</pub-id></mixed-citation></ref><ref id="ref223"><mixed-citation publication-type="journal" id="cit223"><name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>I. M.</given-names></name>; <name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Cook</surname><given-names>N. R.</given-names></name>; <name name-style="western"><surname>Selhub</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Manson</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Buring</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>S. M.</given-names></name><article-title>Plasma
Homocysteine
and Cysteine and Risk of Breast Cancer in Women</article-title>. <source>Cancer Res.</source><year>2010</year>, <volume>70</volume>, <fpage>2397</fpage>&#8211;<lpage>2405</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3648</pub-id>.<pub-id pub-id-type="pmid">20197471</pub-id><pub-id pub-id-type="pmcid">PMC2840179</pub-id></mixed-citation></ref><ref id="ref224"><mixed-citation publication-type="journal" id="cit224"><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Palfrey</surname><given-names>H. A.</given-names></name>; <name name-style="western"><surname>Pathak</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kadowitz</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Gettys</surname><given-names>T. W.</given-names></name>; <name name-style="western"><surname>Murthy</surname><given-names>S. N.</given-names></name><article-title>The Metabolism and Significance of
Homocysteine in Nutrition and Health</article-title>. <source>Nutr.
Metab.</source><year>2017</year>, <volume>14</volume>, <fpage>78</fpage><pub-id pub-id-type="doi">10.1186/s12986-017-0233-z</pub-id>.<pub-id pub-id-type="pmcid">PMC5741875</pub-id><pub-id pub-id-type="pmid">29299040</pub-id></mixed-citation></ref><ref id="ref225"><mixed-citation publication-type="journal" id="cit225"><name name-style="western"><surname>Ueland</surname><given-names>P. M.</given-names></name><article-title>Pharmacological and Biochemical Aspects
of S-Adenosylhomocysteine
and <italic toggle="yes">S</italic>-Adenosylhomocysteine Hydrolase</article-title>. <source>Pharmacol. Rev.</source><year>1982</year>, <volume>34</volume>, <fpage>223</fpage>&#8211;<lpage>253</lpage>.<pub-id pub-id-type="pmid">6760211</pub-id></mixed-citation></ref><ref id="ref226"><mixed-citation publication-type="journal" id="cit226"><name name-style="western"><surname>Sors</surname><given-names>T. G.</given-names></name>; <name name-style="western"><surname>Ellis</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Na</surname><given-names>G. N.</given-names></name>; <name name-style="western"><surname>Lahner</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Leustek</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Pickering</surname><given-names>I. J.</given-names></name>; <name name-style="western"><surname>Salt</surname><given-names>D. E.</given-names></name><article-title>Analysis of Sulfur
and Selenium Assimilation in Astragalus Plants with Varying Capacities
to Accumulate Selenium</article-title>. <source>Plant J.</source><year>2005</year>, <volume>42</volume>, <fpage>785</fpage>&#8211;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2005.02413.x</pub-id>.<pub-id pub-id-type="pmid">15941393</pub-id></mixed-citation></ref><ref id="ref227"><mixed-citation publication-type="journal" id="cit227"><name name-style="western"><surname>Alvarez-Carre&#241;o</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Becerra</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lazcano</surname><given-names>A.</given-names></name><article-title>Norvaline
and Norleucine May Have Been More Abundant Protein Components during
Early Stages of Cell Evolution</article-title>. <source>Orig. Life Evol.
Biosph.</source><year>2013</year>, <volume>43</volume>, <fpage>363</fpage>&#8211;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1007/s11084-013-9344-3</pub-id>.<pub-id pub-id-type="pmid">24013929</pub-id></mixed-citation></ref><ref id="ref228"><mixed-citation publication-type="journal" id="cit228"><name name-style="western"><surname>Karppinen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kumpulainen</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>L&#228;hdesm&#228;ki</surname><given-names>P.</given-names></name><article-title>Synaptosomal
Accumulation of Intracerebral Injected Amino Acids</article-title>. <source>Acta Physiol. Scand.</source><year>1979</year>, <volume>105</volume>, <fpage>156</fpage>&#8211;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.1979.tb06327.x</pub-id>.<pub-id pub-id-type="pmid">420017</pub-id></mixed-citation></ref><ref id="ref229"><mixed-citation publication-type="journal" id="cit229"><name name-style="western"><surname>Moroder</surname><given-names>L.</given-names></name><article-title>Isosteric Replacement of Sulfur With
Other Chalcogens
in Peptides and Proteins</article-title>. <source>J. Pept. Sci.</source><year>2005</year>, <volume>11</volume>, <fpage>187</fpage>&#8211;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1002/psc.654</pub-id>.<pub-id pub-id-type="pmid">15782428</pub-id></mixed-citation></ref><ref id="ref230"><mixed-citation publication-type="journal" id="cit230"><name name-style="western"><surname>Clementi</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Misiti</surname><given-names>F.</given-names></name><article-title>Substitution of Methionine
35 Inhibits
Apoptotic Effects of Abeta(31-35) and Abeta(25-35) Fragments of Amyloid-Beta
Protein in PC12 Cells</article-title>. <source>Med. Sci. Monit.</source><year>2005</year>, <volume>11</volume>, <fpage>Br381</fpage>.<pub-id pub-id-type="pmid">16258386</pub-id></mixed-citation></ref><ref id="ref231"><mixed-citation publication-type="journal" id="cit231"><name name-style="western"><surname>Errington</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Aart</surname><given-names>L. T. v. d.</given-names></name><article-title>Microbe Profile: Bacillus subtilis:
Model Organism for Cellular Development, and Industrial Workhorse</article-title>. <source>Microbiology</source><year>2020</year>, <volume>166</volume>, <fpage>425</fpage>&#8211;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.000922</pub-id>.<pub-id pub-id-type="pmid">32391747</pub-id><pub-id pub-id-type="pmcid">PMC7376258</pub-id></mixed-citation></ref><ref id="ref232"><mixed-citation publication-type="journal" id="cit232"><name name-style="western"><surname>Evans</surname><given-names>I. M.</given-names></name>; <name name-style="western"><surname>Boulter</surname><given-names>D.</given-names></name><article-title><italic toggle="yes">S-Methyl-L</italic>-Cysteine
Content of Various Legume Meals</article-title>. <source>Qualitas Plantarum</source><year>1975</year>, <volume>24</volume>, <fpage>257</fpage>&#8211;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1007/BF01092214</pub-id>.</mixed-citation></ref><ref id="ref233"><mixed-citation publication-type="journal" id="cit233"><name name-style="western"><surname>Polis</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Srikanth</surname><given-names>K. D.</given-names></name>; <name name-style="western"><surname>Elliott</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Gil-Henn</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Samson</surname><given-names>A. O.</given-names></name><article-title>L-Norvaline Reverses Cognitive Decline
and Synaptic
Loss in a Murine Model of Alzheimer&#8217;s Disease</article-title>. <source>Neurotherapeutics</source><year>2018</year>, <volume>15</volume>, <fpage>1036</fpage>&#8211;<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-018-0669-5</pub-id>.<pub-id pub-id-type="pmid">30288668</pub-id><pub-id pub-id-type="pmcid">PMC6277292</pub-id></mixed-citation></ref><ref id="ref234"><mixed-citation publication-type="journal" id="cit234"><name name-style="western"><surname>Morizono</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Woolston</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Colombini</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tuchman</surname><given-names>M.</given-names></name><article-title>The Use of Yeast Mitochondria To Study the Properties
of Wild-Type and Mutant Human Mitochondrial Ornithine Transporter</article-title>. <source>Mol. Genet. Metab.</source><year>2005</year>, <volume>86</volume>, <fpage>431</fpage>&#8211;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2005.08.013</pub-id>.<pub-id pub-id-type="pmid">16256388</pub-id></mixed-citation></ref><ref id="ref235"><mixed-citation publication-type="journal" id="cit235"><name name-style="western"><surname>Gatfield</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Taller</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Wolfe</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Haust</surname><given-names>M. D.</given-names></name><article-title>Hyperornithinemia,
Hyperammonemia, and Homocitrullinuria Associated With Decreased Carbamyl
Phosphate Synthetase I Activity</article-title>. <source>Pediatr. Res.</source><year>1975</year>, <volume>9</volume>, <fpage>488</fpage>&#8211;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-197505000-00006</pub-id>.<pub-id pub-id-type="pmid">166348</pub-id></mixed-citation></ref><ref id="ref236"><mixed-citation publication-type="journal" id="cit236"><name name-style="western"><surname>Mast</surname><given-names>Y. J.</given-names></name>; <name name-style="western"><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Schinko</surname><given-names>E.</given-names></name><article-title>Identification and
Functional Characterization of Phenylglycine Biosynthetic Genes Involved
in Pristinamycin Biosynthesis in Streptomyces pristinaespiralis</article-title>. <source>J. Biotechnol.</source><year>2011</year>, <volume>155</volume>, <fpage>63</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2010.12.001</pub-id>.<pub-id pub-id-type="pmid">21146568</pub-id></mixed-citation></ref><ref id="ref237"><mixed-citation publication-type="journal" id="cit237"><name name-style="western"><surname>Blanc</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Gil</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bamas-Jacques</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Lorenzon</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zagorec</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Schleuniger</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bisch</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Blanche</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Debussche</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Crouzet</surname><given-names>J. l.</given-names></name>; et al. <article-title>Identification and Analysis of Genes From Streptomyces
pristinaespiralis Encoding Enzymes Involved in the Biosynthesis of
the 4-Dimethylamino-L-Phenylalanine Precursor of Pristinamycin I</article-title>. <source>Mol. Microbiol.</source><year>1997</year>, <volume>23</volume>, <fpage>191</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1997.2031574.x</pub-id>.<pub-id pub-id-type="pmid">9044253</pub-id></mixed-citation></ref><ref id="ref238"><mixed-citation publication-type="journal" id="cit238"><name name-style="western"><surname>Mast</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Weber</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>G&#246;lz</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ort-Winklbauer</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Gondran</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Schinko</surname><given-names>E.</given-names></name><article-title>Characterization of the &#8216;Pristinamycin Supercluster&#8217;
of Streptomyces pristinaespiralis</article-title>. <source>Microb. Biotechnol.</source><year>2011</year>, <volume>4</volume>, <fpage>192</fpage>&#8211;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00213.x</pub-id>.<pub-id pub-id-type="pmid">21342465</pub-id><pub-id pub-id-type="pmcid">PMC3818860</pub-id></mixed-citation></ref><ref id="ref239"><mixed-citation publication-type="journal" id="cit239"><name name-style="western"><surname>Pekosak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Filp</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Poot</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name><article-title>From Carbon-11-Labeled
Amino Acids to Peptides in Positron Emission Tomography: the Synthesis
and Clinical Application</article-title>. <source>Mol. Imaging Biol.</source><year>2018</year>, <volume>20</volume>, <fpage>510</fpage>&#8211;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-018-1163-</pub-id>.<pub-id pub-id-type="pmid">29411226</pub-id></mixed-citation></ref><ref id="ref240"><mixed-citation publication-type="journal" id="cit240"><name name-style="western"><surname>Harper</surname><given-names>P. V.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lathrop</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Wickland</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Moossa</surname><given-names>A.</given-names></name><article-title>On the mechanism of alanine localization
in the heart
and pancreas</article-title>. <source>J. Nucl. Med.</source><year>1980</year>, <volume>21</volume> (<issue>6</issue>), <fpage>P77</fpage>.</mixed-citation></ref><ref id="ref241"><mixed-citation publication-type="journal" id="cit241"><name name-style="western"><surname>Ropchan</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name><article-title>Enzymatic Synthesis of [1-<sup>11</sup>C]Pyruvic Acid, <sc>l</sc>-[1-<sup>11</sup>C]Lactic Acid and <sc>l</sc>-[1-<sup>11</sup>C]Alanine via <sc>dl</sc>-[1-<sup>11</sup>C]Alanine</article-title>. <source>J. Nucl. Med.</source><year>1984</year>, <volume>25</volume>, <fpage>887</fpage>&#8211;<lpage>892</lpage>.<pub-id pub-id-type="pmid">6611389</pub-id></mixed-citation></ref><ref id="ref242"><mixed-citation publication-type="journal" id="cit242"><name name-style="western"><surname>Filp</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Peko&#353;ak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Poot</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name><article-title>Enantioselective
Synthesis of Carbon-11 Labeled L-Alanine Using Phase Transfer Catalysis
of Schiff Bases</article-title>. <source>Tetrahedron</source><year>2016</year>, <volume>72</volume>, <fpage>6551</fpage>&#8211;<lpage>6557</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2016.08.069</pub-id>.</mixed-citation></ref><ref id="ref243"><mixed-citation publication-type="journal" id="cit243"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Cankaya</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Hoque</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kersting</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Schueller</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Szalda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; et al. <article-title>Synthesis
of <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Asparagine
by Ring-Opening Nucleophilic <sup>11</sup>C-Cyanation Reaction of
a Chiral Cyclic Sulfamidate Precursor</article-title>. <source>Chemistry</source><year>2018</year>, <volume>24</volume>, <fpage>6848</fpage>&#8211;<lpage>6853</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201801029</pub-id>.<pub-id pub-id-type="pmid">29504637</pub-id></mixed-citation></ref><ref id="ref244"><mixed-citation publication-type="journal" id="cit244"><name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Egbert</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Henze</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Schelbert</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Baumgartner</surname><given-names>F. J.</given-names></name><article-title><italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Aspartic Acid:
Enzymatic Synthesis, Myocardial Uptake, and Metabolism</article-title>. <source>J. Med. Chem.</source><year>1982</year>, <volume>25</volume>, <fpage>93</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1021/jm00343a020</pub-id>.<pub-id pub-id-type="pmid">7086829</pub-id></mixed-citation></ref><ref id="ref245"><mixed-citation publication-type="journal" id="cit245"><name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Orlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Omura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Uptake of <sup>14</sup>C- and <sup>11</sup>C-Labeled Glutamate, Glutamine and Aspartate <italic toggle="yes">in Vitro</italic> and <italic toggle="yes">in Vivo</italic></article-title>. <source>Anticancer Res.</source><year>2000</year>, <volume>20</volume>, <fpage>251</fpage>&#8211;<lpage>256</lpage>.<pub-id pub-id-type="pmid">10769663</pub-id></mixed-citation></ref><ref id="ref246"><mixed-citation publication-type="journal" id="cit246"><name name-style="western"><surname>Nakamura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Akisada</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shigematsu</surname><given-names>A.</given-names></name><article-title>Whole-Body
Distribution of <sup>11</sup>C-<italic toggle="yes">(4)-L</italic>-Aspartic Acid
in Rats</article-title>. <source>Radioisotopes</source><year>1984</year>, <volume>33</volume>, <fpage>363</fpage>&#8211;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.3769/radioisotopes.33.6_363</pub-id>.<pub-id pub-id-type="pmid">6494491</pub-id></mixed-citation></ref><ref id="ref247"><mixed-citation publication-type="journal" id="cit247"><name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of [1-<sup>11</sup>C], [2-<sup>11</sup>C], [1-<sup>11</sup>C](<sup>2</sup>H<sub>3</sub>) and [2-<sup>11</sup>C](<sup>2</sup>H<sub>3</sub>)Acetate for In Vivo Studies of Myocardium Using PET</article-title>. <source>Nucl. Med. Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>1067</fpage>&#8211;<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90178-3</pub-id>.<pub-id pub-id-type="pmid">9234364</pub-id></mixed-citation></ref><ref id="ref248"><mixed-citation publication-type="journal" id="cit248"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Omura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ikemoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Moulder</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Enzyme Catalysed Synthesis of <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Aspartate and <italic toggle="yes">L</italic>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]Glutamate</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>2001</year>, <volume>44</volume>, <fpage>287</fpage>&#8211;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.454</pub-id>.</mixed-citation></ref><ref id="ref249"><mixed-citation publication-type="journal" id="cit249"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Omura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ikemoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Moulder</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Enzyme catalysed synthesis of <italic toggle="yes">L</italic>-[4-<sup>11</sup>C] aspartate and <italic toggle="yes">L</italic>-[<italic toggle="yes">5</italic>-<sup>11</sup>C] glutamate</article-title>. <source>J. Labelled
Comp. Radiopharm.</source><year>2001</year>, <volume>44</volume>, <fpage>287</fpage>&#8211;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.454</pub-id>.</mixed-citation></ref><ref id="ref250"><mixed-citation publication-type="journal" id="cit250"><name name-style="western"><surname>Cohen</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Spolter</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chia</surname><given-names>C. C.</given-names></name>; <name name-style="western"><surname>Behrendt</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Cook</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name><article-title>The Varying Tissue Distribution of <italic toggle="yes">L</italic>-Glutamic Acid Labelled at Three Different Sites</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1982</year>, <volume>33</volume>, <fpage>613</fpage>&#8211;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90058-8</pub-id>.<pub-id pub-id-type="pmid">6126438</pub-id></mixed-citation></ref><ref id="ref251"><mixed-citation publication-type="journal" id="cit251"><name name-style="western"><surname>Filp</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Pees</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Taddei</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Peko&#353;ak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Poot</surname><given-names>A. J.</given-names></name><article-title>Efficient Synthesis
of <sup>11</sup>C-Acrylesters, <sup>11</sup>C-Acrylamides and Their
Application in Michael Addition Reactions for PET Tracer Development</article-title>. <source>Eur. J. Org. Chem.</source><year>2017</year>, <volume>2017</volume>, <fpage>5154</fpage>&#8211;<lpage>5162</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201700932</pub-id>.</mixed-citation></ref><ref id="ref252"><mixed-citation publication-type="journal" id="cit252"><name name-style="western"><surname>Qu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Oya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lieberman</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Ploessl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Wise</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Divgi</surname><given-names>C. R.</given-names></name>; <name name-style="western"><surname>Chodosh</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Thompson</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Kung</surname><given-names>H. F.</given-names></name><article-title>Preparation and Characterization of <italic toggle="yes">L</italic>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]-Glutamine for Metabolic Imaging
of Tumors</article-title>. <source>J. Nucl. Med.</source><year>2012</year>, <volume>53</volume>, <fpage>98</fpage>&#8211;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.111.093831</pub-id>.<pub-id pub-id-type="pmid">22173839</pub-id></mixed-citation></ref><ref id="ref253"><mixed-citation publication-type="journal" id="cit253"><name name-style="western"><surname>Renick</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Mulgaonkar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Co</surname><given-names>C. M.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>C.-Y.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Velazquez</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Pennington</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sherwood</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Castellino</surname><given-names>L.</given-names></name>; et al. <article-title>Imaging of Actively Proliferating Bacterial Infections by Targeting
the Bacterial Metabolic Footprint with <italic toggle="yes">d</italic>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]-Glutamine</article-title>. <source>ACS Infect.
Dis.</source><year>2021</year>, <volume>7</volume>, <fpage>347</fpage>&#8211;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00617</pub-id>.<pub-id pub-id-type="pmid">33476123</pub-id></mixed-citation></ref><ref id="ref254"><mixed-citation publication-type="journal" id="cit254"><name name-style="western"><surname>Cohen</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Grudzinski</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>G. T.</given-names></name>; <name name-style="western"><surname>Peterson</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Whisenant</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Hickman</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Ciombor</surname><given-names>K. K.</given-names></name>; <name name-style="western"><surname>Cardin</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Eng</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Goff</surname><given-names>L. W.</given-names></name><article-title>First-in-Human PET Imaging and Estimated Radiation
Dosimetry of <sc>l</sc>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]-Glutamine
in Patients With Metastatic Colorectal Cancer</article-title>. <source>J. Nucl. Med.</source><year>2022</year>, <volume>63</volume>, <fpage>36</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.120.261594</pub-id>.<pub-id pub-id-type="pmid">33931465</pub-id><pub-id pub-id-type="pmcid">PMC8717201</pub-id></mixed-citation></ref><ref id="ref255"><mixed-citation publication-type="journal" id="cit255"><name name-style="western"><surname>Gleede</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Riehl</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kersting</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Cankaya</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Schueller</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Qu</surname><given-names>W.</given-names></name><article-title>Investigation of SN<sub>2</sub> [<sup>11</sup>C]Cyanation for Base-Sensitive Substrates: An Improved Radiosynthesis
of <italic toggle="yes">l</italic>-[<italic toggle="yes">5</italic>-<sup>11</sup>C]-Glutamine</article-title>. <source>Amino Acids</source><year>2015</year>, <volume>47</volume>, <fpage>525</fpage>&#8211;<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-014-1883-z</pub-id>.<pub-id pub-id-type="pmid">25488428</pub-id></mixed-citation></ref><ref id="ref256"><mixed-citation publication-type="journal" id="cit256"><name name-style="western"><surname>Deussen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hamacher</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Henrich</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Borst</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Walter</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Herzog</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name>; <name name-style="western"><surname>Stocklin</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Feinendegen</surname><given-names>L. E.</given-names></name>; <name name-style="western"><surname>Schrader</surname><given-names>J.</given-names></name><article-title>Noninvasive Assessment of Free Cytosolic
Adenosine Using Positron Emission Tomography</article-title>. <source>PJliigers Arch. Eur. J. Physiol.</source><year>1988</year>, <volume>412</volume>, <fpage>R27</fpage>.<pub-id pub-id-type="pmid">1460505</pub-id></mixed-citation></ref><ref id="ref257"><mixed-citation publication-type="journal" id="cit257"><name name-style="western"><surname>Deussen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Henrich</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hamacher</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Borst</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Herzog</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name>; <name name-style="western"><surname>St&#246;cklin</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Feinendegen</surname><given-names>L. E.</given-names></name>; <name name-style="western"><surname>Schrader</surname><given-names>J.</given-names></name><article-title>Noninvasive Assessment of Regional
Cardiac Adenosine Using Positron Emission Tomography</article-title>. <source>J. Nucl. Med.</source><year>1992</year>, <volume>33</volume>, <fpage>2138</fpage>&#8211;<lpage>2144</lpage>.<pub-id pub-id-type="pmid">1460505</pub-id></mixed-citation></ref><ref id="ref258"><mixed-citation publication-type="journal" id="cit258"><name name-style="western"><surname>Hamacher</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hanu&#353;</surname><given-names>J.</given-names></name><article-title>Synthesis of 1-[<sup>11</sup>C]-<italic toggle="yes">D</italic>, <italic toggle="yes">L</italic>-Homocysteine Thiolactone: A Potential
Tracer for Myocardial Ischemia Using PET</article-title>. <source>J.
Label. Compd. Radiopharm.</source><year>1989</year>, <volume>27</volume>, <fpage>1275</fpage>&#8211;<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580271106</pub-id>.</mixed-citation></ref><ref id="ref259"><mixed-citation publication-type="journal" id="cit259"><name name-style="western"><surname>Sun</surname><given-names>Q. X.</given-names></name>; <name name-style="western"><surname>Ji</surname><given-names>Q. M.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y. C.</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>D. F.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>X. C.</given-names></name>; <name name-style="western"><surname>Ye</surname><given-names>Y. F.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Z. T.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hua</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>S. Y.</given-names></name>; et al. <article-title>Distribution of Pancreas
Imaging Agents With <sup>11</sup>C-Amino Acids in Mice</article-title>. <source>Acta Pharmacol. Sin.</source><year>1984</year>, <volume>5</volume>, <fpage>142</fpage>&#8211;<lpage>144</lpage>.<pub-id pub-id-type="pmid">6235714</pub-id></mixed-citation></ref><ref id="ref260"><mixed-citation publication-type="journal" id="cit260"><name name-style="western"><surname>Takatani</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Tahara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tsuji</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ozaki</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Shibata</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Hashizume</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Onoe</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name><article-title>Synthesis of L-[5-<sup>11</sup>C]Leucine
and L-alpha-[5-<sup>11</sup>C]Methylleucine via Pd(0) -mediated <sup>11</sup>C-Methylation and Microfluidic Hydrogenation: Potentiality
of Leucine PET Probes for Tumor Imaging</article-title>. <source>ChemMedChem.</source><year>2021</year>, <volume>16</volume>, <fpage>3271</fpage>&#8211;<lpage>3279</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.202100255</pub-id>.<pub-id pub-id-type="pmid">34128324</pub-id></mixed-citation></ref><ref id="ref261"><mixed-citation publication-type="journal" id="cit261"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Matsui</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sakuragawa</surname><given-names>N.</given-names></name><article-title>Placental Transfer of Positron-Emitting Radionuclides
in Metabolic Substrates</article-title>. <source>Int. J. Nucl. Med.
Biol.</source><year>1985</year>, <volume>12</volume>, <fpage>33</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/0047-0740(85)90009-9</pub-id>.<pub-id pub-id-type="pmid">3159702</pub-id></mixed-citation></ref><ref id="ref262"><mixed-citation publication-type="journal" id="cit262"><name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Baumgartner</surname><given-names>F. J.</given-names></name>; <name name-style="western"><surname>Henze</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Stauber</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Egbert</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name>; <name name-style="western"><surname>Schelbert</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>F. T.</given-names></name><article-title>Synthesis
and Myocardial Kinetics
of N-13 and C-11 Labeled Branched-Chain <sc>l</sc>-Amino Acids</article-title>. <source>J. Nucl. Med.</source><year>1983</year>, <volume>24</volume>, <fpage>937</fpage>&#8211;<lpage>944</lpage>.<pub-id pub-id-type="pmid">6619964</pub-id></mixed-citation></ref><ref id="ref263"><mixed-citation publication-type="journal" id="cit263"><name name-style="western"><surname>Phelps</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Keen</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Mazziotta</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sokoloff</surname><given-names>L.</given-names></name><article-title>The Measurement
of Local Cerebral Protein-Synthesis in Man With Positron Computed-Tomography
(PCT) and C-11 <sc>l</sc>-Leucine</article-title>. <source>J. Nucl.
Med.</source><year>1982</year>, <volume>23</volume>, <fpage>P6</fpage>.</mixed-citation></ref><ref id="ref264"><mixed-citation publication-type="journal" id="cit264"><name name-style="western"><surname>Hawkins</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Keen</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Mazziotta</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name><article-title>Estimation of Local
Cerebral Protein Synthesis Rates With <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]Leucine and PET: Methods, Model, and Results in Animals and Humans</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1989</year>, <volume>9</volume>, <fpage>446</fpage>&#8211;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1989.68</pub-id>.<pub-id pub-id-type="pmid">2786885</pub-id></mixed-citation></ref><ref id="ref265"><mixed-citation publication-type="journal" id="cit265"><name name-style="western"><surname>Smith</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Burlin</surname><given-names>T. V.</given-names></name>; <name name-style="western"><surname>Cook</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Saunders</surname><given-names>R. C.</given-names></name>; <name name-style="western"><surname>Bacher</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Carson</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; et al. <article-title>Measurement
of Regional
Rates of Cerebral Protein Synthesis With <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]Leucine and PET With Correction for Recycling of Tissue
Amino Acids: II. Validation in Rhesus Monkeys</article-title>. <source>J. Cereb. Blood. Flow. Metab.</source><year>2005</year>, <volume>25</volume>, <fpage>629</fpage>&#8211;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600066</pub-id>.<pub-id pub-id-type="pmid">15703697</pub-id></mixed-citation></ref><ref id="ref266"><mixed-citation publication-type="journal" id="cit266"><name name-style="western"><surname>Schmidt</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Cook</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Burlin</surname><given-names>T. V.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>C. B.</given-names></name><article-title>Measurement of Regional Rates of
Cerebral Protein Synthesis With <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]Leucine and PET With Correction for Recycling of Tissue Amino Acids:
I. Kinetic Modeling Approach</article-title>. <source>J. Cereb. Blood
Flow Metab.</source><year>2005</year>, <volume>25</volume>, <fpage>617</fpage>&#8211;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600067</pub-id>.<pub-id pub-id-type="pmid">15703696</pub-id></mixed-citation></ref><ref id="ref267"><mixed-citation publication-type="journal" id="cit267"><name name-style="western"><surname>Bishu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Burlin</surname><given-names>T. V.</given-names></name>; <name name-style="western"><surname>Charming</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Horowitz</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Z.-h.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Vuong</surname><given-names>B. K.</given-names></name>; <name name-style="western"><surname>Unterman</surname><given-names>A. J.</given-names></name>; et al. <article-title>Propofol Anesthesia
Does Not Alter Regional Rates of Cerebral Protein Synthesis Measured
with <italic toggle="yes">l</italic>-[1-<sup>11</sup>C]Leucine and PET in Healthy
Male Subjects</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2009</year>, <volume>29</volume>, <fpage>1035</fpage>&#8211;<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2009.7</pub-id>.<pub-id pub-id-type="pmid">19223912</pub-id><pub-id pub-id-type="pmcid">PMC3150740</pub-id></mixed-citation></ref><ref id="ref268"><mixed-citation publication-type="journal" id="cit268"><name name-style="western"><surname>Sundaram</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Muzik</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>Mu</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Mangner</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>H. T.</given-names></name><article-title>Quantification of Protein Synthesis
in the Human Brain Using <sc>l</sc>-[1-<sup>11</sup>C]-Leucine PET:
Incorporation of Factors for Large Neutral Amino Acids in Plasma and
for Amino Acids Recycled from Tissue</article-title>. <source>J. Nucl.
Med.</source><year>2006</year>, <volume>47</volume>, <fpage>1787</fpage>.<pub-id pub-id-type="pmid">17079811</pub-id></mixed-citation></ref><ref id="ref269"><mixed-citation publication-type="journal" id="cit269"><name name-style="western"><surname>Shandal</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Sundaram</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Behen</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>H. T.</given-names></name><article-title>Abnormal Brain Protein
Synthesis
in Language Areas of Children With Pervasive Developmental Disorder:
A <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]-Leucine PET Study</article-title>. <source>J. Child Neurol.</source><year>2011</year>, <volume>26</volume>, <fpage>1347</fpage>&#8211;<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1177/0883073811405200</pub-id>.<pub-id pub-id-type="pmid">21636781</pub-id></mixed-citation></ref><ref id="ref270"><mixed-citation publication-type="journal" id="cit270"><name name-style="western"><surname>Alkonyi</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Muzik</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>Sundaram</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Kupsky</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Batista</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Juh&#225;sz</surname><given-names>C.</given-names></name><article-title>Increased <italic toggle="yes">L</italic>-[1-<sup>11</sup>C] Leucine Uptake in the Leptomeningeal
Angioma of Sturge-Weber Syndrome: A PET Study</article-title>. <source>J. Neuroimaging</source><year>2012</year>, <volume>22</volume>, <fpage>177</fpage>&#8211;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1111/j.1552-6569.2010.00565.x</pub-id>.<pub-id pub-id-type="pmid">21223431</pub-id><pub-id pub-id-type="pmcid">PMC3135745</pub-id></mixed-citation></ref><ref id="ref271"><mixed-citation publication-type="journal" id="cit271"><name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Keen</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name><article-title>Synthesis
of 1-(C-11) <sc>l</sc>-Leucine for Measurement of Local Rates of Cerebral
Protein Synthesis in Man With Positron Computed Tomography</article-title>. <source>J. Nucl. Med.</source><year>1982</year>, <volume>23</volume>, <fpage>P46</fpage>.</mixed-citation></ref><ref id="ref272"><mixed-citation publication-type="journal" id="cit272"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of Racemic
[4-<sup>11</sup>C]-Labelled Alanine, 2-Aminobutyric Acid, Norvaline,
Norleucine, Leucine and Phenylalanine and Preparation of <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Alanine and <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Phenylalanine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1987</year>, <volume>24</volume>, <fpage>125</fpage>&#8211;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580240203</pub-id>.</mixed-citation></ref><ref id="ref273"><mixed-citation publication-type="journal" id="cit273"><name name-style="western"><surname>Bolster</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>van Dijk</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Zijlstra</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Wynberg</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name><article-title>Syntheses
of Carbon-11
Labelled Ornithine and Lysine. Preliminary Accumulation Studies in
Rats With Walker 256 Carcinosarcoma</article-title>. <source>Int. J.
Appl. Rad. Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>263</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90082-1</pub-id>.<pub-id pub-id-type="pmid">3926656</pub-id></mixed-citation></ref><ref id="ref274"><mixed-citation publication-type="journal" id="cit274"><name name-style="western"><surname>Bolster</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>van Dijk</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Zijlstra</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Wynberg</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name><article-title>Syntheses of carbon-11
labelled ornithine and lysine. Preliminary accumulation studies in
rats with Walker 256 carcinosarcoma</article-title>. <source>Int. J.
Appl. Radiat Isot</source><year>1985</year>, <volume>36</volume>, <fpage>263</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90082-1</pub-id>.<pub-id pub-id-type="pmid">3926656</pub-id></mixed-citation></ref><ref id="ref275"><mixed-citation publication-type="journal" id="cit275"><name name-style="western"><surname>Fasth</surname><given-names>K.-J.</given-names></name>; <name name-style="western"><surname>Hornfeldt</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Colacio</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Lonnberg</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Arnarp</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bjork</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Gawinecki</surname><given-names>R.</given-names></name><article-title>Asymmetric Synthesis of <sup>11</sup>C-Labelled <italic toggle="yes">L</italic>- and <italic toggle="yes">D</italic>-Amino Acids by Alkylation Imidazolidinone
Derivatives</article-title>. <source>Acta Chem. Scand.</source><year>1995</year>, <volume>49</volume>, <fpage>301</fpage>&#8211;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.3891/acta.chem.scand.49-0301</pub-id>.</mixed-citation></ref><ref id="ref276"><mixed-citation publication-type="journal" id="cit276"><name name-style="western"><surname>Stolc</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Jakub&#237;kov&#225;</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Kukurov&#225;</surname><given-names>I.</given-names></name><article-title>Body Distribution
of C-Methionine and FDG in Rat Measured by microPET</article-title>. <source>Interdiscip. Toxicol.</source><year>2011</year>, <volume>4</volume>, <fpage>52</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.2478/v10102-011-0010-1</pub-id>.<pub-id pub-id-type="pmid">21577285</pub-id><pub-id pub-id-type="pmcid">PMC3090055</pub-id></mixed-citation></ref><ref id="ref277"><mixed-citation publication-type="journal" id="cit277"><name name-style="western"><surname>Thackeray</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Bankstahl</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wollert</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Bengel</surname><given-names>F. M.</given-names></name><article-title>Targeting Amino Acid Metabolism for Molecular Imaging
of Inflammation Early After Myocardial Infarction</article-title>. <source>Theranostics</source><year>2016</year>, <volume>6</volume>, <fpage>1768</fpage>&#8211;<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.7150/thno.15929</pub-id>.<pub-id pub-id-type="pmid">27570549</pub-id><pub-id pub-id-type="pmcid">PMC4997235</pub-id></mixed-citation></ref><ref id="ref278"><mixed-citation publication-type="journal" id="cit278"><name name-style="western"><surname>Afzelius</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Nielsen</surname><given-names>O. L.</given-names></name>; <name name-style="western"><surname>Alstrup</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Bender</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Leifsson</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Jensen</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Sch&#248;nheyder</surname><given-names>H. C.</given-names></name><article-title>Biodistribution
of the Radionuclides <sup>18</sup>F-FDG, <sup>11</sup>C-Methionine, <sup>11</sup>C-PK11195, and <sup>68</sup>Ga-Citrate in Domestic Juvenile
Female Pigs and Morphological and Molecular Imaging of the Tracers
in Hematogenously Disseminated Staphylococcus aureus Lesions</article-title>. <source>Am. J. Nucl. Med. Mol. Imaging</source><year>2016</year>, <volume>6</volume>, <fpage>42</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">27069765</pub-id><pub-id pub-id-type="pmcid">PMC4749504</pub-id></mixed-citation></ref><ref id="ref279"><mixed-citation publication-type="gov" id="cit279"><person-group person-group-type="allauthors"><name name-style="western"><surname>Leung</surname><given-names>K.</given-names></name></person-group><article-title><italic toggle="yes">S</italic>-[<sup>11</sup>C]Methyl-<sc>l</sc>-cysteine</article-title>. In <source>Molecular Imaging and Contrast Agent Database (MICAD)</source>; <publisher-name>National Center for Biotechnology Information (US)</publisher-name>, <year>2004</year>.<pub-id pub-id-type="pmid">20641179</pub-id></mixed-citation></ref><ref id="ref280"><mixed-citation publication-type="journal" id="cit280"><name name-style="western"><surname>Isohashi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Shimosegawa</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Kato</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kanai</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Naka</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Fujino</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Watabe</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hatazawa</surname><given-names>J.</given-names></name><article-title>Optimization
of [<sup>11</sup>C]Methionine PET Study: Appropriate Scan Timing and
Effect of Plasma Amino Acid Concentrations on the SUV</article-title>. <source>EJNMMI Res.</source><year>2013</year>, <volume>3</volume>, <fpage>27</fpage><pub-id pub-id-type="doi">10.1186/2191-219X-3-27</pub-id>.<pub-id pub-id-type="pmid">23587060</pub-id><pub-id pub-id-type="pmcid">PMC3637362</pub-id></mixed-citation></ref><ref id="ref281"><mixed-citation publication-type="journal" id="cit281"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hatazawa</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kubota</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kameyama</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Itoh</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Matsuzawa</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name><article-title>Metabolic Fate of <italic toggle="yes">L</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]methionine in
Human Plasma</article-title>. <source>Eur. J. Nucl. Med.</source><year>1989</year>, <volume>15</volume>, <fpage>665</fpage>&#8211;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1007/BF00251681</pub-id>.<pub-id pub-id-type="pmid">2806329</pub-id></mixed-citation></ref><ref id="ref282"><mixed-citation publication-type="journal" id="cit282"><name name-style="western"><surname>Gomzina</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Kuznetsova</surname><given-names>O. F.</given-names></name><article-title><italic toggle="yes">L</italic>-[<italic toggle="yes">Methyl</italic>-(<sup>11</sup>C)]-Methionine
of High Enantiomeric Purity Production
via Online-<sup>11</sup>C-Methylation of <italic toggle="yes">L</italic>-Homocysteine
Thiolactone Hydrochloride</article-title>. <source>Russ. J. Bioorganic
Chem.</source><year>2011</year>, <volume>37</volume>, <fpage>191</fpage>&#8211;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1134/S1068162011020051</pub-id>.<pub-id pub-id-type="pmid">21721254</pub-id></mixed-citation></ref><ref id="ref283"><mixed-citation publication-type="journal" id="cit283"><name name-style="western"><surname>Deng</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wen</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Yi</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Meng</surname><given-names>Q.</given-names></name><article-title><italic toggle="yes">S</italic>-<sup>11</sup>C-<italic toggle="yes">Methyl-L</italic>-Cysteine: A New Amino Acid
PET Tracer for Cancer Imaging</article-title>. <source>J. Nucl. Med.</source><year>2011</year>, <volume>52</volume>, <fpage>287</fpage>&#8211;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.110.081349</pub-id>.<pub-id pub-id-type="pmid">21233188</pub-id></mixed-citation></ref><ref id="ref284"><mixed-citation publication-type="journal" id="cit284"><name name-style="western"><surname>Yao</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Liang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Nie</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Yue</surname><given-names>D.</given-names></name><article-title>Human Biodistribution
and Radiation Dosimetry of <italic toggle="yes">S</italic>-<sup>11</sup>C-Methyl-<italic toggle="yes">L</italic>-Cysteine Using Whole-Body PET</article-title>. <source>Clin.
Nucl. Med.</source><year>2015</year>, <volume>40</volume>, <elocation-id>e470</elocation-id><pub-id pub-id-type="doi">10.1097/RLU.0000000000000738</pub-id>.<pub-id pub-id-type="pmid">25742235</pub-id></mixed-citation></ref><ref id="ref285"><mixed-citation publication-type="journal" id="cit285"><name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Iida</surname><given-names>S.</given-names></name><article-title>Optimization of [<sup>11</sup>C]HCN
Production and No-Carrier-Added [1-<sup>11</sup>C]Amino Acid Synthesis</article-title>. <source>Int. J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1987</year>, <volume>38</volume>, <fpage>97</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90003-7</pub-id>.<pub-id pub-id-type="pmid">3032866</pub-id></mixed-citation></ref><ref id="ref286"><mixed-citation publication-type="journal" id="cit286"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Asymmetric
Synthesis
of <italic toggle="yes">L-2</italic>-Amino[4-<sup>11</sup>C]Butyric acid, <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Norvaline and <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Valine</article-title>. <source>Acta Chem. Scand., B, Org.
Chem. Biochem.</source><year>1987</year>, <volume>41b</volume>, <fpage>511</fpage>&#8211;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.3891/acta.chem.scand.41b-0511</pub-id>.<pub-id pub-id-type="pmid">3434082</pub-id></mixed-citation></ref><ref id="ref287"><mixed-citation publication-type="journal" id="cit287"><name name-style="western"><surname>Studenov</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Szalda</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>Y. S.</given-names></name><article-title>Synthesis
of No-Carrier-Added
C-11 Labeled <italic toggle="yes">D</italic>- and <italic toggle="yes">L</italic>-Enantiomers
of Phenylalanine and Tyrosine for Comparative PET Studies</article-title>. <source>Nucl. Med. Biol.</source><year>2003</year>, <volume>30</volume>, <fpage>39</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(02)00349-9</pub-id>.<pub-id pub-id-type="pmid">12493541</pub-id></mixed-citation></ref><ref id="ref288"><mixed-citation publication-type="journal" id="cit288"><name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Beerling-Van Der Molen</surname><given-names>H. D.</given-names></name>; <name name-style="western"><surname>Reiffers</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rijskamp</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Wynberg</surname><given-names>H.</given-names></name><article-title>Preparation of Carbon-11
Labelled Phenylalanine and Phenylglycine by a New Amino Acid Synthesis</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1976</year>, <volume>27</volume>, <fpage>153</fpage>&#8211;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(76)90126-5</pub-id>.<pub-id pub-id-type="pmid">1270164</pub-id></mixed-citation></ref><ref id="ref289"><mixed-citation publication-type="journal" id="cit289"><name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of Racemic
[2-<sup>11</sup>C]Phenylglycine</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1985</year>, <volume>22</volume>, <fpage>631</fpage>&#8211;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580220613</pub-id>.</mixed-citation></ref><ref id="ref290"><mixed-citation publication-type="journal" id="cit290"><name name-style="western"><surname>Sv&#228;rd</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Jigerius</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>The Enzymatic
Synthesis of L-[3-<sup>11</sup>C]Serine</article-title>. <source>Int.
J. Appl. Radiat. Isot. A. Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>, <fpage>587</fpage>&#8211;<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(90)90045-I</pub-id>.</mixed-citation></ref><ref id="ref291"><mixed-citation publication-type="journal" id="cit291"><name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T. T.</given-names></name>; <name name-style="western"><surname>Byrd</surname><given-names>B. L.</given-names></name>; <name name-style="western"><surname>Hayes</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Butler</surname><given-names>T. A.</given-names></name><article-title>DL-[Carboxyl-<sup>11</sup>C]Tryptophan,
a Potential
Agent for Pancreatic Imaging; Production and Preclinical Investigations</article-title>. <source>J. Nucl. Med.</source><year>1980</year>, <volume>4</volume>, <fpage>136</fpage><pub-id pub-id-type="doi">10.1097/00004728-198002000-00048</pub-id>.<pub-id pub-id-type="pmid">541734</pub-id></mixed-citation></ref><ref id="ref292"><mixed-citation publication-type="journal" id="cit292"><name name-style="western"><surname>H&#252;bner</surname><given-names>K. F.</given-names></name>; <name name-style="western"><surname>Andrews</surname><given-names>G. A.</given-names></name>; <name name-style="western"><surname>Buonocore</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Hayes</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Collmann</surname><given-names>I. R.</given-names></name>; <name name-style="western"><surname>Gibbs</surname><given-names>W. D.</given-names></name><article-title>Carbon-11-Labeled
Amino Acids for the Rectilinear and Positron Tomographic Imaging of
the Human Pancreas</article-title>. <source>J. Nucl. Med.</source><year>1979</year>, <volume>20</volume>, <fpage>507</fpage>&#8211;<lpage>513</lpage>.<pub-id pub-id-type="pmid">317098</pub-id></mixed-citation></ref><ref id="ref293"><mixed-citation publication-type="journal" id="cit293"><name name-style="western"><surname>H&#252;bner</surname><given-names>K. F.</given-names></name>; <name name-style="western"><surname>Purvis</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Mahaley</surname><given-names>S. M.</given-names><suffix>Jr.</suffix></name>; <name name-style="western"><surname>Robertson</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Rogers</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gibbs</surname><given-names>W. D.</given-names></name>; <name name-style="western"><surname>King</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Partain</surname><given-names>C. L.</given-names></name><article-title>Brain Tumor Imaging by Positron Emission
Computed Tomography
Using <sup>11</sup>C-Labeled Amino Acids</article-title>. <source>J.
Comput. Assist. Tomogr.</source><year>1982</year>, <volume>6</volume>, <fpage>544</fpage>&#8211;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1097/00004728-198206000-00020</pub-id>.<pub-id pub-id-type="pmid">6284814</pub-id></mixed-citation></ref><ref id="ref294"><mixed-citation publication-type="journal" id="cit294"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>C. W.</given-names></name>; <name name-style="western"><surname>Tsukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Positron Emission
Tomographic Studies on Aromatic <italic toggle="yes">L</italic>-Amino Acid Decarboxylase
Activity <italic toggle="yes">In Vivo</italic> for <italic toggle="yes">L</italic>-DOPA and <italic toggle="yes">5-Hydroxy-L</italic>-Tryptophan in the Monkey Brain</article-title>. <source>J. Neural. Transm. Gen. Sect.</source><year>1993</year>, <volume>94</volume>, <fpage>127</fpage>&#8211;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1007/BF01245006</pub-id>.<pub-id pub-id-type="pmid">8110439</pub-id></mixed-citation></ref><ref id="ref295"><mixed-citation publication-type="journal" id="cit295"><name name-style="western"><surname>Lundquist</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Blomquist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hagberg</surname><given-names>G. E.</given-names></name>; <name name-style="western"><surname>Torstenson</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Hammarlund-Udenaes</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Validation
Studies on the <italic toggle="yes">5-Hydroxy-L</italic>-[&#946;-<sup>11</sup>C]-Tryptophan/PET Method for Probing the Decarboxylase Step in Serotonin
Synthesis</article-title>. <source>Synapse</source><year>2006</year>, <volume>59</volume>, <fpage>521</fpage>&#8211;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20268</pub-id>.<pub-id pub-id-type="pmid">16565973</pub-id></mixed-citation></ref><ref id="ref296"><mixed-citation publication-type="journal" id="cit296"><name name-style="western"><surname>Lundquist</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Blomquist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Hammarlund-Udenaes</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title><italic toggle="yes">5</italic>-Hydroxy-<italic toggle="yes">l</italic>-[&#946;-<sup>11</sup>C]tryptophan versus &#945;-[<sup>11</sup>C]Methyl-<italic toggle="yes">l</italic>-tryptophan for Positron Emission
Tomography Imaging of Serotonin Synthesis Capacity in the Rhesus Monkey
Brain</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2007</year>, <volume>27</volume>, <fpage>821</fpage>&#8211;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600381</pub-id>.<pub-id pub-id-type="pmid">16896348</pub-id></mixed-citation></ref><ref id="ref297"><mixed-citation publication-type="journal" id="cit297"><name name-style="western"><surname>Lindner</surname><given-names>K.-J.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fasth</surname><given-names>K.-J.</given-names></name>; <name name-style="western"><surname>Westerberg</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Determination
of <italic toggle="yes">5-Hydroxy-L</italic>-[&#946;-<sup>11</sup>C]Tryptophan
and Its <italic toggle="yes">In Vivo</italic>-Formed Radiolabeled Metabolites in
Brain Tissue
Using High Performance Liquid Chromatography: A Study Supporting Radiotracer
Kinetics Obtained With Positron Emission Tomography</article-title>. <source>Nucl. Med. Biol.</source><year>1997</year>, <volume>24</volume>, <fpage>733</fpage>&#8211;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(97)00114-5</pub-id>.<pub-id pub-id-type="pmid">9428598</pub-id></mixed-citation></ref><ref id="ref298"><mixed-citation publication-type="journal" id="cit298"><name name-style="western"><surname>Di Gialleonardo</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Signore</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Scheerstra</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Visser</surname><given-names>A. K. D.</given-names></name>; <name name-style="western"><surname>van Waarde</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R. A. J. O.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. F. J.</given-names></name><article-title><sup>11</sup>C-Hydroxytryptophan Uptake and Metabolism
in Endocrine and Exocrine Pancreas</article-title>. <source>J. Nucl.
Med.</source><year>2012</year>, <volume>53</volume>, <fpage>1755</fpage><pub-id pub-id-type="doi">10.2967/jnumed.112.104117</pub-id>.<pub-id pub-id-type="pmid">23000748</pub-id></mixed-citation></ref><ref id="ref299"><mixed-citation publication-type="journal" id="cit299"><name name-style="western"><surname>Visser</surname><given-names>A. K. D.</given-names></name>; <name name-style="western"><surname>Ramakrishnan</surname><given-names>N. K.</given-names></name>; <name name-style="western"><surname>Willemsen</surname><given-names>A. T. M.</given-names></name>; <name name-style="western"><surname>Di Gialleonardo</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. F. J.</given-names></name>; <name name-style="western"><surname>Kema</surname><given-names>I. P.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R. A. J. O.</given-names></name>; <name name-style="western"><surname>van Waarde</surname><given-names>A.</given-names></name><article-title>[<sup>11</sup>C]5-HTP and microPET
are Not Suitable for Pharmacodynamic Studies in the Rodent Brain</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2014</year>, <volume>34</volume>, <fpage>118</fpage>&#8211;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2013.171</pub-id>.<pub-id pub-id-type="pmid">24084697</pub-id><pub-id pub-id-type="pmcid">PMC3887351</pub-id></mixed-citation></ref><ref id="ref300"><mixed-citation publication-type="journal" id="cit300"><name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Selvaraju</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Eich</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Willny</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Brismar</surname><given-names>T. B.</given-names></name>; <name name-style="western"><surname>Carlbom</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tufvesson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Lundgren</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Korsgren</surname><given-names>O.</given-names></name><article-title>Positron Emission
Tomography
to Assess the Outcome of Intraportal Islet Transplantation</article-title>. <source>Diabetes</source><year>2016</year>, <volume>65</volume>, <fpage>2482</fpage><pub-id pub-id-type="doi">10.2337/db16-0222</pub-id>.<pub-id pub-id-type="pmid">27325286</pub-id><pub-id pub-id-type="pmcid">PMC5001185</pub-id></mixed-citation></ref><ref id="ref301"><mixed-citation publication-type="journal" id="cit301"><name name-style="western"><surname>Neels</surname><given-names>O. C.</given-names></name>; <name name-style="western"><surname>Koopmans</surname><given-names>K. P.</given-names></name>; <name name-style="western"><surname>Jager</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Vercauteren</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>van Waarde</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Doorduin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Timmer-Bosscha</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Brouwers</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. G. E.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R. A. J. O.</given-names></name>; et al. <article-title>Manipulation of [<sup>11</sup>C]-<italic toggle="yes">5</italic>-Hydroxytryptophan
and 6-[<sup>18</sup>F]Fluoro-4, 4-Dihydroxy-Phenylalanine Accumulation
in Neuroendocrine Tumor Cells</article-title>. <source>Cancer Res.</source><year>2008</year>, <volume>68</volume>, <fpage>7183</fpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0095</pub-id>.<pub-id pub-id-type="pmid">18757434</pub-id></mixed-citation></ref><ref id="ref302"><mixed-citation publication-type="journal" id="cit302"><name name-style="western"><surname>Agren</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Reibring</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>H&#246;rnfeldt</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Andersson</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Low Brain
Uptake of <italic toggle="yes">L</italic>-[<sup>11</sup>C]5-Hydroxytryptophan in
Major Depression:
A Positron Emission Tomography Study on Patients and Healthy Volunteers</article-title>. <source>Acta Psychiatr. Scand.</source><year>1991</year>, <volume>83</volume>, <fpage>449</fpage>&#8211;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1991.tb05574.x</pub-id>.<pub-id pub-id-type="pmid">1882697</pub-id></mixed-citation></ref><ref id="ref303"><mixed-citation publication-type="journal" id="cit303"><name name-style="western"><surname>Reibring</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>&#197;gren</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Uptake and
Utilization of [<italic toggle="yes">Beta</italic>-<sup>11</sup>C] 5-Hydroxytryptophan
in Human Brain Studied by Positron Emission Tomography</article-title>. <source>Psychiatry Res. Neuroimaging</source><year>1992</year>, <volume>45</volume>, <fpage>215</fpage>&#8211;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/0925-4927(92)90017-X</pub-id>.<pub-id pub-id-type="pmid">1292039</pub-id></mixed-citation></ref><ref id="ref304"><mixed-citation publication-type="journal" id="cit304"><name name-style="western"><surname>Hagberg</surname><given-names>G. E.</given-names></name>; <name name-style="western"><surname>Torstenson</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Marteinsdottir</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Fredrikson</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name><article-title>Kinetic Compartment
Modeling of [<sup>11</sup>C]-<italic toggle="yes">5</italic>-Hydroxy-<italic toggle="yes">L</italic>-Tryptophan for Positron Emission Tomography Assessment of Serotonin
Synthesis in Human Brain</article-title>. <source>J. Cereb. Blood Flow
Metab.</source><year>2002</year>, <volume>22</volume>, <fpage>1352</fpage>&#8211;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1097/01.WCB.0000040946.89393.9d</pub-id>.<pub-id pub-id-type="pmid">12439293</pub-id></mixed-citation></ref><ref id="ref305"><mixed-citation publication-type="journal" id="cit305"><name name-style="western"><surname>Frick</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>&#197;hs</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Engman</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jonasson</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Alaie</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Bj&#246;rkstrand</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Frans</surname><given-names>&#214;.</given-names></name>; <name name-style="western"><surname>Faria</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Linnman</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Appel</surname><given-names>L.</given-names></name>; et al. <article-title>Serotonin Synthesis
and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography
Study</article-title>. <source>JAMA Psychiatry</source><year>2015</year>, <volume>72</volume>, <fpage>794</fpage>&#8211;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0125</pub-id>.<pub-id pub-id-type="pmid">26083190</pub-id></mixed-citation></ref><ref id="ref306"><mixed-citation publication-type="journal" id="cit306"><name name-style="western"><surname>Furmark</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Marteinsdottir</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Frick</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Heurling</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tillfors</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Appel</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fischer</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; et al. <article-title>Serotonin
Synthesis Rate and the Tryptophan Hydroxylase-2: G-703T Polymorphism
in Social Anxiety Disorder</article-title>. <source>J. Psychopharmacol.</source><year>2016</year>, <volume>30</volume>, <fpage>1028</fpage>&#8211;<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1177/0269881116648317</pub-id>.<pub-id pub-id-type="pmid">27189957</pub-id></mixed-citation></ref><ref id="ref307"><mixed-citation publication-type="journal" id="cit307"><name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Wall</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Olsson</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Marteinsdottir</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Holstad</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>&#197;gren</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Naess&#233;n</surname><given-names>T.</given-names></name><article-title>Women with
Premenstrual Dysphoria Lack the Seemingly
Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived
Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A
Possible Cause of Disabling Mood Symptoms</article-title>. <source>PLoS
One</source><year>2016</year>, <volume>11</volume>, <elocation-id>e0159538</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0159538</pub-id>.<pub-id pub-id-type="pmid">27617751</pub-id><pub-id pub-id-type="pmcid">PMC5019404</pub-id></mixed-citation></ref><ref id="ref308"><mixed-citation publication-type="journal" id="cit308"><name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Schoeps</surname><given-names>K.-O.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wiesel</surname><given-names>F.-A.</given-names></name><article-title>The B&#252;cherer-Strecker Synthesis of <italic toggle="yes">D</italic>- and <italic toggle="yes">L</italic>-(1-<sup>11</sup>C)Tyrosine and the In Vivo
Study of <italic toggle="yes">L</italic>-(1-<sup>11</sup>C)Tyrosine in Human Brain
Using Positron Emission Tomography</article-title>. <source>Eur. J.
Nucl. Med.</source><year>1987</year>, <volume>13</volume>, <fpage>288</fpage>&#8211;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1007/BF00256552</pub-id>.<pub-id pub-id-type="pmid">3499325</pub-id></mixed-citation></ref><ref id="ref309"><mixed-citation publication-type="journal" id="cit309"><name name-style="western"><surname>Kole</surname><given-names>A. C.</given-names></name>; <name name-style="western"><surname>Nieweg</surname><given-names>O. E.</given-names></name>; <name name-style="western"><surname>Pruim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Plukker</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Hoekstra</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Schraffordt Koops</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title>Standardized Uptake
Value and Quantification of Metabolism
for Breast Cancer Imaging With FDG and <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]tyrosine PET</article-title>. <source>J. Nucl. Med.</source><year>1997</year>, <volume>38</volume>, <fpage>692</fpage>&#8211;<lpage>696</lpage>.<pub-id pub-id-type="pmid">9170429</pub-id></mixed-citation></ref><ref id="ref310"><mixed-citation publication-type="journal" id="cit310"><name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T. T.</given-names></name><article-title>[1-<sup>11</sup>C] <sc>dl</sc>-Valine, a Potential Pancreas-Imaging Agent</article-title>. <source>J. Nucl. Med.</source><year>1978</year>, <volume>19</volume>, <fpage>77</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="pmid">621569</pub-id></mixed-citation></ref><ref id="ref311"><mixed-citation publication-type="journal" id="cit311"><name name-style="western"><surname>Hubner</surname><given-names>K. F.</given-names></name>; <name name-style="western"><surname>Hayes</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name><article-title>Scanning of the
Human Pancreas with <sc>dl</sc>-Valine-1-C-11 and <sc>dl</sc>-Tryptophan-1-C-11</article-title>. <source>J. Nucl. Med.</source><year>1978</year>, <volume>19</volume>, <fpage>686</fpage>.</mixed-citation></ref><ref id="ref312"><mixed-citation publication-type="journal" id="cit312"><name name-style="western"><surname>Hayes</surname><given-names>R.
L.</given-names></name>; <name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T. T.</given-names></name>; <name name-style="western"><surname>Turtle</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Butler</surname><given-names>T. A.</given-names></name><article-title>Carboxyl-Labeled <sup>11</sup>C-1-Aminocyclopentanecarboxylic
Acid, a Potential Agent for Cancer Detection</article-title>. <source>J. Nucl. Med.</source><year>1976</year>, <volume>17</volume>, <fpage>748</fpage>&#8211;<lpage>751</lpage>.<pub-id pub-id-type="pmid">180270</pub-id></mixed-citation></ref><ref id="ref313"><mixed-citation publication-type="journal" id="cit313"><name name-style="western"><surname>Lanstrom</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Stridsberg</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Tewson</surname><given-names>T. J.</given-names></name><article-title>Syntheses of Racemic
[1-<sup>11</sup>C]-Alanine and Partially Resolved [3-<sup>11</sup>C]-Alanine</article-title>. <source>J. Comput. Assist. Tomogr.</source><year>1979</year>, <volume>3</volume>, <fpage>714</fpage><pub-id pub-id-type="doi">10.1097/00004728-197910000-00056</pub-id>.</mixed-citation></ref><ref id="ref314"><mixed-citation publication-type="journal" id="cit314"><name name-style="western"><surname>Machulla</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Laufer</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>St&#246;cklin</surname><given-names>G.</given-names></name><article-title>Radioanalytical
Quality Control of <sup>11</sup>C, <sup>18</sup>F and <sup>123</sup>I-Labelled compounds and Radiopharmaceuticals</article-title>. <source>J. Radioanal. Nucl. Chem.</source><year>1976</year>, <volume>32</volume>, <fpage>381</fpage>&#8211;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1007/BF02517513</pub-id>.</mixed-citation></ref><ref id="ref315"><mixed-citation publication-type="journal" id="cit315"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hatano</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name><article-title>Synthesis
of 1-<sup>11</sup>C-Labeled Fatty Acid form
[<sup>11</sup>C]HCN</article-title>. <source>Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>, <fpage>649</fpage>&#8211;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(90)90079-V</pub-id>.</mixed-citation></ref><ref id="ref316"><mixed-citation publication-type="journal" id="cit316"><name name-style="western"><surname>Gillings</surname><given-names>N. M.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>Synthesis of [4-<sup>11</sup>C]Amino
Acids <italic toggle="yes">via</italic> Ring-Opening of Aziridine-2-Carboxylates</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2001</year>, <volume>44</volume>, <fpage>909</fpage>&#8211;<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.517</pub-id>.</mixed-citation></ref><ref id="ref317"><mixed-citation publication-type="journal" id="cit317"><person-group person-group-type="allauthors"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Omura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A. I.</given-names></name>; <name name-style="western"><surname>Takalo</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y. J.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B. I.</given-names></name></person-group><article-title>XIIth International Symposium
on Radiopharmaceutical Chemistry: Abstracts and Programme</article-title>. In <source>J. Label. Compd. Radiopharm.</source>, <year>1997</year><fpage>807</fpage><lpage>809</lpage>.</mixed-citation></ref><ref id="ref318"><mixed-citation publication-type="book" id="cit318"><person-group person-group-type="allauthors"><name name-style="western"><surname>Ploessl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lieberman</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Choi</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Kung</surname><given-names>H.
F.</given-names></name></person-group><article-title><sc>l</sc>-[5-<sup>11</sup>C]-Glutamine and Metabolic Imaging in Cancer Cells</article-title>. In <source>Glutamine in Clinical Nutrition</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Rajendram</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Preedy</surname><given-names>V. R.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>V. B.</given-names></name></person-group>, Eds.; <publisher-name>Springer</publisher-name>: <publisher-loc>New York</publisher-loc>, <year>2015</year>; pp <fpage>113</fpage>&#8211;<lpage>124</lpage>.</mixed-citation></ref><ref id="ref319"><mixed-citation publication-type="journal" id="cit319"><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ploessl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kung</surname><given-names>H. F.</given-names></name><article-title>Metabolic
Imaging of Glutamine in Cancer</article-title>. <source>J. Nucl. Med.</source><year>2017</year>, <volume>58</volume>, <fpage>533</fpage><pub-id pub-id-type="doi">10.2967/jnumed.116.182345</pub-id>.<pub-id pub-id-type="pmid">28232608</pub-id><pub-id pub-id-type="pmcid">PMC5373500</pub-id></mixed-citation></ref><ref id="ref320"><mixed-citation publication-type="journal" id="cit320"><name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Rodnick</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Brooks</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name><article-title>Synthesis
and Applications of [<sup>11</sup>C]Hydrogen Cyanide</article-title>. <source>Radiochemical Syntheses</source><year>2015</year>, <fpage>233</fpage>&#8211;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1002/9781118834114.ch22</pub-id>.</mixed-citation></ref><ref id="ref321"><mixed-citation publication-type="journal" id="cit321"><name name-style="western"><surname>Rosenberg</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Nickels</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Schulte</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Manning</surname><given-names>H. C.</given-names></name><article-title>Automated
Radiosynthesis of <italic toggle="yes">5</italic>-[<sup>11</sup>C]L-Glutamine,
an Important Tracer for Glutamine Utilization</article-title>. <source>Nucl. Med. Biol.</source><year>2018</year>, <volume>67</volume>, <fpage>10</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2018.09.002</pub-id>.<pub-id pub-id-type="pmid">30359787</pub-id><pub-id pub-id-type="pmcid">PMC6298813</pub-id></mixed-citation></ref><ref id="ref322"><mixed-citation publication-type="journal" id="cit322"><name name-style="western"><surname>Padakanti</surname><given-names>P. K.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schmitz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Mach</surname><given-names>R. H.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>H. S.</given-names></name><article-title>Automated Synthesis
of [<sup>11</sup>C]L-Glutamine on Synthra HCN Plus Synthesis Module</article-title>. <source>EJNMMI Radiopharm. Chem.</source><year>2019</year>, <volume>4</volume>, <fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s41181-019-0057-4</pub-id>.<pub-id pub-id-type="pmid">31659517</pub-id><pub-id pub-id-type="pmcid">PMC6426911</pub-id></mixed-citation></ref><ref id="ref323"><mixed-citation publication-type="journal" id="cit323"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Basuli</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>Z. D.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Blackman</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Choyke</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Swenson</surname><given-names>R. E.</given-names></name><article-title>Automated Synthesis
of [<sup>18</sup>F](<italic toggle="yes">2S</italic>, <italic toggle="yes">4R</italic>)-4-Fluoroglutamine
on a GE TRACERlab FX-N Pro Module</article-title>. <source>Appl. Radiat.
Isot.</source><year>2016</year>, <volume>112</volume>, <fpage>110</fpage>&#8211;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2016.02.016</pub-id>.<pub-id pub-id-type="pmid">27019029</pub-id><pub-id pub-id-type="pmcid">PMC4853275</pub-id></mixed-citation></ref><ref id="ref324"><mixed-citation publication-type="journal" id="cit324"><name name-style="western"><surname>Hayes</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Washburn</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T. T.</given-names></name>; <name name-style="western"><surname>Anon</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Butler</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Callahan</surname><given-names>A. P.</given-names></name><article-title>Synthesis and Purification
of <sup>11</sup>C-Carboxyl-Labeled Amino Acids</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1978</year>, <volume>29</volume>, <fpage>186</fpage>&#8211;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(78)90142-4</pub-id>.</mixed-citation></ref><ref id="ref325"><mixed-citation publication-type="journal" id="cit325"><name name-style="western"><surname>Smith</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Bishu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Bacon</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Burlin</surname><given-names>T. V.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Z. H.</given-names></name>; <name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>T.</given-names></name>; et al. <article-title>Use of Acute Hyperphenylalaninemia in Rhesus
Monkeys To Examine Sensitivity and Stability of the <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]Leucine Method for Measurement of Regional Rates
of Cerebral Protein Synthesis With PET</article-title>. <source>J. Cereb.
Blood Flow Metab.</source><year>2008</year>, <volume>28</volume>, <fpage>1388</fpage>&#8211;<lpage>1398</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2008.27</pub-id>.<pub-id pub-id-type="pmid">18431402</pub-id><pub-id pub-id-type="pmcid">PMC2531290</pub-id></mixed-citation></ref><ref id="ref326"><mixed-citation publication-type="journal" id="cit326"><name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Baumgartner</surname><given-names>F. J.</given-names></name>; <name name-style="western"><surname>Henze</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Stauber</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Egbert</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name>; <name name-style="western"><surname>Schelbert</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>F. T.</given-names></name><article-title>Synthesis and myocardial kinetics
of N-13 and C-11 labeled branched-chain <sc>l</sc>-amino acids</article-title>. <source>J. Nucl. Med.</source><year>1983</year>, <volume>24</volume>, <fpage>937</fpage>&#8211;<lpage>944</lpage>.<pub-id pub-id-type="pmid">6619964</pub-id></mixed-citation></ref><ref id="ref327"><mixed-citation publication-type="journal" id="cit327"><name name-style="western"><surname>Keen</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>S.-C.</given-names></name>; <name name-style="western"><surname>Hawkins</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name><article-title><italic toggle="yes">In vivo</italic> Cerebral Protein Synthesis
Rates with Leucyl-Transfer RNA Used as a Precursor Pool: Determination
of Biochemical Parameters to Structure Tracer Kinetic Models for Positron
Emission Tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1989</year>, <volume>9</volume>, <fpage>429</fpage>&#8211;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1989.67</pub-id>.<pub-id pub-id-type="pmid">2786884</pub-id></mixed-citation></ref><ref id="ref328"><mixed-citation publication-type="journal" id="cit328"><name name-style="western"><surname>Bishu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Burlin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Conant</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Z.-h.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Unterman</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name>; et al. <article-title>Regional Rates of Cerebral
Protein Synthesis Measured with <italic toggle="yes">l</italic>-[1-<sup>11</sup>C]Leucine and PET in Conscious, Young Adult Men: Normal Values, Variability,
and Reproducibility</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2008</year>, <volume>28</volume>, <fpage>1502</fpage>&#8211;<lpage>1513</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2008.43</pub-id>.<pub-id pub-id-type="pmid">18493259</pub-id><pub-id pub-id-type="pmcid">PMC2775471</pub-id></mixed-citation></ref><ref id="ref329"><mixed-citation publication-type="journal" id="cit329"><name name-style="western"><surname>Neumann</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Flavell</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>D. M.</given-names></name><article-title>Exploring
Metabolism
In Vivo Using Endogenous <sup>11</sup>C Metabolic Tracers</article-title>. <source>Semin. Nucl. Med.</source><year>2017</year>, <volume>47</volume>, <fpage>461</fpage>&#8211;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1053/j.semnuclmed.2017.05.003</pub-id>.<pub-id pub-id-type="pmid">28826521</pub-id><pub-id pub-id-type="pmcid">PMC6037183</pub-id></mixed-citation></ref><ref id="ref330"><mixed-citation publication-type="journal" id="cit330"><name name-style="western"><surname>Kilian</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>P&#553;kal</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Juszczyk</surname><given-names>J.</given-names></name><article-title>Synthesis of C-Methionine
Through Gas Phase Iodination Using Synthra MeI Synthesis Module</article-title>. <source>Nukleonika</source><year>2016</year>, <volume>61</volume>, <fpage>29</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1515/nuka-2016-0007</pub-id>.</mixed-citation></ref><ref id="ref331"><mixed-citation publication-type="journal" id="cit331"><name name-style="western"><surname>St&#229;lnacke</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Malmborg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sj&#246;berg</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Larsson</surname><given-names>B.</given-names></name><article-title>Short-Lived Radionuclides in Nutritional Physiology.
A Model Study With <italic toggle="yes">L</italic>-[<italic toggle="yes">Me</italic>-<sup>11</sup>C]methionine in the Pig</article-title>. <source>Br. J. Nutr.</source><year>1982</year>, <volume>47</volume>, <fpage>537</fpage>&#8211;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1079/BJN19820065</pub-id>.<pub-id pub-id-type="pmid">6805502</pub-id></mixed-citation></ref><ref id="ref332"><mixed-citation publication-type="journal" id="cit332"><name name-style="western"><surname>Pascali</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bogni</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Cucchi</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Laera</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Crispu</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Maiocchi</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Crippa</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Bombardieri</surname><given-names>E.</given-names></name><article-title>Detection
of Additional Impurities in the UV-Chromatogram of <italic toggle="yes">L</italic>-[<italic toggle="yes">S-Methyl</italic>-<sup>11</sup>C]Methionine</article-title>. <source>J. Radioanal. Nucl. Chem.</source><year>2011</year>, <volume>288</volume>, <fpage>405</fpage>&#8211;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-011-0995-0</pub-id>.</mixed-citation></ref><ref id="ref333"><mixed-citation publication-type="journal" id="cit333"><name name-style="western"><surname>Afzelius</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Nielsen</surname><given-names>O. L.</given-names></name>; <name name-style="western"><surname>Alstrup</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Bender</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Leifsson</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Jensen</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Sch&#248;nheyder</surname><given-names>H. C.</given-names></name><article-title>Biodistribution
of the radionuclides (18)F-FDG, (11)C-methionine, (11)C-PK11195, and
(68)Ga-citrate in domestic juvenile female pigs and morphological
and molecular imaging of the tracers in hematogenously disseminated
Staphylococcus aureus lesions</article-title>. <source>Am. J. Nucl.
Med. Mol. Imaging</source><year>2016</year>, <volume>6</volume>, <fpage>42</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">27069765</pub-id><pub-id pub-id-type="pmcid">PMC4749504</pub-id></mixed-citation></ref><ref id="ref334"><mixed-citation publication-type="journal" id="cit334"><name name-style="western"><surname>Ito</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Matsuda</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kubota</surname><given-names>K.</given-names></name><article-title>Imaging Spectrum and Pitfalls of <sup>11</sup>C-Methionine Positron Emission Tomography in a Series of
Patients with Intracranial Lesions</article-title>. <source>Korean J.
Radiol.</source><year>2016</year>, <volume>17</volume>, <fpage>424</fpage>&#8211;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.3348/kjr.2016.17.3.424</pub-id>.<pub-id pub-id-type="pmid">27134530</pub-id><pub-id pub-id-type="pmcid">PMC4842861</pub-id></mixed-citation></ref><ref id="ref335"><mixed-citation publication-type="journal" id="cit335"><name name-style="western"><surname>Pirotte</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Goldman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Massager</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>David</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wikler</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Vandesteene</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Salmon</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Brotchi</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Levivier</surname><given-names>M.</given-names></name><article-title>Comparison
of <sup>18</sup>F-FDG and <sup>11</sup>C-Methionine
for PET-Guided Stereotactic Brain Biopsy of Gliomas</article-title>. <source>J. Nucl. Med.</source><year>2004</year>, <volume>45</volume>, <fpage>1293</fpage>&#8211;<lpage>1298</lpage>.<pub-id pub-id-type="pmid">15299051</pub-id></mixed-citation></ref><ref id="ref336"><mixed-citation publication-type="journal" id="cit336"><name name-style="western"><surname>Cook</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Maisey</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Fogelman</surname><given-names>I.</given-names></name><article-title>Normal Variants, Artefacts
and Interpretative Pitfalls in PET Imaging With 18-Fluoro-2-Deoxyglucose
and Carbon-11 Methionine</article-title>. <source>Eur. J. Nucl. Med.</source><year>1999</year>, <volume>26</volume>, <fpage>1363</fpage>&#8211;<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1007/s002590050597</pub-id>.<pub-id pub-id-type="pmid">10541839</pub-id></mixed-citation></ref><ref id="ref337"><mixed-citation publication-type="journal" id="cit337"><name name-style="western"><surname>Noltes</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Coester</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>van der
Horst-Schrivers</surname><given-names>A. N. A.</given-names></name>; <name name-style="western"><surname>Dorgelo</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Jansen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Noordzij</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Lemstra</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Brouwers</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Kruijff</surname><given-names>S.</given-names></name><article-title>Localization of Parathyroid
Adenomas
Using <sup>11</sup>C-Methionine Pet After Prior Inconclusive Imaging</article-title>. <source>Langenbecks Arch. Surg.</source><year>2017</year>, <volume>402</volume>, <fpage>1109</fpage>&#8211;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1007/s00423-017-1549-x</pub-id>.<pub-id pub-id-type="pmid">28091771</pub-id><pub-id pub-id-type="pmcid">PMC5660832</pub-id></mixed-citation></ref><ref id="ref338"><mixed-citation publication-type="journal" id="cit338"><name name-style="western"><surname>Sato</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kameyama</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hatazawa</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Katakura</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Yoshimoto</surname><given-names>T.</given-names></name><article-title>Dynamic Study of Methionine Uptake
in Glioma Using Positron Emission Tomography</article-title>. <source>Eur. J. Nucl. Med.</source><year>1992</year>, <volume>19</volume>, <fpage>426</fpage>&#8211;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1007/BF00177369</pub-id>.<pub-id pub-id-type="pmid">1319905</pub-id></mixed-citation></ref><ref id="ref339"><mixed-citation publication-type="journal" id="cit339"><name name-style="western"><surname>Huang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Nie</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Liang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yi</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Yao</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>C.</given-names></name><article-title>Synthesis and Preliminary Biological Evaluation of <italic toggle="yes">S</italic>-<sup>11</sup>C-Methyl-D-Cysteine as a New Amino Acid PET
Tracer for Cancer Imaging</article-title>. <source>Amino Acids</source><year>2015</year>, <volume>47</volume>, <fpage>719</fpage>&#8211;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-014-1899-4</pub-id>.<pub-id pub-id-type="pmid">25534431</pub-id></mixed-citation></ref><ref id="ref340"><mixed-citation publication-type="journal" id="cit340"><name name-style="western"><surname>Parente</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>van Waarde</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Shoji</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>de Paula
Faria</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Maas</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Zijlma</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R. A. J. O.</given-names></name>; <name name-style="western"><surname>Langendijk</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. F. J.</given-names></name>; <name name-style="western"><surname>Doorduin</surname><given-names>J.</given-names></name><article-title>PET Imaging
with <italic toggle="yes">S</italic>-[<sup>11</sup>C]Methyl-<italic toggle="yes">L</italic>-Cysteine
and L-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Methionine in Rat Models
of Glioma, Glioma Radiotherapy, and Neuroinflammation</article-title>. <source>Mol. Imaging Biol.</source><year>2018</year>, <volume>20</volume>, <fpage>465</fpage>&#8211;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-017-1137-z</pub-id>.<pub-id pub-id-type="pmid">29086198</pub-id><pub-id pub-id-type="pmcid">PMC5938303</pub-id></mixed-citation></ref><ref id="ref341"><mixed-citation publication-type="journal" id="cit341"><name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name><article-title>Syntheses of Carbon-11 Labeled Amino Acids</article-title>. <source>Int. J. Nucl. Med. Biol.</source><year>1985</year>, <volume>12</volume>, <fpage>345</fpage>&#8211;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1016/S0047-0740(85)80001-2</pub-id>.</mixed-citation></ref><ref id="ref342"><mixed-citation publication-type="journal" id="cit342"><name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of Racemic
[4-<sup>11</sup>C]Phenylalanine and [4-<sup>11</sup>C]DOPA</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1984</year>, <volume>35</volume>, <fpage>779</fpage>&#8211;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(84)90086-3</pub-id>.</mixed-citation></ref><ref id="ref343"><mixed-citation publication-type="journal" id="cit343"><name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of [4-<sup>11</sup>C]Phenylpyruvic Acid and Its Use in an Enzymatic
Transamination
to [4-<sup>11</sup>C]Phenylalanine</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>1986</year>, <volume>23</volume>, <fpage>715</fpage>&#8211;<lpage>722</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580230705</pub-id>.</mixed-citation></ref><ref id="ref344"><mixed-citation publication-type="journal" id="cit344"><name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Dischino</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Synthesis of <italic toggle="yes">DL</italic>-[4-<sup>11</sup>C]Phenylalanine</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1984</year>, <volume>35</volume>, <fpage>603</fpage>&#8211;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(84)90103-0</pub-id>.<pub-id pub-id-type="pmid">6469391</pub-id></mixed-citation></ref><ref id="ref345"><mixed-citation publication-type="journal" id="cit345"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis of Racemic
[4-<sup>11</sup>C]-Labelled Alanine, 2-Aminobutyric Acid, Norvaline,
Norleucine, Leucine and Phenylalanine and Preparation of <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Alanine and <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Phenylalanine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1987</year>, <volume>24</volume>, <fpage>125</fpage>&#8211;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580240203</pub-id>.</mixed-citation></ref><ref id="ref346"><mixed-citation publication-type="journal" id="cit346"><name name-style="western"><surname>Fasth</surname><given-names>K.-J.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Langstr&#246;m</surname><given-names>B.</given-names></name><article-title>Asymmetric
Synthesis of L-[4-<sup>11</sup>C]Alanine and <italic toggle="yes">L</italic>-[4-<sup>11</sup>C]Phenylalanine by a Phase-Transfer Alkylation Reaction</article-title>. <source>J. Chem. Soc., Perkin Trans. 1</source><year>1988</year>, <fpage>3081</fpage>&#8211;<lpage>3084</lpage>. <pub-id pub-id-type="doi">10.1039/P19880003081</pub-id>.</mixed-citation></ref><ref id="ref347"><mixed-citation publication-type="journal" id="cit347"><name name-style="western"><surname>Labarre</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Donie</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>The Biosynthesis of <italic toggle="yes">L</italic>-[<sup>11</sup>C]Phenylalanine Using a Mutant Strain of
a Cyanobacterium (Synechocystis PCC 6803)</article-title>. <source>Int.
J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>659</fpage>&#8211;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90036-Z</pub-id>.</mixed-citation></ref><ref id="ref348"><mixed-citation publication-type="journal" id="cit348"><name name-style="western"><surname>Popkov</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P.</given-names></name><article-title>Asymmetric Synthesis
of Carbon-11
Labelled a-Amino Acids for PET</article-title>. <source>Curr. Org. Chem.</source><year>2013</year>, <volume>17</volume>, <fpage>2127</fpage>&#8211;<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.2174/13852728113179990105</pub-id>.</mixed-citation></ref><ref id="ref349"><mixed-citation publication-type="journal" id="cit349"><name name-style="western"><surname>Ermert</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name><article-title>Methods for <sup>11</sup>C- and <sup>18</sup>F-Labelling of Amino Acids and Derivatives
for Positron Emission
Tomography Imaging</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2013</year>, <volume>56</volume>, <fpage>225</fpage>&#8211;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2996</pub-id>.<pub-id pub-id-type="pmid">24285329</pub-id></mixed-citation></ref><ref id="ref350"><mixed-citation publication-type="journal" id="cit350"><name name-style="western"><surname>Ooi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Maruoka</surname><given-names>K.</given-names></name><article-title>Recent Advances in
Asymmetric Phase-Transfer Catalysis</article-title>. <source>Angew.
Chem. Int. Ed.</source><year>2007</year>, <volume>46</volume>, <fpage>4222</fpage>&#8211;<lpage>4266</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200601737</pub-id>.<pub-id pub-id-type="pmid">17525926</pub-id></mixed-citation></ref><ref id="ref351"><mixed-citation publication-type="journal" id="cit351"><name name-style="western"><surname>Peko&#353;ak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Filp</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Rotteveel</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Poot</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name><article-title>Improved Synthesis and Application
of [<sup>11</sup>C]benzyl Iodide in Positron Emission Tomography Radiotracer
Production</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2015</year>, <volume>58</volume>, <fpage>342</fpage>&#8211;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3307</pub-id>.<pub-id pub-id-type="pmid">26031614</pub-id></mixed-citation></ref><ref id="ref352"><mixed-citation publication-type="journal" id="cit352"><name name-style="western"><surname>Zalutsky</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Harper</surname><given-names>P. V.</given-names></name>; <name name-style="western"><surname>Wickland</surname><given-names>T.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Dl-Tryptophan and Its Purification Using High-Pressure
Liquid Chromatography</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1981</year>, <volume>32</volume>, <fpage>182</fpage>&#8211;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(81)90114-9</pub-id>.</mixed-citation></ref><ref id="ref353"><mixed-citation publication-type="journal" id="cit353"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tokushige</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Oda</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Syntheses of &#946;-<sup>11</sup>C-labelled <italic toggle="yes">L</italic>-tryptophan and <italic toggle="yes">5</italic>-hydroxy-<italic toggle="yes">L</italic>-tryptophan using a multi-enzymatic reaction route</article-title>. <source>J. Chem. Soc., Perkin trans.</source><year>1989</year>, <fpage>1331</fpage>&#8211;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1039/P19890001331</pub-id>.</mixed-citation></ref><ref id="ref354"><mixed-citation publication-type="journal" id="cit354"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Enzymatic
Synthesis of Carboxy-<italic toggle="yes">11</italic>-Labelled <italic toggle="yes">L</italic>-Tyrosine, <italic toggle="yes">L</italic>-DOPA, <italic toggle="yes">L</italic>-Tryptophan
and 5-Hydroxy-<italic toggle="yes">L</italic>-Tryptophan</article-title>. <source>Acta Chem. Scand.</source><year>1990</year>, <volume>44</volume>, <fpage>178</fpage>&#8211;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.3891/acta.chem.scand.44-0178</pub-id>.</mixed-citation></ref><ref id="ref355"><mixed-citation publication-type="journal" id="cit355"><name name-style="western"><surname>Uhl&#233;n</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fagerberg</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hallstr&#246;m</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Lindskog</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Oksvold</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mardinoglu</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sivertsson</surname><given-names>&#197;.</given-names></name>; <name name-style="western"><surname>Kampf</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sj&#246;stedt</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Asplund</surname><given-names>A.</given-names></name>; et al. <article-title>Tissue-Based Map of the Human Proteome</article-title>. <source>Science</source><year>2015</year>, <volume>347</volume>, <fpage>1260419</fpage><pub-id pub-id-type="doi">10.1126/science.1260419</pub-id>.<pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation></ref><ref id="ref356"><mixed-citation publication-type="journal" id="cit356"><name name-style="western"><surname>Frick</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>&#197;hs</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Appel</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Jonasson</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wahlstedt</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Bani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Merlo Pich</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Bettica</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lubberink</surname><given-names>M.</given-names></name>; et al. <article-title>Reduced Serotonin Synthesis and Regional Cerebral
Blood Flow After
Anxiolytic Treatment of Social Anxiety Disorder</article-title>. <source>Eur. Neuropsychopharmacol.</source><year>2016</year>, <volume>26</volume>, <fpage>1775</fpage>&#8211;<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2016.09.004</pub-id>.<pub-id pub-id-type="pmid">27642077</pub-id></mixed-citation></ref><ref id="ref357"><mixed-citation publication-type="journal" id="cit357"><name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Wall</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Marteinsdottir</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>&#197;gren</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Naess&#233;n</surname><given-names>T.</given-names></name><article-title>Mood Changes
Correlate to Changes in Brain Serotonin Precursor Trapping in Women
With Premenstrual Dysphoria</article-title>. <source>Psychiatry Res.
Neuroimaging</source><year>2006</year>, <volume>146</volume>, <fpage>107</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2005.02.012</pub-id>.<pub-id pub-id-type="pmid">16515859</pub-id></mixed-citation></ref><ref id="ref358"><mixed-citation publication-type="journal" id="cit358"><name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lilja</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>&#214;berg</surname><given-names>K.</given-names></name><article-title>Positron Emission
Tomography (PET) in Neuroendocrine Gastrointestinal Tumors</article-title>. <source>Acta Oncol.</source><year>1993</year>, <volume>32</volume>, <fpage>189</fpage>&#8211;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.3109/02841869309083911</pub-id>.<pub-id pub-id-type="pmid">7686763</pub-id></mixed-citation></ref><ref id="ref359"><mixed-citation publication-type="journal" id="cit359"><name name-style="western"><surname>Westlin</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Edgren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Letocha</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Stridsberg</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wilander</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>S.</given-names></name><article-title>Positron Emission Tomography Utilizing
C-11 5-Hydroxytryptophan, Plasma Biochemistry and Neuroendocrine Immunohistochemistry
of Metastatic Renal-Cell Carcinoma</article-title>. <source>Oncol. Rep.</source><year>1995</year>, <volume>2</volume>, <fpage>543</fpage>&#8211;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.3892/or.2.4.543</pub-id>.<pub-id pub-id-type="pmid">21597772</pub-id></mixed-citation></ref><ref id="ref360"><mixed-citation publication-type="journal" id="cit360"><name name-style="western"><surname>Norl&#233;n</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Krause</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>St&#229;lberg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hellman</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name><article-title><sup>11</sup>C-5-Hydroxytryptophan
Positron Emission Tomography After Radiofrequency Ablation of Neuroendocrine
Tumor Liver Metastases</article-title>. <source>Nucl. Med. Biol.</source><year>2012</year>, <volume>39</volume>, <fpage>883</fpage>&#8211;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2011.12.013</pub-id>.<pub-id pub-id-type="pmid">22381780</pub-id></mixed-citation></ref><ref id="ref361"><mixed-citation publication-type="journal" id="cit361"><name name-style="western"><surname>Wahlberg</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ekman</surname><given-names>B.</given-names></name><article-title>Atypical or Typical
Adrenocorticotropic
Hormone-Producing Pulmonary Carcinoids and the Usefulness of <sup>11</sup>C-5-Hydroxytryptophan Positron Emission Tomography: Two Case
Reports</article-title>. <source>J. Med. Case Rep.</source><year>2013</year>, <volume>7</volume>, <fpage>80</fpage><pub-id pub-id-type="doi">10.1186/1752-1947-7-80</pub-id>.<pub-id pub-id-type="pmid">23509950</pub-id><pub-id pub-id-type="pmcid">PMC3608321</pub-id></mixed-citation></ref><ref id="ref362"><mixed-citation publication-type="journal" id="cit362"><name name-style="western"><surname>Carlbom</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Espes</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Lubberink</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Martinell</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Johansson</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Carlsson</surname><given-names>P.-O.</given-names></name>; <name name-style="western"><surname>Korsgren</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name><article-title>[<sup>11</sup>C]5-Hydroxy-Tryptophan
PET for Assessment of Islet Mass During Progression of Type 2 Diabetes</article-title>. <source>Diabetes</source><year>2017</year>, <volume>66</volume>, <fpage>1286</fpage><pub-id pub-id-type="doi">10.2337/db16-1449</pub-id>.<pub-id pub-id-type="pmid">28246291</pub-id></mixed-citation></ref><ref id="ref363"><mixed-citation publication-type="journal" id="cit363"><name name-style="western"><surname>K&#228;lkner</surname><given-names>K.-M.</given-names></name>; <name name-style="western"><surname>Ginman</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Westlin</surname><given-names>J.-E.</given-names></name><article-title>Positron Emission
Tomography (PET) With <sup>11</sup>C-5-Hydroxytryptophan (5-HTP) in
Patients With Metastatic Hormone-Refractory
Prostatic Adenocarcinoma</article-title>. <source>Nucl. Med. Biol.</source><year>1997</year>, <volume>24</volume>, <fpage>319</fpage>&#8211;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(97)00064-4</pub-id>.<pub-id pub-id-type="pmid">9257330</pub-id></mixed-citation></ref><ref id="ref364"><mixed-citation publication-type="journal" id="cit364"><name name-style="western"><surname>Orlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lilja</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Oberg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name><article-title>Positron Emission Tomography With
5-Hydroxytryprophan in Neuroendocrine Tumors</article-title>. <source>J. Clin. Oncol.</source><year>1998</year>, <volume>16</volume>, <fpage>2534</fpage>&#8211;<lpage>2541</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.1998.16.7.2534</pub-id>.<pub-id pub-id-type="pmid">9667275</pub-id></mixed-citation></ref><ref id="ref365"><mixed-citation publication-type="journal" id="cit365"><name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>S&#246;rensen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>&#214;rlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fasth</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Whole-Body
PET with [<sup>11</sup>C]-5-Hydroxytryptophan for Localization of
Neuroendocrine Tumors</article-title>. <source>Clin. Positron Imaging</source><year>1999</year>, <volume>2</volume>, <fpage>338</fpage><pub-id pub-id-type="doi">10.1016/S1095-0397(99)00098-9</pub-id>.<pub-id pub-id-type="pmid">14516635</pub-id></mixed-citation></ref><ref id="ref366"><mixed-citation publication-type="journal" id="cit366"><name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K.-J.</given-names></name>; <name name-style="western"><surname>&#214;berg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Demonstration of [<sup>11</sup>C]5-Hydroxy-L-Tryptophan
Uptake and Decarboxylation in Carcinoid Tumors by Specific Positioning
Labeling in Positron Emission Tomography</article-title>. <source>Nucl.
Med. Biol.</source><year>2000</year>, <volume>27</volume>, <fpage>33</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(99)00085-2</pub-id>.<pub-id pub-id-type="pmid">10755643</pub-id></mixed-citation></ref><ref id="ref367"><mixed-citation publication-type="journal" id="cit367"><name name-style="western"><surname>Orlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Garske</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Juhlin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Oberg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Skogseid</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstrom</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name><article-title>Whole-Body <sup>11</sup>C-5-Hydroxytryptophan
Positron Emission Tomography as a Universal Imaging Technique for
Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy
and Computed Tomography</article-title>. <source>J. Clin. Endocrinol.
Metab.</source><year>2005</year>, <volume>90</volume>, <fpage>3392</fpage>&#8211;<lpage>3400</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2004-1938</pub-id>.<pub-id pub-id-type="pmid">15755858</pub-id></mixed-citation></ref><ref id="ref368"><mixed-citation publication-type="journal" id="cit368"><name name-style="western"><surname>&#214;rlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>&#214;berg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name><article-title>Carbidopa
Pretreatment Improves Image Interpretation and Visualisation of Carcinoid
Tumours With <sup>11</sup>C-5-Hydroxytryptophan Positron Emission
Tomography</article-title>. <source>Eur. J. Nucl. Med. Mol. Imaging</source><year>2006</year>, <volume>33</volume>, <fpage>60</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-005-1891-z</pub-id>.<pub-id pub-id-type="pmid">16184369</pub-id></mixed-citation></ref><ref id="ref369"><mixed-citation publication-type="journal" id="cit369"><name name-style="western"><surname>Koopmans</surname><given-names>K. P.</given-names></name>; <name name-style="western"><surname>Neels</surname><given-names>O. C.</given-names></name>; <name name-style="western"><surname>Kema</surname><given-names>I. P.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Sluiter</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Vanghillewe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Brouwers</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Jager</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. G. E.</given-names></name><article-title>Improved Staging
of Patients With Carcinoid and Islet
Cell Tumors With <sup>18</sup>F-Dihydroxy-Phenyl-Alanine and <sup>11</sup>C-5-Hydroxy-Tryptophan Positron Emission Tomography</article-title>. <source>J. Clin. Oncol.</source><year>2008</year>, <volume>26</volume>, <fpage>1489</fpage>&#8211;<lpage>1495</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2007.15.1126</pub-id>.<pub-id pub-id-type="pmid">18349401</pub-id></mixed-citation></ref><ref id="ref370"><mixed-citation publication-type="journal" id="cit370"><name name-style="western"><surname>Nikolaou</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Thomas</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kampanellou</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Alexandraki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Andersson</surname><given-names>L. G.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kaltsas</surname><given-names>G.</given-names></name><article-title>The Value
of <sup>11</sup>C-5-Hydroxy-Tryptophan Positron Emission Tomography
in Neuroendocrine Tumor Diagnosis and Management: Experience From
One Center</article-title>. <source>J. Endocrinol. Invest.</source><year>2010</year>, <volume>33</volume>, <fpage>794</fpage>&#8211;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1007/BF03350344</pub-id>.<pub-id pub-id-type="pmid">20332708</pub-id></mixed-citation></ref><ref id="ref371"><mixed-citation publication-type="journal" id="cit371"><name name-style="western"><surname>Eriksson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>&#214;rlefors</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>&#214;berg</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Developments
in PET for the Detection of Endocrine Tumours</article-title>. <source>Best Pract. Res. Clin. Endocrinol. Metab.</source><year>2005</year>, <volume>19</volume>, <fpage>311</fpage>&#8211;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2004.11.001</pub-id>.<pub-id pub-id-type="pmid">15763703</pub-id></mixed-citation></ref><ref id="ref372"><mixed-citation publication-type="journal" id="cit372"><name name-style="western"><surname>Eriksson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Espes</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Selvaraju</surname><given-names>R. K.</given-names></name>; <name name-style="western"><surname>Jansson</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>S&#246;rensen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lubberink</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Biglarnia</surname><given-names>A.-R.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Sundin</surname><given-names>A.</given-names></name>; et al. <article-title>Positron Emission Tomography Ligand [<sup>11</sup>C]5-Hydroxy-Tryptophan
Can Be Used as a Surrogate Marker for the Human Endocrine Pancreas</article-title>. <source>Diabetes</source><year>2014</year>, <volume>63</volume>, <fpage>3428</fpage><pub-id pub-id-type="doi">10.2337/db13-1877</pub-id>.<pub-id pub-id-type="pmid">24848067</pub-id></mixed-citation></ref><ref id="ref373"><mixed-citation publication-type="journal" id="cit373"><name name-style="western"><surname>de Heide</surname><given-names>L. J. M.</given-names></name>; <name name-style="western"><surname>Glaudemans</surname><given-names>A. W. J. M.</given-names></name>; <name name-style="western"><surname>Oomen</surname><given-names>P. H. N.</given-names></name>; <name name-style="western"><surname>Apers</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Tott&#233;</surname><given-names>E. R. E.</given-names></name>; <name name-style="western"><surname>van Beek</surname><given-names>A. P.</given-names></name><article-title>Functional Imaging in Hyperinsulinemic
Hypoglycemia after Gastric Bypass Surgery for Morbid Obesity</article-title>. <source>J. Clin. Endocrinol. Metab.</source><year>2012</year>, <volume>97</volume>, <elocation-id>E963</elocation-id><pub-id pub-id-type="doi">10.1210/jc.2011-3063</pub-id>.<pub-id pub-id-type="pmid">22466332</pub-id></mixed-citation></ref><ref id="ref374"><mixed-citation publication-type="journal" id="cit374"><name name-style="western"><surname>Goldsmith</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Vallabhajosula</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Morim</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kahn</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Michael</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hamacher</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Warner</surname><given-names>R.</given-names></name><article-title>Initial Experience
With [<sup>11</sup>C]5-Hydroxy-<sc>l</sc>-tryptophan [5-HTP] PET Imaging
Studies in Patients With Neuroendocrine Tumors [NET]</article-title>. <source>J. Nucl. Med.</source><year>2007</year>, <volume>48</volume>, <fpage>153P</fpage>.</mixed-citation></ref><ref id="ref375"><mixed-citation publication-type="journal" id="cit375"><name name-style="western"><surname>Bolster</surname><given-names>J.
M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M. J.</given-names></name>; <name name-style="western"><surname>van
Dijk</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Zijlstra</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Piers</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Mulder</surname><given-names>N. H.</given-names></name>; <name name-style="western"><surname>Woldring</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Wynberg</surname><given-names>H.</given-names></name><article-title>Carbon-11 Labelled
Tyrosine To Study Tumor Metabolism by Positron Emission Tomography
(PET)</article-title>. <source>Eur. J. Nucl. Med.</source><year>1986</year>, <volume>12</volume>, <fpage>321</fpage>&#8211;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1007/BF00263811</pub-id>.<pub-id pub-id-type="pmid">3491757</pub-id></mixed-citation></ref><ref id="ref376"><mixed-citation publication-type="journal" id="cit376"><name name-style="western"><surname>Hoeksma</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Reijngoud</surname><given-names>D.-J.</given-names></name>; <name name-style="western"><surname>Pruim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>de Valk</surname><given-names>H. W.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M. J.</given-names></name>; <name name-style="western"><surname>van
Spronsen</surname><given-names>F. J.</given-names></name><article-title>Phenylketonuria: High Plasma Phenylalanine
Decreases Cerebral Protein Synthesis</article-title>. <source>Mol. Genet.
Metab.</source><year>2009</year>, <volume>96</volume>, <fpage>177</fpage>&#8211;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2008.12.019</pub-id>.<pub-id pub-id-type="pmid">19201235</pub-id></mixed-citation></ref><ref id="ref377"><mixed-citation publication-type="journal" id="cit377"><name name-style="western"><surname>Daemen</surname><given-names>B. J. G.</given-names></name>; <name name-style="western"><surname>Zwertbroek</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M. J.</given-names></name>; <name name-style="western"><surname>Doorenbos</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title>PET Studies With <italic toggle="yes">L</italic>-[1-<sup>11</sup>C]Tyrosine, <italic toggle="yes">L</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Methionine and <sup>18</sup>F-Fluorodeoxyglucose
in Prolactinomas in Relation to Bromocryptine Treatment</article-title>. <source>Eur. J. Nucl. Med.</source><year>1991</year>, <volume>18</volume>, <fpage>453</fpage>&#8211;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1007/BF00181283</pub-id>.<pub-id pub-id-type="pmid">1915472</pub-id></mixed-citation></ref><ref id="ref378"><mixed-citation publication-type="journal" id="cit378"><name name-style="western"><surname>Krabbe</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>van der Werff-Regelink</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Pruim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>van der
Wal</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Roodenburg</surname><given-names>J. L. N.</given-names></name><article-title>Detection of Cervical Metastases
With <sup>11</sup>C-Tyrosine Pet in Patients With Squamous Cell Carcinoma
of the Oral Cavity or Oropharynx: A Comparison With <sup>18</sup>F-FDG
PET</article-title>. <source>Head Neck</source><year>2009</year>, <volume>32</volume>, <fpage>368</fpage>&#8211;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1002/hed.21192</pub-id>.<pub-id pub-id-type="pmid">19626632</pub-id></mixed-citation></ref><ref id="ref379"><mixed-citation publication-type="journal" id="cit379"><name name-style="western"><surname>Willemsen</surname><given-names>A. T.</given-names></name>; <name name-style="western"><surname>van Waarde</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Pruim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Luurtsema</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Go</surname><given-names>K. G.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Protein
Synthesis Rate Determination in Primary or Recurrent Brain
Tumors Using <sc>l</sc>-[1-<sup>11</sup>C]-Tyrosine and PET</article-title>. <source>J. Nucl. Med.</source><year>1995</year>, <volume>36</volume>, <fpage>411</fpage>&#8211;<lpage>419</lpage>.<pub-id pub-id-type="pmid">7884503</pub-id></mixed-citation></ref><ref id="ref380"><mixed-citation publication-type="journal" id="cit380"><name name-style="western"><surname>Locasale</surname><given-names>J. W.</given-names></name><article-title>Serine,
Glycine and One-Carbon Units: Cancer Metabolism
in Full Circle</article-title>. <source>Nat. Rev. Cancer</source><year>2013</year>, <volume>13</volume>, <fpage>572</fpage>&#8211;<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3557</pub-id>.<pub-id pub-id-type="pmid">23822983</pub-id><pub-id pub-id-type="pmcid">PMC3806315</pub-id></mixed-citation></ref><ref id="ref381"><mixed-citation publication-type="journal" id="cit381"><name name-style="western"><surname>Agrawal</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Mihai</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kohen</surname><given-names>A.</given-names></name><article-title>Microscale
Synthesis
of Isotopically Labeled R-[6-<sup>x</sup>H]N<sup>5</sup>,N<sup>10</sup>-Methylene-5,6, 7,8-Tetrahydrofolate as a Cofactor for Thymidylate
Synthase</article-title>. <source>Anal. Biochem.</source><year>2004</year>, <volume>328</volume>, <fpage>44</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2004.01.029</pub-id>.<pub-id pub-id-type="pmid">15081906</pub-id></mixed-citation></ref><ref id="ref382"><mixed-citation publication-type="journal" id="cit382"><name name-style="western"><surname>Van Triest</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Peters</surname><given-names>G. J.</given-names></name><article-title>Thymidylate Synthase:
A Target for
Combination Therapy and Determinant of Chemotherapeutic Response in
Colorectal Cancer</article-title>. <source>Oncology</source><year>1999</year>, <volume>57</volume>, <fpage>179</fpage>&#8211;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1159/000012030</pub-id>.<pub-id pub-id-type="pmid">10545786</pub-id></mixed-citation></ref><ref id="ref383"><mixed-citation publication-type="journal" id="cit383"><name name-style="western"><surname>Danenberg</surname><given-names>P. V.</given-names></name>; <name name-style="western"><surname>Gustavsson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Johnston</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lindberg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Moser</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Odin</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Peters</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Petrelli</surname><given-names>N.</given-names></name><article-title>Folates As
Adjuvants to Anticancer Agents: Chemical Rationale and Mechanism of
Action</article-title>. <source>Crit. Rev. Oncol. Hematol.</source><year>2016</year>, <volume>106</volume>, <fpage>118</fpage>&#8211;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2016.08.001</pub-id>.<pub-id pub-id-type="pmid">27637357</pub-id></mixed-citation></ref><ref id="ref384"><mixed-citation publication-type="journal" id="cit384"><name name-style="western"><surname>Turunen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Olsson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Dallner</surname><given-names>G.</given-names></name><article-title>Metabolism
and Function
of Coenzyme Q</article-title>. <source>Biochim. Biophys. Acta</source><year>2004</year>, <volume>1660</volume>, <fpage>171</fpage>&#8211;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2003.11.012</pub-id>.<pub-id pub-id-type="pmid">14757233</pub-id></mixed-citation></ref><ref id="ref385"><mixed-citation publication-type="journal" id="cit385"><name name-style="western"><surname>Pietrocola</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Galluzzi</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Bravo-San
Pedro</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Madeo</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Kroemer</surname><given-names>G.</given-names></name><article-title>Acetyl Coenzyme A:
A Central Metabolite
and Second Messenger</article-title>. <source>Cell Metab.</source><year>2015</year>, <volume>21</volume>, <fpage>805</fpage>&#8211;<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.014</pub-id>.<pub-id pub-id-type="pmid">26039447</pub-id></mixed-citation></ref><ref id="ref386"><mixed-citation publication-type="book" id="cit386"><person-group person-group-type="allauthors"><name name-style="western"><surname>Webster</surname><given-names>C. R. L.</given-names></name></person-group><article-title>Hepatobiliary
Cytoprotective Agents</article-title>. In <source>Canine and Feline
Gastroenterology</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Washabau</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Day</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Saunders</surname><given-names>W.B.</given-names></name></person-group>, Eds.; <year>2013</year>; Chapter 46, pp <fpage>507</fpage>&#8211;<lpage>511</lpage>.</mixed-citation></ref><ref id="ref387"><mixed-citation publication-type="journal" id="cit387"><name name-style="western"><surname>Zoppolo</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Porcal</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Oliver</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Savio</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Engler</surname><given-names>H.</given-names></name><article-title>Automated
One-pot Radiosynthesis of [<sup>11</sup>C]S-adenosyl
Methionine</article-title>. <source>Curr. Radiopharm.</source><year>2017</year>, <volume>10</volume>, <fpage>203</fpage>&#8211;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.2174/1874471010666170718171441</pub-id>.<pub-id pub-id-type="pmid">28721805</pub-id><pub-id pub-id-type="pmcid">PMC5740492</pub-id></mixed-citation></ref><ref id="ref388"><mixed-citation publication-type="journal" id="cit388"><name name-style="western"><surname>Lu</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Mato</surname><given-names>J. M.</given-names></name><article-title><italic toggle="yes">S</italic>-Adenosylmethionine
in Liver Health, Injury, and Cancer</article-title>. <source>Phys. Rev.</source><year>2012</year>, <volume>92</volume>, <fpage>1515</fpage>&#8211;<lpage>1542</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00047.2011</pub-id>.<pub-id pub-id-type="pmcid">PMC3698976</pub-id><pub-id pub-id-type="pmid">23073625</pub-id></mixed-citation></ref><ref id="ref389"><mixed-citation publication-type="journal" id="cit389"><name name-style="western"><surname>Papakostas</surname><given-names>G. I.</given-names></name>; <name name-style="western"><surname>Mischoulon</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Shyu</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Alpert</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Fava</surname><given-names>M.</given-names></name><article-title><italic toggle="yes">S</italic>-Adenosyl
Methionine (SAMe) Augmentation of Serotonin
Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive
Disorder: A Double-Blind, Randomized Clinical Trial</article-title>. <source>Am. J. Psychiatry</source><year>2010</year>, <volume>167</volume>, <fpage>942</fpage>&#8211;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09081198</pub-id>.<pub-id pub-id-type="pmid">20595412</pub-id></mixed-citation></ref><ref id="ref390"><mixed-citation publication-type="journal" id="cit390"><name name-style="western"><surname>Anglin</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Samaan</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Walter</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>McDonald</surname><given-names>S. D.</given-names></name><article-title>Vitamin
D Deficiency and Depression in Adults: Systematic Review and Meta-Analysis</article-title>. <source>Br. J. Psychiatry</source><year>2013</year>, <volume>202</volume>, <fpage>100</fpage>&#8211;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.111.106666</pub-id>.<pub-id pub-id-type="pmid">23377209</pub-id></mixed-citation></ref><ref id="ref391"><mixed-citation publication-type="journal" id="cit391"><name name-style="western"><surname>Earthman</surname><given-names>C. P.</given-names></name>; <name name-style="western"><surname>Beckman</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Masodkar</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sibley</surname><given-names>S. D.</given-names></name><article-title>The Link
Between Obesity and Low Circulating <italic toggle="yes">25</italic>-Hydroxyvitamin
D Concentrations: Considerations and Implications</article-title>. <source>Int. J. Obes.</source><year>2012</year>, <volume>36</volume>, <fpage>387</fpage>&#8211;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2011.119</pub-id>.<pub-id pub-id-type="pmid">21694701</pub-id></mixed-citation></ref><ref id="ref392"><mixed-citation publication-type="journal" id="cit392"><name name-style="western"><surname>Silva</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Furlanetto</surname><given-names>T. W.</given-names></name><article-title>Intestinal Absorption of Vitamin
D: A Systematic Review</article-title>. <source>Nutr. Rev.</source><year>2018</year>, <volume>76</volume>, <fpage>60</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nux034</pub-id>.<pub-id pub-id-type="pmid">29025082</pub-id></mixed-citation></ref><ref id="ref393"><mixed-citation publication-type="journal" id="cit393"><name name-style="western"><surname>Borel</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Caillaud</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Cano</surname><given-names>N. J.</given-names></name><article-title>Vitamin
D Bioavailability:
State of the Art</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source><year>2015</year>, <volume>55</volume>, <fpage>1193</fpage>&#8211;<lpage>1205</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2012.688897</pub-id>.<pub-id pub-id-type="pmid">24915331</pub-id></mixed-citation></ref><ref id="ref394"><mixed-citation publication-type="journal" id="cit394"><name name-style="western"><surname>Said</surname><given-names>H. M.</given-names></name><article-title>Biotin: Biochemical, Physiological
and Clinical Aspects</article-title>. <source>Subcell Biochem.</source><year>2012</year>, <volume>56</volume>, <fpage>1</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-2199-9_1</pub-id>.<pub-id pub-id-type="pmid">22116691</pub-id></mixed-citation></ref><ref id="ref395"><mixed-citation publication-type="journal" id="cit395"><name name-style="western"><surname>Balamurugan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ortiz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Said</surname><given-names>H. M.</given-names></name><article-title>Biotin
Uptake by
Human Intestinal and Liver Epithelial Cells: Role of the SMVT System</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2003</year>, <volume>285</volume>, <fpage>G73</fpage>&#8211;<lpage>G77</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00059.2003</pub-id>.<pub-id pub-id-type="pmid">12646417</pub-id></mixed-citation></ref><ref id="ref396"><mixed-citation publication-type="journal" id="cit396"><name name-style="western"><surname>Abed</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Alzoubi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Al Mamun
Bhuayn</surname><given-names>A.</given-names></name><article-title>Stimulation of Phospholipid Scrambling of the Erythrocyte Membrane
by <italic toggle="yes">9-Cis</italic>-Retinoic Acid</article-title>. <source>Cell.
Physiol. Biochem.</source><year>2017</year>, <volume>41</volume>, <fpage>543</fpage>&#8211;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1159/000457014</pub-id>.<pub-id pub-id-type="pmid">28214868</pub-id></mixed-citation></ref><ref id="ref397"><mixed-citation publication-type="journal" id="cit397"><name name-style="western"><surname>Carazo</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mac&#225;kov&#225;</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Matou&#353;ov&#225;</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kr&#269;mov&#225;</surname><given-names>L. K.</given-names></name>; <name name-style="western"><surname>Protti</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mlad&#283;nka</surname><given-names>P.</given-names></name><article-title>Vitamin A
Update: Forms, Sources, Kinetics, Detection, Function, Deficiency,
Therapeutic Use and Toxicity</article-title>. <source>Nutrients</source><year>2021</year>, <volume>13</volume>, <fpage>1703</fpage><pub-id pub-id-type="doi">10.3390/nu13051703</pub-id>.<pub-id pub-id-type="pmid">34069881</pub-id><pub-id pub-id-type="pmcid">PMC8157347</pub-id></mixed-citation></ref><ref id="ref398"><mixed-citation publication-type="journal" id="cit398"><name name-style="western"><surname>Chen</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Sass</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Seltmann</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Nau</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Orfanos</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Zouboulis</surname><given-names>C. C.</given-names></name><article-title>Biological Effects and Metabolism
of <italic toggle="yes">9-Cis</italic>-Retinoic Acid and Its Metabolite <italic toggle="yes">9</italic>, <italic toggle="yes">13-Di-Cis</italic>-Retinoic Acid in HaCaT Keratinocytes
In Vitro: Comparison With <italic toggle="yes">All-Trans</italic>-Retinoic Acid</article-title>. <source>Arch. Dermatol. Res.</source><year>2000</year>, <volume>292</volume>, <fpage>612</fpage>&#8211;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1007/s004030000189</pub-id>.<pub-id pub-id-type="pmid">11214822</pub-id></mixed-citation></ref><ref id="ref399"><mixed-citation publication-type="journal" id="cit399"><name name-style="western"><surname>Paik</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Vogel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Piantedosi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Sykes</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Blaner</surname><given-names>W. S.</given-names></name>; <name name-style="western"><surname>Swisshelm</surname><given-names>K.</given-names></name><article-title><italic toggle="yes">9-Cis</italic>-Retinoids: Biosynthesis of <italic toggle="yes">9-Cis</italic>-Retinoic Acid</article-title>. <source>Biochemistry</source><year>2000</year>, <volume>39</volume>, <fpage>8073</fpage>&#8211;<lpage>8084</lpage>. <pub-id pub-id-type="doi">10.1021/bi992152g</pub-id>.<pub-id pub-id-type="pmid">10891090</pub-id></mixed-citation></ref><ref id="ref400"><mixed-citation publication-type="journal" id="cit400"><name name-style="western"><surname>Goldie</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Taylor</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>McCoy</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>X.-Q.</given-names></name>; <name name-style="western"><surname>Preiss</surname><given-names>D.</given-names></name><article-title>Niacin Therapy and the Risk of New-Onset
Diabetes: A Meta-Analysis of Randomised Controlled Trials</article-title>. <source>Heart</source><year>2016</year>, <volume>102</volume>, <fpage>198</fpage><pub-id pub-id-type="doi">10.1136/heartjnl-2015-308055</pub-id>.<pub-id pub-id-type="pmid">26370223</pub-id><pub-id pub-id-type="pmcid">PMC4752613</pub-id></mixed-citation></ref><ref id="ref401"><mixed-citation publication-type="journal" id="cit401"><name name-style="western"><surname>Santolla</surname><given-names>M. F.</given-names></name>; <name name-style="western"><surname>De Francesco</surname><given-names>E. M.</given-names></name>; <name name-style="western"><surname>Lappano</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Rosano</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Abonante</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Maggiolini</surname><given-names>M.</given-names></name><article-title>Niacin Activates
the G Protein Estrogen
Receptor (GPER)-Mediated Signalling</article-title>. <source>Cell. Signal.</source><year>2014</year>, <volume>26</volume>, <fpage>1466</fpage>&#8211;<lpage>1475</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2014.03.011</pub-id>.<pub-id pub-id-type="pmid">24662263</pub-id></mixed-citation></ref><ref id="ref402"><mixed-citation publication-type="journal" id="cit402"><name name-style="western"><surname>Prousky</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Millman</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Kirkland</surname><given-names>J. B.</given-names></name><article-title>Pharmacologic
Use
of Niacin</article-title>. <source>Evid. Based Complementary Altern.
Med.</source><year>2011</year>, <volume>16</volume>, <fpage>91</fpage>&#8211;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1177/2156587211399579</pub-id>.</mixed-citation></ref><ref id="ref403"><mixed-citation publication-type="journal" id="cit403"><name name-style="western"><surname>Petrack</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Greengard</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kalinsky</surname><given-names>H.</given-names></name><article-title>On the Relative Efficacy
of Nicotinamide and Nicotinic Acid as Precursors of Nicotinamide Adenine
Dinucleotide</article-title>. <source>J. Biol. Chem.</source><year>1966</year>, <volume>241</volume>, <fpage>2367</fpage>&#8211;<lpage>2372</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(18)96630-5</pub-id>.<pub-id pub-id-type="pmid">4287855</pub-id></mixed-citation></ref><ref id="ref404"><mixed-citation publication-type="journal" id="cit404"><name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mawatari</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kanazawa</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nomura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kitayoshi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Akimoto</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ninomiya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Labeled Thiamine and Fursultiamine
for <italic toggle="yes">in Vivo</italic> Molecular Imaging of Vitamin B<sub>1</sub> and Its Prodrug Using Positron Emission Tomography</article-title>. <source>J. Org. Chem.</source><year>2015</year>, <volume>80</volume>, <fpage>6250</fpage>&#8211;<lpage>6258</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.5b00685</pub-id>.<pub-id pub-id-type="pmid">25984933</pub-id></mixed-citation></ref><ref id="ref405"><mixed-citation publication-type="journal" id="cit405"><name name-style="western"><surname>Carroll</surname><given-names>V. N.</given-names></name>; <name name-style="western"><surname>Truillet</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Shen</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Flavell</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Evans</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>VanBrocklin</surname><given-names>H. F.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name>; <name name-style="western"><surname>Chin</surname><given-names>F. T.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>D. M.</given-names></name><article-title>[<sup>11</sup>C]Ascorbic
and [<sup>11</sup>C]Dehydroascorbic Acid, an Endogenous Redox Pair
for Sensing Reactive Oxygen Species Using Positron Emission Tomography</article-title>. <source>Chem. Commun.</source><year>2016</year>, <volume>52</volume>, <fpage>4888</fpage>&#8211;<lpage>4890</lpage>. <pub-id pub-id-type="doi">10.1039/C6CC00895J</pub-id>.<pub-id pub-id-type="pmcid">PMC4854297</pub-id><pub-id pub-id-type="pmid">26963495</pub-id></mixed-citation></ref><ref id="ref406"><mixed-citation publication-type="journal" id="cit406"><name name-style="western"><surname>Bonasera</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Grue-S&#248;rensen</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ortu</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Binderup</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bj&#246;rkling</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>The Synthesis
of [<italic toggle="yes">26</italic>, <italic toggle="yes">27</italic>-<sup>11</sup>C]Dihydroxyvitamin
D<sub>3</sub>, a Tracer for Positron Emission Tomography (PET)</article-title>. <source>Bioorg. Med. Chem.</source><year>2001</year>, <volume>9</volume>, <fpage>3123</fpage>&#8211;<lpage>3128</lpage>. <pub-id pub-id-type="doi">10.1016/S0968-0896(01)00178-X</pub-id>.<pub-id pub-id-type="pmid">11711287</pub-id></mixed-citation></ref><ref id="ref407"><mixed-citation publication-type="journal" id="cit407"><name name-style="western"><surname>Saeed</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tewson</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Erdahl</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Kohen</surname><given-names>A.</given-names></name><article-title>A Fast Chemoenzymatic
Synthesis of [<sup>11</sup>C]-N<sub>5</sub>, N<sub>10</sub>-Methylenetetrahydrofolate
as a Potential PET Tracer for Proliferating Cells</article-title>. <source>Nucl. Med. Biol.</source><year>2012</year>, <volume>39</volume>, <fpage>697</fpage>&#8211;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2011.12.003</pub-id>.<pub-id pub-id-type="pmid">22300960</pub-id><pub-id pub-id-type="pmcid">PMC4437690</pub-id></mixed-citation></ref><ref id="ref408"><mixed-citation publication-type="journal" id="cit408"><name name-style="western"><surname>Jacobson</surname><given-names>G. B.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kuratsune</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis of <italic toggle="yes">O</italic>-[<sup>11</sup>C]Acetyl CoA, <italic toggle="yes">O</italic>-[<sup>11</sup>C]Acetyl-L-Carnitine,
and <italic toggle="yes">L</italic>-[<sup>11</sup>C]Carnitine Labelled in Specific
Positions, Applied in PET Studies on Rhesus Monkey</article-title>. <source>Nucl. Med. Biol.</source><year>1997</year>, <volume>24</volume>, <fpage>471</fpage>&#8211;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(97)80017-0</pub-id>.<pub-id pub-id-type="pmid">9290085</pub-id></mixed-citation></ref><ref id="ref409"><mixed-citation publication-type="journal" id="cit409"><name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Eakins</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Allan</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Selwyn</surname><given-names>A. P.</given-names></name><article-title>Preparation
of [1-<sup>11</sup>C]Acetate-An Agent for the Study of Myocardial
Metabolism by Positron Emission Tomography</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1982</year>, <volume>33</volume>, <fpage>505</fpage>&#8211;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90003-5</pub-id>.<pub-id pub-id-type="pmid">6981606</pub-id></mixed-citation></ref><ref id="ref410"><mixed-citation publication-type="book" id="cit410"><person-group person-group-type="allauthors"><name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kuratsune</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kitani</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name></person-group><source>Labelled
Acyl-l-carnitine
and Diagnostic Agent</source>, <year>1998</year>.</mixed-citation></ref><ref id="ref411"><mixed-citation publication-type="journal" id="cit411"><name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sementa</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Dunn</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bordoloi</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sunassee</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Blower</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A.</given-names></name><article-title>Imaging Biotin Trafficking <italic toggle="yes">In Vivo</italic> with Positron Emission Tomography</article-title>. <source>J. Med. Chem.</source><year>2020</year>, <volume>63</volume>, <fpage>8265</fpage>&#8211;<lpage>8275</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c00494</pub-id>.<pub-id pub-id-type="pmid">32658479</pub-id><pub-id pub-id-type="pmcid">PMC7445742</pub-id></mixed-citation></ref><ref id="ref412"><mixed-citation publication-type="conf-proc" id="cit412"><person-group person-group-type="allauthors"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Shinohara</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hamamura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kogure</surname><given-names>K.</given-names></name></person-group><article-title>Synthesis of [<sup>11</sup>C]-coenzyme
Q<sub>10</sub></article-title>. In <source>International Symposium
on Radiopharmaceutical Chemistry</source>, <year>1982</year>; Vol. <volume>19</volume>, pp <fpage>1284</fpage>&#8211;<lpage>1285</lpage>.</mixed-citation></ref><ref id="ref413"><mixed-citation publication-type="journal" id="cit413"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hamamura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kogure</surname><given-names>K.</given-names></name><article-title>[<sup>11</sup>C]Labeling of Coenzyme
Q10 and Its Tissue Distribution</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1985</year>, <volume>22</volume>, <fpage>565</fpage>&#8211;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580220606</pub-id>.</mixed-citation></ref><ref id="ref414"><mixed-citation publication-type="journal" id="cit414"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Miura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yanai</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Monma</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name><article-title><sup>11</sup>C-Coenzyme
Q10: A New Myocardial Imaging Tracer for Positron Emission
Tomography</article-title>. <source>Eur. J. Nucl. Med.</source><year>1985</year>, <volume>11</volume>, <fpage>162</fpage>&#8211;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1007/BF00251367</pub-id>.<pub-id pub-id-type="pmid">3877633</pub-id></mixed-citation></ref><ref id="ref415"><mixed-citation publication-type="journal" id="cit415"><name name-style="western"><surname>Miura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kagaya</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Ishide</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Maruyama</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Takishima</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Watanuki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name><article-title>Myocardial
Imaging
Using <sup>11</sup>CCoQ10 with Positron Emission Tomography</article-title>. <source>Int. J. Radiat. Appl. Instrum. B. Nucl. Med. Biol.</source><year>1987</year>, <volume>14</volume> (<issue>1-3</issue>), <fpage>5</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2897(87)90154-1</pub-id>.<pub-id pub-id-type="pmid">3495522</pub-id></mixed-citation></ref><ref id="ref416"><mixed-citation publication-type="journal" id="cit416"><name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Matuoka</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kubodera</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.-I.</given-names></name>; <name name-style="western"><surname>Goto</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>Synthesis of [<sup>11</sup>C]Coenzyme
Q-Related Compounds for In Vivo Estimation of Mitochondrial Electron
Transduction and Redox State in Brain</article-title>. <source>Nucl.
Med. Biol.</source><year>1999</year>, <volume>26</volume>, <fpage>183</fpage>&#8211;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(98)00096-1</pub-id>.<pub-id pub-id-type="pmid">10100217</pub-id></mixed-citation></ref><ref id="ref417"><mixed-citation publication-type="journal" id="cit417"><name name-style="western"><surname>Watanabe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Goto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kaneko</surname><given-names>K.-i.</given-names></name>; <name name-style="western"><surname>Hayashinaka</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Irie</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nishiyama</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kasai</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Fujii</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Wada</surname><given-names>Y.</given-names></name>; et al. <article-title>PET Imaging
of <sup>11</sup>C-Labeled Coenzyme Q10: Comparison of Biodistribution
Between [<sup>11</sup>C]Ubiquinol-10 and [<sup>11</sup>C]Ubiquinone-10</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>2019</year>, <volume>512</volume>, <fpage>611</fpage>&#8211;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.03.073</pub-id>.<pub-id pub-id-type="pmid">30914201</pub-id></mixed-citation></ref><ref id="ref418"><mixed-citation publication-type="journal" id="cit418"><name name-style="western"><surname>Goto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nishiyama</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Fujii</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Labeled Ubiquinone and Ubiquinol via Pd(0) -Mediated
Rapid C-[<sup>11</sup>C]Methylation Using [<sup>11</sup>C]Methyl Iodide
and <italic toggle="yes">39-Demethyl-39</italic>-(Pinacolboryl)ubiquinone</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2019</year>, <volume>62</volume>, <fpage>86</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3700</pub-id>.<pub-id pub-id-type="pmcid">PMC6590163</pub-id><pub-id pub-id-type="pmid">30556149</pub-id></mixed-citation></ref><ref id="ref419"><mixed-citation publication-type="journal" id="cit419"><name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Takashima-Hirano</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sumi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Koyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name><article-title>Synthesis of <sup>11</sup>C-Labeled
Retinoic Acid, [<sup>11</sup>C]ATRA, via an Alkenylboron
Precursor by Pd(0)-Mediated Rapid C-[<sup>11</sup>C]methylation</article-title>. <source>Bioorg. Med. Chem. Lett.</source><year>2014</year>, <volume>24</volume>, <fpage>3622</fpage>&#8211;<lpage>3625</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2014.05.041</pub-id>.<pub-id pub-id-type="pmid">24930828</pub-id></mixed-citation></ref><ref id="ref420"><mixed-citation publication-type="journal" id="cit420"><name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Barbon</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Ferocino</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Alsulaimani</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Dunn</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sunassee</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A.</given-names></name><article-title>Imaging Niacin
Trafficking With Positron Emission Tomography Reveals <italic toggle="yes">In Vivo</italic> Monocarboxylate Transporter Distribution</article-title>. <source>Nucl. Med. Biol.</source><year>2020</year>, <volume>88-89</volume>, <fpage>24</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2020.07.002</pub-id>.<pub-id pub-id-type="pmid">32683248</pub-id><pub-id pub-id-type="pmcid">PMC7599079</pub-id></mixed-citation></ref><ref id="ref421"><mixed-citation publication-type="journal" id="cit421"><name name-style="western"><surname>Hankes</surname><given-names>L. V.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name>; <name name-style="western"><surname>Rota</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Langen</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Herzog</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Stoecklin</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Feinendegen</surname><given-names>L. E.</given-names></name><article-title>Blood Brain
Barrier Blocks Transport of Carboxyl-<sup>11</sup>C-Nicotinic Acid
Into Human Brain</article-title>. <source>Eur. J. Nucl. Med.</source><year>1988</year>, <volume>14</volume>, <fpage>53</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/BF00252620</pub-id>.<pub-id pub-id-type="pmid">3383906</pub-id></mixed-citation></ref><ref id="ref422"><mixed-citation publication-type="journal" id="cit422"><name name-style="western"><surname>Karimi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Palladium-Mediated
Carboxylation of Aryl Halides (Triflates) or Benzyl Halides Using
[<sup>13</sup>C]/[<sup>11</sup>C]carbon Monoxide With Tetrabutylammonium
Hydroxide or Trimethylphenylammonium Hydroxide</article-title>. <source>J. Chem. Soc., Perkin Trans. 1</source><year>2002</year>, <fpage>2256</fpage>&#8211;<lpage>2259</lpage>. <pub-id pub-id-type="doi">10.1039/B206420K</pub-id>.</mixed-citation></ref><ref id="ref423"><mixed-citation publication-type="journal" id="cit423"><name name-style="western"><surname>Andersson</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Labelled Benzamide Compounds As Potential Tracers
for poly(ADP-Ribose) Synthetase</article-title>. <source>Appl. Radiat.
Isot.</source><year>1994</year>, <volume>45</volume>, <fpage>707</fpage>&#8211;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)90251-8</pub-id>.<pub-id pub-id-type="pmid">8038764</pub-id></mixed-citation></ref><ref id="ref424"><mixed-citation publication-type="journal" id="cit424"><name name-style="western"><surname>Ishii</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Minegishi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nagatsu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M.-R.</given-names></name><article-title>Pd(0)-Mediated
[<sup>11</sup>C]Carbonylation of Aryl and Heteroaryl Boronic Acid
Pinacol Esters With [<sup>11</sup>C]Carbon Monoxide Under Ambient
Conditions and a Facile Process for the Conversion of [<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]Esters to [<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]Amides</article-title>. <source>Tetrahedron</source><year>2015</year>, <volume>71</volume>, <fpage>1588</fpage>&#8211;<lpage>1596</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2015.01.008</pub-id>.</mixed-citation></ref><ref id="ref425"><mixed-citation publication-type="journal" id="cit425"><name name-style="western"><surname>Zoppolo</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Mora-Ramirez</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Reyes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Vasilskis</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Paolino</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Porcal</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Oliver</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Savio</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Bardi&#232;s</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Engler</surname><given-names>H.</given-names></name><article-title>Biological and Dosimetric Evaluation
of [<sup>11</sup>C]S-Adenosyl Methionine as a Potential Agent for
Prostate Cancer Diagnosis</article-title>. <source>Cancer Res. Front.</source><year>2018</year>, <volume>4</volume>, <fpage>27</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.17980/2018.27</pub-id>.</mixed-citation></ref><ref id="ref426"><mixed-citation publication-type="journal" id="cit426"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Matsuzawa</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name><article-title>Tumor Uptake Studies of <italic toggle="yes">S</italic>-Adenosyl-<italic toggle="yes">L</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Methionine and <italic toggle="yes">L</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Methionine</article-title>. <source>Int. J. Radiat. Appl.
Instrum. B. Nucl. Med. Biol.</source><year>1988</year>, <volume>15</volume>, <fpage>123</fpage>&#8211;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2897(88)90077-3</pub-id>.<pub-id pub-id-type="pmid">3259215</pub-id></mixed-citation></ref><ref id="ref427"><mixed-citation publication-type="journal" id="cit427"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yanai</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Watanuki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ohtomo</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kogure</surname><given-names>K.</given-names></name><article-title>Simplified Enzymatic Synthesis and Biodistribution
of <italic toggle="yes">11</italic>C-<italic toggle="yes">S</italic>-Adenosyl-<italic toggle="yes">L</italic>-Methionine</article-title>. <source>Eur. J. Nucl. Med.</source><year>1986</year>, <volume>11</volume>, <fpage>449</fpage>&#8211;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1007/BF00261008</pub-id>.<pub-id pub-id-type="pmid">3486766</pub-id></mixed-citation></ref><ref id="ref428"><mixed-citation publication-type="journal" id="cit428"><name name-style="western"><surname>Gueguen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Morgat</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Mazi&#233;re</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Maman</surname><given-names>M.</given-names></name><article-title>Enzymatic Synthesis
of <sup>11</sup>C Labelled <italic toggle="yes">S</italic>-Adenosylmethionine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1982</year>, <volume>19</volume>, <fpage>157</fpage>&#8211;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580190202</pub-id>.</mixed-citation></ref><ref id="ref429"><mixed-citation publication-type="journal" id="cit429"><name name-style="western"><surname>Nozaki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Mawatari</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nakatani</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hayashinaka</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Wada</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nomura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kitayoshi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Akimoto</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ninomiya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; et al. <article-title>PET Imaging
Analysis of Vitamin B1 Kinetics with [<sup>11</sup>C]Thiamine and
its Derivative [<sup>11</sup>C]Thiamine Tetrahydrofurfuryl Disulfide
in Rats</article-title>. <source>Mol. Imaging Biol.</source><year>2018</year>, <volume>20</volume>, <fpage>1001</fpage>&#8211;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-018-1186-y</pub-id>.<pub-id pub-id-type="pmid">29560588</pub-id></mixed-citation></ref><ref id="ref430"><mixed-citation publication-type="journal" id="cit430"><name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Mawatari</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Aita</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wada</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nakaoka</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Onoe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamano</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Akamatsu</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ohnishi</surname><given-names>A.</given-names></name>; et al. <article-title>PET Imaging
of <sup>11</sup>C-Labeled Thiamine Tetrahydrofurfuryl Disulfide, Vitamin
B<sub>1</sub> Derivative: First-in-Human Study</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>2021</year>, <volume>555</volume>, <fpage>7</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2021.03.119</pub-id>.<pub-id pub-id-type="pmid">33812058</pub-id></mixed-citation></ref><ref id="ref431"><mixed-citation publication-type="journal" id="cit431"><name name-style="western"><surname>Shen</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Palner</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Carrol</surname><given-names>V. N.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>MacKenzie</surname><given-names>J. D.</given-names></name><article-title>PET Imaging of [<sup>11</sup>C]Ascorbic
Acid in a Murine Rheumatoid Arthritis Model</article-title>. <source>Mol. Imaging Biol.</source><year>2015</year>, <volume>18</volume>, <fpage>2</fpage>.</mixed-citation></ref><ref id="ref432"><mixed-citation publication-type="journal" id="cit432"><name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of [1-11C], [2-11C], [1-11C](2H3) and [2-11C](2H3)acetate for in vivo
studies of myocardium using PET</article-title>. <source>Nucl. Med.
Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>1067</fpage>&#8211;<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90178-3</pub-id>.<pub-id pub-id-type="pmid">9234364</pub-id></mixed-citation></ref><ref id="ref433"><mixed-citation publication-type="journal" id="cit433"><name name-style="western"><surname>Kuratsune</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamaguti</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Jacobsson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Machii</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Onoe</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Onoe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; et al. <article-title>High Uptake of [2-<sup>11</sup>C]Acetyl-<italic toggle="yes">L</italic>-Carnitine Into the Brain: a PET
Study</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>1997</year>, <volume>231</volume>, <fpage>488</fpage>&#8211;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.5919</pub-id>.<pub-id pub-id-type="pmid">9070306</pub-id></mixed-citation></ref><ref id="ref434"><mixed-citation publication-type="journal" id="cit434"><name name-style="western"><surname>Yamaguti</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kuratsune</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nakamoto</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Machii</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Jacobsson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Onoe</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; et al. <article-title>Acylcarnitine
Metabolism During Fasting and After Refeeding</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>1996</year>, <volume>225</volume>, <fpage>740</fpage>&#8211;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.1244</pub-id>.<pub-id pub-id-type="pmid">8780683</pub-id></mixed-citation></ref><ref id="ref435"><mixed-citation publication-type="journal" id="cit435"><name name-style="western"><surname>Haji Dheere</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Yusuf</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A.</given-names></name><article-title>Rapid and Efficient
Synthesis of [<sup>11</sup>C]Ureas via the Incorporation of [<sup>11</sup>C]CO<sub>2</sub> Into Aliphatic and Aromatic Amines</article-title>. <source>Chem. Commun.</source><year>2013</year>, <volume>49</volume>, <fpage>8193</fpage>&#8211;<lpage>8195</lpage>. <pub-id pub-id-type="doi">10.1039/c3cc44046j</pub-id>.<pub-id pub-id-type="pmid">23925577</pub-id></mixed-citation></ref><ref id="ref436"><mixed-citation publication-type="journal" id="cit436"><name name-style="western"><surname>Machulla</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Dutschka</surname><given-names>K.</given-names></name><article-title><sup>11</sup>C-Labelled Radiopharmaceuticals:
Synthesis and High Pressure Liquid Chromatography of Nicotinic-<sup>11</sup>C Acid Amide</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>287</fpage>&#8211;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580160208</pub-id>.</mixed-citation></ref><ref id="ref437"><mixed-citation publication-type="journal" id="cit437"><name name-style="western"><surname>Qin</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Carroll</surname><given-names>V. N.</given-names></name>; <name name-style="western"><surname>Sriram</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Villanueva-Meyer</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>von Morze</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z. J.</given-names></name>; <name name-style="western"><surname>Mutch</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Keshari</surname><given-names>K. R.</given-names></name>; <name name-style="western"><surname>Flavell</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Kurhanewicz</surname><given-names>J.</given-names></name>; et al. <article-title>Imaging Glutathione
Depletion in the Rat Brain Using Ascorbate-Derived Hyperpolarized
MR and PET Probes</article-title>. <source>Sci. Rep.</source><year>2018</year>, <volume>8</volume>, <fpage>7928</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-26296-6</pub-id>.<pub-id pub-id-type="pmid">29786697</pub-id><pub-id pub-id-type="pmcid">PMC5962598</pub-id></mixed-citation></ref><ref id="ref438"><mixed-citation publication-type="book" id="cit438"><person-group person-group-type="allauthors"><name name-style="western"><surname>Patel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Miao</surname><given-names>J.
H.</given-names></name>; <name name-style="western"><surname>Yetiskul</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Anokhin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Majmundar</surname><given-names>S. H.</given-names></name></person-group><article-title>Physiology,
Carbon Dioxide Retention</article-title>. In <source>StatPearls</source>; <publisher-name>StatPearls Publishing LLC</publisher-name>, <year>2021</year>.<pub-id pub-id-type="pmid">29494063</pub-id></mixed-citation></ref><ref id="ref439"><mixed-citation publication-type="journal" id="cit439"><name name-style="western"><surname>Deitmer</surname><given-names>J. W.</given-names></name><article-title>A Role for CO<sub>2</sub> and Bicarbonate
Transporters
in Metabolic Exchanges in the Brain</article-title>. <source>J. Neurochem.</source><year>2002</year>, <volume>80</volume>, <fpage>721</fpage>&#8211;<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1046/j.0022-3042.2002.00765.x</pub-id>.<pub-id pub-id-type="pmid">11948234</pub-id></mixed-citation></ref><ref id="ref440"><mixed-citation publication-type="journal" id="cit440"><name name-style="western"><surname>Leibold</surname><given-names>N. K.</given-names></name>; <name name-style="western"><surname>van den Hove</surname><given-names>D. L.</given-names></name>; <name name-style="western"><surname>Esquivel</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>De Cort</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Goossens</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Strackx</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Buchanan</surname><given-names>G. F.</given-names></name>; <name name-style="western"><surname>Steinbusch</surname><given-names>H. W.</given-names></name>; <name name-style="western"><surname>Lesch</surname><given-names>K. P.</given-names></name>; <name name-style="western"><surname>Schruers</surname><given-names>K. R.</given-names></name><article-title>The Brain
Acid-Base Homeostasis and
Serotonin: A Perspective on the Use of Carbon Dioxide As Human and
Rodent Experimental Model of Panic</article-title>. <source>Prog. Neurobiol.</source><year>2015</year>, <volume>129</volume>, <fpage>58</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.04.001</pub-id>.<pub-id pub-id-type="pmid">25930682</pub-id></mixed-citation></ref><ref id="ref441"><mixed-citation publication-type="journal" id="cit441"><name name-style="western"><surname>Kourti</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>W. G.</given-names></name>; <name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><article-title>Aspects of
Carbon Monoxide
in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light
on the Way</article-title>. <source>Oxid. Med. Cell. Longevity</source><year>2017</year>, <volume>2017</volume>, <fpage>9326454</fpage><pub-id pub-id-type="doi">10.1155/2017/9326454</pub-id>.<pub-id pub-id-type="pmcid">PMC5327762</pub-id><pub-id pub-id-type="pmid">28286606</pub-id></mixed-citation></ref><ref id="ref442"><mixed-citation publication-type="journal" id="cit442"><name name-style="western"><surname>Levitt</surname><given-names>D. G.</given-names></name>; <name name-style="western"><surname>Levitt</surname><given-names>M. D.</given-names></name><article-title>Carbon Monoxide:
A Critical Quantitative
Analysis and Review of the Extent and Limitations of Its Second Messenger
Function</article-title>. <source>Clin. Pharmacol.</source><year>2015</year>, <volume>7</volume>, <fpage>37</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.2147/CPAA.S79626</pub-id>.<pub-id pub-id-type="pmid">25750547</pub-id><pub-id pub-id-type="pmcid">PMC4348054</pub-id></mixed-citation></ref><ref id="ref443"><mixed-citation publication-type="journal" id="cit443"><name name-style="western"><surname>Jia</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><article-title>Methane Medicine: A
Rising Star Gas with Powerful Anti-Inflammation, Antioxidant, and
Antiapoptosis Properties</article-title>. <source>Oxid. Med. Cell. Longev.</source><year>2018</year>, <volume>2018</volume>, <fpage>1912746</fpage><pub-id pub-id-type="doi">10.1155/2018/1912746</pub-id>.<pub-id pub-id-type="pmid">29743971</pub-id><pub-id pub-id-type="pmcid">PMC5878870</pub-id></mixed-citation></ref><ref id="ref444"><mixed-citation publication-type="journal" id="cit444"><name name-style="western"><surname>Lockwood</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name><article-title><sup>11</sup>C-Carbon
Dioxide Fixation
and Equilibration in Rat Brain</article-title>. <source>Neurology</source><year>1982</year>, <volume>32</volume>, <fpage>451</fpage>&#8211;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.32.4.451</pub-id>.<pub-id pub-id-type="pmid">6801543</pub-id></mixed-citation></ref><ref id="ref445"><mixed-citation publication-type="journal" id="cit445"><name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Kozawa</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Kozell</surname><given-names>L. B.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Swenson</surname><given-names>E. R.</given-names></name>; <name name-style="western"><surname>Spence</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Bassingthwaighte</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>Contribution of Labeled Carbon Dioxide
to PET Imaging
of Carbon-11-Labeled Compounds</article-title>. <source>J. Nucl. Med.</source><year>1992</year>, <volume>33</volume>, <fpage>581</fpage>&#8211;<lpage>584</lpage>.<pub-id pub-id-type="pmid">1552344</pub-id></mixed-citation></ref><ref id="ref446"><mixed-citation publication-type="journal" id="cit446"><name name-style="western"><surname>Brooks</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Lammertsma</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Beaney</surname><given-names>R. P.</given-names></name>; <name name-style="western"><surname>Leenders</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Buckingham</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Marshall</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name><article-title>Measurement of Regional
Cerebral pH in Human Subjects Using Continuous Inhalation of <sup>11</sup>CO<sub>2</sub> and Positron Emission Tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1984</year>, <volume>4</volume>, <fpage>458</fpage>&#8211;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1984.65</pub-id>.<pub-id pub-id-type="pmid">6432811</pub-id></mixed-citation></ref><ref id="ref447"><mixed-citation publication-type="journal" id="cit447"><name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Alpert</surname><given-names>N. M.</given-names></name>; <name name-style="western"><surname>Mackay</surname><given-names>B. C.</given-names></name>; <name name-style="western"><surname>Buxton</surname><given-names>R. B.</given-names></name>; <name name-style="western"><surname>Correia</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Weise</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Ackerman</surname><given-names>R. H.</given-names></name>; <name name-style="western"><surname>Dorer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Buonanno</surname><given-names>F. S.</given-names></name><article-title>Evaluation of the <sup>11</sup>CO<sub>2</sub> Positron
Emission Tomographic Method for Measuring Brain pH. II. Quantitative
pH Mapping in Patients With Ischemic Cerebrovascular Diseases</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1989</year>, <volume>9</volume>, <fpage>859</fpage>&#8211;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1989.120</pub-id>.<pub-id pub-id-type="pmid">2511212</pub-id></mixed-citation></ref><ref id="ref448"><mixed-citation publication-type="journal" id="cit448"><name name-style="western"><surname>Fowle</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Matthews</surname><given-names>C. M.</given-names></name>; <name name-style="western"><surname>Campbell</surname><given-names>E. J.</given-names></name><article-title>The Rapid
Distribution
of <sup>3</sup>H<sub>2</sub>O and <sup>11</sup>CO<sub>2</sub> in the
Body in Relation to the Immediate Carbon Dioxide Storage Capacity</article-title>. <source>Clin. Sci.</source><year>1964</year>, <volume>27</volume>, <fpage>51</fpage>&#8211;<lpage>65</lpage>.<pub-id pub-id-type="pmid">14203260</pub-id></mixed-citation></ref><ref id="ref449"><mixed-citation publication-type="journal" id="cit449"><name name-style="western"><surname>Johnson</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>Hoop</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Kazemi</surname><given-names>H.</given-names></name><article-title>Movement of CO<sub>2</sub> and HCO<sub>3</sub><sup>&#8211;</sup> from Blood to Brain
in Dogs</article-title>. <source>J. Appl. Physiol.</source><year>1983</year>, <volume>54</volume>, <fpage>989</fpage>&#8211;<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1983.54.4.989</pub-id>.<pub-id pub-id-type="pmid">6406409</pub-id></mixed-citation></ref><ref id="ref450"><mixed-citation publication-type="journal" id="cit450"><name name-style="western"><surname>Brooks</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Beaney</surname><given-names>R. P.</given-names></name>; <name name-style="western"><surname>Thomas</surname><given-names>D. G. T.</given-names></name>; <name name-style="western"><surname>Marshall</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jons</surname><given-names>T.</given-names></name><article-title>Studies on Regional Cerebral pH in
Patients with Cerebral Tumours
Using Continuous Inhalation of <sup>11</sup>CO<sub>2</sub> and Positron
Emission Tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1986</year>, <volume>6</volume>, <fpage>529</fpage>&#8211;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1986.98</pub-id>.<pub-id pub-id-type="pmid">3093489</pub-id></mixed-citation></ref><ref id="ref451"><mixed-citation publication-type="book" id="cit451"><person-group person-group-type="allauthors"><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P.
J. H.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name></person-group><source><sup>11</sup>C Carbon
Dioxide: Starting Point for Labeling PET Radiopharmaceuticals</source>. <publisher-name>InTech</publisher-name>, <year>2018</year>.</mixed-citation></ref><ref id="ref452"><mixed-citation publication-type="journal" id="cit452"><name name-style="western"><surname>Herance</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gispert</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Abad</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>V&#237;ctor</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Pareto</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Torrent</surname><given-names>&#201;.</given-names></name>; <name name-style="western"><surname>Rojas</surname><given-names>S.</given-names></name><article-title>Erythrocytes Labeled
With [<sup>18</sup>F]SFB as an Alternative to Radioactive CO for Quantification
of Blood Volume With PET</article-title>. <source>Contrast Media Mol.
Imaging</source><year>2013</year>, <volume>8</volume>, <fpage>375</fpage>&#8211;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1002/cmmi.1533</pub-id>.<pub-id pub-id-type="pmid">23613441</pub-id></mixed-citation></ref><ref id="ref453"><mixed-citation publication-type="journal" id="cit453"><name name-style="western"><surname>Berglund</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lilja</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Andersson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lindberg</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ulin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name><article-title>Maternal Blood Volume in Placenta of the Rhesus Monkey
Measured <italic toggle="yes">In Vivo</italic> by Positron Emission Tomography</article-title>. <source>Gynecol. Obstet. Invest.</source><year>1991</year>, <volume>31</volume>, <fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1159/000293090</pub-id>.<pub-id pub-id-type="pmid">2010109</pub-id></mixed-citation></ref><ref id="ref454"><mixed-citation publication-type="journal" id="cit454"><name name-style="western"><surname>Carter</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Tompkins</surname><given-names>R. G.</given-names></name>; <name name-style="western"><surname>Hsu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Christian</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Alpert</surname><given-names>N. M.</given-names></name>; <name name-style="western"><surname>Weise</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Fischman</surname><given-names>A. J.</given-names></name><article-title>Metabolic Alterations
in Muscle of Thermally Injured Rabbits, Measured by Positron Emission
Tomography</article-title>. <source>Life Sci.</source><year>1997</year>, <volume>61</volume>, <fpage>39</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S0024-3205(97)00355-X</pub-id>.<pub-id pub-id-type="pmid">9200667</pub-id></mixed-citation></ref><ref id="ref455"><mixed-citation publication-type="journal" id="cit455"><name name-style="western"><surname>Shishido</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tateno</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Takashima</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tamachi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yamaura</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Yamasaki</surname><given-names>T.</given-names></name><article-title>Positron CT Imaging
Using a High Resolution PCT Device (Positologica-I), <sup>11</sup>CO, <sup>13</sup>NH<sub>3</sub>, and <sup>18</sup>FDG in Clinical
Evaluation of Cerebrovascular Diseases</article-title>. <source>Eur.
J. Nucl. Med.</source><year>1984</year>, <volume>9</volume>, <fpage>265</fpage>&#8211;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1007/BF00803248</pub-id>.<pub-id pub-id-type="pmid">6611260</pub-id></mixed-citation></ref><ref id="ref456"><mixed-citation publication-type="journal" id="cit456"><name name-style="western"><surname>Weinreich</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ritzl</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Feinendegen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Schnippering</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>St&#246;cklin</surname><given-names>G.</given-names></name><article-title>Fixation, Retention and Exhalation
of Carrier-Free <sup>11</sup>C-Labeled Carbon Monoxide by Man</article-title>. <source>Radiat. Environ. Biophys.</source><year>1975</year>, <volume>12</volume>, <fpage>271</fpage>&#8211;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1007/BF01323415</pub-id>.<pub-id pub-id-type="pmid">1202560</pub-id></mixed-citation></ref><ref id="ref457"><mixed-citation publication-type="journal" id="cit457"><name name-style="western"><surname>Phelps</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hoffman</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Kuhl</surname><given-names>D.</given-names></name><article-title>Validation
of Tomographic Measurement of Cerebral Blood Volume With C-11-Labeled
Carboxyhemoglobin</article-title>. <source>J. Nucl. Med.</source><year>1979</year>, <volume>20</volume>, <fpage>328</fpage>&#8211;<lpage>334</lpage>.<pub-id pub-id-type="pmid">119833</pub-id></mixed-citation></ref><ref id="ref458"><mixed-citation publication-type="journal" id="cit458"><name name-style="western"><surname>Taddei</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>Recent Progress
in [<sup>11</sup>C]Carbon Dioxide ([<sup>11</sup>C]CO<sub>2</sub>)
and [<sup>11</sup>C]Carbon Monoxide ([<sup>11</sup>C]CO) Chemistry</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2018</year>, <volume>61</volume>, <fpage>237</fpage>&#8211;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3596</pub-id>.<pub-id pub-id-type="pmcid">PMC6485328</pub-id><pub-id pub-id-type="pmid">29274276</pub-id></mixed-citation></ref><ref id="ref459"><mixed-citation publication-type="journal" id="cit459"><name name-style="western"><surname>Beaney</surname><given-names>R. P.</given-names></name>; <name name-style="western"><surname>Lammertsma</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>McKenzie</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Halnan</surname><given-names>K. E.</given-names></name><article-title>Positron Emission
Tomography for In-Vivo Measurement
of Regional Blood Flow, Oxygen Utilisation, and Blood Volume in Patients
With Breast Carcinoma</article-title>. <source>Lancet</source><year>1984</year>, <volume>323</volume>, <fpage>131</fpage>&#8211;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(84)90063-1</pub-id>.<pub-id pub-id-type="pmid">6140443</pub-id></mixed-citation></ref><ref id="ref460"><mixed-citation publication-type="journal" id="cit460"><name name-style="western"><surname>Kurdziel</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Figg</surname><given-names>W. D.</given-names></name>; <name name-style="western"><surname>Carrasquillo</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Huebsch</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Whatley</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sellers</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Libutti</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Pluda</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Dahut</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Reed</surname><given-names>E.</given-names></name>; et al. <article-title>Using
Positron Emission Tomography 2-Deoxy-2-[<sup>18</sup>F]Fluoro-<italic toggle="yes">D</italic>-Glucose, <sup>11</sup>CO, and <sup>15</sup>O-Water for
Monitoring Androgen Independent Prostate Cancer</article-title>. <source>Mol. Imaging Biol.</source><year>2003</year>, <volume>5</volume>, <fpage>86</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/S1536-1632(03)00039-8</pub-id>.<pub-id pub-id-type="pmid">14499149</pub-id></mixed-citation></ref><ref id="ref461"><mixed-citation publication-type="journal" id="cit461"><name name-style="western"><surname>Glass</surname><given-names>H. I.</given-names></name>; <name name-style="western"><surname>Jacoby</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Westerman</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Clark</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Arnot</surname><given-names>R. N.</given-names></name>; <name name-style="western"><surname>Dixon</surname><given-names>H. G.</given-names></name><article-title>Placental Localization
by Inhalation of Radioactive Carbon Monoxide</article-title>. <source>J. Nucl. Med.</source><year>1968</year>, <volume>9</volume>, <fpage>468</fpage>&#8211;<lpage>470</lpage>.<pub-id pub-id-type="pmid">5747863</pub-id></mixed-citation></ref><ref id="ref462"><mixed-citation publication-type="journal" id="cit462"><name name-style="western"><surname>Taddei</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Haji Dheere</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>[<sup>11</sup>C]CO<sub>2</sub> to
[<sup>11</sup>C]CO
Conversion Mediated by [11C]silanes: A Novel Route for [<sup>11</sup>C]carbonylation Reactions</article-title>. <source>Chem. Commun.</source><year>2015</year>, <volume>51</volume>, <fpage>11795</fpage>&#8211;<lpage>11797</lpage>. <pub-id pub-id-type="doi">10.1039/C5CC02095F</pub-id>.<pub-id pub-id-type="pmid">26107103</pub-id></mixed-citation></ref><ref id="ref463"><mixed-citation publication-type="journal" id="cit463"><name name-style="western"><surname>Iida</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rhodes</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Araujo</surname><given-names>L. I.</given-names></name>; <name name-style="western"><surname>Yamamoto</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>de Silva</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Maseri</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name><article-title>Noninvasive
Quantification
of Regional Myocardial Metabolic Rate for Oxygen by Use of <sup>15</sup>O<sub>2</sub> Inhalation and Positron Emission Tomography. Theory,
Error Analysis, and Application in Humans</article-title>. <source>Circulation</source><year>1996</year>, <volume>94</volume>, <fpage>792</fpage>&#8211;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.94.4.792</pub-id>.<pub-id pub-id-type="pmid">8772704</pub-id></mixed-citation></ref><ref id="ref464"><mixed-citation publication-type="journal" id="cit464"><name name-style="western"><surname>Madsen</surname><given-names>M. T.</given-names></name>; <name name-style="western"><surname>Hichwa</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Nickles</surname><given-names>R. J.</given-names></name><article-title>An Investigation
of <sup>11</sup>C-Methane, <sup>13</sup>N-Nitrous Oxide and <sup>11</sup>C-Acetylene As Regional Cerebral Blood Flow Agents</article-title>. <source>Phys. Med. Biol.</source><year>1981</year>, <volume>26</volume>, <fpage>875</fpage>&#8211;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/26/5/007</pub-id>.<pub-id pub-id-type="pmid">7291308</pub-id></mixed-citation></ref><ref id="ref465"><mixed-citation publication-type="journal" id="cit465"><name name-style="western"><surname>Mock</surname><given-names>B. H.</given-names></name>; <name name-style="western"><surname>Mulholland</surname><given-names>G. K.</given-names></name>; <name name-style="western"><surname>Vavrek</surname><given-names>M. T.</given-names></name><article-title>Convenient Gas Phase
Bromination of [<sup>11</sup>C]Methane and Production of [<sup>11</sup>C]Methyl Triflate</article-title>. <source>Nucl. Med. Biol.</source><year>1999</year>, <volume>26</volume>, <fpage>467</fpage>&#8211;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(98)00087-0</pub-id>.<pub-id pub-id-type="pmid">10382852</pub-id></mixed-citation></ref><ref id="ref466"><mixed-citation publication-type="journal" id="cit466"><name name-style="western"><surname>Gillings</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Jorgensen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Larsen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Koziorowski</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jensen</surname><given-names>H.</given-names></name><article-title>Optimisation of [<sup>11</sup>C]Methane Yields From
a High Pressure Gas Target</article-title>. <source>AIP Conf. Proc.</source><year>2012</year>, <volume>1509</volume>, <fpage>181</fpage>&#8211;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1063/1.4773963</pub-id>.</mixed-citation></ref><ref id="ref467"><mixed-citation publication-type="journal" id="cit467"><name name-style="western"><surname>Haji Dheere</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Shakir</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A.</given-names></name><article-title>Direct Incorporation
of [<sup>11</sup>C]CO<sub>2</sub> into Asymmetric [<sup>11</sup>C]Carbonates</article-title>. <source>J. Chem.</source><year>2018</year>, <volume>2018</volume>, <fpage>7641304</fpage><pub-id pub-id-type="doi">10.1155/2018/7641304</pub-id>.<pub-id pub-id-type="pmid">34079623</pub-id><pub-id pub-id-type="pmcid">PMC7610879</pub-id></mixed-citation></ref><ref id="ref468"><mixed-citation publication-type="journal" id="cit468"><name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Ter-Pogossian</surname><given-names>M. M.</given-names></name><article-title>Preparation of Short Half-Lived Radioactive
Gases for Medical Studies</article-title>. <source>Radiat. Res.</source><year>1968</year>, <volume>36</volume>, <fpage>580</fpage>&#8211;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.2307/3572591</pub-id>.<pub-id pub-id-type="pmid">17387889</pub-id></mixed-citation></ref><ref id="ref469"><mixed-citation publication-type="book" id="cit469"><person-group person-group-type="allauthors"><name name-style="western"><surname>Clark</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Buckingham</surname><given-names>P. D.</given-names></name></person-group><source>Short-Lived Radioactive
Gases for Clinical Use</source>; <publisher-loc>Butterworth</publisher-loc>, <year>1975</year>.</mixed-citation></ref><ref id="ref470"><mixed-citation publication-type="journal" id="cit470"><name name-style="western"><surname>Rahman</surname><given-names>O.</given-names></name><article-title>[<sup>11</sup>C]Carbon Monoxide in
Labeling Chemistry
and Positron Emission Tomography Tracer Development: Scope and Limitations</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2015</year>, <volume>58</volume>, <fpage>86</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3262</pub-id>.<pub-id pub-id-type="pmid">25689679</pub-id></mixed-citation></ref><ref id="ref471"><mixed-citation publication-type="journal" id="cit471"><name name-style="western"><surname>Dahl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ulin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Schou</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name><article-title>Reduction
of [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]CO Using Solid
Supported Zinc</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2017</year>, <volume>60</volume>, <fpage>624</fpage>&#8211;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3561</pub-id>.<pub-id pub-id-type="pmid">28868618</pub-id></mixed-citation></ref><ref id="ref472"><mixed-citation publication-type="journal" id="cit472"><name name-style="western"><surname>Nordeman</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Friis</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>Andersen</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Audrain</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Larhed</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Skrydstrup</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name><article-title>Rapid and Efficient
Conversion of <sup>11</sup>CO<sub>2</sub> to <sup>11</sup>CO through
Silacarboxylic Acids: Applications in Pd-Mediated Carbonylations</article-title>. <source>Eur. J. Chem.</source><year>2015</year>, <volume>21</volume>, <fpage>17601</fpage>&#8211;<lpage>17604</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201503262</pub-id>.<pub-id pub-id-type="pmid">26492852</pub-id></mixed-citation></ref><ref id="ref473"><mixed-citation publication-type="journal" id="cit473"><name name-style="western"><surname>Taddei</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>Instantaneous Conversion
of [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]CO via Fluoride-Activated
Disilane Species</article-title>. <source>Eur. J. Chem.</source><year>2017</year>, <volume>23</volume>, <fpage>7682</fpage>&#8211;<lpage>7685</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201701661</pub-id>.<pub-id pub-id-type="pmcid">PMC5488231</pub-id><pub-id pub-id-type="pmid">28419627</pub-id></mixed-citation></ref><ref id="ref474"><mixed-citation publication-type="journal" id="cit474"><name name-style="western"><surname>Eriksson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Itsenko</surname><given-names>O.</given-names></name><article-title>The Development of <sup>11</sup>C-Carbonylation Chemistry:
A Systematic View</article-title>. <source>Nucl. Med. Biol.</source><year>2021</year>, <volume>92</volume>, <fpage>115</fpage>&#8211;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2020.02.005</pub-id>.<pub-id pub-id-type="pmid">32147168</pub-id></mixed-citation></ref><ref id="ref475"><mixed-citation publication-type="journal" id="cit475"><name name-style="western"><surname>Buckley</surname><given-names>K. R.</given-names></name>; <name name-style="western"><surname>Huser</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Jivan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Chun</surname><given-names>K. S.</given-names></name>; <name name-style="western"><surname>Ruth</surname><given-names>T. J.</given-names></name><article-title><sup>11</sup>C-Methane Production
in Small Volume,
High Pressure Gas Targets</article-title>. <source>Radiochim. Acta</source><year>2000</year>, <volume>88</volume>, <fpage>201</fpage>&#8211;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1524/ract.2000.88.3-4.201</pub-id>.</mixed-citation></ref><ref id="ref476"><mixed-citation publication-type="journal" id="cit476"><name name-style="western"><surname>Brown</surname><given-names>H. A.</given-names></name>; <name name-style="western"><surname>Marnett</surname><given-names>L. J.</given-names></name><article-title>Introduction to
Lipid Biochemistry,
Metabolism, and Signaling</article-title>. <source>Chem. Rev.</source><year>2011</year>, <volume>111</volume>, <fpage>5817</fpage>&#8211;<lpage>5820</lpage>. <pub-id pub-id-type="doi">10.1021/cr200363s</pub-id>.<pub-id pub-id-type="pmid">21951202</pub-id></mixed-citation></ref><ref id="ref477"><mixed-citation publication-type="journal" id="cit477"><name name-style="western"><surname>Calder</surname><given-names>P. C.</given-names></name><article-title>Functional Roles of Fatty Acids and
Their Effects on
Human Health</article-title>. <source>JPEN J. Parenter. Enteral. Nutr.</source><year>2015</year>, <volume>39</volume>, <fpage>18s</fpage>&#8211;<lpage>32s</lpage>. <pub-id pub-id-type="doi">10.1177/0148607115595980</pub-id>.<pub-id pub-id-type="pmid">26177664</pub-id></mixed-citation></ref><ref id="ref478"><mixed-citation publication-type="journal" id="cit478"><name name-style="western"><surname>Glick</surname><given-names>N. R.</given-names></name>; <name name-style="western"><surname>Fischer</surname><given-names>M. H.</given-names></name><article-title>The Role of Essential
Fatty Acids
in Human Health</article-title>. <source>Evid. Based Complementary Altern.
Med.</source><year>2013</year>, <volume>18</volume>, <fpage>268</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1177/2156587213488788</pub-id>.</mixed-citation></ref><ref id="ref479"><mixed-citation publication-type="journal" id="cit479"><name name-style="western"><surname>Kendrick</surname><given-names>S. F.</given-names></name>; <name name-style="western"><surname>O&#8217;Boyle</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Mann</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Zeybel</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Palmer</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Day</surname><given-names>C. P.</given-names></name><article-title>Acetate, the Key
Modulator of Inflammatory Responses in Acute Alcoholic Hepatitis</article-title>. <source>Hepatology</source><year>2010</year>, <volume>51</volume>, <fpage>1988</fpage>&#8211;<lpage>1997</lpage>. <pub-id pub-id-type="doi">10.1002/hep.23572</pub-id>.<pub-id pub-id-type="pmid">20232292</pub-id></mixed-citation></ref><ref id="ref480"><mixed-citation publication-type="book" id="cit480"><person-group person-group-type="allauthors"><name name-style="western"><surname>Shipovskaya</surname><given-names>A. B.</given-names></name></person-group><source>Acetate&#8211;Versatile
Buiding Block of Biology and chemistry</source>; <publisher-name>Nova
Science Publishing</publisher-name>, <year>2013</year>.</mixed-citation></ref><ref id="ref481"><mixed-citation publication-type="journal" id="cit481"><name name-style="western"><surname>Mashimo</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Pichumani</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Vemireddy</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Hatanpaa</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Singh</surname><given-names>D. K.</given-names></name>; <name name-style="western"><surname>Sirasanagandla</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nannepaga</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Piccirillo</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Kovacs</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Foong</surname><given-names>C.</given-names></name>; et al. <article-title>Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain
Metastases</article-title>. <source>Cell</source><year>2014</year>, <volume>159</volume>, <fpage>1603</fpage>&#8211;<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.025</pub-id>.<pub-id pub-id-type="pmid">25525878</pub-id><pub-id pub-id-type="pmcid">PMC4374602</pub-id></mixed-citation></ref><ref id="ref482"><mixed-citation publication-type="journal" id="cit482"><name name-style="western"><surname>Schug</surname><given-names>Z. T.</given-names></name>; <name name-style="western"><surname>Vande Voorde</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gottlieb</surname><given-names>E.</given-names></name><article-title>The Metabolic Fate
of Acetate in Cancer</article-title>. <source>Nat. Rev. Cancer</source><year>2016</year>, <volume>16</volume>, <fpage>708</fpage>&#8211;<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1038/nrc.2016.87</pub-id>.<pub-id pub-id-type="pmid">27562461</pub-id><pub-id pub-id-type="pmcid">PMC8992383</pub-id></mixed-citation></ref><ref id="ref483"><mixed-citation publication-type="journal" id="cit483"><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>S. H.</given-names></name>; <name name-style="western"><surname>Ren</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Yao</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>H. B.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>S. X.</given-names></name>; <name name-style="western"><surname>Yan</surname><given-names>G. Q.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>; et al. <article-title>Acetate
Functions as an Epigenetic Metabolite To Promote
Lipid Synthesis Under Hypoxia</article-title>. <source>Nat. Commun.</source><year>2016</year>, <volume>7</volume>, <fpage>11960</fpage><pub-id pub-id-type="doi">10.1038/ncomms11960</pub-id>.<pub-id pub-id-type="pmid">27357947</pub-id><pub-id pub-id-type="pmcid">PMC4931325</pub-id></mixed-citation></ref><ref id="ref484"><mixed-citation publication-type="journal" id="cit484"><name name-style="western"><surname>Grassi</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Nanni</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Allegri</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Morigi</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Montini</surname><given-names>G. C.</given-names></name>; <name name-style="western"><surname>Castellucci</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fanti</surname><given-names>S.</given-names></name><article-title>The Clinical Use of
PET With <sup>11</sup>C-Acetate</article-title>. <source>Am. J. Nucl.
Med. Mol. Imaging</source><year>2012</year>, <volume>2</volume>, <fpage>33</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">23133801</pub-id><pub-id pub-id-type="pmcid">PMC3478117</pub-id></mixed-citation></ref><ref id="ref485"><mixed-citation publication-type="journal" id="cit485"><name name-style="western"><surname>Bouteldja</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Andersen</surname><given-names>L. T.</given-names></name>; <name name-style="western"><surname>M&#248;ller</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Gormsen</surname><given-names>L. C.</given-names></name><article-title>Using Positron Emission
Tomography To Study Human Ketone
Body Metabolism: A Review</article-title>. <source>Metabolism</source><year>2014</year>, <volume>63</volume>, <fpage>1375</fpage>&#8211;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2014.08.001</pub-id>.<pub-id pub-id-type="pmid">25195069</pub-id></mixed-citation></ref><ref id="ref486"><mixed-citation publication-type="journal" id="cit486"><name name-style="western"><surname>Ikenuma</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Koyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kajino</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kimura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ogata</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kawasumi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kato</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Takashima</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ito</surname><given-names>K.</given-names></name>; et al. <article-title>Synthesis
of (<italic toggle="yes">R</italic>, <italic toggle="yes">S</italic>)-Isoproterenol, an Inhibitor
of Tau
Aggregation, as an <sup>11</sup>C-Labeled PET Tracer via Reductive
Alkylation of (<italic toggle="yes">R</italic>, <italic toggle="yes">S</italic>)-Norepinephrine
With [2-<sup>11</sup>C]Acetone</article-title>. <source>Bioorg. Med.
Chem. Lett.</source><year>2019</year>, <volume>29</volume>, <fpage>2107</fpage>&#8211;<lpage>2111</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2019.07.005</pub-id>.<pub-id pub-id-type="pmid">31311732</pub-id></mixed-citation></ref><ref id="ref487"><mixed-citation publication-type="journal" id="cit487"><name name-style="western"><surname>van der Meij</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Carruthers</surname><given-names>N. I.</given-names></name>; <name name-style="western"><surname>Herscheid</surname><given-names>J. D. M.</given-names></name>; <name name-style="western"><surname>Jablonowski</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Leysen</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name><article-title>Reductive <italic toggle="yes">N</italic>-Alkylation
of Secondary Amines with [2-<sup>11</sup>C]Acetone</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2003</year>, <volume>46</volume>, <fpage>1075</fpage>&#8211;<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.740</pub-id>.</mixed-citation></ref><ref id="ref488"><mixed-citation publication-type="journal" id="cit488"><name name-style="western"><surname>Tallima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>El Ridi</surname><given-names>R.</given-names></name><article-title>Arachidonic Acid: Physiological
Roles
and Potential Health Benefits - A Review</article-title>. <source>J.
Adv. Res.</source><year>2018</year>, <volume>11</volume>, <fpage>33</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2017.11.004</pub-id>.<pub-id pub-id-type="pmid">30034874</pub-id><pub-id pub-id-type="pmcid">PMC6052655</pub-id></mixed-citation></ref><ref id="ref489"><mixed-citation publication-type="journal" id="cit489"><name name-style="western"><surname>Farooqui</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Horrocks</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Farooqui</surname><given-names>T.</given-names></name><article-title>Modulation of Inflammation
in Brain: A Matter of Fat</article-title>. <source>J. Neurochem.</source><year>2007</year>, <volume>101</volume>, <fpage>577</fpage>&#8211;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04371.x</pub-id>.<pub-id pub-id-type="pmid">17257165</pub-id></mixed-citation></ref><ref id="ref490"><mixed-citation publication-type="journal" id="cit490"><name name-style="western"><surname>Gollnick</surname><given-names>H.</given-names></name><article-title>Azelaic Acid-Pharmacology, Toxicology
and Mechanisms
of Action on Keratinization <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">In Vivo</italic></article-title>. <source>J. Dermatol. Treat.</source><year>1993</year>, <volume>4</volume>, <fpage>S3</fpage>&#8211;<lpage>S7</lpage>. <pub-id pub-id-type="doi">10.3109/09546639309082151</pub-id>.</mixed-citation></ref><ref id="ref491"><mixed-citation publication-type="journal" id="cit491"><name name-style="western"><surname>Hagen</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Korson</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Sakamoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Evans</surname><given-names>J. E.</given-names></name><article-title>A GC/MS/MS
Screening Method for Multiple Organic Acidemias From Urine Specimens</article-title>. <source>Clin. Chim. Acta</source><year>1999</year>, <volume>283</volume>, <fpage>77</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/S0009-8981(99)00037-6</pub-id>.<pub-id pub-id-type="pmid">10404733</pub-id></mixed-citation></ref><ref id="ref492"><mixed-citation publication-type="journal" id="cit492"><name name-style="western"><surname>Capristo</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Mingrone</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>De Gaetano</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Addolorato</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Greco</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Gasbarrini</surname><given-names>G.</given-names></name><article-title>A New HPLC
Method for the Direct Analysis of Triglycerides of Dicarboxylic Acids
in Biological Samples</article-title>. <source>Clin. Chim. Acta</source><year>1999</year>, <volume>289</volume>, <fpage>11</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/S0009-8981(99)00145-X</pub-id>.<pub-id pub-id-type="pmid">10556649</pub-id></mixed-citation></ref><ref id="ref493"><mixed-citation publication-type="journal" id="cit493"><name name-style="western"><surname>Stilling</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>van de Wouw</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Clarke</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Stanton</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dinan</surname><given-names>T. G.</given-names></name>; <name name-style="western"><surname>Cryan</surname><given-names>J. F.</given-names></name><article-title>The Neuropharmacology
of Butyrate:
The Bread and Butter of the Microbiota-Gut-Brain Axis?</article-title>. <source>Neurochem. Int.</source><year>2016</year>, <volume>99</volume>, <fpage>110</fpage>&#8211;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2016.06.011</pub-id>.<pub-id pub-id-type="pmid">27346602</pub-id></mixed-citation></ref><ref id="ref494"><mixed-citation publication-type="journal" id="cit494"><name name-style="western"><surname>Pituch</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Walkowiak</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Banaszkiewicz</surname><given-names>A.</given-names></name><article-title>Butyric Acid
in Functional Constipation</article-title>. <source>Prz. Gastroenterol.</source><year>2013</year>, <volume>8</volume>, <fpage>295</fpage>&#8211;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.5114/pg.2013.38731</pub-id>.<pub-id pub-id-type="pmid">24868272</pub-id><pub-id pub-id-type="pmcid">PMC4027827</pub-id></mixed-citation></ref><ref id="ref495"><mixed-citation publication-type="journal" id="cit495"><name name-style="western"><surname>Huang</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Tsai</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Chuang</surname><given-names>L. T.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Y. Y.</given-names></name>; <name name-style="western"><surname>Zouboulis</surname><given-names>C. C.</given-names></name>; <name name-style="western"><surname>Tsai</surname><given-names>P. J.</given-names></name><article-title>Anti-Bacterial and
Anti-Inflammatory
Properties of Capric Acid Against Propionibacterium acnes: A Comparative
Study With Lauric Acid</article-title>. <source>J. Dermatol. Sci.</source><year>2014</year>, <volume>73</volume>, <fpage>232</fpage>&#8211;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdermsci.2013.10.010</pub-id>.<pub-id pub-id-type="pmid">24284257</pub-id></mixed-citation></ref><ref id="ref496"><mixed-citation publication-type="journal" id="cit496"><name name-style="western"><surname>Cao</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kevala</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Moon</surname><given-names>H. S.</given-names></name>; <name name-style="western"><surname>Jun</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Lovinger</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>H. Y.</given-names></name><article-title>Docosahexaenoic
Acid Promotes Hippocampal
Neuronal Development and Synaptic Function</article-title>. <source>J. Neurochem.</source><year>2009</year>, <volume>111</volume>, <fpage>510</fpage>&#8211;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06335.x</pub-id>.<pub-id pub-id-type="pmid">19682204</pub-id><pub-id pub-id-type="pmcid">PMC2773444</pub-id></mixed-citation></ref><ref id="ref497"><mixed-citation publication-type="journal" id="cit497"><name name-style="western"><surname>Lauritzen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Brambilla</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mazzocchi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Harsl&#248;f</surname><given-names>L. B.</given-names></name>; <name name-style="western"><surname>Ciappolino</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Agostoni</surname><given-names>C.</given-names></name><article-title>DHA Effects in Brain
Development and Function</article-title>. <source>Nutrients</source><year>2016</year>, <volume>8</volume>, <fpage>6</fpage><pub-id pub-id-type="doi">10.3390/nu8010006</pub-id>.<pub-id pub-id-type="pmid">26742060</pub-id><pub-id pub-id-type="pmcid">PMC4728620</pub-id></mixed-citation></ref><ref id="ref498"><mixed-citation publication-type="journal" id="cit498"><name name-style="western"><surname>Horrocks</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Yeo</surname><given-names>Y. K.</given-names></name><article-title>Health benefits of Docosahexaenoic
Acid (DHA)</article-title>. <source>Pharmacol. Res.</source><year>1999</year>, <volume>40</volume>, <fpage>211</fpage>&#8211;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1006/phrs.1999.0495</pub-id>.<pub-id pub-id-type="pmid">10479465</pub-id></mixed-citation></ref><ref id="ref499"><mixed-citation publication-type="journal" id="cit499"><name name-style="western"><surname>Yassine</surname><given-names>H. N.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Azizkhanian</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Rawat</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Castor</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Fonteh</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Harrington</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Reed</surname><given-names>B. R.</given-names></name>; <name name-style="western"><surname>DeCarli</surname><given-names>C.</given-names></name>; et al. <article-title>Association
of Serum Docosahexaenoic Acid With Cerebral Amyloidosis</article-title>. <source>JAMA Neurol.</source><year>2016</year>, <volume>73</volume>, <fpage>1208</fpage>&#8211;<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.1924</pub-id>.<pub-id pub-id-type="pmid">27532692</pub-id></mixed-citation></ref><ref id="ref500"><mixed-citation publication-type="journal" id="cit500"><name name-style="western"><surname>Dayrit</surname><given-names>F. M.</given-names></name><article-title>The Properties of Lauric Acid and Their Significance
in Coconut Oil</article-title>. <source>J. Am. Oil Chem. Soc.</source><year>2015</year>, <volume>92</volume>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s11746-014-2562-7</pub-id>.</mixed-citation></ref><ref id="ref501"><mixed-citation publication-type="journal" id="cit501"><name name-style="western"><surname>Alves</surname><given-names>N. F.</given-names></name>; <name name-style="western"><surname>de Queiroz</surname><given-names>T. M.</given-names></name>; <name name-style="western"><surname>de Almeida Travassos</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Magnani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>de Andrade Braga</surname><given-names>V.</given-names></name><article-title>Acute Treatment
with Lauric Acid
Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive
Rats</article-title>. <source>Basic Clin. Pharmacol. Toxicol.</source><year>2017</year>, <volume>120</volume>, <fpage>348</fpage>&#8211;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1111/bcpt.12700</pub-id>.<pub-id pub-id-type="pmid">28054477</pub-id></mixed-citation></ref><ref id="ref502"><mixed-citation publication-type="journal" id="cit502"><name name-style="western"><surname>Brosnan</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Brosnan</surname><given-names>J. T.</given-names></name><article-title>Formate: The Neglected
Member of
One-Carbon Metabolism</article-title>. <source>Annu. Rev. Nutr.</source><year>2016</year>, <volume>36</volume>, <fpage>369</fpage>&#8211;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-nutr-071715-050738</pub-id>.<pub-id pub-id-type="pmid">27431368</pub-id></mixed-citation></ref><ref id="ref503"><mixed-citation publication-type="journal" id="cit503"><name name-style="western"><surname>Law</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Wagner</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kopka</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Schober</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Sch&#228;fers</surname><given-names>M.</given-names></name><article-title>Are [<italic toggle="yes">O-methyl</italic>-<sup>11</sup>C]Derivatives of ICI 89,406 &#946;1-Adrenoceptor
Selective
Radioligands Suitable for PET?</article-title>. <source>Eur. J. Nucl.
Med. Mol. Imaging</source><year>2008</year>, <volume>35</volume>, <fpage>174</fpage>&#8211;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-007-0553-8</pub-id>.<pub-id pub-id-type="pmid">17906860</pub-id></mixed-citation></ref><ref id="ref504"><mixed-citation publication-type="journal" id="cit504"><name name-style="western"><surname>Johansen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hansen</surname><given-names>H. D.</given-names></name>; <name name-style="western"><surname>Svarer</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lehel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Leth-Petersen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kristensen</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Gillings</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Knudsen</surname><given-names>G. M.</given-names></name><article-title>The Importance
of Small Polar Radiometabolites in Molecular Neuroimaging: A PET Study
With [<sup>11</sup>C]Cimbi-36 Labeled in Two Positions</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2018</year>, <volume>38</volume>, <fpage>659</fpage>&#8211;<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X17746179</pub-id>.<pub-id pub-id-type="pmid">29215308</pub-id><pub-id pub-id-type="pmcid">PMC5888860</pub-id></mixed-citation></ref><ref id="ref505"><mixed-citation publication-type="journal" id="cit505"><name name-style="western"><surname>Luurtsema</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Molthoff</surname><given-names>C. F. M.</given-names></name>; <name name-style="western"><surname>Schuit</surname><given-names>R. C.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Lammertsma</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Franssen</surname><given-names>E. J. F.</given-names></name><article-title>Evaluation of
(<italic toggle="yes">R</italic>)-[<sup>11</sup>C]Verapamil as PET Tracer of P-Glycoprotein
Function
in the Blood-Brain Barrier: Kinetics and Metabolism in the Rat</article-title>. <source>Nucl. Med. Biol.</source><year>2005</year>, <volume>32</volume>, <fpage>87</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2004.06.007</pub-id>.<pub-id pub-id-type="pmid">15691665</pub-id></mixed-citation></ref><ref id="ref506"><mixed-citation publication-type="journal" id="cit506"><name name-style="western"><surname>Cumming</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Deep</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Dagher</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Reutens</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kapczinski</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>D. F.</given-names></name>; <name name-style="western"><surname>Gjedde</surname><given-names>A.</given-names></name><article-title>Pharmacokinetics of Radiotracers
in Human Plasma During Positron Emission Tomography</article-title>. <source>Synapse</source><year>1999</year>, <volume>34</volume>, <fpage>124</fpage>&#8211;<lpage>134</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-2396(199911)34:2&amp;#x0003c;124::AID-SYN5&amp;#x0003e;3.0.CO;2-O</pub-id>.<pub-id pub-id-type="pmid">10502311</pub-id></mixed-citation></ref><ref id="ref507"><mixed-citation publication-type="journal" id="cit507"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Doll&#233;</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>Synthesis of [<sup>11</sup>C]Formic Acid and Its Conversion
Into [<sup>11</sup>C]Carbon
Monoxide</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2001</year>, <volume>44</volume>, <fpage>S126</fpage>&#8211;<lpage>S127</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580440144</pub-id>.</mixed-citation></ref><ref id="ref508"><mixed-citation publication-type="journal" id="cit508"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Doll&#233;</surname><given-names>F.</given-names></name><article-title>A Rapid, Almost
Quantitative Conversion of [<sup>11</sup>C]Carbon Dioxide Into [<sup>11</sup>C]Carbon Monoxide via [<sup>11</sup>C]Formate and [<sup>11</sup>C]Formyl Chloride</article-title>. <source>Radiochim. Acta</source><year>2004</year>, <volume>92</volume>, <fpage>329</fpage>&#8211;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1524/ract.92.4.329.35604</pub-id>.</mixed-citation></ref><ref id="ref509"><mixed-citation publication-type="journal" id="cit509"><name name-style="western"><surname>Schou</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name><article-title>Radiolabeling of Two <sup>11</sup>C-Labeled Formylating Agents and Their Application in the
Preparation
of [<sup>11</sup>C]benzimidazole</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>2012</year>, <volume>55</volume>, <fpage>460</fpage>&#8211;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2972</pub-id>.</mixed-citation></ref><ref id="ref510"><mixed-citation publication-type="journal" id="cit510"><name name-style="western"><surname>Bonnemaire</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Collet</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ruijter</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Orru</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Windhorst</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Vugts</surname><given-names>D.</given-names></name><article-title>Synthesis of Radiolabeled [C-11]
Formamides: A New Carbon-11 Labeled Building Block To Access Novel
PET Tracers</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2019</year>, <volume>62</volume>, <fpage>S51</fpage>&#8211;<lpage>S52</lpage>.</mixed-citation></ref><ref id="ref511"><mixed-citation publication-type="journal" id="cit511"><name name-style="western"><surname>Mairinger</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Stanek</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wanek</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kuntner</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Langer</surname><given-names>O.</given-names></name><article-title>One-Pot Radiosynthesis of [C-11]
Formic Acid As Labelling
Agent for Heterocycles <italic toggle="yes">via</italic> Cyclization Reaction Using
a GE Tracerlab FX C Pro Synthesis Module</article-title>. <source>J.
Label. Compd. Radiopharm.</source><year>2015</year>, <volume>58</volume>, <fpage>S342</fpage>.</mixed-citation></ref><ref id="ref512"><mixed-citation publication-type="journal" id="cit512"><name name-style="western"><surname>Aranega-Bou</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>de la O
Leyva</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Finiti</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Garcia-Agustin</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gonzalez-Bosch</surname><given-names>C.</given-names></name><article-title>Priming of Plant Resistance by Natural Compounds. Hexanoic
Acid as a Model</article-title>. <source>Front. Plant Sci.</source><year>2014</year>, <volume>5</volume>, <fpage>488</fpage><pub-id pub-id-type="doi">10.3389/fpls.2014.00488</pub-id>.<pub-id pub-id-type="pmid">25324848</pub-id><pub-id pub-id-type="pmcid">PMC4181288</pub-id></mixed-citation></ref><ref id="ref513"><mixed-citation publication-type="journal" id="cit513"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ogawa</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>A Brain Uptake Study of [1-<sup>11</sup>C]Hexanoate in the Mouse:
The Effect of Hypoxia, Starvation and Substrate Competition</article-title>. <source>Ann. Nucl. Med.</source><year>1996</year>, <volume>10</volume>, <fpage>265</fpage>&#8211;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1007/BF03165404</pub-id>.<pub-id pub-id-type="pmid">8800460</pub-id></mixed-citation></ref><ref id="ref514"><mixed-citation publication-type="journal" id="cit514"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ogawa</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Toyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>Synthesis
and Preliminary Evaluation of [1-<sup>11</sup>C]Hexanoate as a PET
Tracer of Fatty Acid Metabolism</article-title>. <source>Ann. Nucl.
Med.</source><year>1995</year>, <volume>9</volume>, <fpage>51</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/BF03165010</pub-id>.<pub-id pub-id-type="pmid">7779532</pub-id></mixed-citation></ref><ref id="ref515"><mixed-citation publication-type="journal" id="cit515"><name name-style="western"><surname>Taha</surname><given-names>A. Y.</given-names></name><article-title>Linoleic Acid-Good or Bad for the
Brain?</article-title>. <source>NPJ. Sci. Food</source><year>2020</year>, <volume>4</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1038/s41538-019-0061-9</pub-id>.<pub-id pub-id-type="pmid">31909187</pub-id><pub-id pub-id-type="pmcid">PMC6940357</pub-id></mixed-citation></ref><ref id="ref516"><mixed-citation publication-type="journal" id="cit516"><name name-style="western"><surname>Sampath</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ntambi</surname><given-names>J. M.</given-names></name><article-title>The Fate and Intermediary Metabolism
of Stearic Acid</article-title>. <source>Lipids</source><year>2005</year>, <volume>40</volume>, <fpage>1187</fpage>&#8211;<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1007/s11745-005-1484-z</pub-id>.<pub-id pub-id-type="pmid">16477801</pub-id></mixed-citation></ref><ref id="ref517"><mixed-citation publication-type="journal" id="cit517"><name name-style="western"><surname>Ntambi</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Miyazaki</surname><given-names>M.</given-names></name><article-title>Recent Insights Into
Stearoyl-CoA
Desaturase-1</article-title>. <source>Curr. Opin. Lipidol.</source><year>2003</year>, <volume>14</volume>, <fpage>255</fpage>&#8211;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1097/00041433-200306000-00005</pub-id>.<pub-id pub-id-type="pmid">12840656</pub-id></mixed-citation></ref><ref id="ref518"><mixed-citation publication-type="journal" id="cit518"><name name-style="western"><surname>Poe</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Robinson</surname><given-names>G. D.</given-names><suffix>Jr.</suffix></name>; <name name-style="western"><surname>Graham</surname><given-names>L. S.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name><article-title>Experimental Basis of Myocardial
Imaging With <sup>123</sup>I-Labeled Hexadecenoic Acid</article-title>. <source>J. Nucl.
Med.</source><year>1976</year>, <volume>17</volume>, <fpage>1077</fpage>&#8211;<lpage>1082</lpage>.<pub-id pub-id-type="pmid">993841</pub-id></mixed-citation></ref><ref id="ref519"><mixed-citation publication-type="journal" id="cit519"><name name-style="western"><surname>Poe</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Robinson</surname><given-names>G. D.</given-names></name>; <name name-style="western"><surname>MacDonald</surname><given-names>N. S.</given-names></name><article-title>Myocardial
Extraction of Labeled Long-Chain Fatty Acid Analogs</article-title>. <source>Proc. Soc. Exp. Biol. Med.</source><year>1975</year>, <volume>148</volume>, <fpage>215</fpage>&#8211;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-148-38509</pub-id>.<pub-id pub-id-type="pmid">1129258</pub-id></mixed-citation></ref><ref id="ref520"><mixed-citation publication-type="journal" id="cit520"><name name-style="western"><surname>Carta</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Murru</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Banni</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Manca</surname><given-names>C.</given-names></name><article-title>Palmitic Acid:
Physiological Role, Metabolism and Nutritional Implications</article-title>. <source>Front. Physiol.</source><year>2017</year>, <volume>8</volume>, <fpage>902</fpage><pub-id pub-id-type="doi">10.3389/fphys.2017.00902</pub-id>.<pub-id pub-id-type="pmid">29167646</pub-id><pub-id pub-id-type="pmcid">PMC5682332</pub-id></mixed-citation></ref><ref id="ref521"><mixed-citation publication-type="journal" id="cit521"><name name-style="western"><surname>Yuille</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Reichardt</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Panda</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dunbar</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mulder</surname><given-names>I. E.</given-names></name><article-title>Human Gut
Bacteria As Potent Class I Histone Deacetylase
Inhibitors In Vitro Through Production of Butyric Acid and Valeric
Acid</article-title>. <source>PLoS One</source><year>2018</year>, <volume>13</volume>, <elocation-id>e0201073</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0201073</pub-id>.<pub-id pub-id-type="pmid">30052654</pub-id><pub-id pub-id-type="pmcid">PMC6063406</pub-id></mixed-citation></ref><ref id="ref522"><mixed-citation publication-type="journal" id="cit522"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Xiao</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fan</surname><given-names>S.</given-names></name><article-title>Gut Commensal
Derived-Valeric Acid Protects Against
Radiation Injuries</article-title>. <source>Gut Microbes</source><year>2020</year>, <volume>11</volume>, <fpage>789</fpage>&#8211;<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2019.1709387</pub-id>.<pub-id pub-id-type="pmid">31931652</pub-id><pub-id pub-id-type="pmcid">PMC7524389</pub-id></mixed-citation></ref><ref id="ref523"><mixed-citation publication-type="journal" id="cit523"><name name-style="western"><surname>Onrust</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Van Driessche</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ducatelle</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Schwarzer</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Haesebrouck</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Van Immerseel</surname><given-names>F.</given-names></name><article-title>Valeric Acid
Glyceride Esters in Feed Promote Broiler Performance and Reduce the
Incidence of Necrotic Enteritis</article-title>. <source>Poult. Sci.</source><year>2018</year>, <volume>97</volume>, <fpage>2303</fpage>&#8211;<lpage>2311</lpage>. <pub-id pub-id-type="doi">10.3382/ps/pey085</pub-id>.<pub-id pub-id-type="pmid">29562369</pub-id></mixed-citation></ref><ref id="ref524"><mixed-citation publication-type="journal" id="cit524"><name name-style="western"><surname>Verruck</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Balthazar</surname><given-names>C. F.</given-names></name>; <name name-style="western"><surname>Rocha</surname><given-names>R. S.</given-names></name>; <name name-style="western"><surname>Silva</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Esmerino</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Pimentel</surname><given-names>T. C.</given-names></name>; <name name-style="western"><surname>Freitas</surname><given-names>M. Q.</given-names></name>; <name name-style="western"><surname>Silva</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>da Cruz</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Prudencio</surname><given-names>E. S.</given-names></name><article-title>Dairy Foods
and Positive Impact on
the Consumer&#8217;s Health</article-title>. <source>Adv. Food Nutr.
Res.</source><year>2019</year>, <volume>89</volume>, <fpage>95</fpage>&#8211;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/bs.afnr.2019.03.002</pub-id>.<pub-id pub-id-type="pmid">31351531</pub-id></mixed-citation></ref><ref id="ref525"><mixed-citation publication-type="journal" id="cit525"><name name-style="western"><surname>Lewis</surname><given-names>D. Y.</given-names></name>; <name name-style="western"><surname>Boren</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Shaw</surname><given-names>G. L.</given-names></name>; <name name-style="western"><surname>Bielik</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ramos-Montoya</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Larkin</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Martins</surname><given-names>C. P.</given-names></name>; <name name-style="western"><surname>Neal</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Soloviev</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Brindle</surname><given-names>K. M.</given-names></name><article-title>Late Imaging with [1-<sup>11</sup>C]Acetate Improves
Detection of Tumor Fatty Acid Synthesis with PET</article-title>. <source>J. Nucl. Med.</source><year>2014</year>, <volume>55</volume>, <fpage>1144</fpage>&#8211;<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.113.134437</pub-id>.<pub-id pub-id-type="pmid">24777291</pub-id></mixed-citation></ref><ref id="ref526"><mixed-citation publication-type="journal" id="cit526"><name name-style="western"><surname>Fontana</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ge</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Su</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Hathi</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Xiang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Cenci</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Civitelli</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Shoghi</surname><given-names>K. I.</given-names></name>; <name name-style="western"><surname>Akers</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>D&#8217;avignon</surname><given-names>A.</given-names></name>; et al. <article-title>Evaluating Acetate Metabolism for Imaging and Targeting in Multiple
Myeloma</article-title>. <source>Clin. Cancer Res.</source><year>2017</year>, <volume>23</volume>, <fpage>416</fpage>&#8211;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-2134</pub-id>.<pub-id pub-id-type="pmid">27486177</pub-id><pub-id pub-id-type="pmcid">PMC5241171</pub-id></mixed-citation></ref><ref id="ref527"><mixed-citation publication-type="journal" id="cit527"><name name-style="western"><surname>Territo</surname><given-names>P. R.</given-names></name>; <name name-style="western"><surname>Maluccio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Riley</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>McCarthy</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Fletcher</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Tann</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Saxena</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Skill</surname><given-names>N. J.</given-names></name><article-title>Evaluation
of <sup>11</sup>C-Acetate and <sup>18</sup>F-FDG PET/CT in Mouse Multidrug
Resistance Gene-2 Deficient Mouse Model of Hepatocellular Carcinoma</article-title>. <source>BMC Med. Imaging</source><year>2015</year>, <volume>15</volume>, <fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s12880-015-0058-z</pub-id>.<pub-id pub-id-type="pmid">25981587</pub-id><pub-id pub-id-type="pmcid">PMC4493966</pub-id></mixed-citation></ref><ref id="ref528"><mixed-citation publication-type="journal" id="cit528"><name name-style="western"><surname>Ponde</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Oyama</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Tai</surname><given-names>Y. C.</given-names></name>; <name name-style="western"><surname>Laforest</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Siegel</surname><given-names>B. A.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title><sup>18</sup>F-Fluoroacetate:
A Potential Acetate Analog for Prostate Tumor Imaging-<italic toggle="yes">In Vivo</italic> Evaluation of <sup>18</sup>F-Fluoroacetate Versus <sup>11</sup>C-Acetate</article-title>. <source>J. Nucl. Med.</source><year>2007</year>, <volume>48</volume>, <fpage>420</fpage>&#8211;<lpage>428</lpage>.<pub-id pub-id-type="pmid">17332620</pub-id></mixed-citation></ref><ref id="ref529"><mixed-citation publication-type="journal" id="cit529"><name name-style="western"><surname>Ng</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Moberly</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Mather</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Brown-Proctor</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Hutchins</surname><given-names>G. D.</given-names></name>; <name name-style="western"><surname>Green</surname><given-names>M. A.</given-names></name><article-title>Equivalence
of Arterial and Venous
Blood for [<sup>11</sup>C]CO<sub>2</sub>-Metabolite Analysis Following
Intravenous Administration of 1-[<sup>11</sup>C]Acetate and 1-[<sup>11</sup>C]Palmitate</article-title>. <source>Nucl. Med. Biol.</source><year>2013</year>, <volume>40</volume>, <fpage>361</fpage>&#8211;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2012.11.011</pub-id>.<pub-id pub-id-type="pmid">23306135</pub-id><pub-id pub-id-type="pmcid">PMC4620575</pub-id></mixed-citation></ref><ref id="ref530"><mixed-citation publication-type="journal" id="cit530"><name name-style="western"><surname>Lindhe</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ulin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rahman</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>S&#246;rensen</surname><given-names>J.</given-names></name><article-title>[<sup>18</sup>F]Fluoroacetate is not a Functional Analogue of [<sup>11</sup>C]Acetate
in Normal Physiology</article-title>. <source>Eur. J. Nucl. Med. Mol.
Imaging</source><year>2009</year>, <volume>36</volume>, <fpage>1453</fpage>&#8211;<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-009-1128-7</pub-id>.<pub-id pub-id-type="pmid">19387639</pub-id></mixed-citation></ref><ref id="ref531"><mixed-citation publication-type="journal" id="cit531"><name name-style="western"><surname>Winstead</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Lamb</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Winchell</surname><given-names>H. S.</given-names></name><article-title>Relationship of
Chemical Structure to In Vivo Scintigraphic Distribution Patterns
of <sup>11</sup>C Compounds. I. <sup>11</sup>C-Carboxylates</article-title>. <source>J. Nucl. Med.</source><year>1973</year>, <volume>14</volume>, <fpage>747</fpage>&#8211;<lpage>754</lpage>.<pub-id pub-id-type="pmid">4743582</pub-id></mixed-citation></ref><ref id="ref532"><mixed-citation publication-type="journal" id="cit532"><name name-style="western"><surname>Seltzer</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Jahan</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Sparks</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Stout</surname><given-names>D. B.</given-names></name>; <name name-style="western"><surname>Satyamurthy</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Dahlbom</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name><article-title>Radiation
Dose Estimates in Humans for <sup>11</sup>C-Acetate Whole-Body PET</article-title>. <source>J. Nucl. Med.</source><year>2004</year>, <volume>45</volume>, <fpage>1233</fpage>&#8211;<lpage>1236</lpage>.<pub-id pub-id-type="pmid">15235071</pub-id></mixed-citation></ref><ref id="ref533"><mixed-citation publication-type="journal" id="cit533"><name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Theobald</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Prenant</surname><given-names>C.</given-names></name><article-title>Simple Production of
[1-Carbon-11]Acetate</article-title>. <source>J. Nucl. Med.</source><year>1996</year>, <volume>37</volume>, <fpage>341</fpage>&#8211;<lpage>342</lpage>.<pub-id pub-id-type="pmid">8667074</pub-id></mixed-citation></ref><ref id="ref534"><mixed-citation publication-type="journal" id="cit534"><name name-style="western"><surname>Prenen</surname><given-names>G. H.</given-names></name>; <name name-style="western"><surname>Go</surname><given-names>K. G.</given-names></name>; <name name-style="western"><surname>Zuiderveen</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title>An Improved Synthesis of Carbon-11
Labeled Acetoacetic Acid and an Evaluation of Its Potential for the
Investigation of Cerebral Pathology by Positron Emission Tomography</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>, <fpage>1209</fpage>&#8211;<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(90)90208-X</pub-id>.<pub-id pub-id-type="pmid">1963420</pub-id></mixed-citation></ref><ref id="ref535"><mixed-citation publication-type="journal" id="cit535"><name name-style="western"><surname>Solingapuram Sai</surname><given-names>K. K.</given-names></name>; <name name-style="western"><surname>Donald Gage</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Almaguel</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Neth</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Hughes</surname><given-names>T. M.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Castellano</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Jorgensen</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Craft</surname><given-names>S.</given-names></name>; et al. <article-title>Automated
Synthesis of 1-[<sup>11</sup>C]Acetoacetate on a TRASIS AIO Module</article-title>. <source>Appl. Radiat. Isot.</source><year>2017</year>, <volume>129</volume>, <fpage>57</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2017.07.066</pub-id>.<pub-id pub-id-type="pmid">28806598</pub-id><pub-id pub-id-type="pmcid">PMC5612895</pub-id></mixed-citation></ref><ref id="ref536"><mixed-citation publication-type="journal" id="cit536"><name name-style="western"><surname>Croteau</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gascon</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dumulon-Perreault</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Labb&#233;</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Rousseau</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Carpentier</surname><given-names>A. C.</given-names></name>; <name name-style="western"><surname>B&#233;nard</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Lecomte</surname><given-names>R.</given-names></name><article-title>[<sup>11</sup>C]-Acetoacetate
PET
Imaging: A Potential Early Marker for Cardiac Heart Failure</article-title>. <source>Nucl. Med. Biol.</source><year>2014</year>, <volume>41</volume>, <fpage>863</fpage>&#8211;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2014.08.006</pub-id>.<pub-id pub-id-type="pmid">25195015</pub-id></mixed-citation></ref><ref id="ref537"><mixed-citation publication-type="journal" id="cit537"><name name-style="western"><surname>Authier</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dumulon</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Dubuc</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ouellet</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Lecomte</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>B&#233;nard</surname><given-names>F.</given-names></name><article-title>[<sup>11</sup>C]Acetoacetate Utilization by Breast
and Prostate Tumors: A PET and
Biodistribution Study in Mice</article-title>. <source>Mol. Imaging
Biol.</source><year>2008</year>, <volume>10</volume>, <fpage>217</fpage>&#8211;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-008-0143-6</pub-id>.<pub-id pub-id-type="pmid">18454299</pub-id></mixed-citation></ref><ref id="ref538"><mixed-citation publication-type="journal" id="cit538"><name name-style="western"><surname>Bentourkia</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Pifferi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Rousseau</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lecomte</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S.</given-names></name><article-title>PET Study of <sup>11</sup>C-Acetoacetate
Kinetics in Rat Brain During Dietary Treatments Affecting Ketosis</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source><year>2009</year>, <volume>296</volume>, <elocation-id>E796</elocation-id><pub-id pub-id-type="doi">10.1152/ajpendo.90644.2008</pub-id>.<pub-id pub-id-type="pmid">19176356</pub-id></mixed-citation></ref><ref id="ref539"><mixed-citation publication-type="journal" id="cit539"><name name-style="western"><surname>Pifferi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Plourde</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tremblay-Mercier</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bentourkia</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name><article-title>Ketones and Brain
Function: Possible
Link to Polyunsaturated Fatty Acids and Availability of a New Brain
PET Tracer, <sup>11</sup>C-Acetoacetate</article-title>. <source>Epilepsia</source><year>2008</year>, <volume>49</volume>, <fpage>76</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01842.x</pub-id>.<pub-id pub-id-type="pmid">19049595</pub-id></mixed-citation></ref><ref id="ref540"><mixed-citation publication-type="journal" id="cit540"><name name-style="western"><surname>Go</surname><given-names>K. G.</given-names></name>; <name name-style="western"><surname>Prenen</surname><given-names>G. H.</given-names></name>; <name name-style="western"><surname>Paans</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Kamman</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Korf</surname><given-names>J.</given-names></name><article-title>Positron Emission Tomography
Study
of <sup>11</sup>C-Acetoacetate Uptake in a Freezing Lesion in Cat
Brain, as Correlated With <sup>11</sup>C-Tyrosine and <sup>18</sup>F-Fluorodeoxyglucose Uptake, and With Proton Magnetic Resonance Imaging</article-title>. <source>Adv. Neurol.</source><year>1990</year>, <volume>52</volume>, <fpage>525</fpage>&#8211;<lpage>528</lpage>.<pub-id pub-id-type="pmid">2396544</pub-id></mixed-citation></ref><ref id="ref541"><mixed-citation publication-type="journal" id="cit541"><name name-style="western"><surname>Courchesne-Loyer</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Croteau</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Castellano</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>St-Pierre</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Hennebelle</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name><article-title>Inverse Relationship
Between Brain Glucose and Ketone Metabolism in Adults During Short-Term
Moderate Dietary Ketosis: A Dual Tracer Quantitative Positron Emission
Tomography Study</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2017</year>, <volume>37</volume>, <fpage>2485</fpage>&#8211;<lpage>2493</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16669366</pub-id>.<pub-id pub-id-type="pmid">27629100</pub-id><pub-id pub-id-type="pmcid">PMC5531346</pub-id></mixed-citation></ref><ref id="ref542"><mixed-citation publication-type="journal" id="cit542"><name name-style="western"><surname>Castellano</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Nugent</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Paquet</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bocti</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lacombe</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Imbeault</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Turcotte</surname><given-names>&#201;.</given-names></name>; <name name-style="western"><surname>Fulop</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name><article-title>Lower Brain <sup>18</sup>F-Fluorodeoxyglucose
Uptake but Normal <sup>11</sup>C-Acetoacetate Metabolism in Mild Alzheimer&#8217;s
Disease Dementia</article-title>. <source>J. Alzheimer's Dis.</source><year>2014</year>, <volume>43</volume>, <fpage>1343</fpage>&#8211;<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-141074</pub-id>.<pub-id pub-id-type="pmid">25147107</pub-id></mixed-citation></ref><ref id="ref543"><mixed-citation publication-type="journal" id="cit543"><name name-style="western"><surname>Gerasimov</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Ferrieri</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Pareto</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>Y. S.</given-names></name><article-title>Synthesis and Evaluation
of Inhaled
[<sup>11</sup>C]Butane and Intravenously Injected [<sup>11</sup>C]Acetone
As Potential Radiotracers for Studying Inhalant Abuse</article-title>. <source>Nucl. Med. Biol.</source><year>2005</year>, <volume>32</volume>, <fpage>201</fpage>&#8211;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2004.11.002</pub-id>.<pub-id pub-id-type="pmid">15721766</pub-id></mixed-citation></ref><ref id="ref544"><mixed-citation publication-type="journal" id="cit544"><name name-style="western"><surname>Chang</surname><given-names>M. C. J.</given-names></name>; <name name-style="western"><surname>Arai</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Freed</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Wakabayashi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Dunn</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Der</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Bell</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; et al. <article-title>Brain Incorporation
of [1-<sup>11</sup>C]Arachidonate in Normocapnic and Hypercapnic Monkeys,
Measured With Positron Emission Tomography</article-title>. <source>Brain Res.</source><year>1997</year>, <volume>755</volume>, <fpage>74</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(97)00088-7</pub-id>.<pub-id pub-id-type="pmid">9163542</pub-id></mixed-citation></ref><ref id="ref545"><mixed-citation publication-type="journal" id="cit545"><name name-style="western"><surname>Esposito</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Giovacchini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Liow</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Bhattacharjee</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Greenstein</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Schapiro</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hallett</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Eckelman</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Carson</surname><given-names>R. E.</given-names></name>; et al. <article-title>Imaging Neuroinflammation
in Alzheimer&#8217;s Disease With Radiolabeled Arachidonic Acid and
PET</article-title>. <source>J. Nucl. Med.</source><year>2008</year>, <volume>49</volume>, <fpage>1414</fpage>&#8211;<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.107.049619</pub-id>.<pub-id pub-id-type="pmid">18703605</pub-id><pub-id pub-id-type="pmcid">PMC2587283</pub-id></mixed-citation></ref><ref id="ref546"><mixed-citation publication-type="journal" id="cit546"><name name-style="western"><surname>Giovacchini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Toczek</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mason</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bokde</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Connolly</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Vuong</surname><given-names>B. K.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Der</surname><given-names>M. G.</given-names></name>; et al. <article-title>Brain
Incorporation of [<sup>11</sup>C]Arachidonic
Acid in Young Healthy Humans Measured With Positron Emission Tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2002</year>, <volume>22</volume>, <fpage>1453</fpage>&#8211;<lpage>1462</lpage>. <pub-id pub-id-type="doi">10.1097/01.WCB.0000033209.60867.7A</pub-id>.<pub-id pub-id-type="pmid">12468890</pub-id></mixed-citation></ref><ref id="ref547"><mixed-citation publication-type="journal" id="cit547"><name name-style="western"><surname>Giovacchini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Lerner</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Toczek</surname><given-names>M. T.</given-names></name>; <name name-style="western"><surname>Fraser</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>DeMar</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Eckelman</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Carson</surname><given-names>R. E.</given-names></name><article-title>Brain Incorporation
of <sup>11</sup>C-Arachidonic Acid,
Blood Volume, and Blood Flow in Healthy Aging: A Study With Partial-Volume
Correction</article-title>. <source>J. Nucl. Med.</source><year>2004</year>, <volume>45</volume>, <fpage>1471</fpage>&#8211;<lpage>1479</lpage>.<pub-id pub-id-type="pmid">15347713</pub-id></mixed-citation></ref><ref id="ref548"><mixed-citation publication-type="journal" id="cit548"><name name-style="western"><surname>Esposito</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Giovacchini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Der</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Liow</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Bhattacharjee</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Eckelman</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Hallett</surname><given-names>M.</given-names></name>; et al. <article-title>Imaging
Signal Transduction via Arachidonic Acid in the Human Brain During
Visual Stimulation, by Means of Positron Emission Tomography</article-title>. <source>Neuroimage</source><year>2007</year>, <volume>34</volume>, <fpage>1342</fpage>&#8211;<lpage>1351</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.11.018</pub-id>.<pub-id pub-id-type="pmid">17196833</pub-id><pub-id pub-id-type="pmcid">PMC2040045</pub-id></mixed-citation></ref><ref id="ref549"><mixed-citation publication-type="journal" id="cit549"><name name-style="western"><surname>Zanderigo</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Nikolopoulou</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mozley</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Oquendo</surname><given-names>M. A.</given-names></name><article-title>[<sup>11</sup>C]Arachidonic
Acid
Incorporation Measurement in Human Brain: Optimization for Clinical
Use</article-title>. <source>Synapse</source><year>2018</year>, <volume>72</volume>, <fpage>e22018</fpage><pub-id pub-id-type="doi">10.1002/syn.22018</pub-id>.<pub-id pub-id-type="pmcid">PMC6075823</pub-id><pub-id pub-id-type="pmid">29144569</pub-id></mixed-citation></ref><ref id="ref550"><mixed-citation publication-type="journal" id="cit550"><name name-style="western"><surname>Thambisetty</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Gallardo</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Liow</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Beason-Held</surname><given-names>L. L.</given-names></name>; <name name-style="western"><surname>Umhau</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Bhattacharjee</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Der</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name><article-title>The Utility of <sup>11</sup>C-Arachidonate
PET To Study In Vivo Dopaminergic Neurotransmission in Humans</article-title>. <source>J. Cereb. Blood. Flow. Metab.</source><year>2012</year>, <volume>32</volume>, <fpage>676</fpage>&#8211;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2011.171</pub-id>.<pub-id pub-id-type="pmid">22167235</pub-id><pub-id pub-id-type="pmcid">PMC3318145</pub-id></mixed-citation></ref><ref id="ref551"><mixed-citation publication-type="journal" id="cit551"><name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Simpson</surname><given-names>N.</given-names></name><article-title>Radiosynthesis of 1-[<sup>11</sup>C]Polyhomoallylic Fatty Acids</article-title>. <source>J. Label.
Compd.
Radiopharm.</source><year>1993</year>, <volume>33</volume>, <fpage>541</fpage>&#8211;<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580330611</pub-id>.</mixed-citation></ref><ref id="ref552"><mixed-citation publication-type="journal" id="cit552"><name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Synthesis of [<italic toggle="yes">19</italic>-<sup>11</sup>C]Arachidonic
Acid</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>1994</year>, <volume>34</volume>, <fpage>617</fpage>&#8211;<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580340705</pub-id>.</mixed-citation></ref><ref id="ref553"><mixed-citation publication-type="journal" id="cit553"><name name-style="western"><surname>Best</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Gifford</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Babst</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Piel</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>R&#246;sch</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name><article-title>Rapid Radiosynthesis
of [<sup>11</sup>C] and [<sup>14</sup>C]Azelaic, Suberic, and Sebacic
Acids for <italic toggle="yes">In Vivo</italic> Mechanistic Studies of Systemic
Acquired Resistance in Plants</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>2012</year>, <volume>55</volume>, <fpage>39</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1951</pub-id>.</mixed-citation></ref><ref id="ref554"><mixed-citation publication-type="journal" id="cit554"><name name-style="western"><surname>Buchanan</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Hastings</surname><given-names>A. B.</given-names></name>; <name name-style="western"><surname>Nesbett</surname><given-names>F. B.</given-names></name><article-title>The Role of Carboxyl-Labeled
Acetic, Propionic, and Butyric Acids in Liver Glycogen Formation</article-title>. <source>J. Biol. Chem.</source><year>1943</year>, <volume>150</volume>, <fpage>413</fpage>&#8211;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(18)72164-9</pub-id>.</mixed-citation></ref><ref id="ref555"><mixed-citation publication-type="journal" id="cit555"><name name-style="western"><surname>Kim</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Hooker</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Otto</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Win</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Muench</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Carter</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>King</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Reid</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; et al. <article-title>Whole-Body Pharmacokinetics
of HDAC Inhibitor Drugs, Butyric Acid, Valproic Acid and 4-Phenylbutyric
Acid Measured With Carbon-11 Labeled Analogs by PET</article-title>. <source>Nucl. Med. Biol.</source><year>2013</year>, <volume>40</volume>, <fpage>912</fpage>&#8211;<lpage>918</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2013.06.007</pub-id>.<pub-id pub-id-type="pmid">23906667</pub-id><pub-id pub-id-type="pmcid">PMC3769509</pub-id></mixed-citation></ref><ref id="ref556"><mixed-citation publication-type="journal" id="cit556"><name name-style="western"><surname>Fadeev</surname><given-names>N. P.</given-names></name>; <name name-style="western"><surname>Tyutin</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Kostenikov</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Ryjkova</surname><given-names>D. V.</given-names></name>; <name name-style="western"><surname>Soukhov</surname><given-names>V. Y.</given-names></name>; <name name-style="western"><surname>Savello</surname><given-names>V. E.</given-names></name>; <name name-style="western"><surname>Mostova</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>Bruskin</surname><given-names>A. B.</given-names></name>; <name name-style="western"><surname>Pavlenko</surname><given-names>K. S.</given-names></name><article-title>Sodium [1-<sup>11</sup>C]-Butyrate
- New Diagnostic Agent for PET</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>2001</year>, <volume>44</volume>, <fpage>S310</fpage>&#8211;<lpage>S312</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.25804401109</pub-id>.</mixed-citation></ref><ref id="ref557"><mixed-citation publication-type="journal" id="cit557"><name name-style="western"><surname>Neu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Synthesis of Saturated Fatty Acids <sup>11</sup>C(<sup>13</sup>C)-Labelled in the w-Methyl Position</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1997</year>, <volume>39</volume>, <fpage>509</fpage>&#8211;<lpage>524</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1344(199706)39:6&amp;#x0003c;509::AID-JLCR996&amp;#x0003e;3.0.CO;2-H</pub-id>.</mixed-citation></ref><ref id="ref558"><mixed-citation publication-type="journal" id="cit558"><name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>L&#228;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of Fatty Acids Specifically Labelled With <sup>11</sup>C in Various
Positions, Including <sup>2</sup>H Substitution, for <italic toggle="yes">In Vivo</italic> Studies of Myocardium Using PET</article-title>. <source>Nucl. Med.
Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>1053</fpage>&#8211;<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90177-5</pub-id>.<pub-id pub-id-type="pmid">9234363</pub-id></mixed-citation></ref><ref id="ref559"><mixed-citation publication-type="journal" id="cit559"><name name-style="western"><surname>Umhau</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Carson</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Polozova</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Demar</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Hussein</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Bhattacharjee</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Esposito</surname><given-names>G.</given-names></name>; et al. <article-title>Imaging Incorporation of Circulating Docosahexaenoic
Acid Into the Human Brain Using Positron Emission Tomography</article-title>. <source>J. Lipid. Res.</source><year>2009</year>, <volume>50</volume>, <fpage>1259</fpage>&#8211;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.M800530-JLR200</pub-id>.<pub-id pub-id-type="pmid">19112173</pub-id><pub-id pub-id-type="pmcid">PMC2694326</pub-id></mixed-citation></ref><ref id="ref560"><mixed-citation publication-type="journal" id="cit560"><name name-style="western"><surname>Yassine</surname><given-names>H. N.</given-names></name>; <name name-style="western"><surname>Croteau</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Rawat</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Hibbeln</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Umhau</surname><given-names>J. C.</given-names></name><article-title>DHA Brain Uptake
and APOE4 Status: A PET Study With [1-<sup>11</sup>C]-DHA</article-title>. <source>Alzheimer's Res. Ther.</source><year>2017</year>, <volume>9</volume>, <fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s13195-017-0250-1</pub-id>.<pub-id pub-id-type="pmid">28335828</pub-id><pub-id pub-id-type="pmcid">PMC5364667</pub-id></mixed-citation></ref><ref id="ref561"><mixed-citation publication-type="journal" id="cit561"><name name-style="western"><surname>Angsten</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Valind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Takalo</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Neu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Meurling</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Inhibition of Carnitine-Acyl
Transferase I by Oxfenicine Studied <italic toggle="yes">In Vivo</italic> With
[<sup>11</sup>C]-Labeled Fatty Acids</article-title>. <source>Nucl.
Med. Biol.</source><year>2005</year>, <volume>32</volume>, <fpage>495</fpage>&#8211;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2005.03.003</pub-id>.<pub-id pub-id-type="pmid">15982580</pub-id></mixed-citation></ref><ref id="ref562"><mixed-citation publication-type="journal" id="cit562"><name name-style="western"><surname>Sakiyama</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Oda</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Toyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nakayama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>Evaluation
of the Brain Uptake Properties of [1-<sup>11</sup>C]Labeled
Hexanoate in Anesthetized Cats by Means of Positron Emission Tomography</article-title>. <source>Ann. Nucl. Med.</source><year>1996</year>, <volume>10</volume>, <fpage>361</fpage>&#8211;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1007/BF03164748</pub-id>.<pub-id pub-id-type="pmid">8883717</pub-id></mixed-citation></ref><ref id="ref563"><mixed-citation publication-type="journal" id="cit563"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>Successive Preparation
of <sup>11</sup>C Labeled Sodium Acetate and/or Sodium Hexanoate</article-title>. <source>Appl. Radiat. Isot.</source><year>1995</year>, <volume>46</volume>, <fpage>1035</fpage>&#8211;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(95)00194-I</pub-id>.</mixed-citation></ref><ref id="ref564"><mixed-citation publication-type="journal" id="cit564"><name name-style="western"><surname>Neu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Synthesis
of [<italic toggle="yes">18</italic>-<sup>11</sup>C/(<sup>13</sup>C)]Linoleic acid</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1997</year>, <volume>39</volume>, <fpage>607</fpage>&#8211;<lpage>619</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1344(199707)39:7&amp;#x0003c;607::AID-JLCR7&amp;#x0003e;3.0.CO;2-A</pub-id>.</mixed-citation></ref><ref id="ref565"><mixed-citation publication-type="journal" id="cit565"><name name-style="western"><surname>Yamamura</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Magata</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kitano</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Konishi</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Saji</surname><given-names>H.</given-names></name><article-title>Evaluation of [1-<sup>11</sup>C]Octanoate
as a New Radiopharmaceutical
for Assessing Liver Function Using Positron Emission Tomography</article-title>. <source>Nucl. Med. Biol.</source><year>1998</year>, <volume>25</volume>, <fpage>467</fpage>&#8211;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(98)00011-0</pub-id>.<pub-id pub-id-type="pmid">9720664</pub-id></mixed-citation></ref><ref id="ref566"><mixed-citation publication-type="journal" id="cit566"><name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yamazaki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name><article-title>[1-<sup>11</sup>C]Octanoate as a Potential PET Tracer
for Studying Glial Functions: PET Evaluation in Rats and Cats</article-title>. <source>Nucl. Med. Biol.</source><year>1996</year>, <volume>23</volume>, <fpage>1009</fpage>&#8211;<lpage>1012</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(96)00148-5</pub-id>.<pub-id pub-id-type="pmid">9004290</pub-id></mixed-citation></ref><ref id="ref567"><mixed-citation publication-type="journal" id="cit567"><name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yajima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yamazaki</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name><article-title>Brain Uptake and Metabolism
of [1-<sup>11</sup>C]Octanoate in Rats: Pharmacokinetic Basis for
Its Application as a Radiopharmaceutical for Studying Brain Fatty
Acid Metabolism</article-title>. <source>Ann. Nucl. Med.</source><year>1995</year>, <volume>9</volume>, <fpage>137</fpage>&#8211;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1007/BF03165040</pub-id>.<pub-id pub-id-type="pmid">8534586</pub-id></mixed-citation></ref><ref id="ref568"><mixed-citation publication-type="journal" id="cit568"><name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Minematsu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hasegawa</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Imanishi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shiomi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tamaki</surname><given-names>N.</given-names></name>; et al. <article-title>[1-<sup>11</sup>C]Octanoate as a PET Tracer for Studying
Ischemic Stroke:
Evaluation in a Canine Model of Thromboembolic Stroke With Positron
Emission Tomography</article-title>. <source>Biol. Pharm. Bull.</source><year>2000</year>, <volume>23</volume>, <fpage>984</fpage>&#8211;<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.23.984</pub-id>.<pub-id pub-id-type="pmid">10963308</pub-id></mixed-citation></ref><ref id="ref569"><mixed-citation publication-type="journal" id="cit569"><name name-style="western"><surname>Weiss</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Hoffman</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Henry</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Ter-Pogossian</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Sobel</surname><given-names>B. E.</given-names></name><article-title>External Detection
and Visualization of Myocardial Ischemia With <sup>11</sup>C-Substrates <italic toggle="yes">In Vitro</italic> and <italic toggle="yes">In Vivo</italic></article-title>. <source>Circ. Res.</source><year>1976</year>, <volume>39</volume>, <fpage>24</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.39.1.24</pub-id>.<pub-id pub-id-type="pmid">776436</pub-id></mixed-citation></ref><ref id="ref570"><mixed-citation publication-type="journal" id="cit570"><name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Imanishi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shiomi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Minematsu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hasegawa</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>N.</given-names></name><article-title>Preliminary
Evaluation of [1-<sup>11</sup>C]Octanoate as a PET Tracer for Studying
Cerebral Ischemia: A PET Study in Rat and Canine Models of Focal Cerebral
Ischemia</article-title>. <source>Ann. Nucl. Med.</source><year>2000</year>, <volume>14</volume>, <fpage>69</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/BF02990482</pub-id>.<pub-id pub-id-type="pmid">10770584</pub-id></mixed-citation></ref><ref id="ref571"><mixed-citation publication-type="journal" id="cit571"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hatano</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name><article-title>Synthesis of 1-<sup>11</sup>C-Labeled
Fatty Acid from
[<sup>11</sup>C]HCN</article-title>. <source>Int. J. Appl. Radiat. Isot.
A. Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>, <fpage>649</fpage>&#8211;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(90)90079-V</pub-id>.</mixed-citation></ref><ref id="ref572"><mixed-citation publication-type="journal" id="cit572"><name name-style="western"><surname>Buckman</surname><given-names>B. O.</given-names></name>; <name name-style="western"><surname>VanBrocklin</surname><given-names>H. F.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Bergmann</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Katzenellenbogen</surname><given-names>J. A.</given-names></name><article-title>Synthesis and Tissue Biodistribution
of [<italic toggle="yes">Omega</italic>-<sup>11</sup>C]palmitic Acid. A Novel PET
Imaging Agent for Cardiac Fatty Acid Metabolism</article-title>. <source>J. Med. Chem.</source><year>1994</year>, <volume>37</volume>, <fpage>2481</fpage>&#8211;<lpage>2485</lpage>. <pub-id pub-id-type="doi">10.1021/jm00041a028</pub-id>.<pub-id pub-id-type="pmid">8057294</pub-id></mixed-citation></ref><ref id="ref573"><mixed-citation publication-type="journal" id="cit573"><name name-style="western"><surname>Iozzo</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bucci</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Roivainen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>J&#228;rvisalo</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Kiss</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Guiducci</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Fielding</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Naum</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Borra</surname><given-names>R.</given-names></name>; et al. <article-title>Fatty
Acid Metabolism in the Liver, Measured by Positron Emission Tomography,
Is Increased in Obese Individuals</article-title>. <source>Gastroenterology</source><year>2010</year>, <volume>139</volume>, <fpage>846</fpage>&#8211;<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.05.039</pub-id>.<pub-id pub-id-type="pmid">20685204</pub-id></mixed-citation></ref><ref id="ref574"><mixed-citation publication-type="journal" id="cit574"><name name-style="western"><surname>Christensen</surname><given-names>N. L.</given-names></name>; <name name-style="western"><surname>Jakobsen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schacht</surname><given-names>A. C.</given-names></name>; <name name-style="western"><surname>Munk</surname><given-names>O. L.</given-names></name>; <name name-style="western"><surname>Alstrup</surname><given-names>A. K. O.</given-names></name>; <name name-style="western"><surname>Tolbod</surname><given-names>L. P.</given-names></name>; <name name-style="western"><surname>Harms</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Nielsen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gormsen</surname><given-names>L. C.</given-names></name><article-title>Whole-Body Biodistribution, Dosimetry,
and Metabolite
Correction of [<sup>11</sup>C]Palmitate: A PET Tracer for Imaging
of Fatty Acid Metabolism</article-title>. <source>Mol. Imaging</source><year>2017</year>, <volume>16</volume>, <fpage>1536012117734485</fpage><pub-id pub-id-type="doi">10.1177/1536012117734485</pub-id>.<pub-id pub-id-type="pmid">29073808</pub-id><pub-id pub-id-type="pmcid">PMC5665104</pub-id></mixed-citation></ref><ref id="ref575"><mixed-citation publication-type="journal" id="cit575"><name name-style="western"><surname>Arai</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Wakabayashi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Channing</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Dunn</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Der</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Bell</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Herscovitch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Eckelman</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>M. C.</given-names></name><article-title>Incorporation
of
[1-Carbon-11]palmitate in Monkey Brain Using PET</article-title>. <source>J. Nucl. Med.</source><year>1995</year>, <volume>36</volume>, <fpage>2261</fpage>&#8211;<lpage>2267</lpage>.<pub-id pub-id-type="pmid">8523117</pub-id></mixed-citation></ref><ref id="ref576"><mixed-citation publication-type="journal" id="cit576"><name name-style="western"><surname>Amor-Coarasa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kelly</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Babich</surname><given-names>J. W.</given-names></name><article-title>Synthesis of [<sup>11</sup>C]Palmitic
Acid for PET Imaging Using a Single Molecular
Sieve 13X Cartridge for Reagent Trapping, Radiolabeling and Selective
Purification</article-title>. <source>Nucl. Med. Biol.</source><year>2015</year>, <volume>42</volume>, <fpage>685</fpage>&#8211;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2015.03.008</pub-id>.<pub-id pub-id-type="pmid">25934348</pub-id></mixed-citation></ref><ref id="ref577"><mixed-citation publication-type="journal" id="cit577"><name name-style="western"><surname>Mock</surname><given-names>B. H.</given-names></name>; <name name-style="western"><surname>Brown-Proctor</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Green</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Steele</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Glick-Wilson</surname><given-names>B. E.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>Q. H.</given-names></name><article-title>An Automated SPE-Based High-Yield
Synthesis of [<sup>11</sup>C]Acetate and [<sup>11</sup>C]Palmitate:
No Liquid-Liquid Extraction, Solvent Evaporation or Distillation Required</article-title>. <source>Nucl. Med. Biol.</source><year>2011</year>, <volume>38</volume>, <fpage>1135</fpage>&#8211;<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2011.05.007</pub-id>.<pub-id pub-id-type="pmid">21831651</pub-id></mixed-citation></ref><ref id="ref578"><mixed-citation publication-type="journal" id="cit578"><name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tada</surname><given-names>M.</given-names></name><article-title>Column Extraction
Method
for Rapid Preparation of [<sup>11</sup>C]Acetic and [<sup>11</sup>C]Palmitic Acids</article-title>. <source>Appl. Radiat. Isot.</source><year>1995</year>, <volume>46</volume>, <fpage>117</fpage>&#8211;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)00135-M</pub-id>.</mixed-citation></ref><ref id="ref579"><mixed-citation publication-type="journal" id="cit579"><name name-style="western"><surname>Eriksson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis
of [1-<sup>11</sup>C]Propyl and [1-<sup>11</sup>C]Butyl Iodide from
[<sup>11</sup>C]Carbon Monoxide and Their Use in Alkylation Reactions</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2006</year>, <volume>49</volume>, <fpage>1105</fpage>&#8211;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1119</pub-id>.</mixed-citation></ref><ref id="ref580"><mixed-citation publication-type="journal" id="cit580"><name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Thorell</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Ingvar</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Grill</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name><article-title>Use of <italic toggle="yes">R-Beta</italic>-[1-<sup>11</sup>C]hydroxybutyrate in PET Studies
of Regional Cerebral Uptake
of Ketone Bodies in Humans</article-title>. <source>Am. J. Physiol.</source><year>1995</year>, <volume>269</volume>, <elocation-id>E948</elocation-id><pub-id pub-id-type="doi">10.1152/ajpendo.1995.269.5.E948</pub-id>.<pub-id pub-id-type="pmid">7491948</pub-id></mixed-citation></ref><ref id="ref581"><mixed-citation publication-type="journal" id="cit581"><name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ouellet</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>B&#232;nard</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name><article-title>Automated Synthesis of <sup>11</sup>C-<italic toggle="yes">B</italic>-Hydroxybutyrate by Enzymatic Conversion of <sup>11</sup>C-Acetoacetate
Using <italic toggle="yes">B</italic>-Hydroxybutyrate Dehydrogenase</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2008</year>, <volume>51</volume>, <fpage>242</fpage>&#8211;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1504</pub-id>.</mixed-citation></ref><ref id="ref582"><mixed-citation publication-type="journal" id="cit582"><name name-style="western"><surname>Thorell</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name><article-title>Synthesis
of [1-<sup>11</sup>C]-Beta-Hydroxybutyric Acid</article-title>. <source>Acta Radiol. Suppl.</source><year>1991</year>, <volume>376</volume>, <fpage>94</fpage>.<pub-id pub-id-type="pmid">1666800</pub-id></mixed-citation></ref><ref id="ref583"><mixed-citation publication-type="journal" id="cit583"><name name-style="western"><surname>Thorell</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Konig</surname><given-names>W. A.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Widen</surname><given-names>L.</given-names></name><article-title>Synthesis of Racemic, <italic toggle="yes">R</italic>- and <italic toggle="yes">S</italic>-[1-<sup>11</sup>C]-<italic toggle="yes">B</italic>-Hydroxybutyric Acid</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1991</year>, <volume>29</volume>, <fpage>709</fpage>&#8211;<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580290612</pub-id>.</mixed-citation></ref><ref id="ref584"><mixed-citation publication-type="journal" id="cit584"><name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Eakins</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Allan</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Selwyn</surname><given-names>A. P.</given-names></name><article-title>Preparation
of Carbon-11 Labelled Acetate and Palmitic Acid for the Study of Myocardial
Metabolism by Emission-Computerised Axial Tomography</article-title>. <source>J. Radioanal. Chem.</source><year>1981</year>, <volume>64</volume>, <fpage>291</fpage>&#8211;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1007/BF02518360</pub-id>.</mixed-citation></ref><ref id="ref585"><mixed-citation publication-type="journal" id="cit585"><name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Horlock</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Brown</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Clark</surname><given-names>J. C.</given-names></name><article-title>The Remotely-controlled
Preparation of a <sup>11</sup>C-Labelled Radiopharmaceutical-[1-<sup>11</sup>C]Acetate</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1984</year>, <volume>35</volume>, <fpage>623</fpage>&#8211;<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(84)90107-8</pub-id>.</mixed-citation></ref><ref id="ref586"><mixed-citation publication-type="journal" id="cit586"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nozaki</surname><given-names>T.</given-names></name><article-title>A Distillation Method of Preparing
C-11 Labeled Acetate
for Routine Clinical Use</article-title>. <source>Appl. Radiat. Isot.</source><year>1993</year>, <volume>44</volume>, <fpage>761</fpage>&#8211;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(93)90145-Z</pub-id>.</mixed-citation></ref><ref id="ref587"><mixed-citation publication-type="journal" id="cit587"><name name-style="western"><surname>Norenberg</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Simpson</surname><given-names>N. R.</given-names></name>; <name name-style="western"><surname>Dunn</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Kiesewetter</surname><given-names>D. O.</given-names></name><article-title>Remote
Synthesis of [<sup>11</sup>C]Acetate</article-title>. <source>Appl.
Radiat. Isot.</source><year>1992</year>, <volume>43</volume>, <fpage>943</fpage>&#8211;<lpage>945</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(92)90162-8</pub-id>.</mixed-citation></ref><ref id="ref588"><mixed-citation publication-type="journal" id="cit588"><name name-style="western"><surname>Mitterhauser</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wadsak</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Krcal</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Schmaljohann</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bartosch</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Eidherr</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Viernstein</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kletter</surname><given-names>K.</given-names></name><article-title>New Aspects on the Preparation of [<sup>11</sup>C]Acetate-A
Simple and Fast Approach via Distillation</article-title>. <source>Appl.
Radiat. Isot.</source><year>2004</year>, <volume>61</volume>, <fpage>1147</fpage>&#8211;<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2004.03.060</pub-id>.<pub-id pub-id-type="pmid">15388102</pub-id></mixed-citation></ref><ref id="ref589"><mixed-citation publication-type="journal" id="cit589"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Doll&#233;</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name><article-title>An Improvement of <sup>11</sup>C
Acetate Synthesis-Non-Radioactive Contaminants by Irradiation-Induced
Species Emanating From the <sup>11</sup>C Carbon Dioxide Production
Target</article-title>. <source>Appl. Radiat. Isot.</source><year>2002</year>, <volume>57</volume>, <fpage>857</fpage>&#8211;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(02)00224-5</pub-id>.<pub-id pub-id-type="pmid">12406629</pub-id></mixed-citation></ref><ref id="ref590"><mixed-citation publication-type="journal" id="cit590"><name name-style="western"><surname>Kruijer</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Ter Linden</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Mooij</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Visser</surname><given-names>F. C.</given-names></name>; <name name-style="western"><surname>Herscheid</surname><given-names>J. D. M.</given-names></name><article-title>A Practical
Method for the Preparation of [<sup>11</sup>C]Acetate</article-title>. <source>Appl. Radiat. Isot.</source><year>1995</year>, <volume>46</volume>, <fpage>317</fpage>&#8211;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(95)00008-2</pub-id>.</mixed-citation></ref><ref id="ref591"><mixed-citation publication-type="journal" id="cit591"><name name-style="western"><surname>Davenport</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Dowsett</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name><article-title>A Simple Technique
for the Automated Production of No-carrier-added [1-<sup>11</sup>C]Acetate</article-title>. <source>Appl. Radiat. Isot.</source><year>1997</year>, <volume>48</volume>, <fpage>1117</fpage>&#8211;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(97)00118-8</pub-id>.<pub-id pub-id-type="pmid">9376826</pub-id></mixed-citation></ref><ref id="ref592"><mixed-citation publication-type="journal" id="cit592"><name name-style="western"><surname>Le Bars</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Malleval</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bonnefoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tourvieille</surname><given-names>C.</given-names></name><article-title>Simple Synthesis
of [1-<sup>11</sup>C]Acetate</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>2006</year>, <volume>49</volume>, <fpage>263</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1024</pub-id>.</mixed-citation></ref><ref id="ref593"><mixed-citation publication-type="journal" id="cit593"><name name-style="western"><surname>Berridge</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Cassidy</surname><given-names>E. H.</given-names></name>; <name name-style="western"><surname>Miraldi</surname><given-names>F.</given-names></name><article-title>[<sup>11</sup>C]Acetate
and [<sup>11</sup>C]Methionine: Improved Syntheses and Quality Control</article-title>. <source>Appl. Radiat. Isot.</source><year>1995</year>, <volume>46</volume>, <fpage>173</fpage>&#8211;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)00133-K</pub-id>.</mixed-citation></ref><ref id="ref594"><mixed-citation publication-type="journal" id="cit594"><name name-style="western"><surname>Moerlein</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Gaehle</surname><given-names>G. G.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Robotic preparation
of Sodium Acetate C 11 Injection for Use in Clinical PET</article-title>. <source>Nucl. Med. Biol.</source><year>2002</year>, <volume>29</volume>, <fpage>613</fpage>&#8211;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(02)00307-4</pub-id>.<pub-id pub-id-type="pmid">12088733</pub-id></mixed-citation></ref><ref id="ref595"><mixed-citation publication-type="journal" id="cit595"><name name-style="western"><surname>Jang</surname><given-names>H. Y.</given-names></name>; <name name-style="western"><surname>Kwon</surname><given-names>S. Y.</given-names></name>; <name name-style="western"><surname>Pyo</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hur</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Park</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>D. Y.</given-names></name>; et al. <article-title>In-House Development of an Optimized Synthetic
Module for Routine [<sup>11</sup>C]Acetate Production</article-title>. <source>Nucl. Med. Commun.</source><year>2015</year>, <volume>36</volume>, <fpage>102</fpage>&#8211;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1097/MNM.0000000000000213</pub-id>.<pub-id pub-id-type="pmid">25244351</pub-id><pub-id pub-id-type="pmcid">PMC4243701</pub-id></mixed-citation></ref><ref id="ref596"><mixed-citation publication-type="journal" id="cit596"><name name-style="western"><surname>Runkle</surname><given-names>A. C.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Tluczek</surname><given-names>L. J. M.</given-names></name>; <name name-style="western"><surname>Henderson</surname><given-names>B. D.</given-names></name>; <name name-style="western"><surname>Hockley</surname><given-names>B. G.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name><article-title>Automated Production of [<sup>11</sup>C]Acetate and [<sup>11</sup>C]Palmitate Using a Modified GE Tracerlab
FXC-Pro</article-title>. <source>Appl. Radiat. Isot.</source><year>2011</year>, <volume>69</volume>, <fpage>691</fpage>&#8211;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2011.01.002</pub-id>.<pub-id pub-id-type="pmid">21256039</pub-id></mixed-citation></ref><ref id="ref597"><mixed-citation publication-type="journal" id="cit597"><name name-style="western"><surname>Lodi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Malizia</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Boschi</surname><given-names>S.</given-names></name><article-title>Synthesis
of [<sup>11</sup>C]Acetate</article-title>. <source>Radiochemical Syntheses</source><year>2012</year>, <fpage>297</fpage>&#8211;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1002/9781118140345.ch29</pub-id>.</mixed-citation></ref><ref id="ref598"><mixed-citation publication-type="journal" id="cit598"><name name-style="western"><surname>Soloviev</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Tamburella</surname><given-names>C.</given-names></name><article-title>Captive Solvent
[<sup>11</sup>C]Acetate
Synthesis in GMP Conditions</article-title>. <source>Appl. Radiat. Isot.</source><year>2006</year>, <volume>64</volume>, <fpage>995</fpage>&#8211;<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2006.04.011</pub-id>.<pub-id pub-id-type="pmid">16806949</pub-id></mixed-citation></ref><ref id="ref599"><mixed-citation publication-type="journal" id="cit599"><name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Nie</surname><given-names>D.</given-names></name><article-title>Fully Automated
Synthesis
of <sup>11</sup>C-Acetate As Tumor PET Tracer by Simple Modified Solid-Phase
Extraction Purification</article-title>. <source>Appl. Radiat. Isot.</source><year>2013</year>, <volume>82</volume>, <fpage>81</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2013.07.012</pub-id>.<pub-id pub-id-type="pmid">23974302</pub-id></mixed-citation></ref><ref id="ref600"><mixed-citation publication-type="journal" id="cit600"><name name-style="western"><surname>Le Bars</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Malleval</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bonnefoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tourvieille</surname><given-names>C.</given-names></name><article-title>Simple synthesis
of [1-11C]acetate</article-title>. <source>Journal of Labelled Compounds
and Radiopharmaceuticals</source><year>2006</year>, <volume>49</volume>, <fpage>263</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.1024</pub-id>.</mixed-citation></ref><ref id="ref601"><mixed-citation publication-type="journal" id="cit601"><name name-style="western"><surname>Malkowski</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Wareluk</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gorycki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Skrobisz</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Studniarek</surname><given-names>M.</given-names></name><article-title>Normal Uptake
of <sup>11</sup>C-Acetate in Pancreas,
Liver, Spleen, and Suprarenal Gland in PET</article-title>. <source>Can. J. Gastroenterol. Hepatol.</source><year>2017</year>, <volume>2017</volume>, <fpage>5478068</fpage><pub-id pub-id-type="doi">10.1155/2017/5478068</pub-id>.<pub-id pub-id-type="pmid">29090208</pub-id><pub-id pub-id-type="pmcid">PMC5635273</pub-id></mixed-citation></ref><ref id="ref602"><mixed-citation publication-type="journal" id="cit602"><name name-style="western"><surname>Karanikas</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Beheshti</surname><given-names>M.</given-names></name><article-title><sup>11</sup>C-Acetate PET/CT Imaging:
Physiologic Uptake, Variants, and Pitfalls</article-title>. <source>PET Clin.</source><year>2014</year>, <volume>9</volume>, <fpage>339</fpage>&#8211;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.cpet.2014.03.006</pub-id>.<pub-id pub-id-type="pmid">25030397</pub-id></mixed-citation></ref><ref id="ref603"><mixed-citation publication-type="journal" id="cit603"><name name-style="western"><surname>Shreve</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Gross</surname><given-names>M. D.</given-names></name><article-title>Imaging of the Pancreas and Related
Diseases With PET Carbon-11-Acetate</article-title>. <source>J. Nucl.
Med.</source><year>1997</year>, <volume>38</volume>, <fpage>1305</fpage>&#8211;<lpage>1310</lpage>.<pub-id pub-id-type="pmid">9255173</pub-id></mixed-citation></ref><ref id="ref604"><mixed-citation publication-type="journal" id="cit604"><name name-style="western"><surname>Hyun O</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lodge</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Jagannath</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Buscaglia</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Olagbemiro</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R. L.</given-names></name><article-title>An Exocrine Pancreatic
Stress Test with <sup>11</sup>C-Acetate PET and Secretin Stimulation</article-title>. <source>J. Nucl. Med.</source><year>2014</year>, <volume>55</volume>, <fpage>1128</fpage>&#8211;<lpage>1131</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.113.135681</pub-id>.<pub-id pub-id-type="pmid">24842893</pub-id></mixed-citation></ref><ref id="ref605"><mixed-citation publication-type="journal" id="cit605"><name name-style="western"><surname>Nesterov</surname><given-names>S. V.</given-names></name>; <name name-style="western"><surname>Turta</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>M&#228;ki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lisinen</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Tuunanen</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Knuuti</surname><given-names>J.</given-names></name><article-title>C-11 Acetate Has Excellent
Reproducibility for Quantification of Myocardial Oxidative Metabolism</article-title>. <source>Eur. Heart J. Cardiovasc. Imaging</source><year>2015</year>, <volume>16</volume>, <fpage>500</fpage>&#8211;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jeu289</pub-id>.<pub-id pub-id-type="pmid">25535214</pub-id></mixed-citation></ref><ref id="ref606"><mixed-citation publication-type="journal" id="cit606"><name name-style="western"><surname>Richard</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Blondin</surname><given-names>D. P.</given-names></name>; <name name-style="western"><surname>Noll</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lebel</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Lepage</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Carpentier</surname><given-names>A. C.</given-names></name><article-title>Determination
of a Pharmacokinetic
Model for [<sup>11</sup>C]-Acetate in Brown Adipose Tissue</article-title>. <source>EJNMMI Res.</source><year>2019</year>, <volume>9</volume>, <fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s13550-019-0497-6</pub-id>.<pub-id pub-id-type="pmid">30919091</pub-id><pub-id pub-id-type="pmcid">PMC6437247</pub-id></mixed-citation></ref><ref id="ref607"><mixed-citation publication-type="journal" id="cit607"><name name-style="western"><surname>Klein</surname><given-names>L. J.</given-names></name>; <name name-style="western"><surname>Visser</surname><given-names>F. C.</given-names></name>; <name name-style="western"><surname>Knaapen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Peters</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Teule</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Visser</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Lammertsma</surname><given-names>A. A.</given-names></name><article-title>Carbon-11
Acetate as a Tracer of Myocardial Oxygen Consumption</article-title>. <source>Eur. J. Nucl. Med.</source><year>2001</year>, <volume>28</volume>, <fpage>651</fpage>&#8211;<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1007/s002590000472</pub-id>.<pub-id pub-id-type="pmid">11383873</pub-id></mixed-citation></ref><ref id="ref608"><mixed-citation publication-type="journal" id="cit608"><name name-style="western"><surname>Ng</surname><given-names>C. K.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Schelbert</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Buxton</surname><given-names>D. B.</given-names></name><article-title>Validation of a Model for [1-<sup>11</sup>C]acetate
as a Tracer of Cardiac Oxidative Metabolism</article-title>. <source>Am. J. Physiol.</source><year>1994</year>, <volume>266</volume>, <fpage>H1304</fpage>&#8211;<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1994.266.4.H1304</pub-id>.<pub-id pub-id-type="pmid">8184908</pub-id></mixed-citation></ref><ref id="ref609"><mixed-citation publication-type="journal" id="cit609"><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Fang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Huo</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Shang</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Knuuti</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>R.</given-names></name>; et al. <article-title>Myocardial Tissue and
Metabolism Characterization in
Men With Alcohol Consumption by Cardiovascular Magnetic Resonance
and <sup>11</sup>C-Acetate PET/CT</article-title>. <source>J. Cardiovasc.
Magn. Reson.</source><year>2020</year>, <volume>22</volume>, <fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s12968-020-00614-2</pub-id>.<pub-id pub-id-type="pmid">32299425</pub-id><pub-id pub-id-type="pmcid">PMC7161264</pub-id></mixed-citation></ref><ref id="ref610"><mixed-citation publication-type="journal" id="cit610"><name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Fang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Dang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Xing</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name><article-title>Characterization of
Myocardial Oxidative Metabolism and Myocardial
External Efficiency in High-Risk Alcohol Cardiotoxicity and Alcoholic
Cardiomyopathy via Dynamic <sup>11</sup>C-Acetate Positron Emission
Tomography</article-title>. <source>J. Nucl. Cardiol.</source><year>2022</year>, <volume>29</volume>, <fpage>278</fpage><pub-id pub-id-type="doi">10.1007/s12350-020-02214-0</pub-id>.<pub-id pub-id-type="pmid">32557237</pub-id></mixed-citation></ref><ref id="ref611"><mixed-citation publication-type="journal" id="cit611"><name name-style="western"><surname>Spick</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Herrmann</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Czernin</surname><given-names>J.</given-names></name><article-title>Evaluation
of Prostate
Cancer with <sup>11</sup>C-Acetate PET/CT</article-title>. <source>J.
Nucl. Med.</source><year>2016</year>, <volume>57</volume>, <fpage>30S</fpage>&#8211;<lpage>37S</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.115.169599</pub-id>.<pub-id pub-id-type="pmid">27694168</pub-id></mixed-citation></ref><ref id="ref612"><mixed-citation publication-type="journal" id="cit612"><name name-style="western"><surname>Ho</surname><given-names>C. L.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Yeung</surname><given-names>D. W.</given-names></name><article-title><sup>11</sup>C-Acetate
PET Imaging in Hepatocellular Carcinoma and Other Liver Masses</article-title>. <source>J. Nucl. Med.</source><year>2003</year>, <volume>44</volume>, <fpage>213</fpage>&#8211;<lpage>221</lpage>.<pub-id pub-id-type="pmid">12571212</pub-id></mixed-citation></ref><ref id="ref613"><mixed-citation publication-type="journal" id="cit613"><name name-style="western"><surname>Straatman</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Hortmann</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Production of 1-<sup>11</sup>C-Acetoacetic
Acid</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1974</year>, <volume>10</volume>, <fpage>175</fpage>&#8211;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2590100121</pub-id>.</mixed-citation></ref><ref id="ref614"><mixed-citation publication-type="journal" id="cit614"><name name-style="western"><surname>Tremblay</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ouellet</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Rodrigue</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Langlois</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>B&#233;nard</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Cunnane</surname><given-names>S. C.</given-names></name><article-title>Automated Synthesis of <sup>11</sup>C-Acetoacetic Acid,
a Key Alternate Brain Fuel to Glucose</article-title>. <source>Appl.
Radiat. Isot.</source><year>2007</year>, <volume>65</volume>, <fpage>934</fpage>&#8211;<lpage>940</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2007.03.015</pub-id>.<pub-id pub-id-type="pmid">17544283</pub-id></mixed-citation></ref><ref id="ref615"><mixed-citation publication-type="journal" id="cit615"><name name-style="western"><surname>Qu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Babich</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Waterhouse</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Dooley</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ponnala</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Urgiles</surname><given-names>J.</given-names></name><article-title>A General <sup>11</sup>C-Labeling Approach Enabled
by Fluoride-Mediated Desilylation of
Organosilanes</article-title>. <source>Nat. Commun.</source><year>2020</year>, <volume>11</volume>, <fpage>1736</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-15556-7</pub-id>.<pub-id pub-id-type="pmid">32269227</pub-id><pub-id pub-id-type="pmcid">PMC7142131</pub-id></mixed-citation></ref><ref id="ref616"><mixed-citation publication-type="journal" id="cit616"><name name-style="western"><surname>Berger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Maziere</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Prenant</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name><article-title>Synthesis
of Carbon-11-Labelled Acetone</article-title>. <source>Int. J. Appl.
Rad. Isot.</source><year>1980</year>, <volume>31</volume>, <fpage>577</fpage>&#8211;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(80)90102-7</pub-id>.</mixed-citation></ref><ref id="ref617"><mixed-citation publication-type="journal" id="cit617"><name name-style="western"><surname>Studenov</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Berridge</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Soloviev</surname><given-names>D. V.</given-names></name>; <name name-style="western"><surname>Matarrese</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Todde</surname><given-names>S.</given-names></name><article-title>High Yield Synthesis of [<sup>11</sup>C]-Acetone Through Selective
Quenching of Methyl Lithium</article-title>. <source>Nucl. Med. Biol.</source><year>1999</year>, <volume>26</volume>, <fpage>431</fpage>&#8211;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(99)00003-7</pub-id>.<pub-id pub-id-type="pmid">10382847</pub-id></mixed-citation></ref><ref id="ref618"><mixed-citation publication-type="journal" id="cit618"><name name-style="western"><surname>Harman</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Stewart</surname><given-names>T. D.</given-names></name>; <name name-style="western"><surname>Ruben</surname><given-names>S.</given-names></name><article-title>Tracer Studies
with
Radioactive Hydrogen. The Synthesis of Labelled Methyl Iodide</article-title>. <source>J. Am. Chem. Soc.</source><year>1942</year>, <volume>64</volume>, <fpage>2293</fpage>&#8211;<lpage>2294</lpage>. <pub-id pub-id-type="doi">10.1021/ja01262a020</pub-id>.</mixed-citation></ref><ref id="ref619"><mixed-citation publication-type="journal" id="cit619"><name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Coenen</surname><given-names>H. H.</given-names></name><article-title>Recommendations for a Practical Production of [<sup>11</sup>C]Methyl Iodide</article-title>. <source>Int. J. Radiat. Appl.
Instrum. A. Appl. Radiat. Isot.</source><year>1987</year>, <volume>38</volume>, <fpage>601</fpage>&#8211;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90123-7</pub-id>.</mixed-citation></ref><ref id="ref620"><mixed-citation publication-type="journal" id="cit620"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Gallagher</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Carbon-11 Labeled Aliphatic Amines in Lung Uptake and
Metabolism Studies: Potential for Dynamic Measurements In Vivo</article-title>. <source>J. Pharmacol. Exp. Ther.</source><year>1976</year>, <volume>198</volume>, <fpage>133</fpage>&#8211;<lpage>145</lpage>.<pub-id pub-id-type="pmid">933003</pub-id></mixed-citation></ref><ref id="ref621"><mixed-citation publication-type="journal" id="cit621"><name name-style="western"><surname>Yajima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yamazaki</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ino</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hayashi</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name><article-title>Automated Synthesis of Radiopharmaceuticals
for Positron Emission Tomography: An Apparatus for [1-<sup>11</sup>C] Labeled Carboxylic Acid</article-title>. <source>J. Automat. Chem.</source><year>1995</year>, <volume>17</volume>, <fpage>109</fpage>&#8211;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1155/S1463924695000198</pub-id>.<pub-id pub-id-type="pmid">18925023</pub-id><pub-id pub-id-type="pmcid">PMC2548068</pub-id></mixed-citation></ref><ref id="ref622"><mixed-citation publication-type="journal" id="cit622"><name name-style="western"><surname>Yajima</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Miyake</surname><given-names>Y.</given-names></name><article-title>Synthesisi of [1-<sup>11</sup>C]Octanoic
Acid, [<sup>11</sup>C]Raclopride and [<sup>11</sup>C]Nicergoline:
General-purpose
Automated Synthesis Apparatus of <sup>11</sup>C-labeled Radiopharmaceuticals</article-title>. <source>Appl. Radiat. Isot.</source><year>1997</year>, <volume>48</volume>, <fpage>763</fpage>&#8211;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(96)00309-0</pub-id>.</mixed-citation></ref><ref id="ref623"><mixed-citation publication-type="journal" id="cit623"><name name-style="western"><surname>Weiss</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Ahmed</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Williamson</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Ter-Pogossian</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Sobel</surname><given-names>B. E.</given-names></name><article-title>Quantification of Infarction in Cross
Sections of Canine Myocardium In Vivo With Positron Emission Transaxial
Tomography and <sup>11</sup>C-Palmitate</article-title>. <source>Circulation</source><year>1977</year>, <volume>55</volume>, <fpage>66</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.55.1.66</pub-id>.<pub-id pub-id-type="pmid">830220</pub-id></mixed-citation></ref><ref id="ref624"><mixed-citation publication-type="journal" id="cit624"><name name-style="western"><surname>Jewett</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Ehrenkaufer</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Ram</surname><given-names>S.</given-names></name><article-title>A Captive Solvent Method
for Rapid Radiosynthesis: Application to the Synthesis of [1-<sup>11</sup>C]Palmitic Acid</article-title>. <source>Int. J. Appl. Rad.
Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>672</fpage>&#8211;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90011-0</pub-id>.<pub-id pub-id-type="pmid">4055091</pub-id></mixed-citation></ref><ref id="ref625"><mixed-citation publication-type="journal" id="cit625"><name name-style="western"><surname>Padgett</surname><given-names>H. C.</given-names></name>; <name name-style="western"><surname>Robinson</surname><given-names>G. D.</given-names></name>; <name name-style="western"><surname>Barrio</surname><given-names>J. R.</given-names></name><article-title>[1-<sup>11</sup>C]Palmitic Acid:
Improved Radiopharmaceutical Preparation</article-title>. <source>Int.
J. Appl. Rad. Isot.</source><year>1982</year>, <volume>33</volume>, <fpage>1471</fpage>&#8211;<lpage>1472</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90189-2</pub-id>.<pub-id pub-id-type="pmid">7169274</pub-id></mixed-citation></ref><ref id="ref626"><mixed-citation publication-type="journal" id="cit626"><name name-style="western"><surname>Amor-Coarasa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kelly</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Babich</surname><given-names>J. W.</given-names></name><article-title>3D-Printed Automation
for Optimized PET Radiochemistry</article-title>. <source>Sci. Adv.</source><year>2019</year>, <volume>5</volume>, <elocation-id>eaax4762</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax4762</pub-id>.<pub-id pub-id-type="pmid">31548988</pub-id><pub-id pub-id-type="pmcid">PMC6744267</pub-id></mixed-citation></ref><ref id="ref627"><mixed-citation publication-type="journal" id="cit627"><name name-style="western"><surname>Wust</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>McCarthy</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>A New Approach
for the Synthesis of [<sup>11</sup>C]-labeled Fatty Acids</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2000</year>, <volume>43</volume>, <fpage>1289</fpage>&#8211;<lpage>1300</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1099-1344(200011)43:13&amp;#x0003c;1289::AID-JLCR420&amp;#x0003e;3.0.CO;2-Q</pub-id>.</mixed-citation></ref><ref id="ref628"><mixed-citation publication-type="journal" id="cit628"><name name-style="western"><surname>Ko</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Strafella</surname><given-names>A. P.</given-names></name><article-title>Dopaminergic
Neurotransmission in
the Human Brain: New Lessons From Perturbation and Imaging</article-title>. <source>Neuroscientist</source><year>2012</year>, <volume>18</volume>, <fpage>149</fpage>&#8211;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1177/1073858411401413</pub-id>.<pub-id pub-id-type="pmid">21536838</pub-id><pub-id pub-id-type="pmcid">PMC3479149</pub-id></mixed-citation></ref><ref id="ref629"><mixed-citation publication-type="journal" id="cit629"><name name-style="western"><surname>Amenta</surname><given-names>F.</given-names></name><article-title>Density and Distribution of Dopamine Receptors in the
Cardiovascular System and in the Kidney</article-title>. <source>J.
Auton. Pharmacol.</source><year>1990</year>, <volume>10</volume>, <fpage>s11</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-8673.1990.tb00222.x</pub-id>.<pub-id pub-id-type="pmid">2151516</pub-id></mixed-citation></ref><ref id="ref630"><mixed-citation publication-type="journal" id="cit630"><name name-style="western"><surname>Tank</surname><given-names>A. W.</given-names></name>; <name name-style="western"><surname>Lee Wong</surname><given-names>D.</given-names></name><article-title>Peripheral and Central
Effects of
Circulating Catecholamines</article-title>. <source>Compr. Physiol.</source><year>2015</year>, <volume>5</volume>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c140007</pub-id>.<pub-id pub-id-type="pmid">25589262</pub-id></mixed-citation></ref><ref id="ref631"><mixed-citation publication-type="journal" id="cit631"><name name-style="western"><surname>Misu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Goshima</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ueda</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Okamura</surname><given-names>H.</given-names></name><article-title>Neurobiology
of <italic toggle="yes">L</italic>-DOPAergic Systems</article-title>. <source>Prog.
Neurobiol.</source><year>1996</year>, <volume>49</volume>, <fpage>415</fpage>&#8211;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(96)00025-1</pub-id>.<pub-id pub-id-type="pmid">8895995</pub-id></mixed-citation></ref><ref id="ref632"><mixed-citation publication-type="journal" id="cit632"><name name-style="western"><surname>Dorszewska</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Prendecki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lianeri</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kozubski</surname><given-names>W.</given-names></name><article-title>Molecular
Effects of <italic toggle="yes">L</italic>-dopa Therapy in Parkinson&#8217;s Disease</article-title>. <source>Curr. Genomics</source><year>2014</year>, <volume>15</volume>, <fpage>11</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.2174/1389202914666131210213042</pub-id>.<pub-id pub-id-type="pmid">24653659</pub-id><pub-id pub-id-type="pmcid">PMC3958954</pub-id></mixed-citation></ref><ref id="ref633"><mixed-citation publication-type="journal" id="cit633"><name name-style="western"><surname>Barbeau</surname><given-names>A.</given-names></name><article-title>L-Dopa Therapy in Parkinson&#8217;s
Disease: A Critical
Review of Nine Years&#8217; Experience</article-title>. <source>Can.
Med. Assoc. J.</source><year>1969</year>, <volume>101</volume>, <fpage>59</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="pmcid">PMC1946468</pub-id><pub-id pub-id-type="pmid">4903690</pub-id></mixed-citation></ref><ref id="ref634"><mixed-citation publication-type="journal" id="cit634"><name name-style="western"><surname>Pretze</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>W&#228;ngler</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>W&#228;ngler</surname><given-names>B.</given-names></name><article-title><italic toggle="yes">6</italic>-[<sup>18</sup>F]Fluoro-<italic toggle="yes">L</italic>-DOPA: A Well-Established
Neurotracer with Expanding Application Spectrum and Strongly Improved
Radiosyntheses</article-title>. <source>Biomed Res. Int.</source><year>2014</year>, <volume>2014</volume>, <fpage>674063</fpage><pub-id pub-id-type="doi">10.1155/2014/674063</pub-id>.<pub-id pub-id-type="pmid">24987698</pub-id><pub-id pub-id-type="pmcid">PMC4058520</pub-id></mixed-citation></ref><ref id="ref635"><mixed-citation publication-type="journal" id="cit635"><name name-style="western"><surname>Torstenson</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fasth</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>A Comparison of <sup>11</sup>C-Labeled <italic toggle="yes">L</italic>-DOPA and <italic toggle="yes">L</italic>-Fluorodopa
As Positron Emission
Tomography Tracers for the Presynaptic Dopaminergic System</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1999</year>, <volume>19</volume>, <fpage>1142</fpage>&#8211;<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-199910000-00011</pub-id>.<pub-id pub-id-type="pmid">10532639</pub-id></mixed-citation></ref><ref id="ref636"><mixed-citation publication-type="journal" id="cit636"><name name-style="western"><surname>Nguyen</surname><given-names>N. T.</given-names></name>; <name name-style="western"><surname>DeGrado</surname><given-names>T. R.</given-names></name>; <name name-style="western"><surname>Chakraborty</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Schwaiger</surname><given-names>M.</given-names></name><article-title>Myocardial Kinetics of Carbon-11-Epinephrine
in the Isolated Working Rat Heart</article-title>. <source>J. Nucl.
Med.</source><year>1997</year>, <volume>38</volume>, <fpage>780</fpage>&#8211;<lpage>785</lpage>.<pub-id pub-id-type="pmid">9170446</pub-id></mixed-citation></ref><ref id="ref637"><mixed-citation publication-type="journal" id="cit637"><name name-style="western"><surname>M&#252;nch</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>N. T. B.</given-names></name>; <name name-style="western"><surname>Nekolla</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ziegler</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Muzik</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Chakraborty</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Schwaiger</surname><given-names>M.</given-names></name><article-title>Evaluation
of Sympathetic Nerve Terminals With [<sup>11</sup>C]Epinephrine and
[<sup>11</sup>C]Hydroxyephedrine and Positron Emission Tomography</article-title>. <source>Circulation</source><year>2000</year>, <volume>101</volume>, <fpage>516</fpage>&#8211;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.101.5.516</pub-id>.<pub-id pub-id-type="pmid">10662749</pub-id></mixed-citation></ref><ref id="ref638"><mixed-citation publication-type="journal" id="cit638"><name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis of &#947;-Amino[4-<sup>11</sup>C]Butyric Acid (GABA)</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1989</year>, <volume>27</volume>, <fpage>571</fpage>&#8211;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580270510</pub-id>.</mixed-citation></ref><ref id="ref639"><mixed-citation publication-type="journal" id="cit639"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>D.</given-names></name><article-title>GABA Receptors
in Brain Development, Function, and
Injury</article-title>. <source>Metab. Brain Dis.</source><year>2015</year>, <volume>30</volume>, <fpage>367</fpage>&#8211;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-014-9560-1</pub-id>.<pub-id pub-id-type="pmid">24820774</pub-id><pub-id pub-id-type="pmcid">PMC4231020</pub-id></mixed-citation></ref><ref id="ref640"><mixed-citation publication-type="journal" id="cit640"><name name-style="western"><surname>Bormann</surname><given-names>J.</given-names></name><article-title>The &#8216;ABC&#8217; of GABA Receptors</article-title>. <source>Trends Pharmacol. Sci.</source><year>2000</year>, <volume>21</volume>, <fpage>16</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-6147(99)01413-3</pub-id>.<pub-id pub-id-type="pmid">10637650</pub-id></mixed-citation></ref><ref id="ref641"><mixed-citation publication-type="journal" id="cit641"><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Danbolt</surname><given-names>N.</given-names></name><article-title>GABA and Glutamate Transporters in
Brain</article-title>. <source>Front. Endocrinol.</source><year>2013</year>, <volume>4</volume>, <fpage>165</fpage><pub-id pub-id-type="doi">10.3389/fendo.2013.00165</pub-id>.<pub-id pub-id-type="pmcid">PMC3822327</pub-id><pub-id pub-id-type="pmid">24273530</pub-id></mixed-citation></ref><ref id="ref642"><mixed-citation publication-type="journal" id="cit642"><name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Suhara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Karlsson</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Schoeps</surname><given-names>K. O.</given-names></name>; <name name-style="western"><surname>Swahn</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Bone</surname><given-names>D.</given-names></name><article-title>Positron Emission Tomography Shows High Specific Uptake of Racemic
Carbon-11 Labelled Norepinephrine in the Primate Heart</article-title>. <source>Eur. J. Nucl. Med.</source><year>1994</year>, <volume>21</volume>, <fpage>345</fpage>&#8211;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1007/BF00947971</pub-id>.<pub-id pub-id-type="pmid">8005159</pub-id></mixed-citation></ref><ref id="ref643"><mixed-citation publication-type="journal" id="cit643"><name name-style="western"><surname>Swahn</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name><article-title>An HPLC-Method for
Determination of Ligand Metabolism During PET
Studies With [<sup>11</sup>C]Metaraminol and [<sup>11</sup>C]Norepinephrine</article-title>. <source>Nucl. Med. Biol.</source><year>1995</year>, <volume>22</volume>, <fpage>1045</fpage>&#8211;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(95)02028-4</pub-id>.<pub-id pub-id-type="pmid">8998464</pub-id></mixed-citation></ref><ref id="ref644"><mixed-citation publication-type="journal" id="cit644"><name name-style="western"><surname>Carhart-Harris</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Nutt</surname><given-names>D. J.</given-names></name><article-title>Serotonin and Brain
Function: A Tale
of Two Receptors</article-title>. <source>J. Psychopharmacol.</source><year>2017</year>, <volume>31</volume>, <fpage>1091</fpage>&#8211;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1177/0269881117725915</pub-id>.<pub-id pub-id-type="pmid">28858536</pub-id><pub-id pub-id-type="pmcid">PMC5606297</pub-id></mixed-citation></ref><ref id="ref645"><mixed-citation publication-type="journal" id="cit645"><name name-style="western"><surname>Castro</surname><given-names>E. C.</given-names></name>; <name name-style="western"><surname>Sen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Parks</surname><given-names>W. T.</given-names></name>; <name name-style="western"><surname>Langston</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Galambos</surname><given-names>C.</given-names></name><article-title>The Role of Serotonin Transporter
in Human Lung Development
and in Neonatal Lung Disorders</article-title>. <source>Can. Respir.
J.</source><year>2017</year>, <volume>2017</volume>, <fpage>9064046</fpage><pub-id pub-id-type="doi">10.1155/2017/9064046</pub-id>.<pub-id pub-id-type="pmid">28316463</pub-id><pub-id pub-id-type="pmcid">PMC5337869</pub-id></mixed-citation></ref><ref id="ref646"><mixed-citation publication-type="journal" id="cit646"><name name-style="western"><surname>Pirina</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Zinellu</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Paliogiannis</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fois</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Marras</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Sotgia</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Carru</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Zinellu</surname><given-names>A.</given-names></name><article-title>Circulating Serotonin Levels in COPD Patients: A Pilot
Study</article-title>. <source>BMC Pulm. Med.</source><year>2018</year>, <volume>18</volume>, <fpage>167</fpage><pub-id pub-id-type="doi">10.1186/s12890-018-0730-5</pub-id>.<pub-id pub-id-type="pmid">30409142</pub-id><pub-id pub-id-type="pmcid">PMC6225723</pub-id></mixed-citation></ref><ref id="ref647"><mixed-citation publication-type="journal" id="cit647"><name name-style="western"><surname>Sadavongvivad</surname><given-names>C.</given-names></name><article-title>Pharmacological Significance of Biogenic
Amines in
the Lungs: 5-Hydroxytryptamine</article-title>. <source>Br. J. Pharmacol.</source><year>1970</year>, <volume>38</volume>, <fpage>353</fpage>&#8211;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1970.tb08523.x</pub-id>.<pub-id pub-id-type="pmid">5417858</pub-id><pub-id pub-id-type="pmcid">PMC1702795</pub-id></mixed-citation></ref><ref id="ref648"><mixed-citation publication-type="journal" id="cit648"><name name-style="western"><surname>Tordjman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Chokron</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Delorme</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Charrier</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bellissant</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Jaafari</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Fougerou</surname><given-names>C.</given-names></name><article-title>Melatonin:
Pharmacology,
Functions and Therapeutic Benefits</article-title>. <source>Curr. Neuropharmacol.</source><year>2017</year>, <volume>15</volume>, <fpage>434</fpage>&#8211;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X14666161228122115</pub-id>.<pub-id pub-id-type="pmid">28503116</pub-id><pub-id pub-id-type="pmcid">PMC5405617</pub-id></mixed-citation></ref><ref id="ref649"><mixed-citation publication-type="journal" id="cit649"><name name-style="western"><surname>Hardeland</surname><given-names>R.</given-names></name><article-title>Neurobiology, Pathophysiology, and
Treatment of Melatonin
Deficiency and Dysfunction</article-title>. <source>Sci. World J.</source><year>2012</year>, <volume>2012</volume>, <fpage>640389</fpage><pub-id pub-id-type="doi">10.1100/2012/640389</pub-id>.<pub-id pub-id-type="pmcid">PMC3354573</pub-id><pub-id pub-id-type="pmid">22629173</pub-id></mixed-citation></ref><ref id="ref650"><mixed-citation publication-type="journal" id="cit650"><name name-style="western"><surname>Le Bars</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Luthra</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Luu Duc</surname><given-names>C.</given-names></name><article-title>The Preparation
of a Carbon-11 Labelled Neurohormone&#8212;[<sup>11</sup>C]Melatonin</article-title>. <source>Int. J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1987</year>, <volume>38</volume>, <fpage>1073</fpage>&#8211;<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90073-6</pub-id>.<pub-id pub-id-type="pmid">2828278</pub-id></mixed-citation></ref><ref id="ref651"><mixed-citation publication-type="journal" id="cit651"><name name-style="western"><surname>Rutigliano</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Accorroni</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Zucchi</surname><given-names>R.</given-names></name><article-title>The Case for TAAR1
as a Modulator of Central Nervous System Function</article-title>. <source>Front. Pharmacol.</source><year>2018</year>, <volume>8</volume>, <fpage>987</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00987</pub-id>.<pub-id pub-id-type="pmid">29375386</pub-id><pub-id pub-id-type="pmcid">PMC5767590</pub-id></mixed-citation></ref><ref id="ref652"><mixed-citation publication-type="journal" id="cit652"><name name-style="western"><surname>Stohs</surname><given-names>S. J.</given-names></name><article-title>Physiological
Functions and Pharmacological and Toxicological
Effects of <italic toggle="yes">P</italic>-Octopamine</article-title>. <source>Drug
Chem. Toxicol.</source><year>2015</year>, <volume>38</volume>, <fpage>106</fpage>&#8211;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.3109/01480545.2014.900069</pub-id>.<pub-id pub-id-type="pmid">24654910</pub-id></mixed-citation></ref><ref id="ref653"><mixed-citation publication-type="journal" id="cit653"><name name-style="western"><surname>Qi</surname><given-names>Y. X.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Gu</surname><given-names>G. X.</given-names></name>; <name name-style="western"><surname>Mao</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ye</surname><given-names>G. Y.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><article-title>A New Drosophila Octopamine
Receptor Responds to Serotonin</article-title>. <source>Insect Biochem.
Mol. Biol.</source><year>2017</year>, <volume>90</volume>, <fpage>61</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.ibmb.2017.09.010</pub-id>.<pub-id pub-id-type="pmid">28942992</pub-id></mixed-citation></ref><ref id="ref654"><mixed-citation publication-type="journal" id="cit654"><name name-style="western"><surname>Zucchi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Chiellini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Scanlan</surname><given-names>T. S.</given-names></name>; <name name-style="western"><surname>Grandy</surname><given-names>D. K.</given-names></name><article-title>Trace Amine-Associated
Receptors and Their Ligands</article-title>. <source>Br. J. Pharmacol.</source><year>2006</year>, <volume>149</volume>, <fpage>967</fpage>&#8211;<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706948</pub-id>.<pub-id pub-id-type="pmid">17088868</pub-id><pub-id pub-id-type="pmcid">PMC2014643</pub-id></mixed-citation></ref><ref id="ref655"><mixed-citation publication-type="journal" id="cit655"><name name-style="western"><surname>Erspamer</surname><given-names>V.</given-names></name><article-title>Active Substances in the Posterior
Salivary Glands
of Octopoda. II. Tyramine and Octopamine (Oxyoctopamine)</article-title>. <source>Acta Pharmacol. Toxicol.</source><year>1948</year>, <volume>4</volume>, <fpage>224</fpage>&#8211;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0773.1948.tb03345.x</pub-id>.</mixed-citation></ref><ref id="ref656"><mixed-citation publication-type="journal" id="cit656"><name name-style="western"><surname>Graham</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Clarke</surname><given-names>C. L.</given-names></name><article-title>Physiological Action
of Progesterone
in Target Tissues</article-title>. <source>Endocr. Rev.</source><year>1997</year>, <volume>18</volume>, <fpage>502</fpage>&#8211;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1210/edrv.18.4.0308</pub-id>.<pub-id pub-id-type="pmid">9267762</pub-id></mixed-citation></ref><ref id="ref657"><mixed-citation publication-type="journal" id="cit657"><name name-style="western"><surname>Taraborrelli</surname><given-names>S.</given-names></name><article-title>Physiology, Production and Action
of Progesterone</article-title>. <source>Acta Obstet. Gynecol. Scand.</source><year>2015</year>, <volume>94</volume>, <fpage>8</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/aogs.12771</pub-id>.<pub-id pub-id-type="pmid">26358238</pub-id></mixed-citation></ref><ref id="ref658"><mixed-citation publication-type="journal" id="cit658"><name name-style="western"><surname>Stefanick</surname><given-names>M. L.</given-names></name><article-title>Estrogens and Progestins: Background
and History, Trends
in Use, and Guidelines and Regimens Approved by the US Food and Drug
Administration</article-title>. <source>Am. J. Med.</source><year>2005</year>, <volume>118</volume>, <fpage>64</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2005.09.059</pub-id>.<pub-id pub-id-type="pmid">16414329</pub-id></mixed-citation></ref><ref id="ref659"><mixed-citation publication-type="journal" id="cit659"><name name-style="western"><surname>Roeder</surname><given-names>T.</given-names></name><article-title>Tyramine and Octopamine: Ruling Behavior
and Metabolism</article-title>. <source>Annu. Rev. Entomol.</source><year>2005</year>, <volume>50</volume>, <fpage>447</fpage>&#8211;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.ento.50.071803.130404</pub-id>.<pub-id pub-id-type="pmid">15355245</pub-id></mixed-citation></ref><ref id="ref660"><mixed-citation publication-type="journal" id="cit660"><name name-style="western"><surname>Philips</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Rozdilsky</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Boulton</surname><given-names>A. A.</given-names></name><article-title>Evidence for the
Presence of M-Tyramine, P-Tyramine, Tryptamine, and Phenylethylamine
in the Rat Brain and Several Areas of the Human Brain</article-title>. <source>Biol. Psychiatry</source><year>1978</year>, <volume>13</volume>, <fpage>51</fpage>&#8211;<lpage>57</lpage>.<pub-id pub-id-type="pmid">623853</pub-id></mixed-citation></ref><ref id="ref661"><mixed-citation publication-type="journal" id="cit661"><name name-style="western"><surname>Ghose</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Coppen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Carrol</surname><given-names>D.</given-names></name><article-title>Intravenous Tyramine
Response in Migraine Before and During Treatment With Indoramin</article-title>. <source>Br. Med. J.</source><year>1977</year>, <volume>1</volume>, <fpage>1191</fpage>&#8211;<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.1.6070.1191</pub-id>.<pub-id pub-id-type="pmid">324566</pub-id><pub-id pub-id-type="pmcid">PMC1606859</pub-id></mixed-citation></ref><ref id="ref662"><mixed-citation publication-type="journal" id="cit662"><name name-style="western"><surname>Hiroi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Imaoka</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Funae</surname><given-names>Y.</given-names></name><article-title>Dopamine Formation
from Tyramine by CYP2D6</article-title>. <source>Biochem. Biophys. Res.
Commun.</source><year>1998</year>, <volume>249</volume>, <fpage>838</fpage>&#8211;<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.9232</pub-id>.<pub-id pub-id-type="pmid">9731223</pub-id></mixed-citation></ref><ref id="ref663"><mixed-citation publication-type="journal" id="cit663"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Ansari</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Atkins</surname><given-names>H. L.</given-names></name>; <name name-style="western"><surname>Bradley-Moore</surname><given-names>P. R.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Synthesis and Preliminary Evaluation
in Animals of Carrier-Free <sup>11</sup>C-1-Dopamine Hydrochloride:
X</article-title>. <source>J. Nucl. Med.</source><year>1973</year>, <volume>14</volume>, <fpage>867</fpage>&#8211;<lpage>869</lpage>.<pub-id pub-id-type="pmid">4743051</pub-id></mixed-citation></ref><ref id="ref664"><mixed-citation publication-type="journal" id="cit664"><name name-style="western"><surname>Schoeps</surname><given-names>K. O.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Nagren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Swahn</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Karlsson</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hall</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name><article-title>Preparation of [1-<sup>11</sup>C]Dopamine,
[1-<sup>11</sup>C]P-Tyramine and [1-<sup>11</sup>C]M-Tyramine. Autoradiography
and PET Examination of [1-<sup>11</sup>C]Dopamine in Primates</article-title>. <source>Nucl. Med. Biol.</source><year>1993</year>, <volume>20</volume>, <fpage>669</fpage>&#8211;<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(93)90038-V</pub-id>.<pub-id pub-id-type="pmid">8358354</pub-id></mixed-citation></ref><ref id="ref665"><mixed-citation publication-type="journal" id="cit665"><name name-style="western"><surname>Soussain</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Gueguen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Morgat</surname><given-names>J.-L.</given-names></name>; <name name-style="western"><surname>Maziere</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name><article-title>Enzymatic Synthesis of <sup>11</sup>C-Labelled (&#8722;)-Epinephrine</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>1984</year>, <volume>21</volume>, <fpage>203</fpage>&#8211;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580210303</pub-id>.</mixed-citation></ref><ref id="ref666"><mixed-citation publication-type="journal" id="cit666"><name name-style="western"><surname>Sasano</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Abraham</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>K.-C.</given-names></name>; <name name-style="western"><surname>Ashikaga</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mills</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Holt</surname><given-names>D. P.</given-names></name>; <name name-style="western"><surname>Hilton</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Nekolla</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lardo</surname><given-names>A. C.</given-names></name>; et al. <article-title>Abnormal Sympathetic
Innervation of Viable Myocardium and the Substrate of Ventricular
Tachycardia After Myocardial Infarction</article-title>. <source>J.
Am. Coll. Cardiol.</source><year>2008</year>, <volume>51</volume>, <fpage>2266</fpage>&#8211;<lpage>2275</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2008.02.062</pub-id>.<pub-id pub-id-type="pmid">18534275</pub-id></mixed-citation></ref><ref id="ref667"><mixed-citation publication-type="journal" id="cit667"><name name-style="western"><surname>Chakraborty</surname><given-names>P. K.</given-names></name>; <name name-style="western"><surname>Gildersleeve</surname><given-names>D. L.</given-names></name>; <name name-style="western"><surname>Jewett</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Toorongian</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Schwaiger</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wieland</surname><given-names>D. M.</given-names></name><article-title>High Yield Synthesis
of High Specific Activity R-(&#8722;)-[<sup>11</sup>C]epinephrine
for Routine PET Studies in Humans</article-title>. <source>Nucl. Med.
Biol.</source><year>1993</year>, <volume>20</volume>, <fpage>939</fpage>&#8211;<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(93)90094-B</pub-id>.<pub-id pub-id-type="pmid">8298573</pub-id></mixed-citation></ref><ref id="ref668"><mixed-citation publication-type="journal" id="cit668"><name name-style="western"><surname>Okada</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nakao</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Hosoi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Fukumura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Inoue</surname><given-names>O.</given-names></name><article-title>Microdialysis With
Radiometric Monitoring of <italic toggle="yes">L</italic>-[&#946;-<sup>11</sup>C]DOPA To Assess Dopaminergic Metabolism: Effect of Inhibitors of <italic toggle="yes">L</italic>-Amino Acid Decarboxylase, Monoamine Oxidase, and Catechol-<italic toggle="yes">O</italic>-Methyltransferase on Rat Striatal Dialysate</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>2011</year>, <volume>31</volume>, <fpage>124</fpage>&#8211;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2010.58</pub-id>.<pub-id pub-id-type="pmid">20407462</pub-id><pub-id pub-id-type="pmcid">PMC3049477</pub-id></mixed-citation></ref><ref id="ref669"><mixed-citation publication-type="journal" id="cit669"><name name-style="western"><surname>Tsukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tani</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Westerberg</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Effect of <italic toggle="yes">6R-L-Erythro-5</italic>, <italic toggle="yes">6</italic>, <italic toggle="yes">7</italic>, <italic toggle="yes">8</italic>-Tetrahydrobiopterin
on In Vivo <italic toggle="yes">L</italic>-[&#946;-<sup>11</sup>C]DOPA Turnover
in the Rat Striatum With Infusion of <italic toggle="yes">L</italic>-Tyrosine</article-title>. <source>J. Neural. Transm.</source><year>1994</year>, <volume>95</volume>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/BF01283026</pub-id>.<pub-id pub-id-type="pmid">7857582</pub-id></mixed-citation></ref><ref id="ref670"><mixed-citation publication-type="journal" id="cit670"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>H&#246;rnfelt</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Regional Brain Kinetics
of <italic toggle="yes">6-Fluoro</italic>-(<italic toggle="yes">Beta</italic>-<sup>11</sup>C)-<italic toggle="yes">L</italic>-Dopa and (<italic toggle="yes">Beta</italic>-<sup>11</sup>C)-<italic toggle="yes">L</italic>-Dopa Following COMT Inhibition. A Study <italic toggle="yes">In Vivo</italic> Using Positron Emission Tomography</article-title>. <source>J. Neural.
Transm. Gen. Sect.</source><year>1992</year>, <volume>87</volume>, <fpage>15</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/BF01253107</pub-id>.<pub-id pub-id-type="pmid">1536715</pub-id></mixed-citation></ref><ref id="ref671"><mixed-citation publication-type="journal" id="cit671"><name name-style="western"><surname>Tsukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Harada</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Nishiyama</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ohba</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kakiuchi</surname><given-names>T.</given-names></name><article-title>Cholinergic
Neuronal Modulation Alters
Dopamine D<sub>2</sub> Receptor Availability <italic toggle="yes">In Vivo</italic> by Regulating Receptor Affinity Induced by Facilitated Synaptic
Dopamine Turnover: Positron Emission Tomography Studies With Microdialysis
in the Conscious Monkey Brain</article-title>. <source>J. Neurosci.</source><year>2000</year>, <volume>20</volume>, <fpage>7067</fpage>&#8211;<lpage>7073</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-18-07067.2000</pub-id>.<pub-id pub-id-type="pmid">10995853</pub-id><pub-id pub-id-type="pmcid">PMC6772834</pub-id></mixed-citation></ref><ref id="ref672"><mixed-citation publication-type="journal" id="cit672"><name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Aquilonius</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Estimation
of Regional Cerebral Utilization
of [<sup>11</sup>C]-<italic toggle="yes">L</italic>-3,4-Dihydroxy-Phenylalanine
(DOPA) in the Primate by Positron Emission Tomography</article-title>. <source>Acta Neurol. Scand.</source><year>1992</year>, <volume>85</volume>, <fpage>166</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.1992.tb04021.x</pub-id>.<pub-id pub-id-type="pmid">1574997</pub-id></mixed-citation></ref><ref id="ref673"><mixed-citation publication-type="journal" id="cit673"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Agren</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Reibring</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Brain Kinetics
of <italic toggle="yes">L</italic>-[<italic toggle="yes">Beta</italic>-<sup>11</sup>C]DOPA in
Humans Studied by Positron Emission Tomography</article-title>. <source>J. Neural. Transm. Gen. Sect.</source><year>1991</year>, <volume>86</volume>, <fpage>25</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/BF01250373</pub-id>.<pub-id pub-id-type="pmid">1751027</pub-id></mixed-citation></ref><ref id="ref674"><mixed-citation publication-type="journal" id="cit674"><name name-style="western"><surname>Ito</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ota</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ikoma</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Seki</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Yasuno</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Takano</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Maeda</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Nakao</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Suhara</surname><given-names>T.</given-names></name><article-title>Quantitative
Analysis of Dopamine Synthesis in Human
Brain Using Positron Emission Tomography With <italic toggle="yes">L</italic>-[beta-<sup>11</sup>C]DOPA</article-title>. <source>Nucl. Med. Commun.</source><year>2006</year>, <volume>27</volume>, <fpage>723</fpage>&#8211;<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1097/01.mnm.0000230069.08576.6d</pub-id>.<pub-id pub-id-type="pmid">16894327</pub-id></mixed-citation></ref><ref id="ref675"><mixed-citation publication-type="journal" id="cit675"><name name-style="western"><surname>Cotzias</surname><given-names>G. C.</given-names></name>; <name name-style="western"><surname>Van Woert</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Schiffer</surname><given-names>L. M.</given-names></name><article-title>Aromatic Amino Acids
and Modification of Parkinsonism</article-title>. <source>N. Engl. J.
Med.</source><year>1967</year>, <volume>276</volume>, <fpage>374</fpage>&#8211;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM196702162760703</pub-id>.<pub-id pub-id-type="pmid">5334614</pub-id></mixed-citation></ref><ref id="ref676"><mixed-citation publication-type="journal" id="cit676"><name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Aquilonius</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bredberg</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Cerebral Uptake and Utilization of
Therapeutic [beta-<sup>11</sup>C]-L-DOPA in Parkinson&#8217;s Disease
Measured by Positron Emission Tomography. Relations to Motor Response</article-title>. <source>Acta Neurol. Scand.</source><year>1992</year>, <volume>85</volume>, <fpage>95</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0404.1992.tb04005.x</pub-id>.<pub-id pub-id-type="pmid">1574995</pub-id></mixed-citation></ref><ref id="ref677"><mixed-citation publication-type="journal" id="cit677"><name name-style="western"><surname>Fusar-Poli</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><article-title>Striatal Presynaptic
Dopamine in
Schizophrenia, Part II: Meta-Analysis of [<sup>18</sup>F/<sup>11</sup>C]-DOPA PET Studies</article-title>. <source>Schizophr Bull.</source><year>2013</year>, <volume>39</volume>, <fpage>33</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbr180</pub-id>.<pub-id pub-id-type="pmid">22282454</pub-id><pub-id pub-id-type="pmcid">PMC3523905</pub-id></mixed-citation></ref><ref id="ref678"><mixed-citation publication-type="journal" id="cit678"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Malmborg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Multi-Enzymatic Syntheses of <italic toggle="yes">L</italic>-Tyrosine
and <italic toggle="yes">L</italic>-DOPA. <sup>11</sup>C Labeling in Two Positions</article-title>. <source>Acta Radiol. Suppl.</source><year>1991</year>, <volume>376</volume>, <fpage>107</fpage>&#8211;<lpage>108</lpage>.<pub-id pub-id-type="pmid">1666734</pub-id></mixed-citation></ref><ref id="ref679"><mixed-citation publication-type="journal" id="cit679"><name name-style="western"><surname>Bars</surname><given-names>D. L.</given-names></name>; <name name-style="western"><surname>Thivolle</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Vitte</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Bojkowski</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chazot</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Arendt</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Frackowiak</surname><given-names>R. S. J.</given-names></name>; <name name-style="western"><surname>Claustrat</surname><given-names>B.</given-names></name><article-title>PET and Plasma Pharmacokinetic Studies After Bolus
Intravenous Administration of [<sup>11</sup>C]Melatonin in Humans</article-title>. <source>Int. J. Radial. Appl. Instrum. B. Nucl. Med. Biol.</source><year>1991</year>, <volume>18</volume>, <fpage>357</fpage>&#8211;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2897(91)90132-5</pub-id>.<pub-id pub-id-type="pmid">2071448</pub-id></mixed-citation></ref><ref id="ref680"><mixed-citation publication-type="journal" id="cit680"><name name-style="western"><surname>Tada</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Oikawa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sugiyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Wakui</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fukuda</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kubota</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>Y.</given-names></name>; et al. <article-title>A Concise Synthesis
of [<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]Melatonin and <italic toggle="yes">N</italic>-[<italic toggle="yes">Carbonyl</italic>-<sup>11</sup>C]Acetylserotonin</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1991</year>, <volume>29</volume>, <fpage>949</fpage>&#8211;<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580290812</pub-id>.</mixed-citation></ref><ref id="ref681"><mixed-citation publication-type="journal" id="cit681"><name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Runser</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Taddei</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dheere</surname><given-names>A. K. H.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>From [<sup>11</sup>C]CO<sub>2</sub> to [<sup>11</sup>C]Amides: A Rapid One-Pot Synthesis via the Mitsunobu
Reaction</article-title>. <source>Chem. Commun.</source><year>2017</year>, <volume>53</volume>, <fpage>5334</fpage>&#8211;<lpage>5337</lpage>. <pub-id pub-id-type="doi">10.1039/C7CC01407D</pub-id>.<pub-id pub-id-type="pmcid">PMC5708528</pub-id><pub-id pub-id-type="pmid">28447672</pub-id></mixed-citation></ref><ref id="ref682"><mixed-citation publication-type="gov" id="cit682"><person-group person-group-type="allauthors"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Christman</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Ansari</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Atkins</surname><given-names>H.</given-names></name></person-group><source>Carrier-Free <sup>11</sup>C-Labeled Catecholamines in Nuclear Medicine
and Biochemical Research.
United States, 1973-01-01</source>; <publisher-name>Brookhaven National
Laboratory</publisher-name>: <publisher-loc>Upton, NY</publisher-loc><year>1973</year>.</mixed-citation></ref><ref id="ref683"><mixed-citation publication-type="journal" id="cit683"><name name-style="western"><surname>Suhara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Nagren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Karlsson</surname><given-names>P.</given-names></name><article-title>Effects of Cocaine on [<sup>11</sup>C]Norepinephrine
and [<sup>11</sup>C]Beta-CIT Uptake in the Primate Peripheral Organs
Measured by PET</article-title>. <source>Ann. Nucl. Med.</source><year>1996</year>, <volume>10</volume>, <fpage>85</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1007/BF03165058</pub-id>.<pub-id pub-id-type="pmid">8814732</pub-id></mixed-citation></ref><ref id="ref684"><mixed-citation publication-type="journal" id="cit684"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Ansari</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Atkins</surname><given-names>H. L.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Radiopharmaceuticals.
12. A New Rapid Synthesis of
Carbon-11 Labeled Norepinephrine Hydrochloride</article-title>. <source>J. Med. Chem.</source><year>1974</year>, <volume>17</volume>, <fpage>246</fpage>&#8211;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1021/jm00248a025</pub-id>.<pub-id pub-id-type="pmid">4809258</pub-id></mixed-citation></ref><ref id="ref685"><mixed-citation publication-type="journal" id="cit685"><name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Schoeps</surname><given-names>K. O.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Swahn</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Farde</surname><given-names>L.</given-names></name><article-title>Selective Synthesis of Racemic 1-<sup>11</sup>C-Labelled Norepinephrine,
Octopamine, Norphenylephrine and Phenylethanolamine Using [<sup>11</sup>C]Nitromethane</article-title>. <source>Appl. Radiat. Isot.</source><year>1994</year>, <volume>45</volume>, <fpage>515</fpage>&#8211;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)90117-1</pub-id>.<pub-id pub-id-type="pmid">8186772</pub-id></mixed-citation></ref><ref id="ref686"><mixed-citation publication-type="journal" id="cit686"><name name-style="western"><surname>Maeda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Koga</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Fukumura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kojima</surname><given-names>M.</given-names></name><article-title>Chemical and
Enzymatic Approaches for <sup>11</sup>C-Labelled Octopamine Synthesis
Using Hydrogen [<sup>11</sup>C]cyanide</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>1991</year>, <volume>30</volume>, <fpage>397</fpage>&#8211;<lpage>398</lpage>.</mixed-citation></ref><ref id="ref687"><mixed-citation publication-type="journal" id="cit687"><name name-style="western"><surname>Maeda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Koga</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Fukumura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kojima</surname><given-names>M.</given-names></name><article-title>[<sup>11</sup>C]Octopamine
Synthesis Using [<sup>11</sup>C]Cyanide: Chemical and
Enzymatic Approaches for the [<sup>11</sup>C]Cyanohydrin Synthesis</article-title>. <source>Int. J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>, <fpage>463</fpage>&#8211;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(90)90006-3</pub-id>.<pub-id pub-id-type="pmid">2166013</pub-id></mixed-citation></ref><ref id="ref688"><mixed-citation publication-type="journal" id="cit688"><article-title>Sixth international symposium on radiopharmaceutical
chemistry. Abstracts.
Part IV</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1986</year>, <volume>23</volume>, <fpage>1352</fpage>&#8211;<lpage>1432</lpage>.<pub-id pub-id-type="doi">10.1002/jlcr.2580231005</pub-id></mixed-citation></ref><ref id="ref689"><mixed-citation publication-type="journal" id="cit689"><name name-style="western"><surname>Lidstr&#246;m</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Neu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Syntheses
of [<italic toggle="yes">21</italic>-<sup>11</sup>C] and [<italic toggle="yes">21</italic>-<sup>13</sup>C]Progesterone</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1997</year>, <volume>39</volume>, <fpage>695</fpage>&#8211;<lpage>704</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1344(199708)39:8&amp;#x0003c;695::AID-JLCR10&amp;#x0003e;3.0.CO;2-4</pub-id>.</mixed-citation></ref><ref id="ref690"><mixed-citation publication-type="journal" id="cit690"><name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Gallagher</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name><article-title><sup>11</sup>C Serotonin: A Tracer for the Pulmonary
Endothelial Extraction of
Serotonin</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1977</year>, <volume>13</volume>, <fpage>194</fpage>&#8211;<lpage>195</lpage>.</mixed-citation></ref><ref id="ref691"><mixed-citation publication-type="journal" id="cit691"><name name-style="western"><surname>Coates</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Firnau</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Gratz</surname><given-names>K. F.</given-names></name><article-title>Noninvasive
Measurement of Lung Carbon-11-Serotonin Extraction in Man</article-title>. <source>J. Nucl. Med.</source><year>1991</year>, <volume>32</volume>, <fpage>729</fpage>&#8211;<lpage>732</lpage>.<pub-id pub-id-type="pmid">2013814</pub-id></mixed-citation></ref><ref id="ref692"><mixed-citation publication-type="journal" id="cit692"><name name-style="western"><surname>Matzke</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Osterholz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Coates</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Firnau</surname><given-names>G.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Labeled
5-Hydroxytryptamine for the Measurement of Pulmonary Endothelial Cell
Function</article-title>. <source>Int. J. Radiat. Appl. Instrum. A.
Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>401</fpage>&#8211;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90145-Q</pub-id>.</mixed-citation></ref><ref id="ref693"><mixed-citation publication-type="journal" id="cit693"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Antoni</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Malmborg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Multi-enzymatic syntheses of L-tyrosine and L-DOPA.
11C labeling in two positions</article-title>. <source>Acta Radiol Suppl</source><year>1991</year>, <volume>376</volume>, <fpage>107</fpage>&#8211;<lpage>108</lpage>.<pub-id pub-id-type="pmid">1666734</pub-id></mixed-citation></ref><ref id="ref694"><mixed-citation publication-type="journal" id="cit694"><name name-style="western"><surname>Sasaki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ikemoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mutoh</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Haradahira</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tanaka</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name><article-title>Automatic
Synthesis
of <italic toggle="yes">L</italic>-[<italic toggle="yes">Beta</italic>-<sup>11</sup>C]Amino
Acids Using an Immobilized Enzyme Column</article-title>. <source>Appl.
Radiat. Isot.</source><year>2000</year>, <volume>52</volume>, <fpage>199</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(99)00118-9</pub-id>.<pub-id pub-id-type="pmid">10697728</pub-id></mixed-citation></ref><ref id="ref695"><mixed-citation publication-type="journal" id="cit695"><name name-style="western"><surname>Tsukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lindner</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tani</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Valtysson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Westerberg</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Langstrom</surname><given-names>B.</given-names></name><article-title>Effect of <italic toggle="yes">6R-L</italic>-Erythro-<italic toggle="yes">5</italic>, <italic toggle="yes">6</italic>, <italic toggle="yes">7</italic>, <italic toggle="yes">8</italic>-Tetrahydrobiopterin and Infusion of <italic toggle="yes">L</italic>-Tyrosine
on the <italic toggle="yes">In Vivo L</italic>-[<italic toggle="yes">Beta</italic>-<sup>11</sup>C]DOPA Disposition in the Monkey Brain</article-title>. <source>Brain
Res.</source><year>1996</year>, <volume>713</volume>, <fpage>92</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(95)01489-6</pub-id>.<pub-id pub-id-type="pmid">8724979</pub-id></mixed-citation></ref><ref id="ref696"><mixed-citation publication-type="journal" id="cit696"><name name-style="western"><surname>Tsukada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Miyasato</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Harada</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Nishiyama</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Fukumoto</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kakiuchi</surname><given-names>T.</given-names></name><article-title>Nicotine Modulates Dopamine Synthesis
Rate As Determined by <italic toggle="yes">L</italic>-[<italic toggle="yes">Beta</italic>-<sup>11</sup>C]DOPA: PET Studies Compared With [<sup>11</sup>C]Raclopride
Binding in the Conscious Monkey Brain</article-title>. <source>Synapse</source><year>2005</year>, <volume>57</volume>, <fpage>120</fpage>&#8211;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20157</pub-id>.<pub-id pub-id-type="pmid">15906385</pub-id></mixed-citation></ref><ref id="ref697"><mixed-citation publication-type="journal" id="cit697"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Torstenson</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Tedroff</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Fasth</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Amphetamine
Effects on Dopamine Release and Synthesis Rate Studied in the Rhesus
Monkey Brain by Positron Emission Tomography</article-title>. <source>J. Neural Transm.</source><year>1997</year>, <volume>104</volume>, <fpage>329</fpage>&#8211;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1007/BF01277655</pub-id>.<pub-id pub-id-type="pmid">9295169</pub-id></mixed-citation></ref><ref id="ref698"><mixed-citation publication-type="journal" id="cit698"><name name-style="western"><surname>Spychala</surname><given-names>J.</given-names></name><article-title>Tumor-Promoting
Functions of Adenosine</article-title>. <source>Pharmacol. Ther.</source><year>2000</year>, <volume>87</volume>, <fpage>161</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-7258(00)00053-X</pub-id>.<pub-id pub-id-type="pmid">11007998</pub-id></mixed-citation></ref><ref id="ref699"><mixed-citation publication-type="journal" id="cit699"><name name-style="western"><surname>Toyohara</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fujibayashi</surname><given-names>Y.</given-names></name><article-title>Trends in
Nucleoside Tracers for
PET Imaging of Cell Proliferation</article-title>. <source>Nucl. Med.
Biol.</source><year>2003</year>, <volume>30</volume>, <fpage>681</fpage>&#8211;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(03)00084-2</pub-id>.<pub-id pub-id-type="pmid">14499325</pub-id></mixed-citation></ref><ref id="ref700"><mixed-citation publication-type="journal" id="cit700"><name name-style="western"><surname>Ascoli</surname><given-names>A.</given-names></name><article-title>Ueber ein
neues Spaltungsprodukt des Hefenucleins</article-title>. <source>Hoppe-Seyler,s
Zeitschrift f&#252;r Physiologische Chemie</source><year>1901</year>, <volume>31</volume>, <fpage>161</fpage>&#8211;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1515/bchm2.1901.31.1-2.161</pub-id>.</mixed-citation></ref><ref id="ref701"><mixed-citation publication-type="book" id="cit701"><person-group person-group-type="allauthors"><name name-style="western"><surname>Garrett</surname><given-names>R. G. C.</given-names></name></person-group><source>Principles of Biochemistry-With
a Human Focus</source>; <publisher-name>Brooks Cole</publisher-name>, <year>2001</year>.</mixed-citation></ref><ref id="ref702"><mixed-citation publication-type="journal" id="cit702"><name name-style="western"><surname>Crawford</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Christman</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Atkins</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Friedkin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Alfred Wolf</surname><given-names>P.</given-names></name><article-title>Scintigraphy
With Positron-Emitting Compounds&#8212;I.
Carbon-11 Labeled Thymidine and Thymidylate</article-title>. <source>Int. J. Nucl. Med. Biol.</source><year>1978</year>, <volume>5</volume>, <fpage>61</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/0047-0740(78)90028-1</pub-id>.<pub-id pub-id-type="pmid">752656</pub-id></mixed-citation></ref><ref id="ref703"><mixed-citation publication-type="journal" id="cit703"><name name-style="western"><surname>Mankoff</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Muzi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Peterson</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Eary</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>Kinetic
Analysis of 2-[<sup>11</sup>C]thymidine PET Imaging Studies: Validation
Studies</article-title>. <source>J. Nucl. Med.</source><year>1999</year>, <volume>40</volume>, <fpage>614</fpage>&#8211;<lpage>624</lpage>.<pub-id pub-id-type="pmid">10210220</pub-id></mixed-citation></ref><ref id="ref704"><mixed-citation publication-type="journal" id="cit704"><person-group person-group-type="allauthors"><name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iwata</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name></person-group><article-title>The Development
of the Short
Lived Radiopharmaceuticals at Tohoku University</article-title>. <source>Kakuigaku</source><year>1982</year>, <volume>19</volume>.</mixed-citation></ref><ref id="ref705"><mixed-citation publication-type="journal" id="cit705"><name name-style="western"><surname>Mathews</surname><given-names>W. B.</given-names></name>; <name name-style="western"><surname>Nakamoto</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Abraham</surname><given-names>E. H.</given-names></name>; <name name-style="western"><surname>Scheffel</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Hilton</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ravert</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Tatsumi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rauseo</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Traughber</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Salikhova</surname><given-names>A. Y.</given-names></name>; et al. <article-title>Synthesis and Biodistribution
of [<sup>11</sup>C]Adenosine <italic toggle="yes">5&#8242;</italic>-Monophosphate
([<sup>11</sup>C]AMP)</article-title>. <source>Mol. Imaging Biol.</source><year>2005</year>, <volume>7</volume>, <fpage>203</fpage>&#8211;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-005-4118-6</pub-id>.<pub-id pub-id-type="pmid">15912424</pub-id></mixed-citation></ref><ref id="ref706"><mixed-citation publication-type="journal" id="cit706"><person-group person-group-type="allauthors"><name name-style="western"><surname>Cho</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Mathews</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Ishimori</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tyler</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Brem</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R.</given-names></name></person-group><article-title><italic toggle="yes">In Vivo</italic> Pre-Clinical
PET/CT Evaluation
of [<sup>11</sup>C] Adenosine <italic toggle="yes">5&#8242;</italic>-Monophosphate
as a Novel PET Radiotracer for Imaging Tumor Nucleoside Transporters</article-title>. <source>J. Nucl. Med.</source><year>2006</year>, <volume>47</volume>.</mixed-citation></ref><ref id="ref707"><mixed-citation publication-type="journal" id="cit707"><name name-style="western"><surname>Cho</surname><given-names>S. Y.</given-names></name>; <name name-style="western"><surname>Polster</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Engles</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Hilton</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Abraham</surname><given-names>E. H.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R. L.</given-names></name><article-title><italic toggle="yes">In Vitro</italic> Evaluation
of Adenosine <italic toggle="yes">5&#8242;</italic>-Monophosphate as an Imaging
Agent of Tumor Metabolism</article-title>. <source>J. Nucl. Med.</source><year>2006</year>, <volume>47</volume>, <fpage>837</fpage>&#8211;<lpage>845</lpage>.<pub-id pub-id-type="pmid">16644754</pub-id></mixed-citation></ref><ref id="ref708"><mixed-citation publication-type="journal" id="cit708"><name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hirobe</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Higashiyama</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K. T.</given-names></name><article-title>Detection of <sup>13</sup>C-<sup>15</sup>N Coupled Units in Adenine Derived from Doubly Labeled Hydrogen
Cyanide or Formamide</article-title>. <source>J. Am. Chem.</source><year>1978</year>, <volume>100</volume>, <fpage>4617</fpage>&#8211;<lpage>4618</lpage>. <pub-id pub-id-type="doi">10.1021/ja00482a061</pub-id>.</mixed-citation></ref><ref id="ref709"><mixed-citation publication-type="journal" id="cit709"><name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Lim</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Grierson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>Utilization of Labeled Thymidine
in DNA Synthesis:
Studies for PET</article-title>. <source>J. Nucl. Med.</source><year>1990</year>, <volume>31</volume>, <fpage>337</fpage>&#8211;<lpage>342</lpage>.<pub-id pub-id-type="pmid">2308005</pub-id></mixed-citation></ref><ref id="ref710"><mixed-citation publication-type="journal" id="cit710"><name name-style="western"><surname>Poupeye</surname><given-names>E. M.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P. P.</given-names></name>; <name name-style="western"><surname>Dams</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>De Leenheer</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Van Eijkeren</surname><given-names>M. E.</given-names></name><article-title>Evaluation of [<sup>11</sup>C]Thymidine
for Measurement
of Cell Proliferation in Fast Dividing Tissues</article-title>. <source>Nucl. Med. Biol.</source><year>1993</year>, <volume>20</volume>, <fpage>359</fpage>&#8211;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(93)90059-4</pub-id>.<pub-id pub-id-type="pmid">8485496</pub-id></mixed-citation></ref><ref id="ref711"><mixed-citation publication-type="journal" id="cit711"><name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lameire</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>van Eijkeren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kesteloot</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Thierens</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Dams</surname><given-names>R.</given-names></name><article-title>[Methyl-Carbon-11]
Thymidine for <italic toggle="yes">In Vivo</italic> Measurement of Cell Proliferation</article-title>. <source>J. Nucl. Med.</source><year>1996</year>, <volume>37</volume>, <fpage>1048</fpage>&#8211;<lpage>1052</lpage>.<pub-id pub-id-type="pmid">8683299</pub-id></mixed-citation></ref><ref id="ref712"><mixed-citation publication-type="journal" id="cit712"><name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>van Eijkeren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lemahieu</surname><given-names>I.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Distribution
and Identification of <sup>11</sup>C-Activity After
Injection of [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine in
Wistar Rats</article-title>. <source>J. Nucl. Med.</source><year>1999</year>, <volume>40</volume>, <fpage>491</fpage>&#8211;<lpage>496</lpage>.<pub-id pub-id-type="pmid">10086716</pub-id></mixed-citation></ref><ref id="ref713"><mixed-citation publication-type="journal" id="cit713"><name name-style="western"><surname>Vander Borght</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Lambotte</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Pauwels</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Labar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Beckers</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dive</surname><given-names>C.</given-names></name><article-title>Noninvasive Measurement
of Liver
Regeneration With Positron Emission Tomography and [2-<sup>11</sup>C]Thymidine</article-title>. <source>Gastroenterology</source><year>1991</year>, <volume>101</volume>, <fpage>794</fpage>&#8211;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1016/0016-5085(91)90541-R</pub-id>.<pub-id pub-id-type="pmid">1860641</pub-id></mixed-citation></ref><ref id="ref714"><mixed-citation publication-type="journal" id="cit714"><name name-style="western"><surname>Conti</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Hilton</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>D. F.</given-names></name>; <name name-style="western"><surname>Alauddin</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>Ravert</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Anderson</surname><given-names>J. H.</given-names></name><article-title>High Performance
Liquid Chromatography of Carbon-11 Labeled Thymidine and Its Major
Catabolites for Clinical PET Studies</article-title>. <source>Nucl.
Med. Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>1045</fpage>&#8211;<lpage>1051</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90176-7</pub-id>.<pub-id pub-id-type="pmid">9234362</pub-id></mixed-citation></ref><ref id="ref715"><mixed-citation publication-type="journal" id="cit715"><name name-style="western"><surname>Gunn</surname><given-names>R. N.</given-names></name>; <name name-style="western"><surname>Ranicar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Yap</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Wells</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Osman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Cunningham</surname><given-names>V. J.</given-names></name><article-title>On-line
Measurement of Exhaled [<sup>11</sup>C]CO<sub>2</sub> During PET</article-title>. <source>J. Nucl. Med.</source><year>2000</year>, <volume>41</volume>, <fpage>605</fpage>&#8211;<lpage>611</lpage>.<pub-id pub-id-type="pmid">10768560</pub-id></mixed-citation></ref><ref id="ref716"><mixed-citation publication-type="journal" id="cit716"><name name-style="western"><surname>Thierens</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>van Eijkeren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name><article-title>Biokinetics and Dosimetry
for [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine</article-title>. <source>Br. J. Radiol.</source><year>1994</year>, <volume>67</volume>, <fpage>292</fpage>&#8211;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1259/0007-1285-67-795-292</pub-id>.<pub-id pub-id-type="pmid">8131003</pub-id></mixed-citation></ref><ref id="ref717"><mixed-citation publication-type="journal" id="cit717"><name name-style="western"><surname>Wells</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Muzi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Eary</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Spence</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>Kinetic Analysis
of 2-[<sup>11</sup>C]Thymidine PET Imaging Studies of Malignant Brain
Tumors: Compartmental Model Investigation and Mathematical Analysis</article-title>. <source>Mol. Imaging</source><year>2002</year>, <volume>1</volume>, <fpage>151</fpage>&#8211;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1162/153535002760235454</pub-id>.<pub-id pub-id-type="pmid">12920853</pub-id></mixed-citation></ref><ref id="ref718"><mixed-citation publication-type="journal" id="cit718"><name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>van Eijkeren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lodewyck</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Dams</surname><given-names>R.</given-names></name><article-title>Measurement
of [<italic toggle="yes">Methyl</italic>-Carbon-11]Thymidine and Its Metabolites
in Head and Neck Tumors</article-title>. <source>J. Nucl. Med.</source><year>1995</year>, <volume>36</volume>, <fpage>880</fpage>&#8211;<lpage>882</lpage>.<pub-id pub-id-type="pmid">7738667</pub-id></mixed-citation></ref><ref id="ref719"><mixed-citation publication-type="journal" id="cit719"><name name-style="western"><surname>Wells</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gunn</surname><given-names>R. N.</given-names></name>; <name name-style="western"><surname>Steel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ranicar</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Brady</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Osman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Price</surname><given-names>P.</given-names></name><article-title>2-[<sup>11</sup>C]Thymidine Positron Emission Tomography Reproducibility
in Humans</article-title>. <source>Clin. Cancer Res.</source><year>2005</year>, <volume>11</volume>, <fpage>4341</fpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1818</pub-id>.<pub-id pub-id-type="pmid">15958616</pub-id></mixed-citation></ref><ref id="ref720"><mixed-citation publication-type="journal" id="cit720"><name name-style="western"><surname>Van De Wiele</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>De Bondt</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Peeters</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Vermeersch</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R. A.</given-names></name><article-title>Radiolabelled Thymidines and Deoxyuridines for Measuring
Cellular Proliferation in Tumours&#8211;An Update</article-title>. <source>Nucl. Med. Commun.</source><year>2002</year>, <volume>23</volume>, <fpage>925</fpage>&#8211;<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1097/00006231-200210000-00001</pub-id>.<pub-id pub-id-type="pmid">12352590</pub-id></mixed-citation></ref><ref id="ref721"><mixed-citation publication-type="journal" id="cit721"><name name-style="western"><surname>Alauddin</surname><given-names>M. M.</given-names></name><article-title>Nucleoside-Based Probes for Imaging
Tumor Proliferation
Using Positron Emission Tomography</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>2013</year>, <volume>56</volume>, <fpage>237</fpage>&#8211;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3003</pub-id>.<pub-id pub-id-type="pmid">24285330</pub-id></mixed-citation></ref><ref id="ref722"><mixed-citation publication-type="journal" id="cit722"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Koyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name><article-title>Efficient Syntheses
of [<sup>11</sup>C]zidovudine and
Its Analogs by Convenient One-Pot palladium(0)-copper(I) Co-Mediated
Rapid C-[<sup>11</sup>C]methylation</article-title>. <source>J. Label.
Compd. Radiopharm.</source><year>2014</year>, <volume>57</volume>, <fpage>540</fpage>&#8211;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3213</pub-id>.<pub-id pub-id-type="pmid">24992010</pub-id></mixed-citation></ref><ref id="ref723"><mixed-citation publication-type="journal" id="cit723"><name name-style="western"><surname>Rejc</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>G&#243;mez-Vallejo</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Alc&#225;zar</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Alonso</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Andr&#233;s</surname><given-names>J. I.</given-names></name>; <name name-style="western"><surname>Arrieta</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Coss&#237;o</surname><given-names>F. P.</given-names></name>; <name name-style="western"><surname>Llop</surname><given-names>J.</given-names></name><article-title>Negishi Coupling Reactions
With [<sup>11</sup>C]CH<sub>3</sub>I:
A Versatile Method for Efficient <sup>11</sup>C-C Bond Formation</article-title>. <source>Chem. Commun.</source><year>2018</year>, <volume>54</volume>, <fpage>4398</fpage>&#8211;<lpage>4401</lpage>. <pub-id pub-id-type="doi">10.1039/C8CC01540F</pub-id>.<pub-id pub-id-type="pmid">29664097</pub-id></mixed-citation></ref><ref id="ref724"><mixed-citation publication-type="journal" id="cit724"><name name-style="western"><surname>Steel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Brady</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Luthra</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Brown</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Khan</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Poole</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sergis</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Price</surname><given-names>P.</given-names></name><article-title>An Automated
Radiosynthesis of 2-[<sup>11</sup>C]Thymidine Using
Anhydrous [<sup>11</sup>C]Urea Derived from [<sup>11</sup>C]Phosgene</article-title>. <source>Appl. Radiat. Isot.</source><year>1999</year>, <volume>51</volume>, <fpage>377</fpage>&#8211;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(99)00051-2</pub-id>.<pub-id pub-id-type="pmid">10464914</pub-id></mixed-citation></ref><ref id="ref725"><mixed-citation publication-type="journal" id="cit725"><name name-style="western"><surname>Vander Borght</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Labar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Pauwels</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lambotte</surname><given-names>L.</given-names></name><article-title>Production
of [2-<sup>11</sup>C]Thymidine for Quantification of Cellular Proliferation
with PET</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl.
Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>103</fpage>&#8211;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90131-J</pub-id>.<pub-id pub-id-type="pmid">1850393</pub-id></mixed-citation></ref><ref id="ref726"><mixed-citation publication-type="book" id="cit726"><person-group person-group-type="allauthors"><name name-style="western"><surname>Courter</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name></person-group><source>Automation of the
Synthesis of [2-Carbon-11]Thymidine</source>; <publisher-name>PSI-PROC-92-01</publisher-name>: <publisher-loc>Switzerland</publisher-loc>, <year>1992</year>.</mixed-citation></ref><ref id="ref727"><mixed-citation publication-type="journal" id="cit727"><name name-style="western"><surname>Ohkura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nishijima</surname><given-names>K.-i.</given-names></name>; <name name-style="western"><surname>Sanoki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tamaki</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Seki</surname><given-names>K.-i.</given-names></name><article-title>A New Convenient Method for the Synthesis
of [2-<sup>11</sup>C]Thymine Utilizing [<sup>11</sup>C]Phosgene</article-title>. <source>Tetrahedron Lett.</source><year>2006</year>, <volume>47</volume>, <fpage>5321</fpage>&#8211;<lpage>5323</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2006.05.143</pub-id>.</mixed-citation></ref><ref id="ref728"><mixed-citation publication-type="journal" id="cit728"><name name-style="western"><surname>Seki</surname><given-names>K.-i.</given-names></name>; <name name-style="western"><surname>Ohkura</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sanoki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nishijima</surname><given-names>K.-i.</given-names></name>; <name name-style="western"><surname>Tamaki</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kuge</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wiebe</surname><given-names>L. I.</given-names></name>; <name name-style="western"><surname>Takahashi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Akizawa</surname><given-names>H.</given-names></name><article-title>New [<sup>11</sup>C]Phosgene Based Synthesis of [<sup>11</sup>C]Pyrimidines for Positron Emission Tomography</article-title>. <source>Heterocycles</source><year>2009</year>, <volume>77</volume>, <fpage>1307</fpage>&#8211;<lpage>1321</lpage>. <pub-id pub-id-type="doi">10.3987/COM-08-S(F)116</pub-id>.</mixed-citation></ref><ref id="ref729"><mixed-citation publication-type="journal" id="cit729"><name name-style="western"><surname>Chakraborty</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mangner</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Chugani</surname><given-names>H.</given-names></name><article-title>The Synthesis of No-Carrier-Added
[<sup>11</sup>C]Urea From [<sup>11</sup>C]Carbon Dioxide and Application
to [<sup>11</sup>C]Uracil Synthesis</article-title>. <source>Appl. Radiat.
Isot.</source><year>1997</year>, <volume>48</volume>, <fpage>619</fpage>&#8211;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(97)00007-9</pub-id>.</mixed-citation></ref><ref id="ref730"><mixed-citation publication-type="journal" id="cit730"><name name-style="western"><surname>Martiat</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Ferrant</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Labar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Cogneau</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bol</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Michel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Michaux</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Sokal</surname><given-names>G.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Measurement of Carbon-11 Thymidine Uptake in Non-Hodgkin&#8217;s
Lymphoma Using Positron Emission Tomography</article-title>. <source>J. Nucl. Med.</source><year>1988</year>, <volume>29</volume>, <fpage>1633</fpage>&#8211;<lpage>1637</lpage>.<pub-id pub-id-type="pmid">3262725</pub-id></mixed-citation></ref><ref id="ref731"><mixed-citation publication-type="journal" id="cit731"><name name-style="western"><surname>Poupeye</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Counsell</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>De Leenheer</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Slegers</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Labelled
Thymidine for Tumor Visualization Using Positron Emission Tomography</article-title>. <source>Int. J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1989</year>, <volume>40</volume>, <fpage>57</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(89)90174-3</pub-id>.<pub-id pub-id-type="pmid">2540122</pub-id></mixed-citation></ref><ref id="ref732"><mixed-citation publication-type="journal" id="cit732"><name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sambre</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Coene</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Casteleyn</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Poupeye</surname><given-names>E.</given-names></name><article-title>A Remotely Controlled Production
System for Routine
Preparation of [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1992</year>, <volume>43</volume>, <fpage>952</fpage>&#8211;<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(92)90165-B</pub-id>.</mixed-citation></ref><ref id="ref733"><mixed-citation publication-type="journal" id="cit733"><name name-style="western"><surname>Alauddin</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Ravert</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Musachio</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Mathews</surname><given-names>W. B.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>Conti</surname><given-names>P. S.</given-names></name><article-title>Selective Alkylation
of Pyrimidyl
Dianions III: No-Carrier-Added Synthesis of [<sup>11</sup>C-<italic toggle="yes">Methyl</italic>]-Thymidine</article-title>. <source>Nucl. Med. Biol.</source><year>1995</year>, <volume>22</volume>, <fpage>791</fpage>&#8211;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(95)00027-U</pub-id>.<pub-id pub-id-type="pmid">8535340</pub-id></mixed-citation></ref><ref id="ref734"><mixed-citation publication-type="thesis" id="cit734"><person-group person-group-type="allauthors"><name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name></person-group><article-title>On
the Synthesis of <sup>11</sup>C-Compounds</article-title>. Thesis
(Ph.D.), Acta Univ. Upsal., Abstr. Upps. Diss. Fac. Sci; no. 555, <publisher-name>LiberTryck</publisher-name>: <publisher-loc>Uppsala, Sweden</publisher-loc>, <year>1980</year>.</mixed-citation></ref><ref id="ref735"><mixed-citation publication-type="journal" id="cit735"><name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Sjoeberg</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bergson</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Malmborg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Staelnacke</surname><given-names>C.-G.</given-names></name>; <name name-style="western"><surname>Larsson</surname><given-names>B.</given-names></name><article-title>[<sup>11</sup>C]Methyl
Iodide in the Synthesis of <sup>11</sup>C-Compounds</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1981</year>, <volume>18</volume>, <fpage>17</fpage>&#8211;<lpage>19</lpage>.</mixed-citation></ref><ref id="ref736"><mixed-citation publication-type="journal" id="cit736"><name name-style="western"><surname>Sundoro-Wu</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Schmall</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Conti</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Robert
Dahl</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Drumm</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Jacobsen</surname><given-names>J. K.</given-names></name><article-title>Selective Alkylation of Pyrimidyl-Dianions:
Synthesis and Purification of <sup>11</sup>C Labeled Thymidine for
Tumor Visualization Using Positron Emission Tomography</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1984</year>, <volume>35</volume>, <fpage>705</fpage>&#8211;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(84)90075-9</pub-id>.<pub-id pub-id-type="pmid">6332784</pub-id></mixed-citation></ref><ref id="ref737"><mixed-citation publication-type="journal" id="cit737"><name name-style="western"><surname>Koyama</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Siqin</surname></name>; <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Sumi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Hatta</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nagata</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name><article-title>Highly Efficient
Syntheses
of [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine and Its Analogue <italic toggle="yes">4&#8242;</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thiothymidine
As Nucleoside PET Probes for Cancer Cell Proliferation by Pd0-Mediated
Rapid C-[<sup>11</sup>C]Methylation</article-title>. <source>Org. Biomol.
Chem.</source><year>2011</year>, <volume>9</volume>, <fpage>4287</fpage>&#8211;<lpage>4294</lpage>. <pub-id pub-id-type="doi">10.1039/c0ob01249a</pub-id>.<pub-id pub-id-type="pmid">21503302</pub-id></mixed-citation></ref><ref id="ref738"><mixed-citation publication-type="journal" id="cit738"><name name-style="western"><surname>Link</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Grierson</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K.</given-names></name><article-title>Alternatives in the
Synthesis of 2-[<sup>11</sup>C]-Thymidine</article-title>. <source>J.
Label. Compd. Radiopharm.</source><year>1995</year>, <volume>37</volume>, <fpage>610</fpage>&#8211;<lpage>612</lpage>.</mixed-citation></ref><ref id="ref739"><mixed-citation publication-type="journal" id="cit739"><name name-style="western"><surname>van Eijkeren</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>De Schyver</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Poupeye</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Schelstraete</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lemahieu</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>De Potter</surname><given-names>C. R.</given-names></name><article-title>Measurement
of Short-Term <sup>11</sup>C-Thymidine Activity in Human Head and
Neck Tumours Using Positron Emission Tomography (PET)</article-title>. <source>Acta Oncol.</source><year>1992</year>, <volume>31</volume>, <fpage>539</fpage>&#8211;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.3109/02841869209088303</pub-id>.<pub-id pub-id-type="pmid">1419100</pub-id></mixed-citation></ref><ref id="ref740"><mixed-citation publication-type="journal" id="cit740"><name name-style="western"><surname>Edgren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Westlin</surname><given-names>J.-E.</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Letocha</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Malmstroem</surname><given-names>P.-U.</given-names></name><article-title>Positron Emission Tomography in the
Management of Metastatic Renal Cell Carcinoma</article-title>. <source>Antib. Immunoconjug. Radiopharm.</source><year>1995</year>, <volume>8</volume>, <fpage>215</fpage>&#8211;<lpage>226</lpage>.</mixed-citation></ref><ref id="ref741"><mixed-citation publication-type="journal" id="cit741"><name name-style="western"><surname>van
Eijkeren</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Thierens</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Seuntjens</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Strijckmans</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lemahieu</surname><given-names>I.</given-names></name><article-title>Kinetics of [<italic toggle="yes">methyl</italic>-<sup>11</sup>C]Thymidine in Patients with Squamous
Cell Carcinoma of the Head and Neck</article-title>. <source>Acta Oncol.</source><year>1996</year>, <volume>35</volume>, <fpage>737</fpage>&#8211;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.3109/02841869609084008</pub-id>.<pub-id pub-id-type="pmid">8938223</pub-id></mixed-citation></ref><ref id="ref742"><mixed-citation publication-type="journal" id="cit742"><name name-style="western"><surname>De Reuck</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Santens</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Goethals</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Strijckmans</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lemahieu</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Boon</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Achten</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Lemmerling</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Vandekerckhove</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Caemaert</surname><given-names>J.</given-names></name><article-title>[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Thymidine Positron Emission Tomography in Tumoral
and Non-Tumoral
Cerebral Lesions</article-title>. <source>Acta Neurol. Belg.</source><year>1999</year>, <volume>99</volume>, <fpage>118</fpage>&#8211;<lpage>125</lpage>.<pub-id pub-id-type="pmid">10427354</pub-id></mixed-citation></ref><ref id="ref743"><mixed-citation publication-type="journal" id="cit743"><name name-style="western"><surname>Pomper</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Constantinides</surname><given-names>C. D.</given-names></name>; <name name-style="western"><surname>Barker</surname><given-names>P. B.</given-names></name>; <name name-style="western"><surname>Bizzi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dobgan</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>McArthur</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>D. F.</given-names></name><article-title>Quantitative
MR Spectroscopic Imaging of Brain Lesions in Patients with AIDS: Correlation
with [<sup>11</sup>C-Methyl]thymidine PET and Thallium-201 SPECT</article-title>. <source>Acad. Radiol.</source><year>2002</year>, <volume>9</volume>, <fpage>398</fpage>&#8211;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/S1076-6332(03)80185-X</pub-id>.<pub-id pub-id-type="pmid">11942654</pub-id></mixed-citation></ref><ref id="ref744"><mixed-citation publication-type="journal" id="cit744"><name name-style="western"><surname>Jouret</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Walrand</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Parreira</surname><given-names>K. S.</given-names></name>; <name name-style="western"><surname>Courtoy</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Pauwels</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Devuyst</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Jamar</surname><given-names>F.</given-names></name><article-title>Single Photon Emission-Computed
Tomography (SPECT) for Functional Investigation of the Proximal Tubule
in Conscious Mice</article-title>. <source>Am. J. Physiol. Renal Physiol.</source><year>2010</year>, <volume>298</volume>, <fpage>F454</fpage>&#8211;<lpage>F460</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00413.2009</pub-id>.<pub-id pub-id-type="pmid">19955188</pub-id></mixed-citation></ref><ref id="ref745"><mixed-citation publication-type="journal" id="cit745"><name name-style="western"><surname>Vander Borght</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Pauwels</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lambotte</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Labar</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>De Maeght</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Stroobandt</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Laterre</surname><given-names>C.</given-names></name><article-title>Brain Tumor Imaging
With PET and 2-[Carbon-11]Thymidine</article-title>. <source>J. Nucl.
Med.</source><year>1994</year>, <volume>35</volume>, <fpage>974</fpage>&#8211;<lpage>982</lpage>.<pub-id pub-id-type="pmid">8195884</pub-id></mixed-citation></ref><ref id="ref746"><mixed-citation publication-type="journal" id="cit746"><name name-style="western"><surname>Mankoff</surname><given-names>D.
A.</given-names></name>; <name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>A Graphical Analysis
Method To Estimate Blood-to-Tissue
Transfer Constants for Tracers With Labeled Metabolites</article-title>. <source>J. Nucl. Med.</source><year>1996</year>, <volume>37</volume>, <fpage>2049</fpage>&#8211;<lpage>2057</lpage>.<pub-id pub-id-type="pmid">8970533</pub-id></mixed-citation></ref><ref id="ref747"><mixed-citation publication-type="journal" id="cit747"><name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kozawa</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>Analysis of 2-Carbon-11-thymidine
Blood Metabolites in PET Imaging</article-title>. <source>J. Nucl. Med.</source><year>1996</year>, <volume>37</volume>, <fpage>290</fpage>&#8211;<lpage>296</lpage>.<pub-id pub-id-type="pmid">8667064</pub-id></mixed-citation></ref><ref id="ref748"><mixed-citation publication-type="journal" id="cit748"><name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Eary</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Kozawa</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lewellen</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lewellen</surname><given-names>T. K.</given-names></name>; <name name-style="western"><surname>Grierson</surname><given-names>J. R.</given-names></name>; et al. <article-title>Carbon-11-thymidine
and FDG To Measure Therapy Response</article-title>. <source>J. Nucl.
Med.</source><year>1998</year>, <volume>39</volume>, <fpage>1757</fpage>&#8211;<lpage>1762</lpage>.<pub-id pub-id-type="pmid">9776283</pub-id></mixed-citation></ref><ref id="ref749"><mixed-citation publication-type="journal" id="cit749"><name name-style="western"><surname>Eary</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Mankoff</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Spence</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Olshen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>2-[C-11]thymidine Imaging of Malignant Brain Tumors</article-title>. <source>Cancer Res.</source><year>1999</year>, <volume>59</volume>, <fpage>615</fpage>&#8211;<lpage>621</lpage>.<pub-id pub-id-type="pmid">9973209</pub-id></mixed-citation></ref><ref id="ref750"><mixed-citation publication-type="journal" id="cit750"><name name-style="western"><surname>Young</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Brock</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wells</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Price</surname><given-names>P.</given-names></name><article-title>Monitoring
Response to Treatment in the Development of Anti-Cancer Drugs Using
Positron Emission Tomography (PET)</article-title>. <source>Drug Inf.
J.</source><year>1999</year>, <volume>33</volume>, <fpage>237</fpage>&#8211;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1177/009286159903300126</pub-id>.</mixed-citation></ref><ref id="ref751"><mixed-citation publication-type="journal" id="cit751"><name name-style="western"><surname>Wells</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gunn</surname><given-names>R. N.</given-names></name>; <name name-style="western"><surname>Alison</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Steel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Golding</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ranicar</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Brady</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Osman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Price</surname><given-names>P.</given-names></name><article-title>Assessment of Proliferation
in Vivo
Using 2-[<sup>11</sup>C]Thymidine Positron Emission Tomography in
Advanced Intra-abdominal Malignancies</article-title>. <source>Cancer
Res.</source><year>2002</year>, <volume>62</volume>, <fpage>5698</fpage>.<pub-id pub-id-type="pmid">12384527</pub-id></mixed-citation></ref><ref id="ref752"><mixed-citation publication-type="journal" id="cit752"><name name-style="western"><surname>Wells</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Aboagye</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Gunn</surname><given-names>R. N.</given-names></name>; <name name-style="western"><surname>Osman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Boddy</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Taylor</surname><given-names>G. A.</given-names></name>; <name name-style="western"><surname>Rafi</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Hughes</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Calvert</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Price</surname><given-names>P. M.</given-names></name>; et al. <article-title>2-[<sup>11</sup>C]Thymidine
Positron Emission Tomography as an Indicator of Thymidylate Synthase
Inhibition in Patients Treated With AG337</article-title>. <source>J.
Natl. Cancer Inst.</source><year>2003</year>, <volume>95</volume>, <fpage>675</fpage>&#8211;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/95.9.675</pub-id>.<pub-id pub-id-type="pmid">12734319</pub-id></mixed-citation></ref><ref id="ref753"><mixed-citation publication-type="journal" id="cit753"><name name-style="western"><surname>Shields</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Grierson</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Dohmen</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Machulla</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Stayanoff</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Lawhorn-Crews</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Obradovich</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Muzik</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Mangner</surname><given-names>T. J.</given-names></name><article-title>Imaging Proliferation <italic toggle="yes">In
Vivo</italic> With [F-18]FLT and Positron Emission Tomography</article-title>. <source>Nat. Med.</source><year>1998</year>, <volume>4</volume>, <fpage>1334</fpage>&#8211;<lpage>1336</lpage>. <pub-id pub-id-type="doi">10.1038/3337</pub-id>.<pub-id pub-id-type="pmid">9809561</pub-id></mixed-citation></ref><ref id="ref754"><mixed-citation publication-type="journal" id="cit754"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Crouzel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Van Der Jagt</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Van Zanten</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Comar</surname><given-names>D.</given-names></name><article-title>Synthesis of <sup>11</sup>C-Urea
for Medical Use</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1980</year>, <volume>31</volume>, <fpage>549</fpage>&#8211;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(80)90096-4</pub-id>.</mixed-citation></ref><ref id="ref755"><mixed-citation publication-type="journal" id="cit755"><name name-style="western"><surname>Emran</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Boothe</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Vora</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Thomas Wooten</surname><given-names>J.</given-names></name><article-title>Optimized
Production of High Specific
Activity [<sup>11</sup>C]Urea</article-title>. <source>Int. J. Appl.
Rad. Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>739</fpage>&#8211;<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90046-8</pub-id>.<pub-id pub-id-type="pmid">3905629</pub-id></mixed-citation></ref><ref id="ref756"><mixed-citation publication-type="journal" id="cit756"><name name-style="western"><surname>Charron</surname><given-names>C. L.</given-names></name>; <name name-style="western"><surname>Hickey</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Nsiama</surname><given-names>T. K.</given-names></name>; <name name-style="western"><surname>Cruickshank</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Turnbull</surname><given-names>W. L.</given-names></name>; <name name-style="western"><surname>Luyt</surname><given-names>L. G.</given-names></name><article-title>Molecular Imaging Probes Derived
From Natural Peptides</article-title>. <source>Nat. Prod. Rep.</source><year>2016</year>, <volume>33</volume>, <fpage>761</fpage>&#8211;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1039/C5NP00083A</pub-id>.<pub-id pub-id-type="pmid">26911790</pub-id></mixed-citation></ref><ref id="ref757"><mixed-citation publication-type="journal" id="cit757"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lundberg</surname><given-names>P. O.</given-names></name>; <name name-style="western"><surname>Muhr</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Terenius</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#228;rkfors</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Kinetics of Four <sup>11</sup>C-Labelled
Enkephalin Peptides in the Brain, Pituitary and Plasma of Rhesus Monkeys</article-title>. <source>Regul. Pept.</source><year>1986</year>, <volume>16</volume>, <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/0167-0115(86)90190-4</pub-id>.<pub-id pub-id-type="pmid">3492729</pub-id></mixed-citation></ref><ref id="ref758"><mixed-citation publication-type="journal" id="cit758"><name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ragnarsson</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>The Synthesis
of the Neuropeptide Met-Enkephalin and two Metabolic Fragments Labelled
with <sup>11</sup>C in the Methionine Methyl Group</article-title>. <source>Int. J. Radiat. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1986</year>, <volume>37</volume>, <fpage>537</fpage>&#8211;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(86)90162-0</pub-id>.<pub-id pub-id-type="pmid">3019952</pub-id></mixed-citation></ref><ref id="ref759"><mixed-citation publication-type="journal" id="cit759"><name name-style="western"><surname>Nagren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Franzen</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ragnarsson</surname><given-names>U.</given-names></name><article-title>Synthesis
of <italic toggle="yes">S</italic>-[<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]Substance
P</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1986</year>, <volume>23</volume>, <fpage>1076</fpage>&#8211;<lpage>1077</lpage>.</mixed-citation></ref><ref id="ref760"><mixed-citation publication-type="journal" id="cit760"><name name-style="western"><surname>Franz&#233;n</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Ragnarsson</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title><sup>11</sup>C-Labelling
of Substance
P. Preparation of a Homocysteine-Containing Precursor and Its Subsequent
Application in the Synthesis of the Labelled Neuropeptide</article-title>. <source>J. Chem. Soc., Perkin trans. 1</source><year>1987</year>, <fpage>2241</fpage>&#8211;<lpage>2247</lpage>. <pub-id pub-id-type="doi">10.1039/P19870002241</pub-id>.</mixed-citation></ref><ref id="ref761"><mixed-citation publication-type="journal" id="cit761"><name name-style="western"><surname>Ball</surname><given-names>R.</given-names></name><article-title>Opioid Peptides and Psychiatric Illness</article-title>. <source>Br.
J. Hosp. Med.</source><year>1987</year>, <volume>37</volume>, <fpage>49</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">2949791</pub-id></mixed-citation></ref><ref id="ref762"><mixed-citation publication-type="journal" id="cit762"><name name-style="western"><surname>Walker</surname><given-names>J.
M.</given-names></name>; <name name-style="western"><surname>Berntson</surname><given-names>G. G.</given-names></name>; <name name-style="western"><surname>Sandman</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Coy</surname><given-names>D. H.</given-names></name>; <name name-style="western"><surname>Schally</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Kastin</surname><given-names>A. J.</given-names></name><article-title>An Analog
of Enkephalin Having Prolonged
Opiate-Like Effects <italic toggle="yes">In Vivo</italic></article-title>. <source>Science</source><year>1977</year>, <volume>196</volume>, <fpage>85</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1126/science.190683</pub-id>.<pub-id pub-id-type="pmid">190683</pub-id></mixed-citation></ref><ref id="ref763"><mixed-citation publication-type="journal" id="cit763"><name name-style="western"><surname>Costa</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Mocchetti</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Supattapone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Snyder</surname><given-names>S. H.</given-names></name><article-title>Opioid Peptide Biosynthesis:
Enzymatic Selectivity
and Regulatory Mechanisms</article-title>. <source>FASEB J.</source><year>1987</year>, <volume>1</volume>, <fpage>16</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.1.1.3111927</pub-id>.<pub-id pub-id-type="pmid">3111927</pub-id></mixed-citation></ref><ref id="ref764"><mixed-citation publication-type="journal" id="cit764"><name name-style="western"><surname>Zagon</surname><given-names>I. S.</given-names></name>; <name name-style="western"><surname>Isayama</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>McLaughlin</surname><given-names>P. J.</given-names></name><article-title>Preproenkephalin
mRNA Expression in the Developing and Adult Rat Brain</article-title>. <source>Mol. Brain Res.</source><year>1994</year>, <volume>21</volume>, <fpage>85</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328X(94)90381-6</pub-id>.<pub-id pub-id-type="pmid">8164525</pub-id></mixed-citation></ref><ref id="ref765"><mixed-citation publication-type="journal" id="cit765"><name name-style="western"><surname>v Euler</surname><given-names>U. S.</given-names></name>; <name name-style="western"><surname>Gaddum</surname><given-names>J. H.</given-names></name><article-title>An Unidentified Depressor Substance
in Certain Tissue Extracts</article-title>. <source>J. Physiol.</source><year>1931</year>, <volume>72</volume>, <fpage>74</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1931.sp002763</pub-id>.<pub-id pub-id-type="pmid">16994201</pub-id><pub-id pub-id-type="pmcid">PMC1403098</pub-id></mixed-citation></ref><ref id="ref766"><mixed-citation publication-type="journal" id="cit766"><name name-style="western"><surname>Harrison</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Geppetti</surname><given-names>P.</given-names></name><article-title>Substance P</article-title>. <source>Int. J. Biochem. Cell Biol.</source><year>2001</year>, <volume>33</volume>, <fpage>555</fpage>&#8211;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1016/S1357-2725(01)00031-0</pub-id>.<pub-id pub-id-type="pmid">11378438</pub-id></mixed-citation></ref><ref id="ref767"><mixed-citation publication-type="journal" id="cit767"><name name-style="western"><surname>Datar</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Srivastava</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Coutinho</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Govil</surname><given-names>G.</given-names></name><article-title>Substance
P: Structure, Function, and Therapeutics</article-title>. <source>Curr.
Top. Med. Chem.</source><year>2004</year>, <volume>4</volume>, <fpage>75</fpage>&#8211;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.2174/1568026043451636</pub-id>.<pub-id pub-id-type="pmid">14754378</pub-id></mixed-citation></ref><ref id="ref768"><mixed-citation publication-type="journal" id="cit768"><name name-style="western"><surname>Wong</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Jeng</surname><given-names>A. Y.</given-names></name><article-title>Posttranslational Modification of
Glycine-Extended Substance P by an &#945;-Amidating Enzyme in Cultured
Sensory Neurons of Dorsal Root Ganglia</article-title>. <source>J. Neurosci.
Res.</source><year>1994</year>, <volume>37</volume>, <fpage>97</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490370113</pub-id>.<pub-id pub-id-type="pmid">7511706</pub-id></mixed-citation></ref><ref id="ref769"><mixed-citation publication-type="journal" id="cit769"><name name-style="western"><surname>Yip</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Chahl</surname><given-names>L. A.</given-names></name><article-title>Localization of NK<sub>1</sub> and NK<sub>3</sub> Receptors
in Guinea-Pig Brain</article-title>. <source>Regul. Pept.</source><year>2001</year>, <volume>98</volume>, <fpage>55</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-0115(00)00228-7</pub-id>.<pub-id pub-id-type="pmid">11179779</pub-id></mixed-citation></ref><ref id="ref770"><mixed-citation publication-type="book" id="cit770"><person-group person-group-type="allauthors"><name name-style="western"><surname>Kumari</surname><given-names>A.</given-names></name></person-group><article-title>Glycolysis</article-title>. In <source>Sweet Biochemistry</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Kumari</surname><given-names>A.</given-names></name></person-group>, Ed.; <publisher-name>Academic
Press</publisher-name>, <year>2018</year>; Chapter 1, pp <fpage>1</fpage>&#8211;<lpage>5</lpage>.</mixed-citation></ref><ref id="ref771"><mixed-citation publication-type="journal" id="cit771"><name name-style="western"><surname>Rich</surname><given-names>L. R.</given-names></name>; <name name-style="western"><surname>Harris</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Brown</surname><given-names>A. M.</given-names></name><article-title>The Role
of Brain
Glycogen in Supporting Physiological Function</article-title>. <source>Front. Neurosci.</source><year>2019</year>, <volume>13</volume>, <fpage>1176</fpage>&#8211;<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.3389/fnins.2019.01176</pub-id>.<pub-id pub-id-type="pmid">31749677</pub-id><pub-id pub-id-type="pmcid">PMC6842925</pub-id></mixed-citation></ref><ref id="ref772"><mixed-citation publication-type="journal" id="cit772"><name name-style="western"><surname>Keiding</surname><given-names>S.</given-names></name><article-title>Bringing Physiology into PET of the Liver</article-title>. <source>J. Nucl. Med.</source><year>2012</year>, <volume>53</volume>, <fpage>425</fpage><pub-id pub-id-type="doi">10.2967/jnumed.111.100214</pub-id>.<pub-id pub-id-type="pmid">22323781</pub-id><pub-id pub-id-type="pmcid">PMC3387357</pub-id></mixed-citation></ref><ref id="ref773"><mixed-citation publication-type="journal" id="cit773"><name name-style="western"><surname>Delidovich</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Palkovits</surname><given-names>R.</given-names></name><article-title>Catalytic Isomerization of Biomass-Derived
Aldoses: A Review</article-title>. <source>ChemSusChem</source><year>2016</year>, <volume>9</volume>, <fpage>547</fpage><pub-id pub-id-type="doi">10.1002/cssc.201501577</pub-id>.<pub-id pub-id-type="pmid">26948404</pub-id><pub-id pub-id-type="pmcid">PMC5069572</pub-id></mixed-citation></ref><ref id="ref774"><mixed-citation publication-type="journal" id="cit774"><name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Lechner</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name><article-title>Remote
System for Production of Carbon-11 Labeled Glucose <italic toggle="yes">via</italic> Photosynthesis</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1984</year>, <volume>21</volume>, <fpage>743</fpage>&#8211;<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580210808</pub-id>.</mixed-citation></ref><ref id="ref775"><mixed-citation publication-type="journal" id="cit775"><name name-style="western"><surname>Saji</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tanaka</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Magata</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Enoki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tokui</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Nishihara</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Yonekura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yokoyama</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Torizuka</surname><given-names>K.</given-names></name><article-title>Procurement
and Biological Significance
of Pure <sup>11</sup>C-Glucose</article-title>. <source>Radioisotopes</source><year>1984</year>, <volume>33</volume>, <fpage>680</fpage>&#8211;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.3769/radioisotopes.33.10_680</pub-id>.<pub-id pub-id-type="pmid">6335262</pub-id></mixed-citation></ref><ref id="ref776"><mixed-citation publication-type="journal" id="cit776"><name name-style="western"><surname>Herrero</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kisrieva-Ware</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Patterson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Coggan</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>D. H.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Eisenbeis</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gropler</surname><given-names>R. J.</given-names></name><article-title>PET Measurements
of Myocardial Glucose Metabolism With
1-<sup>11</sup>C-Glucose and Kinetic Modeling</article-title>. <source>J. Nucl. Med.</source><year>2007</year>, <volume>48</volume>, <fpage>955</fpage>&#8211;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.106.037598</pub-id>.<pub-id pub-id-type="pmid">17536107</pub-id></mixed-citation></ref><ref id="ref777"><mixed-citation publication-type="journal" id="cit777"><name name-style="western"><surname>Herrero</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Weinheimer</surname><given-names>C. J.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Oellerich</surname><given-names>W. F.</given-names></name>; <name name-style="western"><surname>Gropler</surname><given-names>R. J.</given-names></name><article-title>Quantification of Myocardial Glucose Utilization by
PET and 1-Carbon-11-Glucose</article-title>. <source>J. Nucl. Cardiol.</source><year>2002</year>, <volume>9</volume>, <fpage>5</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1067/mnc.2001.120635</pub-id>.<pub-id pub-id-type="pmid">11845124</pub-id></mixed-citation></ref><ref id="ref778"><mixed-citation publication-type="journal" id="cit778"><name name-style="western"><surname>Herrero</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Sharp</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Haraden</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Gropler</surname><given-names>R. J.</given-names></name><article-title>Comparison of 1-<sup>11</sup>C-Glucose
and <sup>18</sup>F-FDG for Quantifying Myocardial Glucose Use with
PET</article-title>. <source>J. Nucl. Med.</source><year>2002</year>, <volume>43</volume>, <fpage>1530</fpage>&#8211;<lpage>1541</lpage>.<pub-id pub-id-type="pmid">12411556</pub-id></mixed-citation></ref><ref id="ref779"><mixed-citation publication-type="journal" id="cit779"><name name-style="western"><surname>Ehrin</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>J. L. G.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Brismar</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Greitz</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Jansson</surname><given-names>P. E.</given-names></name>; <name name-style="western"><surname>Litton</surname><given-names>J.-E.</given-names></name>; et al. <article-title>C-11-Labeled Glucose
and its Utilization in Positron-Emission Tomography</article-title>. <source>J. Nucl. Med.</source><year>1983</year>, <volume>24</volume>, <fpage>326</fpage>&#8211;<lpage>331</lpage>.<pub-id pub-id-type="pmid">6601185</pub-id></mixed-citation></ref><ref id="ref780"><mixed-citation publication-type="journal" id="cit780"><name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Powers</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>Improved Synthesis
of 1-[<sup>11</sup>C]<italic toggle="yes">d</italic>-Glucose</article-title>. <source>Appl. Radiat. Isot.</source><year>1993</year>, <volume>44</volume>, <fpage>971</fpage>&#8211;<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(93)90053-D</pub-id>.<pub-id pub-id-type="pmid">8330025</pub-id></mixed-citation></ref><ref id="ref781"><mixed-citation publication-type="journal" id="cit781"><name name-style="western"><surname>Powers</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Dagogo-Jack</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Markham</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>K. B.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name><article-title>Cerebral Transport and Metabolism of 1-<sup>11</sup>C-D-Glucose During Stepped Hypoglycemia</article-title>. <source>Ann.
Neurol.</source><year>1995</year>, <volume>38</volume>, <fpage>599</fpage>&#8211;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410380408</pub-id>.<pub-id pub-id-type="pmid">7574456</pub-id></mixed-citation></ref><ref id="ref782"><mixed-citation publication-type="journal" id="cit782"><name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name><article-title>Remote-Controlled Production of [1-<sup>11</sup>C]-D-Glucose
and Evaluation of the Effect of Labelling Position
on Loss of [<sup>11</sup>C]CO<sub>2</sub></article-title>. <source>Int.
J. Appl. Radiat. Isot. A. Appl. Radiat. Isot.</source><year>1992</year>, <volume>43</volume>, <fpage>721</fpage>&#8211;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(92)90233-5</pub-id>.</mixed-citation></ref><ref id="ref783"><mixed-citation publication-type="journal" id="cit783"><name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Roland</surname><given-names>P. E.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lindqvist</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Swahn</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Wiesel</surname><given-names>F. A.</given-names></name><article-title>Positron Emission Tomographic Measurements of Cerebral
Glucose Utilization Using [1-<sup>11</sup>C]D-Glucose</article-title>. <source>J. Cereb. Blood Flow Metab.</source><year>1990</year>, <volume>10</volume>, <fpage>467</fpage>&#8211;<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1990.89</pub-id>.<pub-id pub-id-type="pmid">2112135</pub-id></mixed-citation></ref><ref id="ref784"><mixed-citation publication-type="journal" id="cit784"><name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Peterson</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Muzi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Spence</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name><article-title>1-[Carbon-11]-glucose
Radiation Dosimetry and Distribution in Human Imaging Studies</article-title>. <source>J. Nucl. Med.</source><year>1998</year>, <volume>39</volume>, <fpage>1805</fpage>&#8211;<lpage>1810</lpage>.<pub-id pub-id-type="pmid">9776292</pub-id></mixed-citation></ref><ref id="ref785"><mixed-citation publication-type="journal" id="cit785"><name name-style="western"><surname>Gutniak</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hamberger</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Grill</surname><given-names>V.</given-names></name><article-title><italic toggle="yes">D</italic>-[<italic toggle="yes">U</italic>-<sup>11</sup>C]Glucose Uptake and Metabolism in the Brain
of Insulin-Dependent Diabetic Subjects</article-title>. <source>Am.
J. Physiol.: Endocrinol. Metab.</source><year>1990</year>, <volume>258</volume>, <elocation-id>E805</elocation-id><pub-id pub-id-type="doi">10.1152/ajpendo.1990.258.5.E805</pub-id>.<pub-id pub-id-type="pmid">2185663</pub-id></mixed-citation></ref><ref id="ref786"><mixed-citation publication-type="journal" id="cit786"><name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Grill</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Ingvar</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wid&#233;n</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name><article-title>The Effect of Hyperglycaemia on Regional
Cerebral Glucose
Oxidation in Humans Studied With [1-<sup>11</sup>C]-<italic toggle="yes">D</italic>-glucose</article-title>. <source>Acta Physiol. Scand.</source><year>1998</year>, <volume>163</volume>, <fpage>403</fpage>&#8211;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-201X.1998.t01-1-00360.x</pub-id>.<pub-id pub-id-type="pmid">9789584</pub-id></mixed-citation></ref><ref id="ref787"><mixed-citation publication-type="journal" id="cit787"><name name-style="western"><surname>Widen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Greitz</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Litton</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ehrin</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Ericson</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ingvar</surname><given-names>D. H.</given-names></name>; <name name-style="western"><surname>Johansson</surname><given-names>L.</given-names></name>; et al. <article-title>PET Studies of Glucose
Metabolism in Patients With Schizophrenia</article-title>. <source>AJNR
Am. J. Neuroradiol.</source><year>1983</year>, <volume>4</volume>, <fpage>550</fpage>&#8211;<lpage>552</lpage>.<pub-id pub-id-type="pmid">6136180</pub-id><pub-id pub-id-type="pmcid">PMC8334984</pub-id></mixed-citation></ref><ref id="ref788"><mixed-citation publication-type="journal" id="cit788"><name name-style="western"><surname>Wiesel</surname><given-names>F. A.</given-names></name>; <name name-style="western"><surname>Wik</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Sj&#246;gren</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Blomqvist</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Greitz</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name><article-title>Regional Brain
Glucose Metabolism in Drug Free Schizophrenic Patients and Clinical
Correlates</article-title>. <source>Acta Psychiatr. Scand.</source><year>1987</year>, <volume>76</volume>, <fpage>628</fpage>&#8211;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1987.tb02933.x</pub-id>.<pub-id pub-id-type="pmid">3502060</pub-id></mixed-citation></ref><ref id="ref789"><mixed-citation publication-type="journal" id="cit789"><name name-style="western"><surname>Kishimoto</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kuwahara</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ohno</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Takazu</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Hama</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Nomura</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Fujita</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Miyauchi</surname><given-names>T.</given-names></name>; et al. <article-title>Three
Subtypes of Chronic
Schizophrenia Identified Using <sup>11</sup>C-Glucose Positron Emission
Tomography</article-title>. <source>Psychiatry Res.</source><year>1987</year>, <volume>21</volume>, <fpage>285</fpage>&#8211;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1781(87)90011-4</pub-id>.<pub-id pub-id-type="pmid">3498177</pub-id></mixed-citation></ref><ref id="ref790"><mixed-citation publication-type="journal" id="cit790"><name name-style="western"><surname>Kishimoto</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Takazu</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Ohno</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Fujita</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kuwahara</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Matsushita</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name><article-title><sup>11</sup>C-Glucose
Metabolism
in Manic and Depressed Patients</article-title>. <source>Psychiatry
Res. Neuroimaging</source><year>1987</year>, <volume>22</volume>, <fpage>81</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1781(87)90053-9</pub-id>.<pub-id pub-id-type="pmid">3498961</pub-id></mixed-citation></ref><ref id="ref791"><mixed-citation publication-type="journal" id="cit791"><name name-style="western"><surname>Shimizu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ishijima</surname><given-names>B.</given-names></name><article-title>Diagnosis of Temporal Lobe Epilepsy
by Positron Emission Tomography</article-title>. <source>Folia Psychiatr.
Neurol. Jpn.</source><year>1985</year>, <volume>39</volume>, <fpage>251</fpage>&#8211;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1819.1985.tb01996.x</pub-id>.<pub-id pub-id-type="pmid">3879486</pub-id></mixed-citation></ref><ref id="ref792"><mixed-citation publication-type="journal" id="cit792"><name name-style="western"><surname>Hiraiwa</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nonaka</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Sakamoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tagaya</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>lio</surname><given-names>M.</given-names></name><article-title>Reversible Symmetrical White Matter
Low Attenuation in Rubella Encephalitis. Both in X-Ray CT and <sup>11</sup>C-Glucose Positron Emission Tomography</article-title>. <source>Neuropediatrics</source><year>1987</year>, <volume>18</volume>, <fpage>54</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1055/s-2008-1052437</pub-id>.<pub-id pub-id-type="pmid">3494206</pub-id></mixed-citation></ref><ref id="ref793"><mixed-citation publication-type="journal" id="cit793"><name name-style="western"><surname>Spence</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Muzi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Graham</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Krohn</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Link</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Lewellen</surname><given-names>T. K.</given-names></name>; <name name-style="western"><surname>Lewellen</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Freeman</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>M. S.</given-names></name>; et al. <article-title>Glucose Metabolism in
Human Malignant Gliomas Measured Quantitatively With PET, 1-[C-11]Glucose
and FDG: Analysis of the FDG Lumped Constant</article-title>. <source>J. Nucl. Med.</source><year>1998</year>, <volume>39</volume>, <fpage>440</fpage>&#8211;<lpage>448</lpage>.<pub-id pub-id-type="pmid">9529289</pub-id></mixed-citation></ref><ref id="ref794"><mixed-citation publication-type="journal" id="cit794"><name name-style="western"><surname>Ericson</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lilja</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bergstr&#246;m</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Collins</surname><given-names>V. P.</given-names></name>; <name name-style="western"><surname>Eriksson</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ehrin</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>von Hoist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>L&#229;ngstrom</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Mosskin</surname><given-names>M.</given-names></name><article-title>Positron Emission Tomography
with ([<sup>11</sup>C]<italic toggle="yes">Methyl</italic>)-<italic toggle="yes">L</italic>-Methionine,
[<sup>11</sup>C]<italic toggle="yes">D</italic>-Glucose, and [<sup>68</sup>Ga]EDTA
in Supratentorial Tumors</article-title>. <source>J. Comput. Assist.
Tomogr.</source><year>1985</year>, <volume>9</volume>, <fpage>683</fpage>&#8211;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1097/00004728-198507010-00005</pub-id>.<pub-id pub-id-type="pmid">3926834</pub-id></mixed-citation></ref><ref id="ref795"><mixed-citation publication-type="journal" id="cit795"><name name-style="western"><surname>Bender</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>Solid Phase-Supported Reaction of
N.C.A. H<sup>11</sup>CN with Arabinose: a Simplified Automated Synthesis
of <italic toggle="yes">D</italic>-(1-<sup>11</sup>C)Glucose</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1998</year>, <volume>41</volume>, <fpage>287</fpage>&#8211;<lpage>300</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-1344(199804)41:4&amp;#x0003c;287::AID-JLCR80&amp;#x0003e;3.0.CO;2-5</pub-id>.</mixed-citation></ref><ref id="ref796"><mixed-citation publication-type="journal" id="cit796"><name name-style="western"><surname>Shiue</surname><given-names>C.-Y.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>The Syntheses of
1-[<sup>11</sup>C]-<italic toggle="yes">D</italic>-Glucose and Related Compounds
for the Measurement
of Brain Glucose Metabolism</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1985</year>, <volume>22</volume>, <fpage>171</fpage>&#8211;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580220210</pub-id>.</mixed-citation></ref><ref id="ref797"><mixed-citation publication-type="journal" id="cit797"><name name-style="western"><surname>Schoeps</surname><given-names>K. O.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name><article-title>Synthesis of [1-<sup>11</sup>C]D-Glucose and [1-<sup>11</sup>C]D-Mannose from on-line Produced [<sup>11</sup>C]Nitromethane</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>877</fpage>&#8211;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90228-S</pub-id>.<pub-id pub-id-type="pmid">1657835</pub-id></mixed-citation></ref><ref id="ref798"><mixed-citation publication-type="journal" id="cit798"><name name-style="western"><surname>Palmer</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Goulding</surname><given-names>R. W.</given-names></name><article-title>Biosynthetic Preparation
of <sup>11</sup>C-Labelled Galactose, Glycerol and Mannitol</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1974</year>, <volume>10</volume>, <fpage>627</fpage>&#8211;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2590100412</pub-id>.</mixed-citation></ref><ref id="ref799"><mixed-citation publication-type="journal" id="cit799"><name name-style="western"><surname>Schoeps</surname><given-names>K.-O.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name><article-title>Synthesis of [1-<sup>11</sup>C]D-Glucose
and [1-<sup>11</sup>C]D-Mannose from on-Line Produced [<sup>11</sup>C]Nitromethane</article-title>. <source>Int. J. Rad. Appl. Instrum.
A. Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>877</fpage>&#8211;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90228-S</pub-id>.<pub-id pub-id-type="pmid">1657835</pub-id></mixed-citation></ref><ref id="ref800"><mixed-citation publication-type="journal" id="cit800"><name name-style="western"><surname>Ishiwata</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Monma</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ido</surname><given-names>T.</given-names></name><article-title>A Convenient Method
of Preparing Pure [<sup>11</sup>C]Glucose by Photosynthesis</article-title>. <source>Appl. Radiat. Isot.</source><year>1987</year>, <volume>38</volume>, <fpage>475</fpage>&#8211;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90102-X</pub-id>.</mixed-citation></ref><ref id="ref801"><mixed-citation publication-type="journal" id="cit801"><name name-style="western"><surname>Raichle</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>K. B.</given-names></name>; <name name-style="western"><surname>Phelps</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Grubb</surname><given-names>R. L.</given-names><suffix>Jr.</suffix></name>; <name name-style="western"><surname>welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Ter-Pogossian</surname><given-names>M. M.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> Measurement of Brain Glucose Transport and Metabolism
Employing Glucose-<sup>11</sup>C</article-title>. <source>Am. J. Physiol.</source><year>1975</year>, <volume>228</volume>, <fpage>1936</fpage>&#8211;<lpage>1948</lpage>. <pub-id pub-id-type="doi">10.1152/ajplegacy.1975.228.6.1936</pub-id>.<pub-id pub-id-type="pmid">1155625</pub-id></mixed-citation></ref><ref id="ref802"><mixed-citation publication-type="journal" id="cit802"><name name-style="western"><surname>Ferrieri</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Agtuca</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Appel</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Ferrieri</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Schultz</surname><given-names>J. C.</given-names></name><article-title>Temporal Changes in Allocation and
Partitioning of
New Carbon as <sup>11</sup>C Elicited by Simulated Herbivory Suggest
that Roots Shape Aboveground Responses in Arabidopsis</article-title>. <source>Plant Physiol.</source><year>2013</year>, <volume>161</volume>, <fpage>692</fpage>&#8211;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1104/pp.112.208868</pub-id>.<pub-id pub-id-type="pmid">23370716</pub-id><pub-id pub-id-type="pmcid">PMC3561013</pub-id></mixed-citation></ref><ref id="ref803"><mixed-citation publication-type="journal" id="cit803"><name name-style="western"><surname>Roeda</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Westera</surname><given-names>G.</given-names></name><article-title>A Novel Method for the Production
of <sup>11</sup>C-Phosgene. Its Use in the Preoperation of <sup>11</sup>C-Labeled Ethyl Chloroformate, Diethyl Carbonate, Diphenylurea, <italic toggle="yes">5</italic>, <italic toggle="yes">5-Diethyl</italic> Barbiturate, <italic toggle="yes">5</italic>, <italic toggle="yes">5-Ethylphenyl</italic> Barbiturate, <italic toggle="yes">Ethylphenyl</italic> Hydantoin and <italic toggle="yes">Diphenyl</italic> Hydantoin</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1981</year>, <volume>18</volume>, <fpage>11</fpage>&#8211;<lpage>12</lpage>.</mixed-citation></ref><ref id="ref804"><mixed-citation publication-type="journal" id="cit804"><name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Barletta</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Noyori</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis of <sup>11</sup>C-Labelled <italic toggle="yes">N</italic>, <italic toggle="yes">N&#8242;</italic>-Diphenylurea and Ethyl Phenylcarbamate
by a Rhodium-Promoted Carbonylation <italic toggle="yes">via</italic> [<sup>11</sup>C]isocyanatobenzene Using Phenyl Azide and [<sup>11</sup>C]carbon
Monoxide</article-title>. <source>Org. Biomol. Chem.</source><year>2004</year>, <volume>2</volume>, <fpage>3063</fpage>&#8211;<lpage>3066</lpage>. <pub-id pub-id-type="doi">10.1039/B409294E</pub-id>.<pub-id pub-id-type="pmid">15505707</pub-id></mixed-citation></ref><ref id="ref805"><mixed-citation publication-type="journal" id="cit805"><name name-style="western"><surname>Tang</surname><given-names>D. Y.</given-names></name>; <name name-style="western"><surname>Lipman</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>G. J.</given-names></name>; <name name-style="western"><surname>Wan</surname><given-names>C. N.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title><sup>11</sup>C-Labeled Octanal and
Benzaldehyde</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>435</fpage>&#8211;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580160309</pub-id>.</mixed-citation></ref><ref id="ref806"><mixed-citation publication-type="journal" id="cit806"><name name-style="western"><surname>Basset</surname><given-names>G. J. C.</given-names></name>; <name name-style="western"><surname>Quinlivan</surname><given-names>E. P.</given-names></name>; <name name-style="western"><surname>Ravanel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>R&#233;beill&#233;</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Nichols</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Shinozaki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Seki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Adams-Phillips</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Giovannoni</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Gregory</surname><given-names>J. F.</given-names></name>; et al. <article-title>Folate Synthesis in
Plants: The P-Aminobenzoate Branch Is Initiated by a Bifunctional
PabA-PabB Protein That Is Targeted to Plastids</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2004</year>, <volume>101</volume>, <fpage>1496</fpage>&#8211;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308331100</pub-id>.<pub-id pub-id-type="pmid">14745019</pub-id><pub-id pub-id-type="pmcid">PMC341757</pub-id></mixed-citation></ref><ref id="ref807"><mixed-citation publication-type="journal" id="cit807"><name name-style="western"><surname>Kluczyk</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Popek</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kiyota</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>de Macedo</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Stefanowicz</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lazar</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Konishi</surname><given-names>Y.</given-names></name><article-title>Drug Evolution: p-Aminobenzoic
Acid as a Building Block</article-title>. <source>Curr. Med. Chem.</source><year>2002</year>, <volume>9</volume>, <fpage>1871</fpage>&#8211;<lpage>1892</lpage>. <pub-id pub-id-type="doi">10.2174/0929867023368872</pub-id>.<pub-id pub-id-type="pmid">12369873</pub-id></mixed-citation></ref><ref id="ref808"><mixed-citation publication-type="journal" id="cit808"><name name-style="western"><surname>Tabor</surname><given-names>C. W.</given-names></name>; <name name-style="western"><surname>Freeman</surname><given-names>M. V.</given-names></name>; <name name-style="western"><surname>Baily</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>P. K.</given-names></name><article-title>Studies
on the Metabolism of <italic toggle="yes">para</italic>-Aminobenzoic Acid</article-title>. <source>J. Pharmacol. Exp. Ther.</source><year>1951</year>, <volume>102</volume>, <fpage>98</fpage>&#8211;<lpage>102</lpage>.<pub-id pub-id-type="pmid">14841593</pub-id></mixed-citation></ref><ref id="ref809"><mixed-citation publication-type="journal" id="cit809"><name name-style="western"><surname>Lebel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nakamachi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hemming</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Verjee</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Phillips</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Furuya</surname><given-names>K. N.</given-names></name><article-title>Glycine Conjugation of Para-Aminobenzoic
Acid (PABA): A Pilot Study of a Novel Prognostic Test in Acute Liver
Failure in Children</article-title>. <source>J. Pediatr. Gastroenterol.
Nutr.</source><year>2003</year>, <volume>36</volume>, <fpage>62</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1097/00005176-200301000-00013</pub-id>.<pub-id pub-id-type="pmid">12499998</pub-id></mixed-citation></ref><ref id="ref810"><mixed-citation publication-type="journal" id="cit810"><name name-style="western"><surname>Winstead</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Winchell</surname><given-names>H. S.</given-names></name>; <name name-style="western"><surname>Fawwaz</surname><given-names>R.</given-names></name><article-title>The Use of Sodium <sup>11</sup>C-Benzoate
in Renal Visualization</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1969</year>, <volume>20</volume>, <fpage>859</fpage>&#8211;<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(69)90111-2</pub-id>.<pub-id pub-id-type="pmid">5352763</pub-id></mixed-citation></ref><ref id="ref811"><mixed-citation publication-type="journal" id="cit811"><name name-style="western"><surname>Igarashi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kashiwagi</surname><given-names>K.</given-names></name><article-title>The Functional
Role of Polyamines
in Eukaryotic Cells</article-title>. <source>Int. J. Biochem. Cell Biol.</source><year>2019</year>, <volume>107</volume>, <fpage>104</fpage>&#8211;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2018.12.012</pub-id>.<pub-id pub-id-type="pmid">30578954</pub-id></mixed-citation></ref><ref id="ref812"><mixed-citation publication-type="journal" id="cit812"><name name-style="western"><surname>Roth</surname><given-names>B. L.</given-names></name>; <name name-style="western"><surname>Baner</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Westkaemper</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Siebert</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Rice</surname><given-names>K. C.</given-names></name>; <name name-style="western"><surname>Steinberg</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ernsberger</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Rothman</surname><given-names>R. B.</given-names></name><article-title>Salvinorin A: A Potent Naturally
Occurring Nonnitrogenous Kappa Opioid Selective Agonist</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2002</year>, <volume>99</volume>, <fpage>11934</fpage>&#8211;<lpage>11939</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.182234399</pub-id>.<pub-id pub-id-type="pmid">12192085</pub-id><pub-id pub-id-type="pmcid">PMC129372</pub-id></mixed-citation></ref><ref id="ref813"><mixed-citation publication-type="journal" id="cit813"><name name-style="western"><surname>Hooker</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Schiffer</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Carter</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name><article-title>Pharmacokinetics
of the Potent Hallucinogen,
Salvinorin A in Primates Parallels the Rapid Onset and Short Duration
of Effects in Humans</article-title>. <source>Neuroimage</source><year>2008</year>, <volume>41</volume>, <fpage>1044</fpage>&#8211;<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.03.003</pub-id>.<pub-id pub-id-type="pmid">18434204</pub-id><pub-id pub-id-type="pmcid">PMC2464626</pub-id></mixed-citation></ref><ref id="ref814"><mixed-citation publication-type="journal" id="cit814"><name name-style="western"><surname>Hawel</surname><given-names>L.</given-names><suffix>3rd</suffix></name>; <name name-style="western"><surname>Tjandrawinata</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Fukumoto</surname><given-names>G. H.</given-names></name>; <name name-style="western"><surname>Byus</surname><given-names>C. V.</given-names></name><article-title>Biosynthesis and Selective Export
of 1,5-Diaminopentane (Cadaverine) in Mycoplasma-Free Cultured Mammalian
Cells</article-title>. <source>J. Biol. Chem.</source><year>1994</year>, <volume>269</volume>, <fpage>7412</fpage>&#8211;<lpage>7418</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(17)37300-3</pub-id>.<pub-id pub-id-type="pmid">8125959</pub-id></mixed-citation></ref><ref id="ref815"><mixed-citation publication-type="journal" id="cit815"><name name-style="western"><surname>Winstead</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Dischino</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Munder</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Walsh</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Winchell</surname><given-names>H. S.</given-names></name><article-title>Relationship of Molecular Structure
to In Vivo Distribution
of Carbon-11-Labeled Compounds</article-title>. <source>Eur. J. Nucl.
Med.</source><year>1980</year>, <volume>5</volume>, <fpage>165</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1007/BF00252479</pub-id>.<pub-id pub-id-type="pmid">7379819</pub-id></mixed-citation></ref><ref id="ref816"><mixed-citation publication-type="journal" id="cit816"><name name-style="western"><surname>Goh</surname><given-names>Y. Q.</given-names></name>; <name name-style="western"><surname>Cheam</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><article-title>Understanding Choline
Bioavailability and Utilization: First Step Toward Personalizing Choline
Nutrition</article-title>. <source>J. Agric. Food Chem.</source><year>2021</year>, <volume>69</volume>, <fpage>10774</fpage>&#8211;<lpage>10789</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.1c03077</pub-id>.<pub-id pub-id-type="pmid">34392687</pub-id></mixed-citation></ref><ref id="ref817"><mixed-citation publication-type="journal" id="cit817"><name name-style="western"><surname>Roivainen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Forsback</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gr&#246;nroos</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Lehikoinen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>K&#228;hk&#246;nen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sutinen</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Minn</surname><given-names>H.</given-names></name><article-title>Blood Metabolism of [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C]choline;
Implications for <italic toggle="yes">In Vivo</italic> Imaging With Positron Emission
Tomography</article-title>. <source>Eur. J. Nucl. Med.</source><year>2000</year>, <volume>27</volume>, <fpage>25</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1007/PL00006658</pub-id>.<pub-id pub-id-type="pmid">10654143</pub-id></mixed-citation></ref><ref id="ref818"><mixed-citation publication-type="journal" id="cit818"><name name-style="western"><surname>Hedtke</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Bakovic</surname><given-names>M.</given-names></name><article-title>Choline Transport for
Phospholipid
Synthesis: An Emerging Role of Choline Transporter-Like Protein 1</article-title>. <source>Exp. Biol. Med.</source><year>2019</year>, <volume>244</volume>, <fpage>655</fpage>&#8211;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1177/1535370219830997</pub-id>.<pub-id pub-id-type="pmcid">PMC6552397</pub-id><pub-id pub-id-type="pmid">30776907</pub-id></mixed-citation></ref><ref id="ref819"><mixed-citation publication-type="journal" id="cit819"><name name-style="western"><surname>Roci</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Watrous</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Lagerborg</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Jain</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>R.</given-names></name><article-title>Mapping Choline Metabolites in Normal
and Transformed Cells</article-title>. <source>Metabolomics</source><year>2020</year>, <volume>16</volume>, <fpage>125</fpage><pub-id pub-id-type="doi">10.1007/s11306-020-01749-0</pub-id>.<pub-id pub-id-type="pmid">33249526</pub-id><pub-id pub-id-type="pmcid">PMC7701132</pub-id></mixed-citation></ref><ref id="ref820"><mixed-citation publication-type="journal" id="cit820"><name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Franssen</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Hendrikse</surname><given-names>N. H.</given-names></name>; <name name-style="western"><surname>Fluks</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Weemaes</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>van der Graaf</surname><given-names>W. T.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. G.</given-names></name>; <name name-style="western"><surname>Visser</surname><given-names>G. M.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title>Carbon-11-Labeled Daunorubicin
and Verapamil for Probing P-Glycoprotein in Tumors With PET</article-title>. <source>J. Nucl. Med.</source><year>1996</year>, <volume>37</volume>, <fpage>1571</fpage>&#8211;<lpage>1575</lpage>.<pub-id pub-id-type="pmid">8790221</pub-id></mixed-citation></ref><ref id="ref821"><mixed-citation publication-type="journal" id="cit821"><name name-style="western"><surname>Eriks-Fluks</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Elsinga</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Hendrikse</surname><given-names>N. H.</given-names></name>; <name name-style="western"><surname>Franssen</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name><article-title>Enzymatic
Synthesis of [4-Methoxy-<sup>11</sup>C]daunorubicin for Functional
Imaging of P-Glycoprotein With
PET</article-title>. <source>Appl. Radiat. Isot.</source><year>1998</year>, <volume>49</volume>, <fpage>811</fpage>&#8211;<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(97)00302-3</pub-id>.<pub-id pub-id-type="pmid">9570100</pub-id></mixed-citation></ref><ref id="ref822"><mixed-citation publication-type="journal" id="cit822"><name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Palmer</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Horlock</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Perun</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Freiberg</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Dunnigan</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Liss</surname><given-names>R. H.</given-names></name><article-title>Preparation
of a
Carbon-11 Labelled Antibiotic, Erythromycin a Lactobionate</article-title>. <source>J. Chem. Soc., Chem. Commun.</source><year>1982</year>, <fpage>173</fpage>&#8211;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1039/c39820000173</pub-id>.</mixed-citation></ref><ref id="ref823"><mixed-citation publication-type="journal" id="cit823"><name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Palmer</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Horlock</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Perun</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Freiberg</surname><given-names>L. A.</given-names></name>; <name name-style="western"><surname>Dunnigan</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Liss</surname><given-names>R. H.</given-names></name><article-title>Semi-Automated Preparation
of a <sup>11</sup>C-Labelled Antibiotic-[<italic toggle="yes">N-methyl</italic>-<sup>11</sup>C]Erthromycin A Lactobionate</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1984</year>, <volume>35</volume>, <fpage>103</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(84)90192-3</pub-id>.<pub-id pub-id-type="pmid">6231252</pub-id></mixed-citation></ref><ref id="ref824"><mixed-citation publication-type="journal" id="cit824"><name name-style="western"><surname>Weiss</surname><given-names>R. B.</given-names></name><article-title>The Anthracyclines: Will We Ever Find a Better Doxorubicin?</article-title>. <source>Semin. Oncol.</source><year>1992</year>, <volume>19</volume>, <fpage>670</fpage>&#8211;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.5555/URI:PII:009377549290036Z</pub-id>.<pub-id pub-id-type="pmid">1462166</pub-id></mixed-citation></ref><ref id="ref825"><mixed-citation publication-type="journal" id="cit825"><name name-style="western"><surname>Baruffa</surname><given-names>G.</given-names></name><article-title>Clinical Trials in Plasmodium falciparum
Malaria With
a Long-Acting Sulphonamide</article-title>. <source>Trans. R. Soc. Trop.
Med. Hyg.</source><year>1966</year>, <volume>60</volume>, <fpage>222</fpage>&#8211;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/0035-9203(66)90030-7</pub-id>.<pub-id pub-id-type="pmid">5332105</pub-id></mixed-citation></ref><ref id="ref826"><mixed-citation publication-type="journal" id="cit826"><name name-style="western"><surname>Perl</surname><given-names>A. E.</given-names></name><article-title>The Role
of Targeted Therapy in the Management of Patients
With AML</article-title>. <source>Hematol. Am. Soc. Hematol. Educ. Program</source><year>2017</year>, <volume>2017</volume>, <fpage>54</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1182/asheducation-2017.1.54</pub-id>.<pub-id pub-id-type="pmcid">PMC6142552</pub-id><pub-id pub-id-type="pmid">29222237</pub-id></mixed-citation></ref><ref id="ref827"><mixed-citation publication-type="journal" id="cit827"><name name-style="western"><surname>Robergs</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>McMinn</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Mermier</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Leadbetter</surname><given-names>G.</given-names><suffix>III</suffix></name>; <name name-style="western"><surname>Ruby</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Quinn</surname><given-names>C.</given-names></name><article-title>Blood Glucose
and Glucoregulatory
Hormone Responses to Solid and Liquid Carbohydrate Ingestion During
Exercise</article-title>. <source>Int. J. Sport Nutr. Exerc.Metab.</source><year>1998</year>, <volume>8</volume>, <fpage>70</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1123/ijsn.8.1.70</pub-id>.<pub-id pub-id-type="pmid">9534083</pub-id></mixed-citation></ref><ref id="ref828"><mixed-citation publication-type="journal" id="cit828"><name name-style="western"><surname>Pero</surname><given-names>R. W.</given-names></name><article-title>Health Consequences of Catabolic
Synthesis of Hippuric
Acid in Humans</article-title>. <source>Curr. Clin. Pharmacol.</source><year>2010</year>, <volume>5</volume>, <fpage>67</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.2174/157488410790410588</pub-id>.<pub-id pub-id-type="pmid">19891605</pub-id></mixed-citation></ref><ref id="ref829"><mixed-citation publication-type="journal" id="cit829"><name name-style="western"><surname>Toromanovi&#263;</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kova&#269;-Be&#353;ovi&#263;</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>&#352;ap&#269;anin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Tahirovi&#263;</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Rimpapa</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Kroyer</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Sofi&#263;</surname><given-names>E.</given-names></name><article-title>Urinary Hippuric
Acid after Ingestion of Edible Fruits</article-title>. <source>Bosn.
J. Basic Med. Sci.</source><year>2008</year>, <volume>8</volume>, <fpage>38</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.17305/bjbms.2008.2994</pub-id>.<pub-id pub-id-type="pmid">18318670</pub-id><pub-id pub-id-type="pmcid">PMC5724873</pub-id></mixed-citation></ref><ref id="ref830"><mixed-citation publication-type="journal" id="cit830"><name name-style="western"><surname>Harthan</surname><given-names>A. A.</given-names></name><article-title>An Introduction to Pharmacotherapy for Inborn Errors
of Metabolism</article-title>. <source>J. Pediatr. Pharmacol. Ther.</source><year>2018</year>, <volume>23</volume>, <fpage>432</fpage>&#8211;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.5863/1551-6776-23.6.432</pub-id>.<pub-id pub-id-type="pmid">30697128</pub-id><pub-id pub-id-type="pmcid">PMC6336179</pub-id></mixed-citation></ref><ref id="ref831"><mixed-citation publication-type="journal" id="cit831"><name name-style="western"><surname>Adeva-Andany</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>L&#243;pez-Oj&#233;n</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Funcasta-Calder&#243;n</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ameneiros-Rodr&#237;guez</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Donapetry-Garc&#237;a</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Vila-Altesor</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rodr&#237;guez-Seijas</surname><given-names>J.</given-names></name><article-title>Comprehensive Review
on Lactate Metabolism in Human Health</article-title>. <source>Mitochondrion</source><year>2014</year>, <volume>17</volume>, <fpage>76</fpage>&#8211;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2014.05.007</pub-id>.<pub-id pub-id-type="pmid">24929216</pub-id></mixed-citation></ref><ref id="ref832"><mixed-citation publication-type="journal" id="cit832"><name name-style="western"><surname>Keppler</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>M&#252;ller</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kl&#252;nemann</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Guhlmann</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Krauss</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>M&#252;ller</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Leier</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Mayatepek</surname><given-names>E.</given-names></name><article-title>Transport
and <italic toggle="yes">In Vivo</italic> Elimination of Cysteinyl Leukotrienes</article-title>. <source>Adv. Enzyme Regul.</source><year>1992</year>, <volume>32</volume>, <fpage>107</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/0065-2571(92)90011-N</pub-id>.<pub-id pub-id-type="pmid">1496913</pub-id></mixed-citation></ref><ref id="ref833"><mixed-citation publication-type="journal" id="cit833"><name name-style="western"><surname>Nguyen</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Ito</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Maeyama</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schaffer</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Murakami</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ito</surname><given-names>T.</given-names></name><article-title><italic toggle="yes">In Vivo</italic> and <italic toggle="yes">In Vitro</italic> Study of <italic toggle="yes">N</italic>-Methyltaurine on Pharmacokinetics
and Antimuscle Atrophic Effects in Mice</article-title>. <source>ACS
Omega</source><year>2020</year>, <volume>5</volume>, <fpage>11241</fpage>&#8211;<lpage>11246</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.0c01588</pub-id>.<pub-id pub-id-type="pmid">32455249</pub-id><pub-id pub-id-type="pmcid">PMC7241010</pub-id></mixed-citation></ref><ref id="ref834"><mixed-citation publication-type="journal" id="cit834"><name name-style="western"><surname>Abratt</surname><given-names>V. R.</given-names></name>; <name name-style="western"><surname>Reid</surname><given-names>S. J.</given-names></name><article-title>Oxalate-Degrading Bacteria of the
Human Gut As Probiotics in the Management of Kidney Stone Disease</article-title>. <source>Adv. Appl. Microbiol.</source><year>2010</year>, <volume>72</volume>, <fpage>63</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-2164(10)72003-7</pub-id>.<pub-id pub-id-type="pmid">20602988</pub-id></mixed-citation></ref><ref id="ref835"><mixed-citation publication-type="journal" id="cit835"><name name-style="western"><surname>Waikar</surname><given-names>S. S.</given-names></name>; <name name-style="western"><surname>Srivastava</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Palsson</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Shafi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hsu</surname><given-names>C.-y.</given-names></name>; <name name-style="western"><surname>Sharma</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lash</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lieske</surname><given-names>J.</given-names></name><article-title>Association of Urinary Oxalate Excretion With the Risk
of Chronic Kidney Disease Progression</article-title>. <source>JAMA
Int. Med.</source><year>2019</year>, <volume>179</volume>, <fpage>542</fpage>&#8211;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2018.7980</pub-id>.<pub-id pub-id-type="pmcid">PMC6450310</pub-id><pub-id pub-id-type="pmid">30830167</pub-id></mixed-citation></ref><ref id="ref836"><mixed-citation publication-type="journal" id="cit836"><name name-style="western"><surname>Saville</surname><given-names>M. W.</given-names></name>; <name name-style="western"><surname>Lietzau</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Pluda</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Wilson</surname><given-names>W. H.</given-names></name>; <name name-style="western"><surname>Humphrey</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Feigel</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Steinberg</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Broder</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yarchoan</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Odom</surname><given-names>J.</given-names></name>; et al. <article-title>Treatment
of HIV-Associated Kaposi&#8217;s Sarcoma With Paclitaxel</article-title>. <source>Lancet</source><year>1995</year>, <volume>346</volume>, <fpage>26</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(95)92654-2</pub-id>.<pub-id pub-id-type="pmid">7603142</pub-id></mixed-citation></ref><ref id="ref837"><mixed-citation publication-type="journal" id="cit837"><name name-style="western"><surname>Erhardt</surname><given-names>P. W.</given-names></name>; <name name-style="western"><surname>El-Dakdouki</surname><given-names>M.</given-names></name><article-title>Paclitaxel and Epothilone Analogues,
Anticancer Drugs</article-title>. <source>Analogue-Based Drug Discovery
II</source><year>2010</year>, <fpage>243</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1002/9783527630035.ch10</pub-id>.</mixed-citation></ref><ref id="ref838"><mixed-citation publication-type="journal" id="cit838"><name name-style="western"><surname>Holmes</surname><given-names>F. A.</given-names></name>; <name name-style="western"><surname>Walters</surname><given-names>R. S.</given-names></name>; <name name-style="western"><surname>Theriault</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Forman</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Newton</surname><given-names>L. K.</given-names></name>; <name name-style="western"><surname>Raber</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Buzdar</surname><given-names>A. U.</given-names></name>; <name name-style="western"><surname>Frye</surname><given-names>D. K.</given-names></name>; <name name-style="western"><surname>Hortobagyi</surname><given-names>G. N.</given-names></name><article-title>Phase II Trial of Taxol, an Active
Drug in the Treatment of Metastatic Breast Cancer</article-title>. <source>J. Natl. Cancer Inst.</source><year>1991</year>, <volume>83</volume>, <fpage>1797</fpage>&#8211;<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/83.24.1797-a</pub-id>.<pub-id pub-id-type="pmid">1683908</pub-id></mixed-citation></ref><ref id="ref839"><mixed-citation publication-type="book" id="cit839"><person-group person-group-type="allauthors"><name name-style="western"><surname>Gnegy</surname><given-names>M. E.</given-names></name></person-group><article-title>Catecholamines</article-title>. In <source>Basic Neurochemistry</source>, <edition>8th</edition> ed.; <person-group person-group-type="editor"><name name-style="western"><surname>Brady</surname><given-names>S. T.</given-names></name>, <name name-style="western"><surname>Siegel</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Albers</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>D. L.</given-names></name></person-group>, Eds.; <publisher-name>Academic Press</publisher-name>, <year>2012</year>; Chapter 14, pp <fpage>283</fpage>&#8211;<lpage>299</lpage>.</mixed-citation></ref><ref id="ref840"><mixed-citation publication-type="journal" id="cit840"><name name-style="western"><surname>Coban</surname><given-names>H. B.</given-names></name>; <name name-style="western"><surname>Demirci</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Patterson</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>Elias</surname><given-names>R. J.</given-names></name><article-title>Enhanced Phenylpyruvic Acid Production With Proteus
vulgaris by Optimizing of the Fermentation Medium</article-title>. <source>Acta Aliment.</source><year>2016</year>, <volume>45</volume>, <fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1556/066.2016.45.1.1</pub-id>.<pub-id pub-id-type="pmid">25569523</pub-id></mixed-citation></ref><ref id="ref841"><mixed-citation publication-type="journal" id="cit841"><name name-style="western"><surname>Schuck</surname><given-names>F. P.</given-names></name>; <name name-style="western"><surname>Malgarin</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Cararo</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Cardoso</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Streck</surname><given-names>L. E.</given-names></name>; <name name-style="western"><surname>G</surname><given-names>F. C.</given-names></name><article-title>Phenylketonuria Pathophysiology:
on the Role of Metabolic Alterations</article-title>. <source>Aging
Dis.</source><year>2015</year>, <volume>6</volume>, <fpage>390</fpage>&#8211;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2015.0827</pub-id>.<pub-id pub-id-type="pmid">26425393</pub-id><pub-id pub-id-type="pmcid">PMC4567221</pub-id></mixed-citation></ref><ref id="ref842"><mixed-citation publication-type="journal" id="cit842"><name name-style="western"><surname>Gray</surname><given-names>L. R.</given-names></name>; <name name-style="western"><surname>Tompkins</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Taylor</surname><given-names>E. B.</given-names></name><article-title>Regulation of Pyruvate
Metabolism and Human Disease</article-title>. <source>Cell. Mol. Life
Sci.</source><year>2014</year>, <volume>71</volume>, <fpage>2577</fpage>&#8211;<lpage>2604</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-013-1539-2</pub-id>.<pub-id pub-id-type="pmid">24363178</pub-id><pub-id pub-id-type="pmcid">PMC4059968</pub-id></mixed-citation></ref><ref id="ref843"><mixed-citation publication-type="journal" id="cit843"><name name-style="western"><surname>Choi</surname><given-names>H. W.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Powell</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Strickler</surname><given-names>S. R.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Dempsey</surname><given-names>D. A.</given-names></name>; <name name-style="western"><surname>Schroeder</surname><given-names>F. C.</given-names></name>; <name name-style="western"><surname>Klessig</surname><given-names>D. F.</given-names></name><article-title>A Genome-Wide Screen for Human Salicylic Acid (SA)-Binding
Proteins Reveals Targets Through Which SA May Influence Development
of Various Diseases</article-title>. <source>Sci. Rep.</source><year>2019</year>, <volume>9</volume>, <fpage>13084</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-49234-6</pub-id>.<pub-id pub-id-type="pmid">31511554</pub-id><pub-id pub-id-type="pmcid">PMC6739329</pub-id></mixed-citation></ref><ref id="ref844"><mixed-citation publication-type="journal" id="cit844"><name name-style="western"><surname>Sankaranarayanan</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Patel</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bhat</surname><given-names>G. J.</given-names></name><article-title>Do Aspirin
and Flavonoids Prevent Cancer through a Common Mechanism Involving
Hydroxybenzoic Acids?-The Metabolite Hypothesis</article-title>. <source>Molecules</source><year>2020</year>, <volume>25</volume>, <fpage>2243</fpage><pub-id pub-id-type="doi">10.3390/molecules25092243</pub-id>.<pub-id pub-id-type="pmid">32397626</pub-id><pub-id pub-id-type="pmcid">PMC7249170</pub-id></mixed-citation></ref><ref id="ref845"><mixed-citation publication-type="journal" id="cit845"><name name-style="western"><surname>Boji&#263;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sedgeman</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Nagy</surname><given-names>L. D.</given-names></name>; <name name-style="western"><surname>Guengerich</surname><given-names>F. P.</given-names></name><article-title>Aromatic
Hydroxylation of Salicylic Acid and Aspirin by Human Cytochromes P450</article-title>. <source>Eur. J. Pharm. Sci.</source><year>2015</year>, <volume>73</volume>, <fpage>49</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2015.03.015</pub-id>.<pub-id pub-id-type="pmid">25840124</pub-id><pub-id pub-id-type="pmcid">PMC4414920</pub-id></mixed-citation></ref><ref id="ref846"><mixed-citation publication-type="book" id="cit846"><person-group person-group-type="allauthors"><name name-style="western"><surname>Meriney</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>Fanselow</surname><given-names>E. E.</given-names></name></person-group><article-title>Metabotropic
G-Protein-Coupled Receptors and Their Cytoplasmic Signaling Pathways</article-title>. In <source>Synaptic Transmission</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Meriney</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Fanselow</surname><given-names>E. E.</given-names></name></person-group>, Eds.; <publisher-name>Academic
Press</publisher-name>, <year>2019</year>; Chapter 12, pp <fpage>245</fpage>&#8211;<lpage>273</lpage>.</mixed-citation></ref><ref id="ref847"><mixed-citation publication-type="journal" id="cit847"><name name-style="western"><surname>Weiner</surname><given-names>I. D.</given-names></name>; <name name-style="western"><surname>Mitch</surname><given-names>W. E.</given-names></name>; <name name-style="western"><surname>Sands</surname><given-names>J. M.</given-names></name><article-title>Urea and Ammonia
Metabolism and the Control of Renal Nitrogen Excretion</article-title>. <source>Clin. J. Am. Soc. Nephrol.</source><year>2015</year>, <volume>10</volume>, <fpage>1444</fpage>&#8211;<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.2215/CJN.10311013</pub-id>.<pub-id pub-id-type="pmid">25078422</pub-id><pub-id pub-id-type="pmcid">PMC4527031</pub-id></mixed-citation></ref><ref id="ref848"><mixed-citation publication-type="journal" id="cit848"><name name-style="western"><surname>Maiuolo</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Oppedisano</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Gratteri</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Muscoli</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Mollace</surname><given-names>V.</given-names></name><article-title>Regulation of Uric
Acid Metabolism and Excretion</article-title>. <source>Int. J. Cardiol.</source><year>2016</year>, <volume>213</volume>, <fpage>8</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2015.08.109</pub-id>.<pub-id pub-id-type="pmid">26316329</pub-id></mixed-citation></ref><ref id="ref849"><mixed-citation publication-type="journal" id="cit849"><name name-style="western"><surname>Tausche</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Unger</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Richter</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Wunderlich</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gr&#228;ssler</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Roch</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Schr&#246;der</surname><given-names>H. E.</given-names></name><article-title>Hyperurik&#228;mie
und Gicht</article-title>. <source>Der. Internist.</source><year>2006</year>, <volume>47</volume>, <fpage>509</fpage>&#8211;<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1007/s00108-006-1578-y</pub-id>.<pub-id pub-id-type="pmid">16586130</pub-id></mixed-citation></ref><ref id="ref850"><mixed-citation publication-type="journal" id="cit850"><name name-style="western"><surname>Mutch</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Ordonez</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Parker</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bambarger</surname><given-names>L. E.</given-names></name>; <name name-style="western"><surname>Villanueva-Meyer</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Blecha</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Carroll</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Taglang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Flavell</surname><given-names>R.</given-names></name>; et al. <article-title>[<sup>11</sup>C]Para-Aminobenzoic
Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific
Metabolism</article-title>. <source>ACS Infect. Dis.</source><year>2018</year>, <volume>4</volume>, <fpage>1067</fpage>&#8211;<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.8b00061</pub-id>.<pub-id pub-id-type="pmid">29712422</pub-id><pub-id pub-id-type="pmcid">PMC6045447</pub-id></mixed-citation></ref><ref id="ref851"><mixed-citation publication-type="journal" id="cit851"><name name-style="western"><surname>Ruiz-Bedoya</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Ordonez</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Werner</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Plyku</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Klunk</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Leal</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lesniak</surname><given-names>W. G.</given-names></name>; <name name-style="western"><surname>Holt</surname><given-names>D. P.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>Higuchi</surname><given-names>T.</given-names></name>; et al. <article-title><sup>11</sup>C-PABA
as a PET Radiotracer for Functional Renal Imaging: Preclinical and
First-in-Human Study</article-title>. <source>J. Nucl. Med.</source><year>2020</year>, <volume>61</volume>, <fpage>1665</fpage>&#8211;<lpage>1671</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.119.239806</pub-id>.<pub-id pub-id-type="pmid">32198314</pub-id><pub-id pub-id-type="pmcid">PMC9364887</pub-id></mixed-citation></ref><ref id="ref852"><mixed-citation publication-type="journal" id="cit852"><name name-style="western"><surname>Holt</surname><given-names>D. P.</given-names></name>; <name name-style="western"><surname>Kalinda</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Bambarger</surname><given-names>L. E.</given-names></name>; <name name-style="western"><surname>Jain</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name><article-title>Radiosynthesis and Validation of
[<italic toggle="yes">Carboxy</italic>-<sup>11</sup>C]4-Aminobenzoic Acid ([<sup>11</sup>C]PABA), a PET Radiotracer for Imaging Bacterial Infections</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>2019</year>, <volume>62</volume>, <fpage>28</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.3674</pub-id>.<pub-id pub-id-type="pmcid">PMC6338486</pub-id><pub-id pub-id-type="pmid">30089334</pub-id></mixed-citation></ref><ref id="ref853"><mixed-citation publication-type="journal" id="cit853"><name name-style="western"><surname>Conti</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Schmall</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bigler</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Zanzonico</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Reiman</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Dahl</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jacobsen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Winstead</surname><given-names>M.</given-names></name><article-title>Synthesis and Purification of Sodium [<sup>11</sup>C] Benzoate for Physiological and Metabolic Studies: Evaluation in
a Tumor-Bearing Dog</article-title>. <source>Int. J. Nucl. Med. Biol.</source><year>1984</year>, <volume>11</volume>, <fpage>179</fpage>&#8211;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/0047-0740(84)90058-5</pub-id>.<pub-id pub-id-type="pmid">6592159</pub-id></mixed-citation></ref><ref id="ref854"><mixed-citation publication-type="journal" id="cit854"><name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Sherratt</surname><given-names>H. S.</given-names></name><article-title>The Synthesis of
Hippurate From Benzoate
and Glycine by Rat Liver Mitochondria. Submitochondrial Localization
and Kinetics</article-title>. <source>Biochem J.</source><year>1977</year>, <volume>166</volume>, <fpage>39</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1042/bj1660039</pub-id>.<pub-id pub-id-type="pmid">901416</pub-id><pub-id pub-id-type="pmcid">PMC1164954</pub-id></mixed-citation></ref><ref id="ref855"><mixed-citation publication-type="journal" id="cit855"><name name-style="western"><surname>Gatley</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Crawford</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Halama</surname><given-names>J. R.</given-names></name><article-title>Synthesis
of <sup>11</sup>C-Hippuric Acid from <sup>11</sup>C-Benzoic Acid and
Glycine
Using Rat-Liver Mitochondria</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>182</fpage>&#8211;<lpage>184</lpage>.</mixed-citation></ref><ref id="ref856"><mixed-citation publication-type="journal" id="cit856"><name name-style="western"><surname>McPherson</surname><given-names>D. W.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Arnett</surname><given-names>C. D.</given-names></name>; <name name-style="western"><surname>Brodie</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N.</given-names></name><article-title>Synthesis
and Biodistribution of
No-Carrier-Added [1-<sup>11</sup>C]Putrescine</article-title>. <source>J. Nucl. Med.</source><year>1985</year>, <volume>26</volume>, <fpage>1186</fpage>&#8211;<lpage>1189</lpage>.<pub-id pub-id-type="pmid">3876415</pub-id></mixed-citation></ref><ref id="ref857"><mixed-citation publication-type="journal" id="cit857"><name name-style="western"><surname>Jerabek</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Kadmon</surname><given-names>D.</given-names></name><article-title>Synthesis
and Uptake of No-Carrier-Added 1-[<sup>11</sup>C]Putrescine Into Rat
Prostate</article-title>. <source>Int. J. Nucl.
Med. Biol.</source><year>1985</year>, <volume>12</volume>, <fpage>349</fpage>&#8211;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/S0047-0740(85)80002-4</pub-id>.<pub-id pub-id-type="pmid">3833820</pub-id></mixed-citation></ref><ref id="ref858"><mixed-citation publication-type="journal" id="cit858"><name name-style="western"><surname>Hiesiger</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Brodie</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>McPherson</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Christman</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Flamm</surname><given-names>E.</given-names></name><article-title>Serial PET Studies
of Human Cerebral Malignancy with [1-<sup>11</sup>C]Putrescine and
[1-<sup>11</sup>C]2-Deoxy-<sc>d</sc>-Glucose</article-title>. <source>J. Nucl. Med.</source><year>1987</year>, <volume>28</volume>, <fpage>1251</fpage>.<pub-id pub-id-type="pmid">3039083</pub-id></mixed-citation></ref><ref id="ref859"><mixed-citation publication-type="journal" id="cit859"><name name-style="western"><surname>Hiesiger</surname><given-names>E. M.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Logan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Brodie</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name>; <name name-style="western"><surname>Christman</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>Is [1-<sup>11</sup>C]Putrescine Useful as a Brain Tumor
Marker?</article-title>. <source>J. Nucl. Med.</source><year>1992</year>, <volume>33</volume>, <fpage>192</fpage>&#8211;<lpage>200</lpage>.<pub-id pub-id-type="pmid">1732439</pub-id></mixed-citation></ref><ref id="ref860"><mixed-citation publication-type="journal" id="cit860"><name name-style="western"><surname>Wang</surname><given-names>G.-J.</given-names></name>; <name name-style="western"><surname>Volkow</surname><given-names>N. D.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Madajewicz</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Fowler</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Schlyer</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>MacGregor</surname><given-names>R. R.</given-names></name><article-title>Positron
Emission Tomography Study of Human Prostatic Adenocarcinoma Using
Carbon-11 Putrescine</article-title>. <source>Nucl. Med. Biol.</source><year>1994</year>, <volume>21</volume>, <fpage>77</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8051(94)90132-5</pub-id>.<pub-id pub-id-type="pmid">9234267</pub-id></mixed-citation></ref><ref id="ref861"><mixed-citation publication-type="journal" id="cit861"><name name-style="western"><surname>Tolvanen</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yli-Kerttula</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ujula</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Autio</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lehikoinen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Minn</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Roivainen</surname><given-names>A.</given-names></name><article-title>Biodistribution
and Radiation Dosimetry of [<sup>11</sup>C]Choline: A Comparison Between
Rat and Human Data</article-title>. <source>Eur. J. Nucl. Med. Mol.
Imaging</source><year>2010</year>, <volume>37</volume>, <fpage>874</fpage>&#8211;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-009-1346-z</pub-id>.<pub-id pub-id-type="pmid">20069295</pub-id></mixed-citation></ref><ref id="ref862"><mixed-citation publication-type="journal" id="cit862"><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kosaka</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Shinoura</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kondo</surname><given-names>T.</given-names></name><article-title>PET Imaging
of Brain Tumor with [<italic toggle="yes">Methyl</italic>-<sup>11</sup>C] Choline</article-title>. <source>J. Nucl. Med.</source><year>1997</year>, <volume>38</volume>, <fpage>842</fpage>&#8211;<lpage>847</lpage>.<pub-id pub-id-type="pmid">9189127</pub-id></mixed-citation></ref><ref id="ref863"><mixed-citation publication-type="journal" id="cit863"><name name-style="western"><surname>Probst</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wiehr</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Mantlik</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Schmidt</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kolb</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>M&#252;nch</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Delcuratolo</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Stubenrauch</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Pichler</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Iftner</surname><given-names>T.</given-names></name><article-title>Evaluation of Positron
Emission Tomographic Tracers for Imaging of Papillomavirus-Induced
Tumors in Rabbits</article-title>. <source>Molecular imaging</source><year>2014</year>, <volume>13</volume>, <fpage>7290.2013. 00070</fpage><pub-id pub-id-type="doi">10.2310/7290.2013.00070</pub-id>.<pub-id pub-id-type="pmid">24622808</pub-id></mixed-citation></ref><ref id="ref864"><mixed-citation publication-type="journal" id="cit864"><name name-style="western"><surname>Friedland</surname><given-names>R. P.</given-names></name>; <name name-style="western"><surname>Mathis</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Budinger</surname><given-names>T. F.</given-names></name>; <name name-style="western"><surname>Moyer</surname><given-names>B. R.</given-names></name>; <name name-style="western"><surname>Rosen</surname><given-names>M.</given-names></name><article-title>Labeled Choline and Phosphorylcholine:
Body Distribution and Brain
Autoradiography: Concise Communication</article-title>. <source>J. Nucl.
Med.</source><year>1983</year>, <volume>24</volume>, <fpage>812</fpage>&#8211;<lpage>815</lpage>.<pub-id pub-id-type="pmid">6604143</pub-id></mixed-citation></ref><ref id="ref865"><mixed-citation publication-type="journal" id="cit865"><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name><article-title><sup>11</sup>C-Choline and 2-Deoxy-2-[<sup>18</sup>F]Fluoro-<italic toggle="yes">D</italic>-Glucose in Tumor Imaging with
Positron Emission Tomography</article-title>. <source>Mol. Imaging Biol.</source><year>2002</year>, <volume>4</volume>, <fpage>267</fpage>&#8211;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/S1536-1632(02)00015-X</pub-id>.<pub-id pub-id-type="pmid">14537115</pub-id></mixed-citation></ref><ref id="ref866"><mixed-citation publication-type="journal" id="cit866"><name name-style="western"><surname>Han</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Bidulescu</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Barber</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Zeisel</surname><given-names>S. H.</given-names></name>; <name name-style="western"><surname>Joshu</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Prizment</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Vitolins</surname><given-names>M. Z.</given-names></name>; <name name-style="western"><surname>Platz</surname><given-names>E. A.</given-names></name><article-title>Dietary Choline
and Betaine Intakes and Risk of Total and Lethal Prostate Cancer in
the Atherosclerosis Risk in Communities (ARIC) Study</article-title>. <source>Cancer Causes Control</source><year>2019</year>, <volume>30</volume>, <fpage>343</fpage>&#8211;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1007/s10552-019-01148-4</pub-id>.<pub-id pub-id-type="pmid">30825046</pub-id><pub-id pub-id-type="pmcid">PMC6553878</pub-id></mixed-citation></ref><ref id="ref867"><mixed-citation publication-type="journal" id="cit867"><name name-style="western"><surname>L&#243;pez</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Lazo</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Guti&#233;rrez</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Arregui</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>N&#250;&#241;ez</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Sacchetti</surname><given-names>A.</given-names></name><article-title>Influence
of C-Choline PET/CT on Radiotherapy Planning in Prostate Cancer</article-title>. <source>Rep. Pract. Oncol. Radiother.</source><year>2015</year>, <volume>20</volume>, <fpage>104</fpage>&#8211;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.rpor.2014.11.008</pub-id>.<pub-id pub-id-type="pmid">25859399</pub-id><pub-id pub-id-type="pmcid">PMC4338287</pub-id></mixed-citation></ref><ref id="ref868"><mixed-citation publication-type="journal" id="cit868"><name name-style="western"><surname>Kawanaka</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kitajima</surname><given-names>K. D.</given-names></name>; <name name-style="western"><surname>Yamamoto</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nakanishi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamada</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Hashimoto</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Go</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kanematsu</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nojima</surname><given-names>M.</given-names></name>; et al. <article-title>Comparison of <sup>11</sup>C-choline Positron Emission
Tomography/Computed Tomography (PET/CT)
and Conventional Imaging for Detection of Recurrent Prostate Cancer</article-title>. <source>Cureus</source><year>2018</year>, <volume>10</volume>, <elocation-id>e2966</elocation-id><pub-id pub-id-type="doi">10.7759/cureus.2966</pub-id>.<pub-id pub-id-type="pmid">30210954</pub-id><pub-id pub-id-type="pmcid">PMC6135306</pub-id></mixed-citation></ref><ref id="ref869"><mixed-citation publication-type="journal" id="cit869"><name name-style="western"><surname>Noltes</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kruijff</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Jansen</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Westerlaan</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zandee</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Dierckx</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Brouwers</surname><given-names>A.</given-names></name><article-title>A Retrospective Analysis
of the Diagnostic Performance of <sup>11</sup>C-Choline PET/CT for
Detection of Hyperfunctioning Parathyroid Glands After Prior Negative
or Discordant Imaging in Primary Hyperparathyroidism</article-title>. <source>EJNMMI Res.</source><year>2021</year>, <volume>11</volume>, <fpage>32</fpage><pub-id pub-id-type="doi">10.1186/s13550-021-00778-7</pub-id>.<pub-id pub-id-type="pmid">33770255</pub-id><pub-id pub-id-type="pmcid">PMC7997941</pub-id></mixed-citation></ref><ref id="ref870"><mixed-citation publication-type="journal" id="cit870"><name name-style="western"><surname>Parvinian</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Martin-Macintosh</surname><given-names>E. L.</given-names></name>; <name name-style="western"><surname>Goenka</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Durski</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Mullan</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Kemp</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Johnson</surname><given-names>G. B.</given-names></name><article-title><sup>11</sup>C-Choline
PET/CT for Detection and Localization of Parathyroid Adenomas</article-title>. <source>Am. J. Roentgenol.</source><year>2018</year>, <volume>210</volume>, <fpage>418</fpage><pub-id pub-id-type="doi">10.2214/AJR.17.18312</pub-id>.<pub-id pub-id-type="pmid">29140118</pub-id></mixed-citation></ref><ref id="ref871"><mixed-citation publication-type="journal" id="cit871"><name name-style="western"><surname>Zheng</surname><given-names>Q.-H.</given-names></name>; <name name-style="western"><surname>Gardner</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Raikwar</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kao</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Stone</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Martinez</surname><given-names>T. D.</given-names></name>; <name name-style="western"><surname>Mock</surname><given-names>B. H.</given-names></name>; <name name-style="western"><surname>Fei</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>J.-Q.</given-names></name>; <name name-style="western"><surname>Hutchins</surname><given-names>G. D.</given-names></name><article-title>[<sup>11</sup>C]Choline as a PET
Biomarker for Assessment of Prostate Cancer Tumor Models</article-title>. <source>Bioorg. Med. Chem.</source><year>2004</year>, <volume>12</volume>, <fpage>2887</fpage>&#8211;<lpage>2893</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2004.03.051</pub-id>.<pub-id pub-id-type="pmid">15142549</pub-id></mixed-citation></ref><ref id="ref872"><mixed-citation publication-type="journal" id="cit872"><name name-style="western"><surname>Hendrikse</surname><given-names>N. H.</given-names></name>; <name name-style="western"><surname>de Vries</surname><given-names>E. G.</given-names></name>; <name name-style="western"><surname>Eriks-Fluks</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>van der Graaf</surname><given-names>W. T.</given-names></name>; <name name-style="western"><surname>Hospers</surname><given-names>G. A.</given-names></name>; <name name-style="western"><surname>Willemsen</surname><given-names>A. T.</given-names></name>; <name name-style="western"><surname>Vaalburg</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Franssen</surname><given-names>E. J.</given-names></name><article-title>A New <italic toggle="yes">In Vivo</italic> Method
To Study <italic toggle="yes">P</italic>-Glycoprotein Transport in Tumors and the
Blood-Brain Barrier</article-title>. <source>Cancer Res.</source><year>1999</year>, <volume>59</volume>, <fpage>2411</fpage>&#8211;<lpage>2416</lpage>.<pub-id pub-id-type="pmid">10344751</pub-id></mixed-citation></ref><ref id="ref873"><mixed-citation publication-type="journal" id="cit873"><name name-style="western"><surname>Wollmer</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Pride</surname><given-names>N. B.</given-names></name>; <name name-style="western"><surname>Rhodes</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Sanders</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name>; <name name-style="western"><surname>Palmer</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Silvester</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Liss</surname><given-names>R. H.</given-names></name><article-title>Measurement of Pulmonary Erythromycin Concentration
in Patients With Lobar Pneumonia by Means of Positron Tomography</article-title>. <source>Lancet</source><year>1982</year>, <volume>320</volume>, <fpage>1361</fpage>&#8211;<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(82)91269-7</pub-id>.<pub-id pub-id-type="pmid">6129462</pub-id></mixed-citation></ref><ref id="ref874"><mixed-citation publication-type="journal" id="cit874"><name name-style="western"><surname>Kikuchi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Okamura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Okada</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ogawa</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wakizaka</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yui</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fukumura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M. R.</given-names></name><article-title>Benzyl [<sup>11</sup>C]Hippurate
as an Agent for Measuring the Activities of Organic Anion Transporter
3 in the Brain and Multidrug Resistance-Associated Protein 4 in the
Heart of Mice</article-title>. <source>J. Med. Chem.</source><year>2016</year>, <volume>59</volume>, <fpage>5847</fpage>&#8211;<lpage>5856</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00454</pub-id>.<pub-id pub-id-type="pmid">27232368</pub-id></mixed-citation></ref><ref id="ref875"><mixed-citation publication-type="journal" id="cit875"><name name-style="western"><surname>Winstead</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Chern</surname><given-names>C.-i.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>T.-H.</given-names></name>; <name name-style="western"><surname>Khentigan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lamb</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Winchell</surname><given-names>H. S.</given-names></name><article-title>Synthesis and Preliminary
Scintigraphic
Evaluation of <italic toggle="yes">In Vivo</italic> Distribution of <sup>11</sup>C-Hydroxyurea/Isohydroxyurea and <sup>11</sup>C-Cyanate</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1978</year>, <volume>29</volume>, <fpage>443</fpage>&#8211;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(78)90081-9</pub-id>.<pub-id pub-id-type="pmid">213393</pub-id></mixed-citation></ref><ref id="ref876"><mixed-citation publication-type="journal" id="cit876"><name name-style="western"><surname>Cohen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Spolter</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Macdonald</surname><given-names>N.</given-names></name><article-title>Enzymatic
Synthesis of [1-<sup>11</sup>C]Pyruvic Acid, <sc>l</sc>-[1-<sup>11</sup>C]Lactic Acid and <sc>l</sc>-[1-<sup>11</sup>C]Alanine via <sc>dl</sc>-[1-<sup>11</sup>C]Alanine</article-title>. <source>J. Label. Comp.
Radiopharm.</source><year>1979</year>, <volume>16</volume>, <fpage>63</fpage>&#8211;<lpage>65</lpage>.</mixed-citation></ref><ref id="ref877"><mixed-citation publication-type="journal" id="cit877"><name name-style="western"><surname>Cramer</surname><given-names>R.
D.</given-names></name>; <name name-style="western"><surname>Kistiakowsky</surname><given-names>G. B.</given-names></name><article-title>The Synthesis
of Radioactive Lactic
Acid</article-title>. <source>J. Biol. Chem.</source><year>1941</year>, <volume>137</volume>, <fpage>549</fpage>&#8211;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(19)56160-9</pub-id>.</mixed-citation></ref><ref id="ref878"><mixed-citation publication-type="journal" id="cit878"><name name-style="western"><surname>Drandarov</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Schubiger</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Westera</surname><given-names>G.</given-names></name><article-title>Automated No-Carrier-Added
Synthesis of [1-<sup>11</sup>C]-Labeled <italic toggle="yes">D</italic>- and <italic toggle="yes">L</italic>-Enantiomers of Lactic Acid</article-title>. <source>Appl.
Radiat. Isot.</source><year>2006</year>, <volume>64</volume>, <fpage>1613</fpage>&#8211;<lpage>1622</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2006.05.013</pub-id>.<pub-id pub-id-type="pmid">16854588</pub-id></mixed-citation></ref><ref id="ref879"><mixed-citation publication-type="journal" id="cit879"><name name-style="western"><surname>Temma</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kawashima</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Kondo</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Yamazaki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Koshino</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Iida</surname><given-names>H.</given-names></name><article-title>One-Pot Enzymatic Synthesis of L-[4-<sup>11</sup>C]Lactate for Pharmacokinetic
Analysis of Lactate Metabolism
in Rat Brain</article-title>. <source>Nucl. Med. Biol.</source><year>2018</year>, <volume>64-65</volume>, <fpage>28</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2018.07.001</pub-id>.<pub-id pub-id-type="pmid">30015093</pub-id></mixed-citation></ref><ref id="ref880"><mixed-citation publication-type="journal" id="cit880"><name name-style="western"><surname>Herrero</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Coggan</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Kisrieva-Ware</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Eisenbeis</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gropler</surname><given-names>R. J.</given-names></name><article-title><italic toggle="yes">L-3</italic>-<sup>11</sup>C-Lactate as a PET Tracer of Myocardial Lactate Metabolism:
A Feasibility
Study</article-title>. <source>J. Nucl. Med.</source><year>2007</year>, <volume>48</volume>, <fpage>2046</fpage><pub-id pub-id-type="doi">10.2967/jnumed.107.044503</pub-id>.<pub-id pub-id-type="pmid">18056334</pub-id></mixed-citation></ref><ref id="ref881"><mixed-citation publication-type="journal" id="cit881"><name name-style="western"><surname>Kloster</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Laufer</surname><given-names>P.</given-names></name><article-title>Enzymatic Synthesis and Chromatographic
Purification of <italic toggle="yes">L-3</italic>-[<sup>11</sup>C]-Lactic Acid <italic toggle="yes">via D</italic>, <italic toggle="yes">L-3</italic>-[<sup>11</sup>C]-Alanine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1980</year>, <volume>17</volume>, <fpage>889</fpage>&#8211;<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580170614</pub-id>.</mixed-citation></ref><ref id="ref882"><mixed-citation publication-type="journal" id="cit882"><name name-style="western"><surname>Keppler</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Guhlmann</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Krauss</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>M&#220;Ller</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ostertag</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Huber</surname><given-names>M.</given-names></name><article-title>Generation
and Metabolism of Cysteinyl Leukotrienes <italic toggle="yes">In Vivo</italic></article-title>. <source>Ann. N. Y. Acad. Sci.</source><year>1991</year>, <volume>629</volume>, <fpage>100</fpage>&#8211;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1991.tb37965.x</pub-id>.<pub-id pub-id-type="pmid">1952541</pub-id></mixed-citation></ref><ref id="ref883"><mixed-citation publication-type="journal" id="cit883"><name name-style="western"><surname>Guhlmann</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Krauss</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Siegel</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Scheuber</surname><given-names>P. H.</given-names></name>; <name name-style="western"><surname>M&#252;ller</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Csuk-Gl&#228;nzer</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ziegler</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ostertag</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Keppler</surname><given-names>D.</given-names></name><article-title>Noninvasive
Assessment of Hepatobiliary and Renal Elimination of Cysteinyl Leukotrienes
by Positron Emission Tomography</article-title>. <source>Hepatology</source><year>1995</year>, <volume>21</volume>, <fpage>1568</fpage>&#8211;<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1002/hep.1840210615</pub-id>.<pub-id pub-id-type="pmid">7768501</pub-id></mixed-citation></ref><ref id="ref884"><mixed-citation publication-type="journal" id="cit884"><name name-style="western"><surname>Oberdorfer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Siegel</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Guhlmann</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Keppler</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Maier-Borst</surname><given-names>W.</given-names></name><article-title>The Preparation of a <sup>11</sup>C-Labelled <italic toggle="yes">5</italic>-Lipoxygenase Product. <italic toggle="yes">5</italic>(<italic toggle="yes">S</italic>)-Hydroxy-<italic toggle="yes">6</italic>(<italic toggle="yes">R</italic>)-(<italic toggle="yes">N</italic>-[1-<sup>11</sup>C]Acetyl)Cysteinyl-<italic toggle="yes">7</italic>, <italic toggle="yes">9-Trans-11</italic>, <italic toggle="yes">14</italic>-Ciseicosatetraenoic
acid</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1992</year>, <volume>31</volume>, <fpage>903</fpage>&#8211;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580311109</pub-id>.</mixed-citation></ref><ref id="ref885"><mixed-citation publication-type="journal" id="cit885"><name name-style="western"><surname>Schacht</surname><given-names>A. C.</given-names></name>; <name name-style="western"><surname>S&#248;rensen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Munk</surname><given-names>O. L.</given-names></name>; <name name-style="western"><surname>Frisch</surname><given-names>K.</given-names></name><article-title>Radiosynthesis
of <italic toggle="yes">N</italic>-<sup>11</sup>C-Methyl-Taurine-Conjugated Bile
Acids and Biodistribution Studies in Pigs by PET/CT</article-title>. <source>J. Nucl. Med.</source><year>2016</year>, <volume>57</volume>, <fpage>628</fpage><pub-id pub-id-type="doi">10.2967/jnumed.115.161711</pub-id>.<pub-id pub-id-type="pmid">26697965</pub-id></mixed-citation></ref><ref id="ref886"><mixed-citation publication-type="journal" id="cit886"><name name-style="western"><surname>Thorell</surname><given-names>J.-O.</given-names></name>; <name name-style="western"><surname>Stone-Elander</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Elander</surname><given-names>N.</given-names></name><article-title>Preparation of [<sup>11</sup>C]diethyl
Oxalate and [<sup>11</sup>C]oxalic Acid and Demonstration
of Their Use in the Synthesis of [<sup>11</sup>C]-2, 4-Dihydroxyquinoxaline</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1993</year>, <volume>33</volume>, <fpage>995</fpage>&#8211;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580331102</pub-id>.</mixed-citation></ref><ref id="ref887"><mixed-citation publication-type="journal" id="cit887"><name name-style="western"><surname>Ravert</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Klecker Jr</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Collins</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Mathews</surname><given-names>W. B.</given-names></name>; <name name-style="western"><surname>Pomper</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Dannals</surname><given-names>R. F.</given-names></name><article-title>Radiosynthesis of
[<sup>11</sup>C]Paclitaxel</article-title>. <source>J. Label. Compd.
Radiopharm.</source><year>2002</year>, <volume>45</volume>, <fpage>471</fpage>&#8211;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.571</pub-id>.</mixed-citation></ref><ref id="ref888"><mixed-citation publication-type="journal" id="cit888"><name name-style="western"><surname>Maeda</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nishimura</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Fukumura</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kojima</surname><given-names>M.</given-names></name><article-title>Enantioselective
Synthesis of <sup>11</sup>C-Labeled Phenylethanolamine</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1988</year>, <volume>25</volume>, <fpage>233</fpage>&#8211;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580250302</pub-id>.</mixed-citation></ref><ref id="ref889"><mixed-citation publication-type="journal" id="cit889"><name name-style="western"><surname>Korsakov</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Vasil&#8217;ev</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Shatik</surname><given-names>S.</given-names></name><article-title>Distribution of [1-<sup>11</sup>C]Pyruvate in Rats
With Hemic Hypoxia</article-title>. <source>Meditsina Truda i Promyshlennaya
Ekologiya</source><year>1998</year>, <fpage>5</fpage>&#8211;<lpage>9</lpage>.</mixed-citation></ref><ref id="ref890"><mixed-citation publication-type="journal" id="cit890"><name name-style="western"><surname>Korsakov</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Vasil&#8217;ev</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kuznetsova</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Bulatov</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Shatik</surname><given-names>S.</given-names></name><article-title>Automated Synthesis
of [1-<sup>11</sup>C]Pyruvic Acid and Comparative Study of Its Distribution
in Tissues
of Healthy Rats and Rats with Induced Total Hypoxia</article-title>. <source>Radiochemistry</source><year>1998</year>, <volume>40</volume>, <fpage>93</fpage>&#8211;<lpage>99</lpage>.</mixed-citation></ref><ref id="ref891"><mixed-citation publication-type="journal" id="cit891"><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Izuchi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Tsukiyama</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>F.</given-names></name><article-title>Synthesis of Pyruvate-1-<sup>11</sup>C as a Radiopharmaceutical for
Tumor Imaging</article-title>. <source>Eur. J. Nucl. Med.</source><year>1985</year>, <volume>11</volume>, <fpage>275</fpage>&#8211;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1007/BF00279083</pub-id>.<pub-id pub-id-type="pmid">4076234</pub-id></mixed-citation></ref><ref id="ref892"><mixed-citation publication-type="journal" id="cit892"><name name-style="western"><surname>Kelly</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jeitner</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Fung</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Waterhouse</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Williams</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Babich</surname><given-names>J.</given-names></name><article-title>In vivo Characterization
of Prostate
Cancer Metabolic Phenotype using [<sup>11</sup>C]Pyruvate and [<sup>11</sup>C]Alanine PET</article-title>. <source>J. Nucl. Med.</source><year>2021</year>, <volume>62</volume>, <fpage>1514</fpage>.</mixed-citation></ref><ref id="ref893"><mixed-citation publication-type="journal" id="cit893"><name name-style="western"><surname>Hartvig</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Waldenstr&#246;m</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wikstr&#246;m</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Zielinski</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Martinussen</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Carslsten</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Voipio-Pulkki</surname><given-names>L. M.</given-names></name>; <name name-style="western"><surname>Lundqvist</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name><article-title>The Diabetic
Heart: A Porcine Model Evaluated With Positron Emission Tomography
Using 1-<sup>11</sup>C-Palmitate and 3-<sup>11</sup>C-Pyruvate</article-title>. <source>Diabetes Res.</source><year>1989</year>, <volume>12</volume>, <fpage>1</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">2630151</pub-id></mixed-citation></ref><ref id="ref894"><mixed-citation publication-type="journal" id="cit894"><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yokoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name><article-title>Brain Ischemia and
Infarction Positively Visualized by Pyruvate-1-<sup>11</sup>C Using
Positron-Emission Tomography</article-title>. <source>Eur. J. Nucl.
Med.</source><year>1986</year>, <volume>12</volume>, <fpage>21</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/BF00638790</pub-id>.<pub-id pub-id-type="pmid">3488218</pub-id></mixed-citation></ref><ref id="ref895"><mixed-citation publication-type="journal" id="cit895"><name name-style="western"><surname>Tsukiyama</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Kido</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Tsubokawa</surname><given-names>T.</given-names></name><article-title>Preferential
Accumulation of <sup>11</sup>C in Human
Brain Tumors After Intravenous Injection of <sup>11</sup>C-1-Pyruvate</article-title>. <source>Eur. J. Nucl. Med.</source><year>1986</year>, <volume>12</volume>, <fpage>244</fpage>&#8211;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1007/BF00251978</pub-id>.<pub-id pub-id-type="pmid">3023098</pub-id></mixed-citation></ref><ref id="ref896"><mixed-citation publication-type="journal" id="cit896"><name name-style="western"><surname>Yokoi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nonaka</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Satoyoshi</surname><given-names>E.</given-names></name><article-title>1-[<sup>11</sup>C]Pyruvate Turnover in Brain and Muscle
of Patients With Mitochondrial Encephalomyopathy: A Study With Positron
Emission Tomography (PET)</article-title>. <source>J. Neurol. Sci.</source><year>1990</year>, <volume>99</volume>, <fpage>339</fpage>&#8211;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1016/0022-510X(90)90168-M</pub-id>.<pub-id pub-id-type="pmid">2086732</pub-id></mixed-citation></ref><ref id="ref897"><mixed-citation publication-type="journal" id="cit897"><name name-style="western"><surname>Tsukiyama</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Iio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tsubokawa</surname><given-names>T.</given-names></name><article-title>Positron Tracer, <sup>11</sup>C-1-Pyruvate: Pyruvate
Metabolism</article-title>. <source>Nihon Rinsho</source><year>1991</year>, <volume>49</volume>, <fpage>1521</fpage>&#8211;<lpage>1527</lpage>.<pub-id pub-id-type="pmid">1886246</pub-id></mixed-citation></ref><ref id="ref898"><mixed-citation publication-type="journal" id="cit898"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>The Synthesis
of [4-<sup>11</sup>C]Pyruvic Acid, a Useful Synthon, via an Enzymatic
Route</article-title>. <source>Int. J. Rad. Appl. Instrum. A. Appl.
Radiat. Isot.</source><year>1988</year>, <volume>39</volume>, <fpage>627</fpage>&#8211;<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(88)90050-0</pub-id>.</mixed-citation></ref><ref id="ref899"><mixed-citation publication-type="journal" id="cit899"><name name-style="western"><surname>Sasaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ogawa</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Senda</surname><given-names>M.</given-names></name><article-title>Synthesis
of [<sup>11</sup>C]Salicylic Acid and Related Compounds and Their
Biodistribution in Mice</article-title>. <source>Appl. Radiat. Isot.</source><year>1999</year>, <volume>50</volume>, <fpage>905</fpage>&#8211;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(98)00144-4</pub-id>.<pub-id pub-id-type="pmid">10214709</pub-id></mixed-citation></ref><ref id="ref900"><mixed-citation publication-type="journal" id="cit900"><name name-style="western"><surname>Hooker</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Munro</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>B&#233;guin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Alexoff</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Shea</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Cohen</surname><given-names>B. M.</given-names></name><article-title>Salvinorin
A and Derivatives: Protection From Metabolism Does Not Prolong Short-Term,
Whole-Brain Residence</article-title>. <source>Neuropharmacology</source><year>2009</year>, <volume>57</volume>, <fpage>386</fpage>&#8211;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.06.044</pub-id>.<pub-id pub-id-type="pmid">19591852</pub-id><pub-id pub-id-type="pmcid">PMC2745083</pub-id></mixed-citation></ref><ref id="ref901"><mixed-citation publication-type="journal" id="cit901"><name name-style="western"><surname>Hartman</surname><given-names>N. G.</given-names></name>; <name name-style="western"><surname>Jay</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hill</surname><given-names>D. B.</given-names></name>; <name name-style="western"><surname>Bera</surname><given-names>R. K.</given-names></name>; <name name-style="western"><surname>Nickl</surname><given-names>N. J.</given-names></name>; <name name-style="western"><surname>Yun Ryo</surname><given-names>U.</given-names></name><article-title>Noninvasive Detection
of Helicobacter
Pylori Colonization in Stomach Using [11C]Urea</article-title>. <source>Dig. Dis. Sci.</source><year>1992</year>, <volume>37</volume>, <fpage>618</fpage>&#8211;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1007/BF01307590</pub-id>.<pub-id pub-id-type="pmid">1551356</pub-id></mixed-citation></ref><ref id="ref902"><mixed-citation publication-type="journal" id="cit902"><name name-style="western"><surname>Bera</surname><given-names>R. K.</given-names></name>; <name name-style="western"><surname>Hartman</surname><given-names>N. G.</given-names></name>; <name name-style="western"><surname>Jay</surname><given-names>M.</given-names></name><article-title>Continuous Production
of [<sup>11</sup>C]Urea for Medical Application</article-title>. <source>Int. J. Radial. Appl. Instrum. A. Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>407</fpage>&#8211;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90147-S</pub-id>.</mixed-citation></ref><ref id="ref903"><mixed-citation publication-type="journal" id="cit903"><name name-style="western"><surname>Emran</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Boothe</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Vora</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name><article-title>Preparation of <sup>11</sup>C-Urea
from No-carrier-Added <sup>11</sup>C-Cyanide</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1983</year>, <volume>34</volume>, <fpage>1013</fpage>&#8211;<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(83)90082-0</pub-id>.</mixed-citation></ref><ref id="ref904"><mixed-citation publication-type="journal" id="cit904"><name name-style="western"><surname>Yashio</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Katayama</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Takashima</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ishiguro</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Doi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wada</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Tamai</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name><article-title>Synthesis of [<sup>11</sup>C]Uric
Acid, Using [<sup>11</sup>C]Phosgene, as a Possible Biomarker in PET
Imaging for Diagnosis of Gout</article-title>. <source>Bioorg. Med.
Chem. Lett.</source><year>2012</year>, <volume>22</volume>, <fpage>115</fpage>&#8211;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2011.11.055</pub-id>.<pub-id pub-id-type="pmid">22153940</pub-id></mixed-citation></ref><ref id="ref905"><mixed-citation publication-type="journal" id="cit905"><name name-style="western"><surname>Bongarzone</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Raucci</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Fontana</surname><given-names>I. C.</given-names></name>; <name name-style="western"><surname>Luzi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>Carbon-11
Carboxylation of Trialkoxysilane and Trimethylsilane
Derivatives Using [<sup>11</sup>C]CO<sub>2</sub></article-title>. <source>Chem. Commun.</source><year>2020</year>, <volume>56</volume>, <fpage>4668</fpage>&#8211;<lpage>4671</lpage>. <pub-id pub-id-type="doi">10.1039/D0CC00449A</pub-id>.<pub-id pub-id-type="pmcid">PMC7384297</pub-id><pub-id pub-id-type="pmid">32211652</pub-id></mixed-citation></ref><ref id="ref906"><mixed-citation publication-type="journal" id="cit906"><name name-style="western"><surname>Duffy</surname><given-names>I. R.</given-names></name>; <name name-style="western"><surname>Vasdev</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Dahl</surname><given-names>K.</given-names></name><article-title>Copper(I)-Mediated <sup>11</sup>C-Carboxylation
of (Hetero)arylstannanes</article-title>. <source>ACS Omega</source><year>2020</year>, <volume>5</volume>, <fpage>8242</fpage>&#8211;<lpage>8250</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.0c00524</pub-id>.<pub-id pub-id-type="pmid">32309734</pub-id><pub-id pub-id-type="pmcid">PMC7161067</pub-id></mixed-citation></ref><ref id="ref907"><mixed-citation publication-type="journal" id="cit907"><name name-style="western"><surname>Dahl</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Schou</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Amini</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Halldin</surname><given-names>C.</given-names></name><article-title>Palladium-Mediated
[<sup>11</sup>C]Carbonylation at Atmospheric Pressure: A General Method
Using Xantphos as Supporting Ligand</article-title>. <source>Eur. J.
Org. Chem.</source><year>2013</year>, <volume>2013</volume>, <fpage>1228</fpage>&#8211;<lpage>1231</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201201708</pub-id>.</mixed-citation></ref><ref id="ref908"><mixed-citation publication-type="journal" id="cit908"><name name-style="western"><surname>Riss</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Telu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Aigbirhio</surname><given-names>F. I.</given-names></name>; <name name-style="western"><surname>Pike</surname><given-names>V. W.</given-names></name><article-title>CuI-Catalyzed <sup>11</sup>C Carboxylation of Boronic
Acid Esters: A Rapid and Convenient Entry to <sup>11</sup>C-Labeled
Carboxylic Acids, Esters, and Amides</article-title>. <source>Angew.
Chem. Int. Ed.</source><year>2012</year>, <volume>51</volume>, <fpage>2698</fpage>&#8211;<lpage>2702</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201107263</pub-id>.<pub-id pub-id-type="pmcid">PMC3299884</pub-id><pub-id pub-id-type="pmid">22308017</pub-id></mixed-citation></ref><ref id="ref909"><mixed-citation publication-type="journal" id="cit909"><name name-style="western"><surname>Somawardhana</surname><given-names>C. W.</given-names></name>; <name name-style="western"><surname>Sajjad</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lambrecht</surname><given-names>R. M.</given-names></name><article-title>Solid State
Support for the Synthesis of [1-<sup>11</sup>C]-Putrescine</article-title>. <source>Int. J. Appl. Radiat. Isot. A. Appl. Radiat. Isot.</source><year>1991</year>, <volume>42</volume>, <fpage>555</fpage>&#8211;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90161-S</pub-id>.</mixed-citation></ref><ref id="ref910"><mixed-citation publication-type="journal" id="cit910"><name name-style="western"><surname>Rosen</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Yano</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Budinger</surname><given-names>T. F.</given-names></name><article-title>Carbon-11
Choline: Synthesis, Purification, and Brain Uptake Inhibition by 2-Dimethylaminoethanol</article-title>. <source>J. Nucl. Med.</source><year>1985</year>, <volume>26</volume>, <fpage>1424</fpage>&#8211;<lpage>1428</lpage>.<pub-id pub-id-type="pmid">3877796</pub-id></mixed-citation></ref><ref id="ref911"><mixed-citation publication-type="journal" id="cit911"><name name-style="western"><surname>Hara</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yuasa</surname><given-names>M.</given-names></name><article-title>Automated Synthesis of [<sup>11</sup>C]Choline, a Positron-Emitting
Tracer for Tumor Imaging</article-title>. <source>Appl. Radiat. Isot.</source><year>1999</year>, <volume>50</volume>, <fpage>531</fpage>&#8211;<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(98)00097-9</pub-id>.<pub-id pub-id-type="pmid">10070713</pub-id></mixed-citation></ref><ref id="ref912"><mixed-citation publication-type="journal" id="cit912"><name name-style="western"><surname>Cheung</surname><given-names>M.-k.</given-names></name>; <name name-style="western"><surname>Ho</surname><given-names>C.-l.</given-names></name><article-title>A Simple, Versatile,
Low-Cost and
Remotely Operated Apparatus for [<sup>11</sup>C]Acetate, [<sup>11</sup>C]Choline, [<sup>11</sup>C]Methionine and [<sup>11</sup>C]PIB Synthesis</article-title>. <source>Appl. Radiat. Isot.</source><year>2009</year>, <volume>67</volume>, <fpage>581</fpage>&#8211;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2008.08.018</pub-id>.<pub-id pub-id-type="pmid">19168366</pub-id></mixed-citation></ref><ref id="ref913"><mixed-citation publication-type="journal" id="cit913"><name name-style="western"><surname>Lentz</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Warnier</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Morelle</surname><given-names>J.-L.</given-names></name>; <name name-style="western"><surname>Philippart</surname><given-names>G.</given-names></name><article-title>A Single-Use
Cassette for the Automated High-Output Production of [<sup>11</sup>C]Choline</article-title>. <source>J. Nucl. Med.</source><year>2018</year>, <volume>59</volume>, <fpage>1041</fpage>.</mixed-citation></ref><ref id="ref914"><mixed-citation publication-type="journal" id="cit914"><name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Hockley</surname><given-names>B. G.</given-names></name>; <name name-style="western"><surname>Hoareau</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Schnau</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Scott</surname><given-names>P. J. H.</given-names></name><article-title>Fully
Automated Preparation of [<sup>11</sup>C]Choline
and [<sup>18</sup>F]fluoromethylcholine Using TracerLab Synthesis
Modules and Facilitated Quality Control Using Analytical HPLC</article-title>. <source>Appl. Radiat. Isot.</source><year>2011</year>, <volume>69</volume>, <fpage>403</fpage>&#8211;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2010.09.022</pub-id>.<pub-id pub-id-type="pmid">21115355</pub-id></mixed-citation></ref><ref id="ref915"><mixed-citation publication-type="journal" id="cit915"><name name-style="western"><surname>Reischl</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Bieg</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Schmiedl</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Solbach</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Machulla</surname><given-names>H. J.</given-names></name><article-title>Highly Efficient Automated Synthesis
of [<sup>11</sup>C]Choline for Multi Dose Utilization</article-title>. <source>Appl.
Radiat. Isot.</source><year>2004</year>, <volume>60</volume>, <fpage>835</fpage>&#8211;<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2004.01.006</pub-id>.<pub-id pub-id-type="pmid">15110347</pub-id></mixed-citation></ref><ref id="ref916"><mixed-citation publication-type="journal" id="cit916"><name name-style="western"><surname>Quincoces</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Pe&#241;uelas</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Valero</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Serra</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Collantes</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mart&#237;-Climent</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Arbizu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jos&#233;Garc&#237;a-Velloso</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>&#193;ngel Richter</surname><given-names>J.</given-names></name><article-title>Simple Automated
System for Simultaneous Production of <sup>11</sup>C-Labeled Tracers
by Solid Supported Methylation</article-title>. <source>Appl. Radiat.
Isot.</source><year>2006</year>, <volume>64</volume>, <fpage>808</fpage>&#8211;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2006.03.001</pub-id>.<pub-id pub-id-type="pmid">16624561</pub-id></mixed-citation></ref><ref id="ref917"><mixed-citation publication-type="book" id="cit917"><person-group person-group-type="allauthors"><name name-style="western"><surname>Hockley</surname><given-names>B. G.</given-names></name>; <name name-style="western"><surname>Henderson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name></person-group><article-title>Synthesis of [<sup>11</sup>C]Choline Chloride ([<sup>11</sup>C]CHL)</article-title>. In <source>Radiochemical Syntheses</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Scott</surname><given-names>J. H. P.</given-names></name>, <name name-style="western"><surname>Hockley</surname><given-names>G. B.</given-names></name></person-group>, Eds.; <year>2012</year>;
Vol. <volume>1</volume>; pp <fpage>169</fpage>&#8211;<lpage>177</lpage>.</mixed-citation></ref><ref id="ref918"><mixed-citation publication-type="journal" id="cit918"><name name-style="western"><surname>Szyd&#322;o</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Jadwi&#324;ski</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chmura</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Gorczewski</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sok&#243;&#322;</surname><given-names>M.</given-names></name><article-title>Synthesis,
Isolation and Purification of [<sup>11</sup>C]-Choline</article-title>. <source>Contemp. Oncol. (Pozn)</source><year>2016</year>, <volume>20</volume>, <fpage>229</fpage>&#8211;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.5114/wo.2016.61566</pub-id>.<pub-id pub-id-type="pmid">27660552</pub-id><pub-id pub-id-type="pmcid">PMC5013686</pub-id></mixed-citation></ref><ref id="ref919"><mixed-citation publication-type="journal" id="cit919"><name name-style="western"><surname>Szyd&#322;o</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chmura</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kowalski</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Poci&#553;giel</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>d&#8217;Amico</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sok&#243;&#322;</surname><given-names>M.</given-names></name><article-title>Optimisation of [<sup>11</sup>C]-Choline
Synthesis</article-title>. <source>Contemp. Oncol.</source><year>2018</year>, <volume>22</volume>, <fpage>260</fpage>&#8211;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.5114/wo.2018.81751</pub-id>.<pub-id pub-id-type="pmcid">PMC6377417</pub-id><pub-id pub-id-type="pmid">30783391</pub-id></mixed-citation></ref><ref id="ref920"><mixed-citation publication-type="journal" id="cit920"><name name-style="western"><surname>Laitinen</surname><given-names>I. E. K.</given-names></name>; <name name-style="western"><surname>Luoto</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Marjam&#228;ki</surname><given-names>P. M.</given-names></name>; <name name-style="western"><surname>Silvola</surname><given-names>J. M. U.</given-names></name>; <name name-style="western"><surname>Hellberg</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Laine</surname><given-names>V. J. O.</given-names></name>; <name name-style="western"><surname>Yl&#228;-Herttuala</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Knuuti</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Roivainen</surname><given-names>A.</given-names></name><article-title>Uptake of <sup>11</sup>C-Choline in Mouse Atherosclerotic Plaques</article-title>. <source>J. Nucl. Med.</source><year>2010</year>, <volume>51</volume>, <fpage>798</fpage><pub-id pub-id-type="doi">10.2967/jnumed.109.071704</pub-id>.<pub-id pub-id-type="pmid">20395326</pub-id></mixed-citation></ref><ref id="ref921"><mixed-citation publication-type="journal" id="cit921"><name name-style="western"><surname>Zheng</surname><given-names>Q.-H.</given-names></name>; <name name-style="western"><surname>Stone</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Mock</surname><given-names>B. H.</given-names></name>; <name name-style="western"><surname>Miller</surname><given-names>K. D.</given-names></name>; <name name-style="western"><surname>Fei</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>J.-Q.</given-names></name>; <name name-style="western"><surname>Glick-Wilson</surname><given-names>B. E.</given-names></name>; <name name-style="western"><surname>Sledge</surname><given-names>G. W.</given-names></name>; <name name-style="western"><surname>Hutchins</surname><given-names>G. D.</given-names></name><article-title>[<sup>11</sup>C]Choline as a Potential
PET Marker for Imaging of Breast Cancer Athymic Mice</article-title>. <source>Nucl. Med. Biol.</source><year>2002</year>, <volume>29</volume>, <fpage>803</fpage>&#8211;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8051(02)00339-6</pub-id>.<pub-id pub-id-type="pmid">12453589</pub-id></mixed-citation></ref><ref id="ref922"><mixed-citation publication-type="journal" id="cit922"><name name-style="western"><surname>Witney</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Alam</surname><given-names>I. S.</given-names></name>; <name name-style="western"><surname>Turton</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Carroll</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Brickute</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Twyman</surname><given-names>F. J.</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>Q.-D.</given-names></name>; <name name-style="western"><surname>Tomasi</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Awais</surname><given-names>R. O.</given-names></name>; et al. <article-title>Evaluation of Deuterated <sup>18</sup>F- and <sup>11</sup>C-Labeled Choline Analogs for Cancer
Detection by Positron Emission Tomography</article-title>. <source>Clin.
Cancer Res.</source><year>2012</year>, <volume>18</volume>, <fpage>1063</fpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-2462</pub-id>.<pub-id pub-id-type="pmid">22235095</pub-id><pub-id pub-id-type="pmcid">PMC6485417</pub-id></mixed-citation></ref><ref id="ref923"><mixed-citation publication-type="journal" id="cit923"><name name-style="western"><surname>Izquierdo-Garcia</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Fadon</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Beraza</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cossio</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Llop</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ruiz-Cabello</surname><given-names>J.</given-names></name><article-title><italic toggle="yes">In-Vivo</italic> Lung Molecular
Imaging of Choline Metabolism in a Rat Model of Pulmonary Arterial
Hypertension</article-title>. <source>Eur. Respir. J.</source><year>2019</year>, <volume>54</volume>, <fpage>PA1422</fpage>.</mixed-citation></ref><ref id="ref924"><mixed-citation publication-type="journal" id="cit924"><name name-style="western"><surname>Cohen</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Spolter</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>C. C.</given-names></name>; <name name-style="western"><surname>Cook</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Macdonald</surname><given-names>N. S.</given-names></name><article-title>Enzymatic Synthesis of <sup>11</sup>C-Pyruvic Acid
and <sup>11</sup>C-<italic toggle="yes">L</italic>-Lactic Acid</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1980</year>, <volume>31</volume>, <fpage>45</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(80)90229-X</pub-id>.</mixed-citation></ref><ref id="ref925"><mixed-citation publication-type="journal" id="cit925"><name name-style="western"><surname>Bjurling</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>L&#229;ngstr&#246;m</surname><given-names>B.</given-names></name><article-title>Synthesis of 1- and
4-<sup>11</sup>C-Labelled <italic toggle="yes">L</italic>-Lactic Acid Using Multi-Enzyme
Catalysis</article-title>. <source>J. Label. Compd. Radiopharm.</source><year>1990</year>, <volume>28</volume>, <fpage>427</fpage>&#8211;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1002/jlcr.2580280409</pub-id>.</mixed-citation></ref><ref id="ref926"><mixed-citation publication-type="journal" id="cit926"><name name-style="western"><surname>Keiding</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>S&#248;rensen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Frisch</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Gormsen</surname><given-names>L. C.</given-names></name>; <name name-style="western"><surname>Munk</surname><given-names>O. L.</given-names></name><article-title>Quantitative PET
of Liver Functions</article-title>. <source>Am. J. Nucl. Med. Mol. Imaging</source><year>2018</year>, <volume>8</volume>, <fpage>73</fpage>&#8211;<lpage>85</lpage>.<pub-id pub-id-type="pmid">29755841</pub-id><pub-id pub-id-type="pmcid">PMC5944823</pub-id></mixed-citation></ref><ref id="ref927"><mixed-citation publication-type="book" id="cit927"><person-group person-group-type="allauthors"><name name-style="western"><surname>De Lombaerde</surname><given-names>S.</given-names></name></person-group><source><sup>18</sup>F Labeled Bile Acid Analogues As Molecular
Imaging Tools To Monitor
Hepatobiliary Transport in Drug-Induced Cholestasis and Liver Disease</source>. <publisher-name>Ghent University</publisher-name>, <year>2018</year>.</mixed-citation></ref><ref id="ref928"><mixed-citation publication-type="journal" id="cit928"><name name-style="western"><surname>Nahinsky</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Rice</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ruben</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kamen</surname><given-names>M.</given-names></name><article-title>Tracer Studies
With Radioactive Carbon. The Synthesis and Oxidation of Several Three
Carbon Acids</article-title>. <source>J. Am. Chem. Soc.</source><year>1942</year>, <volume>64</volume>, <fpage>2299</fpage>&#8211;<lpage>2302</lpage>. <pub-id pub-id-type="doi">10.1021/ja01262a023</pub-id>.</mixed-citation></ref><ref id="ref929"><mixed-citation publication-type="journal" id="cit929"><name name-style="western"><surname>Christman</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Karlstrom</surname><given-names>K. I.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>A. P.</given-names></name><article-title>The Production of Ultra High Activity 11C-Labeled Hydrogen
Cyanide, Carbon Dioxide, Carbon Monoxide and Methane via the <sup>14</sup>N(p,&#945;)<sup>11</sup>C Reaction (XV)</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1975</year>, <volume>26</volume>, <fpage>435</fpage>&#8211;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(75)90057-5</pub-id>.</mixed-citation></ref><ref id="ref930"><mixed-citation publication-type="journal" id="cit930"><name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>No-Carrier-Added
Synthesis of [1-<sup>11</sup>C]Pyruvic Acid</article-title>. <source>Int. J. Appl. Rad.
Isot.</source><year>1982</year>, <volume>33</volume>, <fpage>359</fpage>&#8211;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90149-1</pub-id>.<pub-id pub-id-type="pmid">7095876</pub-id></mixed-citation></ref><ref id="ref931"><mixed-citation publication-type="journal" id="cit931"><name name-style="western"><surname>Kilbourn</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Dischino</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Dence</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Welch</surname><given-names>M. J.</given-names></name><article-title>SEP-PAK
Preparative Chromatography: Use in Radiopharmaceutical Synthesis</article-title>. <source>J. Liq. Chromatogr.</source><year>1982</year>, <volume>5</volume>, <fpage>2005</fpage>&#8211;<lpage>2016</lpage>. <pub-id pub-id-type="doi">10.1080/01483918208062869</pub-id>.</mixed-citation></ref><ref id="ref932"><mixed-citation publication-type="journal" id="cit932"><person-group person-group-type="allauthors"><name name-style="western"><surname>Takahashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>N&#229;gren</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Aho</surname><given-names>K.</given-names></name></person-group><article-title>An Alternative
Synthesis of <italic toggle="yes">DL</italic>-[1-<sup>11</sup>C]Alanine from [<sup>11</sup>C]HCN</article-title>. <source>Int. J. Appl. Radiat. Isot.
A. Appl. Radiat. Isot.</source><year>1990</year>, <volume>41</volume>.<fpage>1187</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1016/0883-2889(90)90205-U</pub-id></mixed-citation></ref><ref id="ref933"><mixed-citation publication-type="journal" id="cit933"><name name-style="western"><surname>Ikemoto</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sasaki</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Haradahira</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Okamoto</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Omura</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Furuya</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name><article-title>A New Synthesis of [4-<sup>11</sup>C]Pyruvic Acid Using
Alanine Racemase</article-title>. <source>Appl. Radiat. Isot.</source><year>1998</year>, <volume>49</volume>, <fpage>1557</fpage>&#8211;<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(98)00052-9</pub-id>.</mixed-citation></ref><ref id="ref934"><mixed-citation publication-type="journal" id="cit934"><name name-style="western"><surname>Boothe</surname><given-names>T. E.</given-names></name>; <name name-style="western"><surname>Emran</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Finn</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Vora</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Kothari</surname><given-names>P. J.</given-names></name><article-title>Use of <sup>11</sup>C as a Tracer
for Studying the
Synthesis of [<sup>11</sup>C]Urea from [<sup>11</sup>C]Cyanide</article-title>. <source>Int. J. Appl. Rad. Isot.</source><year>1985</year>, <volume>36</volume>, <fpage>141</fpage>&#8211;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(85)90229-7</pub-id>.<pub-id pub-id-type="pmid">3980120</pub-id></mixed-citation></ref><ref id="ref935"><mixed-citation publication-type="journal" id="cit935"><person-group person-group-type="allauthors"><name name-style="western"><surname>Blower</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Cousin</surname><given-names>S. F.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name></person-group><article-title>Convergent
synthesis of <sup>13</sup>N-labelled Peptidic structures using aqueous
[<sup>13</sup>N]NH<sub>3</sub></article-title>. <source>EJNMMI Radiopharm.
Chem.</source><year>2017</year>, <volume>2</volume>.<fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s41181-017-0035-7</pub-id><pub-id pub-id-type="pmid">29503857</pub-id><pub-id pub-id-type="pmcid">PMC5824707</pub-id></mixed-citation></ref><ref id="ref936"><mixed-citation publication-type="journal" id="cit936"><name name-style="western"><surname>Blower</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>M. T.</given-names></name>; <name name-style="western"><surname>Al-Salemee</surname><given-names>F. A. I.</given-names></name>; <name name-style="western"><surname>Gee</surname><given-names>A. D.</given-names></name><article-title>The Hantzsch reaction for nitrogen-13 PET: Preparation
of [<sup>13</sup>N]nifedipine and derivatives</article-title>. <source>Chem. Commun.</source><year>2021</year>, <volume>57</volume>, <fpage>4962</fpage>&#8211;<lpage>4965</lpage>. <pub-id pub-id-type="doi">10.1039/D1CC00495F</pub-id>.<pub-id pub-id-type="pmcid">PMC8132178</pub-id><pub-id pub-id-type="pmid">33876157</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>